000018|G01AF0501|Pevaryl|krem/sti|||15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|0|0|0|0|0|TAE|0|0|0|100|IKR|||lyflausa|||0|15|0|4,5000|Alvogen|Trimb Healthcare AB|Ekónazól|||||||2|0||0|||0 000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|0|0|0|0|0|NED|0|0|0|100|XEU|7226|11444|lyfalmen|V0457|8760|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||7226||7226|11444||2|0|E|0|||0 000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|0|0|0|0|0|NED|0|0|0|100|XEU|22187|31336|lyfalmen|V0475|9452|1|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||22187||22187|31336||2|0|E|0|||0 000193|N05AH0302|Zyprexa Velotab|munndr.t|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|0|0|0|0|0|NED|0|0|0|100|XEU|28658|39520|lyfalmen|V0540|20624|1|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||28658||28658|39520||2|0||0|||0 000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|0|0|FER|0|0|0|100|DKK|4532|7736|lyfalmen|||1|0,9|0|0,0400|Vistor hf|Ferring|Atosíban||4532||4532|7736||1|H|0|0|||0 000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|0|0|0|0|0|BOI|0|0|0|100|DKK|4330|8385|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|Meloxícam||4330||4330|8385||1|0||0|||0 000237|G02CX0101|Tractocile|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|0|0|FER|0|0|0|100|DKK|12048|18081|lyfalmen|||1|5|0|0,2300|Vistor hf|Ferring|Atosíban||12048||12048|18081||1|H|0|0|||0 000546|G03DA0406|Crinone|sk-hlaup|8|%|6|stk|1|sk-ílá||G03DA04|01.02.2018||R|0|0|1|G|0|MEC|0|0|0|100|SEK|2832|5396|lyfalmen|V0942|4914|1|6|0|6,0000|Icepharma hf|Merck AB|Prógesterón||2832||2832|5396||2|0|G|0|||0 000552|G04BE0105|Caverject Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|PLS|0|0|0|100|DKK|3898|6863|lyfalmen|||1|2|0|2,0000|Icepharma hf|Pfizer ApS|Alprostadíl||3898||3898|6863||1|0||0|||0 000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|1|0|0|G|0|JAS|0|0|0|100|SEK|2894|5481|lyfalmen|||1|60|0|3,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||2894||2894|5481||1|0|G|0|||0 000613|G03DA0406|Crinone|sk-hlaup|8|%|15|stk|1|sk-ílá||G03DA04|01.02.2018||R|0|0|1|G|0|MEC|0|0|0|100|SEK|7837|12285|lyfalmen|V0942|12285|1|15|0|15,0000|Icepharma hf|Merck AB|Prógesterón||7837||7837|12285||2|0|G|0|||0 000784|G04BE0105|Caverject Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|PLS|0|0|0|100|DKK|3189|5887|lyfalmen|||1|2|0|1,0000|Icepharma hf|Pfizer ApS|Alprostadíl||3189||3189|5887||1|0||0|||0 000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|1,7500|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1|0||0|||0 000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|0,8750|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1|0||0|||0 000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|0|0|1|G|0|MRP|0|0|0|100|SEK|88716|115482|lyfalmen|||1|6|0|122,7907|Icepharma hf|Merck Europe B.V.|Interferón beta-1a||88716||88716|115482||2|0|G|0|||0 001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|þpakki||C10AA05|01.06.2002||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|15001|22145|lyfalmen|V0115|7967|1|100|0|400,0000|Icepharma hf|Upjohn EESV|Atorvastatín||15001||15001|22145||1|0|E|0|||0 001291|C07AB0206|Seloken ZOC|forðatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|1|0|0|G|0|RDT|0|0|0|100|DKK|1731|3880|lyfalmen|V0050|2510|1|100|0|15,8333|Vistor hf|Recordati Ireland Limited|Metóprólól||1731||1731|3880||1|0|G|0|||0 001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|0|0|0|G|0|NAS|0|0|0|100|DKK|5319|8819|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||5319||5319|8819||1|0|G|0|||0 001512|C04AD0301|Trental|forðatfl|400|mg|100|stk|1|þpakki||C04AD03|01.05.2002||R|1|0|0|G|0|SNP|0|0|0|100|XEU|2658|5156|lyfalmen|||1|100|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||2658||2658|5156||1|0|G|0|||0 001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|FKA|0|0|0|100|DKK|18181|26522|lyfalmen|||1|4104|0||Vistor hf|Fresenius Kabi AB|Blöndur||18181||18181|26522||1|0|0|0|||0 001599|B03AC0002|Venofer|stl|20|mg/ml|5|ml|5|lykjur||B03AC|01.07.2005||R|0|1|0|G|0|VIF|0|0|1|100|CHF|12538|18755|lyfalmen|V0637|18752|1|25|0|5,0000|Vistor hf|Vifor France SA|Járn, stungulyf||12538||12538|18755||1|0|G|0|||0 001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|FKA|0|0|0|100|DKK|24784|34620|lyfalmen|||1|6160|0||Vistor hf|Fresenius Kabi AB|Blöndur||24784||24784|34620||1|0|0|0|||0 001870|QP54AA0601|Slice vet.|forbl|0,2|% w/w|2,5|kg|1|þpakki|duft|QP54AA06|01.02.2019||R|0|0|0|0|0|IBV|0|0|0|100|DKK|130944|211082|veteldis|||0|2,5|0||Vistor hf|Intervet International BV|emamektín||130944||130944|211082||1|0||0|||0 001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|0|0|0|0|0|HES|0|0|0|100|DKK|2339|4717|lyfalmen|||1|10|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlergómetrín||2339||2339|4717||1|H|0|0|||0 001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|0|0|0|G|0|NEL|0|0|0|100|DKK|4368|7510|lyfalmen|||1|15|0|75,0000|Vistor hf|Novartis Europharm Ltd|Brinzólamíð||4368||4368|7510||1|0|G|0|||0 001905|N03AX0901|Lamictal|dreifit.|2|mg|30|stk|1|glas||N03AX09|01.08.2020||R|0|0|0|G|0|GPH|0|0|0|100|DKK|491|2174|lyfalmen|||1|30|0|0,2000|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||491||491|2174||1|0|G|0|||0 001954|N05AX0802|Rison|filmhtfl|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1674|2555|lyfalmen|V0291|2393|2|60|0|12,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Risperídón||768||768|2555||1|0|G|0|||0 001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|0|0|0|0|0|BIG|0|0|1|100|SEK|3276|6007|lyfalmen|||1|45|0||Icepharma hf|Bioglan AB|Capsaicin||3276||3276|6007||2|0|E|0|||0 001965|N05AX0802|Rison|filmhtfl|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2923|3609|lyfalmen|V0292|3494|2|60|0|24,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Risperídón||1534||1534|3609||1|0|G|0|||0 001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|GRH|0|0|1|100|DKK|1556|3640|lyfalmen|V0004|2839|1|28|0|18,6700|Vistor hf|Grünenthal GmbH|Esómeprazól||1556||1556|3640||1|0|E|0|||0 002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|GRH|0|0|1|100|DKK|3169|5860|lyfalmen|V0005|2874|1|28|0|37,3300|Vistor hf|Grünenthal GmbH|Esómeprazól||3169||3169|5860||1|0|E|0|||0 002194|B05BA1010|Kabiven Peripheral|irl|1000|kcal|1440|ml|4|pokar|fleyti|B05BA10|01.02.2002||R|0|0|0|0|0|FKA|0|0|0|100|DKK|21110|29974|lyfalmen|||1|5760|0||Vistor hf|Fresenius Kabi AB|Blöndur||21110||21110|29974||2|0|0|0|||0 002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2790|5338|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||2790||2790|5338||1|0|G|0|||0 002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.08.2002||R|1|0|0|G|0|NVO|0|0|0|100|DKK|11939|17931|lyfalmen|V0492|16267|1|98|0|39,2000|Vistor hf|N.V. Organon|Montelúkast||11939||11939|17931||1|0|G|0|||0 002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lóratadín|||||||1|0||0|||0 002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lóratadín|||||||1|0||0|||0 002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|G|0|ATE|0|0|1|100|IKR|||lyfalmen|||2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lóratadín|||||2728||1|0|G|0|||0 002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|0|0|1|0|0|LPT|0|0|0|100|XEU|29237|33466|lyfalmen|||1|1|0||Teva Pharma Iceland ehf|Allergan Pharmaceuticals Ireland|Clostridium botulinum toxín-A||23871||23871|33466||1|0|0|0|||0 003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.06.2007||R|1|0|0|G|0|NVO|0|0|0|100|DKK|11362|15087|lyfalmen|V0089|3631|1|98|0|98,0000|Vistor hf|N.V. Organon|Lósartan og þvagræsilyf||9873||9873|15087||1|0|G|0|||0 003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|G|0|UCB|0|0|0|100|DKK|7743|12155|lyfalmen|V0515|5198|1|100|0|16,6700|Vistor hf|U.C.B|Levetíracetam||7743||7743|12155||1|0|G|0|||0 003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|G|0|UCB|0|0|0|100|DKK|10749|16293|lyfalmen|V0253|4878|1|100|0|33,3300|Vistor hf|U.C.B|Levetíracetam||10749||10749|16293||1|0|G|0|||0 003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|G|0|UCB|0|0|0|100|DKK|20862|29660|lyfalmen|V0516|12509|1|100|0|66,6700|Vistor hf|U.C.B|Levetíracetam||20862||20862|29660||1|0|G|0|||0 003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|1|G|0|PFP|0|0|0|100|DKK|8185|12764|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||8185||8185|12764||1|0|G|0|||0 003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|1|G|0|PFP|0|0|0|100|DKK|12086|18133|lyfalmen|V0992|15559|1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||12086||12086|18133||1|0|G|0|||0 003310|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|120|skammtar|1|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|G|0|AZD|0|0|0|100|SEK|5798|9478|lyfalmen|V0971|9477|1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||5798||5798|9478||1|0|G|0|||0 003325|R03AK0702|Symbicort mite Turbuhaler|innönddu|84,5|mcg/sk|120|skammtar|1|innö.t|80+4,5 mcg/sk|R03AK07|01.08.2002||R|0|0|0|G|0|AZD|0|0|0|100|SEK|6902|10998|lyfalmen|||1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||6902||6902|10998||1|0|G|0|||0 003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|þpakki||A02BB01|01.08.2002||R|1|0|0|G|0|PLS|0|0|1|100|DKK|2926|5525|lyfalmen|||1|60|0|15,0000|Icepharma hf|Pfizer ApS|Mísóprostól||2926||2926|5525||1|0|G|0|||0 003775|V03AF0701|Fasturtec|st/irþ|1,5|mg/ml|1,5|mg|3|hgl|+leysir|V03AF07|01.12.2015||R|0|0|0|0|0|SGB|0|0|0|100|XEU|32052|43813|lyfalmen|||1|4,5|0|0,1500|Vistor hf|Sanofi-aventis groupe|Rasburicase||32052||32052|43813||1|H|0|0|||0 003859|N05AH0205|Clozapine Actavis|töflur|25|mg|100|stk|1|glas||N05AH02|01.10.2014||R|2|0|0|G|0|ATE|0|0|0|100|XEU|1930|3217|lyfalmen|||2|100|0|8,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klózapín||1249||1249|3217||1|0|G|0|||0 003880|N05AH0205|Clozapine Actavis|töflur|100|mg|500|stk|1|glas||N05AH02|01.06.2015||R|2|0|0|G|0|ATE|0|0|0|100|XEU|23873|26195|lyfalmen|||2|500|0|166,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klózapín||17943||17943|26195||1|0|G|0|||0 003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.11.2000||R|1|0|0|0|0|ATE|0|0|0|100|XEU|1020|2666|lyfalmen|||2|28|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Sertralín||849||849|2666||1|0|E|0|||0 003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.11.2000||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2163|3322|lyfalmen|V0322|2912|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Sertralín||1325||1325|3322||1|0|G|0|||0 004002|L04AD0101|Sandimmun|irþ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|HES|0|0|0|100|DKK|17870|26094|lyfalmen|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||17870||17870|26094||1|H|0|0|||0 004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|0|0|0|G|0|HES|0|0|0|100|DKK|7472|11782|lyfalmen|||1|250|0|15,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||7472||7472|11782||1|0|G|0|||0 004282|R03AK0601|Seretide|innúðal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|0|0|0|G|0|GPH|0|0|0|100|DKK|4070|7100|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||4070||4070|7100||1|0|G|0|||0 004293|R03AK0601|Seretide|innúðal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|0|0|0|G|0|GPH|0|0|0|100|DKK|5470|9027|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||5470||5470|9027||1|0|G|0|||0 004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|0|1|0|0|0|PEU|0|0|0|100|DKK|16383|24047|lyfalmen|||1|1|0|0,5000|Icepharma hf|Pfizer Europe MA EEIG|Voricónazól||16383||16383|24047||1|H|0|0|||0 004388|QJ51RC2501|Benestermycin, vet.|spenalyf|||5|ml|20|spr||QJ51RC25|01.12.1978||R|0|0|0|0|0|BOI|0|0|0|100|DKK|6873|13210|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|Fenetamathýdrójoðíð í blöndum með öðrum sýklalyfjum||6873||6873|13210||1|0||0|||0 004502|J07BC0101|Engerix-B|stl|20|mcg/ml|0,5|ml|1|dæla|einnota dæla|J07BC01|01.01.1990||R|0|0|0|0|0|GPH|0|0|0|100|DKK|2370|4760|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-B, hreinsaðir mótefnavakar||2370||2370|4760||1|0||0|||0 004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.06.2005||R|1|0|0|G|0|SNP|0|0|0|100|XEU|2693|2737|lyfalmen|V0494|2737|1|90|0|180,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||900||900|2737||1|0|G|0|||0 004613|J07BC0101|Engerix-B|stl|20|mcg/ml|1|ml|1|áfspr||J07BC01|01.01.1990||R|0|0|0|0|0|GPH|0|0|0|100|DKK|2881|5463|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-B, hreinsaðir mótefnavakar||2881||2881|5463||1|0||0|||0 004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001|30.09.2021|R|1|0|0|G|0|ATE|0|0|0|100|XEU|3853|4295|lyfalmen|||2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cítalópram||2032||2032|4295||1|0|G|0|||0 004746|A10AE0405|Lantus [Clikstar]|stl|100|ein/ml|3|ml|5|rörlyk|Clikstar/JuniorStar pennar|A10AE04|01.06.2004||R|0|0|0|G|0|SDH|0|0|0|100|XEU|7766|12187|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||7766||7766|12187||1|0|G|0|||0 004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|þpakki||P01AB01|01.12.1972||R|1|0|0|0|0|ATE|0|0|1|100|DKK|793|2589|lyfalmen|||2|24|0|3,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metrónídazól||793||793|2589||1|0||0|||0 004880|J01FA1001|Zitromax|irs|500|mg|10|ml|1|hgl||J01FA10|01.05.2003||R|0|0|0|0|0|PLS|0|0|1|100|DKK|3975|6969|lyfalmen|||1|10|0|1,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||3975||3975|6969||1|0|0|0|||0 004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|1|0|0|0|0|ATE|0|0|1|100|DKK|340|1966|lyfalmen|||2|8|0|2,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metrónídazól||340||340|1966||1|0||0|||0 004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|ATE|0|0|1|100|DKK|872|2698|lyfalmen|||2|14|0|3,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metrónídazól||872||872|2698||1|0||0|||0 004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|ATE|0|0|1|100|DKK|1492|3552|lyfalmen|||2|30|0|7,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metrónídazól||1492||1492|3552||1|0||0|||0 005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 005085|J07AJ5205|Boostrix|stl|||0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|0|0|0|0|0|GPH|0|0|0|100|DKK|2432|4845|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Kíghósti, í blöndum með öðrum toxóíðum||2432||2432|4845||1|0||0|||0 005108|G04CA0201|Omnic|hylki|0,4|mg|90|stk|1|þpakki|með br.losunarhraða|G04CA02|01.08.1998||R|1|0|0|G|0|ASP|0|0|0|100|XEU|8268|7294|lyfalmen|V0148|4445|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4211||4211|7294||1|0|G|0|||0 005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|0|0|0|0|0|ATE|0|0|1|100|DKK|2469|4229|lyfalmen|V0337|4010|2|30|0|7,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díkloxacillín||1984||1984|4229||1|0|E|0|||0 005241|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|120|skammtar|3|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|G|0|AZD|0|0|0|100|SEK|17394|25439|lyfalmen|V0356|25439|1|360|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||17394||17394|25439||1|0|G|0|||0 005330|D08AG0201|Betadine|húðlausn|100|mg/ml|500|ml|1|fl|sprittlausn|D08AG02|01.09.1982||L|0|0|0|0|0|MUP|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Mundipharma A/S|Joð/pólývídón|||||||2|0||0|||0 005390|R03BB0101|Atrovent|innúðal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|0|0|0|G|0|BOI|0|0|0|100|DKK|1689|3823|lyfalmen|||1|200|0|33,3300|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||1689||1689|3823||1|0|G|0|||0 005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|0|0|0|G|0|BII|0|0|0|100|DKK|4600|7829|lyfalmen|||1|30|0|54,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||4600||4600|7829||1|0|G|0|||0 005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|0|0|0|G|0|BII|0|0|0|100|DKK|4641|7886|lyfalmen|||1|30|0|54,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||4641||4641|7886||1|0|G|0|||0 005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|G|0|LLS|0|0|0|100|DKK|1767|3930|lyfalmen|||1|30|0|15,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||1767||1767|3930||2|0|G|0|||0 005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|G|0|LLS|0|0|0|100|DKK|5551|9138|lyfalmen|V0020|7004|1|180|0|90,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||5551||5551|9138||2|0|G|0|||0 005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|G|0|LLS|0|0|0|100|DKK|4055|7079|lyfalmen|V0020|3502|1|90|0|45,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||4055||4055|7079||2|0|G|0|||0 005766|H01CC0201|Cetrotide|sts|0,25|mg|1|hgl|1|pakki||H01CC02|01.12.2016||R|0|0|1|G|0|MRP|0|0|0|100|SEK|4411|7569|lyfalmen|||1|1|0|1,0000|Icepharma hf|Merck Europe B.V.|Cetrorelix||4411||4411|7569||2|0|G|0|||0 005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|LBK|0|0|0|100|DKK|5138|8570|lyfalmen|V0324|3838|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5138||5138|8570||1|0|G|0|||0 005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|LBK|0|0|0|100|DKK|8246|12848|lyfalmen|V0325|4526|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||8246||8246|12848||1|0|E|0|||0 005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|0|0|0|G|0|NED|0|0|0|100|XEU|2589|5061|lyfalmen|||1|1|0|1,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||2589||2589|5061||2|0|G|0|||0 005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|LBK|0|0|0|100|DKK|13853|20459|lyfalmen|V0326|5352|1|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||13776||13776|20459||1|0|E|0|||0 005963|J01CR0204|Amoxin comp|filmhtfl|1000|mg|14|stk|1|þpakki|875+125 mg|J01CR02|01.02.2013||R|0|0|0|0|0|RHA|0|0|1|100|IKR|1834|2668|lyfalmen|V0169|2599|2|14|0|8,1667|Alvogen|ratiopharm Oy|Amoxicillín og beta-laktamasa hemill ||850||850|2668||2|0|E|0|||0 006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|0|0|0|G|0|NAS|0|0|0|100|DKK|5201|8657|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||5201||5201|8657||1|0|G|0|||0 006079|J02AX0403|Cancidas|irþ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|0|0|MSD|0|0|0|100|DKK|94680|123025|lyfalmen|||1|1|0|1,4000|Vistor hf|M.S.D.|Caspofungin||94680||94680|123025||1|H|0|0|||0 006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|0|0|0|G|0|NAS|0|0|0|100|DKK|4967|8334|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||4967||4967|8334||1|0|G|0|||0 006115|J02AX0403|Cancidas|irþ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|0|0|MSD|0|0|0|100|DKK|72334|94762|lyfalmen|||1|1|0|1,0000|Vistor hf|M.S.D.|Caspofungin||72334||72334|94762||1|H|0|0|||0 006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|0|0|0|0|0|BOI|1|0|0|100|DKK|3364|6553|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim|Meloxícam||||3364|6553||1|0||0|||0 006637|D05AX5201|Daivobet|smyrsli|||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2013||R|0|0|0|G|0|LEP|0|0|0|100|DKK|12786|19097|lyfalmen|V1030|16457|1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||12786||12786|19097||1|0|G|0|||0 006732|A16AB0401|Fabrazyme|irþ|5|mg/ml|35|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|0|0|GEB|0|1|0|100|XEU|421992|531351|lyfsjukr|||1|35|0|7,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||421992||421992|531351||1|H|L|0|||0 006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|þpakki||C09CA01|01.05.2002||R|1|0|0|G|0|NVO|0|0|0|100|DKK|12857|19194|lyfalmen|V0099|14667|1|98|0|196,0000|Vistor hf|N.V. Organon|Lósartan||12857||12857|19194||1|0|G|0|||0 007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|1|0|0|0|0|AZD|0|0|0|100|SEK|11223|16945|lyfalmen|V0117|4773|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||11223||11223|16945||1|0|E|0|||0 007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.06.2003||R|1|0|0|0|0|AZD|0|0|0|100|SEK|16071|23618|lyfalmen|V0118|7740|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||16071||16071|23618||1|0|E|0|||0 007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|1|0|0|0|0|AZD|0|0|0|100|SEK|19109|27800|lyfalmen|V0195|9966|1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||19109||19109|27800||1|0|E|0|||0 007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|0|0|1|0|0|PLS|0|1|0|100|DKK|79352|103638|lyfsjukr|||1|3000|0|5,0000|Icepharma hf|Pfizer ApS|Linezolíd||79352||79352|103638||1|0|L|0|||0 007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|þpakki||J01XX08|01.12.2001||R|0|0|1|0|0|PLS|0|1|0|100|DKK|202876|258832|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Linezolíd||202876||202876|258832||1|0|L|0|||0 007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|0|0|0|G|0|UPJ|0|0|0|100|DKK|2157|4467|lyfalmen|||1|2,5|0|25,0000|Icepharma hf|Upjohn EESV|Tímólól í blöndum||2157||2157|4467||1|0|G|0|||0 007448|B05XC04|Cernevit|sts|||5|ml|10|hgl||B05XC|01.05.2002||R|0|0|0|0|0|BAM|0|0|0|100|SEK|7055|11208|lyfalmen|||1|50|0||Icepharma hf|Baxter Medical AB|Vítamín||7055||7055|11208||2|0|0|0|||0 007449|V03AB3402|Fomepizol EUSA Pharma|irþ|5|mg/ml|20|ml|5|hgl||V03AB34|01.09.2003||R|0|0|0|0|0|SER|0|0|0|100|XEU|91789|119368|lyfalmen|||1|100|0||SERB SA|SERB SA|Fómepízól||91789||91789|119368||3|H|0|0|||0 007462|N01AB0801|Sevorane|innö.guf|100|%|250|ml|1|plastf||N01AB08|01.03.2002||R|0|0|0|0|0|ABV|0|0|0|100|DKK|21783|30825|lyfalmen|||1|250|0||Vistor hf|AbbVie Ltd.|Sevóflúran||21783||21783|30825||1|H|0|0|||0 007505|G04BD0702|Detrusitol Retard|forðahlk|2|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|G|0|UPJ|0|0|0|100|DKK|5715|9364|lyfalmen|||1|30|0|15,0000|Icepharma hf|Upjohn EESV|Tólteródín||5715||5715|9364||1|0|G|0|||0 007601|A16AB0301|Replagal|irþ|1|mg/ml|3,5|ml|1|hgl|lausn|A16AB03|01.09.2014||R|0|0|0|0|0|SHG|0|1|0|100|DKK|233321|296697|lyfsjukr|||1|3,5|0|3,5000|Shire Human Genetics Therapies AB|Shire Human Genetic Therapies AB|Agalsídasi alfa||||233321|296697||1|H|L|0|||0 007760|G04BD0702|Detrusitol Retard|forðahlk|4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|G|0|UPJ|0|0|0|100|DKK|4642|7887|lyfalmen|||1|30|0|30,0000|Icepharma hf|Upjohn EESV|Tólteródín||4642||4642|7887||1|0|G|0|||0 007769|G04BD0702|Detrusitol Retard|forðahlk|4|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|G|0|UPJ|0|0|0|100|DKK|14651|21664|lyfalmen|||1|100|0|100,0000|Icepharma hf|Upjohn EESV|Tólteródín||14651||14651|21664||1|0|G|0|||0 007778|N05AX0802|Rison|filmhtfl|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1601|2719|lyfalmen|V0290|2719|2|60|0|6,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Risperídón||887||887|2719||1|0|G|0|||0 007852|G02BB0101|NuvaRing|sk-innl|||3|stk|1|pakki|0,120 mg/0,015 mg/24 klst.|G02BB01|01.11.2002||R|0|0|0|0|0|NVO|0|0|0|100|DKK|3776|5993|lyfalm11|V0983|5293|1|3|0|84,0000|Vistor hf|N.V. Organon|Skeiðarinnleg með progestógeni og östrógeni||3776||3776|5993||1|0||0|||1 007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|0|0|0|0|0|NEL|0|0|0|100|DKK|1300|3287|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Ólópatadín||1300||1300|3287||1|0||0|||0 008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|þpakki||A10BA02|01.01.2002||R|1|0|0|G|0|MCK|0|0|0|100|SEK|326|1947|lyfalmen|V0502|1042|1|30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||326||326|1947||2|0|G|0|||0 008301|N02AX0209|Tramol-L|forðatfl|100|mg|20|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|0|G|0|ATE|0|0|1|100|XEU|844|2266|lyfalmen|V0226|2248|2|20|0|6,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tramadól||558||558|2266||1|0|G|1|30|dagar|0 008326|D07AC0101|Betnovat|húðlausn|1|mg/g|100|ml|1|plglas|í hársvörð|D07AC01|01.07.1988||R|0|0|0|G|0|GPH|0|0|1|100|DKK|991|2862|lyfalmen|||1|100|0||Vistor hf|GlaxoSmithKline Pharma A/S|Betametasón||991||991|2862||1|0|G|0|||0 008338|N02AX0209|Tramol-L|forðatfl|100|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2691|4566|lyfalmen|V0227|4388|2|100|0|33,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tramadól||2229||2229|4566||1|0|G|1|30|dagar|0 008360|N02AX0209|Tramol-L|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3829|5404|lyfalmen|V0228|5214|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tramadól||2838||2838|5404||1|0|G|1|30|dagar|0 008368|N02AX0209|Tramol-L|forðatfl|200|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|0|G|0|ATE|0|0|0|100|XEU|4487|6798|lyfalmen|V0224|6591|2|100|0|66,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tramadól||3851||3851|6798||1|0|G|1|30|dagar|0 008370|H01AB0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|H01AB01|01.01.2006||R|0|0|0|0|0|GEB|0|0|0|100|XEU|119314|154904|lyfalmen|||1|2|0||Vistor hf|Genzyme Europe B.V.|Thyrotropin alfa||119314||119314|154904||1|H|0|0|||0 008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|0|0|0|0|0|CHP|0|0|0|100|IKR|8120|13996|vetorma|||0|1000|0||Icepharma hf|Chanelle Pharmaceuticals |Fenbendazolum||8120||8120|13996||2|0||0|||0 008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|0|0|0|0|0|CHP|1|0|0|100|XEU|11189|21398|vetalmen|||0|50|0||Icepharma hf|Chanelle Pharmaceuticals |Xylazinum||11189||11189|21398||2|0||0|||0 008519|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|G|0|RTH|0|0|1|100|XEU|||lyfalmen|V0575|1677|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Cetirizín|||||2680||2|0|G|0|||0 008545|G03FB0506|NovoFem|filmhtfl|||84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2644|5137|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2644||2644|5137||1|0|G|0|||0 008673|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|10|stk|1|þpakki||R06AE07|01.09.2012|31.07.2021|L|1|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Alvogen|ratiopharm GmbH|Cetirizín|||||||2|0||0|||0 008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|1|G|0|ZGM|0|0|0|100|DKK|93436|121451|lyfalmen|||1|2|0|20,7700|Icepharma hf|zr pharma & GmbH|Peginterferón alfa 2a||93436||93436|121451||2|0|G|0|||0 008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|1|G|0|ZGM|0|0|0|100|DKK|109383|142553|lyfalmen|||1|2|0|27,6900|Icepharma hf|zr pharma & GmbH|Peginterferón alfa 2a||109383||109383|142553||2|0|G|0|||0 008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|NED|0|0|0|100|XEU|6659|10663|lyfalmen|V0145|3629|1|4|0|8,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||||6659|10663||2|0|E|0|||0 008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|NED|0|0|0|100|XEU|13203|19671|lyfalmen|V0145|7257|1|8|0|16,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||||13203|19671||2|0|E|0|||0 008959|R01AA0706|Naso-ratiopharm|nefúði|0,5|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Alvogen|ratiopharm GmbH|Xýlómetazólín|||||||2|0||0|||0 009099|N06AG0202|Moclobemid ratiopharm|filmhtfl|300|mg|60|stk|1|þpakki||N06AG02|01.03.2014||R|1|0|0|G|0|RTH|0|0|0|100|IKR|4383|7531|lyfalmen|||2|60|0|60,0000|Alvogen|ratiopharm GmbH|Móklóbemíð||4383||4383|7531||2|0|G|0|||0 009113|B05DB0005|Balance|kvið.sk|1,5|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|FMC|0|0|0|100|XEU|8208|12795|lyfalmen|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8208||8208|12795||2|0|0|0|||0 009117|N06AG0202|Moclobemid ratiopharm|filmhtfl|150|mg|100|stk|1|þpakki||N06AG02|01.02.2013||R|1|0|0|G|0|RTH|0|0|0|100|IKR|4944|8303|lyfalmen|||2|100|0|50,0000|Alvogen|ratiopharm GmbH|Móklóbemíð||4944||4944|8303||2|0|G|0|||0 009213|B05DB0005|Balance|kvið.sk|2,3|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|FMC|0|0|0|100|XEU|8208|12795|lyfalmen|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8208||8208|12795||2|0|0|0|||0 009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|0|0|0|0|0|PEU|0|0|1|100|DKK|10372|15774|lyfalmen|||1|10|0|10,0000|Icepharma hf|Pfizer Europe MA EEIG|Parekoxíb||10372||10372|15774||1|0||0|||0 009216|B05DB0005|Balance|kvið.sk|4,25|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|FMC|0|0|0|100|XEU|6046|9820|lyfalmen|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6046||6046|9820||2|0|0|0|||0 009270|R01AA0706|Naso-ratiopharm|nefúði|1|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Alvogen|ratiopharm GmbH|Xýlómetazólín|||||||2|0||0|||0 009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|1|1|0|G|0|PEU|0|0|1|100|DKK|20633|29370|lyfalmen|V1033|16358|1|30|0|3,7500|Icepharma hf|Pfizer Europe MA EEIG|Voricónazól||20633||20633|29370||1|0|G|0|||0 009409|G03CA0316|Vivelle Dot|forðapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|G|0|NAA|0|0|0|100|DKK|1076|2979|lyfalmen|||1|8|0|21,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1076||1076|2979||1|0|G|0|||0 009443|G03CA0316|Vivelle Dot|forðapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|G|0|NAA|0|0|0|100|DKK|1187|3132|lyfalmen|||1|8|0|28,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1187||1187|3132||1|0|G|0|||0 009465|G03CA0316|Vivelle Dot|forðapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|G|0|NAA|0|0|0|100|DKK|1373|3388|lyfalmen|||1|8|0|42,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1373||1373|3388||1|0|G|0|||0 009489|G03CA0316|Vivelle Dot|forðapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|G|0|NAA|0|0|0|100|DKK|1720|3865|lyfalmen|||1|8|0|56,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1720||1720|3865||1|0|G|0|||0 009525|B05DB0005|Balance|kvið.sk|1,5|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|FMC|0|0|0|100|XEU|6153|9967|lyfalmen|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6153||6153|9967||2|0|0|0|||0 009560|B05DB0005|Balance|kvið.sk|4,25|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|FMC|0|0|0|100|XEU|8208|12795|lyfalmen|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8208||8208|12795||2|0|0|0|||0 009591|B05DB0005|Balance|kvið.sk|2,3|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|FMC|0|0|0|100|XEU|6153|9967|lyfalmen|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6153||6153|9967||2|0|0|0|||0 009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|1|1|1|0|0|GII|0|1|0|100|DKK|53338|70736|lyfsjukr|||1|30|0|30,0000|Gilead Sciences International Ltd|Gilead Sciences Ireland UC|Tenófóvír dísóproxíl||53338||53338|70736||2|0|L|0|||0 009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|0|0|0|0|0|DPL|0|0|1|100|XEU|8850|13679|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||8850||8850|13679||1|0||0|||0 009905|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|0|0|0|0|0|DPL|0|0|1|100|XEU|10115|15420|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||10115||10115|15420||1|0||0|||0 009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|0|0|0|0|0|DPL|0|0|1|100|XEU|9355|14374|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||9355||9355|14374||1|0||0|||0 009942|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|0|0|0|0|0|DPL|0|0|1|100|XEU|10115|15420|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||10115||10115|15420||1|0||0|||0 009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|0|0|0|0|0|DPL|0|0|1|100|XEU|9355|14374|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||9355||9355|14374||1|0||0|||0 009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|0|0|0|0|0|DPL|0|0|1|100|XEU|8850|13679|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||8850||8850|13679||1|0||0|||0 010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|0|0|0|0|0|MSD|0|0|0|100|DKK|5602|9209|lyfalmen|||1|1|0|1,0000|Vistor hf|M.S.D.|Ertapenem||5602||5602|9209||1|H|0|0|||0 010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|þpakki||N06DX01|01.10.2002||R|1|0|0|G|0|LUN|0|0|0|100|DKK|15067|22236|lyfalmen|V0605|4939|1|100|0|50,0000|Vistor hf|H. Lundbeck A/S|Memantín||15067||15067|22236||1|0|G|0|||0 010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|0|0|0|0|0|BII|0|0|0|100|DKK|7596|11953|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og þvagræsilyf||7596||7596|11953||1|0|E|0|||0 010534|B05BA0108|Vaminolac|irl|||100|ml|10|fl||B05BA01|01.03.2004||R|0|0|0|0|0|FKA|0|0|0|100|DKK|9304|14304|lyfalmen|||1|1000|0||Vistor hf|Fresenius Kabi AB|Amínósýrur||9304||9304|14304||1|H|0|0|||0 010573|S01AE0501|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AE05|01.08.2002||R|0|0|0|0|0|SAO|0|0|1|100|XEU|1312|3304|lyfalmen|||1|5|0||Icepharma hf|Santen Oy|Levófloxacín||1312||1312|3304||2|0||0|||0 010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|1|0|1|0|0|JCI|0|1|0|100|SEK|249641|316995|lyfsjukr|||1|56|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Bósentan||249641||249641|316995||3|0|L|0|||0 010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|1|0|1|0|0|JCI|0|1|0|100|SEK|250287|317798|lyfsjukr|||1|56|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Bósentan||250287||250287|317798||3|0|L|0|||0 010848|H01AX0101|Somavert|sts|20|mg|30|hgl|1|pakki|+ leysir, lausn|H01AX01|01.11.2016|30.09.2021|R|0|0|1|0|0|PEU|0|1|0|100|DKK|658265|825209|lyfsjukr|||1|30|0|60,0000|Icepharma hf|Pfizer Europe MA EEIG|Pegvisómant||658265||658265|825209||1|0|L|0|||0 010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|0|0|0|0|0|BAM|0|0|0|100|SEK|40086|53974|lyfalmen|||2|10|0||Icepharma hf|Baxter Medical AB|Bleómýcín||40086||40086|53974||2|H|0|0|||0 010947|C08CA0203|Felodipin ratiopharm|forðatfl|5|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|G|0|RTH|0|0|0|100|XEU|2612|2709|lyfalmen|V0058|2709|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Felódipín||880||880|2709||2|0|G|0|||0 010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|OPC|0|0|0|100|DKK|19093|27778|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||19093||19093|27778||1|0|E|0|||0 010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|OPC|0|0|0|100|DKK|12864|19204|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||12864||12864|19204||1|0||0|||0 010980|C08CA0203|Felodipin ratiopharm|forðatfl|10|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|G|0|RTH|0|0|0|100|XEU|3591|3130|lyfalmen|V0059|3130|2|100|0|200,0000|Alvogen|ratiopharm GmbH|Felódipín||1186||1186|3130||2|0|G|0|||0 010989|R06AE0707|Cetirizin STADA|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.05.2018||L|1|0|0|G|0|ASR|0|0|1|100|IKR|||lyfalmen|V0575|1677|2|100|0|100,0000|LYFIS ehf|STADA Arzneimittel AG|Cetirizín|||||1677||2|0|G|0|||0 011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|OPC|0|0|0|100|DKK|29330|40370|lyfalmen|V0683|3422|1|56|0|37,3330|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||29330||29330|40370||1|0|E|0|||0 011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|G|0|OPC|0|0|0|100|DKK|23698|33247|lyfalmen|V0684|3422|1|56|0|56,0000|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||23698||23698|33247||1|0|G|0|||0 011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|1|0|0|G|0|NVO|0|0|1|100|DKK|3409|6190|lyfalmen|V0825|2811|1|28|0|28,0000|Vistor hf|N.V. Organon|Etoríkoxíb||3409||3409|6190||1|0|G|0|||0 011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|1|0|0|G|0|NVO|0|0|1|100|DKK|3528|6354|lyfalmen|V0826|3647|1|28|0|42,0000|Vistor hf|N.V. Organon|Etoríkoxíb||3528||3528|6354||1|0|G|0|||0 011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|LBK|0|0|0|100|DKK|15117|22305|lyfalmen|V0327|6315|1|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||15117||15117|22305||1|0|E|0|||0 011326|M01AH0501|Arcoxia|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.01.2010||R|1|0|0|G|0|NVO|0|0|1|100|DKK|1110|3026|lyfalmen|V0827|2186|1|7|0|14,0000|Vistor hf|N.V. Organon|Etoríkoxíb||1110||1110|3026||1|0|G|0|||0 011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|1|0|0|G|0|GPA|0|0|0|100|XEU|2120|2943|lyfalmen|V0069|2884|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lósartan||1050||1050|2943||1|0|G|0|||0 011397|J01CA0102|Doktacillin|stl/irs|||1|g|10|hgl||J01CA01|01.03.2020||R|0|0|0|0|0|MEA|0|0|1|100|SEK|14016|20790|lyfalmen|||1|10|0|1,6667|Icepharma hf|Meda AB|Ampicillín||14016||14016|20790||2|0|0|0|||0 011409|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|skammtar|1|innö.t|320+9 mcg/sk|R03AK07|01.05.2003||R|0|0|0|G|0|AZD|0|0|0|100|SEK|5721|9372|lyfalmen|||1|60|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||5721||5721|9372||1|0|G|0|||0 011489|N06BA0402|Concerta|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|1|0|0|0|JAS|0|0|0|100|SEK|5154|8592|lyfalmen|V0691|5671|1|30|0|18,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||5154||5154|8592||1|0|E|1|30|dagar|0 011555|N06BA0402|Concerta|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|1|0|0|0|JAS|0|0|0|100|SEK|6592|8056|lyfalmen|V0624|5450|1|30|0|36,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||4765||4765|8056||1|0|E|1|30|dagar|0 011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|0|0|0|0|0|CHP|1|0|0|100|XEU|1822|3581|vetalmen|||0|25|0||Icepharma hf|Chanelle Pharmaceuticals |Xylazinum||1822||1822|3581||2|0||0|||0 011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|0|0|0|0|0|PLS|0|0|0|100|DKK|3594|6445|lyfalmen|||1|20|0||Icepharma hf|Pfizer ApS|Esketamín||3594||3594|6445||1|H|0|1|30|dagar|0 011718|QJ01CE0101|Geepenil, vet.|sts|24|g|1|hgl|1|pakki|+ leysir, lausn|QJ01CE01|01.09.2012||R|0|0|0|0|0|OCO|0|0|0|100|DKK|4227|8190|vetalmen|||0|1|0||Icepharma hf|Orion Corporation (I)|Benzylpenicillín sodíum||4227||4227|8190||2|0||0|||0 011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.10.2005||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3443|4991|lyfalmen|V0323|4166|2|98|0|196,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Sertralín||2538||2538|4991||1|0|G|0|||0 011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|MAR|0|0|0|100|DKK|3655|6529|lyfalmen|||1|20|0||Icepharma hf|Aspen Pharma|Búpívakaín||3655||3655|6529||2|H|0|0|||0 011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|MAR|0|0|0|100|DKK|1925|4147|lyfalmen|||1|20|0||Icepharma hf|Aspen Pharma|Búpívakaín||1925||1925|4147||2|H|0|0|||0 012030|J05AG0301|Stocrin|filmhtfl|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|1|0|1|0|0|MSD|0|1|0|100|DKK|26680|37018|lyfsjukr|||1|30|0|30,0000|Vistor hf|M.S.D.|Efavirenz||26680||26680|37018||1|0|L|0|||0 012243|G04CB0201|Avodart|hylki|0,5|mg|30|stk|1|þpakki|hylki mjúk|G04CB02|01.03.2012||R|1|0|0|G|0|GPH|0|0|0|100|DKK|3512|6332|lyfalmen|V0909|2804|1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Dútasteríð||3512||3512|6332||1|0|G|0|||0 012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|NED|0|0|0|100|XEU|6407|10317|lyfalmen|V0924|6005|1|4|0|4,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||6407||6407|10317||2|0|E|0|||0 012326|N06BA0402|Concerta|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|1|1|0|0|0|JAS|0|0|0|100|SEK|8627|10325|lyfalmen|V0622|6242|1|30|0|54,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||6413||6413|10325||1|0|E|1|30|dagar|0 012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|0|0|0|0|0|GPH|0|0|1|100|DKK|901|2738|lyfalmen|||1|80|0|2,6667|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og beta-laktamasa hemill ||901||901|2738||1|0|E|0|||0 012921|G03AA1301|Evra|forðapl|||9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|0|0|0|0|0|GDO|0|0|0|100|SEK|4198|6513|lyfalm11|||1|9|0||Vistor hf|Gedeon Richter Plc.|Norelgestromín og ethinylestradíól||4198||4198|6513||1|0||0|||1 012953|G03BA0306|Testogel|hlaup|50|mg|30|skpokar|1|pakki|hlaup til notkunar um húð|G03BA03|01.12.2003||R|0|0|0|G|0|LBI|0|0|0|100|DKK|5649|9273|lyfalmen|||1|30|0|30,0000|Vistor hf|Laboratoires Besins International|Testósterón||5649||5649|9273||1|0|G|0|||0 012966|N03AX1208|Gabapentin ratiopharm|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.03.2012||R|1|0|0|G|0|RTH|0|0|0|100|IKR|1974|2806|lyfalmen|V0250|2453|2|100|0|16,6667|Alvogen|ratiopharm GmbH|Gabapentín||950||950|2806||2|0|G|0|||0 012988|N03AX1208|Gabapentin ratiopharm|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.03.2012||R|1|0|0|G|0|RTH|0|0|0|100|IKR|2941|3425|lyfalmen|V0251|3150|2|100|0|22,2200|Alvogen|ratiopharm GmbH|Gabapentín||1400||1400|3425||2|0|G|0|||0 013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.02.2004||R|1|1|0|0|0|HES|0|0|0|100|DKK|6260|8574|lyfalmen|V0959|4752|1|30|0|20,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||5141||5141|8574||1|0|E|1|30|dagar|0 013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.02.2004||R|1|1|0|0|0|HES|0|0|0|100|DKK|9017|12633|lyfalmen|V0996|7674|1|30|0|40,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||8090||8090|12633||1|0|E|1|30|dagar|0 013172|J06BB0101|Rhophylac|stl|300|mcg|2|ml|1|áfspr||J06BB01|01.02.2004||R|0|0|0|0|0|CSB|0|0|0|100|SEK|7331|11588|lyfalmen|||1|2|0||Icepharma hf|CSL Behring GmbH|And-D(rh) immúnóglóbúlín||7331||7331|11588||2|H|0|0|||0 013302|C02CA0405|Cardosin Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.09.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2837|4889|lyfalmen|V0042|4116|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Doxazósín||2464||2464|4889||1|0|G|0|||0 013347|L01EB0101|Iressa|töflur|250|mg|30|stk|1|þpakki||L01EB01|01.03.2010||R|0|0|1|0|0|AZE|0|1|0|100|SEK|297224|376175|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Gefitinib||297224||297224|376175||1|0|L|0|||0 013551|N02AA0503|Oxynorm|stl|10|mg/ml|1|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|0|0|0|MUP|0|0|0|100|DKK|1205|3156|lyfalmen|||1|5|0|1,6700|Icepharma hf|Mundipharma A/S|Oxýcódon||1205||1205|3156||2|0|E|1|30|dagar|0 013615|M01AE0113|Ibuxin|filmhtfl|400|mg|100|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|G|0|RTH|0|0|1|100|XEU|783|2424|lyfalmen|V0562|2417|2|100|0|33,3300|Alvogen|ratiopharm GmbH|Íbúprófen||673||673|2424||2|0|G|0|||0 013628|N02AA0503|Oxynorm|stl|10|mg/ml|2|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|0|0|0|MUP|0|0|0|100|DKK|2315|4684|lyfalmen|||1|10|0|3,3300|Icepharma hf|Mundipharma A/S|Oxýcódon||2315||2315|4684||2|0|E|1|30|dagar|0 013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|0|0|0|G|0|NAS|0|0|0|100|DKK|5829|9521|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||5829||5829|9521||1|0|G|0|||0 013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2150|4457|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2150||2150|4457||1|0|G|0|||0 013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|0|0|0|G|0|NAS|0|0|0|100|DKK|4486|7672|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||4486||4486|7672||1|0|G|0|||0 013971|L01EA0101|Glivec|filmhtfl|100|mg|60|stk|1|þpakki||L01EA01|01.06.2012||R|0|0|1|0|0|NEL|0|1|0|100|DKK|95754|124383|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Imatinib||95754||95754|124383||1|0|L|0|||0 013982|L01EA0101|Glivec|filmhtfl|400|mg|30|stk|1|þpakki||L01EA01|01.05.2004||R|0|0|1|0|0|NEL|0|1|0|100|DKK|190633|243605|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Imatinib||190633||190633|243605||1|0|L|0|||0 014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2321|4693|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2321||2321|4693||1|0|G|0|||0 014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|0|0|0|0|0|GRH|0|0|1|100|DKK|6148|9960|lyfalmen|||1|50|0|13,3300|Vistor hf|Grünenthal GmbH|Esómeprazól||6148||6148|9960||1|0|0|0|||0 014081|N03AX1401|Keppra|mixtúra|100|mg/ml|300|ml|1|glas||N03AX14|01.12.2006||R|0|0|0|G|0|UCB|0|0|0|100|DKK|15378|22664|lyfalmen|V1000|16638|1|300|0|20,0000|Vistor hf|U.C.B|Levetíracetam||15378||15378|22664||1|0|G|0|||0 014094|H05AA0202|Forsteo|stl|250|mcg/ml|2,4|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|0|0|0|0|0|NED|0|0|0|100|XEU|48893|65113|lyfalmen|||1|2,4|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Teriparatíð||48893||48893|65113||2|0|E|0|||0 014147|J01CA0417|Amoxicillin Sandoz|mixtduft|100|mg/ml|60|ml|1|glas||J01CA04|01.08.2015||R|0|0|0|0|0|SHS|0|0|1|100|DKK|1285|3267|lyfalmen|V0479|2973|2|60|0|4,0000|Artasan ehf|Sandoz A/S|Amoxicillín||1285||1285|3267||1|0|E|0|||0 014158|J01CA0417|Amoxicillin Sandoz|mixtduft|100|mg/ml|100|ml|1|glas||J01CA04|01.08.2015||R|0|0|0|0|0|SHS|0|0|1|100|DKK|1666|3791|lyfalmen|||2|100|0|6,6667|Artasan ehf|Sandoz A/S|Amoxicillín||1666||1666|3791||1|0|E|0|||0 014185|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|skammtar|3|innö.t|320+9 mcg/sk|R03AK07|01.08.2009||R|0|0|0|G|0|AZD|0|0|0|100|SEK|17165|25124|lyfalmen|||1|180|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||17165||17165|25124||1|0|G|0|||0 014365|M01AE0113|Ibuxin|filmhtfl|600|mg|30|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|G|0|RTH|0|0|1|100|XEU|376|1831|lyfalmen|V0563|1831|2|30|0|15,0000|Alvogen|ratiopharm GmbH|Íbúprófen||242||242|1831||2|0|G|0|||0 014435|QM01AE0303|Dolovet vet.|duft|160|mg/g|15|g|3|pokar||QM01AE03|01.06.2009||R|0|0|0|0|0|VET|0|0|0|100|XEU|2393|4703|vetalmen|||0|45|0||Dýraheilsa ehf|Vetcare Ltd.|Ketóprófen||2393||2393|4703||2|0||0|||0 014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|0|0|1|0|0|GEI|0|1|0|100|DKK|72834|95394|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland|Adefovír||||72834|95394||2|0|L|0|||0 014597|M01AE0113|Ibuxin|filmhtfl|600|mg|100|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|G|0|RTH|0|0|1|100|XEU|1019|2284|lyfalmen|V0564|2284|2|100|0|50,0000|Alvogen|ratiopharm GmbH|Íbúprófen||571||571|2284||2|0|G|0|||0 014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|1|G|0|HES|0|0|0|100|DKK|22596|31853|lyfalmen|||1|60|0|10,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||22596||22596|31853||1|0|G|0|||0 014852|A06AD6502|Movicol|mixtduft|13,8|g|20|pokar|1|pakki|lausn|A06AD65|01.09.2011||L|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||||1|0||0|||0 014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|1|G|0|HES|0|0|0|100|DKK|62605|82456|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||62605||62605|82456||1|0|G|0|||0 014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|1|G|0|HES|0|0|0|100|DKK|41734|56059|lyfalmen|||1|60|0|20,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||41734||41734|56059||1|0|G|0|||0 014889|A16AA0501|Carbaglu|dreifit.|200|mg|60|stk|1|glas||A16AA05|01.12.2016||R|0|0|1|0|0|ECO|0|0|0|100|XEU|683689|856829|lyfalmen|||1|60|0|60,0000|Recordati AB|Recordati Rare Diseases|Carglumicsýra||683689||683689|856829||3|0|E|0|||0 015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2487|4253|lyfalmen|V0673|3975|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mirtazapín||2002||2002|4253||1|0|G|0|||0 015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|0|0|0|G|0|NAS|0|0|0|100|DKK|7195|11401|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||7195||7195|11401||1|0|G|0|||0 015419|G03CA0316|Vivelle Dot|forðapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|0|0|0|G|0|NAA|0|0|0|100|DKK|1032|2918|lyfalmen|||1|8|0|14,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1032||1032|2918||1|0|G|0|||0 015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|þpakki||N02CC01|01.10.2005||R|0|0|0|G|0|GPH|0|0|0|100|DKK|1721|2839|lyfalmen|V0234|1724|1|6|0|12,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||974||974|2839||1|0|G|0|||0 015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|þpakki||N02CC01|01.10.2005||R|0|0|0|G|0|GPH|0|0|0|100|DKK|2457|2839|lyfalmen|V0233|2225|1|12|0|12,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||974||974|2839||1|0|G|0|||0 015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|0|0|0|G|0|NAS|0|0|0|100|DKK|8371|13020|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||8371||8371|13020||1|0|G|0|||0 015460|H01AC0114|Norditropin NordiFlex|stl|5|mg|1,5|ml|1|áfpen||H01AC01|01.04.2021||R|0|0|1|0|0|NAS|0|1|0|100|DKK|14090|20891|lyfsjukr|||1|1,5|0|7,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||14090||14090|20891||1|0|L|0|||0 015591|H01AC0114|Norditropin NordiFlex|stl|10|mg|1,5|ml|1|áfpen||H01AC01|01.04.2021||R|0|0|1|0|0|NAS|0|1|0|100|DKK|28180|38916|lyfsjukr|||1|1,5|0|15,0000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||28180||28180|38916||1|0|L|0|||0 015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|G|0|COR|0|0|0|100|DKK|11409|17201|lyfalmen|||1|100|0|11,1100|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||11409||11409|17201||1|0|G|0|||0 015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|G|0|COR|0|0|0|100|DKK|11343|17110|lyfalmen|V0900|17108|1|100|0|33,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||11343||11343|17110||1|0|G|0|||0 015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|G|0|COR|0|0|0|100|DKK|9911|15139|lyfalmen|V0829|15137|1|100|0|22,2200|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||9911||9911|15139||1|0|G|0|||0 015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|0|1|1|G|0|HES|0|0|0|100|DKK|17359|17362|lyfalmen|V0470|17362|1|120|0|10,8000|Vistor hf|Novartis Healthcare A/S|Mýcófenólsýra||11526||11526|17362||1|0|G|0|||0 015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|0|1|1|G|0|HES|0|0|0|100|DKK|34677|32393|lyfalmen|V1008|32393|1|120|0|21,6000|Vistor hf|Novartis Healthcare A/S|Mýcófenólsýra||23023||23023|32393||1|0|G|0|||0 015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|BAN|0|0|0|100|DKK|3742|6450|vetorma|||0|2,4|0||Icepharma hf|Bayer Animal Health GmbH|Moxidectinum í blöndum||3742||3742|6450||2|0||0|||0 015855|QP54AB5206|Advocate yfirstærðar hundar|bl.lausn|125|mg|4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|BAN|0|0|0|100|DKK|5752|9914|vetorma|||0|12|0||Icepharma hf|Bayer Animal Health GmbH|Moxidectinum í blöndum||5752||5752|9914||2|0||0|||0 015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|BAN|0|0|0|100|DKK|3112|5364|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|Moxidectinum í blöndum||3112||3112|5364||2|0||0|||0 015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|BAN|0|0|0|100|DKK|3157|5441|vetorma|||0|3|0||Icepharma hf|Bayer Animal Health GmbH|Moxidectinum í blöndum||3157||3157|5441||2|0||0|||0 015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|BAN|0|0|0|100|DKK|5522|9518|vetorma|||0|7,5|0||Icepharma hf|Bayer Animal Health GmbH|Moxidectinum í blöndum||5522||5522|9518||2|0||0|||0 015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003|30.09.2021|R|0|0|0|0|0|ETH|0|0|1|100|GBP|1423|3457|lyfalmen|||2|10|0|3,3300|Icepharma hf|Ethypharm|Morfín||1423||1423|3457||2|0|E|1|30|dagar|0 015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|BAN|0|0|0|100|DKK|3036|5233|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|Moxidectinum í blöndum||3036||3036|5233||2|0||0|||0 015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|þpakki||N06AB05|01.12.2006||R|1|0|0|0|0|GPH|0|0|0|100|DKK|1537|3613|lyfalmen|||1|28|0|14,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Paroxetín||1537||1537|3613||1|0|E|0|||0 016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|2357|4742|lyfalmen|||1|14|0|7,0000|Icepharma hf|Upjohn EESV|Pregabalín||2357||2357|4742||1|0|E|0|||0 016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|5004|8385|lyfalmen|V0686|2037|1|56|0|14,0000|Icepharma hf|Upjohn EESV|Pregabalín||5004||5004|8385||1|0|E|0|||0 016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|8825|13645|lyfalmen|V0687|2612|1|56|0|28,0000|Icepharma hf|Upjohn EESV|Pregabalín||8825||8825|13645||1|0|E|0|||0 016317|C03CA0110|Impugan|töflur|40|mg|1000|stk|1|glas||C03CA01|01.01.2016||R|2|0|0|G|0|ATE|0|0|0|100|XEU|4773|8067|lyfalmen|||2|1000|0|1000,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fúrósemíð||4773||4773|8067|30.9.2021|1|0|G|0|||0 016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|1549|3630|lyfalmen|||1|14|0|3,5000|Icepharma hf|Upjohn EESV|Pregabalín||1549||1549|3630||1|0|E|0|||0 016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|11116|16798|lyfalmen|V0689|3390|1|56|0|56,0000|Icepharma hf|Upjohn EESV|Pregabalín||11116||11116|16798||1|0|E|0|||0 016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|0|1|0|0|0|PEU|0|0|1|100|DKK|88843|115642|lyfalmen|||1|70|0|7,0000|Icepharma hf|Pfizer Europe MA EEIG|Voricónazól||88843||88843|115642||1|0|0|0|||0 016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|0|0|0|0|0|PLS|0|0|0|100|DKK|3098|5762|lyfalmen|||1|10|0||Icepharma hf|Pfizer ApS|Cýtarabín||3098||3098|5762||1|H|0|0|||0 016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.01.2007||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|2268|4620|lyfalmen|V0685|2160|1|56|0|4,6667|Icepharma hf|Upjohn EESV|Pregabalín||2268||2268|4620||1|0|E|0|||0 016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.02.2006||R|1|0|0|0|0|OPC|0|0|0|100|DKK|15649|23037|lyfalmen|V0690|6125|1|28|0|9,3330|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||15649||15649|23037||1|0|E|0|||0 016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 016622|A06AG1101|Microlax|innhl|||5|ml|50|túpa||A06AG11|01.09.2005||L|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|250|0|50,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||7997||1|0|E|0|||0 016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.02.2006||R|1|0|0|0|0|OPC|0|0|0|100|DKK|25842|35959|lyfalmen|V0682|3422|1|56|0|18,6670|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||25842||25842|35959||1|0|E|0|||0 016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.02.2004||R|1|1|0|0|0|HES|0|0|0|100|DKK|7453|10153|lyfalmen|V0960|5880|1|30|0|30,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||6288||6288|10153||1|0|E|1|30|dagar|0 016736|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|G|0|LVR|0|0|0|100|DKK|2822|5382|lyfalmen|V0240|5382|3|200|0|40,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||2822||2822|5382||3|0|G|0|||0 016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|AEB|0|0|0|100|DKK|48770|64958|lyfalmen|V0721|11614|1|28|0|28,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||48770||48770|64958||1|0||0|||0 016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|AEB|0|0|0|100|DKK|71851|94151|lyfalmen|V0722|43747|1|28|0|42,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||71851||71851|94151||1|0||0|||0 016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|AEB|0|0|0|100|DKK|26712|37059|lyfalmen|V0720|8242|1|28|0|14,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||26712||26712|37059||1|0||0|||0 016930|A16AB0401|Fabrazyme|irþ|5|mg/ml|5|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|0|0|GEB|0|1|0|100|XEU|61463|81012|lyfsjukr|||1|5|0|1,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||61463||61463|81012||1|H|L|0|||0 016946|A02BC0301|Lanzo|munndr.t|15|mg|56|stk|1|þpakki||A02BC03|01.11.2009||R|0|0|0|0|0|PLS|0|0|1|100|DKK|1487|3545|lyfalmen|||1|56|0|28,0000|Icepharma hf|Pfizer ApS|Lansóprazól||||1487|3545||1|0|E|0|||0 016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|1|0|1|0|0|GEI|0|1|0|100|DKK|30435|41768|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland|Emtrícítabín||30435||30435|41768||2|0|L|0|||0 016979|N02AE0103|Norspan|forðapl|5|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|0|G|0|MUP|0|0|0|100|DKK|1960|4196|lyfalmen|V0943|3945|1|4|0|2,8000|Icepharma hf|Mundipharma A/S|Búprenorfín||1960||1960|4196||2|0|G|1|30|dagar|0 017020|G03AC0601|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03AC06|01.12.1972||R|0|0|0|G|0|PLS|0|0|0|100|DKK|986|2556|lyfalm11|||1|3|0|89,8204|Icepharma hf|Pfizer ApS|Medroxýprógesterón||986||986|2556||1|0|G|0|||1 017182|N05CF0106|Zopiclone Actavis|filmhtfl|5|mg|500|stk|1|plglas||N05CF01|01.10.2012||R|2|0|0|0|0|ATE|0|0|0|100|XEU|6143|9953|lyfalmen|||2|500|0|333,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Zópíklón||6143||6143|9953||1|0||2|225|mg|0 017193|N05CF0106|Zopiclone Actavis|filmhtfl|7,5|mg|500|stk|1|glas||N05CF01|01.05.2013||R|2|0|0|0|0|ATE|0|0|0|100|SEK|6815|10878|lyfalmen|||2|500|0|500,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Zópíklón||6815||6815|10878||1|0||2|225|mg|0 017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|0|0|1|G|0|BNB|0|0|0|100|XEU|85732|111707|lyfalmen|||1|2|0|27,9100|Icepharma hf|Biogen Netherlands B.V.|Interferón beta-1a||85732||85732|111707||2|0|G|0|||0 017266|N02AE0103|Norspan|forðapl|10|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|0|G|0|MUP|0|0|0|100|DKK|3514|6335|lyfalmen|V0944|5883|1|4|0|5,6000|Icepharma hf|Mundipharma A/S|Búprenorfín||3514||3514|6335||2|0|G|1|30|dagar|0 017326|N02AE0103|Norspan|forðapl|20|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|0|G|0|MUP|0|0|0|100|DKK|6260|10114|lyfalmen|V0945|6321|1|4|0|11,2000|Icepharma hf|Mundipharma A/S|Búprenorfín||6260||6260|10114||2|0|G|1|30|dagar|0 017331|A04AD1201|Emend|hylki|||3|stk|1|þpakki|samsett pakkning|A04AD12|01.04.2004||R|1|0|0|G|0|MSD|0|0|1|100|DKK|7276|11513|lyfalmen|V0986|9498|1|3|0|1,7273|Vistor hf|M.S.D.|Aprepitant||7276||7276|11513||1|0|G|0|||0 017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005|31.08.2021|R|1|0|0|G|0|MEA|0|0|1|100|DKK|2513|4957|lyfalmen|||1|30|0|150,0000|Icepharma hf|Meda AB|Prednisón||2513||2513|4957||2|0|G|0|||0 017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|0|0|0|0|0|BOI|0|0|0|100|DKK|6809|13089|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|Meloxícam||6809||6809|13089||1|0||0|||0 017668|J02AC0107|Fluconazol Krka|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|KRK|0|0|1|100|IKR|1500|2186|lyfalmen|V0556|2186|2|4|0|3,0000|LYFIS ehf|Krka Sverige AB|Flúkónazól||500||500|2186||2|0||0|||0 017679|J02AC0107|Fluconazol Krka|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.12.2018||L|1|0|0|0|0|KRK|0|0|1|100|IKR|||lyflausa|||2|1|0|0,7500|LYFIS ehf|Krka Sverige AB|Flúkónazól|||||||2|0||0|||0 017701|J02AC0107|Fluconazol Krka|hylki|150|mg|6|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|KRK|0|0|1|100|IKR|2300|3563|lyfalmen|V0556|3279|2|6|0|4,5000|LYFIS ehf|Krka Sverige AB|Flúkónazól||1500||1500|3563||2|0||0|||0 017712|J02AC0107|Fluconazol Krka|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|KRK|0|0|1|100|IKR|1271|2117|lyfalmen|V0551|2110|2|7|0|1,7500|LYFIS ehf|Krka Sverige AB|Flúkónazól||450||450|2117||2|0||0|||0 017745|J02AC0107|Fluconazol Krka|hylki|50|mg|28|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|KRK|0|0|1|100|IKR|3500|2599|lyfalmen|V0552|2555|2|28|0|7,0000|LYFIS ehf|Krka Sverige AB|Flúkónazól||800||800|2599||2|0||0|||0 017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|8442|13117|lyfalmen|V0107|2530|1|30|0|15,0000|Icepharma hf|Upjohn EESV|Eplerenón||8442||8442|13117||1|0|0|0|||0 018420|C07AG0207|Carvedilol STADA|töflur|6,25|mg|100|stk|1|þpakki||C07AG02|01.03.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|1544|2599|lyfalmen|V0946|2599|2|100|0|16,6700|LYFIS ehf|STADA Arzneimittel AG|Carvedílól||800||800|2599||2|0|G|0|||0 018431|C07AG0207|Carvedilol STADA|töflur|12,5|mg|100|stk|1|þpakki||C07AG02|01.03.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2107|3356|lyfalmen|V0947|3356|2|100|0|33,3300|LYFIS ehf|STADA Arzneimittel AG|Carvedílól||1350||1350|3356||2|0|G|0|||0 018442|C07AG0207|Carvedilol STADA|töflur|25|mg|100|stk|1|pakki||C07AG02|01.03.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2975|3631|lyfalmen|V0948|3631|2|100|0|66,6666|LYFIS ehf|STADA Arzneimittel AG|Carvedílól||1550||1550|3631||2|0|G|0|||0 018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.11.2004||R|1|0|0|G|0|GPH|0|0|0|100|DKK|829|2292|lyfalmen|V0243|2082|1|42|0|3,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||577||577|2292||1|0|G|0|||0 018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|G|0|ASP|0|0|0|100|XEU|6278|10139|lyfalmen|V0985|7087|1|30|0|60,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||6278||6278|10139||1|0|G|0|||0 018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|G|0|ASP|0|0|0|100|XEU|17547|25650|lyfalmen|V0441|11408|1|90|0|180,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||17547||17547|25650||1|0|G|0|||0 018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|þpakki||H02AB06|01.06.2004||R|1|0|0|G|0|MEC|0|0|1|100|SEK|1091|3000|lyfalmen|V0414|3000|1|100|0|50,0000|Icepharma hf|Merck AB|Prednisólón||1091||1091|3000||2|0|G|0|||0 018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|G|0|ASP|0|0|0|100|XEU|5234|8702|lyfalmen|V0438|4657|1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||5234||5234|8702||1|0|G|0|||0 018689|J01EA0108|Idotrim|filmhtfl|100|mg|100|stk|1|glas||J01EA01|01.08.2015||R|1|0|0|0|0|COR|0|0|1|100|DKK|4570|7788|lyfalmen|||2|100|0|25,0000|Vistor hf|Orion Corporation|Trímetóprím||4570||4570|7788||1|0|E|0|||0 018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|G|0|ASP|0|0|0|100|XEU|13238|19719|lyfalmen|V0440|9075|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||13238||13238|19719||1|0|G|0|||0 018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2005||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|30441|41775|lyfalmen|V0111|6315|1|100|0|100,0000|Icepharma hf|Upjohn EESV|Eplerenón||30441||30441|41775||1|0|E|0|||0 018718|L03AX0302|BCG-medac|duft|||3|hgl|1|pakki|+ leysir|L03AX03|01.01.2016||R|0|0|0|0|0|WIL|0|0|0|100|XEU|94674|123017|lyfalmen|||1|3|0|21,0000|Williams & Halls efh|medac Gesellschaft|BCG bóluefni||94674||94674|123017||2|H|0|0|||0 018726|J06BA0209|Nanogam|irl|50|mg/ml|20|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|1|SPP|0|1|0|100|XEU|9539|14627|lyfsjukr|||1|20|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||9539||9539|14627||2|H|L|0|||0 018770|J01EA0108|Idotrim|filmhtfl|160|mg|14|stk|1|glas||J01EA01|01.08.2015||R|1|0|0|0|0|COR|0|0|1|100|DKK|736|2511|lyfalmen|||2|14|0|5,6000|Vistor hf|Orion Corporation|Trímetóprím||736||736|2511||1|0|E|0|||0 018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|0|0|1|G|0|TGM|0|0|0|100|NOK|78196|102176|lyfalmen|||1|28|0|28,0000|Teva Pharma Iceland ehf|TEVA GmbH|Glatíramer acetat||78196||78196|102176||1|0|G|0|||0 019066|V08AB0201|Omnipaque|stl|140|mg J/ml|50|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|GEH|0|0|0|100|NOK|5568|9162|lyfalmen|||1|500|0||Icepharma hf|GE Healthcare AS|Iohexol||5568||5568|9162||2|H|0|0|||0 019098|J06BA0209|Nanogam|irl|50|mg/ml|400|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|SPP|0|1|0|100|IKR|194191|248030|lyfsjukr|||1|400|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||194191||194191|248030||2|H|L|0|||0 019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|GEH|0|0|0|100|NOK|16924|24792|lyfalmen|||1|500|0||Icepharma hf|GE Healthcare AS|Iohexol||16924||16924|24792||2|H|0|0|||0 019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|GEH|0|0|0|100|NOK|20242|28876|lyfalmen|||1|500|0||Icepharma hf|GE Healthcare AS|Iohexol||20242||20242|28876||2|H|0|0|||0 019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|GEH|0|0|0|100|NOK|18200|26548|lyfalmen|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||18200||18200|26548||2|H|0|0|||0 019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|GEH|0|0|0|100|NOK|24494|34254|lyfalmen|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||24494||24494|34254||2|H|0|0|||0 019150|J06BA0209|Nanogam|irl|50|mg/ml|200|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|SPP|0|1|0|100|IKR|97078|126058|lyfsjukr|||1|200|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||97078||97078|126058||2|H|L|0|||0 019214|J06BA0209|Nanogam|irl|50|mg/ml|100|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|SPP|0|1|0|100|IKR|48541|64668|lyfsjukr|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||48541||48541|64668||2|H|L|0|||0 019221|J06BA0209|Nanogam|irl|50|mg/ml|50|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|SPP|0|1|0|100|IKR|24272|33973|lyfsjukr|||1|50|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||24272||24272|33973||2|H|L|0|||0 019308|QG03XB9001|Alizin, vet|stl|30|mg/ml|10|ml|1|hgl|fyrir hunda (tíkur)|QG03XB90|01.05.2012||R|0|0|0|0|0|VIR|1|0|0|100|XEU|6009|11571|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Aglepristonum||6009||6009|11571||1|0||0|||0 019372|C03CA0110|Impugan|töflur|20|mg|100|stk|1|glas||C03CA01|01.02.2014||R|1|0|0|G|0|ATE|0|0|0|100|SEK|466|2029|lyfalmen|V0633|2029|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fúrósemíð||386||386|2029||1|0|G|0|||0 019403|QJ51CE0901|Carepen vet.|spenalyf|600|mg|10|g|100|dælur||QJ51CE09|01.04.2010||R|0|0|0|0|0|CAR|0|0|0|100|DKK|32867|62526|vetalmen|||0|1000|0||Vistor hf|Vetcare Ltd.|Benzylpenicillínprokaín||32867||32867|62526||1|0||0|||0 019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|0|0|0|0|0|NED|0|0|0|100|XEU|6265|10121|lyfalmen|||1|56|0|18,6700|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6265||6265|10121||2|0|E|0|||0 019445|L01XC0701|Avastin|irþ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|0|0|RRG|0|1|0|100|DKK|46683|62318|lyfsjukr|||1|4|0||Icepharma hf|Roche Registration GmbH|Bevacizúmab||46683||46683|62318||2|H|L|0|||0 019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|0|0|0|0|0|NED|0|0|0|100|XEU|5852|9553|lyfalmen|||1|56|0|37,3300|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||5852||5852|9553||2|0|E|0|||0 019781|L01XC0701|Avastin|irþ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|0|0|RRG|0|1|0|100|DKK|176757|226347|lyfsjukr|||1|16|0||Icepharma hf|Roche Registration GmbH|Bevacizúmab||176757||176757|226347||2|H|L|0|||0 019786|J01CA0411|Amoxicillin Mylan|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|0|0|0|0|0|MYL|0|0|1|100|SEK|916|2439|lyfalmen|V0159|2324|2|20|0|6,6667|Icepharma hf|Mylan AB|Amoxicillín||684||684|2439||2|0|E|0|||0 019797|L01BA0401|Alimta|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|0|0|0|0|0|NED|0|1|0|100|XEU|156532|201193|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||156532||156532|201193||2|H|L|0|||0 019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|DAN|0|0|0|100|XEU|12235|18338|lyfalmen|V0812|2940|1|28|0|3,5000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12235||12235|18338||2|0|E|0|||0 019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|DAN|0|0|0|100|XEU|12235|18338|lyfalmen|V0813|2940|1|28|0|6,3000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12235||12235|18338||2|0|E|0|||0 019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|DAN|0|0|0|100|XEU|11556|17404|lyfalmen|V0814|2940|1|28|0|8,7500|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||11556||11556|17404||2|0|E|0|||0 019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|DAN|0|0|0|100|XEU|11556|17404|lyfalmen|V0815|2940|1|28|0|14,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||11556||11556|17404||2|0|E|0|||0 019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|DAN|0|0|0|100|XEU|11556|17404|lyfalmen|V0816|3068|1|28|0|21,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||11556||11556|17404||2|0|E|0|||0 019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|þpakki|600+300 mg|J05AR02|01.05.2004||R|0|0|1|0|0|VIC|0|1|0|100|DKK|24112|33770|lyfsjukr|||1|30|0|30,0000|Vistor hf|ViiV Healthcare BV|Lamívúdín og abacavír||24112||24112|33770||1|0|L|0|||0 019968|J01CA0411|Amoxicillin Mylan|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|0|0|0|0|0|MYL|0|0|1|100|SEK|1137|2841|lyfalmen|V0160|2777|2|30|0|10,0000|Icepharma hf|Mylan AB|Amoxicillín||976||976|2841||2|0|E|0|||0 020011|N06AB0405|Citalopram PCD|filmhtfl|40|mg|100|stk|1|þpakki||N06AB04|01.04.2018||R|1|0|0|G|0|PDA|0|0|0|100|IKR|4500|7692|lyfalmen|V0320|7692|2|100|0|200,0000|LYFIS ehf|PharmaCoDane ApS|Cítalópram||4500||4500|7692||2|0|G|0|||0 020016|B03AA0704|Duroferon|forðatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|1|0|0|0|0|AHN|0|0|1|100|IKR|||lyflausa|||0|100|0|50,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Ferrósúlfat|||||||1|0||0|||0 020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|100|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Díklófenak|||||||1|0||0|||0 020244|J07CA0204|Boostrix Polio|stl|||0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|0|0|0|0|0|GPH|0|0|0|100|DKK|30084|41324|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Pharma A/S|barnaveiki, kíghósti, mænusótt, stífkrampi||30084||30084|41324||1|0||0|||0 020276|A06AB0203|Dulcolax (Lyfjaver)|eþ-stíll|10|mg|50|stk|1|þpakki||A06AB02|01.07.2005||R|0|0|0|0|0|LVR|0|0|0|100|NOK|2671|5174|lyfalmen|||3|50|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||2671||2671|5174||3|0|E|0|||0 020282|L01XX2301|Lysodren|töflur|500|mg|100|stk|1|glas||L01XX23|01.04.2015||R|0|0|1|0|0|RPR|0|1|0|100|XEU|92255|119958|lyfsjukr|||1|100|0||Laboratoire HRA Pharma|HRA Pharma Rare Diseases|Mitotanum||92255||92255|119958||0|0|L|0|||0 020292|M02AA1502|Voltaren|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.06.2010||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|50|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Díklófenak|||||||1|0||0|||0 020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|1|G|0|REI|0|0|0|100|DKK|46154|61649|lyfalmen|||1|2|0|155,7500|Vistor hf|Recordati Ireland Limited|Leuprórelín||46154||46154|61649||1|0|G|0|||0 020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|1|G|0|REI|0|0|0|100|DKK|21387|30324|lyfalmen|||1|2|0|51,9400|Vistor hf|Recordati Ireland Limited|Leuprórelín||21387||21387|30324||1|0|G|0|||0 020685|C08DB0109|Dilmin|forðatfl|120|mg|100|stk|1|þpakki||C08DB01|01.09.2013||R|0|0|0|G|0|RTH|0|0|0|100|XEU|6233|10077|lyfalmen|||2|100|0|50,0000|Alvogen|ratiopharm GmbH|Diltíazem||6233||6233|10077||2|0|G|0|||0 020770|QP54AA5101|Eqvalan Duo|pasta|||7,74|g|1|sk-dæl||QP54AA51|01.10.2006||R|0|0|0|0|0|BOA|0|0|0|100|XEU|2107|3632|vetorma|||0|7,74|0||Vistor hf|Boehringer Ingelheim Animal Health SCS|Ivermectinum í blöndum||2107||2107|3632||1|0||0|||0 020845|N07XX0401|Xyrem|mixtúra|500|mg/ml|180|ml|1|glas|millist., mælispr. + 2 bollar|N07XX04|01.02.2016||R|0|1|1|0|0|UCC|0|0|0|100|DKK|47301|63100|lyfalmen|||1|180|0|12,0000|Vistor hf|UCB Pharma S.A.|sodium oxybate||||47301|63100||1|0|E|3|||0 020992|C09AA0402|Coversyl Novum|filmhtfl|5|mg|30|stk|1|glas||C09AA04|01.08.2011||R|1|0|0|0|0|LLS|0|0|0|100|DKK|2469|4896|lyfalmen|||1|30|0|37,5000|Icepharma hf|Les Laboratoires Servier|Perindópríl||2469||2469|4896||2|0||0|||0 021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|0|0|0|0|0|GAN|0|0|0|100|XEU|1925|4147|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen||1925||1925|4147||2|0||0|||0 021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.03.2005||R|1|0|0|G|0|ATE|0|0|1|100|IKR|633|2357|lyfalmen|V0188|1911|2|30|0|15,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díklófenak||624||624|2357||1|0|G|0|||0 021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.2005||R|1|0|0|G|0|ATE|0|0|1|100|XEU|1339|2771|lyfalmen|V0189|2186|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díklófenak||925||925|2771||1|0|G|0|||0 021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|1|0|0|G|0|NVO|0|0|0|100|DKK|12145|18214|lyfalmen|V0490|15102|1|98|0|98,0000|Vistor hf|N.V. Organon|Montelúkast||12145||12145|18214||1|0|G|0|||0 021428|A06AB0201|Dulcolax|eþ-stíll|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|0|0|0|0|0|SNP|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Bisakódýl|||||||1|0||0|||0 021465|A16AX0501|Wilzin|hylki|25|mg|250|stk|1|glas||A16AX05|01.10.2016||R|1|0|0|G|0|ERD|0|0|0|100|XEU|33442|45571|lyfalmen|||1|250|0|41,6700|Recordati AB|Recordati Rare Diseases|zinc acetate||33442||33442|45571||3|0|G|0|||0 021589|A16AX0501|Wilzin|hylki|50|mg|250|stk|1|glas||A16AX05|01.10.2016||R|1|0|0|G|0|ERD|0|0|0|100|XEU|61264|80760|lyfalmen|||1|250|0|83,3300|Recordati AB|Recordati Rare Diseases|zinc acetate||61264||61264|80760||3|0|G|0|||0 021593|H01BA0201|Minirin|frþ.tfl|60|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|G|0|FEL|0|0|0|100|DKK|3800|6728|lyfalmen|||1|30|0|4,5000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||3800||3800|6728||1|0|G|0|||0 021604|H01BA0201|Minirin|frþ.tfl|60|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|G|0|FEL|0|0|0|100|DKK|12686|18959|lyfalmen|||1|100|0|15,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||12686||12686|18959||1|0|G|0|||0 021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|þpakki||C10AA07|01.01.2006||R|1|0|0|0|0|AZD|0|0|0|100|SEK|11900|17877|lyfalmen|V0214|4512|1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||11900||11900|17877||1|0|E|0|||0 021614|H01BA0201|Minirin|frþ.tfl|120|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|G|0|FEL|0|0|0|100|DKK|6334|10216|lyfalmen|||1|30|0|9,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||6334||6334|10216||1|0|G|0|||0 021625|A07EC0203|Pentasa Sachet|forðakyr|2|g|60|pokar|1|pakki||A07EC02|01.05.2011||R|0|0|0|G|0|FER|0|0|0|100|DKK|13934|20677|lyfalmen|||1|60|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||13934||13934|20677||1|0|G|0|||0 021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|FKA|0|0|0|100|DKK|15000|22144|lyfalmen|||2|1000|0||Vistor hf|Fresenius Kabi AB|Própófól||15000||15000|22144||1|H|0|0|||0 021641|H01BA0201|Minirin|frþ.tfl|120|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|G|0|FEL|0|0|0|100|DKK|17798|25995|lyfalmen|||1|100|0|30,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||17798||17798|25995||1|0|G|0|||0 021659|V01AA0304|Alutard SQ, derm. pter.|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|23089|32477|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||23089||23089|32477||1|0|G|0|||0 021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|FKA|0|0|0|100|DKK|8625|13369|lyfalmen|||2|500|0||Vistor hf|Fresenius Kabi AB|Própófól||8625||8625|13369||1|H|0|0|||0 021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|0|0|0|0|0|PLS|0|0|1|100|DKK|4128|7180|lyfalmen|||1|50|0|2,5000|Icepharma hf|Pfizer ApS|Tranexamsýra||4128||4128|7180||1|0|0|0|||0 021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|18485|26941|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||18485||18485|26941||1|0|G|0|||0 021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|NED|0|0|0|100|XEU|3217|5926|lyfalmen|V0692|2328|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||3217||3217|5926||2|0|E|0|||0 021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|NED|0|0|0|100|XEU|4520|7719|lyfalmen|V0693|5566|1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||4520||4520|7719||2|0|E|0|||0 021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|NED|0|0|0|100|XEU|11807|17749|lyfalmen|V0694|4357|1|98|0|98,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||11807||11807|17749||2|0|E|0|||0 021999|L01XX3501|Xagrid|hylki|0,5|mg|100|stk|1|glas|hart|L01XX35|01.10.2012||R|0|0|1|G|0|SCL|0|0|0|100|DKK|24475|34230|lyfalmen|V1034|34230|1|100|0||Shire Sweden AB |Shire Pharmaceuticals Ireland Limited|Anagrelidum||24475||24475|34230||1|0|G|0|||0 022050|J01CF0204|Cloxacillin Navamedic Nordic|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.03.2016||R|0|0|0|0|0|VIN|0|0|1|100|XEU|2620|5104|lyfalmen|V1053|5104|1|10|0|5,0000|Icepharma hf|Villerton Invest SA|Kloxacillín||2620||2620|5104||2|0|0|0|||0 022112|B05AA0112|Flexbumin|irl|200|g/líter|100|ml|12|pokar|lausn|B05AA01|01.06.2010||R|0|0|0|0|0|AXA|0|0|0|100|DKK|99280|128843|lyfalmen|||1|1200|0||Baxalta Innovations GmbH|Baxalta Innovations GmbH|albumin||99280||99280|128843||1|H|0|0|||0 022165|A10AB0606|Apidra [Clikstar]|stl|100|ein/ml|3|ml|5|lykjur|Clikstar/JuniorStar pennar|A10AB06|01.07.2010||R|0|0|0|G|0|SDH|0|0|0|100|XEU|4223|7310|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insúlín glúlisín||4223||4223|7310||1|0|G|0|||0 022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|0|0|1|0|0|LPT|0|0|0|100|XEU|14804|21874|lyfalmen|||1|1|0||Teva Pharma Iceland ehf|Allergan Pharmaceuticals Ireland|Clostridium botulinum toxín-A||14804||14804|21874||1|0||0|||0 022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|VEO|0|0|0|100|DKK|2154|3713|vetorma|||0|2,24|0||Icepharma hf|Vetoquinol S.A.|Prazikvantelum í blöndum||2154||2154|3713||2|0||0|||0 022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|G|0|UPJ|0|0|0|100|DKK|3607|3156|lyfalmen|V0056|2229|1|100|0|100,0000|Icepharma hf|Upjohn EESV|Amlódipín||1205||1205|3156||1|0|G|0|||0 022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|G|0|UPJ|0|0|0|100|DKK|6396|4116|lyfalmen|V0057|2229|1|100|0|200,0000|Icepharma hf|Upjohn EESV|Amlódipín||1902||1902|4116||1|0|G|0|||0 022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|VEO|0|0|0|100|DKK|2040|3516|vetorma|||0|1,4|0||Icepharma hf|Vetoquinol S.A.|Prazikvantelum í blöndum||2040||2040|3516||2|0||0|||0 022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|VEO|0|0|0|100|DKK|1321|2277|vetorma|||0|0,7|0||Icepharma hf|Vetoquinol S.A.|Prazikvantelum í blöndum||1321||1321|2277||2|0||0|||0 022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1899|3960|lyfalmen|V0321|3960|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paroxetín||1789||1789|3960||1|0|G|0|||0 022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|15|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||4131||2|0|G|0|||0 022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|0|1|1|G|0|ATE|0|0|0|30|XEU|2151|4459|lyfalmen|||2|30|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ísótretínóín||2151||2151|4459||1|0|G|0|||0 022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|0|1|1|G|0|ATE|0|0|0|30|XEU|3197|4918|lyfalmen|V0125|3777|2|30|0|20,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ísótretínóín||2485||2485|4918||1|0|G|0|||0 023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|0|1|1|0|0|GEI|0|1|0|100|DKK|63443|83516|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland|Tenófóvír dísóproxíl og emtrícítabín||63443||63443|83516||2|0|L|0|||0 023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|1|0|0|SHE|0|0|0|100|DKK|22764|32066|lyfalmen|||1|90|0|20,0000|Shire Pharmaceuticals Ireland Limited|Shire Pharmaceuticals Ireland Limited|Lanthanum karbónat||22764||22764|32066||1|0||0|||0 023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|1|0|0|SHE|0|0|0|100|DKK|34927|47449|lyfalmen|||1|90|0|30,0000|Shire Pharmaceuticals Ireland Limited|Shire Pharmaceuticals Ireland Limited|Lanthanum karbónat||34927||34927|47449||1|0||0|||0 023114|D10BA0106|Isotretinoin ratiopharm|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.09.2014||R|0|1|1|G|0|RTH|0|0|0|30|IKR|3000|3907|lyfalmen|V0125|3777|2|30|0|20,0000|Alvogen|ratiopharm GmbH|Ísótretínóín||1750||1750|3907||2|0|G|0|||0 023124|G04BD1001|Emselex|forðatfl|7,5|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|0|0|0|G|0|ZRP|0|0|0|100|DKK|12859|19197|lyfalmen|||1|98|0|98,0000|POA Pharma Scandinavia AB|zr pharma& GmbH|Darífenacín||12859||12859|19197||1|0|G|0|||0 023125|D10BA0106|Isotretinoin ratiopharm|hylki|20|mg|60|stk|1|þpakki||D10BA01|01.09.2014||R|0|1|1|G|0|RTH|0|0|0|30|IKR|5231|7554|lyfalmen|V0125|7554|2|60|0|40,0000|Alvogen|ratiopharm GmbH|Ísótretínóín||4400||4400|7554||2|0|G|0|||0 023193|G04BD1001|Emselex|forðatfl|15|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|0|0|0|G|0|ZRP|0|0|0|100|DKK|15228|22458|lyfalmen|||1|98|0|196,0000|POA Pharma Scandinavia AB|zr pharma& GmbH|Darífenacín||15228||15228|22458||1|0|G|0|||0 023329|N03AX1206|Gabapentin Mylan|hylki|300|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|G|0|MYL|0|0|0|100|SEK|2239|3067|lyfalmen|V0250|2453|2|100|0|16,6667|Icepharma hf|Mylan AB|Gabapentín||1140||1140|3067||2|0|G|0|||0 023376|N03AX1206|Gabapentin Mylan|hylki|400|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|G|0|MYL|0|0|0|100|SEK|2890|3613|lyfalmen|V0251|3150|2|100|0|22,2200|Icepharma hf|Mylan AB|Gabapentín||1537||1537|3613||2|0|G|0|||0 023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.07.2007|31.08.2021|R|1|0|0|G|0|SGB|0|0|0|100|XEU|15927|23420|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis groupe|Klópídógrel||15927||15927|23420||1|0|G|0|||0 023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|0|0|0|G|0|SAO|0|0|0|100|XEU|1945|4175|lyfalmen|||1|12|0|30,0000|Icepharma hf|Santen Oy|Tímólól||1945||1945|4175||2|0|G|0|||0 023608|N01AB0802|Sevofluran Baxter|innö.guf|100|%|250|ml|6|fl||N01AB08|01.04.2012||R|0|0|0|0|0|BAM|0|0|0|100|SEK|118421|153794|lyfalmen|||2|1500|0||Icepharma hf|Baxter Medical AB|Sevóflúran||118421||118421|153794||2|H|0|0|||0 023641|C09AA0211|Enalapril Krka|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|900|2737|lyfalmen|V0066|2693|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||900||900|2737||2|0|G|0|||0 023649|C09AA0211|Enalapril Krka|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|1050|2943|lyfalmen|V0449|2943|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||1050||1050|2943||2|0|G|0|||0 023738|C09AA0211|Enalapril Krka|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|750|2530|lyfalmen|V0448|2309|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||750||750|2530||2|0|G|0|||0 023847|N06AX1106|Mirtazapin Krka|filmhtfl|45|mg|100|stk|1|þpakki||N06AX11|01.04.2015||R|1|0|0|0|0|KRK|0|0|0|100|IKR|6144|9955|lyfalmen|||2|100|0|150,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||6144||6144|9955||2|0|G|0|||0 023897|N06AX1106|Mirtazapin Krka|filmhtfl|30|mg|100|stk|1|þpakki||N06AX11|01.01.2015||R|1|0|0|G|0|KRK|0|0|0|100|IKR|2327|3975|lyfalmen|V0673|3975|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||1800||1800|3975||2|0|G|0|||0 023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.08.2006||R|0|0|1|G|0|UPJ|0|0|0|100|DKK|26098|36282|lyfalmen|V0984|27989|1|90|0|36,0000|Icepharma hf|Upjohn EESV|Síldenafíl||26098||26098|36282||1|0|G|0|||0 023993|A02BC0308|Lansoprazol Krka|sþ-hylki|30|mg|98|stk|1|ílát||A02BC03|01.08.2018||R|1|0|0|G|0|KRK|0|0|1|100|IKR|3500|4939|lyfalmen|V0007|4939|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Lansóprazól||2500||2500|4939||2|0|G|0|||0 024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|1|0|0|G|0|NVO|0|0|0|100|DKK|2538|4991|lyfalmen|||1|100|0|16,6667|Vistor hf|N.V. Organon|Levódópa og dópadekarboxýl­asa­hemill||2538||2538|4991||1|0|G|0|||0 024040|A04AA0109|Ondansetron STADA|filmhtfl|8|mg|30|stk|1|þpakki||A04AA01|01.06.2021||R|1|0|0|G|0|ASR|0|0|1|100|IKR|6000|9756|lyfalmen|V0384|9756|2|30|0|15,0000|LYFIS ehf|STADA Arzneimittel AG|Ondansetrón||6000||6000|9756||2|0|G|0|||0 024053|A04AA0109|Ondansetron STADA|filmhtfl|4|mg|10|stk|1|þpakki||A04AA01|01.06.2021||R|1|0|0|G|0|ASR|0|0|1|100|IKR|2992|4526|lyfalmen|V0381|4526|2|10|0|2,5000|LYFIS ehf|STADA Arzneimittel AG|Ondansetrón||2200||2200|4526||2|0|G|0|||0 024112|A16AA0501|Carbaglu|dreifit.|200|mg|5|stk|1|glas||A16AA05|01.12.2016||R|0|0|1|0|0|ECO|0|0|0|100|XEU|59056|77968|lyfalmen|||1|5|0|5,0000|Recordati AB|Recordati Rare Diseases|Carglumicsýra||59056||59056|77968||3|0|E|0|||0 024276|N06AB0607|Sertralin Krka|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.07.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|3264|4251|lyfalmen|V0323|4251|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Sertralín||2000||2000|4251||2|0|G|0|||0 024307|V01AA1105|Alutard SQ, hundahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|66620|87535|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||66620||66620|87535||1|0|G|0|||0 024366|N06AB0607|Sertralin Krka|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.07.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|1926|3012|lyfalmen|V0322|2971|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Sertralín||1100||1100|3012||2|0|G|0|||0 024478|V04CL0016|Soluprick SQ ALK553 - hundahár|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|ALK|0|0|0|100|DKK|11911|17892|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||11911||11911|17892||1|0||0|||0 024482|V04CL0017|Soluprick SQ ALK555 - kattahár|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|ALK|0|0|0|100|DKK|11720|17629|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||11720||11720|17629||1|0||0|||0 024583|V04CL0011|Soluprick SQ ALK225 - Vallarfoxgras|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|ALK|0|0|0|100|DKK|9351|14369|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||9351||9351|14369||1|0||0|||0 024603|V04CL0001|Soluprick Negativ Kontrol|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|ALK|0|0|0|100|DKK|2324|4697|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||2324||2324|4697||1|0||0|||0 024622|V04CL0005|Soluprick SQ ALK108 - Birkifrjó|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|ALK|0|0|0|100|DKK|9351|14369|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||9351||9351|14369||1|0||0|||0 024670|V04CL0014|Soluprick SQ ALK504 - Rykmaur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|ALK|0|0|0|100|DKK|9491|14561|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||9491||9491|14561||1|0||0|||0 024681|V04CL0002|Soluprick Positiv Kontrol|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|ALK|0|0|0|100|DKK|2324|4697|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||2324||2324|4697||1|0||0|||0 024901|C07AB0212|Metoprolin|töflur|100|mg|100|stk|1|þpakki||C07AB02|01.01.2014||R|1|0|0|G|0|RTH|0|0|0|100|IKR|1820|4003|lyfalmen|||2|100|0|66,6667|Alvogen|ratiopharm GmbH|Metóprólól||1820||1820|4003||2|0|G|0|||0 025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|51922|68945|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||51922||51922|68945||1|0|G|0|||0 025239|C07AB0212|Metoprolin|töflur|50|mg|100|stk|1|þpakki||C07AB02|01.01.2014||R|1|0|0|G|0|RTH|0|0|0|100|IKR|1547|3627|lyfalmen|||2|100|0|33,3333|Alvogen|ratiopharm GmbH|Metóprólól||1547||1547|3627||2|0|G|0|||0 025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|0|0|1|0|0|BSP|0|1|0|100|DKK|54006|71580|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||54006||54006|71580||1|0|L|0|||0 025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|0|0|0|0|0|BOI|1|0|0|100|DKK|9160|17549|vetalmen|||0|20|0||Vistor hf|Boehringer Ingelheim|Meloxícam||9160||9160|17549||1|0||0|||0 025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|0|0|1|0|0|ALK|0|0|0|100|DKK|14361|21264|lyfalmen|||1|30|0||Vistor hf|ALK-Abello A/S|grasfrjó||14361||14361|21264||1|0|E|0|||0 025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|þpakki||M05BA06|01.01.2006||R|0|0|0|0|0|ATP|0|0|0|100|DKK|5016|8402|lyfalmen|V0205|1279|1|1|0|30,0000|Pharmanovia A/S|Atnahs Pharma Netherlands B.V.|Íbandrónsýra||5016||5016|8402||2|0|E|0|||0 025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2006||R|0|0|0|0|0|ATP|0|0|0|100|DKK|13442|19999|lyfalmen|V0205|3838|1|3|0|90,0000|Pharmanovia A/S|Atnahs Pharma Netherlands B.V.|Íbandrónsýra||13442||13442|19999||2|0|E|0|||0 025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|0|0|1|0|0|ALK|0|0|0|100|DKK|41662|55968|lyfalmen|||1|100|0||Vistor hf|ALK-Abello A/S|grasfrjó||41662||41662|55968||1|0|E|0|||0 025747|C01BB0101|Xylocard 100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|0|0|0|0|0|MAR|0|0|0|100|DKK|5930|9660|lyfalmen|||1|25|0|0,1667|Icepharma hf|Aspen Pharma|Lídókaín||5930||5930|9660||2|H|0|0|||0 025814|H01AC0114|Norditropin NordiFlex|stl|15|mg|1,5|ml|1|áfpen||H01AC01|01.04.2021||R|0|0|1|0|0|NAS|0|1|0|100|DKK|42282|56752|lyfsjukr|||1|1,5|0|22,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||42282||42282|56752||1|0|L|0|||0 025841|V01AA1106|Alutard SQ, kattahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|66959|87963|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||66959||66959|87963||1|0|G|0|||0 025911|QD11AH9102|Cytopoint|stl|10|mg|1|ml|2|hgl||QD11AH91|01.08.2021||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|11313|21634|vetalmen|||1|2|0||Icepharma hf|Zoetis Belgium S.A.|lokivetmab||11313||11313|21634||2|0||0|||0 025917|L04AX0201|Thalidomide Celgene|hylki|50|mg|28|stk|1|þpakki|hart|L04AX02|01.09.2011||R|0|1|1|0|0|CPV|0|1|0|100|DKK|49265|65584|lyfsjukr|||1|28|0|14,0000|Celgene Europe ltd|Celgene Europe B.V.|Thalidómíde||||49265|65584||2|0|L|0|||0 025927|N06AX2601|Brintellix|filmhtfl|20|mg|98|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|LUN|0|0|0|100|DKK|27260|37752|lyfalmen|||1|98|0|196,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||27260||27260|37752||1|0||0|||0 025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|BOA|0|0|0|100|XEU|3708|6391|vetorma|||0|1|0||Vistor hf|Boehringer Ingelheim Animal Health SCS|Ivermectinum||3708||3708|6391||1|0||0|||0 025978|L03AX1302|Remurel|stl|20|mg/ml|28|áf.spr|1|pakki||L03AX13|01.07.2017||R|0|0|1|G|0|ZET|0|0|0|100|XEU|87790|87087|lyfalmen|||2|28|0|28,0000|Alvogen|Zentiva, k.s.|Glatíramer acetat||66266||66266|87087||2|0|G|0|||0 025997|A07DA0303|Immex|töflur|2|mg|20|stk|1|þpakki||A07DA03|01.09.2015||L|1|0|0|0|0|GOV|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Alvogen|Alvogen ehf|Lóperamíð|||||||2|0||0|||0 026000|QS02CA0301|Easotic|eyrnadr|||10|ml|1|fl|dreifa|QS02CA03|01.04.2012||R|0|0|0|0|0|VIR|0|0|0|100|XEU|2088|4104|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Hýdrókortisón,miconazol,gentamicin||2088||2088|4104||1|0||0|||0 026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|BOA|0|0|0|100|XEU|8847|15249|vetorma|||0|2,5|0||Vistor hf|Boehringer Ingelheim Animal Health SCS|Ivermectinum||8847||8847|15249||1|0||0|||0 026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|52260|69372|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||52260||52260|69372||1|0|G|0|||0 026490|L04AD0204|Dailiport|forðahlk|2|mg|50|stk|1|stsk.þ||L04AD02|01.09.2020||R|0|0|1|G|0|SHS|0|0|0|100|DKK|15935|23431|lyfalmen|||2|50|0|20,0000|Artasan ehf|Sandoz A/S|Tacrolimus||15935||15935|23431||1|0|G|0|||0 026569|R02AA0305|Strepsils Cool|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.2010||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0||0|||0 026571|N03AX1801|Vimpat|filmhtfl|50|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|G|0|UCB|0|0|0|100|DKK|1737|3889|lyfalmen|||1|14|0|2,3300|Vistor hf|U.C.B|Lacosamíð||||1737|3889||1|0|G|0|||0 026582|N03AX1801|Vimpat|filmhtfl|50|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|G|0|UCB|0|0|0|100|DKK|6857|10936|lyfalmen|||1|56|0|9,3300|Vistor hf|U.C.B|Lacosamíð||||6857|10936||1|0|G|0|||0 026593|N03AX1801|Vimpat|filmhtfl|100|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|G|0|UCB|0|0|0|100|DKK|3431|6220|lyfalmen|||1|14|0|4,6700|Vistor hf|U.C.B|Lacosamíð||||3431|6220||1|0|G|0|||0 026605|N03AX1801|Vimpat|filmhtfl|100|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|G|0|UCB|0|0|0|100|DKK|13391|19929|lyfalmen|||1|56|0|18,6700|Vistor hf|U.C.B|Lacosamíð||||13391|19929||1|0|G|0|||0 026627|N03AX1801|Vimpat|filmhtfl|150|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|G|0|UCB|0|0|0|100|DKK|19990|29012|lyfalmen|||1|56|0|28,0000|Vistor hf|U.C.B|Lacosamíð||||19990|29012||1|0|G|0|||0 026638|N03AX1801|Vimpat|filmhtfl|200|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|G|0|UCB|0|0|0|100|DKK|26535|36835|lyfalmen|||1|56|0|37,3300|Vistor hf|U.C.B|Lacosamíð||||26535|36835||1|0|G|0|||0 026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|MEA|0|0|1|100|DKK|1254|3224|lyfalmen|||2|100|0|25,0000|Icepharma hf|Meda AB|Nítrófúrantóín||1254||1254|3224||2|0|0|0|||0 026698|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|14|stk|1|glas|hart|A02BC01|01.02.2012||L|1|0|0|0|0|RTH|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Alvogen|ratiopharm GmbH|Ómeprazól|||||||2|0||0|||0 026943|C09CA0106|Losatrix|filmhtfl|100|mg|100|stk|1|þpakki||C09CA01|01.01.2014||R|1|0|0|G|0|RTH|0|0|0|100|DKK|9785|14966|lyfalmen|V0099|14966|2|100|0|200,0000|Alvogen|ratiopharm GmbH|Lósartan||9785||9785|14966||2|0|G|0|||0 027017|N06BA0202|Attentin|töflur|5|mg|30|stk|1|þpakki||N06BA02|01.08.2017||R|1|1|0|0|0|PUT|0|0|0|100|IKR|4622|7860|lyfalmen|||1|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Dexamfetamine ||||4622|7860||2|0|E|1|30|dagar|0 027051|A10BK0301|Jardiance|filmhtfl|10|mg|90|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|G|0|BOE|0|0|0|100|DKK|16986|24877|lyfalmen|||1|90|0|51,4300|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||16986||16986|24877||1|0|G|0|||0 027058|N06AX1106|Mirtazapin Krka|filmhtfl|15|mg|100|stk|1|þpakki||N06AX11|01.01.2015||R|1|0|0|G|0|KRK|0|0|0|100|IKR|2043|3700|lyfalmen|V0823|3700|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||1600||1600|3700||2|0|G|0|||0 027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|MEA|0|0|1|100|DKK|881|2711|lyfalmen|||2|50|0|1,2500|Icepharma hf|Meda AB|Nítrófúrantóín||881||881|2711||2|0||0|||0 027202|S01ED5111|Azarga|augndr|15|mg/ml|5|ml|1|glas|10+5 mg/ml|S01ED51|01.10.2009||R|0|0|0|G|0|NEL|0|0|0|100|DKK|2053|4324|lyfalmen|||1|5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Tímólól í blöndum||2053||2053|4324||1|0|G|0|||0 027281|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|12611|11049|lyfalmen|||2|100|0|66,6600|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Dónepezíl||6939||6939|11049||1|0|G|0|||0 027305|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|12143|11049|lyfalmen|V0342|11049|2|100|0|133,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Dónepezíl||6939||6939|11049||1|0|G|0|||0 027505|B05BB0121|Plasmalyte|irl|||1000|ml|10|pokar|lausn|B05BB01|01.05.2014||R|0|0|0|0|0|BAM|0|0|1|100|SEK|2357|4742|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||2357||2357|4742||2|0|0|0|||0 027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|1|0|0|G|0|EIG|0|0|0|100|SEK|6058|9836|lyfalmen|||1|56|0|7,0000|Vistor hf|Eisai GmbH|Zonisamíð||6058||6058|9836||1|0|G|0|||0 027627|N02AE0101|Bupremyl|forðapl|20|mcg/klst|4|stk|1|skpoki||N02AE01|01.03.2018|30.09.2021|R|0|0|0|G|0|MYL|0|0|0|100|SEK|3915|4189|lyfalmen|||2|4|0|11,2000|Icepharma hf|Mylan AB|Búprenorfín||1955||1955|4189||2|0|G|1|30|dagar|0 027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|1|0|0|G|0|OHS|0|0|0|100|DKK|577|2292|lyfalmen|||2|100|0|33,3300|Vistor hf|Orifarm Healthcare A/S|Levótýroxínnatríum||577||577|2292||1|0|G|0|||0 027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|1|0|0|G|0|OHS|0|0|0|100|DKK|664|2412|lyfalmen|||2|100|0|66,6667|Vistor hf|Orifarm Healthcare A/S|Levótýroxínnatríum||664||664|2412||1|0|G|0|||0 027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|0|0|0|0|0|OPC|0|0|0|100|DKK|19602|28478|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||19602||19602|28478||1|0|E|0|||0 027976|N05AH0307|Zypadhera|sts|210|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|NED|0|0|0|100|XEU|29155|40149|lyfalmen|||1|1|0|21,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||29155||29155|40149||2|H|0|0|||0 027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|0|0|0|0|0|OPC|0|0|0|100|DKK|22230|31390|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||22230||22230|31390||1|0|E|0|||0 027988|N05AH0307|Zypadhera|sts|300|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|NED|0|0|0|100|XEU|34871|47378|lyfalmen|||1|1|0|30,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||34871||34871|47378||2|H|0|0|||0 027999|N05AH0307|Zypadhera|sts|405|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|NED|0|0|0|100|XEU|46982|62696|lyfalmen|||1|1|0|40,5000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||46982||46982|62696||2|H|0|0|||0 028045|G03AB0801|Qlaira|töflur|||84|stk|1|þpakki|3x28 stk|G03AB08|01.11.2009||R|0|0|0|0|0|BAB|0|0|0|100|DKK|4042|6321|lyfalm11|||1|84|0|84,0000|Icepharma hf|Bayer AB|Kaflaskipt lyf, prógestógen og östrógen||4042||4042|6321|30.9.2021|2|0||0|||1 028110|A10BD0701|Janumet|filmhtfl|900|mg|196|stk|1|þpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|G|0|MBV|0|0|0|100|DKK|16943|24818|lyfalmen|V0387|24818|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Metforminum og sitagliptinum||16943||16943|24818||1|0|G|0|||0 028112|R06AX2602|Nefoxef|filmhtfl|120|mg|30|stk|1|þpakki||R06AX26|01.07.2008||L|1|0|0|0|0|MYL|0|0|1|100|IKR|||lyfalmen|||2|30|0|30,0000|Icepharma hf|Mylan AB|Fexófenadín|||||2943||2|0||0|||0 028121|A10BD0701|Janumet|filmhtfl|1050|mg|196|stk|1|þpakki|50/1000mg|A10BD07|01.01.2010||R|1|0|0|G|0|MBV|0|0|0|100|DKK|16476|24175|lyfalmen|V0386|24175|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Metforminum og sitagliptinum||16476||16476|24175||1|0|G|0|||0 028268|R03DX0501|Xolair|stl|150|mg|1|áf.spr|1|pakki||R03DX05|01.04.2011||R|0|0|1|0|0|NEL|0|1|0|100|DKK|47170|62934|lyfsjukr|||1|1|0|9,3800|Vistor hf|Novartis Europharm Ltd|Omalizúmab||47170||47170|62934||1|0|L|0|||0 028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ aðsk. nál|J07AP03|01.05.2008||R|0|0|0|0|0|SSS|0|0|0|100|XEU|2939|5543|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Taugaveiki, hreinsaðir mótefnavakar||2939||2939|5543||1|0||0|||0 028342|J07BL0101|Stamaril|sts|||0,5|ml|1|hgl|+1 áf.spr.með leysi+2 nálar|J07BL01|01.04.2020|30.09.2021|R|0|0|0|0|0|SPU|0|0|0|100|XEU|3972|6965|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur|Gulusótt, veikluð veira||3972||3972|6965||1|0||0|||0 028351|J07BL0101|Stamaril|sts|||0,5|ml|10|hgl|+ 10 áf.spr. með leysi|J07BL01|01.01.1996||R|0|0|0|0|0|SSS|0|0|0|100|XEU|40335|54289|lyfalmen|||1|5|0||Vistor hf|Sanofi Pasteur Europe|Gulusótt, veikluð veira||||40335|54289||1|0||0|||0 028387|M03BX0105|Baklofen Mylan|töflur|25|mg|50|stk|1|glas||M03BX01|01.10.2008||R|1|0|0|G|0|MYL|0|0|1|100|SEK|2370|4481|lyfalmen|V0202|4225|2|50|0|25,0000|Icepharma hf|Mylan AB|Baklófen||2167||2167|4481||2|0|G|0|||0 028405|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|1|0|0|G|0|MYL|0|0|1|100|SEK|1754|3912|lyfalmen|V0428|3141|2|50|0|50,0000|Icepharma hf|Mylan AB|Naproxen||1754||1754|3912||2|0|G|0|||0 028497|N04BC0505|Oprymea|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2018||R|1|0|0|G|0|KAN|0|0|0|100|IKR|800|2530|lyfalmen|V0266|2527|2|30|0|1,5000|Krka Sverige AB|Krka d.d. Novo mesto|Pramipexól||750||750|2530||2|0|G|0|||0 028519|N04BC0505|Oprymea|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2018||R|1|0|0|G|0|KAN|0|0|0|100|IKR|2582|4388|lyfalmen|V0267|4347|2|100|0|10,0000|Krka Sverige AB|Krka d.d. Novo mesto|Pramipexól||2100||2100|4388||2|0|G|0|||0 028531|N04BC0505|Oprymea|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.05.2018||R|1|0|0|G|0|KAN|0|0|0|100|IKR|14853|21942|lyfalmen|||2|100|0|40,0000|Krka Sverige AB|Krka d.d. Novo mesto|Pramipexól||14853||14853|21942||2|0|G|0|||0 028586|N03AX0901|Lamictal|dreifit.|100|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|G|0|GPH|0|0|0|100|DKK|5818|5022|lyfalmen|V0245|4679|1|98|0|32,6667|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||2560||2560|5022||1|0|G|0|||0 028598|N03AX0901|Lamictal|dreifit.|200|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|G|0|GPH|0|0|0|100|DKK|10961|11098|lyfalmen|V0232|9761|1|98|0|65,3333|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||6975||6975|11098||1|0|G|0|||0 028599|N04BC0508|Pramipexole Alvogen|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.02.2010||R|1|0|0|G|0|POF|0|0|0|100|XEU|760|2527|lyfalmen|V0266|2527|2|30|0|1,5000|Alvogen|Alvogen|Pramipexól||748||748|2527||2|0|G|0|||0 028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|0|0|0|0|0|OCO|1|0|0|100|DKK|7602|14593|vetalmen|||0|10|0||Icepharma hf|Orion Corporation (I)|Dexmedetomidinum||7602||7602|14593||2|0||0|||0 028610|N04BC0508|Pramipexole Alvogen|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.02.2010||R|1|0|0|G|0|POF|0|0|0|100|XEU|2849|4347|lyfalmen|V0267|4347|2|100|0|10,0000|Alvogen|Alvogen|Pramipexól||2070||2070|4347||2|0|G|0|||0 029066|R01AD0801|Flixonase|nefúði|50|mcg/sk|120|skammtar|1|stauk||R01AD08|01.04.1992||R|0|0|0|G|0|GCA|0|0|1|100|DKK|1155|2967|lyfalmen|V0625|2190|1|120|0|30,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Flútíkasón||1067||1067|2967||1|0|G|0|||0 029078|N06AX2201|Valdoxan|filmhtfl|25|mg|28|stk|1|þpakki||N06AX22|01.01.2010||R|1|1|0|0|0|LLS|0|0|0|100|DKK|5940|9674|lyfalmen|||1|28|0|28,0000|Icepharma hf|Les Laboratoires Servier|Agómelatín||5940||5940|9674||2|0||0|||0 029100|N06AX2201|Valdoxan|filmhtfl|25|mg|84|stk|1|þpakki||N06AX22|01.01.2010||R|1|1|0|0|0|LLS|0|0|0|100|DKK|16340|23988|lyfalmen|||1|84|0|84,0000|Icepharma hf|Les Laboratoires Servier|Agómelatín||16340||16340|23988||2|0||0|||0 029198|R06AX2201|Kestine|filmhtfl|20|mg|30|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||1|30|0|60,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1|0|0|0|||0 029222|N02AB0309|Abstral|tungur.t|400|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|33718|45920|lyfalmen|||1|30|0|20,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||33718||33718|45920||2|0|E|1|30|dagar|0 029255|N02AB0309|Abstral|tungur.t|800|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|33718|45920|lyfalmen|||1|30|0|40,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||33718||33718|45920||2|0|E|1|30|dagar|0 029277|N02AB0309|Abstral|tungur.t|100|mcg|10|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|11221|16943|lyfalmen|V0801|15284|1|10|0|1,6700|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||11221||11221|16943||2|0|E|1|30|dagar|0 029292|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.07.2016||L|1|0|0|0|0|CAM|0|0|1|100|IKR|||lyflausa|||0|10|0|5,0000|CampusPharma AB|CampusPharma AB|Meklózín|||||||1|0||0|||0 029300|N02AB0309|Abstral|tungur.t|100|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|33663|45851|lyfalmen|V0801|45851|1|30|0|5,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||33663||33663|45851||2|0|E|1|30|dagar|0 029311|N02AB0309|Abstral|tungur.t|200|mcg|10|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|10963|16587|lyfalmen|||1|10|0|3,3300|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||10963||10963|16587|31.8.2021|2|0|E|1|30|dagar|0 029335|N02AB0309|Abstral|tungur.t|300|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|33718|45920|lyfalmen|||1|30|0|15,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||33718||33718|45920||2|0|E|1|30|dagar|0 029357|N02AB0309|Abstral|tungur.t|600|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|33718|45920|lyfalmen|||1|30|0|30,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||33718||33718|45920||2|0|E|1|30|dagar|0 029429|L01XX4101|Halaven|stl|0,44|mg/ml|2|ml|1|hgl|lausn|L01XX41|01.11.2011||R|0|0|0|0|0|EIG|0|1|0|100|SEK|47326|63132|lyfsjukr|||1|2|0||Vistor hf|Eisai GmbH|Eribulin||47326||47326|63132||1|H|L|0|||0 029800|J01AA0208|Oracea|hylki|40|mg|56|stk|1|þpakki|með br.losunarhraða|J01AA02|01.12.2011||R|0|0|0|0|0|GAN|0|0|1|100|XEU|5541|9125|lyfalmen|||1|56|0|22,4000|Icepharma hf|Galderma Nordic AB|Doxýcýklín||5541||5541|9125||2|0|E|0|||0 029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 029867|N07BA0152|Zonnic Mint|munnh.du|4|mg|20|stk|1|krukka|munnh.duft í posa|N07BA01|01.09.2017||L|0|0|0|0|0|NIC|0|0|1|100|IKR|||lyflausa|||0|20|0|2,6666|LYFIS ehf|Niconovum AB|Nikótín|||||||2|0||0|||0 029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 030136|J01CR0205|Spectracillin|filmhtfl|625|mg|20|stk|1|þpakki|500+125 mg|J01CR02|01.01.2017||R|0|0|0|0|0|WEH|0|0|1|100|IKR|1096|2874|lyfalmen|V0168|2873|2|20|0|6,6667|Williams & Halls efh|Williams & Halls ehf|Amoxicillín og beta-laktamasa hemill ||1000||1000|2874||2|0|E|0|||0 030170|J07AL0202|Prevenar 13|stl|2,2|mcg|0,5|ml|1|áf.spr||J07AL02|01.07.2014||R|0|0|0|0|0|PEU|0|0|0|100|DKK|7850|12303|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Europe MA EEIG|Hreinsuð pneumococca poly­sakkaríð mótefnavakar (cojugated)||7850||7850|12303||1|0||0|||0 030822|QI02AB0001|Startvac|stl|||2|ml|20|glös|fleyti|QI02AB|01.05.2010||R|0|0|0|0|0|LHS|0|0|0|100|XEU|15716|27088|vetorma|||0|40|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||15716||15716|27088||2|0||0|||0 031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|0|0|0|G|0|NED|0|0|0|100|XEU|2618|5101|lyfalmen|||1|10|0|25,0000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||2618||2618|5101||2|0|G|0|||0 031140|N06AX2701|Spravato|nefúði|28|mg|28|mg|2|úðaílá|lausn|N06AX27|01.10.2020||R|0|1|0|0|0|JCI|0|1|0|100|SEK|64263|84553|lyfsjukr|||1|56|0||Vistor hf|Janssen-Cilag International N.V.|Esketamine||64263||64263|84553||1|H|L|1|30|dagar|0 031201|L04AX0307|Metoject|stl|50|mg/ml|0,25|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|G|0|WIL|0|0|0|100|SEK|2433|4847|lyfalmen|||1|0,25|0|5,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2433||2433|4847||2|0|G|0|||0 031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|0|0|0|G|0|NAS|0|0|0|100|DKK|5487|9050|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5487||5487|9050||1|0|G|0|||0 031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|0|0|0|0|0|FEL|0|0|0|100|DKK|18343|26745|lyfalmen|||1|5|0|0,4200|Vistor hf|Ferring Lægemidler A/S|Terlípressín||18343||18343|26745||1|H|0|0|||0 032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|0|0|0|G|0|OPC|0|0|0|100|DKK|20211|28836|lyfalmen|||1|150|0|10,0000|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||20211||20211|28836||1|0|G|0|||0 032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|0|0|0|0|0|BOA|1|0|0|100|DKK|14709|25352|vetorma|||0|200|0||Vistor hf|Boehringer Ingelheim Animal Health SCS|Ivermectinum||14709||14709|25352||1|0||0|||0 032836|C09CA0107|Losartan Medical Valley|filmhtfl|50|mg|100|stk|1|þpakki||C09CA01|01.06.2016||R|1|0|0|G|0|VAL|0|0|0|100|IKR|2100|3170|lyfalmen|V0069|2943|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Lósartan||1215||1215|3170||2|0|G|0|||0 033124|L02BX0201|Firmagon|sts|80|mg|1|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|1|G|0|FER|0|0|0|100|DKK|21338|30262|lyfalmen|||1|1|0|29,6300|Vistor hf|Ferring|Degarelix||21338||21338|30262||1|0|G|0|||0 033135|L02BX0201|Firmagon|sts|120|mg|2|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|1|G|0|FER|0|0|0|100|DKK|38959|52549|lyfalmen|||1|2|0|88,8900|Vistor hf|Ferring|Degarelix||||38959|52549||1|0|G|0|||0 033193|QP54AA0105|Noromectin|pasta|18,7|mg/g|7,49|g|1|áf.spr|Fyrir hesta|QP54AA01|01.11.2011||R|0|0|0|0|0|BRO|0|0|0|100|IKR|1274|2196|vetorma|||0|7,49|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Ltd|Ivermectinum||1274||1274|2196||2|0||0|||0 033195|N02AA5501|Targin|forðatfl|15|mg|28|stk|1|þpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|0|0|0|MUP|0|0|0|100|DKK|2952|5561|lyfalmen|V1004|4617|1|28|0|3,7400|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||2952||2952|5561||2|0|E|1|30|dagar|0 033201|QJ01DD9001|Eficur vet.|stl|50|mg/ml|100|ml|1|hgl||QJ01DD90|01.02.2010||R|0|0|0|0|0|LHS|0|0|0|100|XEU|8769|16807|vetalmen|||0|100|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Ceftiofurhydróklóríð||||8769|16807||2|0||0|||0 033206|N02AA5501|Targin|forðatfl|15|mg|98|stk|1|þpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|0|0|0|MUP|0|0|0|100|DKK|10125|15434|lyfalmen|V1005|13408|1|98|0|13,0700|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||10125||10125|15434||2|0|E|1|30|dagar|0 033218|N02AA5501|Targin|forðatfl|30|mg|28|stk|1|þpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|0|0|0|MUP|0|0|0|100|DKK|5908|9630|lyfalmen|V1006|8073|1|28|0|7,4700|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||5908||5908|9630||2|0|E|1|30|dagar|0 033229|N02AA5501|Targin|forðatfl|30|mg|98|stk|1|þpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|0|0|0|MUP|0|0|0|100|DKK|19351|28133|lyfalmen|||1|98|0|26,1400|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||19351||19351|28133||2|0|E|1|30|dagar|0 033251|S01CA0102|Tobradex|augndr|||5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|0|0|0|G|0|HES|0|0|1|100|DKK|1469|3520|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Dexametasón||1469||1469|3520||1|0|G|0|||0 033357|M01AB0518|Diclomex Rapid|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.08.2013||R|1|0|0|G|0|GOV|0|0|1|100|XEU|1426|2800|lyfalmen|V0189|2186|2|100|0|50,0000|Alvogen|Alvogen ehf|Díklófenak||946||946|2800||2|0|G|0|||0 033498|M01AB0518|Diclomex Rapid|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.08.2013||R|1|0|0|G|0|GOV|0|0|1|100|XEU|633|2369|lyfalmen|V0188|1911|2|30|0|15,0000|Alvogen|Alvogen ehf|Díklófenak||633||633|2369||2|0|G|0|||0 033644|N07BC0202|Metadon Abcur|töflur|20|mg|100|stk|1|þpakki||N07BC02|01.04.2020||R|1|0|0|G|0|ABC|0|0|0|100|SEK|8591|13323|lyfalmen|||1|100|0|80,0000|Icepharma hf|Abcur AB|Metadón||8591||8591|13323||2|0|G|1|30|dagar|0 033777|L02BG0404|Letromal|filmhtfl|2,5|mg|100|stk|1|þpakki||L02BG04|01.04.2011||R|0|0|0|G|0|WEH|0|0|0|100|XEU|15691|21907|lyfalmen|V0185|21907|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Letrózól||14828||14828|21907||2|0|G|0|||0 033895|J05AE1001|Prezista|filmhtfl|600|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|1|0|1|0|0|JCI|0|1|0|100|SEK|37146|50256|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||37146||37146|50256||1|0|L|0|||0 034033|QJ01MA9001|Baytril vet.|töflur|50|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|BAN|0|0|0|100|DKK|2377|4672|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||2377|4672||2|0||0|||0 034124|C09BA0202|Enalapril comp ratiopharm|töflur|32,5|mg|100|stk|1|þpakki|20+12,5 mg|C09BA02|01.12.2013||R|1|0|0|G|0|RHA|0|0|0|100|XEU|2017|2585|lyfalmen|V0098|2583|2|100|0|100,0000|Alvogen|ratiopharm Oy|Enalapríl og þvagræsilyf||790||790|2585||2|0|G|0|||0 034401|J06BA0208|Privigen|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|CSB|0|1|0|100|SEK|22499|31730|lyfsjukr|||1|25|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||22499||22499|31730||2|H|L|0|||0 034613|N02AB0310|Fentanyl Alvogen|forðapl|50|mcg/klst|5|stk|1|skpoki||N02AB03|01.10.2020||R|0|0|0|G|0|POF|0|0|0|100|XEU|3444|6080|lyfalmen|V0220|6080|2|5|0|15,0000|Alvogen|Alvogen|Fentanýl||3329||3329|6080||2|0|G|1|30|dagar|0 034796|N06AB0604|Sertralin Bluefish|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.10.2017||R|1|0|0|G|0|BLS|0|0|0|100|XEU|3980|4450|lyfalmen|V0323|4251|2|100|0|200,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Sertralín||2145||2145|4450||1|0|G|0|||0 034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|0|0|0|G|0|HEA|0|0|1|100|SEK|1058|2954|lyfalmen|||1|6|0||Vistor hf|GlaxoSmithKline Consumer Healthcare A/S|Díklófenak||1058||1058|2954||1|0|G|0|||0 034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|0|0|0|G|0|HEA|0|0|1|100|SEK|2472|4900|lyfalmen|||1|12|0||Vistor hf|GlaxoSmithKline Consumer Healthcare A/S|Díklófenak||2472||2472|4900||1|0|G|0|||0 035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|0|0|0|0|0|LEP|0|0|1|100|DKK|6778|10827|lyfalmen|||1|25|0||Vistor hf|LEO Pharma A/S|Prótamín||6778||6778|10827||1|0|0|0|||0 035113|B05XA0501|Addex-Magnesium|irþ|1|mmol/ml|10|ml|10|plhgl||B05XA05|01.03.2010||R|0|0|0|0|0|FKA|0|0|0|100|DKK|1944|4174|lyfalmen|||1|100|0||Vistor hf|Fresenius Kabi AB|Magnesíum súlfat||1944||1944|4174||1|H|0|0|||0 035134|B01AF0201|Eliquis|filmhtfl|5|mg|14|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|G|0|BSM|0|0|0|100|DKK|2393|4792|lyfalmen|||1|14|0|7,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||2393|4792||1|0|G|0|||0 035212|A07EC0202|Pentasa|forðatfl|500|mg|300|stk|1|þpakki||A07EC02|01.04.1992||R|1|0|0|G|0|FER|0|0|0|100|DKK|14947|22071|lyfalmen|||1|300|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||14947||14947|22071||1|0|G|0|||0 035495|N02AJ0602|Parkodin forte|filmhtfl|530|mg|20|stk|1|þpakki|30+500 mg|N02AJ06|01.05.2018||R|1|0|0|0|0|ATE|0|0|1|100|XEU|613|2342|lyfalmen|||2|20|0|6,6667|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||613||613|2342||1|0|E|3|||0 035563|C07AB0211|Metoprolol ratiopharm|forðatfl|95|mg|100|stk|1|þpakki||C07AB02|01.05.2012||R|1|0|0|G|0|RTH|0|0|0|100|IKR|2334|3012|lyfalmen|V0049|2910|2|100|0|63,3333|Alvogen|ratiopharm GmbH|Metóprólól||1100||1100|3012||2|0|G|0|||0 035597|C07AB0211|Metoprolol ratiopharm|forðatfl|190|mg|100|stk|1|þpakki||C07AB02|01.06.2012||R|1|0|0|G|0|RTH|0|0|0|100|IKR|4390|5571|lyfalmen|V0054|4939|2|100|0|126,6667|Alvogen|ratiopharm GmbH|Metóprólól||2959||2959|5571||2|0|G|0|||0 035722|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|18|stk|1|þpakki||N02CC01|01.12.2015||R|1|0|0|G|0|BFP|0|0|0|100|XEU|2836|3338|lyfalmen|V0233|3338|2|18|0|18,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||1337||1337|3338||1|0|G|0|||0 035926|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1|0||0|||0 035982|B01AF0102|Rivaroxaban WH|filmhtfl|10|mg|98|stk|1|þpakki||B01AF01|01.02.2021||R|1|1|0|G|0|WEH|0|0|0|100|XEU|31129|42646|lyfalmen|V0975|42646|2|98|0|49,0000|Williams & Halls efh|Williams & Halls ehf|Rivaoxaban||31129||31129|42646||2|0|G|0|||0 036062|V03AE0202|Renvela|filmhtfl|800|mg|180|stk|1|pakki||V03AE02|01.04.2010|31.08.2021|R|0|0|0|0|0|GEB|0|0|0|100|XEU|22797|32107|lyfalmen|||1|180|0|22,5000|Vistor hf|Genzyme Europe B.V.|Sevelamer||22797||22797|32107||1|0||0|||0 036261|B01AC2201|Efient|filmhtfl|10|mg|28|stk|1|þpakki||B01AC22|01.11.2016||R|0|1|0|G|0|DSA|0|0|0|100|XEU|7952|12443|lyfalmen|V0806|9848|1|28|0|28,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Prasugrel||||7952|12443||2|0|G|0|||0 036339|N02BE5107|Paradorm|filmhtfl|525|mg|10|stk|1|þpakki|500+25 mg|N02BE51|01.09.2020||L|1|0|0|0|0|ACE|0|0|1|100|IKR|||lyflausa|||0|10|0|1,6666|Acare ehf|Acare ehf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)|||||||2|0|0|0|||0 036353|R06AX2708|Dasergin|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.04.2020||L|1|0|0|G|0|KAN|0|0|1|100|IKR|||lyfalmen|V0458|2979|2|100|0|100,0000|Krka Sverige AB|Krka d.d. Novo mesto|Deslóratadín|||||2979||2|0|G|0|||0 036431|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.09.2018||R|0|0|0|G|0|PLS|0|0|1|100|DKK|1437|3476|lyfalmen|||1|1|0|6,2500|Icepharma hf|Pfizer Aps|Metýlprednisólón||||1437|3476||1|0|G|0|||0 036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|þpakki||J01CE02|01.01.1988||R|0|0|0|0|0|MEA|0|0|1|100|DKK|712|2478|lyfalmen|||1|20|0|8,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||712||712|2478||2|0|E|0|||0 036529|QI09AB1302|Ingelvac MycoFLEX|stl|||50|ml|1|glas|handa svínum|QI09AB13|01.12.2013||R|0|0|0|0|0|BIV|0|0|0|100|DKK|1472|2537|vetorma|||1|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Óvirkar bakteríur í bóluefnum||1472||1472|2537||1|0||0|||0 036541|A03AX1301|Minifom|dropar|||30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|0|0|0|0|0|AHN|0|0|0|100|IKR|||lyflausa|||0|30|0|6,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Silíkonsambönd|||||||1|0||0|||0 036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|MEA|0|0|1|100|DKK|2470|4898|lyfalmen|||1|125|0|6,2500|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||2470||2470|4898||2|0|E|0|||0 036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|þpakki||J01CE02|01.01.1988||R|0|0|0|0|0|MEA|0|0|1|100|DKK|938|2789|lyfalmen|||1|30|0|12,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||938||938|2789||2|0|E|0|||0 036968|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|60|stk|1|glas|hart|A02BC01|01.03.2017||R|1|0|0|G|0|VAL|0|0|1|100|IKR|342|1969|lyfalmen|V0006|1312|2|60|0|60,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||342||342|1969||2|0|G|0|||0 037141|M01AE0117|Ibutrix|mixtúra|20|mg/ml|200|ml|1|glas||M01AE01|01.10.2021||L|0|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||2|200|0||Williams & Halls efh|Williams & Halls ehf|Íbúprófen|||||||2|0||0|||0 037287|N04BC0404|Requip Depot|forðatfl|2|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|G|0|GPH|0|0|0|100|DKK|6446|7444|lyfalmen|V0532|6849|1|84|0|28,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||4320||4320|7444||1|0|G|0|||0 037305|N04BC0404|Requip Depot|forðatfl|4|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|G|0|GPH|0|0|0|100|DKK|12054|10405|lyfalmen|V0533|8976|1|84|0|56,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||6471||6471|10405||1|0|G|0|||0 037323|N04BC0404|Requip Depot|forðatfl|8|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|G|0|GPH|0|0|0|100|DKK|16663|19421|lyfalmen|V0534|16596|1|84|0|112,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||13022||13022|19421||1|0|G|0|||0 037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|1|0|0|G|0|ROA|0|0|0|100|DKK|2378|4771|lyfalmen|V0434|4676|1|100|0|16,6667|Icepharma hf|Roche A.S.|Levódópa og dópadekarboxýl­asa­hemill||2378||2378|4771||2|0|G|0|||0 037471|C07AB0214|Bloxazoc|forðatfl|200|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|G|0|KNM|0|0|0|100|IKR|3533|4939|lyfalmen|V0054|4939|2|100|0|133,3333|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||2500||2500|4939||2|0|G|0|||0 037846|A12BA0101|Kaleorid|forðatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|G|0|KPA|0|0|0|100|DKK|||lyfalmen|V1047|2676|0|100|0|25,0000|Alvogen|Karo Pharma AB|Kalíumklóríð|||||2727||2|0|G|0|||0 037853|A12BA0101|Kaleorid|forðatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|G|0|KPA|0|0|0|100|DKK|||lyfalmen|V1048|4697|0|250|0|62,5000|Alvogen|Karo Pharma AB|Kalíumklóríð|||||4748||2|0|G|0|||0 037992|J06BA0210|Octagam 10%|irl|100|mg/ml|300|ml|1|hgl||J06BA02|01.07.2021||R|0|0|0|0|1|OCT|0|1|0|100|DKK|346253|437153|lyfsjukr|||1|300|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, gefin í æð||346253||346253|437153||1|H|L|0|||0 038386|R06AE0706|Zensitin|filmhtfl|10|mg|30|stk|1|þpakki||R06AE07|01.07.2017||L|1|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Williams & Halls efh|Williams & Halls ehf|Cetirizín|||||||2|0||0|||0 038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|þpakki||N06AB05|01.04.1993||R|1|0|0|G|0|GPH|0|0|0|100|DKK|3346|4249|lyfalmen|V0321|3960|1|100|0|100,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Paroxetín||1999||1999|4249||1|0|G|0|||0 038494|C10AA0106|Simvastatin Bluefish|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.02.2014||R|1|0|0|G|0|BLS|0|0|0|100|XEU|1636|2774|lyfalmen|V0110|2602|2|100|0|133,3333|Artasan ehf|Bluefish Pharmaceuticals AB|Simvastatín||927||927|2774||1|0|G|0|||0 039141|B01AF0101|Xarelto|filmhtfl|15|mg|42|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|G|0|FIN|0|0|0|100|DKK|13774|20456|lyfalmen|||1|42|0|31,5000|Icepharma hf|Bayer AG|Rivaoxaban||||13774|20456||2|0|G|0|||0 039145|L01XC0303|Trazimera|st/irþ|420|mg|420|mg|1|hgl||L01XC03|01.04.2020||R|0|0|0|0|0|PEU|0|1|0|100|DKK|218089|277753|lyfsjukr|||1|420|0||Icepharma hf|Pfizer Europe MA EEIG|Trastuzumab||218089||218089|277753||1|H|L|0|||0 039147|N04BC0701|Apomorfin PharmSwed|irl|5|mg/ml|20|ml|5|hgl|lausn|N04BC07|01.03.2013||R|0|0|1|0|0|PSS|0|0|0|100|SEK|27709|38320|lyfalmen|||1|100|0|25,0000|Williams & Halls efh|PharmSwed|Apómorfín||27709||27709|38320||2|0|0|0|||0 039395|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|50|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|G|0|BLS|0|0|1|100|XEU|11850|16709|lyfalmen|V0388|13886|2|50|0|25,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Ondansetrón||11051||11051|16709||1|0|G|0|||0 039413|H02AB0205|Dexametason Abcur|töflur|1|mg|20|stk|1|þpakki||H02AB02|01.06.2016||R|1|0|0|G|0|ABC|0|0|1|100|SEK|1567|3655|lyfalmen|||2|20|0|13,3300|Icepharma hf|Abcur AB|Dexametasón||1567||1567|3655||2|0|G|0|||0 039430|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|m.nál, dreifa|J07AL52|01.04.2012||R|0|0|0|0|0|GBI|0|0|0|100|DKK|5489|9053|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v.pneumok.Hreins pneumok polysakk móte.v Hae||5489||5489|9053||1|0||0|||0 039441|A09AA0217|Creon 10.000 (Lyfjaver)|sþ-hylki|||100|stk|1|tfílát||A09AA02|01.12.2019||R|1|0|0|G|0|LVR|0|0|0|100|DKK|3580|6425|lyfalmen|V0706|6425|3|100|0|16,6700|Lyfjaver ehf|Lyfjaver ehf|Hvatablöndur (lípasi, próteasi o.s.frv.)||3580||3580|6425||3|0|G|0|||0 039643|C01BD0701|Multaq|filmhtfl|400|mg|100|stk|1|þpakki||C01BD07|01.08.2010||R|1|1|1|0|0|SGB|0|0|0|100|XEU|17987|26255|lyfalmen|V1027|17511|1|100|0|50,0000|Vistor hf|Sanofi-aventis groupe|Dronedarón||17987||17987|26255||1|0|E|0|||0 039676|N06AX0307|Mianserin Mylan|filmhtfl|30|mg|100|stk|1|þpakki||N06AX03|01.06.2010||R|1|0|0|G|0|MYL|0|0|0|100|SEK|4294|7408|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Míanserín||4294||4294|7408||2|0|G|0|||0 039698|C07AB0311|Atenolol Mylan|töflur|25|mg|98|stk|1|þpakki||C07AB03|01.04.1992||R|1|0|0|G|0|MYL|0|0|0|100|SEK|1063|2961|lyfalmen|||2|98|0|32,6667|Icepharma hf|Mylan AB|Atenólól||1063||1063|2961||2|0|G|0|||0 039709|C07AB0311|Atenolol Mylan|töflur|50|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|1|0|0|G|0|MYL|0|0|0|100|SEK|1066|2965|lyfalmen|||2|98|0|65,3333|Icepharma hf|Mylan AB|Atenólól||1066||1066|2965||2|0|G|0|||0 039776|J01FA1001|Zitromax|mixtduft|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|0|0|0|0|0|PLS|0|0|1|100|DKK|703|2466|lyfalmen|V0821|2186|1|15|0|2,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||703||703|2466||1|0|E|0|||0 039784|J01FA1001|Zitromax|mixtduft|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|0|0|0|0|0|PLS|0|0|1|100|DKK|1481|3536|lyfalmen|V0822|2874|1|22,5|0|3,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1481||1481|3536||1|0|E|0|||0 039829|L04AX0402|Lenalidomid Alvogen|hylki|25|mg|21|stk|1|þpakki|hart|L04AX04|01.04.2019||R|1|1|1|0|0|ALO|0|1|0|100|XEU|719478|886146|lyfsjukr|||2|21|0|52,5000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Lenalídómíd||707261||707261|886146||2|0|L|0|||0 039837|N02BE0107|Paratabs|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.03.2013||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paracetamól|||||||1|0||0|||0 039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2009|2602|lyfalmen|V0110|2550|2|98|0|130,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Simvastatín||802||802|2602||1|0|G|0|||0 039957|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|42|stk|1|þpakki||J05AB11|01.01.2010||R|1|0|0|G|0|ATE|0|0|1|100|XEU|6346|5214|lyfalmen|V0182|5214|2|42|0|7,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Valacíklóvír||2700||2700|5214||1|0|G|0|||0 040092|N02AX0213|Tramadol Krka|forðatfl|100|mg|100|stk|1|þpakki||N02AX02|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|2200|4388|lyfalmen|V0227|4388|2|100|0|33,3300|Krka Sverige AB|Krka d.d. Novo mesto|Tramadól||2100||2100|4388||2|0|G|1|30|dagar|0 040742|C08CA0203|Felodipin ratiopharm|forðatfl|2,5|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|G|0|RTH|0|0|0|100|XEU|2712|5231|lyfalmen|||2|100|0|50,0000|Alvogen|ratiopharm GmbH|Felódipín||2712||2712|5231||2|0|G|0|||0 040771|N06AX2701|Spravato|nefúði|28|mg|28|mg|3|úðaílá|lausn|N06AX27|01.10.2020||R|0|1|0|0|0|JCI|0|1|0|100|SEK|96395|125194|lyfsjukr|||1|84|0||Vistor hf|Janssen-Cilag International N.V.|Esketamine||96395||96395|125194||1|H|L|1|30|dagar|0 040823|A06AD6503|Movicol Junior Neutral|mixtduft|6,9|g|30|pokar|1|pakki|lausn|A06AD65|01.11.2018||L|0|0|0|0|0|NOG|0|0|0|100|IKR|||lyfalmen|||0|30|0||Vistor hf|Norgine BV|Makrógól 3350|||||3874||1|0|E|0|||0 040977|J01DD0402|Ceftriaxona Normon|sts|1000|mg|100|stk|1|hgl|+ 100 lykjur með leysi.|J01DD04|01.06.2018||R|0|0|0|0|0|LNA|0|0|1|100|XEU|223082|283963|lyfalmen|||2|100|0|50,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftríaxón||223082||223082|283963||2|0|0|0|||0 041086|C01EB1701|Procoralan|filmhtfl|5|mg|56|stk|1|þpakki||C01EB17|01.04.2014||R|1|0|0|0|0|LLS|0|0|0|100|DKK|7977|12477|lyfalmen|||1|56|0|28,0000|Icepharma hf|Les Laboratoires Servier|Ivabradín||7977||7977|12477||2|0|E|0|||0 041105|C01EB1701|Procoralan|filmhtfl|7,5|mg|56|stk|1|þpakki||C01EB17|01.04.2014||R|1|0|0|0|0|LLS|0|0|0|100|DKK|7977|12477|lyfalmen|||1|56|0|42,0000|Icepharma hf|Les Laboratoires Servier|Ivabradín||7977||7977|12477||2|0|E|0|||0 041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|0|0|0|0|0|IBV|0|0|0|100|DKK|3876|6681|vetbolu|||0|100|0||Vistor hf|Intervet International BV|Clostridíum bóluefni||3876||3876|6681||1|0||0|||0 041816|N05AX1210|Aripiprazol Medical Valley|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.01.2020||R|1|1|0|G|0|VAL|0|0|0|100|XEU|4849|3422|lyfalmen|V0682|3422|2|56|0|18,6670|Acare ehf|Medical Valley Invest AB|Aripiprazól||1398||1398|3422||2|0|G|0|||0 041898|N06AX0307|Mianserin Mylan|filmhtfl|10|mg|90|stk|1|þpakki||N06AX03|01.06.2008||R|1|0|0|G|0|MYL|0|0|0|100|SEK|1310|3301|lyfalmen|||2|90|0|15,0000|Icepharma hf|Mylan AB|Míanserín||1310||1310|3301||2|0|G|0|||0 041942|N06AX1106|Mirtazapin Krka|filmhtfl|15|mg|300|stk|1|glas||N06AX11|01.01.2015||R|1|0|0|G|0|KRK|0|0|0|100|IKR|8106|11133|lyfalmen|||2|300|0|150,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||7000||7000|11133||2|0|G|0|||0 041951|N06AX1106|Mirtazapin Krka|filmhtfl|30|mg|250|stk|1|glas||N06AX11|01.01.2015||R|1|0|0|G|0|KRK|0|0|0|100|IKR|8023|11354|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||7161||7161|11354||2|0|G|0|||0 041996|A06AG1101|Microlax|innhl|||5|ml|4|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||||1|0||0|||0 042157|C09AA0201|Daren|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.05.2020||R|1|0|0|G|0|TVI|0|0|0|100|XEU|1175|3115|lyfalmen|V0449|2943|2|100|0|200,0000|Teva Pharma Iceland ehf|Teva B.V|Enalapríl||1175||1175|3115||1|0|G|0|||0 042270|D01BA0207|Terbinafin Medical Valley|töflur|250|mg|98|stk|1|þpakki||D01BA02|01.08.2017||R|1|0|0|0|0|VAL|0|0|0|100|XEU|5988|8902|lyfalmen|V0737|8902|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Terbínafín||5379||5379|8902||2|0|E|0|||0 042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|FKA|0|0|0|100|DKK|2298|4661|lyfalmen|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||2298||2298|4661||1|0|0|0|||0 042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|FKA|0|0|0|100|DKK|3397|6174|lyfalmen|||1|7500|0||Vistor hf|Fresenius Kabi AB|Kolvetni||3397||3397|6174||1|0|0|0|||0 042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|FKA|0|0|0|100|DKK|2051|4321|lyfalmen|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||2051||2051|4321||1|0|0|0|||0 042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|0|0|0|0|0|FKA|0|0|1|100|DKK|1980|4223|lyfalmen|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||1980||1980|4223||1|0|0|0|||0 042500|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|3|rörlyk|1 innöndunartæk+3 rörlykjur|R03BB04|01.08.2019||R|0|0|0|G|0|BII|0|0|0|100|DKK|12707|18750|lyfalmen|||1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||12534||12534|18750||1|0|G|0|||0 042549|J07BF0301|Imovax Polio|stl|||0,5|ml|1|áf.spr|með nál|J07BF03|01.01.1996||R|0|0|0|0|0|SSS|0|0|0|100|XEU|2181|4500|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Mænusótt, dauð veira||2181||2181|4500||1|0||0|||0 042628|N06AX2108|Aritavi|sþ-hylki|30|mg|100|stk|1|þpakki||N06AX21|01.07.2019||R|1|0|0|G|0|ATE|0|0|0|100|XEU|6595|5162|lyfalmen|V0811|5162|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Duloxetín||2662||2662|5162||1|0|E|0|||0 042865|N01BB0204|Lidokain Mylan|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.09.2016||R|0|0|0|0|0|MYE|0|0|1|100|DKK|1345|3349|lyfalmen|V0560|3349|2|100|0||Icepharma hf|Mylan Ireland Limited|Lídókaín||1345||1345|3349||2|0||0|||0 043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|þpakki||N05CD05|01.12.1983||R|1|0|0|0|0|PLS|0|0|1|100|DKK|503|2190|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tríazólam||503||503|2190||1|0||2|60|töflur|0 043965|N06BA0404|Methylphenidate Sandoz|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.11.2019||R|1|1|0|0|0|SHS|0|0|0|100|DKK|5116|5450|lyfalmen|V0624|5450|2|30|0|36,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||2871||2871|5450||1|0|E|1|30|dagar|0 044065|H02AB0804|Kenacort-T|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2019||R|0|0|0|0|0|BBB|0|0|1|100|DKK|700|2461|lyfalmen|||0|1|0|5,3330|Vistor hf|Bristol-Myers Squibb AB|Tríamcínólón||700||700|2461||1|0||0|||0 044360|B03AC0004|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC|01.05.2006||R|0|1|0|G|0|LVR|0|0|1|100|CHF|12536|18752|lyfalmen|V0637|18752|3|25|0|5,0000|Lyfjaver ehf|Lyfjaver ehf|Járn, stungulyf||12536||12536|18752||3|0|G|0|||0 044492|G02AD0602|Angusta|töflur|25|mcg|8|stk|1|pakki||G02AD06|01.06.2017||R|0|0|0|0|0|NGV|0|0|0|100|DKK|13358|19884|lyfalmen|||1|8|0|1,0000|Norgine BV|Norgine B.V.|Misóprostól||13358||13358|19884||1|H|0|0|||0 044532|C03DA0407|Eplerenon Krka|filmhtfl|25|mg|100|stk|1|þpakki||C03DA04|01.12.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|8866|13701|lyfalmen|||2|100|0|50,0000|LYFIS ehf|Krka d.d. Novo mesto|Eplerenón||8866||8866|13701||2|0||0|||0 044560|J05AB0105|Zovirax|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.2019||R|0|0|0|G|0|GPH|0|0|1|100|DKK|4994|8372|lyfalmen|||1|100|0|2,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||4994||4994|8372||1|0|G|0|||0 044580|L01EG0201|Afinitor|töflur|5|mg|30|stk|1|þpakki||L01EG02|01.09.2011||R|0|0|1|0|0|NEL|0|1|0|100|DKK|327580|413929|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolimus||327580||327580|413929||1|0|L|0|||0 044591|L01EG0201|Afinitor|töflur|10|mg|30|stk|1|þpakki||L01EG02|01.09.2011||R|0|0|1|0|0|NEL|0|1|0|100|DKK|458732|577045|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolimus||458732||458732|577045||1|0|L|0|||0 044732|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|þpakki||L01AA01|01.06.2014||R|0|0|0|G|0|BAM|0|0|0|100|SEK|5140|8573|lyfalmen|||1|100|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||5140||5140|8573||2|0|G|0|||0 045202|B01AF0102|Rivaroxaban WH|filmhtfl|15|mg|98|stk|1|þpakki||B01AF01|01.02.2021||R|1|1|0|G|0|WEH|0|0|0|100|XEU|30211|41484|lyfalmen|V0976|41208|2|98|0|73,5000|Williams & Halls efh|Williams & Halls ehf|Rivaoxaban||30211||30211|41484||2|0|G|0|||0 045332|V03AN0502|Airapy|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|600|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5|0||0|||0 045475|A10BK0301|Jardiance|filmhtfl|25|mg|30|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|G|0|BOE|0|0|0|100|DKK|7039|11186|lyfalmen|||1|30|0|42,8600|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||7039||7039|11186||1|0|G|0|||0 045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1294|2398|lyfalmen|V0109|2306|2|98|0|65,3400|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Simvastatín||654||654|2398||1|0|G|0|||0 045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1054|2318|lyfalmen|||2|98|0|32,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Simvastatín||596||596|2318|30.9.2021|1|0|G|0|||0 045765|C03CA0110|Impugan|dropar|10|mg/ml|30|ml|1|glas||C03CA01|01.06.2013||R|0|0|0|G|0|ATE|0|0|0|100|SEK|3758|6670|lyfalmen|||2|30|0|7,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fúrósemíð||3758||3758|6670||1|0|G|0|||0 046155|L01AD0105|Carmustine Obvius|sts|100|mg|1|hgl|1|pakki|1 lykja m. 3 ml leysi|L01AD01|01.03.2019||R|0|0|0|0|0|OBV|0|1|0|100|NOK|86774|113025|lyfsjukr|||2|1|0||Oresund Pharma ApS|Obvius Investment B.V.|Carmustine ||86774||86774|113025||2|H|L|0|||0 046188|M01AH0108|Celecoxib Medical|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.05.2018||R|1|0|0|G|0|DIC|0|0|1|100|IKR|2075|4354|lyfalmen|V0429|4138|2|100|0|50,0000|LYFIS ehf|Medical ehf|Celekoxíb||2075||2075|4354||2|0|G|0|||0 046214|J02AC0107|Fluconazol Krka|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|KRK|0|0|1|100|IKR|14206|10582|lyfalmen|V0419|10058|2|28|0|28,0000|LYFIS ehf|Krka Sverige AB|Flúkónazól||6600||6600|10582||2|0||0|||0 046248|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|30|sk-hyl|án rotvarnarefnis|S01EE01|01.03.2013||R|0|0|0|G|0|TEA|0|0|0|100|SEK|1368|3381|lyfalmen|||1|6|0|30,0000|Vistor hf|Laboratories THEA|Latanóprost||||1368|3381||1|0|G|0|||0 046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.03.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|949|2804|lyfalmen|||2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ramipríl||949||949|2804||1|0|G|0|||0 046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|496|2105|lyfalmen|V0021|2004|2|90|0|45,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Glímepíríð||441||441|2105||1|0|G|0|||0 046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|752|2398|lyfalmen|||2|90|0|90,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Glímepíríð||654||654|2398|30.9.2021|1|0|G|0|||0 046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|978|2671|lyfalmen|V0023|2544|2|90|0|135,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Glímepíríð||852||852|2671||1|0|G|0|||0 046625|N06AB1008|Escitalopram STADA|filmhtfl|5|mg|100|stk|1|þpakki||N06AB10|01.08.2021||R|1|0|0|G|0|ASR|0|0|0|100|IKR|1800|3838|lyfalmen|V0324|3838|2|100|0|50,0000|LYFIS ehf|STADA Arzneimittel AG|Escítalópram||1700||1700|3838||2|0|0|0|||0 046724|R01AD0802|Nasofan|nefúði|50|mcg/sk|150|skammtar|1|glas||R01AD08|01.12.2013||R|0|0|0|G|0|TSA|0|0|1|100|IKR|1563|2737|lyfalmen|V0625|2737|2|150|0|37,5000|Alvogen|Teva Sweden AB|Flútíkasón||900||900|2737||2|0|G|0|||0 046812|M05BA0605|Ibandronic acid Alvogen|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.02.2012||R|0|1|0|G|0|POF|0|0|0|100|IKR|6568|3838|lyfalmen|V0205|3838|2|3|0|90,0000|Alvogen|Alvogen|Íbandrónsýra||1700||1700|3838||2|0|G|0|||0 047108|QA14AB0101|Myodine vet|stl|25|mg/ml|10|ml|1|hgl|lausn|QA14AB01|01.04.2019||R|0|0|0|0|0|VEB|0|0|0|100|IKR|3385|6593|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Nandrolone||3385||3385|6593||2|0|0|0|||0 047154|G04CA5204|Duta Tamsaxiro|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.06.2020||R|1|0|0|G|0|VAL|0|0|0|100|XEU|3007|4428|lyfalmen|V1010|3018|2|30|0|30,0000|Acare ehf|Medical Valley Invest AB|Dútasteríð og tamsúlósínhýdroklóríð||2129||2129|4428||2|0|G|0|||0 047238|C01BD0703|Dronedarone Teva|filmhtfl|400|mg|100|stk|1|stsk.þ||C01BD07|01.06.2021||R|1|1|1|0|0|TVI|0|0|0|100|XEU|15258|17511|lyfalmen|V1027|17511|2|100|0|50,0000|Teva Pharma Iceland ehf|Teva B.V|Dronedarón||11634||11634|17511||1|0|E|0|||0 047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|AGA|0|0|0|100|XEU|35099|47667|lyfalmen|||1|10|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||35099||35099|47667||5|H|0|0|||0 047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|AGA|0|0|0|100|XEU|147251|189650|lyfalmen|||1|50|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||147251||147251|189650||5|H|0|0|||0 047709|J05AB1403|Valganciclovir Medical Valley|filmhtfl|450|mg|60|stk|1|glas||J05AB14|01.06.2020||R|1|0|0|0|0|VAL|0|1|1|100|XEU|37549|50766|lyfsjukr|||2|60|0|30,0000|Acare ehf|Medical Valley Invest AB|Valgancíklóvír||37549||37549|50766||2|0|L|0|||0 047840|C02CA0408|Doxazosin Krka|forðatfl|4|mg|120|stk|1|þpakki||C02CA04|01.10.2020||R|1|0|0|G|0|KAN|0|0|0|100|IKR|3622|4939|lyfalmen|V0042|4939|2|120|0|120,0000|Krka Sverige AB|Krka d.d. Novo mesto|Doxazósín||2500||2500|4939||2|0|G|0|||0 048015|B05AA0115|Albumin Baxalta|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|BTP|0|0|0|100|DKK|4181|7253|lyfalmen|||1|250|0||Takeda Pharma A/S|Baxalta Innovations GmbH|albumin||4181||4181|7253||1|H|0|0|||0 048028|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|50|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|FKA|0|0|1|100|DKK|7693|12087|lyfalmen|||1|5000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||7693||7693|12087||1|0|0|0|||0 048043|B05AA0115|Albumin Baxalta|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|BTP|0|0|0|100|DKK|6783|10834|lyfalmen|||1|100|0||Takeda Pharma A/S|Baxalta Innovations GmbH|albumin||6783||6783|10834||1|H|0|0|||0 048100|N06AB1004|Esopram|töflur|5|mg|100|stk|1|þpakki||N06AB10|01.04.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1836|4025|lyfalmen|V0324|3838|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Escítalópram||1836||1836|4025||1|0|G|0|||0 048111|N06AB1004|Esopram|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.04.2010||R|1|0|0|0|0|ATE|0|0|0|100|XEU|1079|2983|lyfalmen|||2|28|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Escítalópram||1079||1079|2983||1|0|E|0|||0 048122|N06AB1004|Esopram|töflur|10|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2565|5028|lyfalmen|V0325|4526|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Escítalópram||2565||2565|5028||1|0|G|0|||0 048144|N06AB1004|Esopram|töflur|15|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3463|6264|lyfalmen|V0326|5352|2|100|0|150,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Escítalópram||3463||3463|6264||1|0|G|0|||0 048166|N06AB1004|Esopram|töflur|20|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|5375|8023|lyfalmen|V0327|6315|2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Escítalópram||4741||4741|8023||1|0|G|0|||0 048196|R03AK0706|DuoResp Spiromax|innönddu|164,5|mcg/sk|120|skammtar|1|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2018||R|0|0|0|G|0|TAB|0|0|0|100|XEU|5290|7594|lyfalmen|||2|120|0|30,0000|Alvogen|Teva Pharma B.V.|Formóteról og budesonide||4429||4429|7594||2|0|G|0|||0 048199|A03CA0201|Librax|töflur|||100|stk|1|glas||A03CA02|01.12.1972||R|1|0|0|G|0|MEA|0|0|0|100|DKK|2034|4298|lyfalmen|||1|100|0||Icepharma hf|Meda AB|Klídín og geðlyf||2034||2034|4298||2|0|G|2|100|töflur|0 048505|L03AX1601|Mozobil|stl|20|mg/ml|1,2|ml|1|hgl|lausn|L03AX16|01.07.2010||R|0|0|0|0|0|GEB|0|1|0|100|XEU|770879|965269|lyfsjukr|||1|1,2|0|1,4300|Vistor hf|Genzyme Europe B.V.|Plerixaforum||770879||770879|965269||1|H|L|0|||0 048744|N02BE0101|Panodil|filmhtfl|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|1|0|0|0|0|GCA|0|0|1|100|DKK|392|2037|lyfalmen|V0230|2037|1|100|0|16,6667|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól||392||392|2037||1|0|E|0|||0 048770|B05ZB0001|Hemosol BO|blóð.sk|||5000|ml|2|pokar||B05ZB|01.04.2013||R|0|0|0|0|0|BMH|0|0|0|100|SEK|5027|8417|lyfalmen|||1|10000|0||Baxter Medical AB|Baxter Holding B.V.|Blóðsölt og stuðpúðalausn||5027||5027|8417||2|H|0|0|||0 048784|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|1|0|0|TMA|0|1|0|100|DKK|36279|49159|lyfsjukr|||1|1|0||Lyfjaver ehf|Takeda Manufacturing Austria AG|Storkuþáttur VIII||36279||36279|49159||3|0|L|0|||0 048797|G04CA0208|Tamsulosin Mylan|hylki|0,4|mg|90|stk|1|þpakki|með br. losunarhraða|G04CA02|01.11.2016||R|1|0|0|G|0|MYL|0|0|0|100|SEK|4420|4459|lyfalmen|V0148|4445|2|90|0|90,0000|Icepharma hf|Mylan AB|Tamsúlósín||2151||2151|4459||2|0|G|0|||0 049033|C08DB0108|Cardil|forðatfl|120|mg|60|stk|1|glas||C08DB01|01.05.2013||R|1|0|0|G|0|COR|0|0|0|100|DKK|6871|10955|lyfalmen|||2|60|0|30,0000|Vistor hf|Orion Corporation|Diltíazem||6871||6871|10955||1|0|G|0|||0 049091|S01EE0101|Xalatan|augndr|50|mcg/ml|2,5|ml|3|glös||S01EE01|01.08.2013||R|0|0|0|G|0|UPJ|0|0|0|100|DKK|5067|8472|lyfalmen|V0376|5059|1|7,5|0|75,0000|Icepharma hf|Upjohn EESV|Latanóprost||||5067|8472||1|0|G|0|||0 049116|H01CB0501|Signifor|sts|20|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|0|ROD|0|1|0|100|DKK|277451|351583|lyfsjukr|||1|1|0|16,6700|Recordati AB|Recordati Rare Diseases|PAsireótið disapartate||277451||277451|351583||1|0|L|0|||0 049319|H02AB0910|Hydrokortison Orion|töflur|10|mg|30|stk|1|þpakki||H02AB09|01.11.2015||R|0|0|0|G|0|ARN|0|0|1|100|DKK|874|2701|lyfalmen|||2|30|0|10,0000|Vistor hf|Orion Corporation|Hýdrókortisón||874||874|2701||1|0|G|0|||0 049549|N03AX2201|Fycompa|filmhtfl|2|mg|7|stk|1|þpakki||N03AX22|01.02.2020||R|1|0|0|G|0|SIE|0|0|0|100|SEK|5124|8551|lyfalmen|||1|7|0|1,7500|Eisai AB|Eisai GmbH|Perampanel||5124||5124|8551||1|0|G|0|||0 049579|C10AA0104|Simvastatin Alvogen|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|1|0|0|G|0|GOV|0|0|0|100|XEU|2322|2306|lyfalmen|V0109|2306|2|98|0|65,3400|Alvogen|Alvogen ehf|Simvastatín||587||587|2306||2|0|G|0|||0 049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.04.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1018|2899|lyfalmen|||2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ramipríl||1018||1018|2899||1|0|G|0|||0 049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.08.2005||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1738|3890|lyfalmen|||2|100|0|400,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ramipríl||1738||1738|3890||1|0|G|0|||0 049696|A04AA0109|Ondansetron STADA|filmhtfl|8|mg|10|stk|1|þpakki||A04AA01|01.06.2021||R|1|0|0|G|0|ASR|0|0|1|100|IKR|3600|4388|lyfalmen|V0384|3252|2|10|0|5,0000|LYFIS ehf|STADA Arzneimittel AG|Ondansetrón||2100||2100|4388||2|0|G|0|||0 049894|N02BG1001|Sativex|munnhúði|52|mg|10|ml|3|úðagl|27 mg + 25 mg|N02BG10|01.07.2013||R|0|0|1|0|0|WPA|0|0|0|100|DKK|71987|94323|lyfalmen|||1|30|0|37,1400|Vistor hf|GW Pharma (International) B.V|Cannabinoids||71987||71987|94323||1|0|E|1|30|dagar|0 049906|N02CC0106|Sumatriptan Apofri|filmhtfl|50|mg|2|stk|1|þpakki||N02CC01|01.06.2020||L|1|0|0|0|0|APO|0|0|0|100|IKR|||lyflausa|||0|2|0||LYFIS ehf|Apofri AB|Súmatriptan|||||||2|0||0|||0 049964|N07BA0106|Nicotinell|forðapl|14|mg/sólh|7|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|7|0|7,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 050068|J05AP5401|Zepatier|filmhtfl|150|mg|28|stk|1|þpakki|100mg/50mg|J05AP54|01.05.2017||R|0|0|1|0|0|MBV|0|1|0|100|DKK|1073610|1341781|lyfsjukr|||1|28|0||Vistor hf|Merck Sharp & Dohme B.V.|Elbasvir og grazoprevir||1073610||1073610|1341781||1|0|L|0|||0 050117|G04BE0309|Vizarsin|munndr.t|100|mg|24|stk|1|þpakki||G04BE03|01.01.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|10000|8380|lyfalmen|||2|24|0|48,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||5000||5000|8380||2|0|E|0|||0 050292|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|100|stk|1|glas||C01DA02|01.06.2014||L|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|100|0|20,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||4058||1|0|G|0|||0 050306|G04CA0104|Alfuzosin hydrochlorid ratiopharm|forðatfl|10|mg|90|stk|1|þpakki||G04CA01|01.12.2012||R|1|0|0|G|0|RTH|0|0|0|100|XEU|7153|11343|lyfalmen|||2|90|0|120,0000|Alvogen|ratiopharm GmbH|Alfúzósín||7153||7153|11343||2|0|G|0|||0 050323|G04BE0806|Tadalafil Krka|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.07.2020||R|1|0|0|0|0|KNM|0|0|0|100|IKR|9201|14162|lyfalmen|V0925|14162|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||||9201|14162||2|0|E|0|||0 050438|L04AA2701|Gilenya|hylki|0,5|mg|7|stk|1|þpakki||L04AA27|01.09.2011||R|0|1|1|0|0|NEL|0|1|0|100|DKK|63255|83279|lyfsjukr|||1|7|0|7,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||63255|83279||1|0|L|0|||0 050510|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.05.2010||L|1|0|0|0|0|ATE|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ómeprazól|||||||1|0||0|||0 050577|N06AX1614|Venlafaxin Krka|forðahlk|37,5|mg|100|stk|1|tfílát|hart|N06AX16|01.02.2018||R|1|0|0|G|0|KNM|0|0|0|100|IKR|2750|5283|lyfalmen|||2|100|0|37,5000|LYFIS ehf|Krka d.d. Novo mesto|Venlafaxín||2750||2750|5283||2|0|G|0|||0 050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2007||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|10838|16415|lyfalmen|V0688|12655|1|56|0|42,0000|Icepharma hf|Upjohn EESV|Pregabalín||10838||10838|16415||1|0|E|0|||0 050660|C02CA0402|Carduran Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.01.2007||R|1|0|0|G|0|UPJ|0|0|0|100|DKK|5261|5517|lyfalmen|V0042|4116|1|100|0|100,0000|Icepharma hf|Upjohn EESV|Doxazósín||2920||2920|5517|||0|G|0|||0 050679|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|0|ATE|0|0|1|100|IKR|4615|7082|lyfalmen|||2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ómeprazól||4057||4057|7082||1|0|0|0|||0 050691|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|G|0|ATE|0|0|1|100|IKR|4360|2324|lyfalmen|V0006|2186|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ómeprazól||600||600|2324||1|0|G|0|||0 050702|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|100|stk|1|plglas||A02BC01|01.08.2010||R|1|0|0|G|0|ATE|0|0|1|100|IKR|6304|2874|lyfalmen|V0001|2874|2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ómeprazól||1000||1000|2874||1|0|G|0|||0 051109|V03AN0502|Airapy|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|50|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5|0||0|||0 051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|þpakki||R06AX26|01.07.2008|30.09.2021|R|1|0|0|G|0|MYL|0|0|1|100|SEK|1031|2705|lyfalmen|||2|30|0|45,0000|Icepharma hf|Mylan AB|Fexófenadín||877||877|2705||2|0|G|0|||0 051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|1|0|0|G|0|MYL|0|0|1|100|SEK|3227|5231|lyfalmen|V0365|5231|2|100|0|150,0000|Icepharma hf|Mylan AB|Fexófenadín||2712||2712|5231||2|0|G|0|||0 051550|N03AX1401|Keppra|irþ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|0|0|0|0|0|UCB|0|0|0|100|DKK|16417|24094|lyfalmen|||1|50|0|3,3300|Vistor hf|U.C.B|Levetíracetam||16417||16417|24094||1|H|0|0|||0 052210|G04BE0313|Sildenafil Medical Valley|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.11.2020||R|1|0|0|0|0|VAL|0|0|0|100|XEU|5111|3944|lyfalmen|V0144|3944|2|12|0|24,0000|Acare ehf|Medical Valley Invest AB|Síldenafíl||1777||1777|3944||2|0|E|0|||0 052286|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|MYL|0|0|1|100|SEK|178|1743|lyfalmen|||2|20|0|5,0000|Icepharma hf|Mylan AB|Alprazólam||178||178|1743||2|0||2|120|töflur|0 052297|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|MYL|0|0|0|100|SEK|687|2321|lyfalmen|V0305|1256|2|50|0|12,5000|Icepharma hf|Mylan AB|Alprazólam||598||598|2321||2|0||2|120|töflur|0 052309|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.07.2009||R|1|0|0|0|0|MYL|0|0|1|100|SEK|266|1864|lyfalmen|V0439|1864|2|20|0|10,0000|Icepharma hf|Mylan AB|Alprazólam||266||266|1864||2|0|0|2||töflur|0 052317|R02AX0101|Strefen|sogtfl|8,75|mg|16|stk|1|þpakki||R02AX01|01.11.2016||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|16|0|3,1800|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Flurbiprofen|||||||1|0||0|||0 052320|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|MYL|0|0|0|100|SEK|612|2340|lyfalmen|||2|50|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||612||612|2340||2|0||2|60|töflur|0 052331|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.08.2009||R|1|0|0|0|0|MYL|0|0|0|100|SEK|847|2511|lyfalmen|V0305|2511|2|100|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||736||736|2511||2|0||2|120|töflur|0 052360|L01EA0201|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01EA02|01.09.2007||R|0|0|1|0|0|BMS|0|1|0|100|DKK|510902|641930|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Dasatinib||510902||510902|641930||1|0|L|0|||0 052405|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|1|glas||S01ED51|01.01.2010||R|0|0|0|G|0|AGC|0|0|0|100|XEU|3223|5934|lyfalmen|||1|3|0|30,0000|Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ltd.|Tímólól í blöndum||3223||3223|5934||1|0|G|0|||0 052414|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|3|glös||S01ED51|01.04.2018||R|0|0|0|G|0|TIC|0|0|0|100|XEU|7764|12184|lyfalmen|||1|9|0|90,0000|Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ireland|Tímólól í blöndum||7764||7764|12184||1|0|G|0|||0 052467|N06AX1615|Venlafaxine Alvogen|forðahlk|150|mg|100|stk|1|þpakki||N06AX16|01.12.2018||R|1|0|0|G|0|POF|0|0|0|100|IKR|7035|2874|lyfalmen|V0335|2598|2|100|0|150,0000|Alvogen|Alvogen|Venlafaxín||1000||1000|2874||2|0|G|0|||0 052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|FKA|0|0|0|100|DKK|29350|40395|lyfalmen|||1|8212|0||Vistor hf|Fresenius Kabi AB|Blöndur||29350||29350|40395||1|0|0|0|||0 052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|0|0|0|0|0|FKA|0|0|0|100|DKK|23861|33453|lyfalmen|||1|7698|0||Vistor hf|Fresenius Kabi AB|Blöndur||23861||23861|33453||1|0|0|0|||0 052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|FKA|0|0|0|100|DKK|24532|34302|lyfalmen|||1|7680|0||Vistor hf|Fresenius Kabi AB|Blöndur||24532||24532|34302||2|0|0|0|||0 052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|FKA|0|0|0|100|DKK|21510|30479|lyfalmen|||1|7200|0||Vistor hf|Fresenius Kabi AB|Blöndur||21510||21510|30479||2|0|0|0|||0 052677|N02AB0310|Fentanyl Alvogen|forðapl|12|mcg/klst|5|stk|1|skpoki||N02AB03|01.09.2020||R|0|0|0|G|0|POF|0|0|0|100|XEU|2275|4629|lyfalmen|||2|5|0|3,6000|Alvogen|Alvogen|Fentanýl||2275||2275|4629||2|0|G|1|30|dagar|0 052737|N05AX1205|Aripiprazol Krka|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|0|0|G|0|KRK|0|0|0|100|IKR|4448|3934|lyfalmen|V0682|3422|2|56|0|18,6670|LYFIS ehf|Krka Sverige AB|Aripiprazól||1770||1770|3934||2|0|G|0|||0 052838|A10BJ0201|Victoza|stl|6|mg/ml|3|ml|2|lyfjap|lausn,áfylltur lyfjapenni|A10BJ02|01.01.2012||R|0|0|0|0|0|NAS|0|0|0|100|DKK|14338|21233|lyfalmen|||1|6|0|24,0000|Vistor hf|Novo-Nordisk A/S|Liraglutide||14338||14338|21233||1|0|E|0|||0 053166|N02AA5501|Targin|forðatfl|60|mg|98|stk|1|þpakki|40+20 mg|N02AA55|01.10.2012||R|1|0|0|0|0|MUP|0|0|0|100|DKK|40112|54007|lyfalmen|V1007|46053|1|98|0|52,2700|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||40112||40112|54007||2|0|E|1|30|dagar|0 053200|N02AA5501|Targin|forðatfl|7,5|mg|98|stk|1|þpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|0|0|0|MUP|0|0|0|100|DKK|5787|9463|lyfalmen|V1003|8332|1|98|0|6,5400|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||5787||5787|9463||2|0|E|1|30|dagar|0 053211|N02AA5501|Targin|forðatfl|7,5|mg|28|stk|1|þpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|0|0|0|MUP|0|0|0|100|DKK|1697|3823|lyfalmen|V1002|2781|1|28|0|1,8700|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||1689||1689|3823||2|0|E|1|30|dagar|0 053304|C10AA0508|Lipistad|filmhtfl|80|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|0|0|ASR|0|0|0|100|IKR|6489|7967|lyfalmen|V0115|7967|2|100|0|400,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||4700||4700|7967||2|0|E|0|||0 053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|0|1|1|G|0|SDH|0|0|0|100|XEU|25322|35301|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíð||25322||25322|35301||1|0|G|0|||0 053846|M05BA0602|Bonviva|stl|3|mg|3|ml|1|áfspr||M05BA06|01.11.2019||R|0|1|0|0|0|ATP|0|0|0|100|DKK|13346|19867|lyfalmen|||1|3|0|0,5000|Pharmanovia A/S|Atnahs Pharma Netherlands B.V.|Íbandrónsýra||13346||13346|19867|30.9.2021|2|0|E|0|||0 053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|0|0|0|0|0|ETH|0|0|0|100|GBP|10792|16352|lyfalmen|||2|10|0|50,0000|Icepharma hf|Ethypharm|Hýdrómorphón||10792||10792|16352||2|0||1|30|dagar|0 053932|N05AX1201|Abilify|stl|7,5|mg/ml|1,33|ml|1|hgl||N05AX12|01.01.2010||R|0|0|0|0|0|OPC|0|0|0|100|DKK|1430|3466|lyfalmen|||1|1,33|0|0,6650|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||1430||1430|3466||1|0|E|0|||0 054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0|1,2500|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1|0||0|||0 054321|J01CA0801|Selexid|filmhtfl|400|mg|15|stk|1|þpakki||J01CA08|01.04.2012||R|0|0|0|0|0|KPA|0|0|1|100|DKK|1920|4141|lyfalmen|||1|15|0|10,0000|Alvogen|Karo Pharma AB|Pívmecillínam||1920||1920|4141||2|0|E|0|||0 054332|J01CA0801|Selexid|filmhtfl|400|mg|20|stk|1|þpakki||J01CA08|01.04.2012||R|0|0|0|0|0|KPA|0|0|1|100|DKK|2706|5222|lyfalmen|||1|20|0|13,3300|Alvogen|Karo Pharma AB|Pívmecillínam||2706||2706|5222||2|0|E|0|||0 054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0|2,5000|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1|0||0|||0 054524|N05BB0101|Atarax|filmhtfl|25|mg|100|stk|1|þpakki||N05BB01|01.06.2014||R|1|0|0|0|0|UCN|0|0|1|100|SEK|1101|3013|lyfalmen|||1|100|0|33,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1101||1101|3013||1|0||0|||0 054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|0|0|0|0|0|UCN|0|0|0|100|SEK|1183|3126|lyfalmen|||1|200|0|5,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1183||1183|3126||1|0||0|||0 054594|QN02AE0101|Vetergesic vet.|stl|300|mcg/ml|10|ml|1|hgl|lausn|QN02AE01|01.10.2010||R|0|0|0|0|0|CES|1|0|0|100|DKK|5398|10412|vetalmen|||0|10|0||Icepharma hf|Ceva Sante Animale|Buprenorphinhýdróklóríð||5398||5398|10412||2|0||1|30|dagar|0 055073|L04AA0606|Myfenax|hylki|250|mg|100|stk|1|þpakki||L04AA06|01.11.2013||R|1|1|1|G|0|TAB|0|0|0|100|XEU|10694|16217|lyfalmen|||2|100|0|12,5000|Alvogen|Teva Pharma B.V.|Mýcófenólsýra||10694||10694|16217||2|0|G|0|||0 055084|L04AA0606|Myfenax|filmhtfl|500|mg|50|stk|1|þpakki||L04AA06|01.11.2013||R|1|1|1|G|0|TAB|0|0|0|100|XEU|6635|10630|lyfalmen|V0187|7524|2|50|0|12,5000|Alvogen|Teva Pharma B.V.|Mýcófenólsýra||6635||6635|10630||2|0|G|0|||0 055164|S01AE0701|Vigamox|augndr|5|mg/ml|5|ml|1|glas|án rotvarnar|S01AE07|01.08.2010||R|0|0|0|0|0|HES|0|0|1|100|DKK|1979|4222|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Moxífloxacín||||1979|4222||1|0||0|||0 055277|N02AA0101|Contalgin|forðatfl|60|mg|100|stk|1|þpakki||N02AA01|01.10.1995||R|1|0|0|G|0|MDI|0|0|0|100|DKK|8928|13786|lyfalmen|||1|100|0|60,0000|Icepharma hf|Mundipharma A/S|Morfín||8928||8928|13786||2|0|G|1|30|dagar|0 055372|N06AX1613|Venlafaxin Medical Valley|forðatfl|75|mg|110|stk|1|glas||N06AX16|01.08.2019||R|0|0|0|G|0|VAL|0|0|0|100|XEU|2795|2858|lyfalmen|V0334|2858|2|110|0|82,5000|Acare ehf|Medical Valley Invest AB|Venlafaxín||988||988|2858||2|0|G|0|||0 055481|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.06.2011||R|0|0|0|0|0|ATE|0|0|1|100|XEU|1812|3601|lyfalmen|V0467|2772|2|56|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rabeprazól||1528||1528|3601||1|0|E|0|||0 055825|J02AC0402|Posaconazol Alvogen|sþ-tfl|100|mg|24|stk|1|stsk.þ||J02AC04|01.01.2021||R|0|0|1|0|0|ALE|0|1|0|100|DKK|92513|120284|lyfsjukr|||1|24|0|8,0000|Alvogen|Alvogen Pharma Trading Europe EOOD|Posacónazól||92513||92513|120284||2|0|L|0|||0 055873|N05AX1304|Paliperidon Krka|forðatfl|9|mg|28|stk|1|þpakki||N05AX13|01.08.2018||R|0|0|0|G|0|KNM|0|0|0|100|IKR|10082|15375|lyfalmen|V0965|15375|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Paliperídón||10082||10082|15375||2|0|G|0|||0 055968|R03AC1302|Oxis Turbuhaler|innönddu|4,5|mcg/sk|60|skammtar|1|stauk||R03AC13|01.01.2016||R|0|0|0|G|0|AZD|0|0|1|100|SEK|3047|5692|lyfalmen|||1|60|0|11,2500|Vistor hf|AstraZeneca A/S DK|Formóteról||3047||3047|5692||1|0|G|0|||0 056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2524|2951|lyfalmen|V0112|2733|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atorvastatín||1056||1056|2951||1|0|G|0|||0 056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3838|3210|lyfalmen|V0113|2735|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atorvastatín||1244||1244|3210||1|0|G|0|||0 056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|5575|3210|lyfalmen|V0114|2736|2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atorvastatín||1244||1244|3210||1|0|G|0|||0 056196|L01XC0501|Mylotarg|st/irþ|5|mg|1|hgl|1|pakki|lausn|L01XC05|01.06.2019||R|0|0|0|0|0|PEU|0|1|0|100|DKK|1052460|1315477|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Gemtuzumab ozogamicin||1052460||1052460|1315477||2|H|L|0|||0 056308|N07XX0701|Fampyra|forðatfl|10|mg|28|stk|1|þpakki||N07XX07|01.03.2013||R|0|0|1|0|0|BNB|0|0|0|100|XEU|22905|32244|lyfalmen|||1|28|0|14,0000|Icepharma hf|Biogen Netherlands B.V.|Fampridine||22905||22905|32244||2|0|E|0|||0 056339|C09BA0203|Enalapril-Hydrochlorthiazid Krka|töflur|32,5|mg|110|stk|1|þpakki|20+12,5 mg|C09BA02|01.06.2019||R|1|0|0|G|0|KRK|0|0|0|100|IKR|1500|2943|lyfalmen|V0098|2841|2|110|0|110,0000|LYFIS ehf|Krka Sverige AB|Enalapríl og þvagræsilyf||1050||1050|2943||2|0|G|0|||0 056442|QG03DA0401|Prid alpha|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.04.2011||R|0|0|0|0|0|CES|1|0|0|100|XEU|26089|44967|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||26089||26089|44967||2|0||0|||0 056500|B01AF0301|Lixiana|filmhtfl|15|mg|10|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|G|0|OPE|0|0|0|100|DKK|3262|5988|lyfalmen|||1|10|0|2,5000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||3262||3262|5988||1|0|G|0|||0 056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|glas||J01FA01|01.01.1986|31.07.2021|R|1|0|0|0|0|MEA|0|0|1|100|DKK|1884|4091|lyfalmen|||1|40|0|10,0000|Icepharma hf|Meda AB|Erýtrómýcín||1884||1884|4091||2|0|E|0|||0 056858|L04AD0204|Dailiport|forðahlk|5|mg|50|stk|1|stsk.þ||L04AD02|01.09.2020||R|0|0|1|G|0|SHS|0|0|0|100|DKK|45781|61177|lyfalmen|||2|50|0|50,0000|Artasan ehf|Sandoz A/S|Tacrolimus||45781||45781|61177||1|0|G|0|||0 056915|L04AA2301|Tysabri|irþ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|0|1|0|0|0|BNB|0|1|0|100|XEU|208008|265215|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Biogen Netherlands B.V.|Natalizumab||208008||208008|265215||2|H|L|0|||0 057304|V03AN0502|Airapy|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN05|01.08.2013||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|4|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5|0||0|||0 057335|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|BAM|0|0|0|100|SEK|3320|6068|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||3320||3320|6068||2|0|0|0|||0 057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|0|0|HES|0|1|0|100|DKK|3433|6223|lyfsjukr|||1|5|0|0,7100|Vistor hf|Novartis Healthcare A/S|Oktreótíð||3433||3433|6223||1|0|L|0|||0 057365|N06AX1614|Venlafaxin Krka|forðahlk|75|mg|100|stk|1|tfílát|hart|N06AX16|01.02.2018||R|1|0|0|G|0|KNM|0|0|0|100|IKR|2859|2874|lyfalmen|V0334|2598|2|100|0|75,0000|LYFIS ehf|Krka d.d. Novo mesto|Venlafaxín||1000||1000|2874||2|0|G|0|||0 057376|N06AX1614|Venlafaxin Krka|forðahlk|150|mg|100|stk|1|tfílát|hart|N06AX16|01.02.2018||R|1|0|0|G|0|KNM|0|0|0|100|IKR|3700|2874|lyfalmen|V0335|2598|2|100|0|150,0000|LYFIS ehf|Krka d.d. Novo mesto|Venlafaxín||1000||1000|2874||2|0|G|0|||0 057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|0|0|HES|0|1|0|100|DKK|2391|4789|lyfsjukr|||1|5|0|0,3600|Vistor hf|Novartis Healthcare A/S|Oktreótíð||2391||2391|4789||1|0|L|0|||0 057867|N06DX0107|Zalatine|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.03.2014||R|1|0|0|G|0|WEH|0|0|0|100|XEU|10126|15435|lyfalmen|V0607|4840|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Memantín||10126||10126|15435||2|0|G|0|||0 057979|L01BC5901|Lonsurf|filmhtfl|21,14|mg|20|stk|1|þpakki|15 mg + 6,14 mg|L01BC59|01.09.2016||R|0|0|1|0|0|LLS|0|1|0|100|DKK|89636|116645|lyfsjukr|||1|20|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||89636|116645||2|0|L|0|||0 058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|þpakki||N07BA03|01.03.2009||R|0|0|0|0|0|PEU|0|0|1|100|DKK|19532|28382|lyfalmen|V1050|28382|1|112|0|56,0000|Icepharma hf|Pfizer Europe MA EEIG|Vareniclin||||19532|28382||1|0||0|||0 058199|N02AA0506|Oxikodon Depot Actavis|forðatfl|20|mg|100|stk|1|tfílát||N02AA05|01.10.2019|30.09.2021|R|1|0|0|G|0|ATE|0|0|0|100|XEU|4635|7809|lyfalmen|||2|100|0|26,6666|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||4585||4585|7809||1|0|G|1|30|dagar|0 058207|H01CB0501|Signifor|sts|40|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|0|ROD|0|1|0|100|DKK|354517|447431|lyfsjukr|||1|1|0|33,3300|Recordati AB|Recordati Rare Diseases|PAsireótið disapartate||354517||354517|447431||1|0|L|0|||0 058283|QI01AD0401|Avipro Thymovac|frþlyf|||500|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|LOH|0|0|0|100|XEU|156741|270159|vetorma|||0|5000|0||Icepharma hf|Lohmann Animal Health|chicken anaemia virus||||156741|270159||2|0||0|||0 058294|QI01AD0401|Avipro Thymovac|frþlyf|||1000|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|LOH|0|0|0|100|XEU|238104|410396|vetorma|||0|10000|0||Icepharma hf|Lohmann Animal Health|chicken anaemia virus||||238104|410396||2|0||0|||0 058503|J01EA0107|Trimetoprim Meda|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|0|0|0|0|0|MEA|0|0|1|100|DKK|2073|4351|lyfalmen|||1|100|0|2,5000|Icepharma hf|Meda AB|Trímetóprím||2073||2073|4351||2|0|E|0|||0 058609|N05AX1302|Xeplion|stl|50|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|JCI|0|0|0|100|SEK|36131|48972|lyfalmen|||1|1|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||36131||36131|48972||1|0|E|0|||0 058622|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|BAM|0|0|0|100|SEK|4880|8215|lyfalmen|||1|7500|0||Icepharma hf|Baxter Medical AB|Kolvetni||4880||4880|8215||2|0|0|0|||0 058735|C03CA0105|Lasix Retard|forðahlk|30|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|1|0|0|G|0|SNP|0|0|0|100|XEU|1157|3090|lyfalmen|||1|100|0|75,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||1157||1157|3090||1|0|G|0|||0 058768|C03CA0105|Lasix Retard|forðahlk|60|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|1|0|0|G|0|SNP|0|0|0|100|XEU|1666|3791|lyfalmen|||1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||1666||1666|3791||1|0|G|0|||0 059012|A06AH0301|Moventig|filmhtfl|25|mg|30|stk|1|þpakki|stakskammtaþynna|A06AH03|01.10.2018||R|1|0|0|0|0|KWA|0|0|0|100|XEU|11675|17567|lyfalmen|||1|30|0|30,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Naloxegol||11675||11675|17567||2|0|0|0|||0 059059|N06DA0405|Galantamin STADA|forðahlk|16|mg|84|stk|1|þpakki|Hart forðahylki|N06DA04|01.04.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|14895|21999|lyfalmen|||2|84|0|84,0000|LYFIS ehf|STADA Arzneimittel AG|Galantamín||14895||14895|21999||2|0|G|0|||0 059070|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|þpakki||A02BC01|01.05.2011||R|1|0|0|G|0|ATE|0|0|1|100|IKR|2374|2737|lyfalmen|V0006|1224|2|56|0|56,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ómeprazól||900||900|2737||1|0|G|0|||0 059211|L01XC2801|Imfinzi|irþ|50|mg/ml|10|ml|1|hgl|500 mg/10 ml|L01XC28|01.06.2019||R|0|0|0|0|0|AZE|0|1|0|100|SEK|440996|554987|lyfsjukr|||1|10|0||Vistor hf|AstraZeneca AB|Durvalumab||||440996|554987||1|H|L|0|||0 059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|0|0|1|G|0|REI|0|0|0|100|DKK|91015|118389|lyfalmen|||1|2|0|311,1900|Vistor hf|Recordati Ireland Limited|Leuprórelín||91015||91015|118389||1|0|G|0|||0 059644|J02AX0601|Ecalta|st/irþ|100|mg|30|ml|1|hgl||J02AX06|01.11.2015||R|0|0|0|0|0|PEU|0|0|0|100|DKK|57138|75542|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer Europe MA EEIG|Anidulafungin||57138||57138|75542||1|H|0|0|||0 059767|N03AF0401|Zebinix|töflur|800|mg|30|stk|1|þpakki||N03AF04|01.03.2010||R|1|0|0|G|0|BPC|0|0|0|100|SEK|24281|33984|lyfalmen|||1|30|0|30,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||24281||24281|33984||1|0|G|0|||0 059803|C08CA0502|Adalat Oros|forðatfl|30|mg|98|stk|1|þpakki||C08CA05|01.04.2013||R|1|0|0|G|0|BAB|0|0|0|100|DKK|4472|7653|lyfalmen|||1|98|0|98,0000|Icepharma hf|Bayer AB|Nífedipín||||4472|7653||2|0|G|0|||0 059882|L04AD0203|Modigraf|mixt.kyr|0,2|mg|50|sk-pokar|1|pakki||L04AD02|01.04.2014||R|0|0|1|0|0|ASP|0|0|0|100|XEU|8643|13394|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||8643||8643|13394||1|0|E|0|||0 059938|L04AD0203|Modigraf|mixt.kyr|1|mg|50|sk-pokar|1|pakki||L04AD02|01.04.2014||R|0|0|1|0|0|ASP|0|0|0|100|XEU|43214|57931|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||43214||43214|57931||1|0|E|0|||0 059976|J01DD0402|Ceftriaxona Normon|irs|2000|mg|1|stk|1|hgl|lausn|J01DD04|01.06.2018||R|0|0|0|0|0|LNA|0|0|1|100|XEU|3138|5817|lyfalmen|||2|1|0|1,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftríaxón||3138||3138|5817||2|0|0|0|||0 060581|A10BD2001|Synjardy|filmhtfl|1012,5|mg|180|stk|1|þpakki|12,5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|G|0|BOE|0|0|0|100|DKK|21087|29944|lyfalmen|V0713|29944|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||21087||21087|29944||1|0|G|0|||0 060930|J01AA0212|Doxycyklin EQL Pharma|töflur|100|mg|100|stk|1|þpakki||J01AA02|01.07.2018||R|1|0|0|0|0|EQL|0|0|1|100|IKR|5000|8380|lyfalmen|||2|100|0|100,0000|LYFIS ehf|EQL Pharma AB|Doxýcýklín||5000||5000|8380||2|0|E|0|||0 061112|L04AA3101|AUBAGIO|filmhtfl|14|mg|28|stk|1|þpakki||L04AA31|01.09.2014||R|1|1|1|0|0|SGB|0|1|0|100|XEU|98884|128342|lyfsjukr|||1|28|0|28,0000|Vistor hf|Sanofi-aventis groupe|Teriflúnomíð||98884||98884|128342||1|0|L|0|||0 061147|N05CF0201|Stilnoct|filmhtfl|10|mg|28|stk|1|þpakki||N05CF02|01.04.2021||R|1|0|0|0|0|SNP|0|0|1|100|XEU|305|1918|lyfalmen|V0060|1832|1|28|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||305||305|1918||1|0||2|30|töflur|0 061388|C10AA0508|Lipistad|filmhtfl|10|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|G|0|ASR|0|0|0|100|IKR|1994|2806|lyfalmen|V0112|2733|2|100|0|50,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||950||950|2806||2|0|G|0|||0 061465|M02AA0702|Felden|hlaup|5|mg/g|50|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|PLS|0|0|1|100|DKK|||lyflausa|||0|50|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1|0||0|||0 061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.07.1998||R|0|0|0|G|0|NVO|0|0|0|100|DKK|4934|8289|lyfalmen|||1|84|0|84,0000|Vistor hf|N.V. Organon|Tíbólón||4934||4934|8289||1|0|G|0|||0 061937|L04AD0101|Sandimmun|irþ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|HES|0|0|0|100|DKK|3713|6608|lyfalmen|||1|10|0|2,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||3713||3713|6608||1|H|0|0|||0 061961|J01XX0901|Cubicin|sts/irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|1|1|0|0|MLD|0|0|0|100|DKK|13951|20700|lyfalmen|||1|1|0|1,2500|Vistor hf|Merck Sharp & Dohme Limited|Daptomýcín||13951||13951|20700||1|0|0|0|||0 061970|J01XX0901|Cubicin|sts/irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|1|1|0|0|MLD|0|0|0|100|DKK|18720|27264|lyfalmen|||1|1|0|1,7900|Vistor hf|Merck Sharp & Dohme Limited|Daptomýcín||18720||18720|27264||1|0|0|0|||0 062347|G04BE0806|Tadalafil Krka|filmhtfl|10|mg|12|stk|1|þpakki||G04BE08|01.12.2017||R|1|0|0|0|0|KNM|0|0|0|100|IKR|15000|18015|lyfalmen|V0924|18015|2|12|0|12,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||12000||12000|18015||2|0|E|0|||0 062544|J05AB0901|Famvir|töflur|125|mg|10|stk|1|þpakki||J05AB09|01.11.2019||R|1|0|0|G|0|PIX|0|0|1|100|NOK|5712|9360|lyfalmen|||1|10|0|1,6667|Phoenix Labs|Phoenix Labs|Famcíclóvír||5712||5712|9360||2|0|G|0|||0 062575|J05AP0801|Sovaldi|filmhtfl|400|mg|28|stk|1|glas||J05AP08|01.09.2015||R|0|0|1|0|0|GSE|0|1|0|100|XEU|1987470|2478367|lyfsjukr|||1|28|0|28,0000|Gilead Sience Sweden AB|Gilead Sciences Ireland|Sofosbuvir||||1987470|2478367||1|0|L|0|||0 062662|R03AC1201|Serevent|innúðal|25|mcg/sk|120|skammtar|1|úðaílá|HFA 134a|R03AC12|01.09.2019||R|0|0|0|G|0|GPH|0|0|1|100|DKK|3659|6534|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról||3659||3659|6534||1|0|G|0|||0 062704|R02AA0305|Strepsils Cool|sogtfl|||36|stk|1|þpakki||R02AA03|01.09.2010||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0||0|||0 062729|N05BA1204|Tafil Retard|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|896|2731|lyfalmen|V0308|2708|1|60|0|30,0000|Icepharma hf|Upjohn EESV|Alprazólam||896||896|2731||1|0||2|60|mg|0 062745|QP53AF0102|Sebacil vet.|húðlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|0|0|0|0|0|BAN|0|0|0|100|DKK|17426|30035|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|Phoximum||17426||17426|30035||2|0||0|||0 062793|J05AE1002|Darunavir Alvogen|filmhtfl|600|mg|60|stk|1|glas||J05AE10|01.07.2017||R|1|0|1|0|0|ALO|0|1|0|100|XEU|71278|63980|lyfsjukr|||2|60|0|30,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Darunavír||47997||47997|63980||2|0|L|0|||0 062987|J07BM0201|Cervarix|stl|||0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|0|0|0|0|0|GBI|0|0|0|100|DKK|11414|15328|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerð 16, 18)||10048||10048|15328||1|0||0|||0 062996|J07BM0201|Cervarix|stl|||0,5|ml|10|áf.spr|dreifa|J07BM02|01.03.2014||R|0|0|0|0|0|GBI|0|0|0|100|DKK|115161|149739|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerð 16, 18)||115161||115161|149739||1|0||0|||0 063180|N05AH0205|Clozapine Actavis|töflur|25|mg|100|stk|1|þpakki||N05AH02|01.05.2015||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1768|3217|lyfalmen|V0276|3217|2|100|0|8,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klózapín||1249||1249|3217||1|0|G|0|||0 063255|N05AH0205|Clozapine Actavis|töflur|100|mg|100|stk|1|þpakki||N05AH02|01.07.2014||R|1|0|0|G|0|ATE|0|0|0|100|XEU|5457|6307|lyfalmen|V0277|6307|2|100|0|33,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klózapín||3494||3494|6307||1|0|G|0|||0 063426|L02BB0601|Nubeqa|filmhtfl|300|mg|112|stk|1|þpakki||L02BB06|01.01.2021||R|1|0|0|0|0|BAB|0|1|0|100|DKK|430987|542538|lyfsjukr|||1|112|0||Icepharma hf|Bayer AB|Darolutamide||430987||430987|542538||2|0|L|0|||0 063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|0|0|0|0|0|MEA|0|0|0|100|DKK|||lyfalmen|||0|500|0|49,7761|Icepharma hf|Meda AB|Laktúlósa|||||3414||2|0|E|0|||0 063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.11.2006||R|1|0|0|0|0|ATE|0|0|0|100|XEU|2101|3596|lyfalmen|V0123|3596|2|28|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Terbínafín||1524||1524|3596||1|0|E|0|||0 063926|L04AC0701|RoActemra|stl|162|mg|4|áf.spr|1|pakki||L04AC07|01.12.2014||R|0|1|1|0|0|RRG|0|1|0|100|DKK|139411|179899|lyfsjukr|||1|4|0|32,4000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||139411||139411|179899||2|0|L|0|||0 063940|N05CD0806|Buccolam|munnh.l|2,5|mg|0,5|ml|4|spr|munngjaf.spr|N05CD08|01.08.2020||R|0|0|0|0|0|LOS|0|0|1|100|DKK|12702|18981|lyfalmen|||2|2|0|1,0000|Laboratorios Lesvi, S.L.|Laboratorios Lesvi, S.L.|Mídazólam||12702||12702|18981||3|H|E|2|450|mg|0 063958|N05BA1204|Tafil Retard|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|934|2783|lyfalmen|V0310|2783|1|60|0|60,0000|Icepharma hf|Upjohn EESV|Alprazólam||934||934|2783||1|0||2|60|mg|0 064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|0|0|FEC|0|1|0|100|XEU|905607|1132833|lyfsjukr|||1|20|0|11,6300|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||||905607|1132833||2|H|L|0|||0 064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|0|0|FEC|0|1|0|100|XEU|359076|453101|lyfsjukr|||1|20|0|4,6500|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||||359076|453101||2|H|L|0|||0 064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|0|0|FEC|0|1|0|100|XEU|3104207|3867276|lyfsjukr|||1|20|0|46,5100|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||||3104207|3867276||2|H|L|0|||0 064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|0|0|FEC|0|1|0|100|XEU|1608643|2007213|lyfsjukr|||1|20|0|23,2600|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||||1608643|2007213||2|H|L|0|||0 064270|B01AC0406|Clopidogrel Krka|filmhtfl|75|mg|28|stk|1|þpakki||B01AC04|01.07.2013||R|1|0|0|G|0|KNM|0|0|0|100|XEU|1977|4219|lyfalmen|||2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Klópídógrel||1977||1977|4219||2|0|G|0|||0 064281|B01AC0406|Clopidogrel Krka|filmhtfl|75|mg|100|stk|1|þpakki||B01AC04|01.07.2013||R|1|0|0|G|0|KNM|0|0|0|100|XEU|6308|5759|lyfalmen|V0029|5759|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Klópídógrel||3096||3096|5759||2|0|G|0|||0 064402|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.06.2013||R|0|0|0|0|0|IBV|0|0|0|100|DKK|1145|2250|vetalmen|||0|100|0||Vistor hf|Intervet International BV|Oxytetracyclinum||1145||1145|2250||1|0||0|||0 064727|QI09AE0401|Enterisol Ileitis vet.|frþlyf|||50|skammtar|1|hgl|+100 ml leysir, dreifa|QI09AE04|01.02.2016||R|0|0|0|0|0|BIV|0|0|0|100|DKK|6535|11264|vetorma|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|lawsonia||||6535|11264||1|0||0|||0 064742|B02BD0101|Octaplex|irs|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.12.2011||R|0|0|0|0|0|OCT|0|1|0|100|DKK|46132|61621|lyfsjukr|||1|1|0||Vistor hf|Octapharma AB|Storkuþættir lX,ll,Vll,X||46132||46132|61621||1|H|L|0|||0 064809|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.03.2020||R|1|0|0|G|0|ATE|0|0|0|100|IKR|4118|3904|lyfalmen|V0679|3904|2|98|0|196,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Valsartan||1748||1748|3904||1|0|G|0|||0 064840|A03FA0102|Afipran|töflur|10|mg|50|stk|1|glas||A03FA01|01.03.2013||R|1|0|0|G|0|OEC|0|0|1|100|DKK|804|2605|lyfalmen|||2|50|0|16,6667|Artasan ehf|Orifarm Generics A/S|Metóklópramíð||804||804|2605||1|0|G|0|||0 064956|A03FA0102|Afipran|stl|5|mg/ml|2|ml|10|lykjur|lausn|A03FA01|01.03.2013||R|0|0|0|G|0|OEC|0|0|1|100|DKK|1080|2984|lyfalmen|||2|20|0|3,3300|Artasan ehf|Orifarm Generics A/S|Metóklópramíð||1080||1080|2984||1|0|G|0|||0 064963|L01ED0401|Alunbrig|filmhtfl|90|mg|28|stk|1|þpakki||L01ED04|01.02.2021||R|1|1|1|0|0|ASS|0|1|0|100|DKK|506735|636748|lyfsjukr|||1|28|0||Vistor hf|Takeda AS|Brigatinib||506735||506735|636748||1|0|L|0|||0 065012|C07AB0215|Metoprolol Alvogen|forðatfl|95|mg|100|stk|1|þpakki||C07AB02|01.02.2021||R|1|0|0|G|0|GOV|0|0|0|100|IKR|2334|2910|lyfalmen|V0049|2910|2|100|0|63,3333|Alvogen|Alvogen ehf|Metóprólól||1026||1026|2910||2|0|G|0|||0 065076|QM01AE0302|Ketodine vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.01.2014||R|0|0|0|0|0|VEB|1|0|0|100|XEU|4816|9307|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Ketóprófen||4816||4816|9307||2|0||0|||0 065093|R03AK0605|Salmex|innönddu|300|mcg/sk|60|skammtar|1|innö.t|50/250 mcg/sk|R03AK06|01.07.2021||R|0|0|0|G|0|GPN|0|0|0|100|DKK|3918|6468|lyfalmen|V0437|5862|2|60|0|30,0000|Icepharma hf|Glenmark Pharmaceuticals Nordic AB|Salmeteról og fluticason||3611||3611|6468||2|0|G|0|||0 065200|J01DB0402|Cefazolina Normon|sts|1|g|1|stk|1|hgl|í vöðva|J01DB04|01.06.2018||R|0|0|0|0|0|LNA|0|0|1|100|XEU|537|2237|lyfalmen|||2|1|0|0,3333|Williams & Halls efh|Laboratorios Normon, S.A.|Cefazólín||537||537|2237||2|0|0|0|||0 065314|G01AF0201|Canesten|sk-tfl|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2|0||0|||0 065332|G01AF0201|Canesten|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2|0||0|||0 065339|A07EA0604|Cortiment|forðatfl|9|mg|30|stk|1|þpakki||A07EA06|01.09.2015||R|0|0|0|G|0|FEL|0|0|0|100|DKK|15202|22422|lyfalmen|||1|30|0|30,0000|Vistor hf|Ferring Lægemidler A/S|Búdesóníð||15202||15202|22422||1|0|G|0|||0 065441|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|GEH|0|0|0|100|NOK|9798|14984|lyfalmen|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||9798||9798|14984||2|H|0|0|||0 065468|M01AH0503|Coxerit|filmhtfl|60|mg|98|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|WEH|0|0|1|100|IKR|5183|7140|lyfalmen|V0830|6864|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||4099||4099|7140||2|0|G|0|||0 065583|C10AX0904|Ezetimib Medical Valley|töflur|10|mg|112|stk|1|þpakki||C10AX09|01.07.2019||R|0|0|0|0|0|VAL|0|0|0|100|DKK|8915|6950|lyfalmen|V0954|6950|2|112|0|112,0000|Acare ehf|Medical Valley Invest AB|Ezetimíb||3961||3961|6950||2|0|0|0|||0 065711|L02AE0306|Zoladex (Lyfjaver)|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.06.2011||R|0|0|1|G|0|LVR|0|0|0|100|SEK|48773|63620|lyfalmen|V0451|53920|3|1|0|83,7209|Lyfjaver ehf|Lyfjaver ehf|Góserelín||47712||47712|63620||3|0|G|0|||0 065729|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|15,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 065740|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|7,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 065751|J01CR0204|Amoxin comp|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg|J01CR02|01.02.2013||R|0|0|0|0|0|RTH|0|0|1|100|DKK|1971|4211|lyfalmen|||2|70|0|3,7333|Alvogen|ratiopharm GmbH|Amoxicillín og beta-laktamasa hemill ||1971||1971|4211||2|0|E|0|||0 065752|N07BA0142|Nicorette Invisi|forðapl|10|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 065775|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|25,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 065786|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|12,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 065827|N02AJ0601|Parkodin|filmhtfl|510|mg|200|stk|1|ílát|10+500 mg|N02AJ06|01.02.2018||R|2|0|0|0|0|ATE|0|0|1|100|XEU|2737|5265|lyfalmen|||2|200|0|33,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||2737||2737|5265||1|0|E|1|||0 065870|V08AB0201|Omnipaque|stl|180|mg J/ml|10|ml|10|glhgl||V08AB02|01.12.2009||R|0|0|0|0|0|GEH|0|0|0|100|NOK|3095|5758|lyfalmen|||1|100|0||Icepharma hf|GE Healthcare AS|Iohexol||3095||3095|5758||2|H|0|0|||0 065934|C08CA1301|Lerkanidipin Actavis|filmhtfl|10|mg|28|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|G|0|ATE|0|0|0|100|SEK|1543|3622|lyfalmen|||2|28|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lerkanidipín||1543||1543|3622||1|0|G|0|||0 065945|C08CA1301|Lerkanidipin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|G|0|ATE|0|0|0|100|SEK|2822|5382|lyfalmen|||2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lerkanidipín||2822||2822|5382||1|0|G|0|||0 065956|C08CA1301|Lerkanidipin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|G|0|ATE|0|0|0|100|SEK|4852|7766|lyfalmen|||2|98|0|196,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lerkanidipín||4554||4554|7766||1|0|G|0|||0 066013|A11HA0801|Vedrop|mixtúra|50|mg/ml|20|ml|1|glas||A11HA08|01.07.2017||R|0|0|1|0|0|ECO|0|0|0|100|XEU|11681|17576|lyfalmen|||1|20|0|5,0000|Recordati AB|Recordati Rare Diseases|Tocofersolanum||11681||11681|17576||3|0|E|0|||0 066111|L01DB0107|Caelyx pegylated liposomal|irþ|2|mg/ml|10|ml|1|hgl||L01DB01|01.10.2021||R|0|0|0|0|0|AXT|0|1|0|100|SEK|54532|72246|lyfsjukr|||1|10|0||Vistor hf|Baxter Holding B.V.|Doxórúbicín||54532||54532|72246||1|H|L|0|||0 066195|QM01AC0605|Melovem|stl|5|mg/ml|100|ml|1|hgl||QM01AC06|01.08.2011||R|0|0|0|0|0|DOR|1|0|0|100|DKK|4347|8418|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|Meloxícam||4347||4347|8418||2|0||0|||0 066411|A01AA0101|Duraphat|tannpast|5|mg/ml|51|g|1|túpa||A01AA01|01.04.2011||R|0|0|0|0|0|GOG|0|0|1|100|DKK|848|2665|lyfalmen|||1|51|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||848||848|2665||2|0||0|||0 066497|N05AH0415|Quetiapin Krka|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.04.2018||R|0|1|0|G|0|KRK|0|0|0|100|IKR|7500|8930|lyfalmen|V0272|8917|2|100|0|75,0000|LYFIS ehf|Krka Sverige AB|Quetíapín||5400||5400|8930||2|0|G|0|||0 066862|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|14|stk|1|þpakki||A02BC01|01.05.2010||L|1|0|0|0|0|ATE|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ómeprazól|||||||1|0||0|||0 066897|L01CD0104|Paclitaxel Actavis|irþ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.06.2010||R|0|0|0|0|0|ATE|0|0|0|100|XEU|12243|18349|lyfalmen|||2|50|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paklítaxel||||12243|18349||1|H|0|0|||0 067001|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|50|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|7925|12406|lyfalmen|||1|5000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||7925||7925|12406||1|0|0|0|||0 067229|J05AR1901|Odefsey|filmhtfl|250|mg|30|stk|1|glas|200+25+25 mg|J05AR19|01.09.2016||R|0|0|1|0|0|GSU|0|1|0|100|DKK|102940|134540|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Sciences Ireland UC|Emtricitabine, tenofovir alafenamide og rilpivirine||||102940|134540||2|0|L|0|||0 067394|A02BC0512|Nexium (Lyfjaver)|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.05.2019||R|1|0|0|0|0|LVR|0|0|1|100|DKK|11066|15817|lyfalmen|V0012|5765|3|100|0|133,3300|Lyfjaver ehf|Lyfjaver ehf|Esómeprazól||10403||10403|15817||3|0|0|0|||0 067829|QA04AD9002|Prevomax|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.06.2020||R|0|0|0|0|0|DER|0|0|0|100|SEK|8255|15832|vetalmen|||0|20|0||Dýraheilsa ehf|Dechra Regulatory B.V|maropitant||||8255|15832||2|0||0|||0 067848|QN02BG9102|Librela|stl|30|mg|1|ml|2|hgl||QN02BG91|01.08.2021||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|17149|32706|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Bedinvetmab||17149||17149|32706||2|0||2|||0 067877|B05BA0314|Glucos Baxter Viaflo|irl|100|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.09.2015||R|0|0|0|0|0|BAM|0|0|0|100|SEK|2334|4710|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||||2334|4710||2|0|0|0|||0 068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|þpakki||C01BC04|01.04.1987||R|1|0|1|G|0|MEA|0|0|0|100|DKK|4465|7644|lyfalmen|||1|100|0|50,0000|Icepharma hf|Meda AB|Flekaíníð||4465||4465|7644||2|0|G|0|||0 068509|R01AD0902|Kalmente|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.11.2015||L|0|0|0|G|0|ZET|0|0|1|100|IKR|||lyfalmen|V0677|2753|2|140|0|35,0000|Alvogen|Zentiva, k.s.|Mómetasón|||||3123||2|0|G|0|||0 068629|A10BG0302|Pioglitazone Actavis|töflur|15|mg|98|stk|1|þpakki||A10BG03|01.02.2017||R|1|0|0|G|0|GRP|0|0|0|100|XEU|8745|13535|lyfalmen|||2|98|0|49,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||8745||8745|13535||1|0|G|0|||0 068776|R06AX2704|Desloratadine ratiopharm|munndr.t|5|mg|30|stk|1|þpakki||R06AX27|01.04.2014|31.07.2021|L|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Alvogen|ratiopharm GmbH|Deslóratadín|||||||2|0||0|||0 068811|L04AX0307|Metoject|stl|50|mg/ml|0,55|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|G|0|WIL|0|0|0|100|SEK|3015|5648|lyfalmen|||1|0,55|0|11,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3015||3015|5648||2|0|G|0|||0 068860|A02BC0308|Lansoprazol Krka|sþ-hylki|15|mg|28|stk|1|þpakki||A02BC03|01.08.2018||L|1|0|0|0|0|KRK|0|0|0|100|IKR|||lyflausa|||2|28|0|14,0000|LYFIS ehf|Krka Sverige AB|Lansóprazól|||||||2|0||0|||0 068896|B05XA0303|Natriumklorid B.Braun|irþ|1|mmol/ml|20|ml|20|plastl||B05XA03|01.09.2010||R|0|0|0|0|0|RAU|0|0|0|100|XEU|2617|5100|lyfalmen|||2|400|0||Actavis Group hf|B.Braun Melsungen AG|Natríumklóríð||2617||2617|5100||2|H|0|0|||0 068905|B05XA0103|Kaliumklorid B.Braun|irþ|1|mmol/ml|20|ml|20|plastl||B05XA01|01.09.2010||R|0|0|0|0|0|RAU|0|0|0|100|XEU|3335|6088|lyfalmen|||2|400|0||Actavis Group hf|B.Braun Melsungen AG|Kalíumklóríð||3335||3335|6088||2|H|0|0|||0 068923|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|200|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3622||2|0||0|||0 068933|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|400|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3805||2|0||0|||0 068951|V07AB0009|Sterilt Vann B. Braun|leysir|||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|200|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3576||2|0||0|||0 068960|V07AB0009|Sterilt Vann B. Braun|leysir|||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|400|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3755||2|0||0|||0 069030|G04BD1202|Betmiga (Lyfjaver)|forðatfl|50|mg|90|stk|1|þpakki||G04BD12|01.08.2020||R|1|0|0|G|0|LVR|0|0|0|100|XEU|15243|22478|lyfalmen|V0651|22478|3|90|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Mírabegrón||15243||15243|22478||3|0|G|0|||0 069106|H01BA0201|Minirin|frþ.tfl|240|mcg|30|stk|1|þpakki||H01BA02|01.08.2012||R|0|0|0|G|0|FEL|0|0|0|100|DKK|12632|18885|lyfalmen|||1|30|0|18,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||12632||12632|18885||1|0|G|0|||0 069115|H01BA0201|Minirin|frþ.tfl|240|mcg|100|stk|1|þpakki||H01BA02|01.08.2012||R|0|0|0|G|0|FEL|0|0|0|100|DKK|36554|49507|lyfalmen|||1|100|0|60,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||36554||36554|49507||1|0|G|0|||0 069177|C10AA0704|Rosuvastatin Xiromed|filmhtfl|40|mg|100|stk|1|þpakki||C10AA07|01.04.2018||R|0|0|0|0|0|VAL|0|0|0|100|IKR|9540|10169|lyfalmen|V0195|10169|2|100|0|400,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||6300||6300|10169||2|0|E|0|||0 069347|C02KX0501|Adempas|filmhtfl|1|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|0|BRE|0|1|0|100|DKK|375088|473016|lyfsjukr|||1|84|0|18,6700|Vistor hf|Bayer AG|Riociguatum||375088||375088|473016||1|0|L|0|||0 069423|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 069536|L04AA0607|Mycofenolsýra Accord|sh-tfl|180|mg|120|stk|1|þpakki||L04AA06|01.01.2020||R|0|1|1|G|0|AEE|0|0|0|100|XEU|14783|17777|lyfalmen|V0470|17362|2|120|0|10,8000|Artasan ehf|Accord Healthcare B.V.|Mýcófenólsýra||11827||11827|17777||1|0|G|0|||0 069596|A02BC0308|Lansoprazol Krka|sþ-hylki|15|mg|56|stk|1|þpakki||A02BC03|01.08.2018||L|1|0|0|G|0|KRK|0|0|0|100|IKR|||lyfalmen|||2|56|0|28,0000|LYFIS ehf|Krka Sverige AB|Lansóprazól|||||3284||2|0|G|0|||0 069912|J05AF1301|Vemlidy|filmhtfl|25|mg|30|stk|1|þpakki||J05AF13|01.08.2017||R|0|0|1|0|0|GEI|0|1|0|100|DKK|64746|85164|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland|Tenófóvír alafenamíð||||64746|85164||2|0|L|0|||0 070203|N05CF0107|Imomed|filmhtfl|7,5|mg|30|stk|1|þpakki||N05CF01|01.05.2020||R|1|0|0|0|0|DIC|0|0|0|100|IKR|450|2117|lyfalmen|V0312|2117|2|30|0|30,0000|LYFIS ehf|Medical ehf|Zópíklón||450||450|2117||2|0||2|30|töflur|0 070512|L01EB0401|Tagrisso|filmhtfl|40|mg|30|stk|1|stsk.þ||L01EB04|01.07.2020||R|0|0|1|0|0|AZE|0|1|0|100|SEK|819131|1025281|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Osimertinib||819131||819131|1025281||1|0|L|0|||0 070563|B02BD0208|Afstyla|sts|250|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|1|0|0|CSB|0|1|0|100|SEK|21034|29877|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||21034||21034|29877||2|0|L|0|||0 070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|með skammtasprautu|N05AX08|01.01.1997||R|0|0|0|G|0|JAS|0|0|0|100|SEK|9555|14649|lyfalmen|||1|100|0|20,0000|Vistor hf|Janssen-Cilag AB|Risperídón||9555||9555|14649||1|0|G|0|||0 070921|QI04AB0901|Gudair|stl|||30|ml|1|glas|dreifa|QI04AB09|01.09.2016||R|0|0|0|0|0|CZV|1|0|0|100|XEU|7318|12613|vetorma|||0|30|0||Vistor hf|CZ Veterinaria SA|Bóluefni gegn Mycobacterium||7318||7318|12613||1|0||0|||0 071450|J01FA1008|Azitromicina Normon|filmhtfl|500|mg|3|stk|1|þpakki||J01FA10|01.03.2019||R|1|0|0|0|0|WEH|0|0|1|100|IKR|1100|3012|lyfalmen|V0174|2599|2|3|0|5,0000|Williams & Halls efh|Williams & Halls ehf|Azitrómýcín||1100||1100|3012||2|0||0|||0 071650|QI09AL0803|Mhyosphere PCV ID|stl|||10|ml|1|hgl|fleyti|QI09AL08|01.10.2021||R|0|0|0|0|0|LHS|0|0|0|100|IKR|10489|18079|vetorma|||0|10|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Mycoplasma hyopneumoniae, Recombinat Porcine Circovirus||10489||10489|18079||2|0||0|||0 071784|A10BD2401|Steglujan|filmhtfl|105|mg|98|stk|1|þpakki|5/100 mg|A10BD24|01.03.2019||R|1|0|0|G|0|MBV|0|0|0|100|DKK|35402|47846|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|sitagliptin og ertugliflozin||35241||35241|47846||1|0|G|0|||0 071975|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|þpakki||L01BB05|01.09.2011||R|0|0|1|0|0|GEB|0|0|0|100|XEU|73393|96101|lyfalmen|||1|20|0||Vistor hf|Genzyme Europe B.V.|Flúdarabín||||73393|96101||1|0|0|0|||0 072103|N05AE0403|Ziprasidon Actavis|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.11.2020||R|1|0|0|0|0|ATE|0|0|0|100|XEU|13527|11506|lyfalmen|||2|56|0|14,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ziprasidon||7271||7271|11506||1|0|E|0|||0 072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|0|0|0|0|0|ORF|1|0|0|100|DKK|6792|13056|vetalmen|||0|5|0||Vistor hf|Orion-Farmos|Detomidinum||6792||6792|13056||1|0||0|||0 072374|N06AX1203|Wellbutrin Retard (Lyfjaver)|töflur|300|mg|30|stk|1|askja|m/br. losunarhraða|N06AX12|01.10.2020||R|0|0|0|0|0|LVR|0|0|0|100|DKK|5306|8801|lyfalmen|V1029|8801|3|30|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Bupropionum||5306||5306|8801||3|0|E|0|||0 072380|B01AC0402|Grepid|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.12.2009||R|1|0|0|G|0|PSA|0|0|0|100|XEU|6308|5759|lyfalmen|V0029|5759|2|100|0|100,0000|Alvogen|Pharmathen S.A.|Klópídógrel||3096||3096|5759||2|0|G|0|||0 072641|V04CX0001|Lung test gas CO (HE) Aga|lyfjagas|0,28|%|20|l|1|hylki|undir þrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|AGA|0|0|0|100|XEU|207638|264755|lyfalmen|||1|20|0||Ísaga ehf|AGA AB|Önnur sjúkdómsgreiningarefni||207638||207638|264755||5|H|0|0|||0 072654|V04CX0002|Lung test gas CO (C2H2/CH4) Aga|lyfjagas|0,3|%|20|l|1|hylki|undir þrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|AGA|0|0|0|100|XEU|220866|281207|lyfalmen|||1|20|0||Ísaga ehf|AGA AB|Önnur sjúkdómsgreiningarefni||220866||220866|281207||5|H|0|0|||0 072701|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|200|stk|1|glas|með br. losunarhraða|G04CA02|01.12.2017||R|1|0|0|G|0|MED|0|0|0|100|IKR|23000|11133|lyfalmen|||2|200|0|200,0000|Medical ehf|Medical ehf|Tamsúlósín||7000||7000|11133||2|0|G|0|||0 072735|L04AX0306|Metojectpen|stl|20|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|2931|5532|lyfalmen|||1|1|0|8,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2931||2931|5532||2|0|G|0|||0 072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|0|0|0|0|0|PBV|0|0|0|100|SEK|513|2204|lyfalmen|||1|10|0||Williams & Halls efh|Piramal Critical Care B.V.|Súfentaníl||513||513|2204||1|0|0|1|30|dagar|0 073027|J05AG0401|Intelence|töflur|200|mg|60|stk|1|glas||J05AG04|01.04.2012||R|0|0|1|0|0|JCI|0|1|0|100|SEK|50604|67278|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||50604||50604|67278||1|0|L|0|||0 073030|N05AH0410|Quetiapin Actavis|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.08.2013||R|1|0|0|G|0|ATE|0|0|0|100|XEU|8562|5714|lyfalmen|V0286|5627|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Quetíapín||3063||3063|5714||1|0|G|0|||0 073178|A10BA0204|Metformin Sandoz|filmhtfl|500|mg|100|stk|1|þpakki||A10BA02|01.01.2016||R|0|0|0|G|0|SHS|0|0|0|100|DKK|448|2115|lyfalmen|V0500|2062|2|100|0|25,0000|Artasan ehf|Sandoz A/S|Metformín||448||448|2115||1|0|G|0|||0 073276|C02KX0401|Opsumit|filmhtfl|10|mg|30|stk|1|þpakki||C02KX04|01.09.2014||R|1|1|1|0|0|JCI|0|1|0|100|SEK|339335|428549|lyfsjukr|||1|30|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Macitentan||||339335|428549||1|0|L|0|||0 073313|L01ED0101|Xalkori|hylki|200|mg|60|stk|1|þpakki||L01ED01|01.05.2013||R|1|1|1|0|0|PEU|0|1|0|100|DKK|499284|627481|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Europe MA EEIG|Crizotinib||499284||499284|627481||1|0|L|0|||0 073495|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|38 mg/8 mg|QP54AB51|01.04.2018|31.08.2021|R|0|0|0|0|0|BIV|0|0|0|100|XEU|2688|4633|vetorma|||0|3|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Milbemycin oxime í blöndum||2688||2688|4633||1|0||0|||0 073559|G04CA5201|Duodart|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.12.2010||R|0|0|0|G|0|GPH|0|0|0|100|DKK|3022|5657|lyfalmen|V1010|3018|1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Dútasteríð og tamsúlósínhýdroklóríð||3022||3022|5657||1|0|G|0|||0 073708|L02BG0405|Letrozol Actavis|filmhtfl|2,5|mg|100|stk|1|þpakki||L02BG04|01.09.2011||R|0|0|0|G|0|ATE|0|0|0|100|XEU|15691|22017|lyfalmen|V0185|21907|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Letrózól||14908||14908|22017||1|0|G|0|||0 073728|L01CB0105|Etópósíð Accord|irþ|20|mg/ml|25|ml|1|hgl||L01CB01|01.06.2020||R|0|0|0|0|0|AEE|0|0|0|100|XEU|8934|13795|lyfalmen|||2|25|0||Artasan ehf|Accord Healthcare B.V.|Etoposíð||8934||8934|13795||1|H|0|0|||0 073803|G04BE0806|Tadalafil Krka|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.12.2017||R|0|0|0|0|0|KNM|0|0|0|100|IKR|4700|7967|lyfalmen|V0924|6005|2|4|0|4,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||4700||4700|7967||2|0|E|0|||0 073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|927|2774|lyfalmen|V0305|2511|1|100|0|25,0000|Icepharma hf|Upjohn EESV|Alprazólam||927||927|2774||1|0||2|120|töflur|0 073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|UPJ|0|0|1|100|DKK|499|2185|lyfalmen|V0439|1864|1|20|0|10,0000|Icepharma hf|Upjohn EESV|Alprazólam||499||499|2185||1|0||2|60|töflur|0 073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|1355|3363|lyfalmen|||1|100|0|50,0000|Icepharma hf|Upjohn EESV|Alprazólam||1355||1355|3363||1|0||2|60|töflur|0 073885|N05CF0201|Stilnoct|filmhtfl|10|mg|150|stk|1|þpakki||N05CF02|01.05.2021||R|1|0|0|0|0|SNP|0|0|0|100|XEU|1839|4029|lyfalmen|||1|150|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||1839||1839|4029||1|0||2|30|töflur|0 073933|C09AA0211|Enalapril Krka|töflur|2,5|mg|100|stk|1|þpakki||C09AA02|01.04.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|1342|3345|lyfalmen|||2|100|0|25,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||1342||1342|3345||2|0|G|0|||0 073935|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|1|l|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|BRO|0|0|0|100|IKR|3687|6355|vetorma|||0|1|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Ltd|Ivermectinum||3687||3687|6355||2|0||0|||0 073947|L04AX0102|Imurel|töflur|25|mg|50|stk|1|þpakki||L04AX01|01.12.2010||R|0|0|0|G|0|AEP|0|0|0|100|DKK|892|2726|lyfalmen|||1|50|0|8,3333|Icepharma hf|Aspen Pharma Trading Limited|Azatíóprín||892||892|2726||2|0|G|0|||0 074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|1|0|0|0|0|NEL|0|0|0|100|DKK|2881|5463|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||2881||2881|5463||1|0|E|0|||0 074348|N03AX2201|Fycompa|filmhtfl|8|mg|28|stk|1|þpakki||N03AX22|01.02.2020||R|1|0|0|G|0|SIE|0|0|0|100|SEK|20494|29194|lyfalmen|||1|28|0|28,0000|Eisai AB|Eisai GmbH|Perampanel||20494||20494|29194||1|0|G|0|||0 074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|ATE|0|0|1|100|DKK|1039|2928|lyfalmen|||2|25|0|12,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||1039||1039|2928||1|0||2|50|töflur|0 074477|N02BE0118|Paracetamol-ratiopharm|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.10.2013||L|1|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||2|30|0|5,0000|Alvogen|ratiopharm GmbH|Paracetamól|||||||2|0||0|||0 074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|1|0|0|0|0|ATE|0|0|0|100|DKK|885|2716|lyfalmen|||2|50|0|25,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||885||885|2716||1|0||2|50|töflur|0 074492|N05BA0105|Stesolid|töflur|5|mg|100|stk|1|glas||N05BA01|01.08.2011||R|1|0|0|0|0|ATE|0|0|0|100|DKK|1413|3443|lyfalmen|||2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||1413||1413|3443||1|0||2|50|töflur|0 074664|N06AB1008|Escitalopram STADA|filmhtfl|15|mg|100|stk|1|þpakki||N06AB10|01.08.2021||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2800|5352|lyfalmen|V0326|5352|2|100|0|150,0000|LYFIS ehf|STADA Arzneimittel AG|Escítalópram||2800||2800|5352||2|0|0|0|||0 074758|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.12.2010||R|0|0|0|G|0|AEP|0|0|0|100|DKK|660|2406|lyfalmen|||1|60|0|12,0000|Icepharma hf|Aspen Pharma Trading Limited|Digoxín||660||660|2406||2|0|G|0|||0 074927|C02AC0201|Intuniv|forðatfl|2|mg|28|stk|1|þpakki||C02AC02|01.10.2020||R|1|1|1|0|0|HPI|0|0|0|100|DKK|10383|15789|lyfalmen|||1|28|0|18,6666|Vistor hf|Shire Pharmaceuticals Ireland Limited|Guanfacine||10383||10383|15789||1|0|E|0|||0 075009|L04AX0102|Imurel|töflur|50|mg|100|stk|1|þpakki||L04AX01|01.08.2011||R|0|0|0|G|0|AEP|0|0|0|100|DKK|2157|4467|lyfalmen|||1|100|0|33,3333|Icepharma hf|Aspen Pharma Trading Limited|Azatíóprín||2157||2157|4467||2|0|G|0|||0 075031|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|0|0|G|0|NEL|0|0|1|100|DKK|5078|8487|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||5078||5078|8487||1|0|G|0|||0 075042|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|0|0|G|0|NEL|0|0|1|100|DKK|14884|21984|lyfalmen|||1|90|0|90,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||14884||14884|21984||1|0|G|0|||0 075064|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|0|0|G|0|NEL|0|0|1|100|DKK|5352|8864|lyfalmen|||1|30|0|60,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||5352||5352|8864||1|0|G|0|||0 075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|G|0|SNP|0|0|1|100|XEU|1105|3019|lyfalmen|||1|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1105||1105|3019||1|0|G|0|||0 075075|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|0|0|G|0|NEL|0|0|1|100|DKK|15668|23063|lyfalmen|||1|90|0|180,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||15668||15668|23063||1|0|G|0|||0 075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 075187|A06AD0001|Moviprep|mixtduft|||4|pokar|1|pakki||A06AD|01.09.2011||L|0|0|0|0|0|NIE|0|0|0|100|DKK|||lyfalmen|||1|4|0||Artasan ehf|Norgine B.V.|Hægðalyf með osmótíska verkun|||||4789||1|0|E|0|||0 075451|G04CB0106|Finasteride Alvogen|filmhtfl|5|mg|98|stk|1|þpakki||G04CB01|01.05.2011||R|1|0|0|G|0|POF|0|0|0|100|IKR|5987|3563|lyfalmen|V0445|2884|2|98|0|98,0000|Alvogen|Alvogen|Fínasteríð||1500||1500|3563||2|0|G|0|||0 075865|G04BD0805|Solifenacin Alvogen|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|G|0|POF|0|0|0|100|XEU|12333|10632|lyfalmen|V0440|9075|2|90|0|90,0000|Alvogen|Alvogen|Sólífenacín||6636||6636|10632||2|0|G|0|||0 075869|B05DB0005|Balance|kvið.sk|1,5|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|FMC|0|0|0|100|XEU|5556|9145|lyfalmen|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5556||5556|9145||2|0|0|0|||0 075888|B05DB0005|Balance|kvið.sk|2,3|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|FMC|0|0|0|100|XEU|5556|9145|lyfalmen|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5556||5556|9145||2|0|0|0|||0 075906|B05DB0005|Balance|kvið.sk|4,25|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|FMC|0|0|0|100|XEU|6388|10290|lyfalmen|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6388||6388|10290||2|0|0|0|||0 075921|N02AA0507|OxyContin Depot|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.11.2020||R|1|0|0|G|0|MUP|0|0|0|100|DKK|3965|6955|lyfalmen|V0598|5341|1|98|0|13,0700|Icepharma hf|Mundipharma A/S|Oxýcódon||3965||3965|6955||2|0|G|1|30|dagar|0 076024|A10BH0101|Januvia|filmhtfl|100|mg|28|stk|1|þpakki||A10BH01|01.01.2010||R|1|0|0|G|0|MBV|0|0|0|100|DKK|4766|8058|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Sítagliptín||4766||4766|8058||1|0|G|0|||0 076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|þpakki||A10BH01|01.11.2007||R|1|0|0|G|0|MBV|0|0|0|100|DKK|16567|24301|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Sítagliptín||||16567|24301||1|0|G|0|||0 076043|A10BH0101|Januvia|filmhtfl|25|mg|98|stk|1|þpakki||A10BH01|01.02.2013||R|1|0|0|G|0|MBV|0|0|0|100|DKK|14719|21757|lyfalmen|||1|98|0|24,5000|Vistor hf|Merck Sharp & Dohme B.V.|Sítagliptín||14719||14719|21757||1|0|G|0|||0 076052|A10BH0101|Januvia|filmhtfl|50|mg|98|stk|1|þpakki||A10BH01|01.10.2012||R|1|0|0|G|0|MBV|0|0|0|100|DKK|14860|21951|lyfalmen|V0982|21950|1|98|0|49,0000|Vistor hf|Merck Sharp & Dohme B.V.|Sítagliptín||14860||14860|21951||1|0|G|0|||0 076237|G04BE0309|Vizarsin|filmhtfl|50|mg|4|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|1605|2461|lyfalmen|V0143|1142|2|4|0|4,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||700||700|2461||2|0|E|0|||0 076248|G04BE0309|Vizarsin|filmhtfl|50|mg|8|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|2971|3571|lyfalmen|V0143|2284|2|8|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1506||1506|3571||2|0|E|0|||0 076259|G04BE0309|Vizarsin|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|3742|3604|lyfalmen|V0143|3426|2|12|0|12,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1530||1530|3604||2|0|E|0|||0 076270|G04BE0309|Vizarsin|filmhtfl|100|mg|4|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|1667|2613|lyfalmen|V0144|1315|2|4|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||810||810|2613||2|0|E|0|||0 076282|G04BE0309|Vizarsin|filmhtfl|100|mg|8|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|3208|3897|lyfalmen|V0144|2629|2|8|0|16,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1743||1743|3897||2|0|E|0|||0 076293|G04BE0309|Vizarsin|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|7023|4182|lyfalmen|V0144|3944|2|12|0|24,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1950||1950|4182||2|0|E|0|||0 076361|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.12.2009||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0 076387|N05AX0805|Risperidon Alvogen|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|1|0|0|G|0|GOV|0|0|0|100|IKR|1944|2393|lyfalmen|V0291|2393|2|60|0|12,0000|Alvogen|Alvogen ehf|Risperídón||650||650|2393||2|0|G|0|||0 076403|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|dropaí||S01GX08|01.06.2013||L|0|0|0|G|0|TEA|0|0|0|100|SEK|||lyfalmen|||1|5|0||Vistor hf|Laboratories THEA|Ketotifen|||||3443||1|0|G|0|||0 076628|N05AX0806|Risperidon Krka|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.08.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|1500|2737|lyfalmen|V0290|2719|2|60|0|6,0000|LYFIS ehf|Krka Sverige AB|Risperídón||900||900|2737||2|0|G|0|||0 076657|N05AH0416|Quetiapin Medical Valley|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.09.2019||R|1|1|0|G|0|VAL|0|0|0|100|IKR|6400|5008|lyfalmen|V0273|5008|2|100|0|50,0000|Acare ehf|Medical Valley Invest AB|Quetíapín||2550||2550|5008||2|0|0|0|||0 076667|B02BD0207|ReFacto AF|sts|3000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|1|0|0|PEU|0|1|0|100|DKK|233615|297063|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur VIII||233615||233615|297063||1|0|L|0|||0 076680|B02BD0207|ReFacto AF|sts|2000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|1|0|0|PEU|0|1|0|100|DKK|135430|174948|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur VIII||135430||135430|174948||1|0|L|0|||0 076691|B02BD0207|ReFacto AF|sts|1000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|1|0|0|PEU|0|1|0|100|DKK|67715|88920|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur VIII||67715||67715|88920||1|0|L|0|||0 076702|B02BD0207|ReFacto AF|sts|500|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|1|0|0|PEU|0|1|0|100|DKK|38936|52520|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur VIII||38936||38936|52520||1|0|L|0|||0 076781|N02AA0506|Oxikodon Depot Actavis|forðatfl|10|mg|98|stk|1|glas||N02AA05|01.09.2015||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2793|5342|lyfalmen|V0598|5341|2|98|0|13,0700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||2793||2793|5342||1|0|G|1|30|dagar|0 076792|B02BD0208|Afstyla|sts|1000|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|1|0|0|CSB|0|1|0|100|SEK|81350|106165|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||81350||81350|106165||2|0|L|0|||0 077085|J01FF0104|Clindamycin EQL Pharma|hylki|300|mg|105|stk|1|glas||J01FF01|01.05.2019||R|1|0|0|0|0|EQL|0|0|1|100|IKR|7330|11587|lyfalmen|||2|105|0|26,2500|LYFIS ehf|EQL Pharma AB|Klindamýcín||7330||7330|11587||2|0|E|0|||0 077324|B02BD0102|Cofact|sts|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.02.2015||R|0|0|0|0|0|SPP|0|1|0|100|XEU|51487|68394|lyfsjukr|||1|1|0||Williams & Halls efh|Sanquin Plasma Product|Storkuþættir lX,ll,Vll,X||51487||51487|68394||2|H|L|0|||0 077555|N07BC0102|Buvidal|stl|8|mg|0,16|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|0|0|0|CMS|0|1|0|100|DKK|13390|19928|lyfsjukr|||1|0,16|0|3,8095|Vistor hf|Camurus AB|Búprenorfín||13390||13390|19928||1|H|L|1|30|dagar|0 077606|N06BA0405|Medikinet|töflur|5|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|819|2625|lyfalmen|||2|30|0|5,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||819||819|2625||2|0|E|1|30|dagar|0 077615|N06BA0405|Medikinet|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|874|2701|lyfalmen|V0671|2701|2|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||874||874|2701||2|0|E|1|30|dagar|0 077624|N06BA0405|Medikinet|töflur|20|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|2324|4697|lyfalmen|||2|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||2324||2324|4697||2|0|E|1|30|dagar|0 077633|N06BA0406|Medikinet CR|hylki|10|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|3300|6040|lyfalmen|||2|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||3300||3300|6040||2|0|E|1|30|dagar|0 077642|N06BA0406|Medikinet CR|hylki|20|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|5000|8380|lyfalmen|||2|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||5000||5000|8380||2|0|E|1|30|dagar|0 077652|N06BA0406|Medikinet CR|hylki|30|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|6300|10169|lyfalmen|||2|30|0|30,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||6300||6300|10169||2|0|E|1|30|dagar|0 077661|N06BA0406|Medikinet CR|hylki|40|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|8120|12674|lyfalmen|||2|30|0|40,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||8120||8120|12674||2|0|E|1|30|dagar|0 077881|N05AH0413|Quetiapin ratiopharm|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.05.2016||R|1|1|0|G|0|TVA|0|0|0|100|IKR|5017|5352|lyfalmen|V0275|4788|2|100|0|12,5000|Alvogen|Teva B.V.|Quetíapín||2800||2800|5352||2|0|G|0|||0 078145|B01AF0301|Lixiana|filmhtfl|30|mg|30|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|G|0|OPE|0|0|0|100|DKK|9786|14967|lyfalmen|||1|30|0|15,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||9786||9786|14967||1|0|G|0|||0 078205|B05AA0116|Alburex|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.09.2021||R|0|0|0|0|0|CSB|0|0|0|100|SEK|5733|9389|lyfalmen|||1|250|0||Icepharma hf|CSL Behring GmbH|albumin||5733||5733|9389||2|H|0|0|||0 078216|B05AA0116|Alburex|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.09.2021||R|0|0|0|0|0|CSB|0|0|0|100|SEK|9144|14084|lyfalmen|||1|100|0||Icepharma hf|CSL Behring GmbH|albumin||9144||9144|14084||2|H|0|0|||0 078457|QD11AH9001|Apoquel|töflur|16|mg|100|stk|1|þpakki||QD11AH90|01.06.2017||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|38090|72435|vetalmen|||0|100|0||Icepharma hf|Zoetis Belgium S.A.|Oclacitinib||38090||38090|72435||2|0||0|||0 078674|N06BA1201|Elvanse Adult|hylki|50|mg|30|stk|1|glas|hart|N06BA12|01.06.2018||R|1|1|0|0|0|SHE|0|0|0|100|DKK|13090|19515|lyfalmen|||1|30|0|50,0000|Shire Pharmaceuticals Ireland Limited|Shire Pharmaceuticals Ireland Limited|lisdexamfetamine||13090||13090|19515||1|0|E|1|30|dagar|0 079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|þpakki||C09CA01|01.01.1995||R|1|0|0|G|0|NVO|0|0|0|100|DKK|8165|6458|lyfalmen|V0069|2884|1|98|0|98,0000|Vistor hf|N.V. Organon|Lósartan||3604||3604|6458||1|0|G|0|||0 079195|G04BE0313|Sildenafil Medical Valley|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.04.2019||R|1|0|0|0|0|VAL|0|0|0|100|XEU|5111|3944|lyfalmen|V0144|3944|2|12|0|24,0000|Acare ehf|Medical Valley Invest AB|Síldenafíl||1777||1777|3944||2|0|E|0|||0 079272|N06DX0109|Marbodin|filmhtfl|10|mg|30|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2071|3975|lyfalmen|||2|30|0|15,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||1800||1800|3975||2|0|G|0|||0 079495|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|100|stk|1|þpakki||N06AB03|01.05.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3826|6764|lyfalmen|||2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúoxetín||3826||3826|6764|30.9.2021|1|0|G|0|||0 079597|L02BG0305|Anastrozole Teva|filmhtfl|1|mg|100|stk|1|þpakki||L02BG03|01.05.2014||R|0|0|0|G|0|GOV|0|0|0|100|XEU|16491|13310|lyfalmen|V0184|13310|2|100|0|100,0000|Alvogen|Alvogen ehf|Anastrózól||8582||8582|13310||2|0|G|0|||0 079654|R05CB0106|Mucolysin|freyðit|600|mg|10|stk|1|pakki||R05CB01|01.04.2016||L|0|0|0|0|0|SHS|0|0|1|100|IKR|||lyflausa|||2|10|0|12,0000|Artasan ehf|Sandoz A/S|Acetýlcýstein|||||||1|0||0|||0 079885|A10BD0801|Eucreas|filmhtfl|1050|mg|60|stk|1|þpakki|50mg/1000mg|A10BD08|01.03.2021||R|1|0|0|G|0|NEL|0|0|0|100|DKK|5760|9426|lyfalmen|V0025|9426|1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||5760||5760|9426||1|0|G|0|||0 080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1992||R|1|0|0|0|0|ATE|0|0|1|100|XEU|484|2164|lyfalmen|||2|10|0|2,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cíprófloxacín||484||484|2164||1|0|E|0|||0 080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1992||R|1|0|0|0|0|ATE|0|0|1|100|XEU|787|2453|lyfalmen|V0418|2453|2|20|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cíprófloxacín||694||694|2453||1|0|E|0|||0 080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.05.2008||R|1|0|0|0|0|ATE|0|0|1|100|XEU|798|2466|lyfalmen|V0177|2466|2|10|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cíprófloxacín||703||703|2466||1|0|E|0|||0 080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1994||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1390|3242|lyfalmen|V0411|3242|2|20|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cíprófloxacín||1267||1267|3242||1|0|E|0|||0 080145|QG02AD9002|Genestran|stl|75|mcg/ml|20|ml|1|hgl|lausn|QG02AD90|01.11.2011||R|0|0|0|0|0|ANI|1|0|0|100|IKR|4985|9628|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|Cloprostenolum||4985||4985|9628||2|0||0|||0 080156|QN02AF0101|Morphasol handa hundum og köttum|stl|4|mg/ml|10|ml|1|hgl||QN02AF01|01.06.2010||R|0|0|0|0|0|ANI|1|0|0|100|XEU|3858|7490|vetalmen|||0|10|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||||3858|7490||2|0||2|||0 080424|G01AF0502|Pevaryl Depot|sk-stíll|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|0|0|0|0|0|TAE|0|0|0|100|IKR|||lyflausa|||0|1|0|1,5000|Alvogen|Trimb Healthcare AB|Ekónazól|||||||2|0||0|||0 080431|H02AB0207|Dexamethasone Krka|töflur|4|mg|20|stk|1|þpakki|stakskammtaþynna|H02AB02|01.04.2018||R|0|0|0|G|0|KNM|0|0|1|100|IKR|3000|3287|lyfalmen|V0422|3287|2|20|0|53,3300|LYFIS ehf|Krka d.d. Novo mesto|Dexametasón||1300||1300|3287||2|0|G|0|||0 080447|QP52AA5103|Drontal Vet.|filmhtfl|250|mg|24|stk|1|þpakki|230+20 mg|QP52AA51|01.11.2011||R|0|0|0|0|0|VEO|0|0|0|100|DKK|12588|21697|vetorma|||0|24|0||Icepharma hf|Vetoquinol S.A.|Prazikvantelum í blöndum||12588||12588|21697||2|0||0|||0 080470|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|30|stk|1|þpakki||L02BG04|01.03.2012||R|0|0|0|G|0|BLS|0|0|0|100|XEU|6692|6980|lyfalmen|||2|30|0|30,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Letrózól||3983||3983|6980||1|0|G|0|||0 080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|1|0|0|G|0|LBK|0|0|0|100|DKK|2204|4532|lyfalmen|||1|100|0|66,6667|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||2204||2204|4532||1|0|G|0|||0 080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|glas|m/br. losunarhraða|N06AX12|01.07.2007||R|0|0|0|0|0|GPH|0|0|0|100|DKK|5308|8804|lyfalmen|V1029|8801|1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||5308||5308|8804||1|0|E|0|||0 080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|glas|m/br. losunarhraða|N06AX12|01.07.2007||R|0|0|0|0|0|GPH|0|0|0|100|DKK|2517|4962|lyfalmen|V1028|4961|1|30|0|15,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||2517||2517|4962||1|0|E|0|||0 080621|B01AF0301|Lixiana|filmhtfl|30|mg|100|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|G|0|OPE|0|0|0|100|DKK|32622|44534|lyfalmen|||1|100|0|50,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||32622||32622|44534||1|0|G|0|||0 080987|G03XB0101|Mifepristone Linepharma|töflur|200|mg|1|stk|1|þpakki||G03XB01|01.06.2015||R|0|0|0|0|0|AMR|0|0|0|100|XEU|3839|6782|lyfalmen|||1|1|0|1,0000|Alvogen|Amring|Mifepriston||3839||3839|6782||2|H|0|0|||0 081038|QI01AN0101|Evalon|innúðal|||1000|skammtar|1|hgl|+50ml af HipramuneT(leysir)|QI01AN01|01.04.2019||R|0|0|0|0|0|LHS|0|0|0|100|IKR|22950|39557|vetorma|||0|1000|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Coccidia||22950||22950|39557||2|0|0|0|||0 081185|N06BA0903|Atomoxetin Medical Valley|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|VAL|0|0|0|100|XEU|10140|3284|lyfalmen|V0815|2940|2|28|0|14,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||1298||1298|3284||2|0|E|0|||0 081305|L01ED0101|Xalkori|hylki|250|mg|60|stk|1|þpakki||L01ED01|01.05.2013||R|1|1|1|0|0|PEU|0|1|0|100|DKK|624104|782722|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Europe MA EEIG|Crizotinib||624104||624104|782722||1|0|L|0|||0 081490|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.07.2013||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6667|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Klórhexidín|||||||1|0||0|||0 081501|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.10.2013||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Klórhexidín|||||||1|0||0|||0 081525|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0 081534|V03AN0101|Conoxia|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|20|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0 081543|V03AN0101|Conoxia|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|50|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0 081552|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0 081561|V03AN0101|Conoxia|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|600|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0 081589|V03AN0101|Conoxia|lyfjagas|100|%|1|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|1|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0 081625|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0 081626|N06AX2108|Aritavi|sþ-hylki|30|mg|30|stk|1|þpakki||N06AX21|01.08.2019||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1888|2494|lyfalmen|V0692|2494|2|30|0|15,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Duloxetín||724||724|2494||1|0|E|0|||0 081634|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi. Bauluventill.|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0 081669|G03DA0404|Lutinus|sk-tafla|100|mg|21|stk|1|þpakki||G03DA04|01.04.2011||R|0|0|1|G|0|FEL|0|0|0|100|DKK|4331|7459|lyfalmen|||1|21|0|23,3300|Vistor hf|Ferring Lægemidler A/S|Prógesterón||4331||4331|7459||1|0|G|0|||0 081671|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi. Kranaventill|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0 081681|N06DA0304|Nimvastid|hylki|1,5|mg|28|stk|1|þpakki||N06DA03|01.04.2018||R|1|0|0|G|0|KNM|0|0|0|100|IKR|6070|9853|lyfalmen|||2|28|0|4,6700|LYFIS ehf|Krka d.d. Novo mesto|Rívastigmín||6070||6070|9853||2|0|G|0|||0 081821|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|lykjur|innr.lyf, fleyti|N01AX10|01.11.2019||R|0|0|0|0|0|FKA|0|0|0|100|DKK|1500|3563|lyfalmen|||2|100|0||Vistor hf|Fresenius Kabi AB|Própófól||1500||1500|3563||1|H|0|0|||0 081987|A10AB0602|Apidra [Solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AB06|01.01.2008||R|0|0|0|G|0|SDH|0|0|0|100|XEU|4798|8102|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insúlín glúlisín||4798||4798|8102||1|0|G|0|||0 081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AE04|01.01.2008||R|0|0|0|G|0|SDH|0|0|0|100|XEU|6491|10432|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||6491||6491|10432||1|0|G|0|||0 082233|V03AN0101|Conoxia|lyfjagas|100|%|36|l|1|hylki|kælt|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|36|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0 082237|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.04.2015||R|0|0|0|0|0|BAM|0|0|0|100|SEK|26961|37374|lyfalmen|||1|60|0||Icepharma hf|Baxter Medical AB|Mesna||26961||26961|37374||2|H|0|0|||0 082334|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.11.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 082512|QI06AH0701|Leucofeligen FeLV/RCP|stl|||10|hgl|1|pakki|frostþurrkað stungulyf|QI06AH07|01.05.2014||R|0|0|0|0|0|VIR|1|0|0|100|XEU|13184|22724|vetorma|||0|10|0||Vistor hf|Virbac S.A|Bóluefni gegn nokkrum kattaveirum||13184||13184|22724||1|0||0|||0 082523|QI06AH0701|Leucofeligen FeLV/RCP|stl|||50|hgl|1|pakki|frostþurrkað stungulyf|QI06AH07|01.05.2014||R|0|0|0|0|0|VIR|1|0|0|100|XEU|55360|95418|vetorma|||0|50|0||Vistor hf|Virbac S.A|Bóluefni gegn nokkrum kattaveirum||55360||55360|95418||1|0||0|||0 082548|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|G|0|NVO|0|0|1|100|DKK|639|2377|lyfalmen|||1|30|0||Vistor hf|N.V. Organon|Mómetasón||639||639|2377||1|0|G|0|||0 082830|N02BE0117|Panodil Zapp|filmhtfl|500|mg|20|stk|1|þpakki||N02BE01|01.01.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||||1|0||0|||0 082883|R03BA0201|Pulmicort|innúðal|0,125|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|G|0|AZD|0|0|0|100|SEK|2942|5547|lyfalmen|||1|40|0|3,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2942||2942|5547||1|0|G|0|||0 082933|R03BA0201|Pulmicort|innúðal|0,25|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|G|0|AZD|0|0|0|100|SEK|2649|5144|lyfalmen|||1|40|0|6,6700|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2649||2649|5144||1|0|G|0|||0 082940|C09CA0602|Candpress|töflur|16|mg|100|stk|1|þpakki||C09CA06|01.01.2012||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3718|6615|lyfalmen|V0080|6315|2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Candesartan||3718||3718|6615||1|0|G|0|||0 083019|L01EB0202|Varlota|filmhtfl|150|mg|30|stk|1|þpakki||L01EB02|01.04.2018||R|1|1|1|0|0|ZET|0|1|0|100|XEU|266301|302074|lyfsjukr|||2|30|0||Alvogen|Zentiva, k.s.|Erlotinib||237644||237644|302074||2|0|L|0|||0 083053|A09AA0206|Creon 10.000|sh-hylki|||100|stk|1|plglas||A09AA02|01.12.2015||L|1|0|0|G|0|MYL|0|0|0|100|DKK|||lyfalmen|V0706|6425|1|100|0|16,6700|Icepharma hf|Mylan AB|Hvatablöndur (lípasi, próteasi o.s.frv.)|||||6427||2|0|G|0|||0 083154|R03BA0201|Pulmicort|innúðal|0,5|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|G|0|AZD|0|0|0|100|SEK|3343|6099|lyfalmen|V0701|5352|1|40|0|13,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3343||3343|6099||1|0|G|0|||0 083209|QN02BG9102|Librela|stl|5|mg|1|ml|2|hgl||QN02BG91|01.08.2021||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|9902|18957|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Bedinvetmab||9902||9902|18957||2|0||2|||0 083275|N03AX1604|Brieka|hylki|75|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|ATE|0|0|0|100|XEU|4946|3637|lyfalmen|V0686|3637|2|100|0|25,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Pregabalín||1554||1554|3637||1|0|E|0|||0 083413|QN05CM9102|Narcostart|stl|1|mg/ml|10|mg|1|hgl|fyrir hunda og ketti|QN05CM91|01.07.2013||R|0|0|0|0|0|BVL|1|0|0|100|XEU|5926|11413|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Metetomidinum||5926||5926|11413||2|0||0|||0 083644|N02BE0101|Panodil|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.02.2013||R|1|0|0|0|0|GCA|0|0|1|100|DKK|856|2581|lyfalmen|V0231|2581|1|300|0|50,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól||787||787|2581||1|0|E|0|||0 083875|N06BA0407|Metylfenidat Actavis|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|0|0|0|ATE|0|0|0|100|XEU|4939|5454|lyfalmen|V0624|5450|2|30|0|36,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metýlfenídat||2874||2874|5454||1|0|E|1|30|dagar|0 083966|R03AK1401|Atectura Breezhaler|innönddu|252,5|mcg/sk|30|stk|1|stsk.þ|125 mcg/127,5mcg|R03AK14|01.01.2021||R|0|0|0|G|0|NEP|0|0|0|100|DKK|4504|7697|lyfalmen|||1|30|0||Vistor hf|Novartis Europharm Limited|Indacaterol og mometasone||4504||4504|7697||1|0|G|0|||0 084182|V03AC0301|Exjade|filmhtfl|180|mg|90|stk|1|þpakki||V03AC03|01.06.2017||R|1|1|1|0|0|NEL|0|0|0|100|DKK|162831|209027|lyfalmen|||1|90|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||162831||162831|209027||1|0||0|||0 084192|N05BA1206|Alprazolam Krka|forðatfl|2|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|KRK|0|0|1|100|IKR|2430|4843|lyfalmen|||2|30|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||2430||2430|4843||2|0||2|60|mg|0 084252|C03EA0115|Amiloride/HCT Alvogen|töflur|55|mg|100|stk|1|þpakki|5+50 mg|C03EA01|01.03.2020||R|1|0|0|G|0|POF|0|0|0|100|IKR|1345|3349|lyfalmen|||2|100|0|100,0000|Alvogen|Alvogen|Hýdróklórtíazíð og kalíumsparandi lyf||1345||1345|3349||2|0|G|0|||0 084454|G04CA5203|Dutasteride/Tamsulosin Teva|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.05.2020||R|0|0|0|G|0|TVI|0|0|0|100|XEU|2840|4428|lyfalmen|V1010|3018|2|30|0|30,0000|Teva Pharma Iceland ehf|Teva B.V|Dútasteríð og tamsúlósínhýdroklóríð||2129||2129|4428||1|0|G|0|||0 084591|L04AB0101|Enbrel|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.04.2012||R|0|1|1|0|0|PEU|0|1|0|100|DKK|59369|78364|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Europe MA EEIG|Etanercept||59369||59369|78364||1|0|L|0|||0 084744|C09CA0604|Kairasec|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.02.2017||R|1|0|0|G|0|VAL|0|0|0|100|XEU|5709|9356|lyfalmen|||2|98|0|392,0000|Acare ehf|Medical Valley Invest AB|Candesartan||5709||5709|9356||2|0|G|0|||0 084866|N02AJ0602|Parkodin forte|filmhtfl|530|mg|40|stk|1|þpakki|30+500 mg|N02AJ06|01.05.2018||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1211|3165|lyfalmen|||2|40|0|13,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||1211||1211|3165||1|0|E|3|||0 084924|J05AG0301|Stocrin|filmhtfl|200|mg|90|stk|1|glas||J05AG03|01.10.2013||R|1|0|1|0|0|MSD|0|1|0|100|DKK|36396|49307|lyfsjukr|||1|90|0|30,0000|Vistor hf|M.S.D.|Efavirenz||36396||36396|49307||1|0|L|0|||0 085068|N02AA0101|Contalgin|forðatfl|100|mg|100|stk|1|þpakki||N02AA01|01.10.1985||R|1|0|0|G|0|MDI|0|0|0|100|DKK|12210|18304|lyfalmen|||1|100|0|100,0000|Icepharma hf|Mundipharma A/S|Morfín||12210||12210|18304||2|0|G|1|30|dagar|0 085184|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.09.2010||R|0|0|1|G|0|GAN|0|0|0|100|XEU|35035|47586|lyfalmen|||1|2|0||Icepharma hf|Galderma Nordic AB|Metýlamínólevúlínat||35035||35035|47586||2|0|G|0|||0 085205|S01AE0501|Oftaquix|augndr|5|mg/ml|0,3|ml|30|sk-hyl||S01AE05|01.03.2008||R|0|0|0|0|0|SAO|0|0|1|100|XEU|2498|4936|lyfalmen|||1|9|0||Icepharma hf|Santen Oy|Levófloxacín||2498||2498|4936||2|0||0|||0 085407|R03AC0206|Ventoline|lausn|1|mg/ml|20|lykjur|1|pakki|fyrir eimgjafa|R03AC02|01.04.1992||R|0|0|0|G|0|GPH|0|0|1|100|DKK|788|2583|lyfalmen|||1|20|0|5,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||788||788|2583||1|0|G|0|||0 085423|B01AB0401|Fragmin|stl|25000|ae/ml|4|ml|1|hgl||B01AB04|01.05.2018||R|0|0|0|0|0|PLS|0|0|0|100|DKK|11807|17749|lyfalmen|||1|4|0|40,0000|Icepharma hf|Pfizer Aps|Dalteparín||11807||11807|17749||1|H|0|0|||0 085488|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|BAM|0|0|1|100|SEK|4211|7294|lyfalmen|||1|7500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||4211||4211|7294||2|0|0|0|||0 085515|G04CB0105|Finasterid STADA|filmhtfl|5|mg|100|stk|1|þpakki||G04CB01|01.05.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|4051|3563|lyfalmen|V0445|2943|2|100|0|100,0000|LYFIS ehf|STADA Arzneimittel AG|Fínasteríð||1500||1500|3563||2|0|G|0|||0 085542|G03GA0202|Menopur|sts|||75|ae|5|hgl|+ 5x1ml lykja m.leysi|G03GA02|01.03.2001||R|0|0|1|G|0|FEL|0|0|0|100|DKK|19822|28781|lyfalmen|||1|375|0|5,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||19822||19822|28781||1|0|G|0|||0 085574|B01AF0201|Eliquis|filmhtfl|5|mg|100|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|G|0|BSM|0|0|0|100|DKK|16675|23219|lyfalmen|V0652|23038|1|100|0|50,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||15781||15781|23219||1|0|G|0|||0 085584|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|75|pokar|lausn|B05BB01|01.01.2019||R|0|0|0|0|0|BAM|0|0|1|100|SEK|8615|13356|lyfalmen|||1|3750|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||8615||8615|13356||2|0|0|0|||0 085627|G03AA0708|Melleva|filmhtfl|||63|stk|1|þpakki|150mcg/30mcg|G03AA07|01.04.2020||R|0|0|0|0|0|EXH|0|0|0|100|XEU|880|1881|lyfalm11|V0545|1881|2|63|0|84,0000|Acare ehf|Exeltis Healthcare S.L.|Levónorgestrel og ethinylestradíól||438||438|1881||2|0||0|||1 085770|G04BE0804|Adcirca|filmhtfl|20|mg|56|stk|1|þpakki||G04BE08|01.12.2010||R|0|0|1|G|0|NED|0|0|0|100|XEU|81365|106184|lyfalmen|||1|56|0|112,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||81365||81365|106184||2|0|G|0|||0 085771|N07XX0202|Riluzol Actavis|filmhtfl|50|mg|56|stk|1|þpakki||N07XX02|01.11.2012||R|1|0|1|G|0|ATE|0|0|0|100|SEK|20902|29710|lyfalmen|V0579|29710|2|56|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rílúzól||20902||20902|29710||1|0|G|0|||0 085804|M05BX0401|Prolia|stl|60|mg/ml|1|ml|1|áf.spr|lausn|M05BX04|01.10.2010||R|0|1|0|0|0|AEB|0|0|0|100|DKK|29783|40943|lyfalmen|||1|1|0|181,8100|Vistor hf|Amgen Europe B.V.|Denosúmab||29783||29783|40943||1|0|E|0|||0 085830|L01XA0211|Carboplatin Actavis|irþ|10|mg/ml|60|ml|1|hgl||L01XA02|01.05.2013||R|0|0|0|0|0|ATE|0|0|0|100|XEU|8152|12718|lyfalmen|||2|60|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Karbóplatín||8152||8152|12718||1|H|0|0|||0 085838|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|1|glös|lausn|S01EE03|01.10.2011||R|0|0|0|G|0|TIC|0|0|0|100|XEU|2573|5039|lyfalmen|||1|3|0|30,0000|Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ireland|Bimatóprost||2573||2573|5039||1|0|G|0|||0 085849|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|3|glös|lausn|S01EE03|01.10.2011||R|0|0|0|G|0|TIC|0|0|0|100|XEU|6253|10105|lyfalmen|||1|9|0|90,0000|Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ireland|Bimatóprost||6253||6253|10105||1|0|G|0|||0 085860|N05CF0101|Imovane|filmhtfl|5|mg|30|stk|1|þpakki||N05CF01|01.12.2013||R|1|0|0|0|0|SNP|0|0|1|100|XEU|365|2000|lyfalmen|||1|30|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||365||365|2000||1|0||2|45|töflur|0 085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|G|0|SNP|0|0|1|100|XEU|1849|4043|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1849||1849|4043||1|0|G|0|||0 086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|G|0|SNP|0|0|1|100|XEU|3014|5646|lyfalmen|V0365|5231|1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||3014||3014|5646||1|0|G|0|||0 086118|L04AA3301|Entyvio|stl|108|mg|1|áf-penni|1|pakki||L04AA33|01.03.2021||R|0|1|0|0|0|TPA|0|1|0|100|DKK|75972|99363|lyfsjukr|||1|1|0|20,0000|Vistor hf|Takeda Pharma A/S|Vedolizumab||75972||75972|99363||1|0|L|0|||0 086142|N07XX0701|Fampyra|forðatfl|10|mg|56|stk|1|þpakki||N07XX07|01.03.2013||R|0|0|1|0|0|BNB|0|0|0|100|XEU|39770|53575|lyfalmen|||1|56|0|28,0000|Icepharma hf|Biogen Netherlands B.V.|Fampridine||39770||39770|53575||2|0|E|0|||0 086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|GPH|0|0|1|100|DKK|7434|11730|lyfalmen|||1|5|0|1,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Ceftazidím||7434||7434|11730||1|0|0|0|||0 086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|GPH|0|0|1|100|DKK|8068|12603|lyfalmen|||1|5|0|2,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Ceftazidím||8068||8068|12603||1|0|0|0|||0 086324|A02BC0501|Nexium|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2013||R|1|0|0|0|0|GRH|0|0|1|100|DKK|10403|15817|lyfalmen|V0012|5765|1|100|0|133,3300|Vistor hf|Grünenthal GmbH|Esómeprazól||10403||10403|15817||1|0|E|0|||0 086368|G03GA0202|Menopur|sts|||600|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|1|G|0|FEL|0|0|0|100|DKK|27321|37829|lyfalmen|||1|600|0|8,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||||27321|37829||1|0|G|0|||0 086380|G03GA0202|Menopur|sts|||1200|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|1|G|0|FEL|0|0|0|100|DKK|47756|63675|lyfalmen|||1|1200|0|16,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||||47756|63675||1|0|G|0|||0 086434|L04AA2401|Orencia|stl/irþ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|0|0|0|0|0|BSP|0|1|0|100|DKK|48106|64118|lyfsjukr|||1|1|0|9,2600|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Abatacept||48106||48106|64118||1|H|L|0|||0 086530|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.08.2012||R|0|0|0|0|0|BAB|0|0|0|100|DKK|16140|21227|lyfalm11|||1|1|0||Icepharma hf|Bayer AB|Plast lyfjalykkja (IUD) með prógestógen||||16140|21227||2|0|E|0|||1 086649|L01XG0301|Ninlaro|hylki|3|mg|1|stk|3|þpakki|Hver hylki sérpakkað í þynnu|L01XG03|01.01.2019||R|0|0|1|0|0|TPA|0|1|0|100|DKK|804355|1006904|lyfsjukr|||1|3|0||Vistor hf|Takeda Pharma A/S|Ixazomib||804355||804355|1006904||1|0|L|0|||0 086969|J05AB1401|Valcyte|mixtúrud|50|mg/ml|100|ml|1|glerfl|lausn|J05AB14|01.09.2009||R|0|0|0|0|0|ROA|0|1|1|100|DKK|43239|57962|lyfsjukr|||1|100|0|5,5000|Icepharma hf|Roche A.S.|Valgancíklóvír||43239||43239|57962||2|0|L|0|||0 087046|R06AX2706|Flynise|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.10.2015||L|1|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín|||||||1|0||0|||0 087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|þpakki|mjúk hylki|A03AX13|01.12.2008||L|1|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|30|0|14,4000|Vistor hf|McNeil Sweden AB|Silíkonsambönd|||||||1|0||0|||0 087233|N05CF0201|Stilnoct|töflur|10|mg|30|stk|1|þpakki||N05CF02|01.08.2012||R|1|0|0|0|0|SNP|0|0|1|100|XEU|338|1963|lyfalmen|V0060|1963|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||338||338|1963||1|0||2|30|töflur|0 087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|SNP|0|0|1|100|XEU|229|1813|lyfalmen|V0312|706|1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||229||229|1813||1|0||2|30|töflur|0 087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|SNP|0|0|0|100|XEU|603|2328|lyfalmen|V0312|2117|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||603||603|2328||1|0||2|30|töflur|0 087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|SNP|0|0|0|100|XEU|1697|3834|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||1697||1697|3834||1|0||2|30|töflur|0 087332|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|250|stk|1|glas||N06DA02|01.01.2014||R|2|0|0|G|0|ATE|0|0|0|100|XEU|14971|22104|lyfalmen|||2|250|0|166,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Dónepezíl||14971||14971|22104||1|0|G|0|||0 087354|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|250|stk|1|glas||N06DA02|01.01.2014||R|2|0|0|G|0|ATE|0|0|0|100|XEU|14971|22104|lyfalmen|||2|250|0|333,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Dónepezíl||14971||14971|22104||1|0|G|0|||0 087572|G04BD0801|Vesicare|mixtúra|1|mg/ml|150|ml|1|glas||G04BD08|01.08.2019||R|0|0|0|G|0|ASP|0|0|0|100|XEU|5475|9034|lyfalmen|||1|150|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||5475||5475|9034||1|0|G|0|||0 087727|D07AC1301|Elocon|húðlausn|0,1|%|100|ml|1|túpa||D07AC13|01.02.2014||R|0|0|0|G|0|NVO|0|0|1|100|DKK|1451|3495|lyfalmen|V0952|3282|1|100|0||Vistor hf|N.V. Organon|Mómetasón||1451||1451|3495||1|0|G|0|||0 087867|QP52AA5108|Prazitel Plus|töflur|||104|stk|1|þpakki|50/144/150|QP52AA51|01.07.2010||R|0|0|0|0|0|CHP|0|0|0|100|XEU|33144|57127|vetorma|||0|104|0||Icepharma hf|Chanelle Pharmaceuticals|Prazikvantelum í blöndum||33144||33144|57127||2|0||0|||0 087932|A02BX1301|Gaviscon|tuggutfl|||20|stk|1|þpakki||A02BX13|01.10.1993||L|1|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||0|20|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||||1|0||0|||0 087969|QD07AC0001|Cortavance|húðúði|0,584|mg/ml|76|ml|1|fl|lausn|QD07AC|01.04.2012||R|0|0|0|0|0|VIR|0|0|0|100|XEU|4725|9135|vetalmen|||0|76|0||Vistor hf|Virbac S.A|Hýdrókortisón aceponat||4725||4725|9135||1|0||0|||0 088026|QG03DA0402|Prid delta|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.02.2012||R|0|0|0|0|0|CES|1|0|0|100|SEK|23287|40137|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||23287||23287|40137||2|0||0|||0 088235|G03AA1204|Yasmin 28|filmhtfl|||84|stk|1|þpakki|3+0,03 mg|G03AA12|01.10.2013||R|0|0|0|0|0|BAB|0|0|0|100|DKK|2997|5033|lyfalm11|||1|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||2997||2997|5033||2|0||0|||1 088261|R01AD1201|Avamys|nefúði|27,5|mcg/sk|120|skammtar|1|glas||R01AD12|01.04.2008||R|0|0|0|G|0|RGP|0|0|1|100|DKK|1022|2905|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Flútíkasón fúróat||1022||1022|2905||1|0|G|0|||0 088300|L04AX0306|Metojectpen|stl|17,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|3087|5747|lyfalmen|||1|1|0|7,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3087||3087|5747||2|0|G|0|||0 088445|N05AX1205|Aripiprazol Krka|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|0|0|G|0|KRK|0|0|0|100|IKR|7196|3934|lyfalmen|V0684|3422|2|56|0|56,0000|LYFIS ehf|Krka Sverige AB|Aripiprazól||1770||1770|3934||2|0|G|0|||0 088558|N06AX2601|Brintellix|filmhtfl|15|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|LUN|0|0|0|100|DKK|7860|12316|lyfalmen|||1|28|0|42,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||7860||7860|12316||1|0||0|||0 088677|N07BC0102|Buvidal|stl|24|mg|0,48|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|0|0|0|CMS|0|1|0|100|DKK|13390|19928|lyfsjukr|||1|0,48|0|11,4286|Vistor hf|Camurus AB|Búprenorfín||13390||13390|19928||1|H|L|1|30|dagar|0 088696|D05AX5201|Daivobet|hlaup|||30|g|1|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|G|0|LEP|0|0|0|100|DKK|4532|7736|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||4532||4532|7736||1|0|G|0|||0 088705|D05AX5201|Daivobet|hlaup|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.02.2011||R|0|0|0|G|0|LEP|0|0|0|100|DKK|7832|12278|lyfalmen|||1|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||7832||7832|12278||1|0|G|0|||0 088714|D05AX5201|Daivobet|hlaup|||60|g|2|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|G|0|LEP|0|0|0|100|DKK|12845|19178|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||12845||12845|19178||1|0|G|0|||0 088817|A10BD2301|Segluromet|filmhtfl|1002,5|mg|56|stk|1|þpakki|2,5mg/1000mg|A10BD23|01.04.2019||R|1|0|0|G|0|DSM|0|0|0|100|DKK|5872|9580|lyfalmen|||1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme|Ertugliflozin og metformin||5872||5872|9580||1|0|G|0|||0 088917|B02BD0801|NovoSeven|sts|5|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|0|0|0|0|NAS|0|1|0|100|DKK|420487|529479|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Storkuþáttur VIIa||420487||420487|529479||1|H|L|0|||0 088961|N02AA0507|OxyContin Depot|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.11.2020||R|1|0|0|G|0|MUP|0|0|0|100|DKK|21079|29934|lyfalmen|V0588|28072|1|98|0|104,5300|Icepharma hf|Mundipharma A/S|Oxýcódon||21079||21079|29934||2|0|G|1|30|dagar|0 088975|G03AA1005|Harmonet|töflur|||63|stk|1|þpakki|20+75 mcg|G03AA10|01.10.2011||R|0|0|0|0|0|PLS|0|0|0|100|DKK|1414|3083|lyfalm11|||1|63|0|84,0000|Icepharma hf|Pfizer ApS|Gestóden og ethinylestradíól||||1414|3083||1|0||0|||1 089077|J07BD5204|M-M-RVAXPRO|sts|||10|hgl|1|pakki|+ lausn í áf.sp|J07BD52|01.02.2013||R|0|0|0|0|0|MPS|0|0|0|100|DKK|22381|31581|lyfalmen|||1|10|0||Vistor hf|Sanofi Pasteur MSD|Mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||22381||22381|31581||1|0|0|0|||0 089089|B02BX0501|Revolade|filmhtfl|25|mg|28|stk|1|þpakki||B02BX05|01.08.2016||R|1|0|1|0|0|NEL|0|1|0|100|DKK|131143|169616|lyfsjukr|||1|28|0|14,0000|Vistor hf|Novartis Europharm Ltd|Eltrombópag||131143||131143|169616||1|0|L|0|||0 089094|A02BX1301|Gaviscon|tuggutfl|||120|stk|1|þpakki||A02BX13|01.01.1989||L|1|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|120|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||6222||1|0||0|||0 089190|H01AC0101|Genotropin|sts|5|mg|1|áf-penni|1|pakki||H01AC01|01.02.2015||R|0|0|1|0|0|PLS|0|1|0|100|DKK|18675|27202|lyfsjukr|||1|1|0|7,5000|Icepharma hf|Pfizer ApS|Sómatrópín||18675||18675|27202||1|0|L|0|||0 089212|H01AC0101|Genotropin|sts|12|mg|1|áf-penni|1|pakki||H01AC01|01.02.2015||R|0|0|1|0|0|PLS|0|1|0|100|DKK|40620|54650|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Pfizer ApS|Sómatrópín||40620||40620|54650||1|0|L|0|||0 089692|C07AB0214|Bloxazoc|forðatfl|50|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|G|0|KNM|0|0|0|100|IKR|1419|3287|lyfalmen|V0048|3030|2|100|0|33,3333|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||1300||1300|3287||2|0|G|0|||0 089801|B03AC0001|Monofer|irl|100|mg/ml|1|ml|5|hgl||B03AC|01.10.2012||R|0|1|0|G|0|PAC|0|0|1|100|DKK|22742|32038|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||22742||22742|32038||1|0|G|0|||0 089936|B03AC0001|Monofer|irl|100|mg/ml|10|ml|2|hgl||B03AC|01.10.2012||R|0|1|0|G|0|PAC|0|0|1|100|DKK|90968|118330|lyfalmen|||1|20|0|20,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||90968||90968|118330||1|0|G|0|||0 090153|N05AH0414|Quetiapin Hexal|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.09.2017|31.07.2021|R|1|1|0|G|0|SSA|0|0|0|100|DKK|15006|17485|lyfalmen|||2|100|0|100,0000|Artasan ehf|Hexal A/S|Quetíapín||11615||11615|17485||1|0|G|0|||0 090229|J01DB0101|Keflex|töflur|500|mg|20|stk|1|þpakki||J01DB01|01.07.2011||R|0|0|0|0|0|STA|0|0|1|100|DKK|2366|4754|lyfalmen|||1|20|0|5,0000|Icepharma hf|STADA Nordic ApS.|Cefalexín||2366||2366|4754||2|0|E|0|||0 090240|J01DB0101|Keflex|töflur|500|mg|40|stk|1|þpakki||J01DB01|01.05.2011||R|0|0|0|0|0|STA|0|0|1|100|DKK|4733|8012|lyfalmen|||1|40|0|10,0000|Icepharma hf|STADA Nordic ApS.|Cefalexín||4733||4733|8012||2|0|E|0|||0 090257|R03AK0606|Salmeterol/Fluticasone Neutec|innönddu|150|mcg/sk|60|skammtar|1|innö.t|50/100 mcg/sk|R03AK06|01.05.2021||R|0|0|0|G|0|NET|0|0|0|100|DKK|3417|5099|lyfalmen|||2|60|0|30,0000|Lyfjaver ehf|Neutec Inhaler Ireland Limited|Salmeteról og fluticason||2616||2616|5099||3|0|G|0|||0 090320|J01DB0101|Keflex|mixt.kyr|50|mg/ml|100|ml|1|fl|dreifa|J01DB01|01.03.2012||R|0|0|0|0|0|STA|0|0|1|100|DKK|716|2483|lyfalmen|||1|100|0|2,5000|Icepharma hf|STADA Nordic ApS.|Cefalexín||716||716|2483||2|0|E|0|||0 090354|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.06.2011||R|0|0|0|0|0|STA|0|0|1|100|DKK|4229|7319|lyfalmen|||1|10|0|3,3333|Icepharma hf|STADA Nordic ApS.|Cefazólín||4229||4229|7319||2|0|0|0|||0 090607|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|6,8000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 090662|R01AD1101|Nasacort|nefúði|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|0|0|0|G|0|SNP|0|0|1|100|XEU|1809|3988|lyfalmen|||1|16,5|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1809||1809|3988||1|0|G|0|||0 090784|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|1|G|0|EIG|0|0|0|100|SEK|783|2576|lyfalmen|||1|10|0|0,7100|Vistor hf|Eisai GmbH|Rúfínamíð||783||783|2576||1|0|G|0|||0 090979|S01JA0101|Anatera|stl|100|mg/ml|5|ml|12|hgl|lausn|S01JA01|01.10.2011||R|0|0|0|0|0|AAS|0|0|0|100|XEU|20048|28630|lyfalmen|||1|60|0||Alcon Danmark A/S|Alcon Nordic A/S|Flúorescein||20048||20048|28630||1|H|0|0|||0 091015|N06AX1614|Venlafaxin Krka|forðahlk|37,5|mg|28|stk|1|þpakki|hart|N06AX16|01.02.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|1084|2990|lyfalmen|V0333|2990|2|28|0|10,5000|LYFIS ehf|Krka d.d. Novo mesto|Venlafaxín||1084||1084|2990||2|0|E|0|||0 091266|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|PLS|0|0|0|100|DKK|2499|4938|lyfalmen|||1|2,5|0|0,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||2499||2499|4938||1|H|0|0|||0 091277|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|PLS|0|0|0|100|DKK|4324|7449|lyfalmen|||1|5|0|1,6667|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||4324||4324|7449||1|H|0|0|||0 091289|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|PLS|0|0|0|100|DKK|12691|18966|lyfalmen|||1|17,5|0|5,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||12691||12691|18966||1|H|0|0|||0 091345|N06BA0403|Ritalin Uno|hylki|10|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.03.2011||R|1|1|0|0|0|HES|0|0|0|100|DKK|3394|5975|lyfalmen|V0958|5802|1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||3253||3253|5975||1|0|E|1|30|dagar|0 091493|A10BH0501|Trajenta|filmhtfl|5|mg|30|stk|1|þpakki||A10BH05|01.12.2012||R|1|0|0|G|0|BII|0|0|0|100|DKK|5957|9697|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||5957||5957|9697||1|0|G|0|||0 091736|S01BA0102|Opnol|augndr|1|mg/ml|30|sk-hyl|1|sk-ílá|lausn|S01BA01|01.05.2011||R|0|0|0|G|0|TAE|0|0|1|100|SEK|3539|6369|lyfalmen|||1|30|0||Alvogen|Trimb Healthcare AB|Dexametasón||3539||3539|6369||2|0|G|0|||0 091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|G|0|SNP|0|0|0|100|XEU|989|2004|lyfalmen|V0021|2004|1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||368||368|2004||1|0|G|0|||0 091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|G|0|SNP|0|0|0|100|XEU|1710|2304|lyfalmen|||1|90|0|90,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||586||586|2304||1|0|G|0|||0 091804|L01EM0301|Piqray|filmhtfl|150|mg|28|stk|1|þpakki||L01EM03|01.05.2021||R|1|1|1|0|0|NEP|0|1|0|100|DKK|248151|315142|lyfsjukr|||1|28|0|14,0000|Vistor hf|Novartis Europharm Limited|Alpelisib||248151||248151|315142||1|0|L|0|||0 091872|C07AA0512|Pranolol|töflur|80|mg|100|stk|1|glas||C07AA05|01.12.2011||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1111|3027|lyfalmen|||2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Própranólól||1111||1111|3027||1|0|G|0|||0 092097|QD11AH9001|Apoquel|töflur|16|mg|20|stk|1|þpakki||QD11AH90|01.06.2017||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|8752|16775|vetalmen|||0|20|0||Icepharma hf|Zoetis Belgium S.A.|Oclacitinib||8752||8752|16775||2|0||0|||0 092176|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|14|stk|1|þpakki||A02BC05|01.05.2016||L|1|0|0|0|0|KRK|0|0|0|100|IKR|||lyflausa|||2|14|0|9,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól|||||||2|0||0|||0 092188|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|28|stk|1|þpakki||A02BC05|01.08.2017||L|1|0|0|0|0|KRK|0|0|0|100|IKR|||lyfalmen|V0004|2839|2|28|0|18,6700|LYFIS ehf|Krka Sverige AB|Esómeprazól|||||2839||2|0|E|0|||0 092199|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|56|stk|1|þpakki||A02BC05|01.10.2016||R|1|0|0|0|0|KRK|0|0|1|100|IKR|2060|4251|lyfalmen|V0011|2733|2|56|0|37,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól||2000||2000|4251||2|0|E|0|||0 092210|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|98|stk|1|glas||A02BC05|01.10.2016||R|1|0|0|G|0|KRK|0|0|1|100|IKR|3453|4801|lyfalmen|V0011|4782|2|98|0|65,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól||2400||2400|4801||2|0|G|0|||0 092234|A02BC0511|Esomeprazol Krka|sþ-hylki|40|mg|28|stk|1|þpakki||A02BC05|01.10.2016||R|1|0|0|0|0|KRK|0|0|1|100|IKR|1510|2874|lyfalmen|V0005|2874|2|28|0|37,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól||1000||1000|2874||2|0|E|0|||0 092245|A02BC0511|Esomeprazol Krka|sþ-hylki|40|mg|56|stk|1|þpakki||A02BC05|01.10.2016||R|1|0|0|0|0|KRK|0|0|1|100|IKR|2400|4251|lyfalmen|V0012|3228|2|56|0|74,6700|LYFIS ehf|Krka Sverige AB|Esómeprazól||2000||2000|4251||2|0|E|0|||0 092256|A02BC0511|Esomeprazol Krka|sþ-hylki|40|mg|98|stk|1|glas||A02BC05|01.10.2016||R|1|0|0|G|0|KRK|0|0|1|100|IKR|4794|5765|lyfalmen|V0012|5650|2|98|0|130,6700|LYFIS ehf|Krka Sverige AB|Esómeprazól||3100||3100|5765||2|0|G|0|||0 092553|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.08.2010||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 092575|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.08.2010||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 092620|H01AC0113|Norditropin FlexPro|stl|5|mg|1,5|ml|1|áfpen||H01AC01|01.04.2021||R|0|0|1|0|0|NAS|0|1|0|100|DKK|30407|41732|lyfsjukr|||1|1,5|0|7,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||30407||30407|41732||1|0|L|0|||0 092631|H01AC0113|Norditropin FlexPro|stl|10|mg|1,5|ml|1|áfpen||H01AC01|01.04.2021||R|0|0|1|0|0|NAS|0|1|0|100|DKK|61034|80469|lyfsjukr|||1|1,5|0|15,0000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||61034||61034|80469||1|0|L|0|||0 092644|H01AC0113|Norditropin FlexPro|stl|15|mg|1,5|ml|1|áfpen||H01AC01|01.04.2021||R|0|0|1|0|0|NAS|0|1|0|100|DKK|91553|119070|lyfsjukr|||1|1,5|0|22,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||91553||91553|119070||1|0|L|0|||0 092655|G03CA0310|Vagifem|sk-tfl|10|mcg|18|stk|1|pakki||G03CA03|01.03.2011||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2168|4482|lyfalmen|||1|18|0|7,2000|Vistor hf|Novo-Nordisk A/S|Estradíól||2168||2168|4482||1|0|G|0|||0 092958|M05BA0408|Ostacid|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.05.2010||R|1|0|0|G|0|WEH|0|0|0|100|IKR|1863|4026|lyfalmen|V0203|4026|2|12|0|84,0000|Williams & Halls efh|Williams & Halls ehf|Alendrónsýra||1837||1837|4026||2|0|G|0|||0 093016|N02AA0504|OxyNorm Dispersa|munndr.t|5|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|0|0|0|MUP|0|0|0|100|DKK|1094|3004|lyfalmen|||1|28|0|1,8700|Icepharma hf|Mundipharma A/S|Oxýcódon||1094||1094|3004||2|0|E|1|30|dagar|0 093027|N02AA0504|OxyNorm Dispersa|munndr.t|10|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|0|0|0|MUP|0|0|0|100|DKK|2183|4503|lyfalmen|||1|28|0|3,7300|Icepharma hf|Mundipharma A/S|Oxýcódon||2183||2183|4503||2|0|E|1|30|dagar|0 093038|N02AA0504|OxyNorm Dispersa|munndr.t|20|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|0|0|0|MUP|0|0|0|100|DKK|4244|7339|lyfalmen|||1|28|0|7,4700|Icepharma hf|Mundipharma A/S|Oxýcódon||4244||4244|7339||2|0|E|1|30|dagar|0 093072|L01EX0301|Votrient|filmhtfl|200|mg|90|stk|1|glas||L01EX03|01.01.2017||R|1|0|1|0|0|NEL|0|1|0|100|DKK|322388|407472|lyfsjukr|||1|90|0||Vistor hf|Novartis Europharm Ltd|Pazopanib||322388||322388|407472||1|0|L|0|||0 093083|L01EX0301|Votrient|filmhtfl|400|mg|60|stk|1|glas||L01EX03|01.01.2017||R|1|0|1|0|0|NEL|0|1|0|100|DKK|430054|541378|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Pazopanib||430054||430054|541378||1|0|L|0|||0 093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|0|0|0|G|0|GPH|0|0|0|100|DKK|4699|7966|lyfalmen|||1|1|0|2,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||4699||4699|7966||1|0|G|0|||0 093284|G04BD1201|Betmiga|forðatfl|50|mg|30|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|G|0|APE|0|0|0|100|XEU|5201|8657|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||5201||5201|8657||1|0|G|0|||0 093306|M03AX0105|Xeomin|sts|100|ein/hgl|1|hgl|1|pakki||M03AX01|01.08.2015||R|0|0|1|0|0|ERZ|0|0|0|100|XEU|23479|30815|lyfalmen|||1|1|0||Williams & Halls efh|Merz Pharmaceuticals GmbH|Clostridium botulinum toxín-A||21775||21775|30815||2|0|0|0|||0 093343|C09CA0301|Diovan|mixtúra|3|mg/ml|160|ml|1|fl|lausn|C09CA03|01.03.2012||R|0|0|0|G|0|HES|0|0|0|100|DKK|1843|4035|lyfalmen|||1|160|0|6,0000|Vistor hf|Novartis Healthcare A/S|Valsartan||1843||1843|4035||1|0|G|0|||0 093496|A07EC0204|Asacol|sþ-tfl|800|mg|60|stk|1|þpakki||A07EC02|01.03.2016||R|1|0|0|G|0|TIL|0|0|0|100|DKK|5229|8695|lyfalmen|||1|60|0|32,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||5229||5229|8695||2|0|G|0|||0 093514|A07EC0204|Asacol|sþ-tfl|400|mg|100|stk|1|þpakki||A07EC02|01.03.2016||R|1|0|0|G|0|TIL|0|0|0|100|DKK|3872|6827|lyfalmen|||1|100|0|26,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||3872||3872|6827||2|0|G|0|||0 093668|N01BB0203|Xylocain|húðúði|100|mg/ml|50|ml|1|glas|+ sk-úðari|N01BB02|01.10.2014||R|0|0|0|0|0|MAR|0|0|1|100|DKK|2331|4706|lyfalmen|||1|50|0||Icepharma hf|Aspen Pharma|Lídókaín||2331||2331|4706||2|0||0|||0 093725|C03BA0802|Metolazon Abcur|töflur|5|mg|100|stk|1|þpakki||C03BA08|01.01.2014||R|0|0|0|G|0|ABC|0|0|0|100|SEK|32486|44362|lyfalmen|||2|100|0|100,0000|Icepharma hf|Abcur AB|Metólazón||32486||32486|44362||2|0|G|0|||0 093827|L04AC0501|Stelara|stl|45|mg/spr|0,5|ml|1|áf.spr||L04AC05|01.04.2011||R|0|0|1|0|0|JCI|0|1|0|100|SEK|400212|504263|lyfsjukr|||1|0,5|0|83,3300|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||400212||400212|504263||1|0|L|0|||0 093838|L04AC0501|Stelara|stl|90|mg/spr|1|ml|1|áf.spr||L04AC05|01.05.2011||R|0|0|1|0|0|JCI|0|1|0|100|SEK|400212|504263|lyfsjukr|||1|1|0|166,6700|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||400212||400212|504263||1|0|L|0|||0 094122|N02CC0501|Almogran|filmhtfl|12,5|mg|9|stk|1|þpakki||N02CC05|01.07.2010||R|1|0|0|G|0|AAC|0|0|0|100|DKK|5275|8758|lyfalmen|||1|9|0|9,0000|Icepharma hf|Almirall S.A.|Almótriptan||5275||5275|8758||2|0|G|0|||0 094132|QM01AC0604|Metacam handa köttum og naggrísum|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|0|0|0|0|0|BOI|0|0|0|100|DKK|1699|3339|vetalmen|||0|15|0||Vistor hf|Boehringer Ingelheim|Meloxícam||1699||1699|3339||1|0||0|||0 094146|L04AA2901|Xeljanz|forðatfl|11|mg|28|stk|1|þpakki||L04AA29|01.06.2020||R|0|1|1|0|0|PEU|0|1|0|100|DKK|115853|150600|lyfsjukr|||1|28|0|30,8000|Icepharma hf|Pfizer Europe MA EEIG|Tofacitinib||115853||115853|150600||1|0|L|0|||0 094441|J05AB0103|Aclovir|töflur|200|mg|25|stk|1|þpakki||J05AB01|01.04.2013||R|1|0|0|G|0|RTH|0|0|1|100|XEU|1745|3900|lyfalmen|||2|25|0|1,2500|Alvogen|ratiopharm GmbH|Acíklóvír||1745||1745|3900||2|0|G|0|||0 094495|N06AB1007|Escitalopram Bluefish|filmhtfl|5|mg|98|stk|1|þpakki||N06AB10|01.08.2015||R|1|0|0|G|0|BLS|0|0|0|100|IKR|1955|4189|lyfalmen|V0324|3761|2|98|0|49,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Escítalópram||1955||1955|4189||1|0|0|0|||0 094757|N04BC0408|Ropinirole Alvogen|forðatfl|8|mg|84|stk|1|glas||N04BC04|01.06.2021||R|1|0|0|G|0|POF|0|0|0|100|XEU|12703|16596|lyfalmen|V0534|16596|2|84|0|112,0000|Alvogen|Alvogen|Rópíníról||10969||10969|16596||2|0|G|0|||0 094801|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|þpakki|300+150+300 mg|J05AR04|01.08.2003||R|1|0|1|0|0|VIC|0|1|0|100|DKK|72463|94925|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare BV|Zídóvúdín, lamívúdín og abacavír||72463||72463|94925||1|0|L|0|||0 094812|N01BX0403|Qutenza|plástur|179|mg|1|plástur|1|pakki||N01BX04|01.01.2011||R|0|1|0|0|0|HAL|0|0|1|100|DKK|43497|58289|lyfalmen|||1|1|0||Vistor hf|Grunenthal GmbH|Capsaicin||||43497|58289||1|0|E|0|||0 094834|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.05.2010||R|0|0|0|0|0|LHS|0|0|0|100|XEU|6152|10604|vetbolu|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Escherichia bóluefni + Clostridium bóluefni||6152||6152|10604||2|0||0|||0 094843|D02AX0001|Oviderm|krem|250|mg/g|100|g|1|túpa||D02AX|01.03.2018||L|0|0|0|0|0|GAB|0|0|0|100|IKR|||lyflausa|||0|100|0||Vistor hf|Galenica AB|Önnur húðverndandi efni|||||||1|0||0|||0 094971|R06AX2709|Desloratadine Alvogen|munndr.t|5|mg|100|stk|1|þpakki||R06AX27|01.05.2021||L|0|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||2|100|0|100,0000|Alvogen|Alvogen|Deslóratadín|||||||2|0||0|||0 095005|B02BC3001|TachoSil|vefjal.n|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC30|01.01.2014||R|0|0|0|0|0|TAG|0|0|0|100|DKK|41198|55381|lyfalmen|||2|1|0||Vistor hf|Takeda Austria GmbH|Blöndur||41198||41198|55381||1|H|0|0|||0 095314|N04BA0211|Duodopa|hlaup|||100|ml|7|askja||N04BA02|01.10.2018||R|0|1|0|0|0|AIS|0|1|0|100|DKK|96780|125681|lyfsjukr|||1|700|0||Vistor hf|AbbVie A/S|Levódópa og dópadekarboxýl­asa­hemill||96780||96780|125681||1|0|L|0|||0 095588|N07BB0101|Antabus|freyðit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|0|0|0|G|0|ATE|0|0|0|100|DKK|8340|12977|lyfalmen|||1|50|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Dísúlfíram||8340||8340|12977||1|0|G|0|||0 095621|L04AX0306|Metojectpen|stl|20|mg|0,4|ml|6|áfpen||L04AX03|01.11.2019||R|0|0|0|G|0|WIL|0|0|0|100|XEU|14629|21633|lyfalmen|||1|2,4|0|48,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||14629||14629|21633||2|0|G|0|||0 095652|N05AX1301|Invega|forðatfl|3|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|0|JCI|0|0|0|100|SEK|15079|22253|lyfalmen|V0963|14969|1|28|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||15079||15079|22253||1|0|E|0|||0 095680|N05AX1301|Invega|forðatfl|6|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|0|JCI|0|0|0|100|SEK|15304|22562|lyfalmen|V0964|16808|1|28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||15304||15304|22562||1|0|E|0|||0 095682|N06BA0408|Methylphenidate Teva|hylki|20|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.11.2019||R|1|1|0|0|0|TVI|0|0|0|100|XEU|5000|4752|lyfalmen|V0959|4752|2|30|0|20,0000|Teva Pharma Iceland ehf|Teva B.V|Metýlfenídat||2364||2364|4752||1|0|E|1|30|dagar|0 095707|N05AX1301|Invega|forðatfl|9|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|G|0|JCI|0|0|0|100|SEK|17817|26021|lyfalmen|V0965|15375|1|28|0|42,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||17817||17817|26021||1|0|G|0|||0 095715|J02AC0105|Fluconazole Alvogen|irl|2|mg/ml|50|ml|1|hgl|lausn|J02AC01|01.10.2011||R|0|0|0|0|0|GOV|0|0|0|100|XEU|1838|4028|lyfalmen|||2|50|0|0,5000|Alvogen|Alvogen ehf|Flúkónazól||||1838|4028||2|H|0|0|||0 095726|J02AC0105|Fluconazole Alvogen|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.09.2011||R|0|0|0|0|0|GOV|0|0|0|100|XEU|3196|5897|lyfalmen|||2|100|0|1,0000|Alvogen|Alvogen ehf|Flúkónazól||||3196|5897||2|H|0|0|||0 095767|R03BA0203|Budesonide Teva|innúðal|0,5|mg/ml|2|ml|20|lykjur||R03BA02|01.07.2015||R|0|0|0|G|0|TAB|0|0|0|100|IKR|3740|5352|lyfalmen|V0701|5352|2|40|0|13,3400|Alvogen|Teva Pharma B.V.|Búdesóníð||2800||2800|5352||2|0|G|0|||0 095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|CHP|0|0|0|100|IKR|4999|9655|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Vedaprofenum||4999||4999|9655||2|0|0|0|||0 095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|CHP|0|0|0|100|XEU|6340|10941|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Vedaprofenum||5677||5677|10941||2|0|0|0|||0 095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|CHP|0|0|0|100|IKR|11467|21926|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Vedaprofenum||11467||11467|21926||2|0|0|0|||0 096201|L01XC3201|Tecentriq|irþ|1200|mg|20|ml|1|hgl|lausn|L01XC32|01.01.2018||R|0|1|0|0|0|RRG|0|1|0|100|DKK|698610|875386|lyfsjukr|||1|20|0||Icepharma hf|Roche Registration GmbH|Atezolizumab||698610||698610|875386||2|H|L|0|||0 096223|N03AX1610|Pregabalin Medical Valley|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.06.2019||R|1|0|0|0|0|VAL|0|0|0|100|IKR|830|2599|lyfalmen|V0685|2160|2|56|0|4,6667|Acare ehf|Medical Valley Invest AB|Pregabalín||800||800|2599||2|0|E|0|||0 096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|1|0|0|BSQ|0|1|0|100|DKK|665517|834228|lyfsjukr|||1|21|0|10,5000|Bristol-Myers Squibb Pharma EEIG|Bristol-Myers Squibb Pharma EEIG|Lenalídómíd||665517||665517|834228||2|0|L|0|||0 096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|1|0|0|BSQ|0|1|0|100|DKK|610864|766255|lyfsjukr|||1|21|0|21,0000|Bristol-Myers Squibb Pharma EEIG|Bristol-Myers Squibb Pharma EEIG|Lenalídómíd||610864||610864|766255||2|0|L|0|||0 096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|1|0|0|BSQ|0|1|0|100|DKK|643003|806227|lyfsjukr|||1|21|0|31,5000|Bristol-Myers Squibb Pharma EEIG|Bristol-Myers Squibb Pharma EEIG|Lenalídómíd||643003||643003|806227||2|0|L|0|||0 096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|1|0|0|BSQ|0|1|0|100|DKK|707282|886172|lyfsjukr|||1|21|0|52,5000|Bristol-Myers Squibb Pharma EEIG|Bristol-Myers Squibb Pharma EEIG|Lenalídómíd||707282||707282|886172||2|0|L|0|||0 096703|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.02.2019||R|0|0|0|0|0|ATE|0|0|0|100|GBP|9627|14749|lyfalmen|||2|25|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Epírúbicín||||9627|14749||1|H|0|0|||0 097061|QI09AB1301|Stellamune One|stl|||100|ml|10|glös|Fleyti|QI09AB13|01.10.2012||R|0|0|0|0|0|ELC|0|0|0|100|DKK|69876|120438|vetorma|||1|1000|0||Elanco Denmark ApS|Elanco GmbH|Óvirkar bakteríur í bóluefnum||69876||69876|120438||2|0||0|||0 097092|QN02AF0102|Alvegesic vet.|stl|10|mg/ml|10|ml|1|hgl||QN02AF01|01.08.2010||R|0|0|0|0|0|VMD|1|0|0|100|XEU|7686|14752|vetalmen|||0|10|0||Icepharma hf|V.M.D. n.v.|Bútorfanóltartrat||||7686|14752||2|0||2|||0 097152|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|36|0|2,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 097531|N06AX1602|Efexor Depot|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.07.2012||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|10568|16044|lyfalmen|V0334|2546|1|98|0|73,5000|Icepharma hf|Upjohn EESV|Venlafaxín||10568||10568|16044||1|0|E|0|||0 097577|N06AX1602|Efexor Depot|forðahlk|150|mg|98|stk|1|þpakki||N06AX16|01.09.2011||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|19660|28558|lyfalmen|V0335|2546|1|98|0|147,0000|Icepharma hf|Upjohn EESV|Venlafaxín||||19660|28558||1|0|E|0|||0 097603|C10AX1301|Repatha|stl|140|mg|1|áf-penni|1|pakki||C10AX13|01.01.2016||R|0|0|0|0|0|AEB|0|0|0|100|DKK|33237|45312|lyfalmen|||1|1|0|14,0000|Vistor hf|Amgen Europe B.V.|Evolocumab||33237||33237|45312||1|0|E|0|||0 097662|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|5891|11347|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||5891||5891|11347||2|0||0|||0 097847|G03AC0803|Nexplanon|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.12.2016||R|0|0|0|0|0|NVO|0|0|0|100|DKK|16843|22093|lyfalm11|||1|1|0|1000,0000|Vistor hf|N.V. Organon|Etónógestrel||16843||16843|22093||1|0||0|||1 097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|G|0|SNP|0|0|0|100|XEU|2454|2544|lyfalmen|V0023|2544|1|90|0|135,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||760||760|2544||1|0|G|0|||0 097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|0|ATE|0|0|0|100|XEU|1524|3596|lyfalmen|||2|30|0|15,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mirtazapín||1524||1524|3596||1|0|E|0|||0 098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|1|0|0|G|0|ATE|0|0|0|100|IKR|2976|3563|lyfalmen|V0678|3563|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Valsartan||1500||1500|3563||1|0|G|0|||0 098233|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|0|0|0|G|0|BIG|0|0|1|100|SEK|566|2277|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||566||566|2277||2|0|G|0|||0 098245|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.08.2011||R|0|0|0|G|0|BIG|0|0|1|100|SEK|566|2277|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||566||566|2277||2|0|G|0|||0 098290|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.06.2011||L|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|250|0||Icepharma hf|Bioglan AB|Klórhexidín|||||||2|0||0|||0 098363|L04AA4201|Mayzent|filmhtfl|0,25|mg|120|stk|1|þpakki||L04AA42|01.11.2020||R|1|1|1|0|0|NEP|0|1|0|100|DKK|243393|309224|lyfsjukr|||1|120|0||Vistor hf|Novartis Europharm Limited|Siponimod||243393||243393|309224||1|0|L|0|||0 098378|N03AX0904|Lamotrigin ratiopharm|dreifit.|25|mg|50|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|G|0|RTH|0|0|0|100|DKK|920|2478|lyfalmen|V0243|2478|2|50|0|4,1600|Alvogen|ratiopharm GmbH|Lamótrigín||712||712|2478||2|0|G|0|||0 098387|N03AX0904|Lamotrigin ratiopharm|dreifit.|50|mg|50|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|G|0|RTH|0|0|0|100|DKK|1595|2932|lyfalmen|V0244|2719|2|50|0|8,3300|Alvogen|ratiopharm GmbH|Lamótrigín||1042||1042|2932||2|0|G|0|||0 098405|N03AX0904|Lamotrigin ratiopharm|dreifit.|100|mg|100|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|G|0|RTH|0|0|0|100|DKK|4250|4774|lyfalmen|V0245|4774|2|100|0|33,3300|Alvogen|ratiopharm GmbH|Lamótrigín||2380||2380|4774||2|0|G|0|||0 098423|N03AX0904|Lamotrigin ratiopharm|dreifit.|200|mg|100|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|G|0|RTH|0|0|0|100|DKK|7404|9960|lyfalmen|V0232|9960|2|100|0|66,6600|Alvogen|ratiopharm GmbH|Lamótrigín||6148||6148|9960||2|0|G|0|||0 098469|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|10|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|G|0|BLS|0|0|1|100|XEU|2565|4822|lyfalmen|V0381|4526|2|10|0|2,5000|Artasan ehf|Bluefish Pharmaceuticals AB|Ondansetrón||2415||2415|4822||1|0|G|0|||0 099100|C03DA0407|Eplerenon Krka|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.12.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|2991|2530|lyfalmen|V0107|2530|2|30|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Eplerenón||750||750|2530||2|0||0|||0 099204|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|2|spr||L02BA03|01.12.2010||R|0|0|0|0|0|AZA|0|0|0|100|SEK|81941|106913|lyfalmen|||1|10|0|60,2400|Vistor hf|AstraZeneca AB|Fulvestrant||81941||81941|106913||1|0|0|0|||0 099327|B02BB0102|Fibryga|sts/irs|1|g|1|g|1|glas|leysir,lausn|B02BB01|01.04.2021||R|0|0|0|0|0|OCT|0|1|0|100|DKK|71542|93760|lyfsjukr|||1|1|0|0,2000|Vistor hf|Octapharma AB|Manna Fíbrínógen||71542||71542|93760||1|H|L|0|||0 099436|L01EM0301|Piqray|filmhtfl|||56|stk|1|þpakki|28x50 mg + 28x200 mg|L01EM03|01.05.2021||R|1|1|1|0|0|NEP|0|1|0|100|DKK|496406|623901|lyfsjukr|||1|56|0|23,3333|Vistor hf|Novartis Europharm Limited|Alpelisib||496406||496406|623901||1|0|L|0|||0 099476|N05AH0406|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|G|0|MYL|0|0|0|100|SEK|2345|2343|lyfalmen|V0284|2343|2|100|0|6,2500|Icepharma hf|Mylan AB|Quetíapín||614||614|2343||2|0|G|0|||0 099482|N05AH0414|Quetiapin Hexal|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.09.2017|31.07.2021|R|1|1|0|G|0|SSA|0|0|0|100|DKK|10529|12908|lyfalmen|||2|100|0|75,0000|Artasan ehf|Hexal A/S|Quetíapín||8290||8290|12908||1|0|G|0|||0 099485|N05AH0406|Quetiapin Mylan|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|G|0|MYL|0|0|0|100|SEK|4383|4222|lyfalmen|V0285|3287|2|100|0|25,0000|Icepharma hf|Mylan AB|Quetíapín||1979||1979|4222||2|0|G|0|||0 099494|N05AH0406|Quetiapin Mylan|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|G|0|MYL|0|0|0|100|SEK|7845|7258|lyfalmen|V0286|5627|2|100|0|50,0000|Icepharma hf|Mylan AB|Quetíapín||4185||4185|7258||2|0|G|0|||0 099705|D08AG0201|Betadine|húðlausn|100|mg/ml|500|ml|1|brusar|vatnslausn|D08AG02|01.04.1985||L|0|0|0|0|0|MUP|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Mundipharma A/S|Joð/pólývídón|||||||2|0||0|||0 099707|N03AX1604|Brieka|hylki|25|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|ATE|0|0|0|100|XEU|2776|3858|lyfalmen|V0685|3858|2|100|0|8,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Pregabalín||1715||1715|3858||1|0|E|0|||0 099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|0|0|0|0|0|MUP|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Mundipharma A/S|Joð/pólývídón|||||||2|0||0|||0 099835|N03AX1107|Topiramat Actavis|filmhtfl|25|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1583|3677|lyfalmen|V0247|3677|2|60|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tópíramat||1583||1583|3677||1|0|G|0|||0 099847|N03AX1107|Topiramat Actavis|filmhtfl|50|mg|60|stk|1|plglas||N03AX11|01.09.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2622|5107|lyfalmen|V0248|5107|2|60|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tópíramat||2622||2622|5107||1|0|G|0|||0 099858|N03AX1107|Topiramat Actavis|filmhtfl|100|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|5458|4317|lyfalmen|V0249|4317|2|60|0|20,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tópíramat||2048||2048|4317||1|0|G|0|||0 099863|L01EX0101|Sutent|hylki|12,5|mg|28|stk|1|þpakki||L01EX01|01.12.2012||R|1|0|1|0|0|PEU|0|1|0|100|DKK|160675|206346|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|Sunitinib||160675||160675|206346||1|0|L|0|||0 099872|L01EX0101|Sutent|hylki|25|mg|28|stk|1|þpakki||L01EX01|01.03.2014||R|1|0|1|0|0|PEU|0|1|0|100|DKK|320634|405290|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|Sunitinib||320634||320634|405290||1|0|L|0|||0 099881|L01EX0101|Sutent|hylki|50|mg|28|stk|1|þpakki||L01EX01|01.03.2014||R|1|0|1|0|0|PEU|0|1|0|100|DKK|641244|804039|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|Sunitinib||641244||641244|804039||1|0|L|0|||0 099959|L01BA0403|Pemetrexed Accord|irþ|500|mg|500|mg|1|hgl|stofn f. innr.þykkni lausn|L01BA04|01.04.2018||R|0|0|0|0|0|CLU|0|1|0|100|XEU|140936|181796|lyfsjukr|||2|500|0||Artasan ehf|Accord Healthcare S.L.U.|Pemetrexed||140936||140936|181796||1|H|L|0|||0 100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|0|0|0|0|0|NED|0|0|0|100|XEU|11020|16666|lyfalmen|V0925|14162|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||||11020|16666||2|0|E|0|||0 100428|N06AX1103|Miron|filmhtfl|15|mg|100|stk|1|plglas||N06AX11|01.01.2012||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2135|3799|lyfalmen|V0823|3700|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mirtazapín||1672||1672|3799||1|0|G|0|||0 100441|M01AE0116|Ibuprofen Bril|filmhtfl|600|mg|30|stk|1|þpakki||M01AE01|01.11.2016||R|1|0|0|G|0|PIL|0|0|1|100|IKR|322|1842|lyfalmen|V0563|1831|2|30|0|15,0000|Williams & Halls efh|Brillpharma (Ireland) Limited|Íbúprófen||250||250|1842||2|0|G|0|||0 100807|N03AX1603|Pregabalin Krka|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|1000|2874|lyfalmen|V0685|2160|2|56|0|4,6667|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1000||1000|2874||2|0|E|0|||0 100830|J01FA1007|Azithromycin STADA|mixtduft|40|mg/ml|15|ml|1|glas|dreifa|J01FA10|01.06.2017||R|0|0|0|0|0|ASR|0|0|1|100|IKR|700|2186|lyfalmen|V0821|2186|2|15|0|2,0000|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||500||500|2186||2|0|E|0|||0 100843|J01FA1007|Azithromycin STADA|mixtduft|40|mg/ml|22,5|ml|1|glas|dreifa|J01FA10|01.06.2017||R|0|0|0|0|0|ASR|0|0|1|100|IKR|1000|2874|lyfalmen|V0822|2874|2|22,5|0|3,0000|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||1000||1000|2874||2|0|E|0|||0 100884|J01AA0401|Lymecycline Actavis|hylki|300|mg|100|stk|1|þpakki||J01AA04|01.07.2015||R|0|0|0|0|0|ATE|0|0|1|100|XEU|3530|6357|lyfalmen|||2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lymecycline||3530||3530|6357||1|0|E|0|||0 101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|1|0|0|G|0|UPJ|0|0|0|100|DKK|9521|13290|lyfalmen|V0254|11748|1|100|0|33,3300|Icepharma hf|Upjohn EESV|Gabapentín||8567||8567|13290||1|0|G|0|||0 101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|1|0|0|G|0|UPJ|0|0|0|100|DKK|13591|20205|lyfalmen|V0256|19263|1|100|0|44,4400|Icepharma hf|Upjohn EESV|Gabapentín||13591||13591|20205||1|0|G|0|||0 101148|QI10AB0301|Alpha Ject 5-3|stl|||500|ml|1|poki||QI10AB03|01.09.2013||R|0|0|0|0|0|PHA|0|0|0|100|NOK|57760|85642|veteldis|||0|500|0||Vistor hf|Pharmaq AS|Aeromónas + moritella + vibrio||53128||53128|85642||1|0||0|||0 101367|QM01AE9104|Canicaral vet|töflur|40|mg|100|stk|1|þpakki||QM01AE91|01.09.2016||R|0|0|0|0|0|VEB|0|0|0|100|IKR|5189|10015|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Vedaprofenum||5189||5189|10015||2|0||0|||0 101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|0|ATE|0|0|0|100|XEU|1822|4006|lyfalmen|||2|30|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mirtazapín||||1822|4006||1|0||0|||0 101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|G|0|ATE|0|0|0|100|XEU|3142|5823|lyfalmen|||2|96|0|96,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mirtazapín||||3142|5823||1|0|G|0|||0 101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|0|0|0|0|0|BOI|0|0|0|100|DKK|12308|23521|vetalmen|||0|250|0||Vistor hf|Boehringer Ingelheim|Meloxícam||12308||12308|23521||1|0||0|||0 101893|G03DB0801|Visanne|töflur|2|mg|28|stk|1|þpakki||G03DB08|01.05.2012||R|0|0|0|0|0|BAB|0|0|0|100|DKK|5868|9575|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer AB|Díenógest||5868||5868|9575||2|0|E|0|||0 101904|G03DB0801|Visanne|töflur|2|mg|84|stk|1|þpakki||G03DB08|01.05.2012||R|0|0|0|0|0|BAB|0|0|0|100|DKK|17407|25457|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Díenógest||17407||17407|25457||2|0|E|0|||0 102051|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|G|0|LBK|0|0|0|100|DKK|1020|2902|lyfalmen|||1|100|0|8,3333|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1020||1020|2902||1|0|G|0|||0 102062|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|G|0|LBK|0|0|0|100|DKK|1539|3616|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1539||1539|3616||1|0|G|0|||0 102121|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|0|0|BAM|0|0|0|100|SEK|5546|9131|lyfalmen|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||5546||5546|9131||2|H|0|0|||0 102173|N02BE0107|Paratabs|filmhtfl|500|mg|100|stk|1|þpakki||N02BE01|01.03.2013||R|1|0|0|0|0|ATE|0|0|1|100|XEU|397|2044|lyfalmen|V0230|2037|2|100|0|16,6667|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paracetamól||397||397|2044||1|0|E|0|||0 102249|N07BA0153|Zonnic Pepparmint|munnhúði|1|mg/úðask|200|skammtar|2|glas|2 x 200 úðaskammtar|N07BA01|01.11.2018||L|0|0|0|0|0|NIC|0|0|1|100|IKR|||lyflausa|||0|400|0|13,3333|LYFIS ehf|Niconovum AB|Nikótín|||||||2|0||0|||0 102518|N05AX1208|Aripiprazol W&H|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|1|0|0|G|0|WEH|0|0|0|100|XEU|7977|3422|lyfalmen|V0684|3422|2|56|0|56,0000|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||1398||1398|3422||2|0|G|0|||0 102871|C01DA1401|Imdur|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.07.1989||R|1|0|0|G|0|TOG|0|0|0|100|SEK|3086|5745|lyfalmen|V0041|3757|1|98|0|147,0000|Navamedic AB|TopRidge Pharma (Ireland) Limited|Ísósorbíð mónónítrat||3086||3086|5745||1|0|G|0|||0 102952|G04BD0805|Solifenacin Alvogen|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|G|0|POF|0|0|0|100|XEU|15157|13763|lyfalmen|V0441|11408|2|90|0|180,0000|Alvogen|Alvogen|Sólífenacín||8911||8911|13763||2|0|G|0|||0 103050|N05CF0205|Zovand|filmhtfl|10|mg|30|stk|1|þpakki||N05CF02|01.04.2015|30.09.2021|R|1|0|0|0|0|WEH|0|0|1|100|IKR|321|1940|lyfalmen|||2|30|0|30,0000|Williams & Halls efh|Williams & Halls ehf|Zolpidem||321||321|1940||2|0||2|30|töflur|0 103114|L04AX0306|Metojectpen|stl|7,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|2505|4946|lyfalmen|||1|1|0|3,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2505||2505|4946||2|0|G|0|||0 103197|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.01.2017||R|1|0|1|0|0|PMA|0|0|0|100|DKK|7112|9350|lyfalmen|V0657|8655|1|30|0|10,0000|Actavis hf|Teva Pharma B.V.|Modafinil||5705||5705|9350||1|0|E|2|||0 103379|L03AA1401|Lonquex|stl|6|mg|0,6|ml|1|áfspr||L03AA14|01.10.2015||R|0|0|1|0|0|TBB|0|1|0|100|NOK|93548|121593|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Teva B.V.|Lipegfilgrastim||93548||93548|121593||1|0|L|0|||0 103444|L04AB0404|IDACIO|stl|40|mg/spr|0,8|ml|2|áf.spr|áfylltar sprautur|L04AB04|01.08.2020||R|0|1|1|0|0|FKA|0|1|0|100|DKK|34421|46809|lyfsjukr|||2|1,6|0|27,5862|Vistor hf|Fresenius Kabi AB|Adalimumab||34421||34421|46809||1|0|L|0|||0 103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2008||R|1|0|0|G|0|GOV|0|0|0|100|IKR|2030|3161|lyfalmen|V0088|3108|2|98|0|98,0000|Alvogen|Alvogen ehf|Lósartan og þvagræsilyf||1208||1208|3161||2|0|G|0|||0 103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.02.2008||R|1|0|0|G|0|GOV|0|0|0|100|IKR|2590|3747|lyfalmen|V0089|3631|2|98|0|98,0000|Alvogen|Alvogen ehf|Lósartan og þvagræsilyf||1634||1634|3747||2|0|G|0|||0 103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|þpakki||C09CA01|01.02.2008||R|1|0|0|G|0|GOV|0|0|0|100|IKR|1845|3934|lyfalmen|V0069|2884|2|98|0|98,0000|Alvogen|Alvogen ehf|Lósartan||1770||1770|3934||2|0|G|0|||0 103678|N06AX1615|Venlafaxine Alvogen|forðahlk|75|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|1|0|0|G|0|POF|0|0|0|100|IKR|5678|2874|lyfalmen|V0334|2598|2|100|0|75,0000|Alvogen|Alvogen|Venlafaxín||1000||1000|2874||2|0|G|0|||0 103813|B02BC3002|TISSEEL|vefjalím|||4|ml|10|áf.spr|+ Duo sett|B02BC30|01.01.2013||R|0|0|0|0|0|BAM|0|0|0|100|SEK|284844|360777|lyfalmen|||1|40|0||Icepharma hf|Baxter Medical AB|Blöndur||284844||284844|360777||2|H|0|0|||0 103854|L01EK0101|INLYTA|filmhtfl|1|mg|56|stk|1|þpakki||L01EK01|01.05.2013||R|1|0|1|0|0|PEU|0|1|0|100|DKK|100729|131790|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Europe MA EEIG|Axitinib||100729||100729|131790||1|0|L|0|||0 103906|QD08AC5201|Malaseb vet.|hársápa|2|%|250|ml|1|glas|w/v|QD08AC52|01.10.2012||R|0|0|0|0|0|DEC|0|0|0|100|DKK|3784|7350|vetalmen|||1|250|0||Vistor hf|Dechra Veterinary Products A/S|Bígvaníð og amídín-Klórhexidín í blöndum||3784||3784|7350||1|0||0|||0 103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|0|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Orion Pharma|Bisakódýl|||||2388||1|0|E|0|||0 104026|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|GEH|0|0|0|100|NOK|8372|13021|lyfalmen|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||8372||8372|13021||2|H|0|0|||0 104401|N06AB0607|Sertralin Krka|filmhtfl|50|mg|250|stk|1|ílát||N06AB06|01.11.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|5696|7004|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Sertralín||4000||4000|7004||2|0|G|0|||0 104482|L01CA0403|Vinorelbine Alvogen|hylki|30|mg|1|stk|1|þpakki|mjúkt|L01CA04|01.10.2019||R|0|0|1|G|0|ALE|0|0|0|100|SEK|11444|15559|lyfalmen|V0992|15559|2|1|0||Alvogen|Alvogen Pharma Trading Europe EOOD|Vínorelbín||10216||10216|15559||2|0|G|0|||0 104503|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 104675|C09DX0401|Entresto|filmhtfl|50|mg|28|stk|1|þpakki|24 + 26 mg|C09DX04|01.04.2016||R|0|0|0|0|0|NEL|0|0|0|100|DKK|10109|15412|lyfalmen|||1|28|0|14,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||10109||10109|15412||1|0|E|0|||0 104688|N05AH0415|Quetiapin Krka|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.04.2018||R|0|1|0|G|0|KRK|0|0|0|100|IKR|4500|4801|lyfalmen|V0275|4788|2|100|0|12,5000|LYFIS ehf|Krka Sverige AB|Quetíapín||2400||2400|4801||2|0|G|0|||0 104760|A07EC0202|Pentasa|eþ-stíll|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|0|0|0|G|0|FER|0|0|0|100|DKK|6822|10888|lyfalmen|||1|28|0|18,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||6822||6822|10888||1|0|G|0|||0 104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|0|0|0|G|0|FER|0|0|0|100|DKK|3563|6402|lyfalmen|V0017|5660|1|700|0|4,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||3563||3563|6402||1|0|G|0|||0 104851|A07EC0202|Pentasa|forðatfl|500|mg|100|stk|1|þpakki||A07EC02|01.04.1992||R|1|0|0|G|0|FER|0|0|0|100|DKK|5693|9334|lyfalmen|||1|100|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||5693||5693|9334||1|0|G|0|||0 104856|R03AK1101|Flutiform|innúðal|55|mcg/sk|120|skammtar|1|pakki|50+5 mcg/sk|R03AK11|01.01.2014||R|0|0|0|G|0|MUP|0|0|0|100|DKK|4331|7459|lyfalmen|||1|120|0|30,0000|Icepharma hf|Mundipharma A/S|Formóteról og flútikasón||4331||4331|7459||2|0|G|0|||0 104959|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|0|RAG|0|1|0|100|DKK|95270|123771|lyfsjukr|||1|2|0|88,8900|Vistor hf|Amgen|Darbepóetín alfa||||95270|123771||1|0|L|0|||0 105331|N02AE0105|Buprenorphine Alvogen|forðapl|10|mcg/klst|4|stk|1|skpoki||N02AE01|01.10.2020||R|0|0|0|G|0|POF|0|0|0|100|DKK|3186|5883|lyfalmen|V0944|5883|2|4|0|5,6000|Alvogen|Alvogen|Búprenorfín||3186||3186|5883||2|0|G|1|30|dagar|0 105363|C03DA0403|Eplerenon Bluefish|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.05.2015||R|1|0|0|0|0|BLS|0|0|0|100|XEU|3183|3169|lyfalmen|V0107|2530|2|30|0|15,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Eplerenón||1214||1214|3169||1|0|E|0|||0 105621|N02BE0127|Dolorin Junior|eþ-stíll|125|mg|10|stk|1|þpakki||N02BE01|01.04.2021||L|0|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|10|0|0,4167|Williams & Halls efh|Williams & Halls ehf|Paracetamól|||||||2|0||0|||0 105669|N07BC0202|Metadon Abcur|töflur|20|mg|20|stk|1|þpakki||N07BC02|01.04.2020||R|1|0|0|G|0|ABC|0|0|0|100|SEK|2003|4255|lyfalmen|||1|20|0|16,0000|Icepharma hf|Abcur AB|Metadón||2003||2003|4255||2|0|G|1|30|dagar|0 105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|MAR|0|0|1|100|DKK|2840|5407|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Mepívakaín||2840||2840|5407||2|0||0|||0 105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|MAR|0|0|1|100|DKK|3407|6187|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Mepívakaín||3407||3407|6187||2|0||0|||0 105827|L01XK0401|Talzenna|hylki|1|mg|30|stk|1|glas||L01XK04|01.09.2021||R|0|0|1|0|0|PEU|0|1|0|100|DKK|641975|804948|lyfsjukr|||1|30|0||Icepharma hf|Pfizer Europe MA EEIG|Talazoparib||641975||641975|804948||2|0|L|0|||0 106006|J05AH0201|Tamiflu|hylki|30|mg|10|stk|1|þpakki||J05AH02|01.11.2011||R|1|0|0|0|0|RRG|0|0|0|100|DKK|1869|4070|lyfalmen|||1|10|0|2,0000|Icepharma hf|Roche Registration GmbH|Oseltamivír||1869||1869|4070||2|0||0|||0 106017|J05AH0201|Tamiflu|hylki|45|mg|10|stk|1|þpakki||J05AH02|01.11.2011||R|1|0|0|0|0|RRG|0|0|0|100|DKK|3046|4072|lyfalmen|||1|10|0|3,0000|Icepharma hf|Roche Registration GmbH|Oseltamivír||1870||1870|4072||2|0||0|||0 106390|L01EJ0101|Jakavi|töflur|10|mg|56|stk|1|þpakki||L01EJ01|01.03.2016||R|1|0|1|0|0|NEL|0|1|0|100|DKK|433581|545765|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||433581||433581|545765||1|0|L|0|||0 106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|0|0|0|0|0|GPH|0|0|0|100|DKK|16747|24548|lyfalmen|||1|5|0|0,6250|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||16747||16747|24548||1|H|0|0|||0 106602|J01MA0207|Ciprofloxacin Navamedic|irl|2|mg/ml|100|ml|10|pokar||J01MA02|01.05.2021||R|0|0|0|0|0|NAV|0|0|1|100|XEU|6518|10469|lyfalmen|||2|1000|0|2,5000|Icepharma hf|Navamedic ASA|Cíprófloxacín||6518||6518|10469||2|0|0|0|||0 106978|C03DA0404|Kalspar|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2015||R|1|0|0|0|0|WEH|0|0|0|100|XEU|3444|2567|lyfalmen|V0107|2530|2|30|0|15,0000|Williams & Halls efh|Williams & Halls ehf|Eplerenón||777||777|2567||2|0|E|0|||0 107002|R07AA0201|Curosurf|innönddr|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.2015||R|0|0|0|0|0|CHI|0|0|0|100|XEU|119368|154972|lyfalmen|||1|3|0|1,5000|Chiesi Farmaceutici SpA|Chiesi Farmaceutici SpA|Náttúrulegir fosfólípíðar||119368||119368|154972||1|H|0|0|||0 107194|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|75 mg/15 mg|QP54AB51|01.04.2018|31.08.2021|R|0|0|0|0|0|BIV|0|0|0|100|XEU|3003|5176|vetorma|||0|3|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Milbemycin oxime í blöndum||3003||3003|5176||1|0||0|||0 107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|1|0|0|G|0|PLS|0|0|0|100|DKK|1496|3557|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1496||1496|3557||1|0|G|0|||0 107322|D01BA0207|Terbinafin Medical Valley|töflur|250|mg|98|stk|1|þpakki||D01BA02|01.02.2021||R|1|0|0|0|0|VAL|0|0|0|100|XEU|5988|8902|lyfalmen|V0737|8902|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Terbínafín||5379||5379|8902||2|0|E|0|||0 107464|G04BD0805|Solifenacin Alvogen|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|G|0|POF|0|0|0|100|XEU|4428|4657|lyfalmen|V0438|4657|2|30|0|30,0000|Alvogen|Alvogen|Sólífenacín||2295||2295|4657||2|0|G|0|||0 107575|N01AB0803|Sevoflurane Piramal|innö.guf|100|%|250|ml|1|fl||N01AB08|01.03.2015||R|0|0|0|0|0|PBV|0|0|0|100|XEU|19073|26199|lyfalmen|||1|250|0||Williams & Halls efh|Piramal Critical Care B.V.|Sevóflúran||17946||17946|26199||2|H|0|0|||0 107643|N06BA0902|Atomoxetin Actavis|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.03.2017||R|1|1|0|0|0|ATE|0|0|0|100|XEU|12217|3284|lyfalmen|V0814|2940|2|28|0|8,7500|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atomoxetín||1298||1298|3284||1|0|E|0|||0 107657|N05AX1205|Aripiprazol Krka|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|0|0|G|0|KRK|0|0|0|100|IKR|5625|3934|lyfalmen|V0683|3422|2|56|0|37,3300|LYFIS ehf|Krka Sverige AB|Aripiprazól||1770||1770|3934||2|0|G|0|||0 107785|L01EF0201|Kisqali|filmhtfl|200|mg|42|stk|1|þpakki||L01EF02|01.11.2018||R|0|0|1|0|0|NEL|0|1|0|100|DKK|285220|361245|lyfsjukr|||1|42|0||Vistor hf|Novartis Europharm Ltd|Ribociclib||285220||285220|361245||1|0|L|0|||0 107935|QN01AX0304|Aniketam vet.|stl|100|mg/ml|50|ml|1|hgl|lausn|QN01AX03|01.04.2015||R|0|0|0|0|0|VEB|1|0|0|100|IKR|7285|13992|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Ketaminum||||7285|13992||2|0||1|30|dagar|0 108205|QN02AC5201|Synthadon|stl|10|mg/ml|10|ml|1|pakki||QN02AC52|01.07.2016||R|0|0|0|0|0|VEB|1|0|0|100|IKR|3258|6352|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Metadón í blöndum nema með geðlyfjum||||3258|6352||2|0||1|30|dagar|0 108413|C10AX1401|Praluent|stl|75|mg/ml|2|áf-penni|1|pakki|lausn í áf.lyfjapenna|C10AX14|01.02.2016||R|0|0|0|0|0|SGB|0|0|0|100|XEU|69701|91431|lyfalmen|||1|2|0|27,7778|Vistor hf|Sanofi-aventis groupe|Alirocumab||69701||69701|91431||1|0|E|0|||0 108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|þpakki||A10BH02|01.09.2008||R|0|0|0|G|0|NEL|0|0|0|100|DKK|8828|13649|lyfalmen|||1|90|0|45,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||8828||8828|13649||1|0|G|0|||0 108697|A16AA0601|Cystadane|duft|1|g|180|g|1|glas||A16AA06|01.07.2013||R|0|0|1|0|0|ECO|0|0|0|100|XEU|80074|104551|lyfalmen|||1|180|0|30,0000|Recordati AB|Recordati Rare Diseases|Betain anhydrous||80074||80074|104551||3|0|E|0|||0 109338|M01AH0502|Coxient|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|ZET|0|0|1|100|IKR|776|2186|lyfalmen|V0827|2186|2|7|0|14,0000|Alvogen|Zentiva, k.s.|Etoríkoxíb||500||500|2186||2|0|G|0|||0 109578|N02AA0505|Oxycodone ratiopharm|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|0|G|0|RTH|0|0|0|100|XEU|5474|7776|lyfalmen|V0585|7776|2|98|0|26,1300|Alvogen|ratiopharm GmbH|Oxýcódon||4561||4561|7776||2|0|G|1|30|dagar|0 109588|N02AA0505|Oxycodone ratiopharm|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.01.2013|31.07.2021|R|1|0|0|G|0|RTH|0|0|0|100|XEU|3869|6823|lyfalmen|||2|28|0|14,9300|Alvogen|ratiopharm GmbH|Oxýcódon||3869||3869|6823||2|0|G|1|30|dagar|0 109597|N02AA0505|Oxycodone ratiopharm|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|0|G|0|RTH|0|0|0|100|XEU|10000|13785|lyfalmen|V0587|13785|2|98|0|52,2700|Alvogen|ratiopharm GmbH|Oxýcódon||8927||8927|13785||2|0|G|1|30|dagar|0 109615|N02AA0505|Oxycodone ratiopharm|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.01.2013|31.07.2021|R|1|0|0|G|0|RTH|0|0|0|100|XEU|18909|25153|lyfalmen|||2|98|0|104,5300|Alvogen|ratiopharm GmbH|Oxýcódon||17186||17186|25153||2|0|G|1|30|dagar|0 110001|N03AX1602|Lyrica (Lyfjaver)|hylki|75|mg|100|stk|1|þpakki||N03AX16|01.12.2019||R|1|0|0|0|0|LVR|0|0|0|100|DKK|8935|13796|lyfalmen|V0686|3637|3|100|0|25,0000|Lyfjaver ehf|Lyfjaver ehf|Pregabalín||8935||8935|13796||3|0|E|0|||0 110033|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|30|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Alvogen|ratiopharm GmbH|Cetirizín|||||||2|0||0|||0 110184|S01ED5117|DUOKOPT|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml, án rotvarnar|S01ED51|01.06.2016||R|0|0|0|G|0|LTH|0|0|0|100|SEK|1785|3955|lyfalmen|||1|5|0|25,0000|Vistor hf|Laboratoires THEA|Tímólól í blöndum||1785||1785|3955||1|0|G|0|||0 110242|V03AN0101|Conoxia|lyfjagas|100|%|3|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.04.2008||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|3|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0 110287|N05AX0806|Risperidon Krka|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|1500|2461|lyfalmen|V0291|2393|2|60|0|12,0000|LYFIS ehf|Krka Sverige AB|Risperídón||700||700|2461||2|0|G|0|||0 110306|N05AX0806|Risperidon Krka|filmhtfl|2|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|2608|3494|lyfalmen|V0292|3494|2|60|0|24,0000|LYFIS ehf|Krka Sverige AB|Risperídón||1450||1450|3494||2|0|G|0|||0 110324|N05AX0806|Risperidon Krka|filmhtfl|3|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|4870|8201|lyfalmen|||2|60|0|36,0000|LYFIS ehf|Krka Sverige AB|Risperídón||4870||4870|8201||2|0|G|0|||0 110341|A10BJ0601|Ozempic|stl|0,25|mg|1,5|ml|1|áfpen|+4 einnota nálar|A10BJ06|01.01.2019||R|0|0|0|0|0|NON|0|0|0|100|DKK|18699|27235|lyfalmen|||1|1,5|0|18,1818|Vistor hf|Novo-Nordisk|Semaglutide||18699||18699|27235||1|0|E|0|||0 110342|N05AX0806|Risperidon Krka|filmhtfl|4|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|5000|8380|lyfalmen|||2|60|0|48,0000|LYFIS ehf|Krka Sverige AB|Risperídón||5000||5000|8380||2|0|G|0|||0 110395|G03AA0902|Mercilon|töflur|||63|stk|1|þpakki|150/20 mcg|G03AA09|01.07.1990||R|0|0|0|0|0|NVO|0|0|0|100|DKK|1464|3145|lyfalm11|||1|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og ethinylestradíól||1464||1464|3145||1|0||0|||1 110397|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.01.2013||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0 110635|C08DA0104|Veraloc Retard|forðatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|1|0|0|G|0|COR|0|0|0|100|DKK|5295|8786|lyfalmen|||1|100|0|83,3333|Vistor hf|Orion Corporation|Verapamíl||5295||5295|8786||1|0|G|0|||0 110750|J05AJ0101|Isentress|filmhtfl|400|mg|60|stk|1|glas||J05AJ01|01.04.2012||R|1|0|1|0|0|MBV|0|1|0|100|DKK|87722|114224|lyfsjukr|||1|60|0|30,0000|Vistor hf|Merck Sharp & Dohme B.V.|Raltegravír||87722||87722|114224||1|0|L|0|||0 110958|L01AX0304|Temozolomide Accord|hylki|100|mg|5|stk|1|skpoki|hart|L01AX03|01.04.2018||R|0|0|1|0|0|CLU|0|1|0|100|XEU|4872|8204|lyfsjukr|||2|5|0||Artasan ehf|Accord Healthcare S.L.U.|Temozolomid||4872||4872|8204||1|0|L|0|||0 111295|G02BA0304|Levosert|leginnle|20|mcg/sólh|1|stk|1|poki||G02BA03|01.09.2015||R|0|1|0|0|0|GED|0|0|0|100|XEU|13846|17202|lyfalm11|||2|1|0||Gedeon Ricther Nordics AB|Gedeon Richter Plc.|Plast lyfjalykkja (IUD) með prógestógen||12873||12873|17202||1|0|E|0|||1 111479|S01ED5118|Dorzolamide/Timolol Alvogen|augndr|5|mg/ml|5|ml|3|glas|+ dorzólamid 20 mg/ml|S01ED51|01.11.2011||R|0|0|0|G|0|POF|0|0|0|100|XEU|4576|4887|lyfalmen|V0373|4887|2|15|0|75,0000|Alvogen|Alvogen|Tímólól í blöndum||2462||2462|4887||2|0|G|0|||0 111775|G03AA1209|Asubtela|filmhtfl|||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.11.2019||R|0|0|0|0|0|EXH|0|0|0|100|DKK|2532|4461|lyfalm11|V0993|4461|2|63|0|84,0000|Acare ehf|Exeltis Healthcare S.L.|Dróspírenón og ethinylestradíól||2532||2532|4461||2|0||0|||1 111955|N02BE0101|Panodil|filmhtfl|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|1|0|0|0|0|GCA|0|0|1|100|DKK|667|2416|lyfalmen|||1|100|0|33,3300|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól||667||667|2416||1|0|E|0|||0 112073|V03AB3301|Cyanokit|irs|5|g|1|hgl|1|pakki|lausn|V03AB33|01.05.2019||R|0|0|0|0|0|SEB|0|0|0|100|XEU|129239|167248|lyfalmen|||2|1|0||Swedish Orphan Biovitrum A/S|SERB S.A.|Hydroxocobalamin||129239||129239|167248||3|H|0|0|||0 112191|C02KX0501|Adempas|filmhtfl|1|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|0|BRE|0|1|0|100|DKK|187545|239765|lyfsjukr|||1|42|0|9,3300|Vistor hf|Bayer AG|Riociguatum||187545||187545|239765||1|0|L|0|||0 112345|J01FF0104|Clindamycin EQL Pharma|hylki|150|mg|32|stk|1|þpakki||J01FF01|01.05.2019||R|1|0|0|0|0|EQL|0|0|1|100|IKR|1500|3563|lyfalmen|||2|32|0|4,0000|LYFIS ehf|EQL Pharma AB|Klindamýcín||1500||1500|3563||2|0|E|0|||0 112704|N05AH0415|Quetiapin Krka|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|1800|2599|lyfalmen|V0284|2343|2|100|0|6,2500|Krka Sverige AB|Krka d.d. Novo mesto|Quetíapín||800||800|2599||2|0|G|0|||0 112713|N05AH0415|Quetiapin Krka|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|3800|3287|lyfalmen|V0285|3287|2|100|0|25,0000|Krka Sverige AB|Krka d.d. Novo mesto|Quetíapín||1300||1300|3287||2|0|G|0|||0 112732|N05AH0415|Quetiapin Krka|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|5000|5627|lyfalmen|V0286|5627|2|100|0|50,0000|Krka Sverige AB|Krka d.d. Novo mesto|Quetíapín||3000||3000|5627||2|0|G|0|||0 112873|J01CA0413|Amoxin|mixtduft|50|mg/ml|100|ml|1|glas||J01CA04|01.12.2015||R|0|0|0|0|0|RTH|0|0|1|100|IKR|1627|3737|lyfalmen|||2|100|0|3,3333|Alvogen|ratiopharm GmbH|Amoxicillín||1627||1627|3737||2|0|E|0|||0 113088|M05BA0802|Aclasta|irl|5|mg|100|ml|1|glas|lausn|M05BA08|01.04.2019||R|0|1|0|0|0|NEL|0|0|0|100|DKK|51582|68515|lyfalmen|||1|100|0|1,2500|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||51582||51582|68515||1|0|E|0|||0 113179|S01LA0601|Beovu|stl|120|mg/ml|0,165|ml|1|áfspr|lausn|S01LA06|01.06.2020||R|0|1|0|0|0|NEP|0|1|0|100|DKK|113314|147442|lyfsjukr|||1|0,165|0||Vistor hf|Novartis Europharm Limited|Brolucizumab||113314||113314|147442||1|H|L|0|||0 113251|D01AE1602|Amorolfin ratiopharm|lakk|5|%|5|ml|1|glas||D01AE16|01.09.2014|31.07.2021|L|0|0|0|0|0|RHA|0|0|1|100|IKR|||lyfalmen|||2|5|0||Alvogen|ratiopharm Oy|Amorolfín|||||5077||2|0|E|0|||0 113394|A10BD0801|Eucreas|filmhtfl|900|mg|60|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|1|0|0|G|0|NEL|0|0|0|100|DKK|6570|10541|lyfalmen|V0024|10541|1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||6570||6570|10541||1|0|G|0|||0 113412|A10BD0801|Eucreas|filmhtfl|1050|mg|60|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|1|0|0|G|0|NEL|0|0|0|100|DKK|5760|9426|lyfalmen|V0025|9426|1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||5760||5760|9426||1|0|G|0|||0 113414|B05AA0114|Albuman|irl|40|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|SPP|0|0|0|100|XEU|2860|5434|lyfalmen|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|albumin||2860||2860|5434||2|H|0|0|||0 113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|áf.spr|einnota dæla|B01AB05|01.10.1995||R|0|0|0|G|0|SNP|0|0|1|100|XEU|3396|6172|lyfalmen|||1|2|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3396||3396|6172||1|0|G|0|||0 113566|C07AB0215|Metoprolol Alvogen|forðatfl|47,5|mg|100|stk|1|þpakki||C07AB02|01.01.2021||R|1|0|0|G|0|GOV|0|0|0|100|XEU|1277|3030|lyfalmen|V0048|3030|2|100|0|31,6667|Alvogen|Alvogen ehf|Metóprólól||1113||1113|3030||2|0|G|0|||0 113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|áf.spr|einnota dæla|B01AB05|01.10.1995||R|0|0|0|G|0|SNP|0|0|1|100|XEU|4724|8000|lyfalmen|||1|4|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||4724||4724|8000||1|0|G|0|||0 113818|L01EA0301|Tasigna|hylki|200|mg|112|stk|1|þpakki||L01EA03|01.06.2008||R|0|1|1|0|0|NEL|0|1|0|100|DKK|485702|610589|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotinib||485702||485702|610589||1|0|L|0|||0 113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|MEA|0|0|1|100|DKK|577|2292|lyfalmen|||1|20|0|10,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||577||577|2292||2|0|E|0|||0 113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|MEA|0|0|1|100|DKK|839|2653|lyfalmen|||1|30|0|15,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||839||839|2653||2|0|E|0|||0 114063|G04BE0806|Tadalafil Krka|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.12.2017||R|1|0|0|0|0|KNM|0|0|0|100|IKR|5000|8380|lyfalmen|V0145|3629|2|4|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||5000||5000|8380||2|0|E|0|||0 114072|A07DA0301|Imodium|filmhtfl|2|mg|16|stk|1|þpakki||A07DA03|01.02.2014||L|1|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|16|0|3,2000|Vistor hf|McNeil Sweden AB|Lóperamíð|||||||1|0||0|||0 114328|L01AX0303|Temomedac|hylki|100|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|1|0|0|WIL|0|1|0|100|XEU|18457|26902|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||||18457|26902||2|0|L|0|||0 114440|M01AH0501|Arcoxia|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.01.2010||R|1|0|0|G|0|NVO|0|0|1|100|DKK|3617|6476|lyfalmen|V0824|3968|1|28|0|14,0000|Vistor hf|N.V. Organon|Etoríkoxíb||3617||3617|6476||1|0|G|0|||0 114505|C07AB0215|Metoprolol Alvogen|forðatfl|190|mg|100|stk|1|þpakki||C07AB02|01.06.2021||R|1|0|0|G|0|POF|0|0|0|100|IKR|4390|4939|lyfalmen|V0054|4939|2|100|0|126,6667|Alvogen|Alvogen|Metóprólól||2500||2500|4939||2|0|G|0|||0 114531|L01AA0201|Leukeran|filmhtfl|2|mg|25|stk|1|glas||L01AA02|01.04.2013||R|0|0|0|G|0|AEP|0|0|0|100|IKR|6061|9840|lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma Trading Limited|Chlorambucíl||6061||6061|9840||2|0|G|0|||0 114605|N03AF0203|Oxcarbazepin Jubilant|filmhtfl|600|mg|100|stk|1|þpakki||N03AF02|01.11.2018||R|1|0|0|G|0|JUB|0|0|0|100|DKK|8471|12066|lyfalmen|V0973|12066|2|100|0|60,0000|Acare ehf|Jubilant Pharmaceuticals nv|Oxkarbazepín||7678||7678|12066||2|0|G|0|||0 114755|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|90|stk|1|þpakki||L02BB03|01.11.2014||R|0|0|0|G|0|MED|0|0|0|100|IKR|14000|16638|lyfalmen|V0420|16638|2|90|0|90,0000|Medical ehf|Medical ehf|Bíkalútamíð||11000||11000|16638||2|0|G|0|||0 114912|QP54AA0501|Stronghold|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|ZBE|1|0|0|100|XEU|5762|9931|vetorma|||0|3|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||5762||5762|9931||2|0||0|||0 114941|N05AH0312|Zalasta|töflur|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|G|0|KNM|0|0|0|100|XEU|1998|3781|lyfalmen|V0278|3781|2|28|0|7,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1659||1659|3781||2|0|G|0|||0 114950|L01BC0702|Azacitidine Accord|sts|25|mg/ml|100|mg|1|hgl||L01BC07|01.05.2020||R|0|0|0|0|0|CLU|0|1|0|100|XEU|46470|62049|lyfsjukr|||2|100|0||Artasan ehf|Accord Healthcare S.L.U.|Azasitidín||46470||46470|62049||1|H|L|0|||0 114952|N05AH0312|Zalasta|töflur|5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|G|0|KNM|0|0|0|100|XEU|2693|3718|lyfalmen|V0279|3718|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1613||1613|3718||2|0|G|0|||0 114963|N05AH0312|Zalasta|töflur|7,5|mg|56|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|G|0|KNM|0|0|0|100|XEU|8011|6858|lyfalmen|V0280|6858|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||3894||3894|6858||2|0|G|0|||0 114985|N05AH0312|Zalasta|töflur|10|mg|56|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|G|0|KNM|0|0|0|100|XEU|11071|6858|lyfalmen|V0282|6858|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||3894||3894|6858||2|0|G|0|||0 114996|N05AH0312|Zalasta|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|0|KNM|0|0|0|100|IKR|5276|8760|lyfalmen|V0457|8760|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||5276||5276|8760||2|0|G|0|||0 115007|N05AH0312|Zalasta|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|G|0|KNM|0|0|0|100|IKR|8022|12539|lyfalmen|||2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||8022||8022|12539||2|0|G|0|||0 115018|N05AH0312|Zalasta|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|G|0|KNM|0|0|0|100|IKR|5779|9452|lyfalmen|V0475|9452|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||5779||5779|9452||2|0|G|0|||0 115029|N05AH0312|Zalasta|munndr.t|20|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|G|0|KNM|0|0|0|100|IKR|13896|20624|lyfalmen|V0540|20624|2|28|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||13896||13896|20624||2|0|G|0|||0 115126|B02BD0801|NovoSeven|sts|1|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|0|0|0|0|NAS|0|1|0|100|DKK|84097|109639|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Storkuþáttur VIIa||84097||84097|109639||1|H|L|0|||0 115241|V03AB1504|Naloxon B. Braun|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.09.2010||R|0|0|0|0|0|RAU|0|0|1|100|XEU|7408|11694|lyfalmen|||2|10|0||Actavis Group hf|B.Braun Melsungen AG|Naloxón||7408||7408|11694||2|0|0|0|||0 115285|J01CA0411|Amoxicillin Mylan|töflur|750|mg|20|stk|1|þpakki||J01CA04|01.10.1998||R|0|0|0|0|0|MYL|0|0|1|100|SEK|1104|3017|lyfalmen|V0158|3017|2|20|0|10,0000|Icepharma hf|Mylan AB|Amoxicillín||1104||1104|3017||2|0|E|0|||0 115309|N05AH0206|Clozapin Medical|töflur|25|mg|100|stk|1|þpakki||N05AH02|01.06.2015||R|1|0|0|G|0|MED|0|0|0|100|IKR|1741|3287|lyfalmen|V0276|3217|2|100|0|8,3300|Medical ehf|Medical ehf|Klózapín||1300||1300|3287||2|0|G|0|||0 115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|G|0|BII|0|0|0|100|DKK|10833|16408|lyfalmen|||1|60|0|15,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||10833||10833|16408||1|0|G|0|||0 115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|G|0|BII|0|0|0|100|DKK|9328|14337|lyfalmen|||1|60|0|22,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||9328||9328|14337||1|0|G|0|||0 115554|B03AC0001|Monofer|irl|100|mg/ml|10|ml|1|hgl||B03AC|01.07.2013||R|0|1|0|G|0|PAC|0|0|1|100|DKK|43311|58053|lyfalmen|||1|10|0|10,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||43311||43311|58053||1|0|G|0|||0 115613|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 115770|D10AF5101|Duac|hlaup|||30|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.03.2018||R|0|0|0|0|0|STE|0|0|0|100|DKK|3458|6258|lyfalmen|||1|30|0||Vistor hf|Stiefel Laboratories L.(Ireland) Ltd.|Klindamýcín í blöndum||3458||3458|6258||1|0|0|0|||0 116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|0|0|0|0|0|GPH|0|0|1|100|DKK|3341|6096|lyfalmen|||1|5|0|2,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Cefúroxím||3341||3341|6096||1|0|0|0|||0 116046|J01DC0202|Zinacef|sts|750|mg|5|hgl|1|pakki||J01DC02|01.09.1983||R|0|0|0|0|0|GPH|0|0|1|100|DKK|1747|3902|lyfalmen|||1|5|0|1,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Cefúroxím||1747||1747|3902||1|0|0|0|||0 116551|M01AE0102|Ibufen|filmhtfl|200|mg|20|stk|1|þpakki||M01AE01|01.12.2008||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Íbúprófen|||||||1|0||0|||0 116573|M01AE0102|Ibufen|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.05.2008||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Íbúprófen|||||||1|0||0|||0 116584|M01AE0102|Ibufen|filmhtfl|400|mg|100|stk|1|glas||M01AE01|01.08.2008||R|1|0|0|G|0|ATE|0|0|1|100|XEU|811|2493|lyfalmen|V0562|2417|2|100|0|33,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Íbúprófen||723||723|2493||1|0|G|0|||0 116595|M01AE0102|Ibufen|filmhtfl|600|mg|30|stk|1|þpakki||M01AE01|01.07.2008||R|1|0|0|G|0|ATE|0|0|1|100|XEU|413|1989|lyfalmen|V0563|1831|2|30|0|15,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Íbúprófen||357||357|1989||1|0|G|0|||0 116606|M01AE0102|Ibufen|filmhtfl|600|mg|100|stk|1|glas||M01AE01|01.05.2008||R|1|0|0|G|0|ATE|0|0|1|100|XEU|863|2665|lyfalmen|V0564|2284|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Íbúprófen||848||848|2665||1|0|G|0|||0 116694|G04BD1101|Toviaz|forðatfl|4|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|G|0|PEU|0|0|0|100|DKK|14154|20979|lyfalmen|||1|84|0|84,0000|Icepharma hf|Pfizer Europe MA EEIG|Fesóteródín||14154||14154|20979||1|0|G|0|||0 116697|C09CA0602|Candpress|töflur|8|mg|100|stk|1|þpakki||C09CA06|01.01.2012||R|1|0|0|G|0|ATE|0|0|0|100|XEU|4247|6761|lyfalmen|V0081|6514|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Candesartan||3824||3824|6761||1|0|G|0|||0 116705|G04BD1101|Toviaz|forðatfl|4|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|G|0|PEU|0|0|0|100|DKK|5517|9092|lyfalmen|||1|28|0|28,0000|Icepharma hf|Pfizer Europe MA EEIG|Fesóteródín||5517||5517|9092||1|0|G|0|||0 116716|G04BD1101|Toviaz|forðatfl|8|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|G|0|PEU|0|0|0|100|DKK|6007|9766|lyfalmen|||1|28|0|56,0000|Icepharma hf|Pfizer Europe MA EEIG|Fesóteródín||6007||6007|9766||1|0|G|0|||0 116727|G04BD1101|Toviaz|forðatfl|8|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|G|0|PEU|0|0|0|100|DKK|15416|22717|lyfalmen|||1|84|0|168,0000|Icepharma hf|Pfizer Europe MA EEIG|Fesóteródín||15416||15416|22717||1|0|G|0|||0 117103|QN01AX0305|Ketabel vet.|stl|100|mg/ml|25|ml|1|hgl|lausn|QN01AX03|01.04.2021||R|0|0|0|0|0|Bel|1|0|0|100|XEU|3072|5999|vetalmen|||0|25|0||Icepharma hf|Bela-Pharma GmbH & CO KG|Ketaminum||3072||3072|5999||2|0|0|1|30|dagar|0 117408|QA12AX0001|Calcimag vet. Kela|irl|||500|ml|12|plastf||QA12AX|01.04.2004||R|0|0|0|0|0|KEL|1|0|0|100|XEU|9287|17790|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum í blöndum með D-vítamíni/eða öðrum efnum||9287||9287|17790||2|0||0|||0 117424|M01AE0303|Orudis|forðahlk|100|mg|100|stk|1|glas||M01AE03|01.12.2014||R|1|0|0|G|0|SNP|0|0|1|100|XEU|1488|3546|lyfalmen|||1|100|0|66,6700|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||1488||1488|3546||1|0|G|0|||0 117550|N05AH0405|Seroquel Prolong|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|0|0|ASZ|0|0|0|100|SEK|11168|16136|lyfalmen|V0275|4788|1|100|0|12,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||10635||10635|16136||1|0|E|0|||0 117561|N05AH0405|Seroquel Prolong|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|G|0|ASZ|0|0|0|100|SEK|20573|27377|lyfalmen|V0273|5008|1|100|0|50,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||18802||18802|27377||1|0|G|0|||0 117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|1|0|0|G|0|ROA|0|0|0|100|DKK|1407|3435|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche A.S.|Levódópa og dópadekarboxýl­asa­hemill||1407||1407|3435||2|0|G|0|||0 117584|N05AH0405|Seroquel Prolong|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|G|0|ASZ|0|0|0|100|SEK|29528|40621|lyfalmen|V0272|8917|1|100|0|75,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||29528||29528|40621||1|0|G|0|||0 117676|L01DB0107|Caelyx pegylated liposomal|irþ|2|mg/ml|10|ml|1|hgl||L01DB01|01.01.2011||R|0|0|0|0|0|AXT|0|1|0|100|SEK|51071|67868|lyfsjukr|||1|10|0||Vistor hf|Baxter Holding B.V.|Doxórúbicín||51071||51071|67868||1|H|L|0|||0 117929|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA03|01.04.2004||R|0|0|0|0|0|KEL|0|0|0|100|NOK|5212|10059|vetalmen|||0|1200|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||5212||5212|10059||2|0||0|||0 117937|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA03|01.04.2004||R|0|0|0|0|0|KEL|0|0|0|100|XEU|13473|25731|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||13473||13473|25731||2|0||0|||0 118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.05.2008||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1737|3889|lyfalmen|V0278|3781|2|28|0|7,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Olanzapín||1737||1737|3889||1|0|G|0|||0 118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2613|3850|lyfalmen|V0279|3718|2|28|0|14,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Olanzapín||1709||1709|3850||1|0|G|0|||0 118046|N07BC0102|Buvidal|stl|96|mg|0,27|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|0|0|0|CMS|0|1|0|100|DKK|57266|75704|lyfsjukr|||1|0,27|0|45,7143|Vistor hf|Camurus AB|Búprenorfín||57266||57266|75704||1|H|L|1|30|dagar|0 118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.2008||R|1|0|0|G|0|ATE|0|0|0|100|XEU|7840|7659|lyfalmen|V0282|6858|2|56|0|56,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Olanzapín||4476||4476|7659||1|0|G|0|||0 118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1662|3785|lyfalmen|V0283|3785|2|28|0|42,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Olanzapín||1662||1662|3785||1|0|G|0|||0 118153|L02BB0401|Xtandi|filmhtfl|40|mg|112|stk|1|þpakki||L02BB04|01.10.2019||R|1|0|0|0|0|APE|0|1|0|100|XEU|412360|519372|lyfsjukr|||1|112|0|28,0000|Vistor hf|Astellas Phama Europe B.V.|Enzalutamid||412360||412360|519372||1|0|L|0|||0 118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|AGA|0|0|0|100|XEU|15357|22635|lyfalmen|||1|4|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||15357||15357|22635||5|H|0|0|||0 118421|C02AC0201|Intuniv|forðatfl|3|mg|28|stk|1|þpakki||C02AC02|01.10.2020||R|1|1|1|0|0|HPI|0|0|0|100|DKK|11429|17229|lyfalmen|||1|28|0|28,0000|Vistor hf|Shire Pharmaceuticals Ireland Limited|Guanfacine||11429||11429|17229||1|0|E|0|||0 118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|G|0|ATE|0|0|0|100|XEU|8011|8285|lyfalmen|V0280|6858|2|56|0|42,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Olanzapín||4931||4931|8285||1|0|G|0|||0 118575|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|5123|9890|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||5123||5123|9890||2|0||0|||0 118612|A07EC0203|Pentasa Sachet|forðakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|0|0|0|G|0|FER|0|0|0|100|DKK|19901|28890|lyfalmen|||1|150|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||19901||19901|28890||1|0|G|0|||0 118658|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|0|0|BAM|0|0|0|100|SEK|1212|3166|lyfalmen|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||1212||1212|3166||2|H|0|0|||0 118793|C01AA0504|Lanoxin mite|töflur|62,5|mcg|120|stk|1|þpakki||C01AA05|01.12.2010||R|1|0|0|G|0|AEP|0|0|0|100|DKK|465|2138|lyfalmen|||1|120|0|30,0000|Icepharma hf|Aspen Pharma Trading Limited|Digoxín||465||465|2138||2|0|G|0|||0 119394|C07AG0101|Trandate|filmhtfl|100|mg|50|stk|1|glas||C07AG01|01.04.2013||R|1|0|0|G|0|AEP|0|0|0|100|DKK|1370|3384|lyfalmen|||1|50|0|8,3333|Icepharma hf|Aspen Pharma Trading Limited|Labetalól||1370||1370|3384||2|0|G|0|||0 119520|M01AH0503|Coxerit|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|WEH|0|0|1|100|IKR|2326|4457|lyfalmen|V0824|3968|2|28|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||2150||2150|4457||2|0|G|0|||0 119528|D11AX2201|Soolantra|krem|10|mg/g|30|g|1|túpa||D11AX22|01.07.2016||R|0|0|1|0|0|GAN|0|0|0|100|XEU|2953|5562|lyfalmen|||1|30|0||Icepharma hf|Galderma Nordic AB|Ivermectin||2953||2953|5562||2|0|E|0|||0 119710|N03AX1603|Pregabalin Krka|hylki|100|mg|84|stk|1|þpakki||N03AX16|01.01.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|5500|9068|lyfalmen|||2|84|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||5500||5500|9068||2|0|E|0|||0 119825|N05BA1206|Alprazolam Krka|forðatfl|1|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|KRK|0|0|1|100|IKR|1297|3283|lyfalmen|||2|30|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1297||1297|3283||2|0||2|60|mg|0 119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|1|1|1|0|0|RGP|0|1|0|100|DKK|321939|406913|lyfsjukr|||1|30|0|20,0000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Ambrisentanum||321939||321939|406913||1|0|L|0|||0 120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|1|1|1|0|0|RGP|0|1|0|100|DKK|298885|378240|lyfsjukr|||1|30|0|40,0000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Ambrisentanum||298885||298885|378240||1|0|L|0|||0 120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|0|0|0|G|0|CLA|0|0|0|100|XEU|1720|3865|lyfalmen|||1|10|0||Vistor hf|Alcon Nordic A/S|Cýklópentólat||1720||1720|3865||1|0|G|0|||0 120062|L01BA0401|Alimta|irþ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|0|0|0|0|0|NED|0|1|0|100|XEU|37119|50222|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||37119||37119|50222||2|H|L|0|||0 120278|L01XC0204|Rixathon|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.05.2020||R|0|1|0|0|0|HSS|0|1|0|100|DKK|52524|69706|lyfsjukr|||2|20|0||Artasan ehf|Sandoz GmbH|Rítúxímab||52524||52524|69706||1|H|L|0|||0 120768|C10AA0703|Rosuvastatin Krka|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.03.2015||R|1|0|0|0|0|KRK|0|0|0|100|IKR|7679|7898|lyfalmen|V0118|7898|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||4650||4650|7898||2|0|E|0|||0 121104|L01XC1401|Kadcyla|irþ|160|mg|1|hgl|1|pakki||L01XC14|01.06.2014||R|0|1|0|0|0|RRG|0|1|0|100|DKK|401991|506475|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration GmbH|Trastuzumab emtansine||401991||401991|506475||2|H|L|0|||0 121133|C10AA0704|Rosuvastatin Xiromed|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.04.2018||R|0|0|0|0|0|VAL|0|0|0|100|IKR|7410|8242|lyfalmen|||2|100|0|200,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||4900||4900|8242|30.9.2021|2|0|E|0|||0 121164|A02BC0501|Nexium|mixt.kyr|10|mg|28|skpokar|1|pakki|dreifa|A02BC05|01.04.2009||R|0|0|0|0|0|GRH|0|0|1|100|DKK|3730|6632|lyfalmen|||1|28|0|9,3300|Vistor hf|Grünenthal GmbH|Esómeprazól||3730||3730|6632||1|0|E|0|||0 121274|H02AB0901|Solu-Cortef|sts|100|mg|5|hgl|1|pakki|Act-O-Vial|H02AB09|01.02.2021||R|0|0|0|G|0|PLS|0|0|1|100|DKK|2415|4822|lyfalmen|||1|5|0|16,6667|Icepharma hf|Pfizer Aps|Hýdrókortisón||2415||2415|4822||1|0|G|0|||0 121302|N02BA5102|Treo|freyðit|||60|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|MDK|0|0|1|100|DKK|||lyflausa|||0|60|0|10,0000|Icepharma hf|Mylan Denmark ApS|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||2|0||0|||0 121792|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.07.2017||R|0|0|0|0|0|PBV|0|0|0|100|XEU|806|2607|lyfalmen|V1051|2607|1|10|0||Williams & Halls efh|Piramal Critical Care B.V.|Fentanýl||806||806|2607||1|0|0|1|30|dagar|0 121912|L04AX0306|Metojectpen|stl|25|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|3071|5725|lyfalmen|||1|1|0|10,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3071||3071|5725||2|0|G|0|||0 122129|B06AC0501|Takhzyro|stl|300|mg|2|ml|1|áfspr|27Gx13mm áföst nál með hlíf|B06AC05|01.04.2021||R|0|0|1|0|0|HPI|0|1|0|100|DKK|1870331|2332679|lyfsjukr|||1|2|0|14,0187|Vistor hf|Shire Pharmaceuticals Ireland Limited|Lanadelumab||1870331||1870331|2332679||1|0|L|0|||0 122231|C10AA0704|Rosuvastatin Xiromed|filmhtfl|5|mg|98|stk|1|þpakki||C10AA07|01.12.2020||R|0|0|0|0|0|VAL|0|0|0|100|IKR|2190|4512|lyfalmen|V0214|4512|2|98|0|49,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||2190||2190|4512||2|0|E|0|||0 122301|R01AD0802|Nasofan|nefúði|50|mcg/sk|60|skammtar|1|glas||R01AD08|01.05.2014||L|0|0|0|0|0|TSA|0|0|1|100|IKR|||lyflausa|||2|60|0|15,0000|Alvogen|Teva Sweden AB|Flútíkasón|||||||2|0||0|||0 122326|A02BC0404|Rabeprazol Medical Valley|sþ-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.09.2018||R|0|0|0|G|0|VAL|0|0|1|100|IKR|2500|2861|lyfalmen|V0010|2193|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Rabeprazól||990||990|2861||2|0|G|0|||0 122411|QI09AA0701|Ingelvac CircoFLEX|stl|||50|ml|1|hgl|dreifa|QI09AA07|01.12.2010||R|0|0|0|0|0|BIV|0|0|0|100|DKK|9061|15618|vetorma|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Porcine circovirus Type ORF-2 protein||9061||9061|15618||1|0||0|||0 123256|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|þpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|CHP|0|0|0|100|XEU|31280|53914|vetorma|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Prazikvantelum í blöndum||31280||31280|53914||2|0||0|||0 123487|L01BC0603|Ecansya|filmhtfl|500|mg|120|stk|1|þpakki||L01BC06|01.06.2020||R|0|0|1|0|0|KAN|0|0|0|100|IKR|18000|26273|lyfalmen|||2|120|0||Krka Sverige AB|Krka d.d. Novo mesto|Capecitabín||18000||18000|26273||2|0|0|0|||0 123806|C07AA0512|Pranolol|töflur|20|mg|100|stk|1|glas||C07AA05|01.09.2011||R|1|0|0|G|0|ATE|0|0|0|100|XEU|628|2362|lyfalmen|||2|100|0|12,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Própranólól||628||628|2362||1|0|G|0|||0 123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|þpakki||N07XX02|01.05.1998||R|1|0|1|G|0|SMA|0|0|0|100|XEU|30978|42455|lyfalmen|V0579|29710|1|56|0|28,0000|Vistor hf|Sanofi Mature IP|Rílúzól||30978||30978|42455||1|0|G|0|||0 124020|QM01AC0603|Rheumocam|mixtúra|1,5|mg/ml|42|ml|1|plastf||QM01AC06|01.08.2009||R|0|0|0|0|0|CHP|0|0|0|100|XEU|1730|3400|vetalmen|||0|42|0||Icepharma hf|Chanelle Pharmaceuticals|Meloxícam||||1730|3400||2|0||0|||0 124141|A11HA0801|Vedrop|mixtúra|50|mg/ml|60|ml|1|glas||A11HA08|01.07.2017||R|0|0|1|0|0|ECO|0|0|0|100|XEU|34758|47236|lyfalmen|||1|60|0|15,0000|Recordati AB|Recordati Rare Diseases|Tocofersolanum||34758||34758|47236||3|0|E|0|||0 124225|B01AF0102|Rivaroxaban WH|filmhtfl|15|mg|28|stk|1|þpakki||B01AF01|01.02.2021||R|1|1|0|G|0|WEH|0|0|0|100|XEU|8694|13464|lyfalmen|V1035|13464|2|28|0|21,0000|Williams & Halls efh|Williams & Halls ehf|Rivaoxaban||8694||8694|13464||2|0|G|0|||0 124347|R03AC0206|Ventoline|innönddu|200|mcg/sk|60|skammtar|1|stk||R03AC02|01.03.2019||R|0|0|0|G|0|GPH|0|0|1|100|DKK|694|2453|lyfalmen|||1|60|0|15,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||694||694|2453||1|0|G|0|||0 124356|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|36|0|1,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 124870|S01ED5110|Duotrav|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|G|0|NEL|0|0|0|100|DKK|7884|12349|lyfalmen|V0995|5283|1|7,5|0|75,0000|Vistor hf|Novartis Europharm Ltd|Tímólól í blöndum||7884||7884|12349||1|0|G|0|||0 124908|D02AX0001|Oviderm|krem|250|mg/g|500|g|1|túpa|fjölskammtaílát m.dælu|D02AX|01.03.2018||L|0|0|0|G|0|GAB|0|0|0|100|IKR|||lyfalmen|||0|500|0||Vistor hf|Galenica AB|Önnur húðverndandi efni|||||4529||1|0|G|0|||0 125038|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 125125|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2013||R|0|0|1|G|0|AEP|0|0|0|100|IKR|3254|5977|lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma Trading Limited|Melphalan||3254||3254|5977||2|0|G|0|||0 125246|N03AX1214|Gabapentin Alvogen|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.06.2021||R|1|0|0|G|0|POF|0|0|0|100|DKK|12907|19263|lyfalmen|V0256|19263|2|100|0|44,4400|Alvogen|Alvogen|Gabapentín||12907||12907|19263||2|0|G|0|||0 125376|B03BA0105|Optovite B12|stl|1000|mcg|2|ml|5|lykjur||B03BA01|01.05.2020||R|0|0|0|G|0|LNA|0|0|1|100|XEU|5850|9550|lyfalmen|||2|10|0|250,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Cyanocobalamin||5850||5850|9550||2|0|G|0|||0 125457|N05AH0411|Quetiapine Teva|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.09.2014||R|1|0|0|G|0|TSA|0|0|0|100|IKR|5524|3356|lyfalmen|V0285|3287|2|100|0|25,0000|Alvogen|Teva Sweden AB|Quetíapín||1350||1350|3356||2|0|G|0|||0 125613|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.01.2019||R|0|1|0|0|0|FEC|0|1|0|100|XEU|1608643|2007213|lyfsjukr|||1|20|0|23,2600|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||1608643||1608643|2007213||2|H|L|0|||0 125713|N06DA0301|Exelon|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.04.2021||R|0|1|0|G|0|NEL|0|0|0|100|DKK|9013|13903|lyfalmen|V0347|13902|1|30|0|14,5300|Vistor hf|Novartis Europharm Ltd|Rívastigmín||9013||9013|13903||1|0|G|0|||0 126390|A10BK0101|Forxiga|filmhtfl|5|mg|28|stk|1|þpakki||A10BK01|01.04.2019||R|1|1|0|G|0|AZE|0|0|0|100|SEK|6622|10612|lyfalmen|||1|28|0|14,0000|Vistor hf|AstraZeneca AB|Dapagliflozin||6622||6622|10612||1|0|G|0|||0 126496|C08CA0105|Amlodipin Bluefish|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.05.2020||R|1|0|0|G|0|BLS|0|0|0|100|XEU|2217|2603|lyfalmen|V0057|2229|2|100|0|200,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Amlódipín||803||803|2603||1|0|G|0|||0 126684|J06BA0208|Privigen|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|CSB|0|1|0|100|SEK|44998|60187|lyfsjukr|||1|50|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||44998||44998|60187||2|H|L|0|||0 126695|J06BA0208|Privigen|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|CSB|0|1|0|100|SEK|89995|117099|lyfsjukr|||1|100|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||89995||89995|117099||2|H|L|0|||0 126707|J06BA0208|Privigen|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|CSB|0|1|0|100|SEK|179991|230370|lyfsjukr|||1|200|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||179991||179991|230370||2|H|L|0|||0 126803|S01LA0501|Eylea|stl|40|mg/ml|1|hgl|1|pakki|lausn|S01LA05|01.10.2013||R|0|1|0|0|0|FIN|0|1|0|100|DKK|121538|157670|lyfsjukr|||1|1|0||Icepharma hf|Bayer AG|Aflibercept||121538||121538|157670||2|H|L|0|||0 126926|B01AF0101|Xarelto|filmhtfl|15|mg|100|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|G|0|FIN|0|0|0|100|DKK|30657|42049|lyfalmen|V0976|42049|1|100|0|75,0000|Icepharma hf|Bayer AG|Rivaoxaban||||30657|42049||2|0|G|0|||0 126949|S01BC1001|Nevanac|augndr|3|mg/ml|3|ml|1|glas||S01BC10|01.02.2014||R|0|0|0|G|0|NEL|0|0|1|100|DKK|3365|6130|lyfalmen|||1|3|0||Vistor hf|Novartis Europharm Ltd|Nepafenak||||3365|6130||1|0|G|0|||0 126955|H02AB0205|Dexametason Abcur|töflur|1|mg|100|stk|1|þpakki||H02AB02|01.08.2016||R|1|0|0|G|0|ABC|0|0|1|100|SEK|7244|11469|lyfalmen|||2|100|0|66,6700|Icepharma hf|Abcur AB|Dexametasón||7244||7244|11469||2|0|G|0|||0 127362|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|100|stk|1|glas||A02BC05|01.02.2015||R|1|0|0|G|0|ATE|0|0|1|100|XEU|3169|4880|lyfalmen|V0011|4880|2|100|0|66,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Esómeprazól||2457||2457|4880||1|0|G|0|||0 127383|R02AA0302|Strepsils med honning og citron|sogtfl|||36|stk|1|þpakki||R02AA03|01.01.2009||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0||0|||0 127403|G04B00001|Lyngonia|filmhtfl|||60|stk|1|þpakki|425,25-519,75 mg|G04B000|01.11.2017||L|0|0|0|0|0|FLO|0|0|0|100|IKR|||lyflausa|||0|60|0||Florealis ehf|Florealis ehf|Dry Bearberry leaf extract|||||||2|0||0|||0 128058|N05AH0301|Zyprexa|húðuðtfl|5|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|1|0|0|0|0|NED|0|0|0|100|XEU|5974|9721|lyfalmen|V0279|3718|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||5974||5974|9721||2|0|E|0|||0 128348|C03AB0102|Centyl mite med kaliumklorid|filmhtfl|||100|stk|1|glas|1,5 mg / 573 mg|C03AB01|01.05.1999||R|1|0|0|G|0|KPA|0|0|0|100|DKK|1484|3540|lyfalmen|||1|100|0|50,0000|Alvogen|Karo Pharma AB|Bendróflúmetíazíð og kalíum||1484||1484|3540||2|0|G|0|||0 128750|L04AA2901|Xeljanz|filmhtfl|10|mg|56|stk|1|þpakki||L04AA29|01.01.2019||R|0|1|1|0|0|PEU|0|1|0|100|DKK|231706|294689|lyfsjukr|||1|56|0|56,0000|Icepharma hf|Pfizer Europe MA EEIG|Tofacitinib||231706||231706|294689||1|0|L|0|||0 129106|N05AH0301|Zyprexa|húðuðtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|1|0|0|G|0|NED|0|0|0|100|XEU|22957|32310|lyfalmen|V0282|6858|1|56|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||22957||22957|32310||2|0|G|0|||0 129152|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|rörlyk|1 innöndunartæki og 1 rörlykja|R03BB04|01.08.2019||R|0|0|0|G|0|BII|0|0|0|100|DKK|4264|7367|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||4264||4264|7367||1|0|G|0|||0 129188|V03AE0204|Sevelamerkarbonat WH|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.03.2016||R|1|0|0|0|0|WEH|0|0|0|100|XEU|17933|14918|lyfalmen|V0680|14780|2|180|0|22,5000|Williams & Halls efh|Williams & Halls ehf|Sevelamer||9750||9750|14918||2|0||0|||0 129289|N06BA0409|Methylphenidate STADA|hylki|60|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.10.2020||R|1|1|0|0|0|ASR|0|0|0|100|IKR|7500|10169|lyfalmen|V0997|9864|2|30|0|60,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||6300||6300|10169||2|0|E|1|30|dagar|0 129668|A02AH0003|Natriumbikarbonat Meda|töflur|1|g|100|stk|1|glas||A02AH|01.08.2005||L|1|0|0|0|0|MEA|0|0|0|100|DKK|||lyfalmen|||0|100|0||Icepharma hf|Meda AB|Natríumhýdrógenkarbonat|||||3435||2|0||0|||0 129817|R03BB0101|Atrovent|lausn|0,25|mg/ml|60|sk-ílát|1|pakki|fyrir eimgjafa|R03BB01|01.04.1989||R|0|0|0|G|0|BOI|0|0|0|100|DKK|3575|6419|lyfalmen|||1|60|0|100,0000|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||3575||3575|6419||1|0|G|0|||0 129860|B01AF0102|Rivaroxaban WH|filmhtfl|20|mg|98|stk|1|þpakki||B01AF01|01.02.2021||R|1|1|0|G|0|WEH|0|0|0|100|XEU|30211|41484|lyfalmen|V0977|41208|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Rivaoxaban||30211||30211|41484||2|0|G|0|||0 129923|N06BA0903|Atomoxetin Medical Valley|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|VAL|0|0|0|100|XEU|10140|3284|lyfalmen|V0812|2940|2|28|0|3,5000|Acare ehf|Medical Valley Invest AB|Atomoxetín||1298||1298|3284||2|0|E|0|||0 129936|N06BA0406|Medikinet CR|hylki|50|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|9929|15164|lyfalmen|||2|30|0|50,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||9929||9929|15164||2|0|E|1|30|dagar|0 130001|N06AB0608|Sertralin WH|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.08.2019||R|0|0|0|G|0|WEH|0|0|0|100|IKR|3423|4251|lyfalmen|V0323|4251|2|100|0|200,0000|Williams & Halls efh|Williams & Halls ehf|Sertralín||2000||2000|4251||2|0|G|0|||0 130242|L04AA4001|Mavenclad|töflur|10|mg|1|stk|1|þpakki||L04AA40|01.11.2018||R|0|1|1|0|0|MRP|0|1|0|100|SEK|311888|394413|lyfsjukr|||1|1|0|29,4118|Icepharma hf|Merck Europe B.V.|Cladribine||311888||311888|394413||2|0|L|0|||0 130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|0|0|0|0|0|MYL|0|0|1|100|DKK|5279|4961|lyfalmen|||2|10|0|20,0000|Icepharma hf|Mylan AB|Adrenalín tartrat||2516||2516|4961||2|0||0|||0 130309|L01AB0102|Busilvex|irþ|6|mg/ml|10|ml|8|hgl||L01AB01|01.06.2016||R|0|0|0|0|0|PFM|0|1|0|100|DKK|332119|419574|lyfsjukr|||1|80|0||Vistor hf|Pierre Fabre Médicament|Búsúlfan||332119||332119|419574||1|H|L|0|||0 130397|QH01CA9301|Suprelorin|vefjalyf|4,7|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|VIR|1|0|0|100|XEU|19596|37348|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||19596||19596|37348||1|0||0|||0 130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|0|0|0|0|0|MYL|0|0|1|100|SEK|1503|3567|lyfalmen|||2|10|0|3,3400|Icepharma hf|Mylan AB|Atrópínsúlfat||1503||1503|3567||2|0||0|||0 130596|N07BA0301|Champix|filmhtfl|||53|stk|1|þpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|0|0|0|0|0|PEU|0|0|1|100|DKK|9792|14976|lyfalmen|V1049|14976|1|53|0|23,7500|Icepharma hf|Pfizer Europe MA EEIG|Vareniclin||||9792|14976||1|0||0|||0 130772|QI10AB0201|Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10AB02|01.05.2009||R|0|0|0|0|0|PHA|0|0|0|100|NOK|41119|66284|veteldis|||0|500|0||Vistor hf|PHARMAQ AS|Aeromónas+Vibrio||||41119|66284||1|0||0|||0 131010|QN01BB0301|Mepidor vet.|stl|20|mg/ml|10|ml|6|hgl|lausn|QN01BB03|01.06.2017||R|0|0|0|0|0|RPG|1|0|0|100|XEU|6719|12918|vetalmen|||0|60|0||Icepharma hf|Richter Pharma AG|Mepivacaine||6719||6719|12918||2|0||0|||0 131136|C01CA2601|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||C01CA26|01.06.2009||R|0|0|0|0|0|MYL|0|0|0|100|SEK|4701|7551|lyfalmen|||2|10|0|10,0000|Icepharma hf|Mylan AB|Efedrínhýdróklóríð||4398||4398|7551||2|0||0|||0 131620|C08CA0107|Amlodipine Vitabalans|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.08.2020||R|1|0|0|G|0|VIB|0|0|0|100|IKR|2050|2461|lyfalmen|V0057|2229|2|100|0|200,0000|LYFIS ehf|Vitabalans Oy|Amlódipín||700||700|2461||2|0|G|0|||0 132106|H05BX0107|Cinacalcet STADA|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.12.2020||R|1|0|0|0|0|ASR|0|0|0|100|IKR|15128|8242|lyfalmen|V0720|8242|2|28|0|14,0000|LYFIS ehf|STADA Arzneimittel AG|Cinacalcet||4900||4900|8242||2|0||0|||0 132322|A02BC0404|Rabeprazol Medical Valley|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.09.2018||R|0|0|0|0|0|VAL|0|0|1|100|XEU|1140|2178|lyfalmen|V0003|2178|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Rabeprazól||494||494|2178||2|0||0|||0 132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|1|0|0|G|0|ATE|0|0|0|100|IKR|5076|5765|lyfalmen|V0581|5765|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||3100||3100|5765|||0|G|0|||0 132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|1|0|0|G|0|ATE|0|0|0|100|IKR|3156|5159|lyfalmen|V0580|5159|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||2660||2660|5159|||0|G|0|||0 132488|L01XC1201|ADCETRIS|irþ|50|mg|1|hgl|1|pakki||L01XC12|01.08.2016||R|0|0|0|0|0|TPA|0|1|0|100|DKK|397053|500334|lyfsjukr|||1|1|0||Vistor hf|Takeda Pharma A/S|Brentuximabum vedotinum||397053||397053|500334||1|H|L|0|||0 132546|A06AX0401|Constella|hylki|290|mcg|28|stk|1|glas||A06AX04|01.05.2013||R|0|0|0|G|0|AGC|0|0|0|100|XEU|8823|13642|lyfalmen|||1|28|0|28,0000|Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ltd.|Linaclotídum||8823||8823|13642||1|0|G|0|||0 132554|L04AD0205|Advagraf (Lyfjaver)|forðahlk|1|mg|50|stk|1|stsk.þ||L04AD02|01.06.2021||R|0|0|1|G|0|LVR|0|0|0|100|XEU|15096|22276|lyfalmen|V1044|22276|3|50|0|10,0000|Lyfjaver ehf|Lyfjaver ehf|Tacrolimus||15096||15096|22276||3|0|G|0|||0 132633|D11AH0501|Dupixent|stl|300|mg|2|áf.spr|1|pakki|með nálarhlíf|D11AH05|01.08.2019||R|0|0|1|0|0|SGB|0|1|0|100|XEU|178863|228967|lyfsjukr|||1|2|0|28,0374|Vistor hf|Sanofi-aventis groupe|Dupilumab||178863||178863|228967||1|0|L|0|||0 132635|C09DA0108|Losartan/Hydrochlorothiazide Medical Val|filmhtfl|125|mg|98|stk|1|þpakki|100 + 25 mg|C09DA01|01.02.2017||R|1|0|0|G|0|VAL|0|0|0|100|IKR|2364|3631|lyfalmen|V0089|3631|2|98|0|100,0000|Acare ehf|Medical Valley Invest AB|Lósartan og þvagræsilyf||1550||1550|3631||2|0|G|0|||0 132663|N06BA0402|Concerta|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|1|1|0|0|0|JAS|0|0|0|100|SEK|4814|8124|lyfalmen|V0681|7466|1|30|0|27,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||4814||4814|8124||1|0|E|1|30|dagar|0 132717|QN05CM9204|Nerfasin vet.|stl|100|mg/ml|50|ml|1|hgl|fyrir nautgripi og hesta|QN05CM92|01.07.2013||R|0|0|0|0|0|BVL|1|0|0|100|XEU|6266|12058|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet B.V.|Xylazinum||||6266|12058||2|0||0|||0 132748|N06AX1610|Venlafaxine Bluefish|forðahlk|150|mg|100|stk|1|þpakki|hart|N06AX16|01.05.2015||R|1|0|0|G|0|BLS|0|0|0|100|XEU|4493|4008|lyfalmen|V0335|2598|2|100|0|150,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1824||1824|4008||1|0|G|0|||0 132761|D08AG0201|Betadine|húðlausn|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|0|0|0|0|0|MUP|0|0|0|100|IKR|||lyflausa|||0|8|0||Icepharma hf|Mundipharma A/S|Joð/pólývídón|||||||2|0||0|||0 132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|0|0|0|0|0|CLA|0|0|0|100|XEU|429|2088|lyfalmen|||1|15|0||Vistor hf|Alcon Nordic A/S|Proxýmetakaín||429||429|2088||1|0||0|||0 132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|0|0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa|||0|100|0|3,0000|Vistor hf|Abigo Medical AB|Lyfjakol|||||||1|0||0|||0 133101|M01AH0108|Celecoxib Medical|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.05.2018||R|1|0|0|G|0|DIC|0|0|1|100|IKR|1323|3319|lyfalmen|V0037|3319|2|20|0|20,0000|LYFIS ehf|Medical ehf|Celekoxíb||1323||1323|3319||2|0|G|0|||0 133384|B05ZB0002|Phoxilium|blóð.sk|1,2|mmól/l|5000|ml|2|pokar|Blóðsk.- blóðsíunarlausn|B05ZB|01.10.2017||R|0|0|0|0|0|BMH|0|0|0|100|SEK|5529|9108|lyfalmen|||1|10000|0||Baxter Medical AB|Baxter Holding B.V.|Blóðsölt og stuðpúðalausn||5529||5529|9108||2|H|0|0|||0 133974|N06AX1610|Venlafaxine Bluefish|forðahlk|37,5|mg|30|stk|1|þpakki|hart|N06AX16|01.04.2014||R|1|0|0|0|0|BLS|0|0|0|100|XEU|1316|3309|lyfalmen|V0333|3204|2|30|0|11,2500|Artasan ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1316||1316|3309||1|0|E|0|||0 134067|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.06.2019||R|0|0|1|G|0|AZA|0|0|0|100|SEK|48811|63620|lyfalmen|V0451|53920|1|1|0|83,7209|Vistor hf|AstraZeneca AB|Góserelín||47712||47712|63620||1|0|G|0|||0 134352|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|30|sk-hyl||S01EE05|01.03.2010||R|0|0|0|G|0|SAO|0|0|0|100|XEU|2833|5397|lyfalmen|||1|9|0|30,0000|Icepharma hf|Santen Oy|Taflúprost||2833||2833|5397||2|0|G|0|||0 134374|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|90|sk-hyl||S01EE05|01.06.2010||R|0|0|0|G|0|SAO|0|0|0|100|XEU|7202|11411|lyfalmen|||1|27|0|90,0000|Icepharma hf|Santen Oy|Taflúprost||7202||7202|11411||2|0|G|0|||0 134642|J05AE0801|Reyataz|hylki|300|mg|30|stk|1|plglas||J05AE08|01.01.2010||R|1|0|1|0|0|BRS|0|1|0|100|DKK|57025|75399|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||57025||57025|75399||1|0|L|0|||0 134862|J05AR0601|Atripla|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|0|0|1|0|0|GAD|0|1|0|100|DKK|101076|132221|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland UC|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||101076||101076|132221||2|0|L|0|||0 135062|C09CA0306|Valsartan Krka|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.08.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|3912|3838|lyfalmen|V0678|3563|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Valsartan||1700||1700|3838||2|0|G|0|||0 135084|C09CA0306|Valsartan Krka|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.08.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|5538|4251|lyfalmen|V0679|3904|2|98|0|196,0000|LYFIS ehf|Krka Sverige AB|Valsartan||2000||2000|4251||2|0|G|0|||0 135216|A10AE0406|Toujeo [SoloStar]|stl|300|ein/ml|1,5|ml|5|pennar|áfylltir lyfjapennar|A10AE04|01.10.2015||R|0|1|0|G|0|SDH|0|0|0|100|XEU|9666|14802|lyfalmen|||1|7,5|0|56,2500|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||9666||9666|14802||1|0|G|0|||0 135253|A10BB0906|Gliclazíð Krka|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.04.2019||R|1|0|0|G|0|KRK|0|0|0|100|IKR|3500|5008|lyfalmen|V0020|3502|2|90|0|45,0000|LYFIS ehf|Krka Sverige AB|Glíklazíð||2550||2550|5008||2|0|G|0|||0 135264|A10BB0906|Gliclazíð Krka|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.04.2019||R|1|0|0|G|0|KRK|0|0|0|100|IKR|4800|7004|lyfalmen|V0020|7004|2|180|0|90,0000|LYFIS ehf|Krka Sverige AB|Glíklazíð||4000||4000|7004||2|0|G|0|||0 135384|R03BA0501|Flixotide|innönddu|500|mcg/sk|60|skammtar|1|sk-ílá|Fjölskammtaílát|R03BA05|01.09.2019||R|0|0|0|G|0|GPH|0|0|0|100|DKK|4277|7385|lyfalmen|||1|60|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||4277||4277|7385||1|0|G|0|||0 135434|R03BA0501|Flixotide|innönddu|100|mcg/sk|60|skammtar|1|pakki|fjölskammtaílát|R03BA05|01.07.1995||R|0|0|0|G|0|GPH|0|0|0|100|DKK|1214|3169|lyfalmen|||1|60|0|10,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||1214||1214|3169||1|0|G|0|||0 135498|G04CB0202|Dutasteride Medical Valley|hylki|0,5|mg|30|stk|1|þpakki|hylki mjúk|G04CB02|01.09.2017||R|1|0|0|G|0|VAL|0|0|0|100|DKK|2245|2804|lyfalmen|V0909|2804|2|30|0|30,0000|Acare ehf|Medical Valley Invest AB|Dútasteríð||949||949|2804||2|0|G|0|||0 135533|R03AC1201|Serevent|innönddu|50|mcg/sk|60|skammtar|1|innö.t||R03AC12|01.10.2019||R|0|0|0|G|0|GPH|0|0|1|100|DKK|2776|5319|lyfalmen|||1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról||2776||2776|5319||1|0|G|0|||0 136121|B06AC0101|Cinryze|sts|500|ae|2|hgl|1|pakki|2 hgl m 5 ml leysi + 2 millist|B06AC01|01.03.2019||R|0|1|1|0|0|SSE|0|1|0|100|DKK|197977|252739|lyfsjukr|||1|2|0|0,7143|Shire Services BVBA|Shire Services BVBA|C1 hemill||197977||197977|252739||1|0|L|0|||0 136180|M05BA0306|Pamidronatdinatrium Pfizer|irþ|3|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.02.2019||R|0|1|0|0|0|PLS|0|0|0|100|DKK|5963|9705|lyfalmen|||2|10|0|0,5000|Icepharma hf|Pfizer ApS|Pamídrónsýra||5963||5963|9705||1|H|0|0|||0 136181|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.01.2013||R|0|0|1|G|0|PEU|0|0|0|100|DKK|35641|48352|lyfalmen|||1|60|0|20,0000|Icepharma hf|Pfizer Europe MA EEIG|Sirolimus||35641||35641|48352||1|0|G|0|||0 136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|1|0|0|0|0|MEA|0|0|0|100|DKK|8609|13347|lyfalmen|||1|100|0|100,0000|Icepharma hf|Meda AB|Ísóníazíð||8609||8609|13347||2|0||0|||0 136281|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.03.2012||R|0|1|1|0|0|PEU|0|1|0|100|DKK|59369|78364|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Europe MA EEIG|Etanercept||59369||59369|78364||1|0|L|0|||0 136653|N06AX2601|Brintellix|filmhtfl|5|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|LUN|0|0|0|100|DKK|2783|5328|lyfalmen|||1|28|0|14,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||2783||2783|5328||1|0||0|||0 136658|N05BA1206|Alprazolam Krka|forðatfl|0,5|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|KRK|0|0|1|100|IKR|804|2605|lyfalmen|||2|30|0|15,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||804||804|2605||2|0||2|60|mg|0 136953|D06BX0106|Rosazol|krem|10|mg/g|25|g|1|túpa||D06BX01|01.04.2016||L|0|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||2|25|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metrónídazól|||||||1|0||0|||0 137635|N05AH0413|Quetiapin ratiopharm|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|1|0|G|0|TAB|0|0|0|100|IKR|16195|14574|lyfalmen|V0261|11408|2|100|0|100,0000|Alvogen|Teva Pharma B.V.|Quetíapín||9500||9500|14574||2|0|G|0|||0 137665|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|7,5|mg|30|stk|1|þpakki|5+2,5 mg|N02AA55|01.11.2019||R|1|0|0|0|0|GOV|0|0|0|100|DKK|1653|2980|lyfalmen|V1002|2980|2|30|0|2,0000|Alvogen|Alvogen ehf|Oxycodonum í blöndum||1077||1077|2980||2|0|E|1|30|dagar|0 137690|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|þpakki||H03AA01|01.05.2020||R|1|0|0|G|0|MEC|0|0|0|100|SEK|634|2371|lyfalmen|||1|100|0|66,6700|Icepharma hf|Merck AB|Levótýroxínnatríum||634||634|2371||2|0|G|0|||0 137721|L04AA4001|Mavenclad|töflur|10|mg|6|stk|1|þpakki||L04AA40|01.11.2018||R|0|1|1|0|0|MRP|0|1|0|100|SEK|1848888|2306010|lyfsjukr|||1|6|0|176,4706|Icepharma hf|Merck Europe B.V.|Cladribine||1848888||1848888|2306010||2|0|L|0|||0 137883|N05AH0415|Quetiapin Krka|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.04.2018||R|0|1|0|G|0|KRK|0|0|0|100|IKR|6500|7004|lyfalmen|V0273|5008|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Quetíapín||4000||4000|7004||2|0|G|0|||0 138302|N03AX1603|Pregabalin Krka|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.04.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|4824|5613|lyfalmen|V0689|3390|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||2990||2990|5613||2|0|E|0|||0 138318|L04AX0307|Metoject|stl|50|mg/ml|0,35|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|G|0|WIL|0|0|0|100|SEK|2672|5176|lyfalmen|||1|0,35|0|7,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2672||2672|5176||2|0|G|0|||0 138505|J05AP5601|Vosevi|filmhtfl|600|mg|28|stk|1|glas|400/100/100 mg|J05AP56|01.11.2017||R|0|0|1|0|0|GSE|0|1|0|100|DKK|2352171|2931953|lyfsjukr|||1|28|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|sofosbuvir,velpatasvir,voxilaprevir||||2352171|2931953||2|0|L|0|||0 138567|C10AA0509|Atorvastatin Xiromed|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.01.2018||R|1|0|0|G|0|MVX|0|0|0|100|IKR|2500|2806|lyfalmen|V0114|2736|2|100|0|200,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||950||950|2806||2|0|G|0|||0 138603|N07BB0501|Selincro|filmhtfl|18|mg|28|stk|1|þpakki||N07BB05|01.06.2013||R|1|0|0|0|0|LBK|0|0|0|100|DKK|16291|23921|lyfalmen|||1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||16291||16291|23921||1|0||0|||0 138619|L04AX0306|Metojectpen|stl|22,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|3450|6247|lyfalmen|||1|1|0|9,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3450||3450|6247||2|0|G|0|||0 138687|N06BA0407|Metylfenidat Actavis|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|0|0|0|ATE|0|0|0|100|XEU|4884|5675|lyfalmen|V0691|5671|2|30|0|18,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metýlfenídat||3035||3035|5675||1|0|E|1|30|dagar|0 139050|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.01.2012||R|0|0|0|G|0|ATE|0|0|0|100|XEU|2636|4887|lyfalmen|V0373|4887|2|15|0|75,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tímólól í blöndum||2462||2462|4887||1|0|G|0|||0 139604|L04AA3201|Otezla|filmhtfl|30|mg|56|stk|1|þpakki||L04AA32|01.05.2016||R|1|0|1|0|0|AEB|0|1|0|100|XEU|103647|135419|lyfsjukr|||1|56|0|28,0000|Vistor hf|Amgen Europe B.V.|Apremilast||103647||103647|135419||1|0|L|0|||0 139959|N06DA0304|Nimvastid|hylki|4,5|mg|112|stk|1|þpakki||N06DA03|01.04.2018||R|1|0|0|G|0|KNM|0|0|0|100|IKR|27510|38068|lyfalmen|||2|112|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Rívastigmín||27510||27510|38068||2|0|G|0|||0 140013|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.12.2017||R|0|0|0|G|0|CPM|0|0|1|100|DKK|523|2218|lyfalmen|||1|30|0||Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Hýdrókortisón bútýrat||523||523|2218||1|0|G|0|||0 140132|C08CA0107|Amlodipine Vitabalans|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.08.2020||R|1|0|0|G|0|VIB|0|0|0|100|IKR|1267|2461|lyfalmen|V0056|2229|2|100|0|100,0000|LYFIS ehf|Vitabalans Oy|Amlódipín||700||700|2461||2|0|G|0|||0 140191|R06AX2708|Dasergin|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.04.2020||L|1|0|0|0|0|KAN|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Krka Sverige AB|Krka d.d. Novo mesto|Deslóratadín|||||||2|0||0|||0 140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|0|0|0|G|0|BII|0|0|0|100|DKK|990|2861|lyfalmen|V0266|2527|1|30|0|1,5000|Vistor hf|Boehringer Ingelheim International |Pramipexól||990||990|2861||1|0|G|0|||0 140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|0|0|0|0|0|LBK|0|0|0|100|DKK|9162|14108|lyfalmen|||1|10|0|16,6700|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||9162||9162|14108||1|0|0|0|||0 140563|A07DA0201|Dropizol|dropar|10|mg/ml|10|ml|1|dropaí||A07DA02|01.06.2018||R|0|0|0|0|0|ARO|0|0|0|100|DKK|6785|10837|lyfalmen|||2|10|0|1,0000|Pharmanovia A/S|Pharmanovia A/S|opium||6785||6785|10837||2|0|E|1|30|dagar|0 140611|N06BA0408|Methylphenidate Teva|hylki|10|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.11.2019||R|1|1|0|0|0|TVI|0|0|0|100|XEU|3127|5802|lyfalmen|V0958|5802|2|30|0|10,0000|Teva Pharma Iceland ehf|Teva B.V|Metýlfenídat||3127||3127|5802||1|0|E|1|30|dagar|0 140729|QN01AX0001|Finquel, vet|duft|100|%|1000|g|1|fl|baðlausn handa fiskum|QN01AX|01.01.2012||R|0|0|0|0|0|SRR|0|0|0|100|NOK|72511|137738|vetalmen|||0|1000|0||Scan Aqua AS|Scan Aqua AS|Tricaine mesylate||72511||72511|137738||1|0||0|||0 140792|L04AD0205|Advagraf (Lyfjaver)|forðahlk|3|mg|50|stk|1|stsk.þ||L04AD02|01.06.2021||R|0|0|1|G|0|LVR|0|0|0|100|XEU|44961|60140|lyfalmen|V1045|60140|3|50|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Tacrolimus||44961||44961|60140||3|0|G|0|||0 140954|N07BA0103|Nicorette|nefúði|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 141015|J05AR1401|REZOLSTA|filmhtfl|950|mg|30|stk|1|glas|800+150 mg|J05AR14|01.01.2016||R|0|0|1|0|0|JAS|0|1|0|100|SEK|63370|83424|lyfsjukr|||1|30|0||Vistor hf|Janssen-Cilag AB|Darunavir og kóbísistat||63370||63370|83424||1|0|L|0|||0 141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|áfspr||H02AB04|01.04.1994||R|0|0|0|G|0|PLS|0|0|1|100|DKK|1150|3081|lyfalmen|V0413|2845|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1150||1150|3081||1|0|G|0|||0 141063|S01BC1001|Nevanac|augndr|1|mg/ml|5|ml|1|dropaí||S01BC10|01.08.2013||R|0|0|0|G|0|NEL|0|0|1|100|DKK|3015|5648|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Nepafenak||3015||3015|5648||1|0|G|0|||0 141153|R01AB0601|Otrivin Comp|nefúði|1,1|mg/ml|10|ml|1|glas|0,5+0,6 mg/ml|R01AB06|01.05.2013||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Xýlómetazóín og Ípratrópíum|||||||1|0||0|||0 141238|N05CH0104|Melatonin Vitabalans|töflur|3|mg|50|stk|1|þpakki||N05CH01|01.03.2019||R|0|0|0|0|0|LYF|0|0|1|100|IKR|4000|4113|lyfalmen|||2|50|0|75,0000|LYFIS ehf|LYFIS ehf|Melatonin||1900||1900|4113||2|0|0|0|||0 141388|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|FKA|0|0|1|100|DKK|3425|6212|lyfalmen|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||3425||3425|6212||1|0|0|0|||0 141438|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.01.2012||R|0|0|1|G|0|MRP|0|0|0|100|SEK|14296|21175|lyfalmen|||1|0,5|0|4,0000|Icepharma hf|Merck Europe B.V.|Follitrópín alfa||||14296|21175||2|0|G|0|||0 141783|R02AX0103|Strefen Körsbär & Mint|munnhúði|16,2|mg/ml|15|ml|1|glas||R02AX01|01.08.2018||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|15|0||Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Flurbiprofen|||||||1|0||0|||0 141847|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|60|mg|100|stk|1|þpakki|40+20 mg|N02AA55|01.11.2019||R|1|0|0|0|0|GOV|0|0|0|100|DKK|34566|46993|lyfalmen|V1007|46993|2|100|0|53,3333|Alvogen|Alvogen ehf|Oxycodonum í blöndum||34566||34566|46993||2|0|E|1|30|dagar|0 141856|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.06.2015||L|0|0|0|0|0|FKA|0|0|1|100|DKK|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||2558||1|0||0|||0 141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|0|0|0|G|0|BII|0|0|0|100|DKK|6002|9759|lyfalmen|V0267|4347|1|100|0|10,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||6002||6002|9759||1|0|G|0|||0 142034|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.07.2012||R|1|0|0|G|0|MYL|0|0|1|100|SEK|1621|3729|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Naproxen||1621||1621|3729||2|0|G|0|||0 142123|R07AX0101|INOmax|lyfjagas|800|ppm|2|l|1|gashyl|undir þrýstingi|R07AX01|01.09.2014||R|0|1|0|0|0|LIN|0|0|0|100|XEU|22012|31114|lyfalmen|||1|2|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíð||||22012|31114||5|H|0|0|||0 142177|QP54AA5401|BROADLINE|bl.lausn|||0,3|ml|3|sk-ílá||QP54AA54|01.04.2018||R|0|0|0|0|0|BIV|0|0|0|100|XEU|2559|4411|vetorma|||0|0,9|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Praziquantelum ,Fipronil, s-Methoprene ,Eprinomectinum||2559||2559|4411||1|0||0|||0 142266|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|10|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|G|0|BLS|0|0|1|100|XEU|4031|4701|lyfalmen|V0384|3252|2|10|0|5,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Ondansetrón||2327||2327|4701||1|0|G|0|||0 142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.04.1987||R|1|0|0|G|0|SNP|0|0|0|100|XEU|881|2711|lyfalmen|||1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||881||881|2711||1|0|G|0|||0 142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|1|0|0|0|0|YLA|0|0|1|100|DKK|3169|5860|lyfalmen|||1|100|0|50,0000|Icepharma hf|Mylan ApS|Metenamín||3169||3169|5860||2|0|E|0|||0 142410|H01AX0101|Somavert|sts|15|mg|30|hgl|1|pakki|+30 áf.spr.m.leysi|H01AX01|01.10.2017||R|0|0|1|0|0|PEU|0|1|0|100|DKK|431760|543500|lyfsjukr|||1|30|0|45,0000|Icepharma hf|Pfizer Europe MA EEIG|Pegvisómant||431760||431760|543500||1|0|L|0|||0 142606|N07BC0202|Metadon Abcur|töflur|10|mg|20|stk|1|þpakki||N07BC02|01.04.2020||R|1|0|0|G|0|ABC|0|0|0|100|SEK|1002|2877|lyfalmen|||1|20|0|8,0000|Icepharma hf|Abcur AB|Metadón||1002||1002|2877||2|0|G|1|30|dagar|0 142615|C07AG0205|Carveratio|töflur|6,25|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|G|0|RTH|0|0|0|100|IKR|1544|2599|lyfalmen|V0946|2599|2|100|0|16,6700|Alvogen|ratiopharm GmbH|Carvedílól||800||800|2599||2|0|G|0|||0 142914|C07AB0214|Bloxazoc|forðatfl|100|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|G|0|KNM|0|0|0|100|IKR|2043|2984|lyfalmen|V0049|2910|2|100|0|66,6667|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||1080||1080|2984||2|0|G|0|||0 143139|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||100|ml|50|hgl|fyrir stungulyf|V07AB|01.11.2012||L|0|0|0|0|0|FKA|0|0|1|100|IKR|||lyfalmen|||0|5000|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||16820||1|0||0|||0 143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|0|0|0|0|0|PLS|0|0|0|100|DKK|2146|4452|lyfalmen|||1|1|0|25,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2146||2146|4452||1|H|0|0|||0 143410|N03AX1604|Brieka|hylki|150|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|ATE|0|0|0|100|XEU|8324|4713|lyfalmen|V0687|4664|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Pregabalín||2336||2336|4713||1|0|E|0|||0 143511|J07BC2002|Twinrix Paediatric|stl|||0,5|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|0|0|0|0|0|GBI|0|0|0|100|DKK|4624|7862|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||4624||4624|7862||1|0||0|||0 143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|0|0|0|0|0|CLA|0|0|0|100|XEU|1013|2892|lyfalmen|||1|15|0||Vistor hf|Alcon Nordic A/S|Trópíkamíð||1013||1013|2892|31.8.2021|1|0||0|||0 143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|þpakki||J01FA10|01.11.1998||R|1|0|0|0|0|PLS|0|0|1|100|DKK|1294|3279|lyfalmen|V0173|2676|1|2|0|3,3333|Icepharma hf|Pfizer ApS|Azitrómýcín||1294||1294|3279||1|0|E|0|||0 143609|A10BD0701|Janumet|filmhtfl|900|mg|56|stk|1|þpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|G|0|MBV|0|0|0|100|DKK|4784|8083|lyfalmen|V0387|7091|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Metforminum og sitagliptinum||4784||4784|8083||1|0|G|0|||0 143631|A10BD0701|Janumet|filmhtfl|1050|mg|56|stk|1|þpakki|50/1000mg|A10BD07|01.03.2009||R|1|0|0|G|0|MBV|0|0|0|100|DKK|4688|7950|lyfalmen|V0386|6907|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Metforminum og sitagliptinum||4688||4688|7950||1|0|G|0|||0 143800|N05AN0101|Litarex|forðatfl|6|mmól|100|stk|1|glas||N05AN01|01.04.1974||R|1|0|0|G|0|ATE|0|0|0|100|DKK|2777|5320|lyfalmen|||2|100|0|25,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Litíum||2777||2777|5320||1|0|G|0|||0 143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.11.1998||R|1|0|0|0|0|PLS|0|0|1|100|DKK|1633|3746|lyfalmen|V0174|2599|1|3|0|5,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1633||1633|3746||1|0|E|0|||0 144419|R03AC1302|Oxis Turbuhaler|innönddu|9|mcg/sk|60|skammtar|1|stauk||R03AC13|01.01.2016||R|0|0|0|G|0|AZD|0|0|1|100|SEK|3913|6884|lyfalmen|||1|60|0|22,5000|Vistor hf|AstraZeneca A/S DK|Formóteról||3913||3913|6884||1|0|G|0|||0 144490|N07XX0801|Vyndaqel|hylki|61|mg|30|stk|1|stsk.þ||N07XX08|01.10.2020||R|0|1|1|0|0|PEU|0|1|0|100|DKK|1386097|1730428|lyfsjukr|||1|30|0|91,5000|Icepharma hf|Pfizer Europe MA EEIG|Tafamidis||1386097||1386097|1730428||1|0|L|0|||0 144498|N02AA0506|Oxikodon Depot Actavis|forðatfl|40|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|0|G|0|ATE|0|0|0|100|XEU|9144|13785|lyfalmen|V0587|13785|2|98|0|52,2700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||8927||8927|13785||1|0|G|1|30|dagar|0 144940|C07AB0706|Bisoprolol Medical Valley|filmhtfl|5|mg|105|stk|1|glas||C07AB07|01.02.2021||R|1|0|0|G|0|VAL|0|0|0|100|XEU|1271|3247|lyfalmen|V1038|3247|2|105|0|52,5000|Acare ehf|Medical Valley Invest AB|bisoprolol||1271||1271|3247||2|0|G|0|||0 144964|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|tfílát||N05BA02|01.04.2020||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1373|3388|lyfalmen|||2|24|0|8,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klórdíazepoxíð||1373||1373|3388||1|0||2|50|töflur|0 144980|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|tfílát||N05BA02|01.04.2021||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1138|3064|lyfalmen|||2|24|0|20,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klórdíazepoxíð||1138||1138|3064||1|0||2|25|töflur|0 145077|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.06.2011||R|0|0|0|0|0|JAN|0|1|0|100|DKK|76851|100475|lyfsjukr|||1|1|0|26,6700|Vistor hf|Janssen Biologics B.V.|Infliximab||76851||76851|100475||1|H|L|0|||0 145158|D11AH0101|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AH01|01.08.2017||R|0|0|0|G|0|OEL|0|0|1|100|DKK|4522|7722|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Takrólímus||||4522|7722||1|0|G|0|||0 145440|QG04CX9001|Ypozane|töflur|1,875|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|VIR|0|0|0|100|XEU|4466|8643|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||4466||4466|8643||1|0||0|||0 145451|QG04CX9001|Ypozane|töflur|3,75|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|VIR|0|0|0|100|XEU|6037|11624|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||6037||6037|11624||1|0||0|||0 145479|L04AX0402|Lenalidomid Alvogen|hylki|15|mg|21|stk|1|þpakki|hart|L04AX04|01.04.2019||R|1|1|1|0|0|ALO|0|1|0|100|XEU|654091|806205|lyfsjukr|||2|21|0|31,5000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Lenalídómíd||642985||642985|806205||2|0|L|0|||0 145545|D07AD0101|Dermovat|krem|0,5|mg/g|30|g|1|túpa||D07AD01|01.12.2017||R|0|0|0|G|0|GPH|0|0|1|100|DKK|484|2164|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||484||484|2164||1|0|G|0|||0 145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|þpakki||P02CX01|01.12.1972||L|1|0|0|0|0|MEA|0|0|0|100|DKK|||lyflausa|||0|8|0|1,1400|Icepharma hf|Meda AB|Pýrvín|||||||2|0||0|||0 145616|QG04CX9001|Ypozane|töflur|7,5|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|VIR|0|0|0|100|XEU|7343|14102|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||7343||7343|14102||1|0||0|||0 145627|QG04CX9001|Ypozane|töflur|15|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|VIR|0|0|0|100|XEU|8790|16847|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||8790||8790|16847||1|0||0|||0 145648|B05BB0121|Plasmalyte|irl|||500|ml|20|pokar|lausn|B05BB01|01.09.2015||R|0|0|0|0|0|BAM|0|0|1|100|SEK|6815|10878|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||6815||6815|10878||2|0|0|0|||0 145691|L03AA1302|Pelgraz|stl|6|mg/spr|0,6|ml|1|spr|áföst nál með nálavörn|L03AA13|01.03.2019||R|0|0|1|0|0|CLU|0|1|0|100|XEU|108711|141717|lyfsjukr|||2|0,6|0|20,0000|Artasan ehf|Accord Healthcare S.L.U.|Pegfilgrastím||108711||108711|141717||1|0|L|0|||0 145806|B03AC0005|Ferinject|irl|50|mg/ml|10|ml|1|hgl||B03AC|01.06.2014||R|0|1|0|G|0|VIF|0|0|1|100|CHF|25079|34994|lyfalmen|||1|10|0|5,0000|Vistor hf|Vifor France SA|Járn, stungulyf||25079||25079|34994||1|0|G|0|||0 146082|L04AA2601|Benlysta|irs|120|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|0|0|RGP|0|1|0|100|DKK|21527|30501|lyfsjukr|||1|1|0|4,8000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Belimumab||21527||21527|30501||1|H|L|0|||0 146428|L04AD0205|Advagraf (Lyfjaver)|forðahlk|5|mg|50|stk|1|þpakki||L04AD02|01.06.2021||R|0|0|1|G|0|LVR|0|0|0|100|XEU|70285|92170|lyfalmen|V1046|92170|3|50|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Tacrolimus||70285||70285|92170||3|0|G|0|||0 146473|N06BA0901|Strattera|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.01.2010||R|1|1|0|0|0|DAN|0|0|0|100|XEU|16878|24729|lyfalmen|V0817|3068|1|28|0|28,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||16878||16878|24729||2|0|E|0|||0 146494|G04BD0806|Solifenacin Mylan|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.07.2019||R|1|0|0|G|0|MYL|0|0|0|100|DKK|14091|11408|lyfalmen|V0441|11408|2|90|0|180,0000|Icepharma hf|Mylan AB|Sólífenacín||7200||7200|11408||2|0|G|0|||0 146529|B06AC0201|Firazyr|stl|30|mg|3|ml|1|áfspr|+ ein nál|B06AC02|01.05.2020||R|0|0|1|0|0|HPI|0|1|0|100|DKK|244611|310739|lyfsjukr|||1|3|0|1,0000|Vistor hf|Shire Pharmaceuticals Ireland Limited|Icatibant ||244611||244611|310739||1|0|L|0|||0 146751|N06BA0903|Atomoxetin Medical Valley|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.11.2019||R|1|1|0|0|0|VAL|0|0|0|100|XEU|10140|3284|lyfalmen|V0815|2940|2|28|0|14,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||1298||1298|3284||2|0|E|0|||0 146812|N05AE0403|Ziprasidon Actavis|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.08.2020||R|1|0|0|G|0|ATE|0|0|0|100|XEU|15347|13389|lyfalmen|||2|56|0|42,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ziprasidon||8639||8639|13389||1|0|G|0|||0 146827|C10AA0509|Atorvastatin Xiromed|filmhtfl|40|mg|105|stk|1|glas||C10AA05|01.08.2021||R|1|0|0|G|0|MVX|0|0|0|100|IKR|2100|2873|lyfalmen|V0114|2873|2|105|0|210,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||999||999|2873||2|0|G|0|||0 147365|G04BD1202|Betmiga (Lyfjaver)|forðatfl|25|mg|90|stk|1|þpakki||G04BD12|01.01.2021||R|1|0|0|G|0|LVR|0|0|0|100|XEU|15586|22950|lyfalmen|V1031|22950|3|90|0|45,0000|Lyfjaver ehf|Lyfjaver ehf|Mírabegrón||15586||15586|22950||3|0|G|0|||0 147481|N06AB0608|Sertralin WH|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.08.2019||R|0|0|0|G|0|WEH|0|0|0|100|IKR|1825|2971|lyfalmen|V0322|2971|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Sertralín||1070||1070|2971||2|0|G|0|||0 147578|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||20|ml|20|plastl|fyrir stungulyf|V07AB|01.06.2015||L|0|0|0|0|0|FKA|0|0|1|100|IKR|||lyfalmen|||0|400|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3370||1|0||0|||0 147605|J01CF0104|Dicloxacillin Bluefish|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.01.2017||R|0|0|0|0|0|BLS|0|0|1|100|XEU|1665|3790|lyfalmen|||2|30|0|3,7500|Artasan ehf|Bluefish Pharmaceuticals AB|Díkloxacillín||1665||1665|3790||1|0|E|0|||0 147788|N03AX1603|Pregabalin Krka|hylki|150|mg|100|stk|1|glas||N03AX16|01.04.2017||R|1|0|0|0|0|KNM|0|0|0|100|IKR|6431|5311|lyfalmen|V0687|4664|2|100|0|50,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||2770||2770|5311||2|0|E|0|||0 147902|L01EX0801|Lenvima|hylki|10|mg|30|stk|1|þpakki||L01EX08|01.12.2018||R|0|0|1|0|0|SIE|0|1|0|100|SEK|233942|297470|lyfsjukr|||1|30|0||Eisai AB|Eisai GmbH|Lenvatinib||233942||233942|297470||1|0|L|0|||0 147931|D11AX1802|Solaraze 3%|hlaup|3|% w/w|100|g|1|túpa||D11AX18|01.01.2020||R|0|0|0|0|0|ALM|0|0|0|100|XEU|15494|22824|lyfalmen|||1|100|0||Vistor hf|Almirall S.A.|Önnur húðlyf-Diclofenacum||15494||15494|22824||1|0|E|0|||0 148087|J01DD0402|Ceftriaxona Normon|irs|2000|mg|50|stk|1|hgl|lausn|J01DD04|01.06.2018||R|0|0|0|0|0|LNA|0|0|1|100|XEU|151334|194728|lyfalmen|||2|50|0|50,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftríaxón||||151334|194728||2|0|0|0|||0 148170|J05AE1003|Darunavir Medical Valley|filmhtfl|600|mg|60|stk|1|glas||J05AE10|01.06.2020||R|1|0|1|0|0|VAL|0|1|0|100|XEU|14417|21341|lyfsjukr|||2|60|0|30,0000|Acare ehf|Medical Valley Invest AB|Darunavír||14417||14417|21341||2|0|L|0|||0 148213|R05CB1301|Pulmozyme|innúðal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|0|0|1|0|0|ROA|0|0|0|100|DKK|94749|123112|lyfalmen|||1|75|0|30,0000|Icepharma hf|Roche A.S.|Dornase alfa||94749||94749|123112||2|0||0|||0 148263|J01CA0802|Penomax|filmhtfl|200|mg|20|stk|1|þpakki||J01CA08|01.09.2012||R|0|0|0|0|0|COR|0|0|1|100|DKK|1144|2796|lyfalmen|V0577|2796|2|20|0|6,6667|Vistor hf|Orion Corporation|Pívmecillínam||943||943|2796||1|0|E|0|||0 148266|QI01AN0101|Evalon|innúðal|||5000|skammtar|1|hgl|+250ml af HipramuneT(leysir)|QI01AN01|01.04.2019||R|0|0|0|0|0|LHS|0|0|0|100|IKR|104840|180702|vetorma|||0|5000|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Coccidia||104840||104840|180702||2|0|0|0|||0 148274|J01CA0802|Penomax|filmhtfl|200|mg|30|stk|1|þpakki||J01CA08|01.09.2012||R|0|0|0|0|0|COR|0|0|1|100|DKK|1702|3841|lyfalmen|||2|30|0|10,0000|Vistor hf|Orion Corporation|Pívmecillínam||1702||1702|3841||1|0|E|0|||0 148285|J01CA0802|Penomax|filmhtfl|200|mg|100|stk|1|glas||J01CA08|01.09.2012||R|0|0|0|0|0|COR|0|0|1|100|DKK|5851|9164|lyfalmen|||2|100|0|33,3300|Vistor hf|Orion Corporation|Pívmecillínam||5570||5570|9164||1|0|E|0|||0 148363|D11AH0401|Toctino|hylki|10|mg|30|stk|1|þpakki|mjúk|D11AH04|01.03.2012||R|0|1|1|0|0|STG|0|0|0|100|DKK|58626|77424|lyfalmen|||1|30|0|15,0000|Vistor hf|Stiefel Laboratories L.(Ireland) Ltd.|Alítretínóín||58626||58626|77424||1|0|E|0|||0 148374|D11AH0401|Toctino|hylki|30|mg|30|stk|1|þpakki|mjúk|D11AH04|01.03.2012||R|0|1|1|0|0|STG|0|0|0|100|DKK|58626|77424|lyfalmen|||1|30|0|45,0000|Vistor hf|Stiefel Laboratories L.(Ireland) Ltd.|Alítretínóín||58626||58626|77424||1|0|E|0|||0 148411|C03CA0110|Impugan|töflur|40|mg|100|stk|1|glas||C03CA01|01.08.2013||R|1|0|0|G|0|ATE|0|0|0|100|SEK|540|2102|lyfalmen|V0601|2102|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fúrósemíð||439||439|2102||1|0|G|0|||0 148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|þpakki||N04AA02|01.11.2005||R|1|0|0|G|0|LFS|0|0|0|100|DKK|942|2794|lyfalmen|||1|100|0|20,0000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||942||942|2794||1|0|G|0|||0 148642|N01AX6301|Livopan|lyfjagas|||5|l|1|hylki|50% + 50%|N01AX63|01.05.2012||R|0|0|0|0|0|AGA|0|0|0|100|XEU|92515|120287|lyfalmen|||1|5|0||Ísaga ehf|AGA AB|Tvínituroxíð og súrefni||92515||92515|120287||5|H|0|0|||0 148780|J01DH0205|Meropenem WH|sts/irs|500|mg/hgl|10|hgl|1|pakki|lausn|J01DH02|01.06.2019||R|0|0|0|0|0|WEH|0|0|1|100|XEU|13148|15156|lyfalmen|||2|10|0|1,6667|Williams & Halls efh|Williams & Halls ehf|Meropenem||9581||9923|15156|31.8.2021|2|0|0|0|||0 148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|0|0|0|0|0|BAN|1|0|0|100|DKK|3445|6706|vetalmen|||0|25|0||Icepharma hf|Bayer Animal Health GmbH|Xylazinum||3445||3445|6706||2|0||0|||0 149203|R03AC0206|Ventoline|innúðal|0,1|mg/sk|200|skammtar|1|úðaílá|dreifa|R03AC02|01.04.2019||R|0|0|0|G|0|GPH|0|0|1|100|DKK|445|2110|lyfalmen|||1|200|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||445||445|2110||1|0|G|0|||0 149240|A02BX1301|Gaviscon|mixtúra|||400|ml|1|glas||A02BX13|01.06.2019||L|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|400|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||4121||1|0||0|||0 149279|L01XC2401|Darzalex|irþ|20|mg/ml|20|ml|1|hgl|lausn|L01XC24|01.06.2017||R|0|1|0|0|0|JCI|0|1|0|100|SEK|268501|340451|lyfsjukr|||1|20|0||Vistor hf|Janssen-Cilag International N.V.|Daratumumab||268501||268501|340451||1|H|L|0|||0 149624|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Kabipac|B05BB01|01.11.2015|31.07.2021|R|0|0|0|0|0|FKA|0|0|1|100|DKK|2282|4639|lyfalmen|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||2282||2282|4639||1|0|0|0|||0 149908|J02AC0303|Vortil|irs|200|mg|1|hgl|1|pakki|lausn|J02AC03|01.10.2017||R|0|0|0|0|0|WEH|0|0|0|100|XEU|14521|21485|lyfalmen|||2|1|0|0,5000|Williams & Halls efh|Williams & Halls ehf|Voricónazól||14521||14521|21485||2|H|0|0|||0 150005|N05AE0403|Ziprasidon Actavis|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.11.2020||R|1|0|0|G|0|ATE|0|0|0|100|XEU|13271|14045|lyfalmen|||2|56|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ziprasidon||9116||9116|14045||1|0|G|0|||0 150162|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.01.2013||L|0|0|0|G|0|TEA|0|0|0|100|SEK|||lyfalmen|||1|24|0||Vistor hf|Laboratories THEA|Ketotifen|||||7470||1|0|G|0|||0 150281|N03AX1408|Levetiracetam STADA|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.08.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|4613|6591|lyfalmen|V0253|4878|2|100|0|33,3300|LYFIS ehf|STADA Arzneimittel AG|Levetíracetam||3700||3700|6591||2|0|G|0|||0 150448|L01XG0201|Kyprolis|irs|60|mg|1|hgl|1|pakki||L01XG02|01.10.2016||R|0|0|0|0|0|AEB|0|1|0|100|DKK|160365|205960|lyfsjukr|||1|1|0||Vistor hf|Amgen Europe B.V.|Carfilzomib||160365||160365|205960||1|H|L|0|||0 150498|B01AC2202|Prasugrel Krka|filmhtfl|5|mg|30|stk|1|þpakki||B01AC22|01.04.2019||R|0|1|0|G|0|KAN|0|0|0|100|IKR|6577|10551|lyfalmen|V0805|10551|2|30|0|15,0000|Krka Sverige AB|Krka d.d. Novo mesto|Prasugrel||6577||6577|10551||2|0|G|0|||0 150521|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|0|RAG|0|1|0|100|DKK|38524|51999|lyfsjukr|||1|1,6|0|35,5600|Vistor hf|Amgen|Darbepóetín alfa||||38524|51999||1|0|L|0|||0 151037|N06DX0109|Marbodin|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|G|0|ASR|0|0|0|100|IKR|4300|5627|lyfalmen|V0607|4840|2|98|0|98,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||3000||3000|5627||2|0|G|0|||0 151060|J01DB0402|Cefazolina Normon|sts|1|g|100|stk|1|hgl|í bláæð|J01DB04|01.06.2018||R|0|0|0|0|0|LNA|0|0|1|100|XEU|43463|55070|lyfalmen|||2|100|0|33,3333|Williams & Halls efh|Laboratorios Normon, S.A.|Cefazólín||40952||40952|55070||2|0|0|0|||0 151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|0|0|0|G|0|LBK|0|0|0|100|DKK|5742|9401|lyfalmen|||1|10|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||5742||5742|9401||1|0|G|0|||0 151207|N07BA0153|Zonnic Pepparmint|munnhúði|1|mg/úðask|200|skammtar|1|glas|1 x 200 úðaskammtar|N07BA01|01.11.2018||L|0|0|0|0|0|NIC|0|0|1|100|IKR|||lyflausa|||0|200|0|6,6667|LYFIS ehf|Niconovum AB|Nikótín|||||||2|0||0|||0 151217|G01AF0102|Flagyl|sk-stíll|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|0|0|0|G|0|SNP|0|0|0|100|XEU|1455|3501|lyfalmen|||1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1455||1455|3501||1|0|G|0|||0 151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.11.2008||R|1|0|0|G|0|LUN|0|0|0|100|DKK|29026|39986|lyfalmen|V0607|4840|1|98|0|98,0000|Vistor hf|H. Lundbeck A/S|Memantín||29026||29026|39986||1|0|G|0|||0 151532|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.04.2014||R|1|0|0|G|0|OHS|0|0|0|100|DKK|402|2051|lyfalmen|V0633|2029|2|100|0|50,0000|Vistor hf|Orifarm Healthcare A/S|Fúrósemíð||402||402|2051||1|0|G|0|||0 151627|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|pakki|lausn,áf.lyfjap.+ spr.nál|G03GA08|01.04.2012||R|0|0|1|G|0|MRP|0|0|0|100|SEK|4131|7184|lyfalmen|||1|0,5|0|1,0000|Icepharma hf|Merck Europe B.V.|Chóríógónadótrópín alfa||||4131|7184||2|0|G|0|||0 151682|N05AX1210|Aripiprazol Medical Valley|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.10.2016||R|1|1|0|G|0|VAL|0|0|0|100|XEU|4977|3422|lyfalmen|V0682|3422|2|56|0|18,6670|Acare ehf|Medical Valley Invest AB|Aripiprazól||1398||1398|3422||2|0|G|0|||0 151737|S01AA2601|Azyter|augndr|15|mg/g|0,25|g|6|sk-ílá||S01AA26|01.04.2016||R|0|0|0|0|0|LTH|0|0|1|100|SEK|1058|2954|lyfalmen|||1|1,5|0||Vistor hf|Laboratoires THEA|azithromycin||1058||1058|2954|31.8.2021|1|0||0|||0 151810|QJ01CE9003|Penethaone vet.|sts|10|m.ae/hgl|1|hgl|1|pakki|+leysir|QJ01CE90|01.03.2016||R|0|0|0|0|0|DIV|0|0|0|100|IKR|1195|2349|vetalmen|||0|1|0||Dýraheilsa ehf|Divasa-Farmavic S.A.|Penetamathýdrójoðíð||||1195|2349||2|0||0|||0 151873|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|þpakki||N02CC01|01.03.2018||R|1|0|0|G|0|BFP|0|0|0|100|XEU|1814|2761|lyfalmen|V0234|1724|2|6|0|12,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||918||918|2761||1|0|G|0|||0 151905|L03AX1302|Remurel|stl|40|mg/ml|12|áf.spr|1|pakki||L03AX13|01.07.2018||R|0|0|1|G|0|ZET|0|0|0|100|XEU|111022|96192|lyfalmen|||2|12|0|24,0000|Alvogen|Zentiva, k.s.|Glatíramer acetat||73465||73465|96192||2|0|G|0|||0 152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|0|0|HES|0|0|0|100|DKK|1678|3808|lyfalmen|||1|5|0|0,4500|Vistor hf|Novartis Healthcare A/S|Baklófen||1678||1678|3808||1|H|0|0|||0 152348|M02AA0702|Felden|hlaup|5|mg/g|25|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|PLS|0|0|1|100|DKK|||lyflausa|||0|25|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1|0||0|||0 152397|R03BA0202|Pulmicort Turbuhaler|innönddu|100|mcg/sk|200|skammtar|1|stauk||R03BA02|01.04.1991||R|0|0|0|G|0|AZD|0|0|0|100|SEK|2680|5187|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2680||2680|5187||1|0|G|0|||0 152408|R03AK1401|Atectura Breezhaler|innönddu|385|mcg/sk|30|stk|1|stsk.þ|125 mcg/260mcg|R03AK14|01.01.2021||R|0|0|0|G|0|NEP|0|0|0|100|DKK|4974|8344|lyfalmen|||1|30|0||Vistor hf|Novartis Europharm Limited|Indacaterol og mometasone||4974||4974|8344||1|0|G|0|||0 152410|N05AH0416|Quetiapin Medical Valley|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.09.2019||R|1|1|0|G|0|VAL|0|0|0|100|IKR|7800|8917|lyfalmen|V0272|8917|2|100|0|75,0000|Acare ehf|Medical Valley Invest AB|Quetíapín||5390||5390|8917||2|0|0|0|||0 152413|R03BA0202|Pulmicort Turbuhaler|innönddu|200|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|G|0|AZD|0|0|0|100|SEK|4300|7416|lyfalmen|||1|200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4300||4300|7416||1|0|G|0|||0 152421|R03BA0202|Pulmicort Turbuhaler|innönddu|400|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|G|0|ASZ|0|0|0|100|SEK|7863|12321|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Búdesóníð||7863||7863|12321||1|0|G|0|||0 152675|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|42|stk|1|þpakki||J05AB11|01.06.2014||R|1|0|0|G|0|BLS|0|0|1|100|XEU|6169|5214|lyfalmen|V0182|5214|2|42|0|7,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Valacíklóvír||2700||2700|5214||1|0|G|0|||0 152687|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|90|stk|1|þpakki||J05AB11|01.06.2014||R|1|0|0|G|0|BLS|0|0|1|100|XEU|6356|9860|lyfalmen|||2|90|0|15,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Valacíklóvír||6075||6075|9860||1|0|G|0|||0 153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cetirizín|||||||1|0||0|||0 153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|0|0|0|0|0|MAR|0|0|1|100|DKK|1468|3518|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Lídókaín í blöndum||1468||1468|3518||2|0||0|||0 153145|N06DA0301|Exelon|forðapl|13,3|mg/sólh|30|pokar|1|pakki||N06DA03|01.04.2021||R|0|1|0|G|0|NEL|0|0|0|100|DKK|16188|23779|lyfalmen|||1|30|0|42,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||16188||16188|23779||1|0|G|0|||0 153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cetirizín|||||||1|0||0|||0 153222|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|0|RAG|0|1|0|100|DKK|29014|39971|lyfsjukr|||1|1,2|0|26,6700|Vistor hf|Amgen|Darbepóetín alfa||||29014|39971||1|0|L|0|||0 153288|R06AE0704|Histasin|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|G|0|ATE|0|0|1|100|XEU|||lyfalmen|V0575|1677|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cetirizín|||||5107||1|0|G|0|||0 153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|0|0|0|0|0|GSE|0|1|0|100|DKK|170482|218543|lyfsjukr|||1|10|0|14,2857|Gilead Sience Sweden AB|Gilead Sciences Ireland|Amfóterícín||170482||170482|218543||2|H|L|0|||0 153417|C07AA0512|Pranolol|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.2011||R|1|0|0|G|0|ATE|0|0|0|100|XEU|820|2627|lyfalmen|||2|100|0|25,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Própranólól||820||820|2627||1|0|G|0|||0 153507|L02BG0602|Exemestan- Actavis|filmhtfl|25|mg|100|stk|1|þpakki||L02BG06|01.08.2011||R|0|0|0|G|0|ATE|0|0|0|100|XEU|37264|50405|lyfalmen|V0452|50405|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Exemestan||37264||37264|50405||1|0|G|0|||0 153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|þpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|JAS|0|0|1|100|SEK|3541|6372|lyfalmen|||1|15|0|7,5000|Vistor hf|Janssen-Cilag AB|Ítracónazól||3541||3541|6372||1|0|E|0|||0 154014|R06AX2705|Desloratadine Teva|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.09.2013||R|1|0|0|G|0|TVA|0|0|1|100|IKR|726|2131|lyfalmen|V0908|2048|2|30|0|30,0000|Alvogen|Teva B.V.|Deslóratadín||460||460|2131||2|0|G|0|||0 154048|L02AE0307|Reseligo|vefjalyf|3,6|mg|1|áf.spr|1|pakki||L02AE03|01.05.2016||R|0|0|1|G|0|ZET|0|0|0|100|SEK|21173|19682|lyfalmen|V0183|19682|2|1|0|27,9070|Alvogen|Zentiva, k.s.|Góserelín||13211||13211|19682||2|0|G|0|||0 154116|S01ED5121|Travoprost/Timolol STADA|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.11.2019||R|0|0|0|G|0|ASR|0|0|0|100|IKR|6978|5352|lyfalmen|V0995|5283|2|7,5|0|75,0000|LYFIS ehf|STADA Arzneimittel AG|Tímólól í blöndum||2800||2800|5352||2|0|G|0|||0 154147|R03AL0801|Trelegy Ellipta|innönddu|||30|skammtar|1|innö.t|92 mcg/55 mcg/22 mcg|R03AL08|01.06.2019||R|0|0|0|G|0|GSD|0|0|0|100|DKK|8367|13014|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline Trading Services Ltd.|Vilanterol, umeclidinium bromide, fluticasone furoate||8367||8367|13014||1|0|G|0|||0 154377|G03CA0325|Estrofem 1 mg|filmhtfl|1|mg|84|stk|1|skífup||G03CA03|01.05.2020||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2166|4479|lyfalmen|V0129|2223|1|84|0|42,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||2166||2166|4479||1|0|G|0|||0 154480|R06AX2201|Kestine|filmhtfl|20|mg|100|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|G|0|APS|0|0|1|100|DKK|||lyfalmen|||1|100|0|200,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||12673||1|0|G|0|||0 154558|N03AX2201|Fycompa|filmhtfl|12|mg|28|stk|1|þpakki||N03AX22|01.02.2020||R|1|0|0|G|0|SIE|0|0|0|100|SEK|20494|29194|lyfalmen|||1|28|0|42,0000|Eisai AB|Eisai GmbH|Perampanel||20494||20494|29194||1|0|G|0|||0 154618|B05BA1021|SmofKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|16927|24796|lyfalmen|||1|3944|0||Vistor hf|Fresenius Kabi AB|Blöndur||16927||16927|24796||1|0|0|0|||0 154629|B05BA1021|SmofKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|19341|28119|lyfalmen|||1|5908|0||Vistor hf|Fresenius Kabi AB|Blöndur||19341||19341|28119||1|0|0|0|||0 154640|B05BA1021|SmofKabiven|irl|2200|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|24195|33875|lyfalmen|||1|7880|0||Vistor hf|Fresenius Kabi AB|Blöndur||24195||24195|33875||1|0|0|0|||0 154651|B05BA1021|SmofKabiven|irl|2700|kcal|2463|ml|3|pokar|fleyti|B05BA10|01.03.2014||R|0|0|0|0|0|FKA|0|0|0|100|DKK|22074|31193|lyfalmen|||1|7389|0||Vistor hf|Fresenius Kabi AB|Blöndur||22074||22074|31193||1|0|0|0|||0 154662|B05BA1022|SmofKabiven Elektrolytfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|22134|31269|lyfalmen|||1|3944|0||Vistor hf|Fresenius Kabi AB|Blöndur||22134||22134|31269||1|0|0|0|||0 154673|B05BA1022|SmofKabiven Elektrolytfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|26825|37202|lyfalmen|||1|5908|0||Vistor hf|Fresenius Kabi AB|Blöndur||26825||26825|37202||1|0|0|0|||0 154706|B05BA1023|SmofKabiven Perifer|irl|800|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|14431|21361|lyfalmen|||1|4824|0||Vistor hf|Fresenius Kabi AB|Blöndur||14431||14431|21361||1|0|0|0|||0 154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|þpakki|0,2+50 mg|M01AB55|01.04.1993||R|1|0|0|G|0|PLS|0|0|1|100|DKK|2890|5476|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||2890||2890|5476||1|0|G|0|||0 154717|B05BA1023|SmofKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|21326|30247|lyfalmen|||1|7616|0||Vistor hf|Fresenius Kabi AB|Blöndur||21326||21326|30247||1|0|0|0|||0 154739|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3325|2766|lyfalmen|V0334|2546|2|98|0|73,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Venlafaxín||921||921|2766||1|0|G|0|||0 154761|N06AX1608|Venlafaxin Actavis|forðahlk|150|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|5827|2764|lyfalmen|V0335|2546|2|98|0|147,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Venlafaxín||920||920|2764||1|0|G|0|||0 155121|L04AA4001|Mavenclad|töflur|10|mg|4|stk|1|þpakki||L04AA40|01.11.2018||R|0|1|1|0|0|MRP|0|1|0|100|SEK|1232592|1539511|lyfsjukr|||1|4|0|117,6471|Icepharma hf|Merck Europe B.V.|Cladribine||1232592||1232592|1539511||2|0|L|0|||0 155219|N03AX1106|Topiramate Alvogen|filmhtfl|25|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|G|0|GOV|0|0|0|100|XEU|1583|3677|lyfalmen|V0247|3677|2|60|0|5,0000|Alvogen|Alvogen ehf|Tópíramat||1583||1583|3677||2|0|G|0|||0 155230|N03AX1106|Topiramate Alvogen|filmhtfl|50|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|G|0|GOV|0|0|0|100|XEU|2959|5107|lyfalmen|V0248|5107|2|60|0|10,0000|Alvogen|Alvogen ehf|Tópíramat||2622||2622|5107||2|0|G|0|||0 155241|N03AX1106|Topiramate Alvogen|filmhtfl|100|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|G|0|GOV|0|0|0|100|XEU|5593|4317|lyfalmen|V0249|4317|2|60|0|20,0000|Alvogen|Alvogen ehf|Tópíramat||2048||2048|4317||2|0|G|0|||0 155246|C10BA0501|Atozet|filmhtfl|30|mg|90|stk|1|þpakki|10 mg + 20 mg|C10BA05|01.03.2015||R|0|0|0|0|0|NVO|0|0|0|100|DKK|16816|24643|lyfalmen|||1|90|0||Vistor hf|N.V. Organon|Atorvastin og ezetimibe||16816||16816|24643||1|0||0|||0 155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|G|0|LBK|0|0|0|100|DKK|1475|3528|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1475||1475|3528||1|0|G|0|||0 155415|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|G|0|GRP|0|0|0|100|XEU|5468|6680|lyfalmen|V0253|4878|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||3765||3765|6680||1|0|G|0|||0 155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|G|0|LBK|0|0|0|100|DKK|636|2373|lyfalmen|||1|100|0|5,0000|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||636||636|2373||1|0|G|0|||0 155478|G03AC0902|Gestrina|filmhtfl|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2013||R|0|0|0|0|0|ATE|0|0|0|100|XEU|1339|2991|lyfalm11|V0590|2955|2|84|0|84,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Desógestrel||1339||1339|2991||1|0||0|||1 155485|L01XK0101|Lynparza|filmhtfl|150|mg|56|stk|1|þpakki||L01XK01|01.03.2020||R|0|0|1|0|0|AZA|0|1|0|100|SEK|364961|460421|lyfsjukr|||1|56|0||Vistor hf|AstraZeneca AB|Olaparib||364961||364961|460421||1|0|L|0|||0 155494|M01AE0113|Ibuxin|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.09.2014||L|1|0|0|0|0|RHG|0|0|1|100|IKR|||lyflausa|||2|30|0|10,0000|Alvogen|ratiopharm GmbH|Íbúprófen|||||||2|0||0|||0 155579|H02AB0908|Plenadren|töflur|5|mg|50|stk|1|glas|með breyttan losunarhraða|H02AB09|01.03.2020||R|1|0|0|0|0|SSE|0|0|1|100|DKK|36331|49225|lyfalmen|||1|50|0|8,3300|Shire Services BVBA|Shire Services BVBA|Hýdrókortisón||36331||36331|49225||1|0|E|0|||0 155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|þpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|JAS|0|0|1|100|SEK|5711|9359|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||5711||5711|9359||1|0|E|0|||0 156066|J05AR0603|Efavirenz/Emtricitabine/Tenofovir Krka|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.06.2020||R|0|0|1|0|0|KAN|0|1|0|100|IKR|59860|78985|lyfsjukr|||2|30|0|30,0000|Krka Sverige AB|Krka d.d. Novo mesto|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||59860||59860|78985||2|0|L|0|||0 156195|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|100|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|G|0|BLS|0|0|1|100|XEU|19427|28237|lyfalmen|V0383|18136|2|100|0|25,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Ondansetrón||19427||19427|28237||1|0|G|0|||0 156427|J02AC0106|Fungyn|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.11.2017||R|1|0|0|0|0|POF|0|0|1|100|IKR|4589|2737|lyfalmen|V0552|2737|2|30|0|7,5000|Alvogen|Alvogen|Flúkónazól||900||900|2737||2|0|E|0|||0 156506|A10AB0405|Humalog KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AB04|01.05.2011||R|0|0|0|G|0|NED|0|0|0|100|XEU|4937|8293|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||4937||4937|8293||2|0|G|0|||0 156517|A10AD0403|Humalog Mix25 KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AD04|01.05.2011||R|0|0|0|G|0|NED|0|0|0|100|XEU|5730|9385|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||5730||5730|9385||2|0|G|0|||0 156528|J01XE0101|Furadantin|töflur|50|mg|15|stk|1|þpakki||J01XE01|01.08.2010||R|1|0|0|0|0|MEA|0|0|1|100|DKK|374|2013|lyfalmen|||2|15|0|3,7500|Icepharma hf|Meda AB|Nítrófúrantóín||374||374|2013||2|0|0|0|||0 156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|þpakki||P02CA01|01.12.1982||R|1|0|0|0|0|CNI|0|0|0|100|SEK|617|2347|lyfalmen|||1|6|0|3,0000|Vistor hf|McNeil Sweden AB|Mebendazól||617||617|2347||1|0||0|||0 156723|QN01AX0303|Ketador vet.|stl|100|mg/ml|50|ml|1|hgl|lausn|QN01AX03|01.04.2013||R|0|0|0|0|0|RPG|1|0|0|100|DKK|7465|13754|vetalmen|||0|50|0||Icepharma hf|Richter Pharma AG|Ketaminum||7160||7160|13754||2|0|0|1|30|dagar|0 157054|N06BA0202|Attentin|töflur|10|mg|30|stk|1|þpakki||N06BA02|01.08.2017||R|1|1|0|0|0|PUT|0|0|0|100|IKR|8684|13451|lyfalmen|||1|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Dexamfetamine ||||8684|13451||2|0|E|1|30|dagar|0 157257|QJ01DB0101|Cefabactin vet.|töflur|50|mg|100|stk|1|þpakki||QJ01DB01|01.03.2018||R|0|0|0|0|0|BVL|0|0|0|100|IKR|2589|5082|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Cefalexin||||2589|5082||2|0||0|||0 157331|QN03AA0201|Phenoleptil|töflur|100|mg|100|stk|1|þpakki|handa hundum|QN03AA02|01.05.2016||R|0|0|0|0|0|BVL|0|0|0|100|IKR|2895|5663|vetalmen|||1|100|0||Dýraheilsa ehf|Le Vet B.V.|Phenobarbitalum||2895||2895|5663||2|0||2|||0 157673|D05AX5205|Calcipotriol/Betamethasone Teva|smyrsli|||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.01.2021||R|0|0|0|G|0|TVI|0|0|0|100|XEU|11264|16457|lyfalmen|V1030|16457|2|120|0||Teva Pharma Iceland ehf|Teva B.V|Kalcípótríól í blöndum||10868||10868|16457||1|0|G|0|||0 157745|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|20|ml|10|áfspr|lausn,áf.spr.|V08CA02|01.10.2017||R|0|0|0|0|0|GEH|0|0|0|100|NOK|62899|82828|lyfalmen|||1|200|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||62899||62899|82828||2|H|0|0|||0 157756|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.12.2015||R|0|0|1|0|0|SAR|0|1|0|100|DKK|34904|45938|lyfsjukr|||1|2,5|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||33732||33732|45938||1|0|L|0|||0 157863|N03AF0104|Tegretol|töflur|200|mg|100|stk|1|þpakki||N03AF01|01.01.2010||R|1|0|0|G|0|HES|0|0|0|100|DKK|1396|3419|lyfalmen|||1|100|0|20,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||1396||1396|3419||1|0|G|0|||0 157869|D11AX1601|Vaniqa|krem|11,5|%|30|g|1|túpa||D11AX16|01.01.2013||R|0|0|0|0|0|ALM|0|0|0|100|DKK|6138|9946|lyfalmen|||1|30|0||Vistor hf|Almirall S.A.|Eflórníthin||6138||6138|9946||1|0||0|||0 157995|J06BA0210|Octagam 10%|irl|100|mg/ml|20|ml|1|hgl||J06BA02|01.07.2021||R|0|0|0|0|1|OCT|0|1|0|100|DKK|23084|32470|lyfsjukr|||1|20|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, gefin í æð||23084||23084|32470||1|H|L|0|||0 158007|J06BA0210|Octagam 10%|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.07.2021||R|0|0|0|0|1|OCT|0|1|0|100|DKK|57709|76264|lyfsjukr|||1|50|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, gefin í æð||57709||57709|76264||1|H|L|0|||0 158018|J06BA0210|Octagam 10%|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.07.2021||R|0|0|0|0|1|OCT|0|1|0|100|DKK|115417|150058|lyfsjukr|||1|100|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, gefin í æð||115417||115417|150058||1|H|L|0|||0 158040|J06BA0210|Octagam 10%|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.07.2021||R|0|0|0|0|1|OCT|0|1|0|100|DKK|230834|293604|lyfsjukr|||1|200|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, gefin í æð||230834||230834|293604||1|H|L|0|||0 158098|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|6|lykjur||C01BD01|01.08.2013||R|0|0|0|0|0|SNP|0|0|0|100|XEU|971|2834|lyfalmen|||1|18|0|4,5000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||971||971|2834||1|H|0|0|||0 158185|N05AH0405|Seroquel Prolong|forðatfl|150|mg|100|stk|1|þpakki||N05AH04|01.10.2011||R|1|1|0|0|0|ASA|0|0|0|100|SEK|19138|27839|lyfalmen|V0910|7540|1|100|0|37,5000|Vistor hf|Astra Zeneca A/S|Quetíapín||||19138|27839||1|0||0|||0 158608|J02AX0501|Mycamine|irþstofn|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|0|0|APG|0|0|0|100|XEU|43196|57908|lyfalmen|||1|1|0|0,5000|Vistor hf|Astellas Pharma GmbH|Micafungin||||43196|57908||1|H|0|0|||0 158619|J02AX0501|Mycamine|irþstofn|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|0|0|APG|0|0|0|100|XEU|66251|87068|lyfalmen|||1|1|0|1,0000|Vistor hf|Astellas Pharma GmbH|Micafungin||66251||66251|87068||1|H|0|0|||0 158639|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.12.2016||R|1|0|0|0|0|GPA|0|0|0|100|XEU|3816|3576|lyfalmen|V0143|3426|2|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||1510||1510|3576||1|0|E|0|||0 158698|L01BC5901|Lonsurf|filmhtfl|21,14|mg|60|stk|1|þpakki|15 mg + 6,14 mg|L01BC59|01.09.2016||R|0|0|1|0|0|LLS|0|1|0|100|DKK|241024|306278|lyfsjukr|||1|60|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||241024||241024|306278||2|0|L|0|||0 158849|N06BA0903|Atomoxetin Medical Valley|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|VAL|0|0|0|100|XEU|13805|3421|lyfalmen|V0817|3068|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||1397||1397|3421||2|0|E|0|||0 158860|J01FA0904|Clarithromycin Krka|filmhtfl|250|mg|14|stk|1|þpakki||J01FA09|01.09.2018||R|1|0|0|0|0|KNM|0|0|1|100|IKR|1724|3871|lyfalmen|||2|14|0|7,0000|LYFIS ehf|Krka d.d. Novo mesto|Klaritrómýcín||1724||1724|3871||2|0||0|||0 158992|A04AA0501|Aloxi|hylki|500|mcg|5|stk|1|þpakki||A04AA05|01.02.2021||R|0|0|0|0|0|HBL|0|0|1|100|DKK|54630|72370|lyfalmen|||1|5|0|5,0000|Biovitrum AB|Helsinn Birex Pharmaceuticals Ltd.|Palonosetrón||54630||54630|72370||3|0|E|0|||0 159013|P02CF0103|Ivermectin Medical Valley|töflur|3|mg|4|stk|1|þpakki||P02CF01|01.10.2021||R|0|0|0|0|0|VAL|0|0|0|100|XEU|7125|11305|lyfalmen|||2|4|0|1,0000|Acare ehf|Medical Valley Invest AB|ivermectin||7125||7125|11305||2|0|0|0|||0 159107|N02AB0303|Fentanyl Actavis|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|0|G|0|ATE|0|0|0|100|XEU|1920|4141|lyfalmen|V0219|4141|2|5|0|7,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fentanýl||1920||1920|4141||1|0|G|1|30|dagar|0 159118|N02AB0303|Fentanyl Actavis|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|0|G|0|ATE|0|0|0|100|XEU|3412|6080|lyfalmen|V0220|6080|2|5|0|15,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fentanýl||3329||3329|6080||1|0|G|1|30|dagar|0 159130|N02AB0303|Fentanyl Actavis|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|0|G|0|ATE|0|0|0|100|XEU|4926|8278|lyfalmen|||2|5|0|22,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fentanýl||4926||4926|8278||1|0|G|1|30|dagar|0 159138|A02AA0403|Magnesia medic|filmhtfl|500|mg|200|stk|1|glas||A02AA04|01.07.2020||L|1|0|0|0|0|MEA|0|0|0|100|IKR|||lyfalmen|||0|200|0|33,3333|Icepharma hf|Meda AB|Magnesíum hýdroxíð|||||3180||2|0||0|||0 159141|N02AB0303|Fentanyl Actavis|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|0|G|0|ATE|0|0|0|100|XEU|4876|8209|lyfalmen|V0223|8209|2|5|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fentanýl||4876||4876|8209||1|0|G|1|30|dagar|0 159207|G04CB0204|Dutasteride Sumar Pharma|hylki|0,5|mg|30|stk|1|þpakki|hylki mjúk|G04CB02|01.04.2021||R|1|0|0|G|0|POF|0|0|0|100|DKK|2180|2804|lyfalmen|V0909|2804|2|30|0|30,0000|Alvogen|Alvogen|Dútasteríð||949||949|2804||2|0|G|0|||0 159387|N06BA0905|Atomoxetin STADA|hylki|25|mg|30|stk|1|þpakki|hart hylki|N06BA09|01.08.2020||R|1|1|0|0|0|LYF|0|0|0|100|IKR|4800|3150|lyfalmen|V0814|3150|2|30|0|9,3750|LYFIS ehf|LYFIS ehf|Atomoxetín||1200||1200|3150||2|0|E|0|||0 159405|A10BD2401|Steglujan|filmhtfl|115|mg|28|stk|1|þpakki|15/100 mg|A10BD24|01.03.2019||R|1|0|0|G|0|MBV|0|0|0|100|DKK|10181|15295|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|sitagliptin og ertugliflozin||10024||10024|15295||1|0|G|0|||0 159454|L01XG0102|VORTEMYEL|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XG01|01.12.2015||R|0|0|0|0|0|ZET|0|1|0|100|SEK|125111|147920|lyfsjukr|||2|1|0||Alvogen|Zentiva, k.s.|Bortezomib||113698||113698|147920||2|H|L|0|||0 159458|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|28|stk|1|glas|hart|A02BC01|01.11.2016||L|1|0|0|0|0|VAL|0|0|0|100|IKR|||lyflausa|||2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól|||||||2|0||0|||0 159605|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.09.2017||R|0|0|0|0|0|ESS|0|0|0|100|DKK|42230|56686|lyfalmen|||1|5|0|5,0000|Essential Pharma Ltd.|Essential Pharma Ltd.|Samtengt laxakalsítónín||42230||42230|56686||2|H|0|0|||0 159672|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|25|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|G|0|MYL|0|0|1|100|SEK|662|2409|lyfalmen|||2|25|0|10,0000|Icepharma hf|Mylan AB|Acetýlcýstein||662||662|2409||2|0|G|0|||0 159683|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|100|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|G|0|MYL|0|0|1|100|SEK|1626|3736|lyfalmen|||2|100|0|40,0000|Icepharma hf|Mylan AB|Acetýlcýstein||1626||1626|3736||2|0|G|0|||0 159711|R03AK0605|Salmex|innönddu|550|mcg/sk|60|skammtar|1|innö.t|50/500 mcg/sk|R03AK06|01.01.2021||R|0|0|0|G|0|GPN|0|0|0|100|DKK|5085|7930|lyfalmen|V0981|6973|2|60|0|30,0000|Icepharma hf|Glenmark Pharmaceuticals Nordic AB|Salmeteról og fluticason||4673||4673|7930||2|0|G|0|||0 159762|N06DA0304|Nimvastid|hylki|6|mg|112|stk|1|þpakki||N06DA03|01.04.2018||R|1|0|0|G|0|KNM|0|0|0|100|IKR|27510|38068|lyfalmen|||2|112|0|74,6700|LYFIS ehf|Krka d.d. Novo mesto|Rívastigmín||27510||27510|38068||2|0|G|0|||0 159765|N05AX1212|Abilify Maintena (Lyfjaver)|sts|400|mg|1|hgl|1|pakki||N05AX12|01.05.2019||R|0|0|0|0|0|LVR|0|0|0|100|DKK|41719|56040|lyfalmen|V0980|56040|3|1|0|30,0800|Lyfjaver ehf|Lyfjaver ehf|Aripiprazól||41719||41719|56040||3|0|E|0|||0 159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|0|0|0|0|0|GRP|0|0|0|100|DKK|130333|168609|lyfalmen|||1|2|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||130333||130333|168609||1|H|0|0|||0 159973|QM01AG9002|Flunixin|stl|50|mg/ml|50|ml|1|hgl|nautg,hesta og svín|QM01AG90|01.11.2011||R|0|0|0|0|0|NIL|1|0|0|100|XEU|3991|7742|vetalmen|||0|50|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Limited|Flunixinum||3991||3991|7742||2|0||0|||0 160155|L04AB0102|Benepali|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.10.2017||R|0|1|1|0|0|SUG|0|1|0|100|XEU|59506|78537|lyfsjukr|||2|4|0|14,2900|Icepharma hf|Samsung Bioepis NL B.V.|Etanercept||59506||59506|78537||2|0|L|0|||0 160279|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2011||R|0|0|0|G|0|ATE|0|0|1|100|XEU|5438|3000|lyfalmen|V0010|2193|2|56|0|56,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rabeprazól||1091||1091|3000||1|0|E|0|||0 160487|N06BA0409|Methylphenidate STADA|hylki|40|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.10.2020||R|1|1|0|0|0|ASR|0|0|0|100|IKR|5600|7898|lyfalmen|V0996|7674|2|30|0|40,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||4650||4650|7898||2|0|E|1|30|dagar|0 161091|H02AB0901|Solu-Cortef|sts|250|mg|1|hgl|1|pakki|Act-O-Vial|H02AB09|01.12.1972|31.08.2021|R|0|0|0|0|0|PLS|0|0|0|100|DKK|855|2675|lyfalmen|||1|1|0|8,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||855||855|2675||1|H|0|0|||0 161113|J01CR0202|Augmentin|töflur|1|g|14|stk|1|þpakki|875+125 mg|J01CR02|01.11.2015||R|0|0|0|0|0|GPH|0|0|1|100|DKK|1399|3424|lyfalmen|V0169|2599|1|14|0|8,1667|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og beta-laktamasa hemill ||1399||1399|3424||1|0|E|0|||0 161117|H02AB0901|Solu-Cortef|sts|100|mg|5|hgl|1|pakki|Act-O-Vial |H02AB09|01.08.1998|31.08.2021|R|0|0|0|G|0|PLS|0|0|1|100|DKK|2355|4739|lyfalmen|||1|5|0|16,6667|Icepharma hf|Pfizer ApS|Hýdrókortisón||2355||2355|4739||1|0|G|0|||0 161125|H02AB0901|Solu-Cortef|sts|100|mg|1|hgl|1|pakki|Act-O-Vial|H02AB09|01.12.1972|31.08.2021|R|0|0|0|G|0|PLS|0|0|1|100|DKK|563|2273|lyfalmen|||1|1|0|3,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||563||563|2273||1|0|G|0|||0 161180|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.2017||R|1|0|0|0|0|GPA|0|0|0|100|XEU|1606|2450|lyfalmen|V0143|1142|2|4|0|4,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||692||692|2450||1|0|E|0|||0 161424|G04BE0806|Tadalafil Krka|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.12.2017||R|1|0|0|0|0|KNM|0|0|0|100|IKR|10000|7692|lyfalmen|V0145|7257|2|8|0|16,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||4500||4500|7692||2|0|E|0|||0 161488|N07BA0301|Champix|filmhtfl|||53|stk|1|þpakki|0,5 mg og 1 mg|N07BA03|01.06.2021||R|0|0|0|0|0|PEU|0|0|1|100|DKK|9792|14976|lyfalmen|V1049|14976|1|53|0|23,7500|Icepharma hf|Pfizer Europe MA EEIG|Vareniclin||||9792|14976||1|0||0|||0 161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|þpakki||L02BG06|01.06.2001||R|0|0|0|G|0|PLS|0|0|0|100|DKK|54524|72236|lyfalmen|V0452|50405|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Exemestan||54524||54524|72236||1|0|G|0|||0 161592|J01DD0103|Cefotaxim Navamedic|sts|1|g|10|ml|10|hgl|lausn|J01DD01|01.02.2016||R|0|0|0|0|0|NAV|0|0|1|100|DKK|6190|10018|lyfalmen|||2|100|0|2,5000|Icepharma hf|Navamedic ASA|Cefotaximum||||6190|10018||2|0|0|0|||0 161596|R03BA0501|Flixotide|innönddu|250|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.08.2019||R|0|0|0|G|0|GPH|0|0|0|100|DKK|2555|5015|lyfalmen|||1|60|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||2555||2555|5015||1|0|G|0|||0 161824|A06AX0401|Constella|hylki|290|mcg|90|stk|1|glas||A06AX04|01.12.2016||R|0|0|0|G|0|AGC|0|0|0|100|XEU|26687|37027|lyfalmen|||1|90|0|90,0000|Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ltd.|Linaclotídum||26687||26687|37027||1|0|G|0|||0 162055|QN02BG9102|Librela|stl|10|mg|1|ml|2|hgl||QN02BG91|01.08.2021||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|10774|20611|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Bedinvetmab||10774||10774|20611||2|0||2|||0 162261|H01CB0501|Signifor|stl|0,6|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|ROD|0|0|0|100|DKK|519326|652407|lyfalmen|||1|60|0|30,0000|Recordati AB|Recordati Rare Diseases|PAsireótið disapartate||519326||519326|652407||1|0|E|0|||0 162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|1|0|0|G|0|PLS|0|0|0|100|DKK|1851|4046|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1851||1851|4046||1|0|G|0|||0 162440|G04BE0806|Tadalafil Krka|filmhtfl|20|mg|12|stk|1|þpakki||G04BE08|01.12.2017||R|1|0|0|0|0|KNM|0|0|0|100|IKR|13997|20763|lyfalmen|V0145|10886|2|12|0|24,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||13997||13997|20763||2|0|E|0|||0 162778|QN05CM9002|Detonervin, vet.|stl|10|mg/ml|5|ml|1|hgl|f.hesta og nautgr.|QN05CM90|01.12.2011||R|0|0|0|0|0|LEV|1|0|0|100|XEU|5374|10366|vetalmen|||0|5|0||Le Vet B.V.|Le Vet B.V.|Detomidinum||5374||5374|10366||2|0||0|||0 162808|C01DA1404|Fem-Mono Retard|forðatfl|60|mg|100|stk|1|þpakki||C01DA14|01.10.2013||R|1|0|0|G|0|MYL|0|0|0|100|SEK|2378|3834|lyfalmen|V0041|3834|2|100|0|150,0000|Icepharma hf|Mylan AB|Ísósorbíð mónónítrat||1697||1697|3834||2|0|G|0|||0 162841|A10BA0203|Metformin Bluefish|filmhtfl|500|mg|100|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|G|0|BLS|0|0|0|100|XEU|470|2062|lyfalmen|V0500|2062|2|100|0|25,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Metformín||410||410|2062||1|0|G|0|||0 162852|A10BA0203|Metformin Bluefish|filmhtfl|850|mg|100|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|G|0|BLS|0|0|0|100|XEU|679|2432|lyfalmen|||2|100|0|42,5000|Artasan ehf|Bluefish Pharmaceuticals AB|Metformín||679||679|2432||1|0|G|0|||0 162863|A10BA0203|Metformin Bluefish|filmhtfl|1000|mg|60|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|G|0|BLS|0|0|0|100|XEU|425|2083|lyfalmen|V0502|2083|2|60|0|30,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Metformín||425||425|2083||1|0|G|0|||0 162872|L01AX0304|Temozolomide Accord|hylki|140|mg|5|stk|1|skpoki||L01AX03|01.10.2019||R|0|0|1|0|0|CLU|0|1|0|100|XEU|24666|34471|lyfsjukr|||2|5|0||Artasan ehf|Accord Healthcare S.L.U.|Temozolomid||24666||24666|34471||1|0|L|0|||0 162933|R03BA0501|Flixotide|innúðal|50|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|G|0|GPH|0|0|0|100|DKK|1136|3062|lyfalmen|||1|120|0|20,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||1136||1136|3062||1|0|G|0|||0 163036|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|1|G|0|EIG|0|0|0|100|SEK|9286|14279|lyfalmen|||1|60|0|8,5700|Vistor hf|Eisai GmbH|Rúfínamíð||9286||9286|14279||1|0|G|0|||0 163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.12.1972||R|1|1|0|0|0|HES|0|0|0|100|DKK|1167|3104|lyfalmen|V0671|2701|1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||1167||1167|3104||1|0|E|1|30|dagar|0 163164|QH01CA9002|Busol|stl|0,004|mg/ml|10|ml|5|hgl|lausn|QH01CA90|01.11.2018||R|0|0|0|0|0|TPW|1|0|0|100|IKR|14280|27263|vetalmen|||0|50|0||Dýraheilsa ehf|T.P. Whelehan Son & Co. Ltd.|Buserelin||14280||14280|27263||2|0||0|||0 163239|L04AX0306|Metojectpen|stl|30|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|3795|6721|lyfalmen|||1|1|0|12,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3795||3795|6721|31.8.2021|2|0|G|0|||0 163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|þpakki||P01AB01|01.10.1995||R|1|0|0|0|0|SNP|0|0|1|100|XEU|1079|2983|lyfalmen|||1|30|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1079||1079|2983||1|0||0|||0 163324|C09CA0107|Losartan Medical Valley|filmhtfl|12,5|mg|100|stk|1|þpakki||C09CA01|01.06.2016||R|1|0|0|G|0|VAL|0|0|0|100|IKR|1455|3501|lyfalmen|V0213|3291|2|100|0|25,0000|Acare ehf|Medical Valley Invest AB|Lósartan||1455||1455|3501||2|0|G|0|||0 163354|C10BA0501|Atozet|filmhtfl|30|mg|30|stk|1|þpakki|10 mg + 20 mg|C10BA05|01.03.2015||R|0|0|0|0|0|NVO|0|0|0|100|DKK|6011|9771|lyfalmen|||1|30|0||Vistor hf|N.V. Organon|Atorvastin og ezetimibe||6011||6011|9771||1|0||0|||0 163429|C01CA0601|Fenylefrin Abcur|stl|0,1|mg/ml|5|ml|10|lykjur||C01CA06|01.09.2013||R|0|0|0|0|0|ABC|0|0|0|100|SEK|10499|15949|lyfalmen|||2|50|0|1,2500|Icepharma hf|Abcur AB|Phenylephrin||10499||10499|15949||2|H|0|0|||0 163445|A04AA0109|Ondansetron STADA|filmhtfl|4|mg|50|stk|1|þpakki||A04AA01|01.06.2021||R|1|0|0|G|0|ASR|0|0|1|100|IKR|6200|9068|lyfalmen|V0383|9068|2|50|0|12,5000|LYFIS ehf|STADA Arzneimittel AG|Ondansetrón||5500||5500|9068||2|0|G|0|||0 163493|R03BA0501|Flixotide|innúðal|125|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|G|0|GPH|0|0|0|100|DKK|2312|4680|lyfalmen|||1|120|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||2312||2312|4680||1|0|G|0|||0 163494|L01EX0201|Nexavar|filmhtfl|200|mg|112|stk|1|þpakki||L01EX02|01.06.2013||R|0|0|1|0|0|FIN|0|1|0|100|DKK|413207|520425|lyfsjukr|||1|112|0||Icepharma hf|Bayer AG|Sorafenib||413207||413207|520425||2|0|L|0|||0 163646|L04AX0305|Methotrexate Pfizer|töflur|2,5|mg|100|stk|1|þpakki||L04AX03|01.06.2016||R|0|0|0|G|0|PLS|0|0|0|100|DKK|1684|3816|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Metótrexat||1684||1684|3816||1|0|G|0|||0 163667|M01AE0113|Ibuxin|filmhtfl|800|mg|30|stk|1|þpakki||M01AE01|01.03.2013||R|1|0|0|G|0|RHG|0|0|1|100|XEU|579|2295|lyfalmen|||2|30|0|20,0000|Alvogen|ratiopharm GmbH|Íbúprófen||579||579|2295||2|0|G|0|||0 163675|M01AE0113|Ibuxin|filmhtfl|800|mg|100|stk|1|þpakki||M01AE01|01.03.2013||R|1|0|0|G|0|RTH|0|0|1|100|XEU|1736|3887|lyfalmen|||2|100|0|66,6700|Alvogen|ratiopharm GmbH|Íbúprófen||1736||1736|3887||2|0|G|0|||0 163967|M01AH0504|Etoricoxib Krka|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|776|2186|lyfalmen|V0827|2186|2|7|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||500||500|2186||2|0|G|0|||0 164256|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|3514|6335|lyfalmen|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||3514||3514|6335||1|0|0|0|||0 164324|L01BB0202|Xaluprine|mixtúra|20|mg/ml|100|ml|1|glas||L01BB02|01.05.2015||R|0|0|1|0|0|NRO|0|0|0|100|DKK|37605|50836|lyfalmen|||1|100|0||Pharmanovia A/S|Nova Laboratories Ireland Limited|Merkaptópúrín||37605||37605|50836||2|0|0|0|||0 164592|QN03AX9001|Pexion|töflur|400|mg|100|stk|1|glas|handa hundum|QN03AX90|01.05.2014||R|0|0|0|0|0|BIV|0|0|0|100|DKK|10549|20184|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Imepitoin||10549||10549|20184||1|0||0|||0 164827|C02KX0501|Adempas|filmhtfl|2,5|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|0|BRE|0|1|0|100|DKK|366934|462874|lyfsjukr|||1|84|0|46,6700|Vistor hf|Bayer AG|Riociguatum||366934||366934|462874||1|0|L|0|||0 164829|N06AA0406|Klomipramin Mylan|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.2010||R|1|0|0|G|0|MYL|0|0|0|100|SEK|970|2833|lyfalmen|||2|100|0|10,0000|Icepharma hf|Mylan AB|Klómípramín||970||970|2833||2|0|G|0|||0 164871|A07EC0204|Asacol|eþ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|0|0|0|G|0|TIL|0|0|0|100|DKK|5041|8436|lyfalmen|||1|60|0|20,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||5041||5041|8436||2|0|G|0|||0 164944|M01AX0001|Harpatinum|hylki|225|mg|90|stk|1|þpakki||M01AX00|01.01.2018||L|0|0|0|0|0|FLO|0|0|1|100|IKR|||lyflausa|||0|90|0||Florealis ehf|Florealis ehf|Devil´s claw dry extrakt ethanolic 60%|||||||2|0||0|||0 165019|C05AA0102|Proctosedyl|eþ-smyr|||30|g|1|túpa||C05AA01|01.03.1981||L|0|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||0|30|0||Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||||1|0||0|||0 165175|N05BA0205|Risolid|filmhtfl|10|mg|100|stk|1|glas||N05BA02|01.03.2012||R|1|0|0|0|0|ATE|0|0|0|100|GBP|4008|7015|lyfalmen|||2|100|0|33,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klórdíazepoxíð||4008||4008|7015||1|0||2|50|töflur|0 165179|N03AX2201|Fycompa|filmhtfl|10|mg|28|stk|1|þpakki||N03AX22|01.02.2020||R|1|0|0|G|0|SIE|0|0|0|100|SEK|20494|29194|lyfalmen|||1|28|0|35,0000|Eisai AB|Eisai GmbH|Perampanel||20494||20494|29194||1|0|G|0|||0 165306|QN05CM9101|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM91|01.05.2009||R|0|0|0|0|0|LAS|1|0|0|100|XEU|6575|12645|vetalmen|||0|10|0||Dýraheilsa ehf|Laboratorios SYVA S.A.|Metetomidinum||6575||6575|12645||2|0||0|||0 165507|L01CE0201|Irinotecan Actavis|irþ|20|mg/ml|25|ml|1|hgl|lausn|L01CE02|01.04.2018||R|0|0|0|0|0|ATE|0|0|0|100|XEU|8152|12718|lyfalmen|||2|25|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Irinotecan||8152||8152|12718||1|H|0|0|||0 165603|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|5|rörlyk||H01AC01|01.05.2011||R|0|0|1|0|0|MEC|0|1|0|100|SEK|159578|204982|lyfsjukr|||1|7,5|0|90,0000|Icepharma hf|Merck AB|Sómatrópín||159578||159578|204982||2|0|L|0|||0 165689|N06AB0406|Citalopram STADA|filmhtfl|20|mg|100|stk|1|þpakki||N06AB04|01.09.2020||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2600|5077|lyfalmen|V0318|5077|2|100|0|100,0000|LYFIS ehf|STADA Arzneimittel AG|Cítalópram||2600||2600|5077||2|0|G|0|||0 165799|C02KX0501|Adempas|filmhtfl|2|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|0|BRE|0|1|0|100|DKK|187545|239765|lyfsjukr|||1|42|0|18,6700|Vistor hf|Bayer AG|Riociguatum||187545||187545|239765||1|0|L|0|||0 165859|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|3985|6983|lyfalmen|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||3985||3985|6983||1|0|0|0|||0 165903|QA03DB0401|Spasmium vet.|stl|504|mg/ml|100|ml|1|hgl|500 mg/ml+4 mg/ml, lausn|QA03DB04|01.02.2016||R|0|0|0|0|0|RPG|1|0|0|100|XEU|5689|10964|vetalmen|||0|100|0||Icepharma hf|Richter Pharma AG|butylscopolamine and analgesics||||5689|10964||2|0||0|||0 166029|G04BE0309|Vizarsin|munndr.t|50|mg|24|stk|1|þpakki||G04BE03|01.01.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|8916|6728|lyfalmen|||2|24|0|24,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||3800||3800|6728||2|0|E|0|||0 166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|þpakki||P01BA02|01.12.1972||R|1|0|0|G|0|SNP|0|0|0|100|XEU|1454|3499|lyfalmen|||1|100|0|38,7597|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||1454||1454|3499||1|0|G|0|||0 166165|H01CA0201|Synarela|nefúði|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|0|0|1|G|0|PLS|0|0|0|100|DKK|13720|20382|lyfalmen|||1|8|0|30,0000|Icepharma hf|Pfizer ApS|Nafarelín||13720||13720|20382||1|0|G|0|||0 166277|C10AA0508|Lipistad|filmhtfl|20|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2665|2806|lyfalmen|V0113|2735|2|100|0|100,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||950||950|2806||2|0|G|0|||0 166351|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|G|0|MYL|0|0|1|100|SEK|1837|4026|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Naproxen||1837||1837|4026||2|0|G|0|||0 166362|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|G|0|MYL|0|0|1|100|SEK|3476|6282|lyfalmen|V0428|6282|2|100|0|100,0000|Icepharma hf|Mylan AB|Naproxen||3476||3476|6282||2|0|G|0|||0 166628|L04AB0401|Humira|stl|40|mg/penna|0,4|ml|2|áfpen|áfylltur penni|L04AB04|01.11.2016||R|0|1|1|0|0|ABD|0|1|0|100|DKK|117002|152029|lyfsjukr|||1|0,8|0|27,5900|Vistor hf|AbbVie Deutschland GmbH & Co. KG|Adalimumab||117002||117002|152029||1|0|L|0|||0 167366|C01CA1702|Midodrin Evolan|töflur|2,5|mg|50|stk|1|þpakki||C01CA17|01.05.2018||R|1|0|0|G|0|EVO|0|0|0|100|IKR|8346|12985|lyfalmen|V0968|10556|2|50|0|4,1666|LYFIS ehf|Evolan Pharma AB|midodrine||8346||8346|12985||2|0|G|0|||0 167588|B02BD0208|Afstyla|sts|500|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|1|0|0|CSB|0|1|0|100|SEK|41465|55719|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||41465||41465|55719||2|0|L|0|||0 167753|M01AH0504|Etoricoxib Krka|filmhtfl|90|mg|30|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|2548|3907|lyfalmen|||2|30|0|45,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1750||1750|3907|31.7.2021|2|0|G|0|||0 167887|M01AB0521|Voltafenak Rapid|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.11.2019||R|1|0|0|G|0|EVO|0|0|1|100|IKR|1220|2186|lyfalmen|V0189|2186|2|100|0|50,0000|LYFIS ehf|Evolan Pharma AB|Díklófenak||500||500|2186||2|0|G|0|||0 167905|A02BC0508|Esomeprazol Actavis|sþ-tfl|40|mg|28|stk|1|þpakki||A02BC05|01.01.2015||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1705|2958|lyfalmen|V0005|2874|2|28|0|37,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Esómeprazól||1061||1061|2958||1|0|E|0|||0 168038|J05AR0901|Stribild|filmhtfl|745|mg|30|stk|1|glas|150+150+200+245 mg|J05AR09|01.11.2013||R|0|1|1|0|0|GEI|0|1|0|100|DKK|128619|166477|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Sciences Ireland|Emtrícítabín,tenófóvír disóproxíl,elvítegravír og kóbísistat||128619||128619|166477||2|0|L|0|||0 168079|D01BA0207|Terbinafin Medical Valley|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.02.2021||R|1|0|0|0|0|VAL|0|0|0|100|XEU|1977|3596|lyfalmen|V0123|3596|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Terbínafín||1524||1524|3596||2|0|E|0|||0 168083|L02BB0305|Bicalutamide Alvogen|filmhtfl|50|mg|90|stk|1|þpakki||L02BB03|01.11.2016||R|0|0|0|G|0|GOV|0|0|0|100|IKR|19158|16638|lyfalmen|V0420|16638|2|90|0|90,0000|Alvogen|Alvogen ehf|Bíkalútamíð||11000||11000|16638||2|0|G|0|||0 168119|B06AC0102|Berinert|sts/irs|500|ae|1|hgl|1|pakki||B06AC01|01.05.2020||R|0|0|1|0|0|CSB|0|1|0|100|SEK|98135|127395|lyfsjukr|||1|1|0|0,3571|Icepharma hf|CSL Behring GmbH|C1 hemill||98135||98135|127395||2|0|L|0|||0 168222|B05BA1024|SmofKabiven extra Nitrogen|irl|||1518|ml|4|pokar|fleyti|B05BA10|01.05.2021||R|0|0|0|0|0|FKA|0|0|0|100|DKK|40704|54756|lyfalmen|||1|6072|0||Vistor hf|Fresenius Kabi AB|Blöndur||40704||40704|54756||1|0|0|0|||0 168309|A02BC0306|Lanser|sþ-hylki|30|mg|98|stk|1|þpakki||A02BC03|01.08.2009||R|1|0|0|G|0|ATE|0|0|1|100|IKR|5208|5737|lyfalmen|V0007|4939|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lansóprazól||3080||3080|5737||1|0|E|0|||0 168388|L04AC1301|Taltz|stl|80|mg|1|ml|1|áfpen||L04AC13|01.06.2020||R|0|0|1|0|0|ELY|0|1|0|100|XEU|143065|184444|lyfsjukr|||1|1|0|27,5862|Icepharma hf|Eli Lilly and Company (Ireland) Limited|Ixekizumab||143065||143065|184444||2|0|L|0|||0 168640|L04AX0307|Metoject|stl|50|mg/ml|0,3|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|G|0|WIL|0|0|0|100|SEK|2407|4811|lyfalmen|||1|0,3|0|6,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2407||2407|4811||2|0|G|0|||0 168662|L04AX0307|Metoject|stl|50|mg/ml|0,5|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|G|0|WIL|0|0|0|100|SEK|2866|5443|lyfalmen|||1|0,5|0|10,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2866||2866|5443||2|0|G|0|||0 168740|N03AF0105|Tegretol Retard|forðatfl|200|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|1|0|0|G|0|HES|0|0|0|100|DKK|3176|5869|lyfalmen|V0240|5382|1|200|0|40,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||3176||3176|5869||1|0|G|0|||0 168778|N07BA0106|Nicotinell|forðapl|14|mg/sólh|21|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|21|0|21,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 168971|N03AF0105|Tegretol Retard|forðatfl|400|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|1|0|0|G|0|HES|0|0|0|100|DKK|5790|9467|lyfalmen|||1|200|0|80,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||5790||5790|9467||1|0|G|0|||0 169175|N03AX1603|Pregabalin Krka|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|8106|12655|lyfalmen|V0688|12655|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||8106||8106|12655||2|0|E|0|||0 169293|L01XX2702|Arsenic Trioxide Accord|irþ|1|mg/ml|10|ml|10|hgl||L01XX27|01.05.2020||R|0|0|0|0|0|CLU|0|1|0|100|XEU|504396|633839|lyfsjukr|||2|100|0||Artasan ehf|Accord Healthcare S.L.U.|Arsenic trioxide||504396||504396|633839||1|H|L|0|||0 169402|S01ED5121|Travoprost/Timolol STADA|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.11.2019||R|0|0|0|G|0|ASR|0|0|0|100|IKR|2815|2461|lyfalmen|V0994|2448|2|2,5|0|25,0000|LYFIS ehf|STADA Arzneimittel AG|Tímólól í blöndum||700||700|2461||2|0|G|0|||0 169751|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|500|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|GOV|0|0|1|100|XEU|1546|3242|lyfalmen|V0411|3242|2|20|0|10,0000|Alvogen|Alvogen ehf|Cíprófloxacín||1267||1267|3242||2|0|E|0|||0 169762|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|500|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|GOV|0|0|1|100|XEU|1023|2466|lyfalmen|V0177|2466|2|10|0|5,0000|Alvogen|Alvogen ehf|Cíprófloxacín||703||703|2466||2|0|E|0|||0 169773|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|250|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|GOV|0|0|1|100|XEU|1009|2455|lyfalmen|V0418|2453|2|20|0|5,0000|Alvogen|Alvogen ehf|Cíprófloxacín||695||695|2455||2|0|E|0|||0 169872|QG03XA9101|Improvac|stl|||100|ml|1|glas||QG03XA91|01.04.2019||R|0|0|0|0|0|ZBE|0|0|0|100|IKR|9550|18289|vetalmen|||0|100|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||9550||9550|18289||2|0|0|0|||0 169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|MAR|0|0|1|100|DKK|3153|5838|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín||3153||3153|5838||2|0||0|||0 169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|MAR|0|0|1|100|DKK|3884|6844|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín||3884||3884|6844||2|0||0|||0 169944|L01ED0501|Lorviqua|filmhtfl|100|mg|30|stk|1|þpakki||L01ED05|01.04.2021||R|1|0|1|0|0|PEU|0|1|0|100|DKK|724252|907278|lyfsjukr|||1|30|0||Icepharma hf|Pfizer Europe MA EEIG|Lorlatinib||724252||724252|907278||1|0|L|0|||0 169998|S01GA0101|Cleye|augndr|0,12|mg/ml|10|ml|1|glas||S01GA01|01.08.2017||L|0|0|0|0|0|EVE|0|0|0|100|IKR|||lyflausa|||1|10|0||LYFIS ehf|Elara Pharmaservices Europe Limited|Nafazólín|||||||2|0||0|||0 170062|L04AC0701|RoActemra|irþ|20|mg/ml|4|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|0|0|RRG|0|1|0|100|DKK|20086|28678|lyfsjukr|||1|4|0|4,0000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||20086||20086|28678||2|H|L|0|||0 170085|L04AC0701|RoActemra|irþ|20|mg/ml|10|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|0|0|RRG|0|1|0|100|DKK|49951|66452|lyfsjukr|||1|10|0|10,0000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||49951||49951|66452||2|H|L|0|||0 170092|J07BC2001|Twinrix Adult|stl|||1|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|0|0|0|0|0|GBI|0|0|0|100|DKK|5030|8421|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||5030||5030|8421||1|0||0|||0 170107|L04AC0701|RoActemra|irþ|20|mg/ml|20|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|0|0|RRG|0|1|0|100|DKK|100035|130927|lyfsjukr|||1|20|0|20,0000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||100035||100035|130927||2|H|L|0|||0 170237|L04AA2701|Gilenya|hylki|0,25|mg|28|stk|1|þpakki||L04AA27|01.07.2019||R|0|1|1|0|0|NEL|0|1|0|100|DKK|253114|321314|lyfsjukr|||1|28|0|14,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||253114||253114|321314||1|0|L|0|||0 170309|C10AA0106|Simvastatin Bluefish|filmhtfl|10|mg|100|stk|1|þpakki||C10AA01|01.07.2018||R|1|0|0|G|0|BLS|0|0|0|100|XEU|902|2212|lyfalmen|||2|100|0|33,3400|Artasan ehf|Bluefish Pharmaceuticals AB|Simvastatín||519||519|2212||1|0|G|0|||0 170335|N02AX0213|Tramadol Krka|forðatfl|100|mg|20|stk|1|þpakki||N02AX02|01.08.2019||R|1|0|0|G|0|KAN|0|0|1|100|IKR|550|2248|lyfalmen|V0226|2248|2|20|0|6,6700|Krka Sverige AB|Krka d.d. Novo mesto|Tramadól||545||545|2248||2|0|G|1|30|dagar|0 170486|C10AX1401|Praluent|stl|75|mg/ml|6|áf-penni|1|pakki|lausn í áf.lyfjapenna|C10AX14|01.02.2016||R|0|0|0|0|0|SGB|0|0|0|100|XEU|182558|233562|lyfalmen|||1|6|0|83,3333|Vistor hf|Sanofi-aventis groupe|Alirocumab||182558||182558|233562||1|0|E|0|||0 170534|L01ED0401|Alunbrig|filmhtfl|180|mg|28|stk|1|þpakki||L01ED04|01.02.2021||R|1|1|1|0|0|ASS|0|1|0|100|DKK|675647|846827|lyfsjukr|||1|28|0||Vistor hf|Takeda AS|Brigatinib||675647||675647|846827||1|0|L|0|||0 170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|0|0|0|0|0|MAR|0|0|1|100|DKK|2314|4683|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Mepívakaín í blöndum||2314||2314|4683||2|0||0|||0 170672|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.12.2015||R|0|0|1|0|0|SAR|0|1|0|100|DKK|29603|36970|lyfsjukr|||1|2,5|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||26642||26642|36970||1|0|L|0|||0 170758|R03AC0302|Bricanyl Turbuhaler|innönddu|0,25|mg/sk|120|skammtar|1|stauk||R03AC03|01.02.2019||R|0|0|0|G|0|AZD|0|0|1|100|SEK|909|2749|lyfalmen|||1|120|0|15,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||909||909|2749||1|0|G|0|||0 170881|QM01AC0607|Meloxoral|mixtúra|0,5|mg/ml|5|ml|1|glas|handa köttum|QM01AC06|01.12.2016||R|0|0|0|0|0|DER|0|0|0|100|IKR|1158|2276|vetalmen|||0|5|0||Dýraheilsa ehf|Dechra Regulatory B.V|Meloxícam||1158||1158|2276||2|0||0|||0 170997|L01BC0701|Vidaza|sts|25|mg/ml|4|ml|1|hgl|dreifa|L01BC07|01.09.2009||R|0|0|0|0|0|BSE|0|1|0|100|DKK|49857|66333|lyfsjukr|||1|4|0||Celgene Europe ltd|Bristol-Myers Squibb Pharma EEIG|Azasitidín||49857||49857|66333||2|H|L|0|||0 171174|N02AA0116|Morfin Abcur|stl|10|mg/ml|1|ml|10|lykjur|10 x 1 ml|N02AA01|01.10.2021||R|0|0|0|0|0|ABC|0|0|1|100|SEK|1986|4231|lyfalmen|||2|10|0|3,3300|Icepharma hf|Abcur AB|Morfín||1986||1986|4231||2|0|E|1|30|dagar|0 171292|G04BD0807|Solifenacin Krka|filmhtfl|10|mg|100|stk|1|þpakki||G04BD08|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|12809|13886|lyfalmen|V0441|12676|2|100|0|200,0000|Krka Sverige AB|Krka d.d. Novo mesto|Sólífenacín||9000||9000|13886||2|0|G|0|||0 171340|R01AX0302|Lomuspray|nefúði|21|mcg/sk|15|ml|1|úðaílá|180 sk, lausn|R01AX03|01.04.2020||L|0|0|0|G|0|SNP|0|0|1|100|XEU|||lyfalmen|||1|15|0|15,7500|Vistor hf|Sanofi-aventis Norge AS|Ípratrópínbrómíð|||||2956||1|0|G|0|||0 171486|L04AB0202|Remsima|st/irþ|100|mg|1|hgl|1|pakki||L04AB02|01.12.2018||R|0|0|0|0|0|HUN|0|1|0|100|DKK|45206|60450|lyfsjukr|||2|1|0|26,6700|Vistor hf|Celltrion Healthcare Hunary Kft|Infliximab||45206||45206|60450||1|H|L|0|||0 171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|MAR|0|0|1|100|DKK|3195|5896|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín í blöndum||||3195|5896||2|0||0|||0 171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|MAR|0|0|1|100|DKK|3626|6489|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín í blöndum||3626||3626|6489||2|0||0|||0 171762|A03AA0407|Duspatalin Retard|forðahlk|200|mg|30|stk|1|þpakki||A03AA04|01.11.2016||R|0|0|0|G|0|VIA|0|0|0|100|DKK|1207|3159|lyfalmen|||1|30|0|20,0000|Icepharma hf|Viatris ApS|Mebeverín||1207||1207|3159||2|0|G|0|||0 171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|G|0|JAS|0|0|0|100|SEK|2879|5461|lyfalmen|V0247|3677|1|60|0|5,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||2879||2879|5461||1|0|G|0|||0 171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|G|0|JAS|0|0|0|100|SEK|4990|8366|lyfalmen|V0248|5107|1|60|0|10,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||4990||4990|8366||1|0|G|0|||0 172269|N03AX1408|Levetiracetam STADA|filmhtfl|500|mg|200|stk|1|þpakki||N03AX14|01.12.2019||R|1|0|0|G|0|ASR|0|0|0|100|IKR|13449|9756|lyfalmen|V0253|9756|2|200|0|66,6666|LYFIS ehf|STADA Arzneimittel AG|Levetíracetam||6000||6000|9756||2|0|G|0|||0 172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|G|0|JAS|0|0|0|100|SEK|9233|14206|lyfalmen|V0249|4317|1|60|0|20,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||9233||9233|14206||1|0|G|0|||0 172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|G|0|JAS|0|0|0|100|SEK|16731|24526|lyfalmen|||1|60|0|40,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||16731||16731|24526||1|0|G|0|||0 172592|N06AX2601|Brintellix|filmhtfl|10|mg|98|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|LUN|0|0|0|100|DKK|15497|22828|lyfalmen|||1|98|0|98,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||15497||15497|22828||1|0||0|||0 172627|C07FB0202|Logimax forte|forðatfl|105|mg|98|stk|1|pakki|þp 10 + 95 mg|C07FB02|01.07.1999||R|1|0|0|G|0|RDT|0|0|0|100|DKK|8761|13557|lyfalmen|||1|98|0|98,0000|Vistor hf|Recordati Ireland Limited|Metóprólól og Felodipin||8761||8761|13557||1|0|G|0|||0 172723|N05AH0410|Quetiapin Actavis|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.07.2013||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2589|2391|lyfalmen|V0284|2343|2|100|0|6,2500|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Quetíapín||649||649|2391||1|0|G|0|||0 173284|C10AA0702|Rosuvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.12.2012||R|1|0|0|0|0|ATE|0|0|0|100|XEU|7252|7900|lyfalmen|V0118|7740|2|98|0|196,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rósuvastatín||4651||4651|7900||1|0|E|0|||0 173344|A06AG1101|Microlax|innhl|||5|ml|12|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|60|0|12,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||3986||1|0|E|0|||0 173750|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|áf.spr|nálarvörn|B03XA02|01.08.2011||R|0|0|1|0|0|RAG|0|1|0|100|DKK|11568|17420|lyfsjukr|||1|1,6|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||11568||11568|17420||1|0|L|0|||0 174063|C03EA0115|Amiloride/HCT Alvogen|töflur|27,5|mg|100|stk|1|þpakki|2,5+25 mg|C03EA01|01.03.2020||R|1|0|0|G|0|POF|0|0|0|100|IKR|2015|4271|lyfalmen|||2|100|0|100,0000|Alvogen|Alvogen|Hýdróklórtíazíð og kalíumsparandi lyf||2015||2015|4271||2|0|G|0|||0 174267|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|387,5|mg|100|stk|1|ílát|150+37,5+200 mg|N04BA03|01.05.2021||R|1|0|0|G|0|LVR|0|0|0|100|DKK|11341|17108|lyfalmen|V0900|17108|3|100|0|33,3300|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||11341||11341|17108||3|0|G|0|||0 174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|þpakki||J01CE02|01.01.1989|31.07.2021|R|0|0|0|0|0|MEA|0|0|1|100|DKK|541|2243|lyfalmen|||1|14|0|7,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||541||541|2243||2|0|E|0|||0 174433|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|0|0|0|G|0|LPT|0|0|0|100|XEU|1365|3377|lyfalmen|||1|5|0|25,0000|Teva Pharma Iceland ehf|Allergan Pharmaceuticals Ireland|Brímónidín||1365||1365|3377||1|0|G|0|||0 174522|N04BC0505|Oprymea|forðatfl|0,26|mg|30|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|G|0|KNM|0|0|0|100|IKR|2900|5489|lyfalmen|||2|30|0|4,5000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||2900||2900|5489||2|0|G|0|||0 174626|A10AE0601|Tresiba|stl|200|ae/ml|3|ml|3|áfpen|FlexTouch|A10AE06|01.12.2016||R|0|1|0|G|0|NAS|0|0|0|100|DKK|10055|15338|lyfalmen|||1|9|0|45,0000|Vistor hf|Novo-Nordisk A/S|Insulin degludec||10055||10055|15338||1|0|G|0|||0 174664|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|0|0|0|G|0|LPT|0|0|0|100|XEU|3572|6414|lyfalmen|V0368|4544|1|15|0|75,0000|Teva Pharma Iceland ehf|Allergan Pharmaceuticals Ireland|Brímónidín||3572||3572|6414||1|0|G|0|||0 174806|J05AE1002|Darunavir Alvogen|filmhtfl|800|mg|30|stk|1|glas||J05AE10|01.07.2017||R|1|0|1|0|0|ALO|0|1|0|100|XEU|49064|45735|lyfsjukr|||2|30|0|20,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Darunavír||33572||33572|45735||2|0|L|0|||0 174825|N02CX0001|Glitinum|hylki|100|mg|30|stk|1|þpakki||N02CX|01.12.2018||L|0|0|0|0|0|FLO|0|0|0|100|IKR|||lyflausa|||0|30|0||Florealis ehf|Florealis ehf|Tanacetum parthenium|||||||2|0||0|||0 174903|N06BA1201|Elvanse Adult|hylki|70|mg|30|stk|1|glas|hart|N06BA12|01.06.2018||R|1|1|0|0|0|SHE|0|0|0|100|DKK|15659|23051|lyfalmen|||1|30|0|70,0000|Shire Pharmaceuticals Ireland Limited|Shire Pharmaceuticals Ireland Limited|lisdexamfetamine||15659||15659|23051||1|0|E|1|30|dagar|0 175246|B02BD0205|Elocta|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|1|0|0|SAB|0|1|0|100|DKK|22616|31878|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||22616|31878||3|0|L|0|||0 175253|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.07.2016||R|0|0|0|G|0|NAA|0|0|1|100|DKK|6831|8863|lyfalmen|||1|10|0|1,2500|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||5351||5351|8863||1|0|G|0|||0 175333|QM01AC0603|Rheumocam|mixtúra|15|mg/ml|100|ml|1|glas|handa hestum|QM01AC06|01.09.2013||R|0|0|0|0|0|CHP|0|0|0|100|XEU|5083|9814|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Meloxícam||5083||5083|9814||2|0||0|||0 175351|L01XC0203|Truxima|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.08.2019||R|0|1|0|0|0|CTH|0|1|0|100|DKK|176568|226112|lyfsjukr|||2|50|0||Vistor hf|Celltrion Healthcare Hungary Kft.|Rítúxímab||176568||176568|226112||1|H|L|0|||0 175868|V03AN0101|Conoxia|lyfjagas|100|%|37|l|1|gashyl|kælt|V03AN01|01.10.2012||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|37|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0 176214|N05AH0301|Zyprexa|húðuðtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.1999||R|1|0|0|0|0|NED|0|0|0|100|XEU|4440|7609|lyfalmen|V0278|3781|1|28|0|7,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||4440||4440|7609||2|0|E|0|||0 176472|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.09.2017||R|0|0|0|G|0|KPA|0|0|1|100|DKK|1313|3305|lyfalmen|||1|100|0||Alvogen|Karo Pharma AB|Hýdrókortisón||1313||1313|3305||2|0|G|0|||0 176520|M01AH0105|Cloxabix|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|G|0|WEH|0|0|1|100|XEU|2525|4476|lyfalmen|V0429|4138|2|100|0|50,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||2164||2164|4476||2|0|G|0|||0 176616|N05CH0101|Circadin|forðatfl|2|mg|30|stk|1|þpakki||N05CH01|01.10.2012||R|0|0|0|0|0|RNE|0|0|1|100|DKK|2623|5108|lyfalmen|||2|30|0|30,0000|Vistor hf|RAD Neurim Pharmaceuticals EEC SARL|Melatonin||2623||2623|5108||1|0|0|0|||0 176773|R02AA0308|Strepsils Ingefær|sogtfl|||24|stk|1|þpakki||R02AA03|01.08.2018||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0||0|||0 176835|C09CA0106|Losatrix|filmhtfl|25|mg|100|stk|1|þpakki||C09CA01|01.01.2018||R|1|0|0|G|0|RTH|0|0|0|100|IKR|3105|5772|lyfalmen|||2|100|0|50,0000|Alvogen|ratiopharm GmbH|Lósartan||3105||3105|5772||2|0|G|0|||0 176889|QP53AC5501|Seresto|hálsband|1,81|g|1|stk|1|poki|1,25 + 0,56 g|QP53AC55|01.06.2016||R|0|0|0|0|0|BAN|0|0|0|100|DKK|6285|10833|vetorma|||0|1|0||Icepharma hf|Bayer Animal Health GmbH|Flúmetrín í blöndum||6285||6285|10833||2|0||0|||0 177099|L01XC1901|Blincyto|st/irþ|38,5|mcg/ml|1|hgl|1|pakki|lausn|L01XC19|01.04.2017||R|0|1|0|0|0|AEB|0|1|0|100|DKK|361655|456309|lyfsjukr|||1|1|0||Vistor hf|Amgen Europe B.V.|Blinatumomab||361655||361655|456309||1|H|L|0|||0 177176|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|BAM|0|0|0|100|SEK|7504|11826|lyfalmen|||1|5000|0||Icepharma hf|Baxter Medical AB|Kolvetni||7504||7504|11826||2|0|0|0|||0 177199|L01EF0101|Ibrance|hylki|125|mg|21|stk|1|þpakki||L01EF01|01.02.2017||R|1|0|1|0|0|PEU|0|1|0|100|DKK|311653|394120|lyfsjukr|||1|21|0||Icepharma hf|Pfizer Europe MA EEIG|Palbociclib||311653||311653|394120||1|0|L|0|||0 177320|A04AA0501|Aloxi|hylki|500|mcg|1|stk|1|þpakki||A04AA05|01.02.2021||R|0|0|0|0|0|HBL|0|0|1|100|DKK|11175|16879|lyfalmen|||1|1|0|1,0000|Biovitrum AB|Helsinn Birex Pharmaceuticals Ltd.|Palonosetrón||11175||11175|16879||3|0|E|0|||0 177454|N02BE0107|Paratabs|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.05.2013||R|1|0|0|0|0|ATE|0|0|1|100|XEU|966|2828|lyfalmen|V0231|2581|2|300|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paracetamól||||966|2828||1|0|0|0|||0 177627|QH02AB0201|Dexaject|stl|2|mg/ml|100|ml|1|hgl||QH02AB02|01.06.2013||R|0|0|0|0|0|DOR|1|0|0|100|XEU|4363|8448|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|Dexamethasón||4363||4363|8448||2|0||0|||0 177723|G04BE0313|Sildenafil Medical Valley|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.11.2020||R|1|0|0|0|0|VAL|0|0|0|100|XEU|3529|3426|lyfalmen|V0143|3426|2|12|0|12,0000|Acare ehf|Medical Valley Invest AB|Síldenafíl||1401||1401|3426||2|0|E|0|||0 177754|N06AX1203|Wellbutrin Retard (Lyfjaver)|töflur|150|mg|30|stk|1|askja|m/br. losunarhraða|N06AX12|01.10.2020||R|0|0|0|0|0|LVR|0|0|0|100|DKK|2516|4961|lyfalmen|V1028|4961|3|30|0|15,0000|Lyfjaver ehf|Lyfjaver ehf|Bupropionum||2516||2516|4961||3|0|E|0|||0 177812|R03AL1101|Trixeo Aerosphere|innúðal|||120|skammtar|1|innö.t|5 mcg/7,2 mcg/160mcg|R03AL11|01.10.2021||R|0|0|0|G|0|AZE|0|0|0|100|SEK|8318|12947|lyfalmen|||1|120|0||Vistor hf|AstraZeneca AB|Formoterol, glycopyrronium bromide and budesonide||8318||8318|12947||1|0|G|0|||0 177882|L04AX0501|Esbriet|filmhtfl|801|mg|84|stk|1|þpakki||L04AX05|01.11.2017||R|1|1|1|0|0|RRG|0|0|0|100|DKK|345581|436317|lyfalmen|||1|84|0|28,0350|Icepharma hf|Roche Registration GmbH|Pírfenidon||||345581|436317||2|0|E|0|||0 177937|M04AC0102|Colrefuz|töflur|500|mcg|100|stk|1|þpakki||M04AC01|01.10.2015||R|0|0|0|G|0|ATE|0|0|0|100|XEU|8923|11934|lyfalmen|||2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kolkisín||7582||7582|11934||1|0|G|0|||0 178223|B01AF0101|Xarelto|filmhtfl|10|mg|100|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|G|0|FIN|0|0|0|100|DKK|32394|44246|lyfalmen|V0975|43516|1|100|0|50,0000|Icepharma hf|Bayer AG|Rivaoxaban||32394||32394|44246||2|0|G|0|||0 178273|L01EE0101|Mekinist|filmhtfl|2|mg|30|stk|1|glas||L01EE01|01.01.2016||R|0|0|1|0|0|NEL|0|1|0|100|DKK|787236|985612|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Trametinib||787236||787236|985612||1|0|L|0|||0 178511|B02BD0205|Elocta|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|1|0|0|SAB|0|1|0|100|DKK|90466|117695|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||90466|117695||3|0|L|0|||0 178752|L04AD0204|Dailiport|forðahlk|1|mg|50|stk|1|stsk.þ||L04AD02|01.09.2020||R|0|0|1|G|0|SHS|0|0|0|100|DKK|9661|14795|lyfalmen|||2|50|0|10,0000|Artasan ehf|Sandoz A/S|Tacrolimus||9661||9661|14795||1|0|G|0|||0 178991|N05AH0416|Quetiapin Medical Valley|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.09.2019||R|1|1|0|G|0|VAL|0|0|0|100|IKR|3000|4788|lyfalmen|V0275|4788|2|100|0|12,5000|Acare ehf|Medical Valley Invest AB|Quetíapín||2390||2390|4788||2|0|0|0|||0 179100|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.10.2017||R|0|0|1|0|0|SDG|0|1|0|100|DKK|127814|153936|lyfsjukr|||1|7,5|0|75,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||118535||118535|153936||1|0|L|0|||0 179207|N02BE0122|Dolorin|töflur|500|mg|20|stk|1|þpakki||N02BE01|01.12.2017||L|1|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Williams & Halls efh|Williams & Halls ehf|Paracetamól|||||||2|0||0|||0 179552|B01AF0101|Xarelto|filmhtfl|15|mg|28|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|G|0|FIN|0|0|0|100|DKK|8702|13475|lyfalmen|V1035|13464|1|28|0|21,0000|Icepharma hf|Bayer AG|Rivaoxaban||||8702|13475||2|0|G|0|||0 179557|C10BA0501|Atozet|filmhtfl|50|mg|90|stk|1|þpakki|10 mg + 40 mg|C10BA05|01.03.2015||R|0|0|0|0|0|NVO|0|0|0|100|DKK|17050|24966|lyfalmen|||1|90|0||Vistor hf|N.V. Organon|Atorvastin og ezetimibe||17050||17050|24966||1|0||0|||0 179733|N02AA0507|OxyContin Depot|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.11.2020||R|1|0|0|G|0|MUP|0|0|0|100|DKK|1321|3316|lyfalmen|V0597|2738|1|28|0|3,7300|Icepharma hf|Mundipharma A/S|Oxýcódon||1321||1321|3316||2|0|G|1|30|dagar|0 179790|N06BA0903|Atomoxetin Medical Valley|hylki|100|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2020||R|1|1|0|0|0|VAL|0|0|0|100|XEU|7542|11879|lyfalmen|V0818|11879|2|28|0|35,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||7542||7542|11879||2|0|E|0|||0 180130|L01AX0303|Temomedac|hylki|250|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|1|0|0|WIL|0|1|0|100|XEU|111223|144842|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||111223||111223|144842||2|0|L|0|||0 180500|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|100|stk|1|þpakki|með br. losunarhraða|G04CA02|01.12.2012||R|1|0|0|G|0|MED|0|0|0|100|IKR|5799|4939|lyfalmen|V0148|4939|2|100|0|100,0000|Medical ehf|Medical ehf|Tamsúlósín||2500||2500|4939||2|0|G|0|||0 180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|||5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|0|0|0|G|0|PLS|0|0|1|100|DKK|679|2432|lyfalmen|||1|5|0||Icepharma hf|Pfizer ApS|Hýdrókortisón og sýkingalyf||679||679|2432||1|0|G|0|||0 181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|50|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2|0||0|||0 181502|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|60|pokar|lausn|B05BA03|01.07.2021||R|0|0|0|0|0|BAM|0|0|0|100|SEK|9253|14234|lyfalmen|||1|6000|0||Icepharma hf|Baxter Medical AB|Kolvetni||9253||9253|14234||2|0|0|0|||0 181750|L01BA0108|Methotrexate Pfizer|irþ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|0|0|0|0|0|PLS|0|0|0|100|DKK|9323|14330|lyfalmen|||1|10|0||Icepharma hf|Pfizer ApS|Metótrexat||9323||9323|14330||1|H|0|0|||0 181890|G03AD0102|Postinor|töflur|1,5|mg|1|stk|1|þpakki||G03AD01|01.11.2016||L|0|0|0|0|0|RIC|0|0|0|100|IKR|||lyflau11|||0|1|0|1,0000|Gedeon Ricther Nordics AB|Gedeon Richter Plc.|Levonorgestrel|||||||1|0||0|||1 181980|C10BA0201|Inegy|töflur|30|mg|28|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.07.2013||R|1|0|0|0|0|NVO|0|0|0|100|DKK|5836|9531|lyfalmen|||1|28|0|28,0000|Vistor hf|N.V. Organon|Ezetimíb og simvastatín||5836||5836|9531||1|0||0|||0 182086|S01XA2020|Hyprosan|augndr|3,2|mg|10|ml|3|dropaí||S01XA20|01.09.2014||L|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|30|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||6478||2|0|G|0|||0 182177|J02AC0106|Fungyn|hylki|150|mg|4|stk|1|þpakki|hart|J02AC01|01.06.2017||R|1|0|0|0|0|POF|0|0|1|100|IKR|2031|2186|lyfalmen|V0556|2186|2|4|0|3,0000|Alvogen|Alvogen|Flúkónazól||500||500|2186||2|0|E|0|||0 182307|L04AD0201|Advagraf|forðahlk|0,5|mg|50|stk|1|þpakki||L04AD02|01.11.2012||R|0|0|1|G|0|APE|0|0|0|100|XEU|9221|14190|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||9221||9221|14190||1|0|G|0|||0 182416|C07AB0213|Metoprololsuccinat Hexal|forðatfl|50|mg|100|stk|1|glas|47,5 mg metoprololsuccinat|C07AB02|01.12.2019||R|1|0|0|G|0|SSA|0|0|0|100|DKK|1329|3327|lyfalmen|V0048|3030|2|100|0|33,3333|Artasan ehf|Hexal A/S|Metóprólól||1329||1329|3327||1|0|G|0|||0 182502|C01CA0302|Noradrenalin Abcur|irþ|1|mg/ml|5|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|0|ABC|0|0|0|100|SEK|14457|21397|lyfalmen|||2|50|0|8,3333|Icepharma hf|Abcur AB|Noradrenalín||14457||14457|21397||2|H|0|0|||0 182561|L01EB0201|Erlotinib WH|filmhtfl|150|mg|30|stk|1|þpakki||L01EB02|01.06.2020||R|0|1|1|0|0|WEH|0|1|0|100|XEU|303251|290108|lyfsjukr|||2|30|0||Williams & Halls efh|Williams & Halls ehf|Erlotinib||228023||228023|290108||2|0|L|0|||0 182569|N06BA0902|Atomoxetin Actavis|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|ATE|0|0|0|100|XEU|7886|3421|lyfalmen|V0817|3068|2|28|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atomoxetín||1397||1397|3421||1|0|E|0|||0 182763|QC01CE9001|Vetmedin vet.|tuggutfl|10|mg|100|stk|1|þpakki|fyrir hunda|QC01CE90|01.04.2017||R|0|0|0|0|0|BIV|0|0|0|100|DKK|16587|31639|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||16587||16587|31639||1|0||0|||0 182805|A10BD0801|Eucreas|filmhtfl|900|mg|60|stk|1|þpakki|50mg/850mg|A10BD08|01.03.2021||R|1|0|0|G|0|NEL|0|0|0|100|DKK|6570|10541|lyfalmen|V0024|10541|1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||6570||6570|10541||1|0|G|0|||0 182831|QN51AA0102|Exagon vet.|stl|400|mg/ml|100|ml|5|hgl||QN51AA01|01.09.2014||R|0|0|0|0|0|RPG|1|0|0|100|XEU|19662|37473|vetalmen|||0|500|0||Icepharma hf|Richter Pharma AG|Pentobarbital||||19662|37473||2|0||1|30|dagar|0 183133|J01DD5201|Zavicefta|st/irþ|||20|ml|10|hgl|2g/0,5g|J01DD52|01.12.2017||R|0|0|0|0|0|PIP|0|0|1|100|DKK|169530|217359|lyfalmen|||1|200|0|3,3333|Icepharma hf|Pfizer Ireland Pharmaceuticals|Ceftazidime og beta-laktamasa hemill||169530||169530|217359||1|0|0|0|||0 183175|R03AK1401|Atectura Breezhaler|innönddu|187,5|mcg/sk|90|stk|3|stsk.þ|125 mcg/62,5mcg|R03AK14|01.01.2021||R|0|0|0|G|0|NEP|0|0|0|100|DKK|11457|17267|lyfalmen|||1|270|0||Vistor hf|Novartis Europharm Limited|Indacaterol og mometasone||11457||11457|17267||1|0|G|0|||0 183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|0|0|0|0|0|IBV|1|0|0|100|DKK|5141|9924|vetalmen|||0|50|0||Vistor hf|Intervet International BV|Flunixinum||5141||5141|9924||1|0||0|||0 183366|L04AD0204|Dailiport|forðahlk|0,5|mg|50|stk|1|stsk.þ||L04AD02|01.09.2020||R|0|0|1|G|0|SHS|0|0|0|100|DKK|5784|9459|lyfalmen|||2|50|0|5,0000|Artasan ehf|Sandoz A/S|Tacrolimus||5784||5784|9459||1|0|G|0|||0 183455|C10AX0903|Ezetimib Krka|töflur|10|mg|30|stk|1|þpakki||C10AX09|01.05.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|3187|5885|lyfalmen|V0612|5885|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Ezetimíb||3187||3187|5885||2|0|E|0|||0 183485|L01EF0201|Kisqali|filmhtfl|200|mg|21|stk|1|þpakki||L01EF02|01.11.2018||R|0|0|1|0|0|NEL|0|1|0|100|DKK|144144|185786|lyfsjukr|||1|21|0||Vistor hf|Novartis Europharm Ltd|Ribociclib||144144||144144|185786||1|0|L|0|||0 183660|C01CA2407|Jext|stl|300|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|1|0|G|0|ALK|0|0|1|100|DKK|5520|9096|lyfalmen|||1|1|0|0,6000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5520|9096||1|0|G|0|||0 183794|B01AF0202|Eliquis (Lyfjaver)|filmhtfl|5|mg|168|stk|1|þpakki||B01AF02|01.03.2020||R|1|1|0|G|0|LVR|0|0|0|100|DKK|28013|38704|lyfalmen|V0652|38704|3|168|0|84,0000|Lyfjaver ehf|Lyfjaver ehf|Apixaban ||28013||28013|38704||3|0|G|0|||0 183825|QP53AC5501|Seresto|hálsband|6,53|g|1|stk|1|poki|4,50 +2,03 g|QP53AC55|01.06.2016||R|0|0|0|0|0|BAN|0|0|0|100|DKK|6640|11445|vetorma|||0|1|0||Icepharma hf|Bayer Animal Health GmbH|Flúmetrín í blöndum||6640||6640|11445||2|0||0|||0 183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|0|0|0|G|0|MDK|0|0|0|100|SEK|1745|3900|lyfalmen|||1|100|0|100,0000|Icepharma hf|Mylan Denmark ApS|Flúdrókortisón||1745||1745|3900||2|0|G|0|||0 183924|N06BA0905|Atomoxetin STADA|hylki|40|mg|30|stk|1|þpakki|hart hylki|N06BA09|01.08.2020||R|1|1|0|0|0|LYF|0|0|0|100|IKR|4500|3150|lyfalmen|V0815|3150|2|30|0|15,0000|LYFIS ehf|LYFIS ehf|Atomoxetín||1200||1200|3150||2|0|E|0|||0 184205|L04AC0501|Stelara|irþ|130|mg|26|ml|1|hgl|lausn|L04AC05|01.09.2017||R|0|0|0|0|0|JCI|0|1|0|100|SEK|339959|429325|lyfsjukr|||1|26|0|240,7407|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||339959||339959|429325||1|H|L|0|||0 184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|0|0|0|G|0|TIL|0|0|0|100|DKK|3024|5660|lyfalmen|V0017|5660|1|700|0|4,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||3024||3024|5660||2|0|G|0|||0 184247|V08CA0901|Gadovist|stl|1|mmol/ml|10|ml|5|áfspr|lausn|V08CA09|01.04.2018||R|0|0|0|0|0|BAB|0|0|0|100|DKK|41967|56353|lyfalmen|||1|50|0||Icepharma hf|Bayer AB|Gadóbútról||||41967|56353||2|H|0|0|||0 184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.03.1998||R|0|0|0|G|0|HES|0|0|0|100|DKK|44742|59863|lyfalmen|V0185|21907|1|100|0|100,0000|Vistor hf|Novartis Healthcare A/S|Letrózól||44742||44742|59863||1|0|G|0|||0 184418|QB03AC0001|Uniferon|stl|200|mg/ml|100|ml|5|hgl|lausn|QB03AC|01.07.2017||R|0|0|0|0|0|PHM|0|0|0|100|XEU|12185|23288|vetalmen|||0|500|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíð||12185||12185|23288||2|0||0|||0 184731|N05AX1205|Aripiprazol Krka|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.04.2017||R|1|0|0|0|0|KRK|0|0|0|100|IKR|3362|6125|lyfalmen|V0690|6125|2|28|0|9,3300|LYFIS ehf|Krka Sverige AB|Aripiprazól||3362||3362|6125||2|0|E|0|||0 185025|R01AC0102|Glinor|nefúði|5,2|mg/sk|15|ml|1|glas||R01AC01|01.03.2015||L|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|15|0|1,9500|Alvogen|ratiopharm GmbH|Krómóglíkatsýra|||||||2|0||0|||0 185248|G03AA0707|Microstad|húðuðtfl|||63|stk|1|þpakki|150/30 mcg|G03AA07|01.05.2017||R|0|0|0|0|0|ASR|0|0|0|100|IKR|985|2554|lyfalm11|V0545|1881|1|63|0|84,0000|LYFIS ehf|STADA Arzneimittel AG|Levónorgestrel og ethinylestradíól||985||985|2554||2|0||0|||1 185822|A02BC0512|Nexium (Lyfjaver)|sþ-tfl|20|mg|100|stk|1|glas||A02BC05|01.10.2020||R|1|0|0|0|0|LVR|0|0|1|100|DKK|9290|6238|lyfalmen|V0011|4880|3|100|0|66,6667|Lyfjaver ehf|Lyfjaver ehf|Esómeprazól||3444||3444|6238||3|0|E|0|||0 185859|C02AC0201|Intuniv|forðatfl|4|mg|28|stk|1|þpakki||C02AC02|01.10.2020||R|1|1|1|0|0|HPI|0|0|0|100|DKK|12837|19167|lyfalmen|||1|28|0|37,3333|Vistor hf|Shire Pharmaceuticals Ireland Limited|Guanfacine||12837||12837|19167||1|0|E|0|||0 186026|B02BD0205|Elocta|sts|3000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|1|0|0|SAB|0|1|0|100|DKK|271397|344053|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||271397|344053||3|0|L|0|||0 186236|N06BA0409|Methylphenidate STADA|hylki|30|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.10.2020||R|1|1|0|0|0|ASR|0|0|0|100|IKR|4000|6040|lyfalmen|V0960|5880|2|30|0|30,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||3300||3300|6040||2|0|E|1|30|dagar|0 186259|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.02.2016||R|1|0|0|0|0|ATE|0|0|1|100|XEU|16955|10776|lyfalmen|V0419|10776|2|30|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúkónazól||6741||6741|10776||1|0|E|0|||0 186615|R03AK0706|DuoResp Spiromax|innönddu|164,5|mcg/sk|120|skammtar|3|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2018||R|0|0|0|G|0|TAB|0|0|0|100|XEU|15483|18891|lyfalmen|||2|360|0|90,0000|Alvogen|Teva Pharma B.V.|Formóteról og budesonide||12637||12637|18891||2|0|G|0|||0 186638|D01AE1502|Lamisil Once|húðlausn|1|%|4|g|1|túpa||D01AE15|01.10.2019||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|4|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Terbínafín|||||||1|0||0|||0 186713|N02AA0506|Oxikodon Depot Actavis|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|0|G|0|ATE|0|0|0|100|XEU|950|2738|lyfalmen|V0597|2738|2|28|0|3,7300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||901||901|2738||1|0|G|1|30|dagar|0 186790|N06DX0106|Memantine ratiopharm|filmhtfl|20|mg|100|stk|1|glas||N06DX01|01.10.2013||R|1|0|0|G|0|RTH|0|0|0|100|IKR|10028|4939|lyfalmen|V0607|4939|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Memantín||2500||2500|4939||2|0|G|0|||0 186867|C10BA0501|Atozet|filmhtfl|20|mg|30|stk|1|þpakki|10 mg + 10 mg|C10BA05|01.03.2015||R|0|0|0|0|0|NVO|0|0|0|100|DKK|5941|9675|lyfalmen|||1|30|0||Vistor hf|N.V. Organon|Atorvastin og ezetimibe||5941||5941|9675||1|0||0|||0 187067|L04AB0205|Flixabi|st/irþ|100|mg|1|hgl|1|pakki||L04AB02|01.12.2018||R|0|1|0|0|0|SUG|0|1|0|100|XEU|40135|54036|lyfsjukr|||2|1|0|26,6700|Icepharma hf|Samsung Bioepis NL B.V.|Infliximab||40135||40135|54036||2|H|L|0|||0 187191|A10BX0204|Repaglinide Krka|töflur|0,5|mg|120|stk|1|þpakki||A10BX02|01.11.2013||R|1|0|0|G|0|KNM|0|0|0|100|IKR|2459|4882|lyfalmen|V0462|4882|2|120|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2459||2459|4882||2|0|G|0|||0 187399|QP54AA0501|Stronghold|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|ZBE|1|0|0|100|XEU|5559|9581|vetorma|||0|6|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||5559||5559|9581||2|0||0|||0 187595|D11AH0201|Elidel|krem|1|%|30|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|G|0|MEA|0|0|1|100|DKK|3702|6593|lyfalmen|||1|30|0||Icepharma hf|Meda AB|Pímekrólímus||3702||3702|6593||2|0|G|0|||0 187612|C09AA0201|Daren|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.05.2020||R|1|0|0|G|0|TVI|0|0|0|100|XEU|868|2693|lyfalmen|V0066|2693|2|100|0|100,0000|Teva Pharma Iceland ehf|Teva B.V|Enalapríl||868||868|2693||1|0|G|0|||0 188338|S01XA2020|Hyprosan|augndr|3,2|mg|10|ml|1|dropaí||S01XA20|01.09.2014||L|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||3158||2|0|G|0|||0 188364|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.08.2012||R|0|0|0|0|0|PEU|0|0|0|100|DKK|67481|88624|lyfalmen|||1|10|0|5,0000|Icepharma hf|Pfizer Europe MA EEIG|Tigecýklín||67481||67481|88624||1|H|0|0|||0 188405|N02CC0406|Rizatriptan Alvogen|munndr.t|10|mg|6|stk|1|þpakki||N02CC04|01.09.2013||R|0|0|0|G|0|POF|0|0|0|100|XEU|2033|3781|lyfalmen|V0621|2972|2|6|0|6,0000|Alvogen|Alvogen|Rizatriptan||1659||1659|3781||2|0|G|0|||0 188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|0|1|0|G|0|DEA|0|0|0|100|XEU|5148|8584|lyfalmen|||1|250|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||5148||5148|8584||1|0|G|0|||0 188827|S01ED5117|DUOKOPT|augndr|25|mg/ml|5|ml|3|glas|5+20 mg/ml, án rotvarnar|S01ED51|01.06.2016||R|0|0|0|G|0|LTH|0|0|0|100|SEK|5354|8867|lyfalmen|||1|15|0|75,0000|Vistor hf|Laboratoires THEA|Tímólól í blöndum||5354||5354|8867||1|0|G|0|||0 188829|R06AX2707|Dasselta|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.09.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|1400|3012|lyfalmen|V0458|2979|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Deslóratadín||1100||1100|3012||2|0|G|0|||0 188988|H02AB0205|Dexametason Abcur|töflur|4|mg|20|stk|1|þpakki|stakskammtaþynna|H02AB02|01.02.2016||R|1|0|0|G|0|ABC|0|0|1|100|IKR|2931|3631|lyfalmen|V0422|3287|2|20|0|53,3300|Icepharma hf|Abcur AB|Dexametasón||1550||1550|3631||2|0|G|0|||0 189052|M05BA0604|Iasibon|irþ|1|mg/ml|2|ml|1|lykja||M05BA06|01.10.2012||R|0|0|0|0|0|PSA|0|0|0|100|DKK|9205|13456|lyfalmen|||2|2|0|0,3400|Alvogen|Pharmathen S.A.|Íbandrónsýra||8688||8688|13456||2|H|0|0|||0 189148|J05AG0501|EDURANT|filmhtfl|25|mg|30|stk|1|glas||J05AG05|01.04.2013||R|0|0|1|0|0|JCI|0|1|0|100|SEK|37862|51161|lyfsjukr|||1|30|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Rilpívírin||37862||37862|51161||1|0|L|0|||0 189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|0|0|0|0|0|HES|0|0|0|100|DKK|6494|10436|lyfalmen|||1|10|0||Vistor hf|Novartis Healthcare A/S|Deferoxamín||6494||6494|10436||1|H|0|0|||0 189312|N02CD0101|Aimovig|stl|140|mg|1|ml|1|áfpen||N02CD01|01.12.2019||R|0|0|1|0|0|NEL|0|0|0|100|DKK|73632|96403|lyfalmen|||1|1|0|56,0000|Vistor hf|Novartis Europharm Ltd|Erenumab||73632||73632|96403||1|0|E|0|||0 189430|N07BC0202|Metadon Abcur|töflur|40|mg|25|stk|1|glas||N07BC02|01.04.2020||R|1|0|0|G|0|ABC|0|0|0|100|SEK|5186|8636|lyfalmen|||1|25|0|40,0000|Icepharma hf|Abcur AB|Metadón||5186||5186|8636||2|0|G|1|30|dagar|0 189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|G|0|PLS|0|0|1|100|DKK|2562|5024|lyfalmen|||1|5|0|10,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2562||2562|5024||1|0|G|0|||0 189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|G|0|PLS|0|0|1|100|DKK|979|2845|lyfalmen|V0413|2845|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||979||979|2845||1|0|G|0|||0 189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|G|0|PLS|0|0|1|100|DKK|474|2150|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||474||474|2150||1|0|G|0|||0 189567|D01BA0203|Terbinafin Actavis|töflur|250|mg|98|stk|1|þpakki||D01BA02|01.04.2021||R|1|0|0|0|0|ATE|0|0|0|100|XEU|5897|8936|lyfalmen|V0737|8902|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Terbínafín||5404||5404|8936||1|0|E|0|||0 190042|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|þpakki||G03CA04|01.11.2015||R|0|0|0|G|0|AEP|0|0|0|100|DKK|1628|3739|lyfalmen|||1|90|0|45,0000|Icepharma hf|Aspen Pharma Trading Limited|Estríól||1628||1628|3739||2|0|G|0|||0 190696|N03AX1610|Pregabalin Medical Valley|hylki|25|mg|70|stk|1|þpakki||N03AX16|01.04.2020||R|1|0|0|0|0|VAL|0|0|0|100|IKR|1038|2737|lyfalmen|V0685|2701|2|70|0|5,8333|Acare ehf|Medical Valley Invest AB|Pregabalín||900||900|2737||2|0|E|0|||0 190715|M04AA0106|Allopurinol Alvogen|töflur|300|mg|100|stk|1|þpakki||M04AA01|01.03.2021||R|1|0|0|G|0|POF|0|0|0|100|IKR|2615|5097|lyfalmen|||2|100|0|75,0000|Alvogen|Alvogen|Allópúrinol||2615||2615|5097||2|0|G|0|||0 191045|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|100|stk|1|glas||C01DA02|01.06.2014||L|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|100|0|10,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||4042||1|0|G|0|||0 191064|B05XC03|Vitalipid Infant|irþ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|FKA|0|0|0|100|DKK|3383|6154|lyfalmen|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||3383||3383|6154||1|0|0|0|||0 191079|C10AA0702|Rosuvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.12.2012||R|1|0|0|0|0|ATE|0|0|0|100|XEU|5169|4986|lyfalmen|V0117|4773|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rósuvastatín||2534||2534|4986||1|0|E|0|||0 191242|C07AA0705|Sotalol Mylan|töflur|40|mg|100|stk|1|þpakki||C07AA07|01.08.2020||R|1|0|0|G|0|MYL|0|0|0|100|SEK|1158|3092|lyfalmen|||2|100|0|25,0000|Icepharma hf|Mylan AB|Sótalól||1158||1158|3092||2|0|G|0|||0 191247|B05XC02|Vitalipid Adult|irþ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|FKA|0|0|0|100|DKK|3470|6274|lyfalmen|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||3470||3470|6274||1|0|0|0|||0 191251|C09DA0108|Losartan/Hydrochlorothiazide Medical Val|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2017||R|1|0|0|G|0|VAL|0|0|0|100|IKR|2149|3108|lyfalmen|V0088|3108|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Lósartan og þvagræsilyf||1170||1170|3108||2|0|G|0|||0 191254|B05XC01|Soluvit|irs|||10|ml|10|hgl||B05XC|01.10.1985||R|0|0|0|0|0|FKA|0|0|0|100|DKK|3673|6553|lyfalmen|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||3673||3673|6553||1|0|0|0|||0 191403|R01AA0503|Nezeril|nefúði|0,25|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|7,5|0|4,6875|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1|0||0|||0 191724|S01ED5119|Cosopt sine|augndr|25|mg/ml|10|ml|1|glas|20mg/ml+5mg/ml|S01ED51|01.05.2019||R|0|0|0|G|0|SAO|0|0|0|100|XEU|3417|6201|lyfalmen|||1|10|0|50,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3417||3417|6201||2|0|G|0|||0 191986|N03AX1604|Brieka|hylki|300|mg|100|stk|1|glas||N03AX16|01.12.2018||R|1|0|0|0|0|ATE|0|0|0|100|XEU|17798|8582|lyfalmen|V0689|6053|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Pregabalín||5147||5147|8582||1|0|E|0|||0 192030|QD06AA0203|Cyclospray|húðúði|78,6|mg/g|200|ml|1|úðaílá||QD06AA02|01.12.2016||R|0|0|0|0|0|ERO|0|0|0|100|XEU|1089|2140|vetalmen|||0|200|0||Vistor hf|Eurovet Animal Health B.V.|Chlortetracycline||1089||1089|2140||1|0||0|||0 192400|J05AB1106|Valablis|filmhtfl|500|mg|10|stk|1|þpakki||J05AB11|01.05.2017||L|1|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||2|10|0|1,6667|Alvogen|Alvogen|Valacíklóvír||||||31.8.2021|2|0|0|0|||0 192456|N06AX1104|Miron Smelt|munndr.t|15|mg|96|stk|1|þpakki||N06AX11|01.12.2011||R|0|0|0|G|0|ATE|0|0|0|100|XEU|5002|7990|lyfalmen|||2|96|0|48,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mirtazapín||4717||4717|7990||1|0|G|0|||0 192514|M01AH0106|Celecoxib Actavis|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|G|0|ATE|0|0|1|100|XEU|2904|4138|lyfalmen|V0429|4138|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Celekoxíb||1918||1918|4138||1|0|G|0|||0 192617|C03AB0101|Centyl med kaliumklorid|filmhtfl|||100|stk|1|glas|2,5 mg / 573 mg|C03AB01|01.12.1972||R|1|0|0|G|0|KPA|0|0|0|100|DKK|2430|4843|lyfalmen|||1|100|0|100,0000|Alvogen|Karo Pharma AB|Bendróflúmetíazíð og kalíum||2430||2430|4843||2|0|G|0|||0 192699|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|BAM|0|0|1|100|SEK|6317|10193|lyfalmen|||1|5000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||6317||6317|10193||2|0|0|0|||0 192867|S01BA0103|Ozurdex|vefjalyf|700|mcg|1|stk|1|pakki|til ísetningar, vefjalyf|S01BA01|01.10.2012||R|0|1|0|0|0|TIC|0|1|0|100|XEU|141700|182746|lyfsjukr|||2|1|0||Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ireland|Dexametasón||141700||141700|182746||1|H|L|0|||0 193122|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|12|stk|1|þpakki||N02CC01|01.07.2014||R|1|0|0|G|0|BFP|0|0|0|100|XEU|2591|2760|lyfalmen|V0233|2225|2|12|0|12,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||917||917|2760||1|0|G|0|||0 193242|A07DA0301|Imodium|filmhtfl|2|mg|100|stk|1|þpakki||A07DA03|01.02.2014||R|1|0|0|G|0|MCS|0|0|0|100|SEK|820|2627|lyfalmen|||1|100|0|20,0000|Vistor hf|McNeil Sweden AB|Lóperamíð||820||820|2627||1|0|G|0|||0 193285|N06DX0109|Marbodin|filmhtfl|10|mg|98|stk|1|stsk.þ||N06DX01|01.11.2020||R|1|0|0|G|0|ASR|0|0|0|100|IKR|4000|5627|lyfalmen|V0605|4840|2|98|0|49,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||3000||3000|5627||2|0|G|0|||0 193821|A12AA0601|Calcium-Sandoz|freyðit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|0|0|0|0|0|SHS|0|0|0|100|IKR|||lyfalmen|||0|20|0|20,0000|Artasan ehf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2760||1|0|E|0|||0 193975|R03DX1001|Fasenra|stl|30|mg|1|ml|1|áfspr||R03DX10|01.12.2018||R|0|0|1|0|0|ZEN|0|1|0|100|SEK|338387|427370|lyfsjukr|||1|1|0|55,5556|Vistor hf|AstraZeneca AB|Benralizumab||338387||338387|427370||1|0|L|0|||0 194245|G04BE0313|Sildenafil Medical Valley|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.04.2019||R|1|0|0|0|0|VAL|0|0|0|100|XEU|3529|3426|lyfalmen|V0143|3426|2|12|0|12,0000|Acare ehf|Medical Valley Invest AB|Síldenafíl||1401||1401|3426||2|0|E|0|||0 194356|J02AC0102|Candizol|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|ATE|0|0|1|100|XEU|2386|2285|lyfalmen|V0556|2186|2|4|0|3,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúkónazól||572||572|2285||1|0|E|0|||0 194404|QM01AC0606|Meloxidolor|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.07.2014||R|0|0|0|0|0|VEB|1|0|0|100|XEU|5207|10049|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Meloxícam||5207||5207|10049||2|0||0|||0 194672|A02BC0508|Esomeprazol Actavis|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.02.2015||R|1|0|0|G|0|ATE|0|0|1|100|IKR|5841|5765|lyfalmen|V0012|5765|2|100|0|133,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Esómeprazól||3100||3100|5765||1|0|G|0|||0 195040|C07AB0311|Atenolol Mylan|töflur|25|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|G|0|MYL|0|0|0|100|SEK|2803|5243|lyfalmen|||2|250|0|83,3300|Icepharma hf|Mylan AB|Atenólól||2721||2721|5243||2|0|G|0|||0 195104|R01AA0707|Otrivin Junior ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas||R01AA07|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Xýlómetazólín|||||||1|0||0|||0 195449|A02BC0403|Rabeprazol Krka|sh-tfl|10|mg|14|stk|1|þpakki||A02BC04|01.01.2019||L|0|0|0|0|0|KRK|0|0|0|100|IKR|||lyflausa|||2|14|0|7,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól|||||||2|0||0|||0 195455|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|||100|ml|50|pokar|leysir f.stungulyf|V07AB|01.07.2013||L|0|0|0|0|0|BAM|0|0|1|100|IKR|||lyfalmen|||0|5000|0||Icepharma hf|Baxter Medical AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||13320||2|0||0|||0 195518|N05AH0206|Clozapin Medical|töflur|100|mg|500|stk|1|glas||N05AH02|01.01.2018||R|1|0|0|G|0|MED|0|0|0|100|IKR|23000|28570|lyfalmen|||2|500|0|166,6666|Medical ehf|Medical ehf|Klózapín||20000||20000|28570||2|0|G|0|||0 195583|H01AC0104|Saizen|sts|8|mg/ml|2,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|1|0|0|MEC|0|1|0|100|SEK|53193|70552|lyfsjukr|||1|2,5|0|30,0000|Icepharma hf|Merck AB|Sómatrópín||53193||53193|70552||2|0|L|0|||0 195587|L04AB0601|Simponi|stl|50|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.06.2011||R|0|1|1|0|0|JAN|0|1|0|100|DKK|144995|186844|lyfsjukr|||1|1|0|30,1200|Vistor hf|Janssen Biologics B.V.|Golimumab||144995||144995|186844||1|0|L|0|||0 195618|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|G|0|NVO|0|0|1|100|DKK|910|2750|lyfalmen|||1|30|0||Vistor hf|N.V. Organon|Mómetasón||910||910|2750||1|0|G|0|||0 195669|D01AC2002|Pevisone|krem|||15|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|KPA|0|0|1|100|SEK|643|2383|lyfalmen|||1|15|0||Alvogen|Karo Pharma AB|Blöndur||643||643|2383||2|0|E|0|||0 195999|M05BA0606|Ibandronic acid WH|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2018||R|1|1|0|G|0|WEH|0|0|0|100|IKR|3842|3893|lyfalmen|V0205|3838|2|3|0|90,0000|Williams & Halls efh|Williams & Halls ehf|Íbandrónsýra||1740||1740|3893||2|0|G|0|||0 196022|C07AB0311|Atenolol Mylan|töflur|50|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|G|0|MYL|0|0|0|100|SEK|3130|5243|lyfalmen|||2|250|0|166,6700|Icepharma hf|Mylan AB|Atenólól||2721||2721|5243||2|0|G|0|||0 196218|N02AA0508|Oxycodone Alvogen|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.12.2020||R|1|0|0|G|0|GOV|0|0|0|100|XEU|1607|3710|lyfalmen|V0584|3568|2|28|0|7,4700|Alvogen|Alvogen ehf|Oxýcódon||1607||1607|3710||2|0|G|1|30|dagar|0 196444|M04AA0105|Allonol|töflur|300|mg|100|stk|1|þpakki||M04AA01|01.06.2014|31.07.2021|R|1|0|0|G|0|RTH|0|0|0|100|IKR|2615|5097|lyfalmen|||2|100|0|75,0000|Alvogen|ratiopharm GmbH|Allópúrinol||2615||2615|5097||2|0|G|0|||0 196518|L01CE0101|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01CE01|01.04.2019||R|0|0|0|0|0|NEL|0|0|0|100|DKK|53404|70819|lyfalmen|||1|1|0||Vistor hf|Novartis Europharm Ltd|Topotecan||53404||53404|70819||1|H|0|0|||0 196551|N02BE0114|Pinex|mixtúra|24|mg/ml|100|ml|1|fl||N02BE01|01.07.2012||L|0|0|0|0|0|ATE|0|0|1|100|IKR|||lyfalmen|||0|100|0|0,8000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paracetamól|||||2141||1|0|E|0|||0 196851|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.05.2012||R|0|0|0|G|0|AEP|0|0|0|100|DKK|5888|9602|lyfalmen|||1|100|0|0,8333|Icepharma hf|Aspen Pharma Trading Limited|Labetalól||5888||5888|9602||2|0|G|0|||0 196889|D07AB0202|Locoid Crelo|húðfl|0,1|%|30|g|1|glas|á húð|D07AB02|01.03.2018||R|0|0|0|G|0|CPM|0|0|1|100|DKK|589|2309|lyfalmen|||1|30|0||Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Hýdrókortisón bútýrat||589||589|2309||1|0|G|0|||0 196913|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|0|RAG|0|1|0|100|DKK|19358|28142|lyfsjukr|||1|2|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||||19358|28142||1|0|L|0|||0 197160|M04AA0105|Allonol|töflur|100|mg|100|stk|1|þpakki||M04AA01|01.05.2014|31.07.2021|R|1|0|0|G|0|RTH|0|0|0|100|IKR|842|2657|lyfalmen|||2|100|0|25,0000|Alvogen|ratiopharm GmbH|Allópúrinol||842||842|2657||2|0|G|0|||0 197320|L04AB0204|Inflectra|st/irþ|100|mg|100|mg|1|hgl||L04AB02|01.06.2020||R|0|0|0|0|0|PEU|0|1|0|100|DKK|40398|54369|lyfsjukr|||2|100|0|26,6700|Icepharma hf|Pfizer Europe MA EEIG|Infliximab||40398||40398|54369||1|H|L|0|||0 197554|N07BA0147|Nicorette QuickMist|munnhúði|1|mg/sk|150|skammtar|1|úðapum|1 x 150 úðaskammtar|N07BA01|01.01.2013||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|150|0|5,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr|án rotvarnarefnis|N01BB02|01.10.2003||R|0|0|0|0|0|MAR|0|0|1|100|DKK|3716|6613|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Lídókaín||3716||3716|6613||2|0||0|||0 197927|L01EX0901|Ofev|hylki|100|mg|60|stk|1|þpakki||L01EX09|01.07.2016||R|0|0|1|0|0|BOE|0|0|0|100|DKK|244099|310102|lyfalmen|||1|60|0||Vistor hf|Boehringer Ingelheim International GmbH|Nintedanib||244099||244099|310102||1|0|E|0|||0 198334|M02AA1502|Voltaren|hlaup|11,6|mg/g|150|g|1|túpa||M02AA15|01.02.2015||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|150|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Díklófenak|||||||1|0||0|||0 198361|J01FA0904|Clarithromycin Krka|filmhtfl|500|mg|14|stk|1|þpakki||J01FA09|01.09.2018||R|1|0|0|0|0|KNM|0|0|1|100|IKR|2872|3563|lyfalmen|||2|14|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Klaritrómýcín||1500||1500|3563|31.7.2021|2|0||0|||0 198582|C09CA0106|Losatrix|filmhtfl|50|mg|100|stk|1|þpakki||C09CA01|01.01.2014||R|1|0|0|G|0|RTH|0|0|0|100|IKR|3429|2943|lyfalmen|V0069|2943|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Lósartan||1050||1050|2943||2|0|G|0|||0 198665|H01BA0208|NOCDURNA|frþ.tfl|50|mcg|30|stk|1|þpakki||H01BA02|01.04.2017||R|0|0|0|G|0|FEL|0|0|0|100|DKK|3833|6774|lyfalmen|||1|30|0|3,7500|Vistor hf|Ferring Lægemidler A/S|Desmópressín||3833||3833|6774||1|0|G|0|||0 199454|B01AC2201|Efient|filmhtfl|5|mg|28|stk|1|þpakki||B01AC22|01.11.2016||R|0|1|0|G|0|DSA|0|0|0|100|XEU|7952|12443|lyfalmen|V0805|9848|1|28|0|14,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Prasugrel||||7952|12443||2|0|G|0|||0 199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|þpakki||N05CD05|01.11.1981||R|1|0|0|0|0|PLS|0|0|1|100|DKK|599|2322|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tríazólam||599||599|2322||1|0||2|30|töflur|0 199637|A02AA0403|Magnesia medic|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.07.2020||L|1|0|0|0|0|MEA|0|0|0|100|IKR|||lyfalmen|||0|100|0|16,6700|Icepharma hf|Meda AB|Magnesíum hýdroxíð|||||2299||2|0||0|||0 199692|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|0|RAG|0|1|0|100|DKK|70520|92467|lyfsjukr|||1|0,6|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||||70520|92467||1|0|L|0|||0 199903|A10BK0401|Steglatro|filmhtfl|15|mg|28|stk|1|þpakki||A10BK04|01.01.2019||R|1|0|0|G|0|MSD|0|0|0|100|DKK|5656|9283|lyfalmen|||1|28|0|42,0000|Vistor hf|M.S.D.|Ertugliflozin||5656||5656|9283||1|0|G|0|||0 199940|L01XC1101|Yervoy|stþ|5|mg/ml|40|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|0|0|BMS|0|1|0|100|DKK|2158896|2691573|lyfsjukr|||1|40|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||2158896||2158896|2691573||1|H|L|0|||0 370173|QH01CA9301|Suprelorin|vefjalyf|9,4|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|VIR|1|0|0|100|XEU|37137|70627|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||37137||37137|70627||1|0||0|||0 370395|J01CA0413|Amoxin|filmhtfl|375|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|RTH|0|0|1|100|SEK|1814|3995|lyfalmen|||2|20|0|5,0000|Alvogen|ratiopharm GmbH|Amoxicillín||1814||1814|3995||2|0|E|0|||0 370901|L01EB0202|Varlota|filmhtfl|100|mg|30|stk|1|þpakki||L01EB02|01.07.2017||R|1|1|1|0|0|ZET|0|1|0|100|XEU|242883|286455|lyfsjukr|||2|30|0||Alvogen|Zentiva, k.s.|Erlotinib||225086||225086|286455||2|0|L|0|||0 371583|A06AG1001|Klyx|innhl|||240|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|240|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||||1|0||0|||0 371609|A06AG1001|Klyx|innhl|||120|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|120|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||||1|0||0|||0 371617|A06AG1001|Klyx|innhl|||120|ml|10|fl||A06AG10|01.12.1978||L|0|0|0|0|0|FEL|0|0|0|100|DKK|||lyfalmen|||0|1200|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||10021||1|0|E|0|||0 371826|L01ED0301|Alecensa|hylki|150|mg|224|stk|1|þpakki|4 x 56|L01ED03|01.06.2017||R|0|0|1|0|0|RRG|0|1|0|100|DKK|736724|922790|lyfsjukr|||1|224|0||Icepharma hf|Roche Registration GmbH|Alectinib||736724||736724|922790||2|0|L|0|||0 372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|1|0|0|G|0|SNP|0|0|0|100|XEU|3527|6352|lyfalmen|||1|90|0|11,2500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||3527||3527|6352||1|0|G|0|||0 372074|L01XX3502|Anagrelide AOP|hylki|0,5|mg|100|stk|1|glas|hart|L01XX35|01.05.2020||R|0|0|1|G|0|AOP|0|0|0|100|XEU|30851|42294|lyfalmen|V1034|34230|1|100|0||AOP Orphan Pharmaceuticals AG|AOP Orphan Pharmaceuticals AG|Anagrelidum||||30851|42294||2|0|G|0|||0 372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|0|0|0|G|0|ROA|0|0|0|100|DKK|3107|5774|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche A.S.|Levódópa og dópadekarboxýl­asa­hemill||3107||3107|5774||2|0|G|0|||0 372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|42|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 372180|L01AA0903|Bendamustine medac|st/irþ|2,5|mg/ml|25|mg|1|hgl|lausn|L01AA09|01.03.2018||R|0|0|0|0|0|WIL|0|1|0|100|XEU|6760|10802|lyfsjukr|||2|25|0||Williams & Halls efh|medac Gesellschaft|Bendamústín||6760||6760|10802||2|H|L|0|||0 372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|18|0|3,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 372531|N06BA0408|Methylphenidate Teva|hylki|40|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.11.2019||R|1|1|0|0|0|TVI|0|0|0|100|XEU|7916|7674|lyfalmen|V0996|7674|2|30|0|40,0000|Teva Pharma Iceland ehf|Teva B.V|Metýlfenídat||4487||4487|7674||1|0|E|1|30|dagar|0 372571|G03CA0401|Ovestin|sk-stíll|0,5|mg|15|stk|1|þpakki||G03CA04|01.08.2015||L|0|0|0|G|0|AEP|0|0|0|100|DKK|||lyfalmen|||0|15|0|37,5000|Icepharma hf|Aspen Pharma Trading Limited|Estríól|||||2867||2|0|G|0|||0 372780|A02BC0403|Rabeprazol Krka|sþ-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.07.2021||L|0|0|0|0|0|KRK|0|0|1|100|IKR|||lyflausa|||2|28|0|14,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól|||||||2|0|0|0|||0 373184|P01BB5103|Malastad|filmhtfl|350|mg|12|stk|1|þpakki|250 + 100 mg|P01BB51|01.01.2018||R|1|0|0|0|0|ASR|0|0|0|100|IKR|3105|5772|lyfalmen|V0934|5772|2|12|0|3,0000|LYFIS ehf|STADA Arzneimittel AG|Prógúaníl í blöndum||3105||3105|5772||2|0||0|||0 373205|V04CX0005|Hexvix|duft|85|mg|1|hgl|1|pakki|og leysir|V04CX|01.05.2018||R|0|0|0|0|0|CUR|0|0|0|100|XEU|78672|102778|lyfalmen|||1|1|0||PhotoCure ASA|PhotoCure ASA|Önnur sjúkdómsgreiningarefni||||78672|102778||3|H|0|0|||0 373234|C09AA0211|Enalapril Krka|töflur|10|mg|250|stk|1|glas||C09AA02|01.02.2016||R|1|0|0|G|0|KRK|0|0|0|100|IKR|2770|5311|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2770||2770|5311||2|0|G|0|||0 373239|R03AK0706|DuoResp Spiromax|innönddu|329|mcg/sk|60|skammtar|1|innö.t|320+9 mcg/sk|R03AK07|01.05.2018||R|0|0|0|G|0|TAB|0|0|0|100|XEU|5178|7594|lyfalmen|||2|60|0|30,0000|Alvogen|Teva Pharma B.V.|Formóteról og budesonide||4429||4429|7594||2|0|G|0|||0 373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|1|0|0|G|0|SNP|0|0|0|100|XEU|12023|18046|lyfalmen|||1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||12023||12023|18046||1|0|G|0|||0 373251|L03AB1301|Plegridy|stl|||2|áf-penni|1|pakki|63 og 94 mcg|L03AB13|01.07.2015||R|0|0|1|G|0|BNB|0|0|0|100|XEU|81321|106128|lyfalmen|||1|2|0|17,6400|Icepharma hf|Biogen Netherlands B.V.|Peginterferón beta-1a||81321||81321|106128||2|0|G|0|||0 373324|R03AK0601|Seretide|innönddu|150|mcg/sk|60|skammtar|1|innö.t|50/100 mcg/sk|R03AK06|01.05.2000||R|0|0|0|G|0|GPH|0|0|0|100|DKK|3622|6483|lyfalmen|V0436|5590|1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||3622||3622|6483||1|0|G|0|||0 373340|R03AK0601|Seretide|innönddu|300|mcg/sk|60|skammtar|1|innö.t|50/250 mcg/sk|R03AK06|01.05.2000||R|0|0|0|G|0|GPH|0|0|0|100|DKK|4423|7586|lyfalmen|V0437|5862|1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||4423||4423|7586||1|0|G|0|||0 373365|R03AK0601|Seretide|innönddu|550|mcg/sk|60|skammtar|1|innö.t|50/500 mcg/sk|R03AK06|01.05.2000||R|0|0|0|G|0|GPH|0|0|0|100|DKK|5603|9210|lyfalmen|V0981|6973|1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||5603||5603|9210||1|0|G|0|||0 373611|J07AL0103|Pneumovax|stl|25|mcg|0,5|ml|1|áfspr|lausn|J07AL01|01.06.2017||R|0|0|0|0|0|MBV|0|0|0|100|DKK|4021|7032|lyfalmen|||1|0,5|0||Vistor hf|Merck Sharp & Dohme B.V.|Hreinsuð pneumococca poly­sakkaríð mótefnavakar||4021||4021|7032||1|0||0|||0 373887|A05AA0401|Ocaliva|töflur|5|mg|30|stk|1|glas||A05AA04|01.12.2018||R|1|0|0|0|0|ILT|0|1|0|100|XEU|395872|498865|lyfsjukr|||1|30|0|15,0000|Intercept|Intercept Pharma International Ltd|Obeticholic acid||395872||395872|498865||2|0|L|0|||0 374036|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.12.2016||R|0|0|0|0|0|EUS|0|0|0|100|XEU|8027|12546|lyfalmen|||1|1|0|0,1354|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||8027||8027|12546||3|H|0|0|||0 374077|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 374143|L01EX0401|Caprelsa|filmhtfl|100|mg|30|stk|1|þpakki||L01EX04|01.07.2012||R|1|1|1|0|0|GEB|0|1|0|100|XEU|343470|423976|lyfsjukr|||1|30|0||Vistor hf|Genzyme Europe B.V.|Vandetanib||335658||335658|423976||1|0|L|0|||0 374194|L01EE0101|Mekinist|filmhtfl|0,5|mg|30|stk|1|glas||L01EE01|01.01.2016||R|0|0|1|0|0|NEL|0|1|0|100|DKK|226115|287735|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Trametinib||226115||226115|287735||1|0|L|0|||0 374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|þpakki||A10BA02|01.01.1987||R|1|0|0|G|0|MCK|0|0|0|100|SEK|467|2141|lyfalmen|V0500|2062|1|100|0|25,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||467||467|2141||2|0|G|0|||0 374251|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|5217|8679|lyfalmen|||1|7500|0||Vistor hf|Fresenius Kabi AB|Kolvetni||5217||5217|8679||1|0|0|0|||0 374348|G04CA0201|Omnic|hylki|0,4|mg|30|stk|1|þpakki|með br.losunarhraða|G04CA02|01.08.1998||R|1|0|0|G|0|ASP|0|0|0|100|XEU|3628|6491|lyfalmen|V0926|4386|1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||3628||3628|6491||1|0|G|0|||0 374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|þpakki||J05AB11|01.01.2003||R|1|0|0|G|0|GPH|0|0|1|100|DKK|10271|15635|lyfalmen|||1|60|0|5,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Valacíklóvír||10271||10271|15635||1|0|G|0|||0 374450|L01EF0101|Ibrance|hylki|100|mg|21|stk|1|þpakki||L01EF01|01.02.2017||R|1|0|1|0|0|PEU|0|1|0|100|DKK|311653|394120|lyfsjukr|||1|21|0||Icepharma hf|Pfizer Europe MA EEIG|Palbociclib||311653||311653|394120||1|0|L|0|||0 374504|G01AF0502|Pevaryl Depot|krem/sti|||15|g|1|sett|kr.+1sk-stíll m.forðaverkun|G01AF05|01.01.1997||L|0|0|0|0|0|TAE|0|0|0|100|IKR|||lyflausa|||0|15|0|1,5000|Alvogen|Trimb Healthcare AB|Ekónazól|||||||2|0||0|||0 374527|J07CA0602|Pentavac|sts|||0,5|ml|1|hgl|1 hgl og1 áf spr+ 2 aðsk nálar|J07CA06|01.04.2020|30.09.2021|R|0|0|0|0|0|SSS|0|0|0|100|XEU|5019|8406|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||5019||5019|8406||1|0||0|||0 374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|G|0|SNP|0|0|1|100|XEU|7727|12133|lyfalmen|||1|6|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||7727||7727|12133||1|0|G|0|||0 374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|G|0|SNP|0|0|1|100|XEU|10239|15591|lyfalmen|||1|8|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||10239||10239|15591||1|0|G|0|||0 374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|G|0|SNP|0|0|1|100|XEU|12153|18225|lyfalmen|||1|10|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||12153||12153|18225||1|0|G|0|||0 374672|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|50|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|G|0|BLS|0|0|1|100|XEU|6178|10001|lyfalmen|V0383|9068|2|50|0|12,5000|Artasan ehf|Bluefish Pharmaceuticals AB|Ondansetrón||6178||6178|10001||1|0|G|0|||0 374941|QJ01CA0403|Amoxibactin vet.|töflur|50|mg|100|stk|1|þpakki||QJ01CA04|01.12.2016||R|0|0|0|0|0|VEB|0|0|0|100|IKR|2720|3774|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Amoxicillinum||1920||1920|3774||2|0|0|0|||0 375005|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.01.2019||R|0|1|0|0|0|FEC|0|1|0|100|XEU|3104207|3867276|lyfsjukr|||1|20|0|46,5100|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||3104207||3104207|3867276||2|H|L|0|||0 375153|C09DA0311|Valsartan/ Hydrochlorothiazide Krka|filmhtfl|92,5|mg|98|stk|1|þpakki|80/12,5 mg|C09DA03|01.08.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|3448|5352|lyfalmen|V0580|5159|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Valsartan og þvagræsilyf||2800||2800|5352||2|0|G|0|||0 375275|J02AC0304|Voriconazole Accord|filmhtfl|50|mg|30|stk|1|þpakki||J02AC03|01.04.2018||R|1|1|0|G|0|ACC|0|0|1|100|XEU|10796|16358|lyfalmen|V1033|16358|2|30|0|3,7500|Artasan ehf|Accord Healthcare Limited|Voricónazól||||10796|16358||1|0|G|0|||0 375508|S01EE0501|Taflotan|augndr|15|mcg/ml|3|ml|1|glas||S01EE05|01.03.2019||R|0|0|0|G|0|SAO|0|0|0|100|XEU|2453|4874|lyfalmen|||1|3|0|30,0000|Icepharma hf|Santen Oy|Taflúprost||2453||2453|4874||2|0|G|0|||0 375938|QI09AL0802|CircoMax Myco|stl|||100|ml|1|hgl|fleyti|QI09AL08|01.10.2021||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|9266|15971|vetorma|||0|100|0||Icepharma hf|Zoetis Belgium S.A.|Mycoplasma hyopneumoniae, Recombinat Porcine Circovirus||9266||9266|15971||2|0||0|||0 376235|A04AA5501|Akynzeo|hylki|||1|stk|1|þpakki|300 mg/0,5 mg|A04AA55|01.02.2021||R|1|0|0|0|0|HBI|0|0|1|100|DKK|10498|15947|lyfalmen|||1|1|0||Swedish Orphan Biovitrum A/S|Helsinn Birex Pharmaceuticals Ltd.|Palonosetron,combinations||10498||10498|15947||3|0|E|0|||0 376246|B01AC2401|Brilique|filmhtfl|90|mg|168|stk|1|þpakki||B01AC24|01.06.2011||R|1|0|0|G|0|AZA|0|0|0|100|SEK|30849|42291|lyfalmen|V0459|41058|1|168|0|84,0000|Vistor hf|AstraZeneca AB|Ticagrelor||30849||30849|42291||1|0|G|0|||0 376387|R03AK1001|Relvar Ellipta|innönddu|206|mcg/sk|30|skammtar|1|pakki|184+22 mcg|R03AK10|01.04.2014||R|0|0|0|G|0|RGP|0|0|0|100|DKK|5524|9101|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline (Ireland) Limited|Vilanterol og flútícason||5524||5524|9101||1|0|G|0|||0 376509|L04AD0202|Prograf|hylki|1|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|1|G|0|ASP|0|0|0|100|XEU|16058|23600|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||16058||16058|23600||1|0|G|0|||0 376510|R06AE0706|Zensitin|filmhtfl|10|mg|10|stk|1|þpakki||R06AE07|01.07.2017||L|1|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Williams & Halls efh|Williams & Halls ehf|Cetirizín|||||||2|0||0|||0 376533|L04AD0202|Prograf|hylki|5|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|1|G|0|ASP|0|0|0|100|XEU|84082|109621|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||84082||84082|109621||1|0|G|0|||0 377134|QP54AA0105|Noromectin|stl|1|% w/v|250|ml|1|hgl|lausn|QP54AA01|01.03.2014||R|0|0|0|0|0|BRO|1|0|0|100|IKR|13110|22596|vetorma|||0|250|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Ltd|Ivermectinum||13110||13110|22596||2|0||0|||0 377249|C10AX1301|Repatha|stl|140|mg|6|áf-penni|1|pakki||C10AX13|01.10.2016||R|0|0|0|0|0|AEB|0|0|0|100|DKK|204077|260326|lyfalmen|||1|6|0|84,0000|Vistor hf|Amgen Europe B.V.|Evolocumab||204077||204077|260326||1|0|E|0|||0 377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|þpakki||J05AB11|01.10.1996||R|1|0|0|G|0|GPH|0|0|1|100|DKK|8696|7728|lyfalmen|V0182|5214|1|42|0|7,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Valacíklóvír||4526||4526|7728||1|0|G|0|||0 377504|G04CB0203|Dutasteride ratiopharm|hylki|0,5|mg|30|stk|1|þpakki|hylki mjúk|G04CB02|01.06.2018|31.07.2021|R|1|0|0|G|0|TVA|0|0|0|100|DKK|2135|2777|lyfalmen|||2|30|0|30,0000|Alvogen|Teva B.V.|Dútasteríð||929||929|2777||2|0|G|0|||0 377577|G03DA0408|Cyclogest|sk-stíll|400|mg|15|stk|1|pakki||G03DA04|01.05.2020||R|0|0|1|G|0|GRI|0|0|0|100|SEK|4926|8278|lyfalmen|||1|15|0||Gedeon Ricther Nordics AB|Gedeon Richter Plc.|Prógesterón||4926||4926|8278||3|0|G|0|||0 377640|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.10.2017||R|0|0|1|0|0|SDG|0|1|0|100|DKK|25563|33259|lyfsjukr|||1|1,5|0|15,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||23708||23708|33259||1|0|L|0|||0 377966|R03AK0606|Salmeterol/Fluticasone Neutec|innönddu|550|mcg/sk|60|skammtar|1|innö.t|50/500 mcg/sk|R03AK06|01.05.2021||R|0|0|0|G|0|NET|0|0|0|100|DKK|5085|6973|lyfalmen|V0981|6973|2|60|0|30,0000|Lyfjaver ehf|Neutec Inhaler Ireland Limited|Salmeteról og fluticason||3978||3978|6973||3|0|G|0|||0 378432|L01EM0101|Zydelig|filmhtfl|100|mg|60|stk|1|glas||L01EM01|01.07.2016||R|1|0|1|0|0|GSE|0|1|0|100|DKK|540258|678441|lyfsjukr|||1|60|0|20,0000|Gilead Sience Sweden AB|Gilead Sciences Ireland|Idelalisib||540258||540258|678441||2|0|L|0|||0 378535|D07AC1301|Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|G|0|NVO|0|0|1|100|DKK|2081|4362|lyfalmen|||1|100|0||Vistor hf|N.V. Organon|Mómetasón||2081||2081|4362||1|0|G|0|||0 378801|A10BH0102|Januvia (Lyfjaver)|filmhtfl|50|mg|98|stk|1|þpakki||A10BH01|01.06.2019||R|1|0|0|G|0|LVR|0|0|0|100|DKK|14859|21950|lyfalmen|V0982|21950|3|98|0|49,0000|Lyfjaver ehf|Lyfjaver ehf|Sítagliptín||14859||14859|21950||3|0|G|0|||0 378870|N04BA0210|Sinemet 12,5/50|töflur|62,5|mg|100|stk|1|þpakki|12,5+50 mg|N04BA02|01.02.2018||R|1|0|0|G|0|NVO|0|0|0|100|DKK|1822|4006|lyfalmen|||1|100|0|8,3300|Vistor hf|N.V. Organon|Levódópa og dópadekarboxýl­asa­hemill||1822||1822|4006||1|0|G|0|||0 379158|R01AD0901|Nasonex|nefúði|50|mcg/sk|140|skammtar|1|úðagl|18 g í pakkn.|R01AD09|01.02.2015||R|0|0|0|G|0|NVO|0|0|1|100|DKK|1318|3312|lyfalmen|V0677|2753|1|140|0|35,0000|Vistor hf|N.V. Organon|Mómetasón||1318||1318|3312||1|0|G|0|||0 379173|M01AH0504|Etoricoxib Krka|filmhtfl|60|mg|100|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|5289|7004|lyfalmen|V0830|7004|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||4000||4000|7004||2|0|G|0|||0 379419|B02BD0205|Elocta|sts|2000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|1|0|0|SAB|0|1|0|100|DKK|175431|224698|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||175431|224698||3|0|L|0|||0 379570|L04AB0101|Enbrel|stl|50|mg|4|pennar|1|pakki|lausn|L04AB01|01.03.2012||R|0|1|1|0|0|PEU|0|1|0|100|DKK|117855|153090|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Europe MA EEIG|Etanercept||117855||117855|153090||1|0|L|0|||0 379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|0|HES|0|1|0|100|DKK|110944|92639|lyfsjukr|||1|2|0|14,2900|Vistor hf|Novartis Healthcare A/S|Oktreótíð||70656||70656|92639||1|0|L|0|||0 379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|0|HES|0|1|0|100|DKK|121436|101574|lyfsjukr|||1|2|0|28,5700|Vistor hf|Novartis Healthcare A/S|Oktreótíð||77720||77720|101574||1|0|L|0|||0 379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|0|HES|0|1|0|100|DKK|154934|128689|lyfsjukr|||1|2|0|42,8600|Vistor hf|Novartis Healthcare A/S|Oktreótíð||99158||99158|128689||1|0|L|0|||0 379796|N04BC0408|Ropinirole Alvogen|forðatfl|2|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|G|0|POF|0|0|0|100|XEU|5523|6849|lyfalmen|V0532|6849|2|84|0|28,0000|Alvogen|Alvogen|Rópíníról||3888||3888|6849||2|0|G|0|||0 379875|N05BA0105|Stesolid|eþ-lausn|5|mg/2,5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|ATE|0|0|1|100|DKK|3009|5640|lyfalmen|||2|12,5|0|2,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||3009||3009|5640||1|0||2|50|túpur|0 379883|N05BA0105|Stesolid|eþ-lausn|10|mg/2,5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|ATE|0|0|1|100|DKK|2946|5553|lyfalmen|||2|12,5|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||2946||2946|5553||1|0||2|25|túpur|0 379945|N06AB0604|Sertralin Bluefish|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.09.2017||R|1|0|0|G|0|BLS|0|0|0|100|XEU|2207|3169|lyfalmen|V0322|2971|2|100|0|100,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Sertralín||1214||1214|3169||1|0|G|0|||0 380141|QN03AA0201|Phenoleptil|töflur|25|mg|100|stk|1|þpakki|handa hundum|QN03AA02|01.05.2016||R|0|0|0|0|0|BVL|0|0|0|100|IKR|2057|4043|vetalmen|||1|100|0||Dýraheilsa ehf|Le Vet B.V.|Phenobarbitalum||2057||2057|4043||2|0||2|||0 380308|N03AX1610|Pregabalin Medical Valley|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.06.2019||R|1|0|0|0|0|VAL|0|0|0|100|IKR|2075|3563|lyfalmen|V0687|2612|2|56|0|28,0000|Acare ehf|Medical Valley Invest AB|Pregabalín||1500||1500|3563||2|0|E|0|||0 380466|B01AF0201|Eliquis|filmhtfl|2,5|mg|168|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|G|0|BSM|0|0|0|100|DKK|27964|38642|lyfalmen|V0653|38641|1|168|0|42,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||27964|38642||1|0|G|0|||0 380621|D07AD0101|Dermovat|smyrsli|0,5|mg/g|30|g|1|túpa||D07AD01|01.12.2017||R|0|0|0|G|0|GPH|0|0|1|100|DKK|570|2282|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||570||570|2282||1|0|G|0|||0 380658|G04CA5204|Duta Tamsaxiro|hylki|0,9|mg|90|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.06.2020||R|1|0|0|G|0|VAL|0|0|0|100|XEU|8400|9053|lyfalmen|V1010|9053|2|90|0|90,0000|Acare ehf|Medical Valley Invest AB|Dútasteríð og tamsúlósínhýdroklóríð||5489||5489|9053||2|0|G|0|||0 380732|C10AA0703|Rosuvastatin Krka|filmhtfl|40|mg|100|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|KRK|0|0|0|100|IKR|10426|10169|lyfalmen|V0195|10169|2|100|0|400,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||6300||6300|10169||2|0|E|0|||0 380922|D07AB0201|Locoid|húðlausn|1|mg/ml|30|ml|1|glas||D07AB02|01.09.2017||R|0|0|0|G|0|CPM|0|0|1|100|DKK|547|2251|lyfalmen|||1|30|0||Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Hýdrókortisón bútýrat||547||547|2251||1|0|G|0|||0 380973|S01FA5601|MYDRANE|stl|||20|lykjur|1|pakki|0,2+3,1+10 mg/ml|S01FA56|01.05.2021||R|0|0|0|0|0|TEA|0|0|0|100|SEK|21788|30831|lyfalmen|V1042|30831|1|20|0||Vistor hf|Laboratories THEA|Tropikamid í blöndum||21788||21788|30831||1|H|0|0|||0 381120|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.11.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 381231|QP54AA0501|Stronghold|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|ZBE|1|0|0|100|XEU|3003|5176|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||3003||3003|5176||2|0||0|||0 381510|A10BK0101|Forxiga|filmhtfl|5|mg|98|stk|1|þpakki||A10BK01|01.04.2019||R|1|1|0|G|0|AZE|0|0|0|100|SEK|21884|30952|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca AB|Dapagliflozin||21884||21884|30952||1|0|G|0|||0 381578|M02AA1506|Diclofenac Teva|hlaup|23,2|mg/g|100|g|1|túpa||M02AA15|01.07.2021||L|0|0|0|0|0|TVI|0|0|1|100|IKR|||lyflausa|||0|100|0||Teva Pharma Iceland ehf|Teva B.V|Díklófenak|||||||1|0||0|||0 381794|V03AC0301|Exjade|filmhtfl|360|mg|90|stk|1|þpakki||V03AC03|01.06.2017||R|1|1|1|0|0|NEL|0|0|0|100|DKK|299491|378994|lyfalmen|||1|90|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||299491||299491|378994||1|0||0|||0 382162|N04BC0408|Ropinirole Alvogen|forðatfl|4|mg|84|stk|1|glas||N04BC04|01.06.2021||R|1|0|0|G|0|POF|0|0|0|100|XEU|6051|8976|lyfalmen|V0533|8976|2|84|0|56,0000|Alvogen|Alvogen|Rópíníról||5433||5433|8976||2|0|G|0|||0 382318|S01XA2103|Cystadrops|augndr|3,8|mg/ml|5|ml|1|glas||S01XA21|01.01.2019||R|0|0|1|0|0|ECO|0|0|0|100|XEU|183514|234751|lyfalmen|||1|5|0||Recordati AB|Recordati Rare Diseases|mercaptamine ||183514||183514|234751||3|0||0|||0 382383|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|kælt|V03AN01|01.10.2012||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0 382474|V03AN0502|Airapy|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|20|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5|0||0|||0 382657|B02BD0205|Elocta|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|1|0|0|SAB|0|1|0|100|DKK|135698|175282|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||135698|175282||3|0|L|0|||0 382764|R03AK0705|Bufomix Easyhaler|innönddu|164,5|mcg/sk|120|skammtar|1|innö.t|160+4,5 mcg/sk|R03AK07|01.11.2014||R|0|0|0|G|0|COR|0|0|0|100|DKK|4783|8081|lyfalmen|||2|120|0|30,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||4783||4783|8081||1|0|G|0|||0 383037|N02CD0301|AJOVY|stl|225|mg|1,5|ml|1|áfspr||N02CD03|01.11.2019||R|0|0|1|0|0|TGH|0|0|0|100|XEU|70961|93025|lyfalmen|||1|1,5|0|30,0000|Actavis Pharmaceuticals Iceland ehf.|TEVA GmbH|Fremanezumab||70961||70961|93025||1|0|E|0|||0 383105|J06BA0104|Cutaquig|stl|165|mg/ml|6|ml|1|hgl||J06BA01|01.04.2020||R|0|0|1|0|0|OCT|0|1|0|100|DKK|11573|17427|lyfsjukr|||1|6|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||11573||11573|17427||1|0|L|0|||0 383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|þpakki|230+20 mg|QP52AA51|01.06.2000||R|0|0|0|0|0|VEO|0|0|0|100|DKK|1219|2070|vetorma|||0|2|0||Icepharma hf|Vetoquinol S.A.|Prazikvantelum í blöndum||1201||1201|2070||2|0||0|||0 383238|N02AA0508|Oxycodone Alvogen|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.12.2020||R|1|0|0|G|0|GOV|0|0|0|100|XEU|5474|7776|lyfalmen|V0585|7776|2|98|0|26,1300|Alvogen|Alvogen ehf|Oxýcódon||4561||4561|7776||2|0|G|1|30|dagar|0 383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|60|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ketókónazól|||||||1|0||0|||0 383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|120|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ketókónazól|||||||1|0||0|||0 383672|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|þpakki||N06AA04|01.02.2019||R|1|0|0|G|0|ZRB|0|0|0|100|DKK|1590|3686|lyfalmen|||1|100|0|25,0000|zr pharma& GmbH|zr pharma& GmbH|Klómípramín||1590||1590|3686|31.7.2021|0|0|G|0|||0 383719|L01BA0402|Pemetrexed W&H|irþ|25|mg/hgl|20|ml|1|hgl||L01BA04|01.05.2020||R|0|0|0|0|0|WEH|0|1|0|100|XEU|156815|201545|lyfsjukr|||2|20|0||Williams & Halls efh|Williams & Halls ehf|Pemetrexed||156815||156815|201545||2|H|L|0|||0 384125|A10BK0301|Jardiance|filmhtfl|10|mg|30|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|G|0|BOE|0|0|0|100|DKK|6792|10846|lyfalmen|||1|30|0|17,1400|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||6792||6792|10846||1|0|G|0|||0 384716|D01AE1504|Terbinafin Actavis|krem|10|mg/g|15|g|1|túpa||D01AE15|01.09.2015||L|0|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|15|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Terbínafín|||||||1|0||0|||0 384837|N07BC0102|Buvidal|stl|32|mg|0,64|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|0|0|0|CMS|0|1|0|100|DKK|13390|19928|lyfsjukr|||1|0,64|0|15,2381|Vistor hf|Camurus AB|Búprenorfín||13390||13390|19928||1|H|L|1|30|dagar|0 384858|L01EA0103|Imatinib ratiopharm|filmhtfl|400|mg|30|stk|1|þpakki||L01EA01|01.01.2019||R|1|0|1|0|0|RTH|0|1|0|100|XEU|160346|105304|lyfsjukr|||2|30|0||Alvogen|ratiopharm GmbH|Imatinib||80669||80669|105304||2|0|L|0|||0 385238|C10BA0201|Inegy|töflur|50|mg|28|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|NVO|0|0|0|100|DKK|7195|11401|lyfalmen|||1|28|0|28,0000|Vistor hf|N.V. Organon|Ezetimíb og simvastatín||7195||7195|11401||1|0||0|||0 385343|G04CB0107|Finasteride Medical Valley|filmhtfl|5|mg|100|stk|1|þpakki||G04CB01|01.05.2021||R|1|0|0|G|0|VAL|0|0|0|100|IKR|3900|2943|lyfalmen|V0445|2943|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Fínasteríð||1050||1050|2943||2|0|G|0|||0 386133|H01CB0501|Signifor|sts|60|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|0|ROD|0|1|0|100|DKK|354517|447431|lyfsjukr|||1|1|0|50,0000|Recordati AB|Recordati Rare Diseases|PAsireótið disapartate||354517||354517|447431||1|0|L|0|||0 386950|L04AB0404|IDACIO|stl|40|mg/penna|0,8|ml|2|áfpen|áfylltur penni|L04AB04|01.08.2020||R|0|1|1|0|0|FKA|0|1|0|100|DKK|34421|46809|lyfsjukr|||2|1,6|0|27,5862|Vistor hf|Fresenius Kabi AB|Adalimumab||34421||34421|46809||1|0|L|0|||0 386959|C03DA0406|Eplerenon Alvogen|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2014||R|1|0|0|0|0|POF|0|0|0|100|IKR|13329|6701|lyfalmen|V0111|6315|2|100|0|100,0000|Alvogen|Alvogen|Eplerenón||3780||3780|6701||2|0|E|0|||0 387012|S01EC5401|Simbrinza|augndr|12|mg/ml|5|ml|3|glas|10 + 2 mg/ml|S01EC54|01.01.2015||R|0|0|0|G|0|NEL|0|0|0|100|DKK|7378|11653|lyfalmen|||1|15|0||Vistor hf|Novartis Europharm Ltd|Brimoníð og brinzolamið||7378||7378|11653||1|0|G|0|||0 387263|L01BA0402|Pemetrexed W&H|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.06.2016||R|0|0|0|0|0|WEH|0|1|0|100|XEU|140936|181796|lyfsjukr|||2|1|0||Williams & Halls efh|Williams & Halls ehf|Pemetrexed||140936||140936|181796||2|H|L|0|||0 387579|N05BA1206|Alprazolam Krka|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|KRK|0|0|0|100|XEU|879|2708|lyfalmen|V0308|2708|2|60|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||879||879|2708||2|0||2|60|mg|0 387854|QM01AE9103|Carprofelican|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2014||R|0|0|0|0|0|VEB|1|0|0|100|XEU|5459|10527|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Vedaprofenum||5459||5459|10527||2|0||0|||0 387884|C01CA0701|Dobutamin Medical|irþ|12,5|mg/ml|20|ml|5|lykjur||C01CA07|01.10.2016|31.08.2021|R|0|0|0|0|0|DIC|0|0|0|100|IKR|6709|10732|lyfalmen|||2|100|0|2,5000|LYFIS ehf|Medical ehf|Dobutamin||6709||6709|10732||2|H|0|0|||0 387918|QD11AH9102|Cytopoint|stl|30|mg|1|ml|2|hgl||QD11AH91|01.08.2021||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|22281|42442|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|lokivetmab||22281||22281|42442||2|0||0|||0 388032|A02BC0513|Esomeprazole Jubilant|sþ-tfl|20|mg|30|stk|1|þpakki||A02BC05|01.09.2019||L|1|0|0|0|0|JUB|0|0|0|100|IKR|||lyflausa|||2|30|0|20,0000|Acare ehf|Jubilant Pharmaceuticals nv|Esómeprazól|||||||2|0||0|||0 388180|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.07.2020||L|1|0|0|0|0|BAB|0|0|1|100|IKR|||lyflausa|||1|30|0|30,0000|Icepharma hf|Bayer AB|Lóratadín|||||||2|0||0|||0 388256|N01BB2001|Emla|krem|50|mg/g|5|g|5|túpa|25mg/g+25mg/g|N01BB20|01.01.1987||R|0|0|0|0|0|MAR|0|0|1|100|DKK|2486|4920|lyfalmen|V1024|4920|1|25|0||Icepharma hf|Aspen Pharma|Blöndur||2486||2486|4920||2|0||0|||0 388272|N01BB2001|Emla|plástur|||2|stk|1|pakki||N01BB20|01.04.1994||L|0|0|0|0|0|MAR|0|0|0|100|IKR|||lyflausa|||0|2|0||Icepharma hf|Aspen Pharma|Blöndur|||||||2|0||0|||0 388836|H05BX0102|Cinacalcet WH|filmhtfl|90|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|WEH|0|0|0|100|XEU|63968|44767|lyfalmen|V0722|43747|2|28|0|42,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||32806||32806|44767||2|0||0|||0 388898|S01ED5116|Taptiqom|augndr|||0,3|ml|90|Sk-ílá|15mcg/ml + 5mg/ml|S01ED51|01.07.2015||R|0|0|0|G|0|SAO|0|0|0|100|XEU|8653|13408|lyfalmen|||1|27|0|90,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||8653||8653|13408||2|0|G|0|||0 389095|A04AA0108|Cinveron|stl|2|mg/ml|4|ml|5|lykjur|lausn|A04AA01|01.07.2018||R|0|0|0|G|0|WEH|0|0|0|100|XEU|6482|10420|lyfalmen|||2|20|0|2,5000|Williams & Halls efh|Williams & Halls ehf|Ondansetrón||6482||6482|10420||2|H|G|0|||0 389106|G03FA0103|Femanor|töflur|||84|stk|1|pakki|þp 2+1 mg |G03FA01|01.08.1998||R|0|0|0|G|0|MEA|0|0|0|100|DKK|2430|4307|lyfalmen|V0410|4307|1|84|0|84,0000|Icepharma hf|Meda AB|Noretísterón og östrógen||2041||2041|4307||2|0|G|0|||0 389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|0|0|0|G|0|MEA|0|0|0|100|DKK|762|2547|lyfalmen|V0128|2547|1|84|0|84,0000|Icepharma hf|Meda AB|Estradíól||762||762|2547||2|0|G|0|||0 389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|0|0|0|G|0|MEA|0|0|0|100|DKK|527|2223|lyfalmen|V0129|2223|1|84|0|42,0000|Icepharma hf|Meda AB|Estradíól||527||527|2223||2|0|G|0|||0 389330|L01BC5901|Lonsurf|filmhtfl|28,19|mg|60|stk|1|þpakki|20 mg + 8,19 mg|L01BC59|01.09.2016||R|0|0|1|0|0|LLS|0|1|0|100|DKK|311779|394277|lyfsjukr|||1|60|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||311779|394277||2|0|L|0|||0 389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|0|0|0|G|0|HEA|0|0|1|100|SEK|762|2547|lyfalmen|||1|3|0||Vistor hf|GlaxoSmithKline Consumer Healthcare A/S|Díklófenak||762||762|2547||1|0|G|0|||0 389404|N06DA0405|Galantamin STADA|forðahlk|24|mg|84|stk|1|þpakki|Hart forðahylki|N06DA04|01.04.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|11830|17781|lyfalmen|||2|84|0|126,0000|LYFIS ehf|STADA Arzneimittel AG|Galantamín||11830||11830|17781||2|0|G|0|||0 389424|N06AX1613|Venlafaxin Medical Valley|forðatfl|300|mg|100|stk|1|þpakki||N06AX16|01.11.2019||R|0|0|0|0|0|VAL|0|0|0|100|IKR|7500|11821|lyfalmen|||2|100|0|300,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||7500||7500|11821||2|0|0|0|||0 389603|R06AX2709|Desloratadine Alvogen|munndr.t|5|mg|30|stk|1|þpakki||R06AX27|01.11.2020||L|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Alvogen|ratiopharm GmbH|Deslóratadín|||||||2|0||0|||0 389637|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg)|G03GA05|01.01.2012||R|0|0|1|G|0|MRP|0|0|0|100|SEK|41140|55307|lyfalmen|||1|1,5|0|12,0000|Icepharma hf|Merck Europe B.V.|Follitrópín alfa||||41140|55307||2|0|G|0|||0 389944|L04AD0201|Advagraf|forðahlk|1|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|1|G|0|APE|0|0|0|100|XEU|15098|22279|lyfalmen|V1044|22276|1|50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||15098||15098|22279||1|0|G|0|||0 390439|R01AD0905|Mometason Apofri|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.10.2018||L|0|0|0|G|0|APO|0|0|1|100|IKR|||lyfalmen|V0677|2753|2|140|0|35,0000|LYFIS ehf|Apofri AB|Mómetasón|||||2753||2|0|G|0|||0 390541|R03DX0801|Cinqaero|irþ|10|mg/ml|10|ml|1|hgl||R03DX08|01.12.2018||R|0|0|0|0|0|TVB|0|1|0|100|NOK|67725|88932|lyfsjukr|||1|10|0|14,0845|Actavis Pharmaceuticals Iceland ehf.|Teva B.V.|Reslizumab||67725||67725|88932||1|H|L|0|||0 390699|N05CM1801|Dexdor|irþ|100|mcg/ml|2|ml|25|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|0|0|COR|0|0|0|100|DKK|74586|97610|lyfalmen|||1|50|0|5,0000|Vistor hf|Orion Corporation|Dexmedetómid||74586||74586|97610||1|H|0|0|||0 390835|A04AA0101|Zofran|filmhtfl|4|mg|10|stk|1|þpakki||A04AA01|01.07.2019||R|1|0|0|G|0|NAA|0|0|1|100|DKK|3258|5982|lyfalmen|V0381|4526|1|10|0|2,5000|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||3258||3258|5982||1|0|G|0|||0 390878|N06BA0202|Attentin|töflur|20|mg|30|stk|1|þpakki||N06BA02|01.08.2017||R|1|1|0|0|0|PUT|0|0|0|100|IKR|12127|18190|lyfalmen|||1|30|0|40,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Dexamfetamine ||||12127|18190||2|0|E|1|30|dagar|0 390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|G|0|UPJ|0|0|1|100|DKK|5608|9217|lyfalmen|V0429|4138|1|100|0|50,0000|Icepharma hf|Upjohn EESV|Celekoxíb||5608||5608|9217||1|0|G|0|||0 390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|G|0|UPJ|0|0|1|100|DKK|2631|5119|lyfalmen|V0037|3319|1|20|0|20,0000|Icepharma hf|Upjohn EESV|Celekoxíb||2631||2631|5119||1|0|G|0|||0 391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|G|0|UPJ|0|0|1|100|DKK|9623|14743|lyfalmen|V0196|6059|1|100|0|100,0000|Icepharma hf|Upjohn EESV|Celekoxíb||9623||9623|14743||1|0|G|0|||0 391354|B02BX0501|Revolade|filmhtfl|50|mg|28|stk|1|þpakki||B02BX05|01.08.2016||R|1|0|1|0|0|NEL|0|1|0|100|DKK|248039|315002|lyfsjukr|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Eltrombópag||248039||248039|315002||1|0|L|0|||0 392000|G03AA0706|Erlibelle|töflur|||63|stk|1|þpakki||G03AA07|01.08.2014||R|0|0|0|0|0|ATE|0|0|0|100|XEU|926|2001|lyfalm11|V0545|1881|2|63|0|84,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Levónorgestrel og ethinylestradíól||536||536|2001||1|0||0|||1 392024|G04BE0311|Revastad|filmhtfl|20|mg|100|stk|1|þpakki||G04BE03|01.11.2017||R|0|0|1|G|0|ASR|0|0|0|100|IKR|45000|31099|lyfalmen|V0984|31099|2|100|0|40,0000|LYFIS ehf|STADA Arzneimittel AG|Síldenafíl||22000||22000|31099||2|0|G|0|||0 392196|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|þpakki||G03DC02|01.07.2019||R|0|0|0|G|0|BAB|0|0|0|100|DKK|970|2833|lyfalmen|||1|30|0|30,0000|Icepharma hf|Bayer AB|Noretísterón||970||970|2833||2|0|G|0|||0 392390|S01XA1802|Ikervis|augndr|1|mg/ml|0,3|ml|30|sk-ílá|fleyti, stakskammtar|S01XA18|01.02.2016||R|0|0|1|0|0|SAO|0|0|0|100|XEU|12590|18827|lyfalmen|||1|9|0||Icepharma hf|Santen Oy|Ciclosporin||12590||12590|18827||2|0|E|0|||0 392402|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|G|0|ATE|0|0|0|100|XEU|8927|10332|lyfalmen|||2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Olanzapín||6418||6418|10332||1|0|G|0|||0 392438|L04AX0701|Tecfidera|hylki|120|mg|14|stk|1|þpakki||L04AX07|01.12.2014||R|0|0|1|0|0|BNB|0|1|0|100|XEU|22936|32283|lyfsjukr|||1|14|0|3,5000|Icepharma hf|Biogen Netherlands B.V.|Dimethyl fumarate||22936||22936|32283||2|0|L|0|||0 393642|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||10|ml|20|plastl|fyrir stungulyf|V07AB|01.06.2015||L|0|0|0|0|0|FKA|0|0|1|100|IKR|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3474||1|0||0|||0 393939|S01EE0404|Travoprost Alvogen|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.01.2015||R|0|0|0|G|0|POF|0|0|0|100|DKK|2173|3953|lyfalmen|V0669|3953|2|2,5|0|25,0000|Alvogen|Alvogen|Travóprost||1784||1784|3953||2|0|G|0|||0 394026|C10AA0704|Rosuvastatin Xiromed|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.04.2021||R|0|0|0|0|0|VAL|0|0|0|100|XEU|4881|7810|lyfalmen|V0118|7740|2|98|0|196,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||4586||4586|7810||2|0|E|0|||0 394139|D01BA0207|Terbinafin Medical Valley|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.08.2017||R|1|0|0|0|0|VAL|0|0|0|100|XEU|1977|3596|lyfalmen|V0123|3596|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Terbínafín||1524||1524|3596||2|0|E|0|||0 394364|J01DB0402|Cefazolina Normon|sts|1|g|100|stk|1|hgl|í vöðva|J01DB04|01.06.2018||R|0|0|0|0|0|LNA|0|0|1|100|XEU|49988|66498|lyfalmen|||2|100|0|33,3333|Williams & Halls efh|Laboratorios Normon, S.A.|Cefazólín||49988||49988|66498||2|0|0|0|||0 394768|N06BA0404|Methylphenidate Sandoz|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.11.2019||R|1|1|0|0|0|SHS|0|0|0|100|DKK|4970|7466|lyfalmen|V0681|7466|2|30|0|27,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||4336||4336|7466||1|0|E|1|30|dagar|0 395077|V03AC0301|Exjade|filmhtfl|90|mg|90|stk|1|þpakki||V03AC03|01.06.2017||R|1|1|1|0|0|NEL|0|0|0|100|DKK|81003|105726|lyfalmen|||1|90|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||81003||81003|105726||1|0||0|||0 395175|A10BJ0202|Saxenda|stl|6|mg/ml|3|ml|5|lyfjap|lausn,áfylltur lyfjapenni|A10BJ02|01.09.2017||R|0|0|0|0|0|NAS|0|0|0|100|DKK|34046|46335|lyfalmen|||1|15|0|60,0000|Vistor hf|Novo-Nordisk A/S|Liraglutide||34046||34046|46335||1|0|E|0|||0 395522|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|áf.spr|nálarvörn|B03XA02|01.08.2011||R|0|0|1|0|0|RAG|0|1|0|100|DKK|136824|176682|lyfsjukr|||1|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||136824||136824|176682||1|0|L|0|||0 395539|C10BA0501|Atozet|filmhtfl|50|mg|30|stk|1|þpakki|10 mg + 40 mg|C10BA05|01.03.2015||R|0|0|0|0|0|NVO|0|0|0|100|DKK|6088|9877|lyfalmen|||1|30|0||Vistor hf|N.V. Organon|Atorvastin og ezetimibe||6088||6088|9877||1|0||0|||0 395781|A04AA0109|Ondansetron STADA|filmhtfl|8|mg|50|stk|1|þpakki||A04AA01|01.06.2021||R|1|0|0|G|0|ASR|0|0|1|100|IKR|10000|13886|lyfalmen|V0388|13886|2|50|0|25,0000|LYFIS ehf|STADA Arzneimittel AG|Ondansetrón||9000||9000|13886||2|0|G|0|||0 395886|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|120|skammtar|3|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|G|0|LVR|0|0|0|100|SEK|17394|25439|lyfalmen|V0356|25439|3|360|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||17394||17394|25439||3|0|G|0|||0 396120|R03AK0705|Bufomix Easyhaler|innönddu|329|mcg/sk|60|skammtar|1|innö.t|320+9 mcg/sk|R03AK07|01.11.2014||R|0|0|0|G|0|COR|0|0|0|100|DKK|4712|7984|lyfalmen|||2|60|0|30,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||4712||4712|7984||1|0|G|0|||0 396318|R06AX2201|Kestine|filmhtfl|10|mg|100|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|G|0|APS|0|0|1|100|DKK|||lyfalmen|||1|100|0|100,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||5271||1|0|G|0|||0 396319|QN01BA0201|Procamidor vet.|stl|20|mg/ml|100|ml|10|hgl||QN01BA02|01.03.2014||R|0|0|0|0|0|RPG|1|0|0|100|DKK|20274|38634|vetalmen|||0|1000|0||Icepharma hf|Richter Pharma AG|Procaine Hydrochlorid||20274||20274|38634||2|0||0|||0 396463|J07CA0602|Pentavac|sts|||0,5|ml|10|hgl|dreifa,dreifa|J07CA06|01.04.2019||R|0|0|0|0|0|SSS|0|0|0|100|XEU|51243|68086|lyfalmen|||1|5|0||Vistor hf|Sanofi Pasteur Europe|Barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||51243||51243|68086||1|0|0|0|||0 396841|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|56|stk|1|glas|hart|A02BC01|01.07.2016||R|1|0|0|G|0|VAL|0|0|1|100|IKR|2300|2048|lyfalmen|V0006|1224|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||400||400|2048||2|0|G|0|||0 396865|QN03AX9001|Pexion|töflur|100|mg|100|stk|1|glas|handa hundum|QN03AX90|01.05.2014||R|0|0|0|0|0|BIV|0|0|0|100|DKK|5355|10330|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Imepitoin||5355||5355|10330||1|0||0|||0 396873|J01CF0104|Dicloxacillin Bluefish|hylki|500|mg|50|stk|1|þpakki||J01CF01|01.07.2019||R|0|0|0|0|0|BLS|0|0|1|100|XEU|3183|5879|lyfalmen|||2|50|0|12,5000|Artasan ehf|Bluefish Pharmaceuticals AB|Díkloxacillín||3183||3183|5879||1|0|0|0|||0 397353|N03AX1603|Pregabalin Krka|hylki|75|mg|100|stk|1|glas||N03AX16|01.04.2017||R|1|0|0|0|0|KNM|0|0|0|100|IKR|4186|3838|lyfalmen|V0686|3637|2|100|0|25,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1700||1700|3838||2|0|E|0|||0 397458|N03AX1209|Gabapentin Sandoz|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.12.2015||R|1|0|0|G|0|SHS|0|0|0|100|DKK|2196|2821|lyfalmen|V0250|2453|2|100|0|16,6667|Artasan ehf|Sandoz A/S|Gabapentín||961||961|2821||1|0|G|0|||0 397494|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.12.2011||R|0|0|0|0|0|MRP|0|1|0|100|SEK|30178|41443|lyfsjukr|||1|20|0||Icepharma hf|Merck Europe B.V.|Cetúxímab||30178||30178|41443||2|H|L|0|||0 397659|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|10|lykjur|innr.lyf, fleyti|N01AX10|01.05.2020||R|0|0|0|0|0|FKA|0|0|0|100|DKK|3279|6011|lyfalmen|||2|200|0||Vistor hf|Fresenius Kabi AB|Própófól||3279||3279|6011||1|H|0|0|||0 397796|A06AB5801|Picoprep|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.10.2011||L|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyfalmen|||0|2|0||Vistor hf|Ferring Lægemidler A/S|Natríumpicosúlfat|||||5828||1|0|E|0|||0 397933|L04AA0607|Mycofenolsýra Accord|sh-tfl|360|mg|120|stk|1|þpakki||L04AA06|01.01.2020||R|0|1|1|G|0|AEE|0|0|0|100|XEU|29902|33529|lyfalmen|V1008|32393|2|120|0|21,6000|Artasan ehf|Accord Healthcare B.V.|Mýcófenólsýra||23921||23921|33529||1|0|G|0|||0 397981|A02BC0401|Pariet|sh-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.08.2021||R|0|0|0|0|0|EIS|0|0|1|100|IKR|7518|6501|lyfalmen|V0010|3838|1|98|0|98,0000|Vistor hf|Eisai Ltd|Rabeprazól||3635||3635|6501||1|0|E|0|||0 398181|N05CD0804|Midazolam Accord|stl/irl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.2019||R|0|0|0|0|0|AEE|0|0|0|100|XEU|1396|3419|lyfalmen|||2|50|0|3,3333|Artasan ehf|Accord Healthcare B.V.|Mídazólam||1396||1396|3419||1|H|0|2|450|mg|0 398265|R03AL1201|Enerzair Breezhaler|innönddu|||90|stk|1|stsk.þ|114 mcg/46 mcg/136mcg|R03AL12|01.01.2021||R|0|0|0|G|0|NEP|0|0|0|100|DKK|24190|33869|lyfalmen|||1|90|0||Vistor hf|Novartis Europharm Limited|Indacaterol, glycopyrronium bromide, mometasone||24190||24190|33869||1|0|G|0|||0 398565|N06AA0907|Amitriptylin Abcur|filmhtfl|10|mg|100|stk|1|glas||N06AA09|01.12.2017||R|1|0|0|G|0|ABC|0|0|0|100|SEK|638|2376|lyfalmen|||2|100|0|13,3333|Icepharma hf|Abcur AB|Amitriptýlín||638||638|2376||2|0|G|0|||0 398659|L01BB0503|Fludarabin Actavis|stl/irþ|25|mg/ml|2|ml|1|hgl|lausn|L01BB05|01.08.2019||R|0|0|0|0|0|ATE|0|0|0|100|XEU|22126|31259|lyfalmen|||2|2|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúdarabín||22126||22126|31259||1|H|0|0|||0 399039|R03DX0901|Nucala|sts|100|mg|1|hgl|1|pakki||R03DX09|01.06.2016||R|0|0|1|0|0|GSD|0|1|0|100|DKK|167588|214944|lyfsjukr|||1|1|0|27,7778|Vistor hf|GlaxoSmithKline Trading Services Ltd.|Mepolizumab||167588||167588|214944||1|0|L|0|||0 399210|N07BA0152|Zonnic Mint|munnh.du|4|mg|20|stk|1|krukka|munnh.duft í posa|N07BA01|01.07.2019||L|0|0|0|0|0|NIC|0|0|1|100|IKR|||lyflausa|||0|20|0|2,6666|LYFIS ehf|Niconovum AB|Nikótín|||||||2|0||0|||0 399390|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|þpakki||A02BC04|01.06.2021||R|0|0|0|0|0|EIS|0|0|1|100|IKR|1160|1527|lyfalmen|V0003|1089|1|14|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||21||21|1527||1|0|E|0|||0 399482|B02BD0101|Octaplex|irs|1000|ae|1|hgl|1|hgl|+leysir,lausn|B02BD01|01.02.2018||R|0|0|0|0|0|OCT|0|1|0|100|DKK|93108|121037|lyfsjukr|||1|1|0||Vistor hf|Octapharma AB|Storkuþættir lX,ll,Vll,X||93108||93108|121037||1|H|L|0|||0 399510|N02AX0204|Tradolan|filmhtfl|50|mg|100|stk|1|þpakki||N02AX02|01.05.2012||R|1|0|0|G|0|GLP|0|0|0|100|DKK|476|2153|lyfalmen|||1|100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||476||476|2153||1|0|G|1|30|dagar|0 399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|1|0|0|G|0|GPH|0|0|0|100|DKK|2571|3045|lyfalmen|V0244|3045|1|56|0|9,3333|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||1124||1124|3045||1|0|G|0|||0 399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|áf.spr|7500 a.e. anti-Xa/sprautu|B01AB04|01.04.1993||R|0|0|0|G|0|PLS|0|0|1|100|DKK|8589|13320|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||8589||8589|13320||1|0|G|0|||0 399825|L01EF0101|Ibrance|hylki|75|mg|21|stk|1|þpakki||L01EF01|01.02.2017|30.09.2021|R|1|0|1|0|0|PEU|0|1|0|100|DKK|306824|388114|lyfsjukr|||1|21|0||Icepharma hf|Pfizer Europe MA EEIG|Palbociclib||306824||306824|388114||1|0|L|0|||0 399904|M01AH0502|Coxient|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|ZET|0|0|1|100|IKR|2326|4251|lyfalmen|V0824|3968|2|28|0|14,0000|Alvogen|Zentiva, k.s.|Etoríkoxíb||2000||2000|4251||2|0|G|0|||0 399997|C10AA0509|Atorvastatin Xiromed|filmhtfl|20|mg|105|stk|1|glas||C10AA05|01.08.2021||R|1|0|0|G|0|MVX|0|0|0|100|IKR|2100|2872|lyfalmen|V0113|2872|2|105|0|105,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||998||998|2872||2|0|G|0|||0 400044|S03CA0102|Sofradex|aug.eydr|||8|ml|1|glas||S03CA01|01.03.1980||R|0|0|0|G|0|SNP|0|0|1|100|XEU|1169|3107|lyfalmen|||1|8|0||Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||1169||1169|3107||1|0|G|0|||0 400134|J05AR2201|Symtuza|filmhtfl|||30|stk|1|glas|800+150+200+10 mg|J05AR22|01.03.2018||R|0|0|1|0|0|JCI|0|1|0|100|SEK|120781|156729|lyfsjukr|||1|30|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavir, Kobicistat, Emtricitabin, Tenofoviralafenamid||120781||120781|156729||1|0|L|0|||0 400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|þpakki||C10AB04|01.04.1988||R|1|0|0|0|0|PLS|0|0|0|100|DKK|2477|4907|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||2477||2477|4907||1|0|E|0|||0 400244|B03AC0005|Ferinject|irl|50|mg/ml|20|ml|1|hgl||B03AC|01.08.2016||R|0|1|0|G|0|VIF|0|0|1|100|CHF|57223|75649|lyfalmen|||1|20|0|10,0000|Vistor hf|Vifor France SA|Járn, stungulyf||57223||57223|75649||1|0|G|0|||0 400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|PLS|0|0|1|100|DKK|473|2149|lyfalmen|||1|25|0|12,5000|Icepharma hf|Pfizer ApS|Oxazepam||473||473|2149||1|0||2|50|töflur|0 400422|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.09.2017||R|0|0|0|G|0|CPM|0|0|1|100|DKK|523|2218|lyfalmen|||1|30|0||Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Hýdrókortisón bútýrat||523||523|2218||1|0|G|0|||0 400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|PLS|0|0|0|100|DKK|1501|3564|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Oxazepam||1501||1501|3564||1|0||2|100|töflur|0 400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|PLS|0|0|1|100|DKK|419|2075|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Oxazepam||419||419|2075||1|0||2|100|töflur|0 400573|C10AX0901|Ezetrol|töflur|10|mg|28|stk|1|þpakki||C10AX09|01.07.2013||R|1|0|0|0|0|MBV|0|0|0|100|DKK|5132|8562|lyfalmen|V0612|5493|1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb||5132||5132|8562||1|0|E|0|||0 400574|L04AX0701|Tecfidera|hylki|240|mg|56|stk|1|þpakki||L04AX07|01.12.2014||R|0|0|1|0|0|BNB|0|1|0|100|XEU|146428|188627|lyfsjukr|||1|56|0|28,0000|Icepharma hf|Biogen Netherlands B.V.|Dimethyl fumarate||146428||146428|188627||2|0|L|0|||0 401084|M01AH0105|Cloxabix|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|G|0|WEH|0|0|1|100|XEU|2218|3422|lyfalmen|V0037|3319|2|20|0|20,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||1398||1398|3422||2|0|G|0|||0 401139|J02AC0301|Vfend|töflur|50|mg|30|stk|1|þpakki||J02AC03|01.04.2020||R|1|1|0|G|0|PEU|0|0|1|100|DKK|20633|29370|lyfalmen|V1033|16358|1|30|0|3,7500|Icepharma hf|Pfizer Europe MA EEIG|Voricónazól||20633||20633|29370||1|0|G|0|||0 401403|J01FA1007|Azithromycin STADA|filmhtfl|500|mg|2|stk|1|þpakki||J01FA10|01.06.2017||R|1|0|0|0|0|ASR|0|0|1|100|IKR|856|2676|lyfalmen|V0173|2676|2|2|0|3,3300|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||856||856|2676||2|0|E|0|||0 401801|B01AC2401|Brilique|filmhtfl|90|mg|56|stk|1|þpakki||B01AC24|01.06.2011||R|1|0|0|G|0|AZA|0|0|0|100|SEK|8855|13686|lyfalmen|V0459|13686|1|56|0|28,0000|Vistor hf|AstraZeneca AB|Ticagrelor||8855||8855|13686||1|0|G|0|||0 401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|G|0|LBK|0|0|0|100|DKK|785|2578|lyfalmen|||1|100|0|13,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||785||785|2578||1|0|G|0|||0 401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|G|0|LBK|0|0|0|100|DKK|1151|3082|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1151||1151|3082||1|0|G|0|||0 402038|N06AB0313|Fluoxetin WH|hylki|20|mg|28|stk|1|þpakki|Hart|N06AB03|01.07.2017||R|0|0|0|0|0|WEH|0|0|0|100|IKR|1032|2918|lyfalmen|||2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Flúoxetín||1032||1032|2918||2|0|G|0|||0 402141|J05AE1003|Darunavir Medical Valley|filmhtfl|800|mg|30|stk|1|glas||J05AE10|01.06.2020||R|1|0|1|0|0|VAL|0|1|0|100|XEU|11510|17340|lyfsjukr|||2|30|0|20,0000|Acare ehf|Medical Valley Invest AB|Darunavír||11510||11510|17340||2|0|L|0|||0 402203|D07AC1302|Ovixan|húðlausn|1|mg/g|100|ml|1|glas||D07AC13|01.08.2013||R|0|0|0|G|0|GAB|0|0|1|100|SEK|1296|3282|lyfalmen|V0952|3282|2|100|0||Vistor hf|Galenica AB|Mómetasón||1296||1296|3282||1|0|G|0|||0 402673|N06BX1301|Raxone|filmhtfl|150|mg|180|stk|1|glas||N06BX13|01.05.2016||R|1|0|1|0|0|SPD|0|1|0|100|DKK|733976|919372|lyfsjukr|||1|180|0|30,0000|Vistor hf|Santhera Pharmaceuticals GmbH|Idebenone||733976||733976|919372||1|0|L|0|||0 402743|QJ01RA0102|Streptocillin, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.11.1979||R|0|0|0|0|0|BID|0|0|0|100|DKK|2009|3948|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|Penicillín í blöndum með öðrum sýklalyfjum||2009||2009|3948||1|0||0|||0 402801|L04AC1601|Tremfya|stl|100|mg|1|stk|1|áfspr||L04AC16|01.01.2019||R|0|0|1|0|0|JCI|0|1|0|100|SEK|327733|414119|lyfsjukr|||1|1|0|55,8659|Vistor hf|Janssen-Cilag International N.V.|Guselkumab||327733||327733|414119||1|0|L|0|||0 402873|N06DA0302|Exelon (Lyfjaver)|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|1|0|G|0|LVR|0|0|0|100|DKK|8168|12482|lyfalmen|V0349|12482|3|30|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||7980||7980|12482||3|0|G|0|||0 402988|J02AC0102|Candizol|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|ATE|0|0|1|100|XEU|4920|2967|lyfalmen|V0552|2737|2|30|0|7,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúkónazól||1067||1067|2967||1|0|E|0|||0 403163|N02AA0508|Oxycodone Alvogen|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.12.2020||R|1|0|0|G|0|GOV|0|0|0|100|XEU|960|2819|lyfalmen|V0597|2738|2|28|0|3,7300|Alvogen|Alvogen ehf|Oxýcódon||960||960|2819||2|0|G|1|30|dagar|0 403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|0|0|0|0|0|IBV|1|0|0|100|DKK|6229|11988|vetalmen|||0|20|0||Vistor hf|Intervet International BV|Cloprostenolum||6229||6229|11988||1|0||0|||0 403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|dropaí||S01GX01|01.09.2018||R|0|0|0|G|0|SNP|0|0|0|100|XEU|1006|2883|lyfalmen|||1|13,5|0||Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||||1006|2883||1|0|G|0|||0 403966|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|10|áf.spr||B01AX05|01.11.2015||R|0|0|0|G|0|MYR|0|0|0|100|DKK|31629|43278|lyfalmen|||1|6|0|30,0000|Icepharma hf|Mylan IRE Healthcare Limited|Fondaparinux||31629||31629|43278||2|0|G|0|||0 404136|J01XD0102|Flagyl|irl|5|mg/ml|100|ml|40|pokar||J01XD01|01.04.2020||R|0|0|0|0|0|SNP|0|0|1|100|XEU|20615|29347|lyfalmen|||1|4000|0|13,3333|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||20615||20615|29347||1|0|0|0|||0 404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||2719||2|0|G|0|||0 404491|B01AD0201|Actilyse|sts/irs|20|mg|1|hgl|1|pakki||B01AD02|01.12.2019||R|0|0|0|0|0|BOI|0|0|0|100|DKK|37585|50811|lyfalmen|||1|1|0|0,2000|Vistor hf|Boehringer Ingelheim|Alteplasi||37585||37585|50811||1|H|0|0|||0 404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.03.2020||R|0|0|0|0|0|BOI|0|0|0|100|DKK|62851|82768|lyfalmen|||1|1|0|0,5000|Vistor hf|Boehringer Ingelheim|Alteplasi||62851||62851|82768||1|H|0|0|||0 404818|C03AA0305|Hydromed|töflur|25|mg|100|stk|1|þpakki||C03AA03|01.06.2013||R|1|0|0|G|0|MEV|0|0|0|100|DKK|978|2844|lyfalmen|||2|100|0|100,0000|Vistor hf|MediLink A/S|hýdróklórtíazíð||978||978|2844||1|0|G|0|||0 404832|R02AA0306|Strepsils Jordbær Sukkerfri|sogtfl|||36|stk|1|þpakki||R02AA03|01.03.2014||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0||0|||0 405129|QP54AA0501|Stronghold|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|ZBE|1|0|0|100|DKK|3011|5190|vetorma|||0|2,25|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||3011||3011|5190||2|0||0|||0 405168|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.06.2015||L|0|0|0|0|0|FKA|0|0|1|100|DKK|||lyfalmen|||0|400|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3619||1|0||0|||0 405200|A05AA0401|Ocaliva|töflur|10|mg|30|stk|1|glas||A05AA04|01.12.2018||R|1|0|0|0|0|ILT|0|1|0|100|XEU|395872|498865|lyfsjukr|||1|30|0|30,0000|Intercept|Intercept Pharma International Ltd|Obeticholic acid||395872||395872|498865||2|0|L|0|||0 405220|A02BC0403|Rabeprazol Krka|sþ-tfl|10|mg|98|stk|1|þpakki||A02BC04|01.04.2017||R|0|0|0|G|0|KRK|0|0|1|100|IKR|2436|4851|lyfalmen|V0467|4851|2|98|0|49,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||2436||2436|4851||2|0|G|0|||0 405491|V08CA0901|Gadovist|stl|1|mmol/ml|7,5|ml|5|áfspr|lausn|V08CA09|01.04.2018||R|0|0|0|0|0|BAB|0|0|0|100|DKK|31476|43084|lyfalmen|||1|37,5|0||Icepharma hf|Bayer AB|Gadóbútról||||31476|43084||2|H|0|0|||0 405677|J01DD0401|Rocephalin|irs|2|g|1|hgl|1|pakki|lausn|J01DD04|01.03.2013||R|0|0|0|0|0|ROA|0|0|1|100|DKK|5040|8435|lyfalmen|||1|1|0|1,0000|Icepharma hf|Roche A.S.|Ceftríaxón||5040||5040|8435||2|0|0|0|||0 405823|C10BA0501|Atozet|filmhtfl|90|mg|90|stk|1|þpakki|10 mg + 80 mg|C10BA05|01.03.2015||R|0|0|0|0|0|NVO|0|0|0|100|DKK|17471|25545|lyfalmen|||1|90|0||Vistor hf|N.V. Organon|Atorvastin og ezetimibe||17471||17471|25545||1|0||0|||0 405998|A10BA0202|Metformin Actavis|filmhtfl|1000|mg|60|stk|1|þpakki||A10BA02|01.11.2014||R|1|0|0|G|0|ATE|0|0|0|100|XEU|416|2071|lyfalmen|||2|60|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metformín||416||416|2071|31.7.2021|1|0|G|0|||0 406106|C10AX1401|Praluent|stl|150|mg/ml|6|áf-penni|1|pakki|lausn í áf.lyfjapenna|C10AX14|01.02.2016||R|0|0|0|0|0|SGB|0|0|0|100|XEU|182558|233562|lyfalmen|||1|6|0|166,6667|Vistor hf|Sanofi-aventis groupe|Alirocumab||182558||182558|233562||1|0|E|0|||0 406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|LBK|0|0|0|100|DKK|17494|25577|lyfalmen|||1|100|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||17494||17494|25577||1|0|E|0|||0 406356|L01XK0101|Lynparza|hylki|50|mg|448|stk|1|pakki|4 x 112 hylki|L01XK01|01.07.2016||R|0|0|1|0|0|AZA|0|1|0|100|SEK|720120|902139|lyfsjukr|||1|448|0||Vistor hf|AstraZeneca AB|Olaparib||720120||720120|902139||1|0|L|0|||0 406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|LBK|0|0|0|100|DKK|52779|70028|lyfalmen|||1|100|0|75,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||52779||52779|70028||1|0|E|0|||0 406435|L01ED0501|Lorviqua|filmhtfl|25|mg|90|stk|1|þpakki||L01ED05|01.04.2021||R|1|0|1|0|0|PEU|0|1|0|100|DKK|724252|907278|lyfsjukr|||1|90|0||Icepharma hf|Pfizer Europe MA EEIG|Lorlatinib||724252||724252|907278||1|0|L|0|||0 407043|B03BA0102|Betolvex|filmhtfl|1|mg|100|stk|1|glas||B03BA01|01.10.2016||L|1|0|0|G|0|ATE|0|0|1|100|XEU|||lyfalmen|||2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cyanocobalamin|||||4505||1|0|G|0|||0 407101|N02AA0507|OxyContin Depot|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.11.2020||R|1|0|0|G|0|MUP|0|0|0|100|DKK|7611|11974|lyfalmen|V0585|7776|1|98|0|26,1300|Icepharma hf|Mundipharma A/S|Oxýcódon||7611||7611|11974||2|0|G|1|30|dagar|0 407393|L04AA3701|OLUMIANT|filmhtfl|2|mg|28|stk|1|þpakki||L04AA37|01.04.2020||R|0|1|1|0|0|NED|0|1|0|100|XEU|119073|154605|lyfsjukr|||1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Baricitinib||119073||119073|154605||2|0|L|0|||0 407423|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|10|hgl|1|pakki|+leysir 30 ml x 10 hgl, dreifa|QJ01CE90|01.02.2016||R|0|0|0|0|0|BIV|0|0|0|100|DKK|17592|33546|vetalmen|||0|10|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Penetamathýdrójoðíð||||17592|33546||2|0||0|||0 407586|N06BA0905|Atomoxetin STADA|hylki|80|mg|30|stk|1|þpakki|hart hylki|N06BA09|01.08.2020||R|1|1|0|0|0|LYF|0|0|0|100|IKR|7000|3287|lyfalmen|V0817|3287|2|30|0|30,0000|LYFIS ehf|LYFIS ehf|Atomoxetín||1300||1300|3287||2|0|E|0|||0 407933|QP54AA5401|BROADLINE|bl.lausn|||0,9|ml|3|sk-ílá||QP54AA54|01.04.2018||R|0|0|0|0|0|BIV|0|0|0|100|DKK|4247|7320|vetorma|||0|2,7|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Praziquantelum ,Fipronil, s-Methoprene ,Eprinomectinum||4247||4247|7320||1|0||0|||0 407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|PLS|0|0|1|100|DKK|350|1980|lyfalmen|||1|25|0|5,0000|Icepharma hf|Pfizer ApS|Oxazepam||350||350|1980||1|0||2|150|töflur|0 407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|PLS|0|0|0|100|DKK|629|2364|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Oxazepam||629||629|2364||1|0||2|150|töflur|0 408102|B01AF0301|Lixiana|filmhtfl|60|mg|100|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|G|0|OPE|0|0|0|100|DKK|29787|40948|lyfalmen|||1|100|0|100,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||29787||29787|40948||1|0|G|0|||0 408145|B01AF0101|Xarelto|filmhtfl|2,5|mg|100|stk|1|þpakki|stakskammtaþynna|B01AF01|01.04.2015||R|1|1|0|G|0|FIN|0|0|0|100|DKK|16200|23796|lyfalmen|V0974|20004|1|100|0|12,5000|Icepharma hf|Bayer AG|Rivaoxaban||16200||16200|23796||2|0|G|0|||0 408166|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|3|rörlyk|lausn|R03BB04|01.08.2019||R|0|0|0|G|0|BII|0|0|0|100|DKK|13877|18224|lyfalmen|||1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||12152||12152|18224||1|0|G|0|||0 408266|N05BA1206|Alprazolam Krka|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|KRK|0|0|0|100|XEU|1857|4054|lyfalmen|V0310|2783|2|60|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1857||1857|4054||2|0||2|60|mg|0 408561|M02AA1504|Diklofenak Apofri|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.01.2019||L|0|0|0|0|0|APO|0|0|1|100|IKR|||lyflausa|||0|100|0||LYFIS ehf|Apofri AB|Díklófenak|||||||2|0||0|||0 408596|N03AX1214|Gabapentin Alvogen|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.09.2021||R|1|0|0|G|0|POF|0|0|0|100|IKR|2941|3425|lyfalmen|V0251|3150|2|100|0|22,2200|Alvogen|Alvogen|Gabapentín||1400||1400|3425||2|0|G|0|||0 408675|D10AD5301|Epiduo|hlaup|||60|g|1|túpa|0,1% / 2,5%|D10AD53|01.07.2017||R|0|0|0|0|0|GAN|0|0|0|100|XEU|4392|7543|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen og benzóýl peroxíð||4392||4392|7543||2|0||0|||0 408909|N06BA0903|Atomoxetin Medical Valley|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|VAL|0|0|0|100|XEU|10140|3284|lyfalmen|V0813|2940|2|28|0|6,3000|Acare ehf|Medical Valley Invest AB|Atomoxetín||1298||1298|3284||2|0|E|0|||0 408927|N03AX1408|Levetiracetam STADA|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.08.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2688|5198|lyfalmen|V0515|5198|2|100|0|16,6700|LYFIS ehf|STADA Arzneimittel AG|Levetíracetam||2688||2688|5198||2|0|G|0|||0 409019|QP54AA0501|Stronghold|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|ZBE|1|0|0|100|XEU|3119|5376|vetorma|||0|1,5|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||3119||3119|5376||2|0||0|||0 409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|0|0|0|0|0|PLS|0|0|1|100|DKK|3666|6544|lyfalmen|||1|35|0|1,7500|Icepharma hf|Pfizer ApS|Flúkónazól||3666||3666|6544||1|0|E|0|||0 409115|QJ51CE0902|Procapen vet.|spenalyf|3|g|10|ml|24|dælur|dreifa|QJ51CE09|01.04.2020||R|0|0|0|0|0|ANI|0|0|0|100|IKR|5258|10146|vetalmen|||0|240|0||Dýraheilsa ehf|aniMedica GmbH|Benzylpenicillínprokaín||5258||5258|10146||2|0||0|||0 409193|N02BE0101|Panodil|filmhtfl|500|mg|20|stk|1|þpakki||N02BE01|01.10.2021||L|1|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||||1|0||0|||0 409210|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|60|mg|30|stk|1|þpakki|40+20 mg|N02AA55|01.11.2019||R|1|0|0|0|0|GOV|0|0|0|100|DKK|10666|16179|lyfalmen|||2|30|0|16,0000|Alvogen|Alvogen ehf|Oxycodonum í blöndum||10666||10666|16179||2|0|E|1|30|dagar|0 409594|H02AB0609|Prednisolon EQL Pharma|töflur|5|mg|105|stk|1|glas||H02AB06|01.02.2019||R|1|0|0|G|0|EQL|0|0|1|100|IKR|1330|3329|lyfalmen|V0414|3150|2|105|0|52,5000|LYFIS ehf|EQL Pharma AB|Prednisólón||1330||1330|3329||2|0|G|0|||0 409673|N04BC0409|Adartrel (Lyfjaver)|filmhtfl|2|mg|28|stk|1|þpakki||N04BC04|01.11.2020||R|1|0|0|G|0|LVR|0|0|0|100|XEU|2696|5209|lyfalmen|||3|28|0|9,3333|Lyfjaver ehf|Lyfjaver ehf|Rópíníról||2696||2696|5209||3|0|G|0|||0 409720|A10BG0302|Pioglitazone Actavis|töflur|30|mg|98|stk|1|þpakki||A10BG03|01.04.2017||R|1|0|0|G|0|GRP|0|0|0|100|XEU|15064|22232|lyfalmen|||2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||15064||15064|22232||1|0|G|0|||0 409745|N05AX1302|Xeplion|stl|100|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|JCI|0|0|0|100|SEK|57384|75853|lyfalmen|||1|1|0|40,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||57384||57384|75853||1|0|E|0|||0 409748|C01DA1401|Imdur|forðatfl|30|mg|98|stk|1|þpakki||C01DA14|01.12.2019||R|1|0|0|G|0|TOG|0|0|0|100|SEK|2012|4267|lyfalmen|V1001|4267|1|98|0|73,5000|Navamedic AB|TopRidge Pharma (Ireland) Limited|Ísósorbíð mónónítrat||2012||2012|4267||1|0|G|0|||0 409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|0|0|0|0|0|BII|0|0|0|100|DKK|6541|10501|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||6541||6541|10501||1|0|E|0|||0 409850|J07BA0104|TicoVac Junior|stl|1,2|mcg/sk|0,25|ml|1|áfspr|bóluefni|J07BA01|01.06.2019||R|0|0|0|0|0|PLS|0|0|0|100|DKK|3271|6000|lyfalmen|||1|0,25|0||Icepharma hf|Pfizer Aps|Heilabólguveira óvirk, borin með blóðmaur||3271||3271|6000||1|0||0|||0 409927|G04BD1201|Betmiga|forðatfl|50|mg|90|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|G|0|APE|0|0|0|100|XEU|15244|22480|lyfalmen|V0651|22478|1|90|0|90,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||15244||15244|22480||1|0|G|0|||0 409975|M01AH0105|Cloxabix|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|G|0|WEH|0|0|1|100|XEU|3690|6577|lyfalmen|V0196|6059|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||3690||3690|6577||2|0|G|0|||0 410223|L01EL0101|IMBRUVICA|filmhtfl|280|mg|28|stk|1|þpakki||L01EL01|01.04.2020||R|1|0|1|0|0|JCI|0|1|0|100|SEK|473923|595939|lyfsjukr|||1|28|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||473923||473923|595939||1|0|L|0|||0 410382|C03DA0103|Spiron|töflur|100|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|G|0|COR|0|0|0|100|DKK|3527|5679|lyfalmen|||2|100|0|133,3300|Vistor hf|Orion Corporation|Spírónólaktón||3038||3038|5679||1|0|G|0|||0 410465|N03AX1214|Gabapentin Alvogen|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.07.2021||R|1|0|0|G|0|POF|0|0|0|100|IKR|1974|2806|lyfalmen|V0250|2453|2|100|0|16,6667|Alvogen|Alvogen|Gabapentín||950||950|2806||2|0|G|0|||0 411033|M03BX0105|Baklofen Mylan|töflur|10|mg|50|stk|1|þpakki||M03BX01|01.01.1990||R|1|0|0|G|0|MYL|0|0|1|100|SEK|674|2426|lyfalmen|||2|50|0|10,0000|Icepharma hf|Mylan AB|Baklófen||674||674|2426||2|0|G|0|||0 411034|N06AA0907|Amitriptylin Abcur|filmhtfl|25|mg|100|stk|1|glas||N06AA09|01.12.2017||R|1|0|0|G|0|ABC|0|0|0|100|SEK|847|2664|lyfalmen|||2|100|0|33,3333|Icepharma hf|Abcur AB|Amitriptýlín||847||847|2664||2|0|G|0|||0 411076|N05AD0301|Buronil|húðuðtfl|25|mg|100|stk|1|glas||N05AD03|01.12.2014||R|1|0|0|G|0|MEV|0|0|0|100|DKK|1972|4212|lyfalmen|||1|100|0|8,3333|Vistor hf|MediLink A/S|Melperón||1972||1972|4212||1|0|G|0|||0 411184|N02BE0118|Paracetamol-ratiopharm|töflur|500|mg|100|stk|1|glas||N02BE01|01.10.2013||R|1|0|0|0|0|RTH|0|0|1|100|XEU|415|2037|lyfalmen|V0230|2037|2|100|0|16,6667|Alvogen|ratiopharm GmbH|Paracetamól||392||392|2037||2|0|E|0|||0 411409|N03AX1602|Lyrica (Lyfjaver)|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2019||R|1|0|0|0|0|LVR|0|0|0|100|DKK|11115|16797|lyfalmen|V0689|3390|3|56|0|56,0000|Lyfjaver ehf|Lyfjaver ehf|Pregabalín||11115||11115|16797||3|0|E|0|||0 411723|N06BA0703|Aspendos|töflur|100|mg|90|stk|1|þpakki||N06BA07|01.05.2019||R|1|0|1|0|0|MOL|0|0|0|100|IKR|12650|18909|lyfalmen|||2|90|0|30,0000|LYFIS ehf|Medochemie Limited|Modafinil||12650||12650|18909||2|0|E|2|||0 411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|1|0|1|0|0|VIC|0|1|0|100|DKK|22654|31926|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare BV|Lamívúdín||22654||22654|31926||1|0|L|0|||0 411859|J02AC0102|Candizol|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.02.2014||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyfalmen|V0554|1916|2|1|0|0,7500|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúkónazól|||||2292||1|0|E|0|||0 411913|S01ED5120|Travoprost/Timolol Medical Valley|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.11.2019||R|0|0|0|G|0|VAL|0|0|0|100|IKR|2695|2448|lyfalmen|V0994|2448|2|2,5|0|25,0000|Acare ehf|Medical Valley Invest AB|Tímólól í blöndum||690||690|2448||2|0|G|0|||0 412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|með rotv.|B01AB05|01.02.1999||R|0|0|0|0|0|SNP|0|0|0|100|XEU|2932|5534|lyfalmen|||1|3|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||2932||2932|5534||1|H|0|0|||0 412395|QM01AE0301|Romefen vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|0|0|0|0|0|CES|1|0|0|100|DKK|4224|8184|vetalmen|||0|100|0||Icepharma hf|Ceva Sante Animale|Ketóprófen||4224||4224|8184||2|0||0|||0 412468|QM01AC0606|Meloxidolor|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.07.2014||R|0|0|0|0|0|VEB|1|0|0|100|XEU|4686|9061|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Meloxícam||4686||4686|9061||2|0||0|||0 412520|M01AB0523|Dimax Rapid|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.09.2021||R|1|0|0|G|0|GOV|0|0|1|100|XEU|1426|2686|lyfalmen|V0189|2186|2|100|0|50,0000|Alvogen|Alvogen ehf|Díklófenak||863||863|2686||2|0|G|0|||0 412547|L03AB0701|Avonex|stl|30|mcg/pen|0,5|ml|4|spr|lausn,áfylltur lyfjapenni|L03AB07|01.11.2011||R|0|0|1|G|0|BNB|0|0|0|100|XEU|85732|111707|lyfalmen|||1|2|0|27,9100|Icepharma hf|Biogen Netherlands B.V.|Interferón beta-1a||85732||85732|111707||2|0|G|0|||0 412555|N04BD0201|Azilect|töflur|1|mg|112|stk|1|þpakki||N04BD02|01.06.2016||R|0|0|0|G|0|TEE|0|0|0|100|NOK|46433|62002|lyfalmen|V0711|29328|1|112|0|112,0000|Actavis Pharmaceuticals Iceland ehf.|Teva. B.V.|Rasagilín||46433||46433|62002||1|0|G|0|||0 412566|N03AX1213|Gabapentin Teva|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.08.2019||R|1|0|0|G|0|TVA|0|0|0|100|DKK|7447|11748|lyfalmen|V0254|11748|2|100|0|33,3300|Alvogen|Teva B.V.|Gabapentín||7447||7447|11748||2|0|G|0|||0 412581|N05AX1302|Xeplion|stl|75|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|JCI|0|0|0|100|SEK|45604|60954|lyfalmen|||1|1|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||45604||45604|60954||1|0|E|0|||0 412662|C09DA0311|Valsartan/ Hydrochlorothiazide Krka|filmhtfl|172,5|mg|98|stk|1|þpakki|160/12,5 mg|C09DA03|01.08.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|5864|7004|lyfalmen|V0581|5765|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Valsartan og þvagræsilyf||4000||4000|7004||2|0|G|0|||0 412924|L02BA0107|Tamoxifen Mylan|töflur|20|mg|100|stk|1|glas||L02BA01|01.01.2010||R|1|0|0|G|0|MYL|0|0|0|100|SEK|3236|5952|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Tamoxífen||3236||3236|5952||2|0|G|0|||0 413053|N07BC0202|Metadon Abcur|töflur|10|mg|100|stk|1|þpakki||N07BC02|01.04.2020||R|1|0|0|G|0|ABC|0|0|0|100|SEK|4154|7215|lyfalmen|||1|100|0|40,0000|Icepharma hf|Abcur AB|Metadón||4154||4154|7215||2|0|G|1|30|dagar|0 413116|N02BE0122|Dolorin|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.12.2017||L|1|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Williams & Halls efh|Williams & Halls ehf|Paracetamól|||||||2|0||0|||0 413220|V03AB1703|Methylthioninium chloride Proveblue|stl|5|mg/ml|10|ml|5|lykjur||V03AB17|01.05.2015||R|0|0|0|0|0|OVE|0|0|0|100|DKK|32054|43815|lyfalmen|||1|50|0||Pharmanovia A/S|Provepharm S.A.S.|Metýltíónín||32054||32054|43815||2|H|0|0|||0 413289|L01BA0403|Pemetrexed Accord|irþ|500|mg|500|mg|1|hgl|stofn f. innr.þykkni lausn|L01BA04|01.04.2021||R|0|0|0|0|0|CLU|0|1|0|100|XEU|140936|181796|lyfsjukr|||2|500|0||Artasan ehf|Accord Healthcare S.L.U.|Pemetrexed||140936||140936|181796||1|H|L|0|||0 413988|N02BE0107|Paratabs|filmhtfl|500|mg|20|stk|1|þpakki||N02BE01|01.03.2013||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paracetamól|||||||1|0||0|||0 414424|N06AA0907|Amitriptylin Abcur|filmhtfl|50|mg|100|stk|1|glas||N06AA09|01.10.2017||R|1|0|0|G|0|ABC|0|0|0|100|SEK|1206|3158|lyfalmen|||2|100|0|66,6666|Icepharma hf|Abcur AB|Amitriptýlín||1206||1206|3158||2|0|G|0|||0 414592|L03AX1301|Copaxone|stl|40|mg/spr|12|áf.spr|1|pakki||L03AX13|01.11.2015||R|0|0|1|G|0|TGM|0|0|0|100|NOK|90309|117496|lyfalmen|||1|12|0|24,0000|Teva Pharma Iceland ehf|TEVA GmbH|Glatíramer acetat||90309||90309|117496||1|0|G|0|||0 414661|L01DC0302|Mitomycin medac|duft|40|mg|1|hgl|1|pakki|+ leysir fyrir þvagblöðrulausn|L01DC03|01.03.2017||R|0|0|0|0|0|WIL|0|0|0|100|XEU|39596|53355|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Mitomycin||39596||39596|53355||2|H|0|0|||0 414680|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|90|stk|1|þpakki||C03BA11|01.03.1999||R|1|0|0|G|0|LLS|0|0|0|100|DKK|1244|3210|lyfalmen|||1|90|0|54,0000|Icepharma hf|Les Laboratoires Servier|Indapamíð||1244||1244|3210||2|0|G|0|||0 414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|0|0|0|G|0|HES|0|0|0|100|DKK|1174|3114|lyfalmen|||1|300|0|6,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||1174||1174|3114||1|0|G|0|||0 414921|L04AA4201|Mayzent|filmhtfl|2|mg|28|stk|1|þpakki||L04AA42|01.11.2020||R|1|1|1|0|0|NEP|0|1|0|100|DKK|227166|289042|lyfsjukr|||1|28|0||Vistor hf|Novartis Europharm Limited|Siponimod||227166||227166|289042||1|0|L|0|||0 414991|M05BA0409|Alendronat Bluefish|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.12.2020||R|1|0|0|G|0|BLS|0|0|0|100|IKR|3122|4030|lyfalmen|V0203|4026|2|12|0|84,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Alendrónsýra||1840||1840|4030||1|0|G|0|||0 415202|B05AA0116|Alburex|irl|50|g/líter|500|ml|1|hgl||B05AA01|01.09.2021||R|0|0|0|0|0|CSB|0|0|0|100|SEK|11505|17333|lyfalmen|||1|500|0||Icepharma hf|CSL Behring GmbH|albumin||11505||11505|17333||2|H|0|0|||0 415368|C02KX0501|Adempas|filmhtfl|2,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|0|BRE|0|1|0|100|DKK|187545|239765|lyfsjukr|||1|42|0|23,3300|Vistor hf|Bayer AG|Riociguatum||187545||187545|239765||1|0|L|0|||0 415635|N05AX1303|TREVICTA|stl|263|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|G|0|JCI|0|0|0|100|SEK|153704|197676|lyfalmen|||1|1|0|105,2000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||153704||153704|197676||1|0|G|0|||0 415724|G04CA5202|Dutaprostam|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.10.2019||R|0|0|0|G|0|ZET|0|0|0|100|DKK|3022|4428|lyfalmen|V1010|3018|2|30|0|30,0000|Alvogen|Zentiva, k.s.|Dútasteríð og tamsúlósínhýdroklóríð||2129||2129|4428||2|0|G|0|||0 415946|N03AX1405|Matever|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.02.2012||R|1|0|0|G|0|PSA|0|0|0|100|XEU|5468|6580|lyfalmen|V0253|4878|2|100|0|33,3300|Alvogen|Pharmathen S.A.|Levetíracetam||3692||3692|6580||2|0|G|0|||0 416021|N06AB0406|Citalopram STADA|filmhtfl|40|mg|100|stk|1|þpakki||N06AB04|01.10.2021||R|1|0|0|G|0|ASR|0|0|0|100|IKR|4500|7692|lyfalmen|V0320|7692|2|100|0|200,0000|LYFIS ehf|STADA Arzneimittel AG|Cítalópram||4500||4500|7692||2|0|G|0|||0 416072|L01AX0304|Temozolomide Accord|hylki|140|mg|5|stk|1|skpoki||L01AX03|01.06.2021||R|0|0|1|0|0|CLU|0|1|0|100|XEU|24666|34471|lyfsjukr|||2|5|0||Artasan ehf|Accord Healthcare S.L.U.|Temozolomid||24666||24666|34471||1|0|L|0|||0 416121|M02AA1505|Voltaren Forte|hlaup|23,2|mg/g|150|g|1|túpa||M02AA15|01.05.2021||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|150|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Díklófenak|||||||1|0||0|||0 416330|A10BD2401|Steglujan|filmhtfl|115|mg|98|stk|1|þpakki|15/100 mg|A10BD24|01.03.2019||R|1|0|0|G|0|MBV|0|0|0|100|DKK|35402|47846|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|sitagliptin og ertugliflozin||35241||35241|47846||1|0|G|0|||0 416446|C09DA0101|Cozaar Comp|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|1|0|0|G|0|NVO|0|0|0|100|DKK|8804|9701|lyfalmen|V0088|3108|1|98|0|98,0000|Vistor hf|N.V. Organon|Lósartan og þvagræsilyf||5960||5960|9701||1|0|G|0|||0 416859|A01AA0101|Duraphat|tanndrei|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|0|0|0|G|0|GOG|0|0|1|100|XEU|2747|5279|lyfalmen|||1|10|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||2747||2747|5279||2|0|G|0|||0 417562|N03AX1214|Gabapentin Alvogen|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.07.2021||R|1|0|0|G|0|POF|0|0|0|100|DKK|7447|11748|lyfalmen|V0254|11748|2|100|0|33,3300|Alvogen|Alvogen|Gabapentín||7447||7447|11748||2|0|G|0|||0 417633|A10BJ0601|Ozempic|stl|0,5|mg|1,5|ml|1|áfpen|+4 einnota nálar|A10BJ06|01.01.2019||R|0|0|0|0|0|NON|0|0|0|100|DKK|18699|27235|lyfalmen|||1|1,5|0|18,1818|Vistor hf|Novo-Nordisk|Semaglutide||18699||18699|27235||1|0|E|0|||0 417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|þpakki||J05AF06|01.07.2005||R|1|0|1|0|0|VIC|0|1|0|100|DKK|37080|50172|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare BV|Abacavír||37080||37080|50172||1|0|L|0|||0 417880|B02BD0401|BeneFIX|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD04|01.07.2012||R|0|0|1|0|0|PEU|0|1|0|100|DKK|94581|122900|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Faktor IX||94581||94581|122900||1|0|L|0|||0 417898|C01CA1703|Hypotron|töflur|5|mg|100|stk|1|þpakki||C01CA17|01.10.2018||R|1|0|0|G|0|RET|0|0|0|100|IKR|17695|25853|lyfalmen|V0969|20079|2|100|0|16,6666|CampusPharma AB|Brancaster Pharma Ireland Ltd|midodrine||17695||17695|25853||1|0|G|0|||0 418043|B01AE0701|Pradaxa|hylki|150|mg|180|stk|1|þpakki|hart|B01AE07|01.10.2011||R|0|1|0|G|0|BII|0|0|0|100|DKK|27008|37433|lyfalmen|V0460|37433|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||27008|37433||1|0|G|0|||0 418642|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.02.2019||R|0|1|1|G|0|BIO|0|0|0|100|DKK|28300|38553|lyfalmen|||1|4,69|0|7,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Anakinra||27893||27893|38553||3|0|G|0|||0 418667|L01XC0203|Truxima|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.08.2019||R|0|1|0|0|0|CTH|0|1|0|100|DKK|70627|92603|lyfsjukr|||2|20|0||Vistor hf|Celltrion Healthcare Hungary Kft.|Rítúxímab||70627||70627|92603||1|H|L|0|||0 418714|C10BA0202|Ezetimib/Simvastatin Krka|töflur|50|mg|100|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.10.2019||R|1|0|0|0|0|KNM|0|0|0|100|IKR|18000|26273|lyfalmen|V0615|26273|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Ezetimíb og simvastatín||18000||18000|26273||2|0||0|||0 419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|1|0|0|G|0|CHE|0|0|0|100|DKK|2380|4774|lyfalmen|||1|100|0|25,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Alfakalsídól||2380||2380|4774||1|0|G|0|||0 419294|J01DD0403|Rocephalin IV|sts|1|g|1|stk|1|hgl|+ leysir, lausn|J01DD04|01.09.2018||R|0|0|0|0|0|ROA|0|0|1|100|DKK|2826|5388|lyfalmen|||1|1|0|0,5000|Icepharma hf|Roche A.S.|Ceftríaxón||2826||2826|5388||2|0|0|0|||0 419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|1|0|0|G|0|CHE|0|0|0|100|DKK|8661|13419|lyfalmen|||1|100|0|100,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Alfakalsídól||8661||8661|13419||1|0|G|0|||0 419311|N03AX1408|Levetiracetam STADA|mixtúra|100|mg/ml|300|ml|1|glas|+ 10 ml munngj.spr.|N03AX14|01.12.2019||R|0|0|0|G|0|ASR|0|0|0|100|IKR|11000|16638|lyfalmen|V1000|16638|2|300|0|20,0000|LYFIS ehf|STADA Arzneimittel AG|Levetíracetam||11000||11000|16638||2|0|G|0|||0 419828|N06BA0406|Medikinet CR|hylki|5|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|2854|5426|lyfalmen|||2|30|0|5,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||2854||2854|5426||2|0|E|1|30|dagar|0 419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|1|0|1|0|0|ECO|0|0|0|100|XEU|37912|51225|lyfalmen|||1|100|0|7,5000|Recordati AB|Recordati Rare Diseases|Mercaptamín||37912||37912|51225||3|0|E|0|||0 419937|A16AA0401|Cystagon|hylki|50|mg|100|stk|1|glas||A16AA04|01.10.2016||R|1|0|1|0|0|ECO|0|0|0|100|XEU|13034|19438|lyfalmen|||1|100|0|2,5000|Recordati AB|Recordati Rare Diseases|Mercaptamín||13034||13034|19438||3|0|E|0|||0 419952|D07AD0101|Dermovat|húðlausn|0,5|mg/ml|100|ml|1|glas||D07AD01|01.10.2018||R|0|0|0|G|0|GPH|0|0|1|100|DKK|1738|3890|lyfalmen|||1|100|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||1738||1738|3890||1|0|G|0|||0 419969|S01AD0302|Xorox|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.03.2020||R|0|0|0|G|0|AGE|0|0|1|100|XEU|2140|4443|lyfalmen|||1|4,5|0||Agepha Pharma s.r.o.|Agepha Pharma s.r.o.|Acíklóvír||2140||2140|4443||2|0|G|0|||0 420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|0|0|0|G|0|PLS|0|0|1|100|DKK|11476|17293|lyfalmen|||1|10|0|40,0000|Icepharma hf|Pfizer ApS|Dalteparín||11476||11476|17293||1|0|G|0|||0 420176|J05AR1801|Genvoya|filmhtfl|||30|stk|1|glas|150mg+150mg+200mg+10mg|J05AR18|01.07.2016||R|0|0|1|0|0|GEI|0|1|0|100|DKK|126710|164103|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Sciences Ireland|Elvitegravír, kóbísistat, emtrícítabín og tenófóvír alafenam||126710||126710|164103||2|0|L|0|||0 420209|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|100|stk|1|þpakki|hart|A02BC01|01.08.2015||R|1|0|0|G|0|RTH|0|0|1|100|IKR|4816|2186|lyfalmen|V0006|2186|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Ómeprazól||500||500|2186||2|0|G|0|||0 420471|B01AB0401|Fragmin|stl|12500|ae/ml|0,2|ml|10|áf.spr|2.500 a.e. anti-Xa/sprautu|B01AB04|01.05.2018||R|0|0|0|G|0|PLS|0|0|1|100|DKK|3563|6402|lyfalmen|||1|2|0|10,0000|Icepharma hf|Pfizer Aps|Dalteparín||3563||3563|6402||1|0|G|0|||0 420497|B01AB0401|Fragmin|stl|25000|ae/ml|0,2|ml|10|áf.spr|5.000 a.e. anti-Xa/sprautu|B01AB04|01.05.2018||R|0|0|0|G|0|PLS|0|0|1|100|DKK|5078|8487|lyfalmen|||1|2|0|20,0000|Icepharma hf|Pfizer Aps|Dalteparín||5078||5078|8487||1|0|G|0|||0 420510|J01CA0413|Amoxin|mixtduft|100|mg/ml|60|ml|1|glas||J01CA04|01.01.2016||R|0|0|0|0|0|RTH|0|0|1|100|DKK|1478|2973|lyfalmen|V0479|2973|2|60|0|4,0000|Alvogen|ratiopharm GmbH|Amoxicillín||1072||1072|2973||2|0|E|0|||0 420639|L01EL0101|IMBRUVICA|filmhtfl|140|mg|28|stk|1|þpakki||L01EL01|01.04.2020||R|1|0|1|0|0|JCI|0|1|0|100|SEK|236626|300808|lyfsjukr|||1|28|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||236626||236626|300808||1|0|L|0|||0 420696|M02AA1504|Diklofenak Apofri|hlaup|11,6|mg/g|60|g|1|túpa||M02AA15|01.01.2019||L|0|0|0|0|0|APO|0|0|1|100|IKR|||lyflausa|||0|60|0||LYFIS ehf|Apofri AB|Díklófenak|||||||2|0||0|||0 420952|J01CF0204|Cloxacillin Navamedic Nordic|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.08.2021||R|0|0|0|0|0|NAV|0|0|1|100|XEU|4241|7335|lyfalmen|V1053|5104|1|10|0|5,0000|Icepharma hf|Navamedic ASA|Kloxacillín||4241||4241|7335||2|0|0|0|||0 421120|C10AA0704|Rosuvastatin Xiromed|filmhtfl|5|mg|100|stk|1|þpakki||C10AA07|01.04.2018||R|0|0|0|0|0|VAL|0|0|0|100|IKR|2280|4636|lyfalmen|||2|100|0|50,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||2280||2280|4636|30.9.2021|2|0|E|0|||0 421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.07.1989||R|1|0|0|G|0|SNP|0|0|0|100|XEU|1225|3184|lyfalmen|||1|30|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1225||1225|3184||1|0|G|0|||0 421434|C10AA0509|Atorvastatin Xiromed|filmhtfl|40|mg|98|stk|1|þpakki||C10AA05|01.07.2018||R|1|0|0|G|0|MVX|0|0|0|100|IKR|2000|2779|lyfalmen|V0114|2681|2|98|0|196,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||931||931|2779||2|0|G|0|||0 421673|M04AA0303|Febuxostat Medical Valley|filmhtfl|80|mg|28|stk|1|þpakki||M04AA03|01.10.2019||R|1|0|0|0|0|VAL|0|0|0|100|XEU|8770|9312|lyfalmen|V1011|9068|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|febuxostat||5677||5677|9312||2|0|E|0|||0 421816|QN04BC0201|Prascend|töflur|1|mg|160|stk|1|þpakki|handa hestum|QN04BC02|01.05.2014||R|0|0|0|0|0|BIV|0|0|0|100|DKK|37074|70507|vetalmen|||0|160|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pergolide||37074||37074|70507||1|0||0|||0 421938|R06AX2705|Desloratadine Teva|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.09.2013||R|1|0|0|G|0|TVA|0|0|1|100|XEU|1684|3312|lyfalmen|V0458|2979|2|100|0|100,0000|Alvogen|Teva B.V.|Deslóratadín||1318||1318|3312||2|0|G|0|||0 421962|A06AB0202|Toilax|sþ-tfl|5|mg|25|stk|1|glas||A06AB02|01.12.2016||L|1|0|0|0|0|ERC|0|0|0|100|IKR|||lyfalmen|||0|25|0|12,5000|Vistor hf|Orion Pharma|Bisakódýl|||||1925||1|0||0|||0 422115|N02AA0506|Oxikodon Depot Actavis|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|0|G|0|ATE|0|0|0|100|XEU|634|2371|lyfalmen|V0596|2371|2|28|0|1,8600|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||634||634|2371||1|0|G|1|30|dagar|0 422246|C07AB0206|Seloken ZOC|forðatfl|95|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|1|0|0|G|0|RDT|0|0|0|100|DKK|2680|5187|lyfalmen|V0049|2852|1|98|0|62,0667|Vistor hf|Recordati Ireland Limited|Metóprólól||2680||2680|5187||1|0|G|0|||0 422323|L01DB1101|Pixuvri|st/irþ|29|mg|1|hgl|1|pakki||L01DB11|01.02.2020||R|0|0|0|0|0|LLS|0|0|0|100|DKK|93428|121441|lyfalmen|||1|1|0||Icepharma hf|Les Laboratoires Servier|Pixantron||93428||93428|121441||2|H|0|0|||0 422337|C07AB0206|Seloken ZOC|forðatfl|190|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|1|0|0|G|0|RDT|0|0|0|100|DKK|6828|10896|lyfalmen|V0054|4840|1|98|0|124,1333|Vistor hf|Recordati Ireland Limited|Metóprólól||6828||6828|10896||1|0|G|0|||0 422340|C02AC0201|Intuniv|forðatfl|1|mg|28|stk|1|þpakki||C02AC02|01.10.2020||R|1|1|1|0|0|HPI|0|0|0|100|DKK|9487|14556|lyfalmen|||1|28|0|9,3333|Vistor hf|Shire Pharmaceuticals Ireland Limited|Guanfacine||9487||9487|14556||1|0|E|0|||0 422474|B02BB0101|Riastap|sts/irs|1|g|1|hgl|1|pakki|lausn|B02BB01|01.12.2011||R|0|0|0|0|0|CSB|0|1|0|100|SEK|71526|93740|lyfsjukr|||1|1|0|0,2000|Icepharma hf|CSL Behring GmbH|Manna Fíbrínógen||71526||71526|93740||2|H|L|0|||0 422545|B02BD0205|Elocta|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|1|0|0|SAB|0|1|0|100|DKK|45233|60484|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||45233|60484||3|0|L|0|||0 422591|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|þpakki||C10AA07|01.10.2020||R|1|0|0|0|0|ASA|0|0|0|100|SEK|19109|27800|lyfalmen|V0195|9966|1|98|0|392,0000|Vistor hf|Astra Zeneca A/S|Rósuvastatín||19109||19109|27800||1|0|E|0|||0 422738|G03GA0503|Bemfola|stl|75|ae|0,125|ml|1|penni||G03GA05|01.01.2015||R|0|0|1|G|0|FBA|0|0|0|100|SEK|2842|5410|lyfalmen|||1|0,125|0|1,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||2842||2842|5410||3|0|G|0|||0 422860|N03AF0401|Zebinix|töflur|200|mg|60|stk|1|þpakki||N03AF04|01.12.2018||R|1|0|0|G|0|BPC|0|0|0|100|SEK|10795|16356|lyfalmen|||1|60|0|15,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||10795||10795|16356||1|0|G|0|||0 422937|B01AF0101|Xarelto|filmhtfl|2,5|mg|56|stk|1|þpakki||B01AF01|01.04.2015||R|1|1|0|G|0|FIN|0|0|0|100|DKK|9093|14014|lyfalmen|||1|56|0|7,0000|Icepharma hf|Bayer AG|Rivaoxaban||9093||9093|14014||2|0|G|0|||0 423361|G03AA1201|Yasmin|filmhtfl|||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.01.2014||R|0|0|0|0|0|BAB|0|0|0|100|DKK|2920|4939|lyfalm11|V0993|4461|1|63|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||||2920|4939||2|0||0|||1 423414|R01AA0705|Otrivin Menthol ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.11.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Xýlómetazólín|||||||1|0||0|||0 423737|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|10|fl||J01GB03|01.07.2012||R|0|0|0|0|0|LEM|0|0|1|100|XEU|18564|27049|lyfalmen|||2|1200|0|15,0000|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||18564||18564|27049||2|0|0|0|||0 423859|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.09.2015||R|0|0|0|G|0|SAO|0|0|0|100|XEU|5571|9166|lyfalmen|V0373|4887|1|15|0|75,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||5571||5571|9166||2|0|G|0|||0 424199|H02AB0908|Plenadren|töflur|20|mg|50|stk|1|glas|með breyttan losunarhraða|H02AB09|01.03.2020||R|1|0|0|0|0|SSE|0|0|1|100|DKK|68052|89346|lyfalmen|||1|50|0|33,3300|Shire Services BVBA|Shire Services BVBA|Hýdrókortisón||68052||68052|89346||1|0|E|0|||0 424477|N06BA1201|Elvanse Adult|hylki|30|mg|30|stk|1|glas|hart|N06BA12|01.06.2018||R|1|1|0|0|0|SHE|0|0|0|100|DKK|11134|16823|lyfalmen|||1|30|0|30,0000|Shire Pharmaceuticals Ireland Limited|Shire Pharmaceuticals Ireland Limited|lisdexamfetamine||11134||11134|16823||1|0|E|1|30|dagar|0 424761|A07AA0204|Nystatin Orifarm|mixtúra|100000|ae/ml|100|ml|1|glas|dreifa|A07AA02|01.03.2020||R|0|0|0|0|0|IRO|0|0|1|100|XEU|5364|8881|lyfalmen|||2|100|0|6,6667|Artasan ehf|Orifarm Generics A/S|Nýstatín||5364||5364|8881||1|0|0|0|||0 424829|N06AX2108|Aritavi|sþ-hylki|60|mg|100|stk|1|þpakki||N06AX21|01.08.2019||R|1|0|0|G|0|ATE|0|0|0|100|XEU|9788|4446|lyfalmen|V0694|4446|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Duloxetín||2142||2142|4446||1|0|G|0|||0 424973|R03BB0404|Braltus|innönddu|10|mcg|30|stk|3|glas|hart hylki|R03BB04|01.09.2018||R|0|0|0|G|0|TVA|0|0|0|100|DKK|12409|17057|lyfalmen|||2|90|0|90,0000|Alvogen|Teva B.V.|Tíótrópíumbrómíð||11304||11304|17057|31.8.2021|2|0|G|0|||0 424981|J07BX0304|COVID-19 Vaccine Janssen|stl|||2,5|ml|20|hgl|hvert hgl.inniheldur 5x0,5ml|J07BX03|01.05.2021||R|0|0|0|0|0|JCI|0|0|0|100|IKR|||lyfalmen|||1|50|0||Vistor hf|Janssen-Cilag International N.V.|Covid-19 vaccines|||||||1|0||0|||0 425016|L02AE0301|Zoladex|vefjalyf|3,6|mg|1|áf.spr|1|pakki||L02AE03|01.01.1990||R|0|0|1|G|0|AZA|0|0|0|100|SEK|21675|25330|lyfalmen|V0183|19682|1|1|0|27,9070|Vistor hf|AstraZeneca AB|Góserelín||17315||17315|25330||1|0|G|0|||0 425282|L01EA0102|Imatinib Accord|filmhtfl|100|mg|60|stk|1|þpakki||L01EA01|01.09.2017||R|0|0|1|0|0|ACC|0|1|0|100|XEU|18646|27162|lyfsjukr|||2|60|0||Artasan ehf|Accord Healthcare Limited|Imatinib||18646||18646|27162||1|0|L|0|||0 425939|C09CA0102|Lopress|töflur|12,5|mg|100|stk|1|glas||C09CA01|01.06.2012||R|1|0|0|G|0|GPA|0|0|0|100|XEU|1567|3506|lyfalmen|V0213|3291|2|100|0|25,0000|Actavis Group hf|Actavis Group PTC ehf|Lósartan||1459||1459|3506||1|0|G|0|||0 425943|A07EA0601|Entocort|forðahlk|3|mg|100|stk|1|glas||A07EA06|01.06.2016||R|1|0|0|G|0|TTT|0|0|0|100|DKK|13681|20328|lyfalmen|||1|100|0|33,3300|Icepharma hf|Tillotts Pharma GmbH|Búdesóníð||13681||13681|20328||2|0|G|0|||0 426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|MEA|0|0|1|100|DKK|962|2822|lyfalmen|||1|20|0|5,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||962||962|2822||2|0|E|0|||0 427075|M01AE0115|Alvofen Express|hylki|400|mg|50|stk|1|þpakki||M01AE01|01.04.2014||L|1|0|0|0|0|IPC|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Alvogen|Alvogen IPco S.á.r.l.|Íbúprófen|||||||2|0||0|||0 427186|C10BA0201|Inegy|töflur|90|mg|28|stk|1|þpakki|10 mg + 80 mg|C10BA02|01.07.2013||R|1|0|0|0|0|NVO|0|0|0|100|DKK|8090|12633|lyfalmen|||1|28|0|28,0000|Vistor hf|N.V. Organon|Ezetimíb og simvastatín||8090||8090|12633||1|0||0|||0 427289|B01AC0603|Hjartamagnýl|sþ-tfl|75|mg|100|stk|1|þpakki||B01AC06|01.04.2019||L|1|0|0|0|0|ATE|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Asetýlsalicýlsýra|||||||1|0|0|0|||0 427324|A12BA0103|Kaliumklorid Orifarm (Lyfjaver)|forðatfl|750|mg|250|stk|1|glas||A12BA01|01.06.2021||L|1|0|0|G|0|LVR|0|0|0|100|DKK|||lyfalmen|V1048|4697|3|250|0|62,5000|Lyfjaver ehf|Lyfjaver ehf|Kalíumklóríð|||||4697||3|0|G|0|||0 427556|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|15|mg|30|stk|1|þpakki|10+5 mg|N02AA55|01.11.2019||R|1|0|0|0|0|GOV|0|0|0|100|DKK|3051|4947|lyfalmen|V1004|4947|2|30|0|4,0000|Alvogen|Alvogen ehf|Oxycodonum í blöndum||2506||2506|4947||2|0|E|1|30|dagar|0 427754|B01AF0102|Rivaroxaban WH|filmhtfl|20|mg|28|stk|1|þpakki||B01AF01|01.02.2021||R|1|1|0|G|0|WEH|0|0|0|100|XEU|8694|13464|lyfalmen|V1036|13464|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Rivaoxaban||8694||8694|13464||2|0|G|0|||0 427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|0|0|0|0|0|SNP|0|0|0|100|IKR|||lyfalmen|||0|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Natríum pícósúlfat|||||3268||1|0|E|0|||0 428089|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|25|stk|1|glas||C01DA02|01.05.2014||L|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||2428||1|0|G|0|||0 428489|L02BB0501|Erleada|filmhtfl|60|mg|112|stk|1|þpakki||L02BB05|01.02.2021||R|0|0|0|0|0|JCI|0|1|0|100|SEK|418823|527410|lyfsjukr|||1|112|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Apalutamide||418823||418823|527410||1|0|L|0|||0 428515|N02AA0508|Oxycodone Alvogen|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.01.2021||R|1|0|0|G|0|GOV|0|0|0|100|XEU|3215|5341|lyfalmen|V0598|5341|2|98|0|13,0700|Alvogen|Alvogen ehf|Oxýcódon||2792||2792|5341||2|0|G|1|30|dagar|0 429098|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|BAM|0|0|1|100|SEK|3255|5978|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||3255||3255|5978||2|0|0|0|||0 429503|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|glas||J02AC04|01.07.2014||R|0|0|1|0|0|MLD|0|1|0|100|DKK|77748|101609|lyfsjukr|||1|105|0|14,0000|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||77748||77748|101609||1|0|L|0|||0 429584|N06BA0902|Atomoxetin Actavis|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|ATE|0|0|0|100|XEU|6572|3284|lyfalmen|V0812|2940|2|28|0|3,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atomoxetín||1298||1298|3284||1|0|E|0|||0 429759|S01EE0501|Taflotan|augndr|15|mcg/ml|3|ml|3|glös||S01EE05|01.03.2019||R|0|0|0|G|0|SAO|0|0|0|100|XEU|7350|11614|lyfalmen|||1|9|0|90,0000|Icepharma hf|Santen Oy|Taflúprost||7350||7350|11614||2|0|G|0|||0 429787|D07AA0210|Hydrokortison Evolan|krem|10|mg/g|50|g|1|túpa||D07AA02|01.08.2021||L|0|0|0|0|0|EVO|0|0|1|100|IKR|||lyflausa|||0|50|0||LYFIS ehf|Evolan Pharma AB|Hýdrókortisón|||||||2|0||0|||0 429815|N02AJ0602|Parkodin forte|filmhtfl|530|mg|200|stk|1|tfílát|30+500 mg|N02AJ06|01.02.2018||R|2|0|0|0|0|ATE|0|0|1|100|XEU|4363|7503|lyfalmen|||2|200|0|66,6667|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||4363||4363|7503||1|0|E|1|||0 429875|G03GA0503|Bemfola|stl|225|ae|0,375|ml|1|penni||G03GA05|01.01.2015||R|0|0|1|G|0|FBA|0|0|0|100|SEK|9390|14422|lyfalmen|||1|0,375|0|3,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||9390||9390|14422||3|0|G|0|||0 430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990|30.09.2021|R|0|0|0|0|0|IBV|0|0|0|100|DKK|5352|10324|vetalmen|||0|100|0||Vistor hf|Intervet International BV|Sulfadiazinum og trimethoprimum||5352||5352|10324||1|0||0|||0 430281|L02BG0303|Astrozol|filmhtfl|1|mg|98|stk|1|þpakki||L02BG03|01.08.2011||R|0|0|0|G|0|WEH|0|0|0|100|XEU|17634|24134|lyfalmen|V0184|13044|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Anastrózól||16446||16446|24134||2|0|G|0|||0 430458|M01AH0503|Coxerit|filmhtfl|90|mg|98|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|WEH|0|0|1|100|IKR|5488|7875|lyfalmen|V0831|7403|2|98|0|147,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||4633||4633|7875||2|0|G|0|||0 430507|A07EA0601|Entocort|endaþ.dr|2|mg|7|stk|1|þpakki|samsett pk|A07EA06|01.06.2016||R|0|0|0|G|0|TTT|0|0|0|100|DKK|5546|9131|lyfalmen|||1|7|0|7,0000|Icepharma hf|Tillotts Pharma GmbH|Búdesóníð||5546||5546|9131||2|0|G|0|||0 430839|M01AE0116|Ibuprofen Bril|filmhtfl|400|mg|50|stk|1|þpakki||M01AE01|01.11.2016||L|1|0|0|0|0|PIL|0|0|1|100|IKR|||lyflausa|||2|50|0|16,6600|Williams & Halls efh|Brillpharma (Ireland) Limited|Íbúprófen|||||||2|0||0|||0 431017|B06AC0501|Takhzyro|stl|300|mg|2|ml|1|hgl|+ein spr og tvær nálar|B06AC05|01.09.2020||R|0|0|1|0|0|HPI|0|1|0|100|DKK|1870333|2332682|lyfsjukr|||1|2|0|14,0187|Vistor hf|Shire Pharmaceuticals Ireland Limited|Lanadelumab||1870333||1870333|2332682||1|0|L|0|||0 431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|0|0|0|0|0|LEP|0|0|1|100|DKK|1084|2990|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||1084||1084|2990||1|0||0|||0 431154|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.11.2013||L|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|4|0||Vistor hf|McNeil Sweden AB|Levókabastín|||||||1|0||0|||0 431759|M01AB5503|Arthrotec Forte|töflur|75,2|mg|20|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|G|0|PLS|0|0|1|100|DKK|1345|3349|lyfalmen|||1|20|0|15,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||1345||1345|3349||1|0|G|0|||0 431783|M01AB5503|Arthrotec Forte|töflur|75,2|mg|100|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|G|0|PLS|0|0|1|100|DKK|3494|6307|lyfalmen|||1|100|0|75,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||3494||3494|6307||1|0|G|0|||0 431922|S01ED5120|Travoprost/Timolol Medical Valley|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.11.2019||R|0|0|0|G|0|VAL|0|0|0|100|IKR|7042|5283|lyfalmen|V0995|5283|2|7,5|0|75,0000|Acare ehf|Medical Valley Invest AB|Tímólól í blöndum||2750||2750|5283||2|0|G|0|||0 431930|N06BA0406|Medikinet CR|hylki|60|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|11696|17596|lyfalmen|||2|30|0|60,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||11696||11696|17596||2|0|E|1|30|dagar|0 431978|L04AA3301|Entyvio|irþ|300|mg|1|hgl|1|pakki||L04AA33|01.07.2016||R|0|1|0|0|0|TPA|0|1|0|100|DKK|300400|380125|lyfsjukr|||1|1|0|55,5600|Vistor hf|Takeda Pharma A/S|Vedolizumab||300400||300400|380125||1|H|L|0|||0 431985|D07XC0101|Diprosalic|húðlausn|||100|ml|1|glas|0,5 mg/ml+20 mg/ml|D07XC01|01.04.2014||R|0|0|0|G|0|NVO|0|0|1|100|DKK|2240|4581|lyfalmen|||1|100|0||Vistor hf|N.V. Organon|Betametasón||2240||2240|4581||1|0|G|0|||0 432189|L01EM0301|Piqray|filmhtfl|200|mg|28|stk|1|þpakki||L01EM03|01.05.2021||R|1|1|1|0|0|NEP|0|1|0|100|DKK|496406|623901|lyfsjukr|||1|28|0|18,6667|Vistor hf|Novartis Europharm Limited|Alpelisib||496406||496406|623901||1|0|L|0|||0 432220|QM01AC0603|Rheumocam|stl|20|mg/ml|100|ml|1|hgl|handa nautg, svínum og hestum|QM01AC06|01.06.2018||R|0|0|0|0|0|CHP|1|0|0|100|IKR|6850|13166|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Meloxícam||||6850|13166||2|0||0|||0 432410|N06AX2105|Duloxetin Krka|sþ-hylki|60|mg|30|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|0|KNM|0|0|0|100|IKR|3245|5964|lyfalmen|V0693|5964|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||3245||3245|5964||2|0|E|0|||0 432723|A10BJ0602|Rybelsus|töflur|7|mg|30|stk|1|þpakki||A10BJ06|01.12.2020||R|0|0|0|0|0|NAS|0|0|0|100|DKK|21171|30051|lyfalmen|||1|30|0||Vistor hf|Novo-Nordisk A/S|Semaglutide||21171||21171|30051||1|0|E|0|||0 432972|QJ01CR0201|Combisyn|töflur|50|mg|100|stk|1|pakki||QJ01CR02|01.02.2012||R|0|0|0|0|0|BRO|0|0|0|100|XEU|2754|4153|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Ltd|Amoxicillín og beta-laktamasa hemill||2113||2113|4153||2|0|0|0|||0 433126|N02BE0102|Panodil Brus|freyðit|500|mg|20|stk|1|þpakki||N02BE01|01.05.2014||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyfalmen|||0|20|0|3,3300|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||2176||1|0|E|0|||0 433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|1|0|0|G|0|COR|0|0|0|100|DKK|10606|16096|lyfalmen|||1|100|0|20,0000|Vistor hf|Orion Corporation|Entakapón||10606||10606|16096||1|0|G|0|||0 433292|N02AA0106|Contalgin Uno|forðahlk|30|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|1|0|0|G|0|MDI|0|0|0|100|DKK|2389|4786|lyfalmen|||1|28|0|8,4000|Icepharma hf|Mundipharma A/S|Morfín||2389||2389|4786||2|0|G|1|30|dagar|0 433318|N02AA0106|Contalgin Uno|forðahlk|90|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|1|0|0|G|0|MDI|0|0|0|100|DKK|5249|8723|lyfalmen|||1|28|0|25,2000|Icepharma hf|Mundipharma A/S|Morfín||5249||5249|8723||2|0|G|1|30|dagar|0 433345|QI08AA0101|Eravac|stl|||0,5|ml|10|hgl|fleyti|QI08AA01|01.05.2020||R|0|0|0|0|0|LHS|0|0|0|100|IKR|14085|24277|vetbolu|||0|5|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Rabbit haemorrhagic disease virus||14085||14085|24277||2|0||0|||0 433666|J02AC0401|Noxafil|sþ-tfl|100|mg|96|stk|1|þpakki||J02AC04|01.11.2015||R|0|0|1|0|0|MLD|0|1|0|100|DKK|392158|494246|lyfsjukr|||1|96|0|32,0000|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||392158||392158|494246||1|0|L|0|||0 434088|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.03.2013||R|0|0|0|0|0|BAB|0|0|0|100|DKK|150494|193684|lyfalmen|||1|150|0||Icepharma hf|Bayer AB|Gadóbútról||150494||150494|193684||2|H|0|0|||0 434261|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|1000|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|QAS|0|0|0|100|NOK|67621|103489|veteldis|||0|1000|0||PHARMAQ Ltd.|PHARMAQ AS|Tricaine Methane Sulfónat||64199||64199|103489||1|0||0|||0 434353|QM01AE9104|Canicaral vet|töflur|160|mg|100|stk|1|þpakki||QM01AE91|01.09.2016||R|0|0|0|0|0|VEB|0|0|0|100|IKR|15098|28814|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Vedaprofenum||15098||15098|28814||2|0||0|||0 434366|G03GA1001|REKOVELLE|stl|12|mcg|0,36|ml|1|áfpen|+ 3 inndælingarnálar|G03GA10|01.08.2018||R|0|0|1|G|0|FEP|0|0|0|100|DKK|14083|20882|lyfalmen|||1|0,36|0|1,0000|Vistor hf|Ferring Pharmaceuticals A/S|Follitrópín delta||14083||14083|20882||1|0|G|0|||0 434461|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|þpakki||N03AX15|01.03.2014||R|1|0|0|G|0|EIG|0|0|0|100|SEK|7744|12157|lyfalmen|||1|56|0|14,0000|Vistor hf|Eisai GmbH|Zonisamíð||7744||7744|12157||1|0|G|0|||0 434576|A02BC0403|Rabeprazol Krka|sþ-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|G|0|KRK|0|0|1|100|IKR|3272|3838|lyfalmen|V0010|3838|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1700||1700|3838||2|0|G|0|||0 434601|N07BC0102|Buvidal|stl|128|mg|0,36|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|0|0|0|CMS|0|1|0|100|DKK|57266|75704|lyfsjukr|||1|0,36|0|60,9524|Vistor hf|Camurus AB|Búprenorfín||57266||57266|75704||1|H|L|1|30|dagar|0 434670|D01AC2001|Daktacort|krem|||50|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|MCS|0|0|1|100|SEK|753|2534|lyfalmen|||1|50|0||Vistor hf|McNeil Sweden AB|Blöndur||753||753|2534||1|0|E|0|||0 434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|1|0|G|0|MEA|0|0|1|100|IKR|6486|10425|lyfalmen|||1|1|0|0,6000|Icepharma hf|Meda AB|Adrenalín tartrat||6486||6486|10425||2|0|G|0|||0 434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|1|0|G|0|MEA|0|0|1|100|IKR|6471|10405|lyfalmen|||1|1|0|0,3000|Icepharma hf|Meda AB|Adrenalín tartrat||6471||6471|10405||2|0|G|0|||0 434852|N06AB0302|Fontex|dreifit.|20|mg|100|stk|1|pakki|þp (10x10 stk)|N06AB03|01.06.1998||R|0|0|0|0|0|DAN|0|0|0|100|XEU|9763|14936|lyfalmen|||1|100|0|100,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||9763||9763|14936||2|0|E|0|||0 434967|A16AX1401|Galafold|hylki|123|mg|14|stk|1|þpakki|Hart|A16AX14|01.05.2017||R|0|0|1|0|0|AMC|0|1|0|100|XEU|2382862|2970124|lyfsjukr|||1|14|0|28,0000|Vistor hf|Amicus Therapeutics Europe Limited|Migalastat||2382862||2382862|2970124||1|0|L|0|||0 435072|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.10.2017||R|0|0|1|0|0|SDG|0|1|0|100|DKK|13171|19626|lyfsjukr|||1|1,5|0|7,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||13171||13171|19626||1|0|L|0|||0 435151|R06AX2706|Flynise|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.10.2015||L|1|0|0|G|0|GRP|0|0|1|100|IKR|||lyfalmen|V0458|2979|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín|||||3847||1|0|G|0|||0 435882|N05CD0806|Buccolam|munnh.l|5|mg|1|ml|4|spr|munngjaf.spr|N05CD08|01.08.2020||R|0|0|0|0|0|LOS|0|0|1|100|DKK|12702|18981|lyfalmen|||2|4|0|2,0000|Laboratorios Lesvi, S.L.|Laboratorios Lesvi, S.L.|Mídazólam||12702||12702|18981||3|0|E|2|450|mg|0 436010|L01AA0901|Levact|irþ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|0|0|AST|0|1|0|100|DKK|207317|264356|lyfsjukr|||1|500|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||207317||207317|264356||2|H|L|0|||0 436044|N02AJ0601|Parkodin|filmhtfl|510|mg|10|stk|1|þpakki|10+500 mg|N02AJ06|01.07.2018||R|1|0|0|0|0|ATE|0|0|1|100|XEU|286|1892|lyfalmen|||2|10|0|1,6667|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||286||286|1892||1|0|E|3|||0 436147|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|20|stk|1|þpakki||M01AE02|01.07.1993||L|1|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Icepharma hf|Mylan AB|Naproxen|||||||2|0||0|||0 436308|J05AR2001|Biktarvy|filmhtfl|275|mg|30|stk|1|glas|50+200+25 mg|J05AR20|01.10.2018||R|0|0|1|0|0|GSE|0|1|0|100|DKK|130845|169246|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|Emtricitabine, Tenofovir alafenamide og Bictegravir||130845||130845|169246||2|0|L|0|||0 436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|0|0|0|0|0|LEP|0|0|1|100|DKK|1044|2935|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||1044||1044|2935||1|0||0|||0 436647|A16AA0402|Procysbi|hylki|25|mg|60|stk|1|glas||A16AA04|01.04.2016||R|0|1|1|0|0|CFS|0|1|0|100|XEU|69896|91678|lyfsjukr|||1|60|0|0,7500|Chiesi Pharma AB|Chiesi Farmaceutici S.p.A|Mercaptamín||69896||69896|91678||3|0|L|0|||0 436810|R03AC1901|Striverdi Respimat|innöndl|2,5|mcg|60|skammtar|1|rörlyk|Stök áfyllingarpakkning|R03AC19|01.08.2019||R|0|0|0|G|0|BII|0|0|1|100|DKK|4061|7087|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Olodaterol||4061||4061|7087||1|0|G|0|||0 436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|1|0|0|G|0|JAS|0|0|0|100|SEK|693|2452|lyfalmen|||1|100|0|12,5000|Vistor hf|Janssen-Cilag AB|Halóperídól||693||693|2452||1|0|G|0|||0 437007|N06BA0905|Atomoxetin STADA|hylki|18|mg|30|stk|1|þpakki|hart hylki|N06BA09|01.08.2020||R|1|1|0|0|0|LYF|0|0|0|100|IKR|4200|3150|lyfalmen|V0813|3150|2|30|0|6,7500|LYFIS ehf|LYFIS ehf|Atomoxetín||1200||1200|3150||2|0|E|0|||0 437221|R03AL0601|Spiolto Respimat|innöndl|5|mcg|1|rörlyk|1|pakki|Stök áfyllingarpakkn|R03AL06|01.08.2019||R|0|0|0|G|0|BOE|0|0|0|100|DKK|7838|9752|lyfalmen|||1|1|0||Vistor hf|Boehringer Ingelheim International GmbH|Olodaterol og tiotropiumbromide||5997||5997|9752||1|0|G|0|||0 437223|V10XX0301|Xofigo|stl|1100|kBq/ml|6|ml|1|hgl||V10XX03|01.06.2015||R|0|0|0|0|0|FIN|0|1|0|100|DKK|611264|766753|lyfsjukr|||1|6|0||Icepharma hf|Bayer AG|radium-223 dichloride||611264||611264|766753||2|H|L|0|||0 437581|N03AX1402|Keppra (Lyfjaver)|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.03.2019||R|1|0|0|G|0|LVR|0|0|0|100|DKK|10748|16291|lyfalmen|V0253|4878|3|100|0|33,3300|Lyfjaver ehf|Lyfjaver ehf|Levetíracetam||10748||10748|16291||3|0|G|0|||0 437763|A10BD2001|Synjardy|filmhtfl|1005|mg|180|stk|1|þpakki|5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|G|0|BOE|0|0|0|100|DKK|20858|29655|lyfalmen|V0712|29655|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||20858||20858|29655||1|0|G|0|||0 437767|N03AG0102|Orfiril|sþ-tfl|150|mg|100|stk|1|glas||N03AG01|01.08.2015||R|1|1|0|G|0|DEA|0|0|0|100|XEU|1124|3045|lyfalmen|||1|100|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1124||1124|3045||1|0|G|0|||0 437935|L01AA0901|Levact|irþ|2,5|mg/ml|25|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|0|0|AST|0|1|0|100|DKK|54655|72401|lyfsjukr|||1|125|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||54655||54655|72401||2|H|L|0|||0 438084|QM05BA0201|Osphos|stl|51|mg/ml|1|hgl|1|pakki|handa hestum|QM05BA02|01.12.2016||R|0|0|0|0|0|DEH|1|0|0|100|XEU|22570|42990|vetalmen|||0|1|0||Vistor hf|Dechra Regulatory B.V.|Clodronic acid||22570||22570|42990||1|0|0|0|||0 438353|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|0|FKA|0|0|1|100|DKK|1980|4223|lyfalmen|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||1980||1980|4223||1|0|0|0|||0 438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|||10|ml|1|dropaí|2 mg + 10 mg/ml|S02CA03|01.09.2002|31.07.2021|R|0|0|0|G|0|HES|0|0|1|100|DKK|2049|4318|lyfalmen|||1|10|0||Vistor hf|Novartis Healthcare A/S|Hýdrókortisón og sýkingalyf||2049||2049|4318||1|0|G|0|||0 438514|R06AE0708|Cetirizine Alvogen|filmhtfl|10|mg|10|stk|1|þpakki||R06AE07|01.06.2021||L|1|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Alvogen|Alvogen|Cetirizín|||||||2|0||0|||0 438571|A07EC0204|Asacol|töflur|1600|mg|60|stk|1|þpakki|með breyttan.losunarhraða|A07EC02|01.02.2019||R|1|0|0|G|0|TIL|0|0|0|100|DKK|10135|15448|lyfalmen|||1|60|0|64,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||10135||10135|15448||2|0|G|0|||0 438591|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.06.2017||R|0|0|0|G|0|CPM|0|0|1|100|DKK|1627|3737|lyfalmen|||1|100|0||Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Hýdrókortisón bútýrat||1627||1627|3737||1|0|G|0|||0 438639|N06DX0107|Zalatine|filmhtfl|10|mg|98|stk|1|þpakki||N06DX01|01.03.2014||R|1|0|0|G|0|WEH|0|0|0|100|XEU|5789|9466|lyfalmen|V0605|4840|2|98|0|49,0000|Williams & Halls efh|Williams & Halls ehf|Memantín||5789||5789|9466||2|0|G|0|||0 438759|L01EC0101|Zelboraf|filmhtfl|240|mg|56|stk|1|þpakki||L01EC01|01.08.2012||R|0|0|1|0|0|RRG|0|1|0|100|DKK|230158|292763|lyfsjukr|||1|56|0||Icepharma hf|Roche Registration GmbH|Vemurafenib||230158||230158|292763||2|0|L|0|||0 438775|R03AK1401|Atectura Breezhaler|innönddu|187,5|mcg/sk|30|stk|1|stsk.þ|125 mcg/62,5mcg|R03AK14|01.01.2021||R|0|0|0|G|0|NEP|0|0|0|100|DKK|3822|6759|lyfalmen|||1|30|0||Vistor hf|Novartis Europharm Limited|Indacaterol og mometasone||3822||3822|6759||1|0|G|0|||0 438806|B03XA0201|Aranesp|stl|130|mcg/spr|0,65|ml|4|áf.spr|nálavörn|B03XA02|01.12.2010||R|0|0|1|0|0|RAG|0|1|0|100|DKK|154649|198851|lyfsjukr|||1|2,6|0|115,5600|Vistor hf|Amgen|Darbepóetín alfa||154649||154649|198851||1|0|L|0|||0 438974|D01AE1501|Lamisil|krem|1|%|15|g|1|túpa||D01AE15|01.10.2018||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|15|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Terbínafín|||||||1|0||0|||0 439089|R01AA0704|Otrivin ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.11.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Xýlómetazólín|||||||1|0||0|||0 439419|B06AC0102|Berinert|sts/irs|2000|ae|1|hgl|1|pakki||B06AC01|01.07.2020||R|0|0|1|0|0|CSB|0|1|0|100|SEK|458913|577271|lyfsjukr|||1|1|0|1,4286|Icepharma hf|CSL Behring GmbH|C1 hemill||458913||458913|577271||2|0|L|0|||0 439489|C07FB0201|Logimax|forðatfl|55|mg|98|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|1|0|0|G|0|RDT|0|0|0|100|DKK|4914|8262|lyfalmen|||1|98|0|98,0000|Vistor hf|Recordati Ireland Limited|Metóprólól og Felodipin||4914||4914|8262||1|0|G|0|||0 439594|C10BA0201|Inegy|töflur|50|mg|98|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|NVO|0|0|0|100|DKK|20353|29016|lyfalmen|V0615|25748|1|98|0|98,0000|Vistor hf|N.V. Organon|Ezetimíb og simvastatín||20353||20353|29016||1|0||0|||0 439766|N06BA0902|Atomoxetin Actavis|hylki|100|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019|30.09.2021|R|1|1|0|0|0|ATE|0|0|0|100|XEU|15281|11719|lyfalmen|||2|28|0|35,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atomoxetín||7426||7426|11719||1|0|E|0|||0 439822|R03DC0306|Montelukast ratiopharm|tuggutfl|5|mg|98|stk|1|þpakki||R03DC03|01.09.2019||R|1|0|0|G|0|TSA|0|0|0|100|XEU|10886|16481|lyfalmen|||2|98|0|49,0000|Alvogen|Teva Sweden AB|Montelúkast||10886||10886|16481||2|0|G|0|||0 439954|H02AB0901|Solu-Cortef|sts|250|mg|1|hgl|1|pakki|Act-O-Vial|H02AB09|01.02.2021||R|0|0|0|0|0|PLS|0|0|0|100|DKK|876|2704|lyfalmen|||1|1|0|8,3333|Icepharma hf|Pfizer Aps|Hýdrókortisón||876||876|2704||1|H|0|0|||0 440410|N05AX1303|TREVICTA|stl|350|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|G|0|JCI|0|0|0|100|SEK|173349|222109|lyfalmen|||1|1|0|140,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||173349||173349|222109||1|0|G|0|||0 440431|N02AX0213|Tramadol Krka|forðatfl|200|mg|100|stk|1|þpakki||N02AX02|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|4500|6591|lyfalmen|V0224|6591|2|100|0|66,6700|Krka Sverige AB|Krka d.d. Novo mesto|Tramadól||3700||3700|6591||2|0|G|1|30|dagar|0 440652|C09AA0211|Enalapril Krka|töflur|20|mg|250|stk|1|glas||C09AA02|01.02.2016||R|1|0|0|G|0|KRK|0|0|0|100|IKR|3115|5785|lyfalmen|||2|250|0|500,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||3115||3115|5785||2|0|G|0|||0 440677|J01CE0106|Penicillin Actavis|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|ATE|0|0|1|100|DKK|1341|3344|lyfalmen|||2|10|0|1,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Benzýlpenicillín||1341||1341|3344||1|0|0|0|||0 440693|J01CE0106|Penicillin Actavis|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|ATE|0|0|1|100|DKK|2115|4409|lyfalmen|||2|10|0|3,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Benzýlpenicillín||2115||2115|4409||1|0|0|0|||0 440739|C03DA0403|Eplerenon Bluefish|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.10.2021||R|1|0|0|0|0|BLS|0|0|0|100|XEU|3183|3169|lyfalmen|V0107|2530|2|30|0|15,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Eplerenón||1214||1214|3169||1|0|E|0|||0 441191|N07BA0151|Nicorette Cooldrops|munnstfl|2|mg|80|stk|1|pakki|4 x 20 stykki|N07BA01|01.07.2016||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|80|0|5,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 441279|D01AC2002|Pevisone|krem|||30|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|KPA|0|0|1|100|SEK|1087|2994|lyfalmen|||1|30|0||Alvogen|Karo Pharma AB|Blöndur||1087||1087|2994||2|0|E|0|||0 441312|N07BA0151|Nicorette Cooldrops|munnstfl|4|mg|80|stk|1|pakki|4 x 20 stykki|N07BA01|01.07.2016||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|80|0|10,6700|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 441341|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.11.2013||R|1|0|0|G|0|ORA|0|0|0|100|DKK|1091|3000|lyfalmen|V0046|2424|2|100|0|33,3333|Artasan ehf|Orifarm Healthcare A/S|Spírónólaktón||1091||1091|3000||1|0|G|0|||0 441432|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.07.2021||R|0|0|0|0|0|PBV|0|0|0|100|XEU|806|2607|lyfalmen|V1051|2607|1|10|0||Williams & Halls efh|Piramal Critical Care B.V.|Fentanýl||806||806|2607||1|0|0|1|30|dagar|0 441451|N02CC0101|Imigran|nefúði|20|mg/sk|0,1|ml|6|úðaílá||N02CC01|01.04.2020||R|0|0|0|G|0|GPH|0|0|0|100|DKK|5907|9628|lyfalmen|||1|0,6|0|6,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||5907||5907|9628||1|0|G|0|||0 441619|J05AR0801|Eviplera|filmhtfl|470|mg|30|stk|1|glas|200+25+245 mg|J05AR08|01.05.2012||R|0|0|1|0|0|GEI|0|1|0|100|DKK|99631|129287|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Sciences Ireland|Emtrícítabín, rilpívírin og tenófóvír||99631||99631|129287||2|0|L|0|||0 442258|J07BK0101|Varilrix|sts|||0,5|ml|1|hgl|2.000 PFU bóluefni|J07BK01|01.01.2020||R|0|0|0|0|0|GPH|0|0|0|100|DKK|5656|9283|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Hlaupabóla, veikluð veira||5656||5656|9283||1|0|0|0|||0 442407|N05AH0312|Zalasta|töflur|15|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|G|0|KNM|0|0|0|100|XEU|2532|4983|lyfalmen|V0283|3785|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||2532||2532|4983||2|0|G|0|||0 442678|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|1|0|0|TMA|0|1|0|100|DKK|71176|93297|lyfsjukr|||1|1|0||Lyfjaver ehf|Takeda Manufacturing Austria AG|Storkuþáttur VIII||71176||71176|93297||3|0|L|0|||0 442705|B01AE0701|Pradaxa|hylki|150|mg|60|stk|1|þpakki|hart|B01AE07|01.10.2011||R|0|1|0|G|0|BII|0|0|0|100|DKK|10620|16115|lyfalmen|V0460|12478|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||10620|16115||1|0|G|0|||0 443122|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.01.2018||R|0|0|0|0|0|MAR|0|0|1|100|DKK|1611|3715|lyfalmen|V0560|3349|1|100|0||Icepharma hf|Aspen Pharma|Lídókaín||1611||1611|3715||2|0||0|||0 443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|hgl|1|pakki|dæla|H04AA01|01.01.1989||R|0|0|0|G|0|NAS|0|0|1|100|DKK|3193|5893|lyfalmen|||1|1|0|1,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||3193||3193|5893||1|0|G|0|||0 443255|N02BE0127|Dolorin Junior|eþ-stíll|250|mg|10|stk|1|þpakki||N02BE01|01.04.2021||L|0|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|10|0|0,8333|Williams & Halls efh|Williams & Halls ehf|Paracetamól|||||||2|0||0|||0 443325|H04AA0103|GlucaGen|sts|1|mg|10|hgl|1|pakki|leysir, lausn|H04AA01|01.07.2016||R|0|0|0|G|0|NAS|0|0|1|100|DKK|25345|35330|lyfalmen|||1|10|0|10,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||25345||25345|35330||1|0|G|0|||0 443358|N02AA0101|Contalgin|forðatfl|200|mg|90|stk|1|þpakki||N02AA01|01.04.1993||R|1|0|0|G|0|MDI|0|0|0|100|DKK|23394|32862|lyfalmen|||1|90|0|180,0000|Icepharma hf|Mundipharma A/S|Morfín||23394||23394|32862||2|0|G|1|30|dagar|0 443586|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.12.2016||R|0|0|0|0|0|EUS|0|0|0|100|XEU|24083|33734|lyfalmen|||1|1|0|0,5417|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||24083||24083|33734||3|H|0|0|||0 443903|N06AB0311|Fluoxetin Mylan|hylki|20|mg|100|stk|1|glas||N06AB03|01.11.2015||R|1|0|0|G|0|MYL|0|0|0|100|SEK|1802|3033|lyfalmen|V0039|3033|2|100|0|100,0000|Icepharma hf|Mylan AB|Flúoxetín||1115||1115|3033||2|0|G|0|||0 444098|L04AX0306|Metojectpen|stl|15|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|2575|5042|lyfalmen|||1|1|0|6,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2575||2575|5042||2|0|G|0|||0 444260|L04AC0801|Ilaris|stl|150|mg/ml|1|ml|1|hgl|lausn|L04AC08|01.04.2018||R|0|1|1|0|0|NEP|0|1|0|100|DKK|1605187|2002914|lyfsjukr|||1|1|0||Vistor hf|Novartis Europharm Limited|Canakinumab||1605187||1605187|2002914||1|0|L|0|||0 444285|J01CF0104|Dicloxacillin Bluefish|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.01.2017||R|0|0|0|0|0|BLS|0|0|1|100|XEU|2047|4010|lyfalmen|V0337|4010|2|30|0|7,5000|Artasan ehf|Bluefish Pharmaceuticals AB|Díkloxacillín||1825||1825|4010||1|0|E|0|||0 444315|N06AB0302|Fontex|dreifit.|20|mg|30|stk|1|pakki|þp (2 x 15 stk)|N06AB03|01.06.1998||R|0|0|0|0|0|DAN|0|0|0|100|XEU|2971|5587|lyfalmen|||1|30|0|30,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||2971||2971|5587||2|0|E|0|||0 444362|N01AF0302|Pentocur|sts|1|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|0|ABC|0|0|0|100|SEK|20826|29614|lyfalmen|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||20826||20826|29614||2|H|0|0|||0 444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|0|0|0|G|0|ROA|0|0|0|100|DKK|2139|4442|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche A.S.|Levódópa og dópadekarboxýl­asa­hemill||2139||2139|4442||2|0|G|0|||0 444511|N06DA0301|Exelon|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.04.2021||R|0|1|0|G|0|NEL|0|0|0|100|DKK|8437|13111|lyfalmen|V0349|12482|1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||8437||8437|13111||1|0|G|0|||0 444574|N07CA0102|Betahistin ratiopharm|töflur|8|mg|100|stk|1|þpakki||N07CA01|01.12.2013||R|1|0|0|G|0|RHA|0|0|0|100|IKR|3537|6366|lyfalmen|||2|100|0|33,3300|Alvogen|ratiopharm Oy|Betahistín||3537||3537|6366||2|0|G|0|||0 444765|A05AA0207|Ursochol|hylki|250|mg|100|stk|1|þpakki||A05AA02|01.11.2014||R|1|0|0|G|0|IRO|0|0|0|100|XEU|5011|8395|lyfalmen|||2|100|0|33,3300|Artasan ehf|Orifarm Generics A/S|Úrsódeoxýkól sýra||5011||5011|8395||1|0|G|0|||0 444932|B02BD0208|Afstyla|sts|2000|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|1|0|0|CSB|0|1|0|100|SEK|161885|207851|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||161885||161885|207851||2|0|L|0|||0 445022|A10BD1101|Jentadueto|filmhtfl|1002,5|mg|180|stk|1|þpakki|2,5mg/1000mg|A10BD11|01.11.2015||R|0|0|0|G|0|BOE|0|0|0|100|DKK|18504|26967|lyfalmen|||1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og linagliptinum||18504||18504|26967||1|0|G|0|||0 445149|R03AK1001|Relvar Ellipta|innönddu|114|mcg/sk|30|skammtar|1|pakki|92+22 mcg|R03AK10|01.04.2014||R|0|0|0|G|0|RGP|0|0|0|100|DKK|4674|7931|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline (Ireland) Limited|Vilanterol og flútícason||4674||4674|7931||1|0|G|0|||0 445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|0|0|0|G|0|LEO|0|0|1|100|DKK|1902|4116|lyfalmen|||1|30|0||Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||1902||1902|4116||1|0|G|0|||0 445169|L01CE0202|Irinotecan Accord|irþ|20|mg/ml|25|ml|1|hgl|lausn|L01CE02|01.06.2020||R|0|0|0|0|0|AEE|0|0|0|100|XEU|40622|54652|lyfalmen|||2|25|0||Artasan ehf|Accord Healthcare B.V.|Irinotecan||40622||40622|54652||1|H|0|0|||0 445240|N05CH0104|Melatonin Vitabalans|töflur|5|mg|50|stk|1|þpakki||N05CH01|01.03.2019||R|0|0|0|0|0|LYF|0|0|1|100|IKR|7000|5902|lyfalmen|||2|50|0|125,0000|LYFIS ehf|LYFIS ehf|Melatonin||3200||3200|5902||2|0|0|0|||0 445418|N05AX1210|Aripiprazol Medical Valley|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.10.2016||R|1|1|0|G|0|VAL|0|0|0|100|XEU|6829|3422|lyfalmen|V0684|3422|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Aripiprazól||1398||1398|3422||2|0|G|0|||0 445576|L04AC1001|Cosentyx|stl|300|mg|2|ml|1|áfpen||L04AC10|01.08.2021||R|0|0|1|0|0|NEL|0|1|0|100|DKK|161012|206765|lyfsjukr|||1|2|0|30,0000|Vistor hf|Novartis Europharm Ltd|Secukinumab||161012||161012|206765||1|0|L|0|||0 445705|A10AE0406|Toujeo [SoloStar]|stl|300|ein/ml|1,5|ml|3|pennar|áfylltir lyfjapennar|A10AE04|01.10.2015||R|0|1|0|G|0|SDH|0|0|0|100|XEU|5644|9266|lyfalmen|||1|4,5|0|33,7500|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||5644||5644|9266||1|0|G|0|||0 445892|QD11AH9102|Cytopoint|stl|40|mg|1|ml|2|hgl||QD11AH91|01.08.2021||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|28280|53823|vetalmen|||1|2|0||Icepharma hf|Zoetis Belgium S.A.|lokivetmab||28280||28280|53823||2|0||0|||0 446618|N03AF0301|Inovelon|mixtúra|40|mg/ml|460|ml|1|fl||N03AF03|01.09.2012||R|0|0|1|G|0|EIG|0|0|0|100|SEK|15973|23483|lyfalmen|||1|460|0|13,1400|Vistor hf|Eisai GmbH|Rúfínamíð||15973||15973|23483||1|0|G|0|||0 446639|C10BA0202|Ezetimib/Simvastatin Krka|töflur|30|mg|100|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.10.2019||R|1|0|0|0|0|KNM|0|0|0|100|IKR|17377|22144|lyfalmen|||2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Ezetimíb og simvastatín||15000||15000|22144||2|0||0|||0 447013|L04AB0402|Imraldi|stl|40|mg/spr|0,8|ml|2|áf.spr|áfylltar sprautur|L04AB04|01.03.2019||R|0|1|1|0|0|SUG|0|1|0|100|XEU|57948|76566|lyfsjukr|||2|1,6|0|27,5900|Icepharma hf|Samsung Bioepis NL B.V.|Adalimumab||57948||57948|76566||2|0|L|0|||0 447040|N06AX2105|Duloxetin Krka|sþ-hylki|60|mg|100|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|G|0|KNM|0|0|0|100|IKR|7968|5214|lyfalmen|V0694|4446|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||2700||2700|5214||2|0|G|0|||0 447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|18000 a.e. anti-Xa/sprautu|B01AB04|01.04.2008||R|0|0|0|G|0|PLS|0|0|1|100|DKK|11019|16664|lyfalmen|||1|3,6|0|36,0000|Icepharma hf|Pfizer ApS|Dalteparín||11019||11019|16664||1|0|G|0|||0 447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|10000 a.e. anti-Xa/sprautu|B01AB04|01.04.2008||R|0|0|0|G|0|PLS|0|0|1|100|DKK|6168|9988|lyfalmen|||1|2|0|20,0000|Icepharma hf|Pfizer ApS|Dalteparín||6168||6168|9988||1|0|G|0|||0 447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|12500 a.e. anti-Xa/sprautu|B01AB04|01.04.2008||R|0|0|0|G|0|PLS|0|0|1|100|DKK|7754|12171|lyfalmen|||1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Dalteparín||7754||7754|12171||1|0|G|0|||0 447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|15000 a.e. anti-Xa/sprautu|B01AB04|01.04.2008||R|0|0|0|G|0|PLS|0|0|1|100|DKK|8023|12541|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||8023||8023|12541||1|0|G|0|||0 447357|A10AE0407|Toujeo [DoubleStar]|stl|300|ein/ml|3|ml|3|áfpen|áfylltir lyfjapennar|A10AE04|01.09.2019||R|0|1|0|G|0|SDH|0|0|0|100|XEU|11287|17033|lyfalmen|||1|9|0|67,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||11287||11287|17033||1|0|G|0|||0 447596|C07AG0205|Carveratio|töflur|25|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|G|0|RTH|0|0|0|100|IKR|2999|3631|lyfalmen|V0948|3631|2|100|0|66,6700|Alvogen|ratiopharm GmbH|Carvedílól||1550||1550|3631||2|0|G|0|||0 447608|J06BA0104|Cutaquig|stl|165|mg/ml|12|ml|1|hgl||J06BA01|01.04.2020||R|0|0|1|0|0|OCT|0|1|0|100|DKK|23145|32547|lyfsjukr|||1|12|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||23145||23145|32547||1|0|L|0|||0 447939|G04BE0806|Tadalafil Krka|filmhtfl|5|mg|84|stk|1|þpakki||G04BE08|01.07.2020||R|1|0|0|0|0|KNM|0|0|0|100|IKR|28000|38688|lyfalmen|||2|84|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||28000||28000|38688||2|0|E|0|||0 448253|A10AB0505|Fiasp|stl|100|ein/ml|10|ml|1|hgl||A10AB05|01.02.2019||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2850|5421|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||2850||2850|5421||1|0|G|0|||0 448379|G03AD0103|Levonorgestrel Apofri|töflur|1,5|mg|1|stk|1|þpakki||G03AD01|01.12.2019||L|0|0|0|0|0|APO|0|0|0|100|IKR|||lyflau11|||0|1|0|1,0000|LYFIS ehf|Apofri AB|Levonorgestrel|||||||2|0||0|||1 448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|þpakki||M03BX01|01.12.1972||R|1|0|0|G|0|HES|0|0|1|100|DKK|1981|4225|lyfalmen|V0202|4225|1|50|0|25,0000|Vistor hf|Novartis Healthcare A/S|Baklófen||1981||1981|4225||1|0|G|0|||0 448821|C10AA0703|Rosuvastatin Krka|filmhtfl|5|mg|100|stk|1|þpakki||C10AA07|01.02.2017||R|1|0|0|0|0|KRK|0|0|0|100|IKR|4087|4636|lyfalmen|V0214|4604|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||2280||2280|4636||2|0|E|0|||0 449470|B05BB0120|Natriumhydrogenkarbonat B.Braun|irl|500|mmól/l|0,25|l|1|fl|lausn|B05BB01|01.02.2012||R|0|0|0|0|0|RAU|0|0|0|100|XEU|1089|2997|lyfalmen|||2|0,25|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||1089||1089|2997||2|H|0|0|||0 449480|B02BC3002|TISSEEL|vefjalím|||4|ml|1|áf.spr|4 nálar og 2 millistykki|B02BC30|01.06.2020||R|0|0|0|0|0|BAM|0|0|0|100|SEK|33182|45242|lyfalmen|||1|4|0||Icepharma hf|Baxter Medical AB|Blöndur||33182||33182|45242||2|H|0|0|||0 449485|N03AX1603|Pregabalin Krka|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|2271|3474|lyfalmen|V0686|2037|2|56|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1436||1436|3474||2|0|E|0|||0 449611|C07AB0311|Atenolol Mylan|töflur|100|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|1|0|0|G|0|MYL|0|0|0|100|SEK|1838|3180|lyfalmen|||2|98|0|130,6667|Icepharma hf|Mylan AB|Atenólól||1222||1222|3180||2|0|G|0|||0 449697|R03DX1001|Fasenra|stl|30|mg|1|ml|1|áfpen||R03DX10|01.05.2020||R|0|0|1|0|0|ZEN|0|1|0|100|SEK|338387|427370|lyfsjukr|||1|1|0|55,5556|Vistor hf|AstraZeneca AB|Benralizumab||338387||338387|427370||1|0|L|0|||0 449819|J01CE0106|Penicillin Actavis|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|ATE|0|0|1|100|DKK|5014|8399|lyfalmen|||2|10|0|8,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Benzýlpenicillín||5014||5014|8399||1|0|0|0|||0 449842|L01XX2401|Oncaspar|stl/irs|750|ein/ml|5|ml|1|hgl||L01XX24|01.04.2019||R|0|0|0|0|0|LLS|0|1|0|100|DKK|238764|303467|lyfsjukr|||1|5|0||Icepharma hf|Les Laboratoires Servier|Pegaspargase||||238764|303467||2|H|L|0|||0 449868|B01AF0101|Xarelto|filmhtfl|10|mg|10|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|G|0|FIN|0|0|0|100|DKK|3292|6029|lyfalmen|||1|10|0|5,0000|Icepharma hf|Bayer AG|Rivaoxaban||3292||3292|6029||2|0|G|0|||0 450009|QN51AA0101|Euthasol vet.|stl|400|mg/ml|100|ml|1|fl||QN51AA01|01.07.2012||R|0|0|0|0|0|LEV|1|0|0|100|XEU|4612|8920|vetalmen|||0|100|0||Le Vet B.V.|Le Vet B.V.|Pentobarbital||4612||4612|8920||2|0||1|30|dagar|0 450054|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|þpakki||G03CA04|01.12.2014||R|0|0|0|G|0|AEP|0|0|0|100|DKK|1171|3110|lyfalmen|||1|30|0|30,0000|Icepharma hf|Aspen Pharma Trading Limited|Estríól||1171||1171|3110||2|0|G|0|||0 450201|V03AB3501|Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.07.2014||R|0|0|0|0|0|MBV|0|0|0|100|DKK|120581|156480|lyfalmen|||1|20|0||Vistor hf|Merck Sharp & Dohme B.V.|Sugammadex||120581||120581|156480||1|H|0|0|||0 450216|N06BA0903|Atomoxetin Medical Valley|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.12.2019||R|1|1|0|0|0|VAL|0|0|0|100|XEU|10140|3284|lyfalmen|V0814|2940|2|28|0|8,7500|Acare ehf|Medical Valley Invest AB|Atomoxetín||1298||1298|3284||2|0|E|0|||0 450413|V03AB3701|Praxbind|stl/irl|2,5|g|50|ml|2|hgl||V03AB37|01.05.2016||R|0|0|0|0|0|BOE|0|0|0|100|DKK|351483|443658|lyfalmen|||1|100|0||Vistor hf|Boehringer Ingelheim International GmbH|Idarucizumab||351483||351483|443658||1|H|0|0|||0 450537|N05CD0806|Buccolam|munnh.l|10|mg|2|ml|4|spr|munngjaf.spr|N05CD08|01.11.2019||R|0|0|0|0|0|LOS|0|0|1|100|DKK|12702|18981|lyfalmen|||2|8|0|4,0000|Laboratorios Lesvi, S.L.|Laboratorios Lesvi, S.L.|Mídazólam||12702||12702|18981||3|0|E|2|450|mg|0 450846|QN01AX9401|AQUI-S vet.|baðþ|540|g/líter|4000|ml|1|glas|HDPE plastílát|QN01AX94|01.03.2019||R|0|0|0|0|0|SAS|0|0|0|100|NOK|251925|406103|veteldis|||0|4000|0||Vistor hf|Scan Aqua AS|Isoeugenol||251925||251925|406103||1|0||0|||0 450979|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.11.2011||R|0|0|0|0|0|NIL|0|0|0|100|IKR|9072|15636|vetorma|||0|2,5|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Limited|Ivermectinum||9072||9072|15636||2|0||0|||0 450993|R07AX0101|INOmax|lyfjagas|800|ppm|10|l|1|gashyl|undir þrýstingi|R07AX01|01.09.2014||R|0|1|0|0|0|LIN|0|0|0|100|XEU|20312|28964|lyfalmen|||1|10|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíð||||20312|28964||5|H|0|0|||0 451009|L01ED0401|Alunbrig|filmhtfl|30|mg|28|stk|1|þpakki||L01ED04|01.02.2021||R|1|1|1|0|0|ASS|0|1|0|100|DKK|168912|216590|lyfsjukr|||1|28|0||Vistor hf|Takeda AS|Brigatinib||168912||168912|216590||1|0|L|0|||0 451135|N04BC0409|Adartrel (Lyfjaver)|filmhtfl|0,5|mg|84|stk|1|þpakki||N04BC04|01.11.2020||R|1|0|0|G|0|LVR|0|0|0|100|XEU|3237|5953|lyfalmen|||3|84|0|7,0000|Lyfjaver ehf|Lyfjaver ehf|Rópíníról||3237||3237|5953||3|0|G|0|||0 451293|N05AX1204|ABILIFY MAINTENA|sts|400|mg|1|hgl|1|pakki||N05AX12|01.07.2014||R|0|0|0|0|0|OTS|0|0|0|100|DKK|41720|56041|lyfalmen|V0980|56040|1|1|0|30,0800|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||41720||41720|56041||1|0|E|0|||0 451378|H02AB0607|Prednisolon Actavis|töflur|10|mg|25|stk|1|glas||H02AB06|01.12.2016||R|1|0|0|G|0|ATE|0|0|1|100|XEU|641|2380|lyfalmen|||2|25|0|25,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Prednisólón||641||641|2380||1|0|G|0|||0 451428|B06AC0102|Berinert|sts/irs|1500|ae|1|hgl|1|pakki||B06AC01|01.05.2020||R|0|0|1|0|0|CSB|0|1|0|100|SEK|300384|380105|lyfsjukr|||1|1|0|1,0714|Icepharma hf|CSL Behring GmbH|C1 hemill||300384||300384|380105||2|0|L|0|||0 451655|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.09.2018||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|30|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Terbínafín|||||||1|0||0|||0 451670|N03AX1610|Pregabalin Medical Valley|hylki|150|mg|70|stk|1|þpakki||N03AX16|01.04.2020||R|1|0|0|0|0|VAL|0|0|0|100|IKR|2594|3563|lyfalmen|V0687|3265|2|70|0|35,0000|Acare ehf|Medical Valley Invest AB|Pregabalín||1500||1500|3563||2|0|E|0|||0 451761|L01AB0101|Myleran|filmhtfl|2|mg|100|stk|1|glas||L01AB01|01.06.2013||R|0|0|1|G|0|AEP|0|0|0|100|IKR|16132|23702|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma Trading Limited|Búsúlfan||16132||16132|23702||2|0|G|0|||0 452022|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|fl||D01AC08|01.01.2012||L|0|0|0|0|0|TAE|0|0|1|100|IKR|||lyflausa|||0|120|0||Alvogen|Trimb Healthcare AB|Ketókónazól|||||||2|0||0|||0 452215|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.12.2016||L|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0||Vistor hf|Omega Pharma Nordic AB|Pencíklóvír|||||||1|0||0|||0 452258|R03AK1101|Flutiform|innúðal|260|mcg/sk|120|skammtar|1|pakki|250+10 mcg/sk|R03AK11|01.01.2014||R|0|0|0|G|0|MUP|0|0|0|100|DKK|7725|12131|lyfalmen|||1|120|0|60,0000|Icepharma hf|Mundipharma A/S|Formóteról og flútikasón||7725||7725|12131||2|0|G|0|||0 452482|V07AB0009|Sterilt Vann B. Braun|leysir|||100|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|2000|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||5813||2|0||0|||0 452499|A10BJ0602|Rybelsus|töflur|3|mg|30|stk|1|þpakki||A10BJ06|01.12.2020||R|0|0|0|0|0|NAS|0|0|0|100|DKK|21171|30051|lyfalmen|||1|30|0||Vistor hf|Novo-Nordisk A/S|Semaglutide||21171||21171|30051||1|0|E|0|||0 452500|L01EE0201|Cotellic|filmhtfl|20|mg|63|stk|1|þpakki|3 x 21|L01EE02|01.02.2016||R|1|0|1|0|0|RRG|0|1|0|100|DKK|792120|991687|lyfsjukr|||1|63|0||Icepharma hf|Roche Registration GmbH|Cobimetinib||||792120|991687||2|0|L|0|||0 452594|A02BC0403|Rabeprazol Krka|sþ-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|G|0|KRK|0|0|1|100|IKR|3500|2874|lyfalmen|V0010|2193|2|56|0|56,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1000||1000|2874||2|0|G|0|||0 452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|0|0|0|0|0|MEA|0|0|1|100|DKK|8290|12908|lyfalmen|||1|3000|0||Icepharma hf|Meda AB|Imikvímóð||8290||8290|12908||2|0|E|0|||0 452866|B05AA0114|Albuman|irl|200|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|SPP|0|0|0|100|XEU|12109|18165|lyfalmen|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|albumin||12109||12109|18165||2|H|0|0|||0 453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dæl||QP54AA01|01.01.1991||R|0|0|0|0|0|BOA|0|0|0|100|XEU|1401|2415|vetorma|||0|6,4|0||Vistor hf|Boehringer Ingelheim Animal Health SCS|Ivermectinum||1401||1401|2415||1|0||0|||0 453560|L04AX0501|Esbriet|filmhtfl|267|mg|63|stk|1|þpakki||L04AX05|01.11.2017||R|1|1|1|0|0|RRG|0|0|0|100|DKK|100132|131047|lyfalmen|||1|63|0|7,0000|Icepharma hf|Roche Registration GmbH|Pírfenidon||||100132|131047||2|0|E|0|||0 453731|N06AX1613|Venlafaxin Medical Valley|forðatfl|225|mg|100|stk|1|glas||N06AX16|01.10.2017||R|0|0|0|G|0|VAL|0|0|0|100|IKR|3500|6315|lyfalmen|||2|100|0|225,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||3500||3500|6315||2|0|G|0|||0 454442|QH01BB0204|Oxytobel|stl|10|ae/ml|50|ml|12|hgl||QH01BB02|01.11.2015||R|0|0|0|0|0|Bel|1|0|0|100|DKK|5054|9759|vetalmen|||0|600|0||Icepharma hf|Bela-Pharma GmbH & CO KG|Oxytocin||5054||5054|9759||2|0||0|||0 454650|D05AX5204|Enstilar|húðfroða|||60|g|1|ílát|50 mcg/g+0,5 mg/g|D05AX52|01.06.2018||R|0|0|0|G|0|LEP|0|0|0|100|DKK|8413|13078|lyfalmen|||1|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||8413||8413|13078||1|0|G|0|||0 454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|1|0|0|G|0|PLS|0|0|0|100|DKK|33906|42494|lyfalmen|V0342|10828|1|98|0|130,6667|Icepharma hf|Pfizer ApS|Dónepezíl||31009||31009|42494||1|0|G|0|||0 454819|N02BE0115|Paracet|eþ-stíll|60|mg|10|stk|1|pakki||N02BE01|01.07.2011||L|0|0|0|0|0|KPA|0|0|1|100|IKR|||lyflausa|||0|10|0|0,2000|Alvogen|Karo Pharma AB|Paracetamól|||||||2|0||0|||0 454882|A16AX0701|Kuvan|lausnart|100|mg|120|stk|1|glas||A16AX07|01.05.2017||R|0|0|1|0|0|BIM|0|0|0|100|SEK|384853|485161|lyfalmen|||1|120|0||Icepharma hf|BioMarin International Limited|Saprópterín||384853||384853|485161||2|0||0|||0 454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|0|0|0|0|0|BID|0|0|0|100|DKK|1093|2148|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|Prókaínpenicillín (BAN)||1093||1093|2148||1|0||0|||0 454973|J01FA1007|Azithromycin STADA|filmhtfl|500|mg|3|stk|1|þpakki||J01FA10|01.06.2017||R|1|0|0|0|0|ASR|0|0|1|100|IKR|1100|2599|lyfalmen|V0174|2599|2|3|0|5,0000|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||800||800|2599||2|0|E|0|||0 455266|A10BD2001|Synjardy|filmhtfl|1012,5|mg|60|stk|1|þpakki|12,5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|G|0|BOE|0|0|0|100|DKK|7405|11690|lyfalmen|V0713|9981|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||7405||7405|11690||1|0|G|0|||0 455325|L04AX0601|Imnovid|hylki|2|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|1|0|0|BSE|0|1|0|100|DKK|1054301|1317766|lyfsjukr|||1|21|0|14,0000|Celgene Europe ltd|Bristol-Myers Squibb Pharma EEIG|Pomalidómide||1054301||1054301|1317766||2|0|L|0|||0 455398|B01AF0202|Eliquis (Lyfjaver)|filmhtfl|2,5|mg|168|stk|1|þpakki||B01AF02|01.03.2020||R|1|1|0|G|0|LVR|0|0|0|100|DKK|27963|38641|lyfalmen|V0653|38641|3|168|0|42,0000|Lyfjaver ehf|Lyfjaver ehf|Apixaban ||27963||27963|38641||3|0|G|0|||0 455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|þpakki||J01AA02|01.10.2008||R|1|0|0|0|0|ATE|0|0|1|100|XEU|774|2563|lyfalmen|||2|10|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Doxýcýklín||774||774|2563||1|0|E|0|||0 455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|þpakki||J01AA02|01.01.2009||R|1|0|0|0|0|ATE|0|0|1|100|XEU|874|2701|lyfalmen|||2|15|0|15,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Doxýcýklín||874||874|2701||1|0|E|0|||0 455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|þpakki||J01AA02|01.10.2008||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1635|3748|lyfalmen|||2|30|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Doxýcýklín||1635||1635|3748||1|0|E|0|||0 456724|L01EA0101|Glivec|filmhtfl|100|mg|60|stk|1|þpakki||L01EA01|01.05.2021||R|0|0|1|0|0|NEL|0|1|0|100|DKK|95754|124383|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Imatinib||95754||95754|124383||1|0|L|0|||0 456734|C07AB0704|Bisbetol|filmhtfl|10|mg|100|stk|1|þpakki||C07AB07|01.01.2017||R|0|0|0|G|0|WEH|0|0|0|100|XEU|4370|7513|lyfalmen|V1040|4144|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|bisoprolol||4370||4370|7513||2|0|G|0|||0 456795|L01EB0401|Tagrisso|filmhtfl|80|mg|30|stk|1|stsk.þ||L01EB04|01.06.2019||R|0|0|1|0|0|ZEN|0|1|0|100|SEK|898393|1123861|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Osimertinib||898393||898393|1123861||1|0|L|0|||0 456895|N05AH0206|Clozapin Medical|töflur|100|mg|100|stk|1|þpakki||N05AH02|01.06.2015||R|1|0|0|G|0|MED|0|0|0|100|IKR|4926|6315|lyfalmen|V0277|6307|2|100|0|33,3300|Medical ehf|Medical ehf|Klózapín||3500||3500|6315||2|0|G|0|||0 457112|N06BA0902|Atomoxetin Actavis|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|ATE|0|0|0|100|XEU|6572|3421|lyfalmen|V0816|3068|2|28|0|21,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atomoxetín||1397||1397|3421||1|0|E|0|||0 457185|H05BX0107|Cinacalcet STADA|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.12.2020||R|1|0|0|0|0|ASR|0|0|0|100|IKR|28190|11614|lyfalmen|V0721|11614|2|28|0|28,0000|LYFIS ehf|STADA Arzneimittel AG|Cinacalcet||7350||7350|11614||2|0||0|||0 457204|L02AE0307|Reseligo|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.05.2016||R|0|0|1|G|0|ZET|0|0|0|100|SEK|49324|53920|lyfalmen|V0451|53920|2|1|0|83,7200|Alvogen|Zentiva, k.s.|Góserelín||40043||40043|53920||2|0|G|0|||0 457282|N06AB1007|Escitalopram Bluefish|filmhtfl|15|mg|98|stk|1|þpakki||N06AB10|01.04.2019||R|1|0|0|G|0|BLS|0|0|0|100|XEU|3467|6270|lyfalmen|V0326|5245|2|98|0|147,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Escítalópram||3467||3467|6270||1|0|0|0|||0 457359|N01BB0204|Lidokain Mylan|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.09.2016||R|0|0|0|0|0|MYE|0|0|1|100|DKK|1503|3567|lyfalmen|V0561|3567|2|100|0||Icepharma hf|Mylan Ireland Limited|Lídókaín||1503||1503|3567||2|0||0|||0 457508|J07AH0801|Nimenrix|sts|5|mcg|0,5|ml|1|hgl|+áfyllt sprauta|J07AH08|01.07.2013||R|0|0|0|0|0|PEU|0|0|0|100|DKK|6097|9890|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Europe MA EEIG|Hreinsaðir fjórgildi A,C,Y,W-135 og fl.||6097||6097|9890||1|0||0|||0 457692|L04AX0307|Metoject|stl|50|mg/ml|0,45|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|G|0|WIL|0|0|0|100|SEK|2883|5466|lyfalmen|||1|0,45|0|9,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2883||2883|5466||2|0|G|0|||0 457726|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2011||R|0|0|0|0|0|ATE|0|0|1|100|XEU|2585|2178|lyfalmen|V0003|2178|2|28|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rabeprazól||494||494|2178||1|0|E|0|||0 457755|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|rörlyk|lausn|R03BB04|01.08.2019||R|0|0|0|G|0|BII|0|0|0|100|DKK|4180|7251|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||4180||4180|7251||1|0|G|0|||0 457991|QI09AB0401|Rhiniseng|stl|||50|ml|1|hgl|dreifa|QI09AB04|01.08.2016||R|0|0|0|0|0|LHS|0|0|0|100|XEU|10604|18277|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||10604||10604|18277||2|0||0|||0 458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|1|0|0|0|0|CHE|0|0|1|100|DKK|1089|2997|lyfalmen|||1|25|0|5,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Clómetíazól||1089||1089|2997||1|0|E|2|150|hylki|0 458149|L01EX0501|Stivarga|filmhtfl|40|mg|84|stk|1|glas|3 x 28|L01EX05|01.06.2014||R|0|0|1|0|0|FIN|0|1|0|100|DKK|375772|473866|lyfsjukr|||1|84|0||Icepharma hf|Bayer AG|Regorafenib||375772||375772|473866||2|0|L|0|||0 458266|L04AB0402|Imraldi|stl|40|mg/penna|0,8|ml|2|áfpen|áfylltur penni|L04AB04|01.03.2019||R|0|1|1|0|0|SUG|0|1|0|100|XEU|57948|76566|lyfsjukr|||2|1,6|0|27,5900|Icepharma hf|Samsung Bioepis NL B.V.|Adalimumab||57948||57948|76566||2|0|L|0|||0 458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|þpakki||J01CA08|01.12.1980||R|0|0|0|0|0|KPA|0|0|1|100|DKK|1254|3224|lyfalmen|V0577|2796|1|20|0|6,6667|Alvogen|Karo Pharma AB|Pívmecillínam||1254||1254|3224||2|0|E|0|||0 458666|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|1|0|0|TMA|0|1|0|100|DKK|108890|141940|lyfsjukr|||1|1|0||Lyfjaver ehf|Takeda Manufacturing Austria AG|Storkuþáttur VIII||108890||108890|141940||3|0|L|0|||0 458805|B01AF0201|Eliquis|filmhtfl|2,5|mg|60|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|G|0|BSM|0|0|0|100|DKK|9614|14051|lyfalmen|V0653|13800|1|60|0|15,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||9120||9120|14051||1|0|G|0|||0 458838|M09AX0701|Spinraza|stl|12|mg|5|ml|1|hgl|lausn|M09AX07|01.11.2018||R|0|0|0|0|0|BNB|0|1|0|100|XEU|11429700|14221858|lyfsjukr|||1|5|0|120,0000|Icepharma hf|Biogen Netherlands B.V.|Nusinersen||11429700||11429700|14221858||2|H|L|0|||0 459037|L01EC0201|Tafinlar|hylki|75|mg|120|stk|1|glas||L01EC02|01.11.2013||R|1|0|1|0|0|NEL|0|1|0|100|DKK|834662|1044597|lyfsjukr|||1|120|0||Vistor hf|Novartis Europharm Ltd|Dabrafenib||834662||834662|1044597||1|0|L|0|||0 459242|L03AB1301|Plegridy|stl|||2|áf.spr|1|pakki|63 og 94 mcg|L03AB13|01.07.2015||R|0|0|1|G|0|BNB|0|0|0|100|XEU|81321|106128|lyfalmen|||1|2|0|17,6400|Icepharma hf|Biogen Netherlands B.V.|Peginterferón beta-1a||81321||81321|106128||2|0|G|0|||0 459324|V08CA0901|Gadovist|stl|1|mmol/ml|5|ml|5|áfspr|lausn|V08CA09|01.04.2018||R|0|0|0|0|0|BAB|0|0|0|100|DKK|20984|29814|lyfalmen|||1|25|0||Icepharma hf|Bayer AB|Gadóbútról||||20984|29814||2|H|0|0|||0 459342|N05AX1304|Paliperidon Krka|forðatfl|6|mg|28|stk|1|þpakki||N05AX13|01.08.2018||R|0|0|0|G|0|KNM|0|0|0|100|IKR|11123|16808|lyfalmen|V0964|16808|2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Paliperídón||11123||11123|16808||2|0|G|0|||0 459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|PLS|0|0|1|100|DKK|815|2620|lyfalmen|||1|2|0|0,1667|Icepharma hf|Pfizer ApS|Klindamýcín||815||815|2620||1|0|0|0|||0 459405|L01EL0101|IMBRUVICA|filmhtfl|560|mg|28|stk|1|þpakki||L01EL01|01.04.2020||R|1|0|1|0|0|JCI|0|1|0|100|SEK|956252|1195821|lyfsjukr|||1|28|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||956252||956252|1195821||1|0|L|0|||0 459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|PLS|0|0|1|100|DKK|1494|3554|lyfalmen|||1|4|0|0,3333|Icepharma hf|Pfizer ApS|Klindamýcín||1494||1494|3554||1|0|0|0|||0 459423|N07BC0102|Buvidal|stl|16|mg|0,32|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|0|0|0|CMS|0|1|0|100|DKK|13390|19928|lyfsjukr|||1|0,32|0|7,6190|Vistor hf|Camurus AB|Búprenorfín||13390||13390|19928||1|H|L|1|30|dagar|0 459447|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.04.2015||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|20198|38490|vetalmen|||0|10|0||Icepharma hf|Zoetis Belgium S.A.|Cefovecinum||20198||20198|38490||2|0||0|||0 459812|N05AH0411|Quetiapine Teva|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.09.2014||R|1|0|0|G|0|TSA|0|0|0|100|IKR|2514|2393|lyfalmen|V0284|2343|2|100|0|6,2500|Alvogen|Teva Sweden AB|Quetíapín||650||650|2393||2|0|G|0|||0 459838|N05AH0416|Quetiapin Medical Valley|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.09.2019||R|1|1|0|G|0|VAL|0|0|0|100|IKR|10500|11408|lyfalmen|V0261|11408|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Quetíapín||7200||7200|11408||2|0|0|0|||0 459845|A10BD2301|Segluromet|filmhtfl|1007,5|mg|56|stk|1|þpakki|7,5mg/1000mg|A10BD23|01.04.2019||R|1|0|0|G|0|DSM|0|0|0|100|DKK|5872|9580|lyfalmen|||1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme|Ertugliflozin og metformin||5872||5872|9580||1|0|G|0|||0 459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|þpakki||B02AA02|01.04.1989||R|1|0|0|G|0|MEA|0|0|1|100|DKK|1951|4183|lyfalmen|||1|30|0|7,5000|Icepharma hf|Meda AB|Tranexamsýra||1951||1951|4183||2|0|G|0|||0 459926|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|10|stk|1|þpakki||J05AB11|01.04.2019||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||2|10|0|1,6667|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Valacíklóvír|||||||1|0|0|0|||0 460062|L01AA0902|Bendamustine Accord|st/irþ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.01.2016||R|0|0|0|0|0|AEE|0|1|0|100|XEU|135346|174844|lyfsjukr|||2|500|0||Artasan ehf|Accord Healthcare B.V.|Bendamústín||135346||135346|174844||1|H|L|0|||0 460293|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|þpakki||J04AB02|01.09.2012||R|1|0|0|G|0|HSS|0|0|0|100|DKK|9013|13903|lyfalmen|||1|100|0|25,0000|Artasan ehf|Sandoz GmbH|Rífampicín||9013||9013|13903||1|0|G|0|||0 460339|L01XC0301|Herceptin|stl|600|mg/hgl|5|ml|1|hgl||L01XC03|01.12.2013||R|0|0|0|0|0|RRG|0|1|0|100|DKK|241098|306370|lyfsjukr|||1|5|0||Icepharma hf|Roche Registration GmbH|Trastuzumab||241098||241098|306370||2|H|L|0|||0 460632|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.03.2017||R|1|0|0|0|0|GPA|0|0|0|100|XEU|7162|4150|lyfalmen|V0144|3944|2|12|0|24,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||1927||1927|4150||1|0|E|0|||0 460826|QJ01CR0201|Combisyn|töflur|250|mg|100|stk|1|pakki||QJ01CR02|01.11.2011||R|0|0|0|0|0|BRO|0|0|0|100|XEU|4890|8793|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Ltd|Amoxicillín og beta-laktamasa hemill||4545||4545|8793||2|0|0|0|||0 460889|N02AE0105|Buprenorphine Alvogen|forðapl|5|mcg/klst|4|stk|1|skpoki||N02AE01|01.10.2020||R|0|0|0|G|0|POF|0|0|0|100|DKK|1778|3945|lyfalmen|V0943|3945|2|4|0|2,8000|Alvogen|Alvogen|Búprenorfín||1778||1778|3945||2|0|G|1|30|dagar|0 461035|N02AA0506|Oxikodon Depot Actavis|forðatfl|20|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|0|G|0|ATE|0|0|0|100|XEU|4671|7776|lyfalmen|V0585|7776|2|98|0|26,1300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||4561||4561|7776||1|0|G|1|30|dagar|0 461113|L01EJ0101|Jakavi|töflur|20|mg|56|stk|1|þpakki||L01EJ01|01.02.2014||R|1|0|1|0|0|NEL|0|1|0|100|DKK|435071|547618|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||435071||435071|547618||1|0|L|0|||0 461206|J02AC0104|Fluconazol ratiopharm|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.08.2013||L|1|0|0|0|0|RTH|0|0|1|100|IKR|||lyfalmen|V0554|1916|2|1|0|0,7500|Alvogen|ratiopharm GmbH|Flúkónazól|||||1916||2|0|E|0|||0 461405|N02AA0508|Oxycodone Alvogen|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.12.2020||R|1|0|0|G|0|GOV|0|0|0|100|XEU|3950|6935|lyfalmen|||2|28|0|14,9300|Alvogen|Alvogen ehf|Oxýcódon||3950||3950|6935||2|0|G|1|30|dagar|0 461441|L04AX0601|Imnovid|hylki|4|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|1|0|0|BSE|0|1|0|100|DKK|1086903|1358314|lyfsjukr|||1|21|0|28,0000|Celgene Europe ltd|Bristol-Myers Squibb Pharma EEIG|Pomalidómide||1086903||1086903|1358314||2|0|L|0|||0 461563|V03AB1506|Nyxoid|nefúði|1,8|mg|0,1|ml|2|stsk.í||V03AB15|01.03.2020||R|0|1|0|0|0|MIP|0|0|1|100|DKK|6186|10012|lyfalmen|||1|0,2|0||Icepharma hf|Mundipharma Corporation (Ireland) Ltd|Naloxón||6186||6186|10012||2|0|E|0|||0 461641|V03AB3501|Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.09.2015||R|0|0|0|0|0|MBV|0|0|0|100|DKK|301450|381431|lyfalmen|||1|50|0||Vistor hf|Merck Sharp & Dohme B.V.|Sugammadex||301450||301450|381431||1|H|0|0|||0 461917|N07BA0106|Nicotinell|forðapl|21|mg/sólh|21|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|21|0|31,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 462070|A10BK0101|Forxiga|filmhtfl|10|mg|98|stk|1|þpakki||A10BK01|01.09.2015||R|1|0|0|G|0|AZE|0|0|0|100|SEK|18240|26603|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca AB|Dapagliflozin||18240||18240|26603||1|0|G|0|||0 462130|N06BA0903|Atomoxetin Medical Valley|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|VAL|0|0|0|100|XEU|10140|3421|lyfalmen|V0816|3068|2|28|0|21,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||1397||1397|3421||2|0|E|0|||0 462302|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|þpakki|2+0,5 mg|N07BC51|01.07.2016||R|0|0|1|0|0|IND|0|1|0|100|DKK|3898|6863|lyfsjukr|||1|28|0|7,0000|Vistor hf|Indivior Europe Limited|Búprenorfín í blöndum||3898||3898|6863||1|0|L|1|30|dagar|0 462429|L01EM0301|Piqray|filmhtfl|150|mg|56|stk|1|þpakki||L01EM03|01.05.2021||R|1|1|1|0|0|NEP|0|1|0|100|DKK|496406|623901|lyfsjukr|||1|56|0|28,0000|Vistor hf|Novartis Europharm Limited|Alpelisib||496406||496406|623901||1|0|L|0|||0 462849|C09DA0311|Valsartan/ Hydrochlorothiazide Krka|filmhtfl|185|mg|98|stk|1|þpakki|160/25 mg|C09DA03|01.08.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|4245|7341|lyfalmen|||2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Valsartan og þvagræsilyf||4245||4245|7341||2|0|G|0|||0 463251|N06DX0106|Memantine ratiopharm|filmhtfl|10|mg|100|stk|1|glas||N06DX01|01.10.2013||R|1|0|0|G|0|RTH|0|0|0|100|IKR|5821|4939|lyfalmen|V0605|4939|2|100|0|50,0000|Alvogen|ratiopharm GmbH|Memantín||2500||2500|4939||2|0|G|0|||0 463262|N06AB1007|Escitalopram Bluefish|filmhtfl|10|mg|98|stk|1|þpakki||N06AB10|01.04.2020||R|1|0|0|G|0|BLS|0|0|0|100|XEU|2602|5079|lyfalmen|V0325|4435|2|98|0|98,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Escítalópram||2602||2602|5079||1|0|0|0|||0 463632|M03BX0107|Baclofen Sintetica í mænuvökva|irl|2|mg/ml|5|ml|5|lykja||M03BX01|01.10.2021||R|0|0|1|0|0|SIN|0|0|0|100|XEU|148605|69402|lyfalmen|||2|25|0|90,9090|Williams & Halls efh|Sintetica GmbH|Baklófen||52284||52284|69402||2|0|0|0|||0 463654|J05AE1001|Prezista|filmhtfl|800|mg|30|stk|1|plglas||J05AE10|01.08.2013||R|1|0|1|0|0|JCI|0|1|0|100|SEK|24764|34595|lyfsjukr|||1|30|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||||24764|34595||1|0|L|0|||0 463744|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|tfílát||G02CB03|01.07.1993||R|1|0|0|G|0|PLS|0|0|0|100|DKK|4424|7587|lyfalmen|||1|8|0|8,0000|Icepharma hf|Pfizer Aps|Kabególín||||4424|7587||1|0|G|0|||0 463861|D07AC1301|Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.11.2020||R|0|0|0|G|0|NVO|0|0|1|100|DKK|1889|4098|lyfalmen|||1|100|0||Vistor hf|N.V. Organon|Mómetasón||1889||1889|4098||1|0|G|0|||0 463941|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|þpakki||M01AX05|01.11.2012||L|1|0|0|0|0|LEX|0|0|1|100|IKR|||lyflausa|||0|60|0|52,8000|Icepharma hf|Laboratoires Expanscience|Glúkósamín|||||||2|0||0|||0 463956|R02AX0102|Strefen Orange Sukkerfri|sogtfl|8,75|mg|16|stk|1|þpakki||R02AX01|01.11.2016||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|16|0|3,1800|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Flurbiprofen|||||||1|0||0|||0 464078|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|150 mg/30 mg|QP54AB51|01.04.2018|31.08.2021|R|0|0|0|0|0|BIV|0|0|0|100|XEU|3253|5607|vetorma|||0|3|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Milbemycin oxime í blöndum||3253||3253|5607||1|0||0|||0 464164|N02BE0101|Panodil|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.04.1992||L|1|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||||1|0||0|||0 464170|N02BA5104|Treo Citrus|freyðit|550|mg|20|stk|1|tfílát|500+50 mg|N02BA51|01.08.2019||L|0|0|0|0|0|MEA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Icepharma hf|Meda AB|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||2|0||0|||0 464201|J07BX0304|COVID-19 Vaccine Janssen|stl|||2,5|ml|10|hgl|hvert hgl.inniheldur 5x0,5ml|J07BX03|01.04.2021||R|0|0|0|0|0|JCI|0|0|0|100|IKR|||lyfalmen|||1|25|0||Vistor hf|Janssen-Cilag International N.V.|Covid-19 vaccines|||||||1|0||0|||0 464226|C07AG0205|Carveratio|töflur|12,5|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|G|0|RTH|0|0|0|100|IKR|2130|3356|lyfalmen|V0947|3356|2|100|0|33,3300|Alvogen|ratiopharm GmbH|Carvedílól||1350||1350|3356||2|0|G|0|||0 464327|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|10|hgl||B01AB01|01.07.2019||R|0|0|0|0|0|LEP|0|0|0|100|DKK|7454|11758|lyfalmen|||1|50|0|25,0000|Vistor hf|LEO Pharma A/S|Heparín||7454||7454|11758||1|H|0|0|||0 464545|L01XX0502|Hydroxyurea medac|hylki|500|mg|100|stk|1|þpakki||L01XX05|01.01.2016||R|0|0|1|G|0|WIL|0|0|0|100|XEU|6308|10180|lyfalmen|||1|100|0||Williams & Halls efh|medac Gesellschaft|Hýdroxýkarbamíð||6308||6308|10180||2|0|G|0|||0 464751|N07BA0106|Nicotinell|forðapl|7|mg/sólh|7|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|7|0|3,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 464762|R01AD0904|Mometasone Actavis|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.12.2016|31.07.2021|L|0|0|0|G|0|ATE|0|0|1|100|XEU|||lyfalmen|||2|140|0|35,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mómetasón|||||2991||1|0|G|0|||0 464827|M01AB0521|Voltafenak Rapid|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.11.2019||R|1|0|0|G|0|EVO|0|0|1|100|IKR|505|1911|lyfalmen|V0188|1911|2|30|0|15,0000|LYFIS ehf|Evolan Pharma AB|Díklófenak||300||300|1911||2|0|G|0|||0 465065|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|2,5|ml|3|glös||S01EE01|01.10.2011||R|0|0|0|G|0|ATE|0|0|0|100|DKK|2587|5059|lyfalmen|V0376|5059|2|7,5|0|75,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Latanóprost||2587||2587|5059||1|0|G|0|||0 465203|QJ01RA0103|Depomycine, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.12.1982||R|0|0|0|0|0|IBV|0|0|0|100|DKK|1360|2673|vetalmen|||0|100|0||Vistor hf|Intervet International BV|Penicillín í blöndum með öðrum sýklalyfjum||1360||1360|2673||1|0||0|||0 465307|C08DA0103|Isoptin retard|forðatfl|120|mg|98|stk|1|þpakki||C08DA01|01.01.2016||R|1|0|0|G|0|MDK|0|0|0|100|DKK|1949|4181|lyfalmen|||1|98|0|49,0000|Icepharma hf|Mylan Denmark ApS|Verapamíl||1949||1949|4181||2|0|G|0|||0 465333|L04AX0307|Metoject|stl|50|mg/ml|0,6|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|G|0|WIL|0|0|0|100|SEK|3194|5894|lyfalmen|||1|0,6|0|12,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3194||3194|5894||2|0|G|0|||0 465772|L01XC0302|Kanjinti|st/irþ|150|mg|1|hgl|1|pakki||L01XC03|01.12.2018||R|0|0|0|0|0|AEB|0|1|0|100|DKK|72043|94394|lyfsjukr|||2|1|0||Vistor hf|Amgen Europe B.V.|Trastuzumab||72043||72043|94394||1|H|L|0|||0 466086|N02AA0101|Contalgin|forðatfl|10|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|0|G|0|MDI|0|0|0|100|DKK|596|2318|lyfalmen|||1|25|0|2,5000|Icepharma hf|Mundipharma A/S|Morfín||596||596|2318||2|0|G|1|30|dagar|0 466094|N02AA0101|Contalgin|forðatfl|10|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|1|0|0|G|0|MDI|0|0|0|100|DKK|1856|4053|lyfalmen|||1|100|0|10,0000|Icepharma hf|Mundipharma A/S|Morfín||1856||1856|4053||2|0|G|1|30|dagar|0 466122|G03AA0702|Microgyn|töflur|||63|stk|1|þpakki||G03AA07|01.08.2013||R|0|0|0|0|0|BAB|0|0|0|100|DKK|1230|2856|lyfalm11|V0545|1881|1|63|0|84,0000|Icepharma hf|Bayer AB|Levónorgestrel og ethinylestradíól||||1230|2856||2|0||0|||1 466169|N02AA0101|Contalgin|forðatfl|30|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|0|G|0|MDI|0|0|0|100|DKK|1407|3435|lyfalmen|||1|25|0|7,5000|Icepharma hf|Mundipharma A/S|Morfín||1407||1407|3435||2|0|G|1|30|dagar|0 466219|N02AA0101|Contalgin|forðatfl|30|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|1|0|0|G|0|MDI|0|0|0|100|DKK|4876|8209|lyfalmen|||1|100|0|30,0000|Icepharma hf|Mundipharma A/S|Morfín||4876||4876|8209||2|0|G|1|30|dagar|0 466276|J01XD0103|Metronidazol Normon|irl|5|mg/ml|100|ml|50|pokar||J01XD01|01.09.2019||R|0|0|0|0|0|LNA|0|0|1|100|XEU|28794|35076|lyfalmen|||2|5000|0|16,6667|Williams & Halls efh|Laboratorios Normon, S.A.|Metrónídazól||25144||25144|35076||2|0|0|0|||0 466278|L01XC1401|Kadcyla|irþ|100|mg|1|hgl|1|pakki||L01XC14|01.06.2014||R|0|1|0|0|0|RRG|0|1|0|100|DKK|251632|319471|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration GmbH|Trastuzumab emtansine||251632||251632|319471||2|H|L|0|||0 466394|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|þpakki||N03AX15|01.03.2014||R|1|0|0|G|0|EIG|0|0|0|100|SEK|18161|26495|lyfalmen|||1|98|0|49,0000|Vistor hf|Eisai GmbH|Zonisamíð||18161||18161|26495||1|0|G|0|||0 466466|N02AA0101|Contalgin|forðatfl|60|mg|25|stk|1|þpakki||N02AA01|01.10.1995||R|1|0|0|G|0|MDI|0|0|0|100|DKK|2616|5099|lyfalmen|||1|25|0|15,0000|Icepharma hf|Mundipharma A/S|Morfín||2616||2616|5099||2|0|G|1|30|dagar|0 466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|G|0|HES|0|0|0|100|DKK|6771|10818|lyfalmen|||1|50|0|5,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||6771||6771|10818||1|0|G|0|||0 466571|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|325|mg|100|stk|1|ílát|100+25+200mg|N04BA03|01.05.2021||R|1|0|0|G|0|LVR|0|0|0|100|DKK|9909|15137|lyfalmen|V0829|15137|3|100|0|22,2200|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||9909||9909|15137||3|0|G|0|||0 466588|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.02.2017||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 466610|N02BE0120|Paracetamol Sandoz|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.03.2016||L|1|0|0|0|0|SHS|0|0|1|100|IKR|||lyflausa|||2|30|0|5,0000|Artasan ehf|Sandoz A/S|Paracetamól|||||||1|0||0|||0 466658|V08CA1001|Primovist|stl|0,25|mmol/ml|10|ml|5|áfspr|lausn|V08CA10|01.02.2021||R|0|0|0|0|0|BAB|0|0|0|100|DKK|101580|132848|lyfalmen|||1|50|0||Icepharma hf|Bayer AB|Gadoxetic acid||101580||101580|132848||1|H|0|0|||0 466667|L01AA0501|LEDAGA|hlaup|160|mcg/g|60|g|1|túpa||L01AA05|01.03.2020||R|0|1|0|0|0|HEL|0|1|0|100|XEU|359651|453816|lyfsjukr|||1|60|0||Recordati AB|Helsinn Birex Pharmaceuticals Ltd.|Chlormethine||359651||359651|453816||3|0|L|0|||0 466680|N02AA0101|Contalgin|forðatfl|100|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|0|G|0|MDI|0|0|0|100|DKK|4304|7422|lyfalmen|||1|25|0|25,0000|Icepharma hf|Mundipharma A/S|Morfín||4304||4304|7422||2|0|G|1|30|dagar|0 466723|V03AN0502|Airapy|lyfjagas|100|%|2,5|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|2,5|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5|0||0|||0 466739|C09DX0401|Entresto|filmhtfl|200|mg|56|stk|1|þpakki|97 + 103 mg|C09DX04|01.04.2016||R|0|0|0|0|0|NEL|0|0|0|100|DKK|20220|28848|lyfalmen|V0728|26665|1|56|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||20220||20220|28848||1|0|E|0|||0 466902|N02BE0122|Dolorin|töflur|500|mg|100|stk|1|þpakki||N02BE01|01.12.2017||R|1|0|0|0|0|WEH|0|0|1|100|IKR|361|1995|lyfalmen|||2|100|0|16,6666|Williams & Halls efh|Williams & Halls ehf|Paracetamól||361||361|1995||2|0|E|0|||0 467189|N06BA0407|Metylfenidat Actavis|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|0|0|0|ATE|0|0|0|100|XEU|6707|6249|lyfalmen|V0622|6242|2|30|0|54,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metýlfenídat||3452||3452|6249||1|0|E|1|30|dagar|0 467437|QP51AJ0103|Baycoxine vet|mixtúra|50|mg/ml|250|ml|1|glas||QP51AJ01|01.08.2018||R|0|0|0|0|0|BAN|0|0|0|100|DKK|5709|9840|vetorma|||0|250|0||Icepharma hf|Bayer Animal Health GmbH|Toltrazuril||5709||5709|9840||2|0||0|||0 467459|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|BAM|0|0|1|100|SEK|5946|9682|lyfalmen|||1|2500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||5946||5946|9682||2|0|0|0|||0 467473|H02AB0912|Alkindi|kyrnhylk|2|mg|50|stk|1|glas|Kyrni í hylkjum sem á að opna|H02AB09|01.08.2019||R|1|0|0|G|0|DIU|0|0|1|100|SEK|29558|40659|lyfalmen|||1|50|0|3,3333|Diurnal Ltd.|Diurnal Europe B.V.|Hýdrókortisón||29558||29558|40659||2|0|G|0|||0 467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|G|0|HES|0|0|0|100|DKK|11504|17332|lyfalmen|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||11504||11504|17332||1|0|G|0|||0 467699|G03FA1701|Angemin|töflur|||84|stk|1|þpakki|2+1 mg|G03FA17|01.10.2012||R|0|0|0|0|0|BAB|0|0|0|100|DKK|5914|9638|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og östrogen||5914||5914|9638||2|0||0|||0 467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|G|0|HES|0|0|0|100|DKK|21590|30581|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||21590||21590|30581||1|0|G|0|||0 467756|A10BJ0301|Lyxumia|stl|20|mcg/sk|3|ml|2|áfpen||A10BJ03|01.10.2013||R|0|0|0|0|0|SGB|0|0|0|100|XEU|10994|16630|lyfalmen|||1|6|0|28,0000|Vistor hf|Sanofi-aventis groupe|Lixisenatide||10994||10994|16630||1|0|E|0|||0 467810|J01DI0201|Zinforo|irþ|600|mg|10|hgl|1|pakki|lausn|J01DI02|01.04.2013||R|0|0|0|0|0|PIP|0|0|1|100|DKK|76796|100405|lyfalmen|||1|10|0|5,0000|Icepharma hf|Pfizer Ireland Pharmaceuticals|Ceftarólin||76796||76796|100405||1|0|0|0|||0 467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|0|0|0|0|0|JAS|0|0|0|100|SEK|396|2043|lyfalmen|||1|5|0|3,1250|Vistor hf|Janssen-Cilag AB|Halóperídól||396||396|2043||1|0|0|0|||0 468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|1|0|0|G|0|LBK|0|0|0|100|DKK|5808|6929|lyfalmen|V0317|3700|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3946||3946|6929||1|0|G|0|||0 468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|1|0|0|G|0|LBK|0|0|0|100|DKK|7156|6903|lyfalmen|V0318|5077|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3927||3927|6903||1|0|G|0|||0 468374|R03AC0302|Bricanyl Turbuhaler|innönddu|0,5|mg/sk|120|skammtar|1|stauk||R03AC03|01.02.2019||R|0|0|0|G|0|AZD|0|0|1|100|SEK|949|2804|lyfalmen|||1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||949||949|2804||1|0|G|0|||0 468537|QP54AA0501|Stronghold|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|ZBE|1|0|0|100|XEU|2233|3849|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2233||2233|3849||2|0||0|||0 468996|A02BC0402|Rabeprazol Actavis|sþ-tfl|10|mg|100|stk|1|glas||A02BC04|01.01.2012||R|0|0|0|G|0|ATE|0|0|1|100|XEU|3280|5110|lyfalmen|V0467|4950|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rabeprazól||2624||2624|5110||1|0|G|0|||0 469086|A10BD2001|Synjardy|filmhtfl|1005|mg|60|stk|1|þpakki|5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|G|0|BOE|0|0|0|100|DKK|7094|11262|lyfalmen|V0712|9885|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||7094||7094|11262||1|0|G|0|||0 469152|N06BA0408|Methylphenidate Teva|hylki|30|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.11.2019||R|1|1|0|0|0|TVI|0|0|0|100|XEU|6123|5880|lyfalmen|V0960|5880|2|30|0|30,0000|Teva Pharma Iceland ehf|Teva B.V|Metýlfenídat||3184||3184|5880||1|0|E|1|30|dagar|0 469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|þpakki||C10AB04|01.07.1991||R|1|0|0|0|0|PLS|0|0|0|100|DKK|3097|5761|lyfalmen|||1|98|0|49,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||3097||3097|5761||1|0|E|0|||0 469422|G03AB0501|Gracial|töflur|||66|stk|1|þpakki|Þp 3 * (15+7 stk)|G03AB05|01.08.2015||R|0|0|0|0|0|AEP|0|0|0|100|DKK|3361|5482|lyfalm11|||1|66|0|66,0000|Icepharma hf|Aspen Pharma Trading Limited|Desógestrel og ethinylestradíól||3361||3361|5482||2|0||0|||1 469480|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|6617|10606|lyfalmen|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||6617||6617|10606||1|0|0|0|||0 469847|M01AH0106|Celecoxib Actavis|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|G|0|ATE|0|0|1|100|XEU|2352|3150|lyfalmen|||2|20|0|20,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Celekoxíb||1200||1200|3150|30.9.2021|1|0|G|0|||0 469899|C01CA1703|Hypotron|töflur|2,5|mg|100|stk|1|þpakki||C01CA17|01.10.2018||R|1|0|0|G|0|RET|0|0|0|100|IKR|14250|21112|lyfalmen|V0968|21112|2|100|0|8,3333|CampusPharma AB|Brancaster Pharma Ireland Ltd|midodrine||14250||14250|21112||1|0|G|0|||0 469912|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|þpakki||C01AA05|01.08.2020||R|1|0|0|G|0|AEP|0|0|0|100|DKK|372|2010|lyfalmen|||1|100|0|100,0000|Icepharma hf|Aspen Pharma Trading Limited|Digoxín||372||372|2010||2|0|G|0|||0 469990|L04AB0403|Amgevita|stl|40|mg/penna|0,8|ml|2|áfpen|SureClick penni|L04AB04|01.06.2020||R|0|1|1|0|0|AEB|0|1|0|100|DKK|59575|78624|lyfsjukr|||1|1,6|0|27,5860|Vistor hf|Amgen Europe B.V.|Adalimumab||59575||59575|78624||1|0|L|0|||0 470202|R03AK0706|DuoResp Spiromax|innönddu|329|mcg/sk|60|skammtar|3|innö.t|320+9 mcg/sk|R03AK07|01.05.2018||R|0|0|0|G|0|TAB|0|0|0|100|XEU|14948|18891|lyfalmen|||2|180|0|90,0000|Alvogen|Teva Pharma B.V.|Formóteról og budesonide||12637||12637|18891||2|0|G|0|||0 470315|J05AF0703|Virofob|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.01.2017||R|1|1|1|0|0|ZET|0|1|0|100|DKK|46775|56566|lyfsjukr|||2|30|0|30,0000|Alvogen|Zentiva, k.s.|Tenófóvír dísóproxíl||42135||42135|56566||2|0|L|0|||0 470385|R03BA0501|Flixotide|innúðal|250|mcg/sk|120|skammtar|1|stauk||R03BA05|01.04.1995||R|0|0|0|G|0|GPH|0|0|0|100|DKK|3933|6911|lyfalmen|||1|120|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||3933||3933|6911||1|0|G|0|||0 470471|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|10|áf.spr||B01AX05|01.01.2016||R|0|0|0|G|0|MYR|0|0|0|100|DKK|9290|14285|lyfalmen|||1|5|0|10,0000|Icepharma hf|Mylan IRE Healthcare Limited|Fondaparinux||9290||9290|14285||2|0|G|0|||0 470817|C09DX0401|Entresto|filmhtfl|200|mg|168|stk|1|þpakki|97 + 103 mg|C09DX04|01.07.2020||R|0|0|0|0|0|NEL|0|0|0|100|DKK|60660|79996|lyfalmen|V0728|79996|1|168|0|84,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||60660||60660|79996||1|0|E|0|||0 471066|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|þpakki||H03AA01|01.05.2020||R|1|0|0|G|0|MEC|0|0|0|100|SEK|490|2172|lyfalmen|||1|100|0|33,3300|Icepharma hf|Merck AB|Levótýroxínnatríum||490||490|2172||2|0|G|0|||0 471122|M01AE5102|Parapró|filmhtfl|700|mg|20|stk|1|þpakki|200/500mg|M01AE51|01.03.2021||L|1|0|0|0|0|ACE|0|0|1|100|IKR|||lyflausa|||2|20|0||Acare ehf|Acare ehf|Íbúprófen í blöndum|||||||2|0||0|||0 471632|QA05AX9001|Menbutil|stl|100|mg/ml|100|ml|1|hgl|lausn|QA05AX90|01.06.2021||R|0|0|0|0|0|ANI|1|0|0|100|IKR|2753|5393|vetalmen|||0|100|0||Dýraheilsa ehf|aniMedica GmbH|Menbutone||2753||2753|5393||2|0||0|||0 471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|0|0|0|0|0|COR|1|0|0|100|DKK|5628|10848|vetalmen|||0|10|0||Vistor hf|Orion Corporation|Atipamesól||5628||5628|10848||1|0||0|||0 471970|N05CH0105|Slenyto|forðatfl|5|mg|30|stk|1|þpakki||N05CH01|01.12.2019||R|1|0|0|0|0|RNU|0|0|1|100|XEU|16321|23962|lyfalmen|||2|30|0|75,0000|Williams & Halls efh|RAD Neurim Pharmaceuticals EEC SARL|Melatonin||16321||16321|23962||2|0|0|0|||0 472092|C07AB0206|Seloken ZOC|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.07.1989||R|1|0|0|G|0|RDT|0|0|0|100|DKK|1652|3772|lyfalmen|V0048|2969|1|98|0|31,0333|Vistor hf|Recordati Ireland Limited|Metóprólól||1652||1652|3772||1|0|G|0|||0 472332|J07BC0201|Havrix|stl|1440|ein/ml|0,5|ml|1|dæla|einnota dæla|J07BC02|01.10.1995||R|0|0|0|0|0|GPH|0|0|0|100|DKK|3652|6525|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3652||3652|6525||1|0||0|||0 472338|S01AA2701|APROKAM|sts|50|mg|10|hgl|1|pakki|lausn|S01AA27|01.04.2013||R|0|0|0|0|0|TEA|0|0|0|100|SEK|8258|12864|lyfalmen|||1|10|0||Vistor hf|Laboratories THEA|Cefuroxím||8258||8258|12864||1|H|0|0|||0 472590|B05BA1024|SmofKabiven extra Nitrogen|irl|||2025|ml|4|pokar|fleyti|B05BA10|01.05.2021||R|0|0|0|0|0|FKA|0|0|0|100|DKK|51839|68840|lyfalmen|||1|8100|0||Vistor hf|Fresenius Kabi AB|Blöndur||51839||51839|68840||1|0|0|0|||0 472610|N06AX2106|Duloxetin W&H|sþ-hylki|30|mg|98|stk|1|þpakki||N06AX21|01.12.2018||R|1|0|0|G|0|WEH|0|0|0|100|XEU|5029|5278|lyfalmen|V0811|5059|2|98|0|49,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||2746||2746|5278||2|0|G|0|||0 472741|N03AX1402|Keppra (Lyfjaver)|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.03.2019||R|1|0|0|G|0|LVR|0|0|0|100|DKK|20861|29659|lyfalmen|V0516|12509|3|100|0|66,6700|Lyfjaver ehf|Lyfjaver ehf|Levetíracetam||20861||20861|29659||3|0|G|0|||0 472759|R06AX2701|Aerius|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.12.2019||R|1|0|0|G|0|NVO|0|0|1|100|DKK|3053|5700|lyfalmen|V0458|2979|1|100|0|100,0000|Vistor hf|N.V. Organon|Deslóratadín||3053||3053|5700||1|0|G|0|||0 472984|S01EC5401|Simbrinza|augndr|12|mg/ml|5|ml|1|glas|10 + 2 mg/ml|S01EC54|01.01.2015||R|0|0|0|G|0|NEL|0|0|0|100|DKK|2505|4946|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Brimoníð og brinzolamið||2505||2505|4946||1|0|G|0|||0 473213|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.07.2016||R|0|0|0|G|0|ATR|0|0|1|100|DKK|1380|3397|lyfalmen|||1|5|0|5,0000|Atnahs Pharma Nordics A/S|Atnahs Pharma Netherlands B.V.|Ketórólak||1380||1380|3397||2|0|G|0|||0 473879|B01AF0101|Xarelto|filmhtfl|2,5|mg|196|stk|1|þpakki||B01AF01|01.05.2020||R|1|1|0|G|0|FIN|0|0|0|100|DKK|28411|39208|lyfalmen|V0974|39208|1|196|0|24,5000|Icepharma hf|Bayer AG|Rivaoxaban||28411||28411|39208||2|0|G|0|||0 473957|L04AB0102|Benepali|stl|50|mg|4|áf-penni|1|pakki|lausn|L04AB01|01.10.2017||R|0|1|1|0|0|SUG|0|1|0|100|XEU|84182|109747|lyfsjukr|||2|4|0|28,5800|Icepharma hf|Samsung Bioepis NL B.V.|Etanercept||84182||84182|109747||2|0|L|0|||0 473968|D11AH0101|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AH01|01.11.2017||R|0|0|0|G|0|OEL|0|0|1|100|DKK|4383|7531|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Takrólímus||4383||4383|7531||1|0|G|0|||0 474608|QB03AC0001|Uniferon|stl|200|mg/ml|100|ml|12|hgl|lausn|QB03AC|01.08.2011||R|0|0|0|0|0|PHM|0|0|0|100|DKK|28942|55079|vetalmen|||0|1200|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíð||28942||28942|55079||2|0||0|||0 475669|N03AX1603|Pregabalin Krka|hylki|50|mg|56|stk|1|þpakki||N03AX16|01.01.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|2904|5495|lyfalmen|||2|56|0|9,3333|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||2904||2904|5495||2|0|E|0|||0 475705|QN02AF0104|Torphadine vet.|stl|10|mg/ml|10|ml|1|hgl|lausn|QN02AF01|01.03.2018||R|0|0|0|0|0|VEB|1|0|0|100|IKR|5789|11153|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Bútorfanóltartrat||||5789|11153||2|0||2|||0 475862|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|28|stk|1|þpakki|hart|A02BC01|01.04.2015||L|1|0|0|0|0|RTH|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Alvogen|ratiopharm GmbH|Ómeprazól|||||||2|0||0|||0 476249|QJ01CA0403|Amoxibactin vet.|töflur|250|mg|100|stk|1|þpakki||QJ01CA04|01.12.2016||R|0|0|0|0|0|VEB|0|0|0|100|IKR|5695|10975|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Amoxicillinum||5695||5695|10975||2|0||0|||0 476434|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|0|RAG|0|1|0|100|DKK|57673|76218|lyfsjukr|||1|1,2|0|53,3300|Vistor hf|Amgen|Darbepóetín alfa||||57673|76218||1|0|L|0|||0 476818|L01XK0401|Talzenna|hylki|0,25|mg|30|stk|1|glas||L01XK04|01.09.2021||R|0|0|1|0|0|PEU|0|1|0|100|DKK|213992|272657|lyfsjukr|||1|30|0||Icepharma hf|Pfizer Europe MA EEIG|Talazoparib||213992||213992|272657||2|0|L|0|||0 476873|B05BA0314|Glucos Baxter Viaflo|irl|100|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.09.2015||R|0|0|0|0|0|BAM|0|0|0|100|SEK|4294|7408|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||||4294|7408||2|0|0|0|||0 477017|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|þpakki||C10AX09|01.07.2013||R|1|0|0|0|0|MBV|0|0|0|100|DKK|15066|22235|lyfalmen|V0954|6081|1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb||15066||15066|22235||1|0|E|0|||0 477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|þpakki|250 + 100 mg|P01BB51|01.02.2006||R|1|0|0|0|0|GPH|0|0|0|100|DKK|4337|7467|lyfalmen|V0934|5772|1|12|0|3,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Prógúaníl í blöndum||4337||4337|7467||1|0||0|||0 477099|L04AA3201|Otezla|filmhtfl|||27|stk|1|þpakki|10+20+30 mg upphafs.pkn|L04AA32|01.05.2016||R|1|0|1|0|0|AEB|0|1|0|100|XEU|56262|74434|lyfsjukr|||1|27|0|11,5000|Vistor hf|Amgen Europe B.V.|Apremilast||56262||56262|74434||1|0|L|0|||0 477201|L04AB0102|Benepali|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.10.2017||R|0|1|1|0|0|SUG|0|1|0|100|XEU|84182|109747|lyfsjukr|||2|4|0|28,5800|Icepharma hf|Samsung Bioepis NL B.V.|Etanercept||84182||84182|109747||2|0|L|0|||0 477295|N05AH0413|Quetiapin ratiopharm|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|1|0|G|0|TAB|0|0|0|100|IKR|10359|9481|lyfalmen|V0272|8917|2|100|0|75,0000|Alvogen|Teva Pharma B.V.|Quetíapín||5800||5800|9481||2|0|G|0|||0 477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||20|ml|10|hgl|fyrir stungulyf|V07AB|01.02.2007||L|0|0|0|0|0|FKA|0|0|1|100|IKR|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3400||2|0||0|||0 477631|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|lykja|5+2 mg/ml|H02AB01|01.04.2021||R|0|0|0|G|0|NVO|0|0|1|100|DKK|977|2843|lyfalmen|||1|1|0|4,6700|Vistor hf|N.V. Organon|Betametasón||977||977|2843||1|0|G|0|||0 477752|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|FKA|0|0|1|100|IKR|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3400||1|0||0|||0 477864|L01EF0101|Ibrance|filmhtfl|100|mg|21|stk|1|þpakki||L01EF01|01.03.2021||R|1|0|1|0|0|PEU|0|1|0|100|DKK|311653|394120|lyfsjukr|||1|21|0||Icepharma hf|Pfizer Europe MA EEIG|Palbociclib||311653||311653|394120||1|0|L|0|||0 478119|A10BA0202|Metformin Actavis|filmhtfl|500|mg|100|stk|1|glas||A10BA02|01.12.2011||R|1|0|0|G|0|ATE|0|0|0|100|XEU|509|2064|lyfalmen|V0500|2062|2|100|0|25,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metformín||411||411|2064||1|0|G|0|||0 478163|D05AX5204|Enstilar|húðfroða|||60|g|2|ílát|50 mcg/g+0,5 mg/g|D05AX52|01.06.2018||R|0|0|0|G|0|LEP|0|0|0|100|DKK|16826|24657|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||16826||16826|24657||1|0|G|0|||0 478360|QM01AC0603|Rheumocam|stl|5|mg/ml|20|ml|1|hgl|handa hundum og köttum|QM01AC06|01.09.2013||R|0|0|0|0|0|CHP|1|0|0|100|XEU|7212|13853|vetalmen|||0|20|0||Icepharma hf|Chanelle Pharmaceuticals|Meloxícam||7212||7212|13853||2|0||0|||0 478386|G02BB0102|Ornibel|sk-innl|||3|stk|1|pakki|0,120 mg/0,015 mg/24 klst|G02BB01|01.10.2019||R|0|0|0|0|0|EXH|0|0|0|100|DKK|3587|5293|lyfalm11|V0983|5293|2|3|0|84,0000|Acare ehf|Exeltis Healthcare S.L.|Skeiðarinnleg með progestógeni og östrógeni||3208||3208|5293||2|0||0|||1 478808|R03DX0901|Nucala|stl|100|mg|1|pennar|1|pakki||R03DX09|01.07.2020||R|0|0|1|0|0|GSD|0|1|0|100|DKK|145554|187540|lyfsjukr|||1|1|0|27,7778|Vistor hf|GlaxoSmithKline Trading Services Ltd.|Mepolizumab||145554||145554|187540||1|0|L|0|||0 478993|M01AH0502|Coxient|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|ZET|0|0|1|100|IKR|2221|3287|lyfalmen|V0825|2811|2|28|0|28,0000|Alvogen|Zentiva, k.s.|Etoríkoxíb||1300||1300|3287||2|0|G|0|||0 479127|C10AA0509|Atorvastatin Xiromed|filmhtfl|80|mg|98|stk|1|þpakki||C10AA05|01.04.2018||R|1|0|0|0|0|MVX|0|0|0|100|IKR|4900|7829|lyfalmen|V0115|7808|2|98|0|392,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||4600||4600|7829||2|0|E|0|||0 479703|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.07.2017||R|0|0|0|0|0|PBV|0|0|0|100|XEU|3267|5995|lyfalmen|V1052|5995|1|50|0||Williams & Halls efh|Piramal Critical Care B.V.|Fentanýl||3267||3267|5995||1|0|0|1|30|dagar|0 479904|L01EA0401|Bosulif|filmhtfl|100|mg|28|stk|1|þpakki||L01EA04|01.09.2014||R|1|0|1|0|0|PEU|0|1|0|100|DKK|116495|151398|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|bosutinib||116495||116495|151398||1|0|L|0|||0 479954|L01XC1701|OPDIVO|irþ|10|mg/ml|24|ml|1|hgl||L01XC17|01.10.2019||R|0|1|0|0|0|BMS|0|1|0|100|DKK|393464|495870|lyfsjukr|||1|24|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Nivolumab||393464||393464|495870||1|H|L|0|||0 479991|L01XG0301|Ninlaro|hylki|4|mg|1|stk|3|þpakki|Hvert hylki sérpakkað í þynnu|L01XG03|01.01.2019||R|0|0|1|0|0|TPA|0|1|0|100|DKK|804355|1006904|lyfsjukr|||1|3|0||Vistor hf|Takeda Pharma A/S|Ixazomib||804355||804355|1006904||1|0|L|0|||0 480454|QN05CM1802|Sileo|munnh.hl|0,1|mg/ml|3|ml|1|spr||QN05CM18|01.01.2017||R|0|0|0|0|0|OCO|0|0|0|100|DKK|3137|6122|vetalmen|||0|3|0||Icepharma hf|Orion Corporation (I)|Dexmedetomidinum||3137||3137|6122||2|0||0|||0 480519|C09CA0604|Kairasec|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.02.2017||R|1|0|0|G|0|VAL|0|0|0|100|XEU|4191|6189|lyfalmen|V0080|6189|2|98|0|196,0000|Acare ehf|Medical Valley Invest AB|Candesartan||3408||3408|6189||2|0|G|0|||0 480750|B01AF0101|Xarelto|filmhtfl|10|mg|98|stk|1|þpakki||B01AF01|01.12.2018||R|1|1|0|G|0|FIN|0|0|0|100|DKK|31157|42681|lyfalmen|V0975|42646|1|98|0|49,0000|Icepharma hf|Bayer AG|Rivaoxaban||31157||31157|42681||2|0|G|0|||0 481176|N06AX1201|Zyban|forðatfl|150|mg|100|stk|1|þpakki||N06AX12|01.09.2000||R|1|0|0|0|0|GPH|0|0|0|100|DKK|12481|18677|lyfalmen|||1|100|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||12481||12481|18677||1|0||0|||0 481208|D07AC1302|Ovixan|krem|1|mg/g|30|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|G|0|GAB|0|0|1|100|SEK|685|2441|lyfalmen|||2|30|0||Vistor hf|Galenica AB|Mómetasón||685||685|2441||1|0|G|0|||0 481345|N06DA0304|Nimvastid|hylki|3|mg|112|stk|1|þpakki||N06DA03|01.04.2018||R|1|0|0|G|0|KNM|0|0|0|100|IKR|25104|35025|lyfalmen|||2|112|0|37,3300|LYFIS ehf|Krka d.d. Novo mesto|Rívastigmín||25104||25104|35025||2|0|G|0|||0 481506|N06BA0407|Metylfenidat Actavis|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|0|0|0|ATE|0|0|0|100|XEU|5696|7469|lyfalmen|V0681|7466|2|30|0|27,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metýlfenídat||4338||4338|7469||1|0|E|1|30|dagar|0 481534|N02AX0204|Tradolan|filmhtfl|50|mg|20|stk|1|þpakki||N02AX02|01.05.2012||R|1|0|0|G|0|GLP|0|0|1|100|DKK|248|1839|lyfalmen|||1|20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||248||248|1839||1|0|G|1|30|dagar|0 482183|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|hgl||G03BA03|01.05.2014||R|0|0|0|G|0|BAB|0|0|0|100|DKK|14966|22097|lyfalmen|||1|4|0|55,5600|Icepharma hf|Bayer AB|Testósterón||14966||14966|22097||2|0|G|0|||0 482457|N02BA5102|Treo|freyðit|||20|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|MDK|0|0|1|100|DKK|||lyflausa|||0|20|0|3,3333|Icepharma hf|Mylan Denmark ApS|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||2|0||0|||0 482751|QJ01DB0101|Cefabactin vet.|töflur|500|mg|100|stk|1|þpakki||QJ01DB01|01.03.2018||R|0|0|0|0|0|BVL|0|0|0|100|IKR|6458|12423|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Cefalexin||||6458|12423||2|0||0|||0 483104|L01XC0801|Vectibix|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.03.2013||R|0|0|0|0|0|AEB|0|1|0|100|DKK|56869|75202|lyfsjukr|||1|5|0||Vistor hf|Amgen Europe B.V.|Panitúmúmab||56869||56869|75202||1|H|L|0|||0 483217|B01AF0101|Xarelto|filmhtfl|20|mg|98|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|G|0|FIN|0|0|0|100|DKK|30238|41519|lyfalmen|V0977|41208|1|98|0|98,0000|Icepharma hf|Bayer AG|Rivaoxaban||||30238|41519||2|0|G|0|||0 483371|B05AA0114|Albuman|irl|40|g/líter|400|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|SPP|0|0|0|100|XEU|10209|15550|lyfalmen|||1|400|0||Williams & Halls efh|Sanquin Plasma Product|albumin||10209||10209|15550||2|H|0|0|||0 483485|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|15|ml|10|áfspr|lausn,áf.spr.|V08CA02|01.10.2017||R|0|0|0|0|0|GEH|0|0|0|100|NOK|47173|62938|lyfalmen|||1|150|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||47173||47173|62938||2|H|0|0|||0 483540|A10AC0110|Humulin NPH KwikPen|stl|100|ae/ml|3|ml|5|pennar|áfylltur penni|A10AC01|01.01.2017||R|0|0|0|G|0|DAN|0|0|0|100|XEU|4848|8171|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||4848||4848|8171||2|0|G|0|||0 483556|S01EA0502|Brimonidin Bluefish|augndr|2|mg/ml|5|ml|3|glös|lausn|S01EA05|01.04.2018||R|0|0|0|G|0|BLS|0|0|0|100|XEU|2213|4544|lyfalmen|V0368|4544|2|15|0|75,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Brímónidín||2213||2213|4544||1|0|G|0|||0 483663|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|3|lykja||B03BA03|01.07.2012||R|0|0|0|G|0|SHS|0|0|1|100|DKK|6466|10398|lyfalmen|||1|3|0|150,0000|Artasan ehf|Sandoz A/S|Hýdroxókóbalamín||6466||6466|10398||1|0|G|0|||0 483903|N06DX0109|Marbodin|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2486|4920|lyfalmen|||2|28|0|28,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||2486||2486|4920||2|0|G|0|||0 483968|C03AA0305|Hydromed|töflur|12,5|mg|100|stk|1|þpakki||C03AA03|01.06.2013||R|0|0|0|G|0|MEV|0|0|0|100|DKK|1103|3016|lyfalmen|||2|100|0|50,0000|Vistor hf|MediLink A/S|hýdróklórtíazíð||1103||1103|3016||1|0|G|0|||0 483996|N02AX0212|Tramadol Actavis|hylki|50|mg|20|stk|1|þpakki||N02AX02|01.09.2011||R|1|0|0|G|0|ATE|0|0|1|100|XEU|272|1832|lyfalmen|||2|20|0|3,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tramadól||243||243|1832|30.9.2021|1|0|G|1|30|dagar|0 484271|L01EX0901|Ofev|hylki|150|mg|60|stk|1|þpakki||L01EX09|01.07.2016||R|0|0|1|0|0|BOE|0|0|0|100|DKK|335363|423609|lyfalmen|||1|60|0||Vistor hf|Boehringer Ingelheim International GmbH|Nintedanib||335363||335363|423609||1|0|E|0|||0 484327|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|nálavörn|L03AA13|01.11.2010||R|0|0|1|0|0|AEB|0|1|0|100|DKK|81158|105922|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||81158||81158|105922||1|0|L|0|||0 484658|B01AF0101|Xarelto|filmhtfl|10|mg|30|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|G|0|FIN|0|0|0|100|DKK|9876|15091|lyfalmen|||1|30|0|15,0000|Icepharma hf|Bayer AG|Rivaoxaban||9876||9876|15091||2|0|G|0|||0 484721|L04AD0201|Advagraf|forðahlk|3|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|1|G|0|APE|0|0|0|100|XEU|44963|60143|lyfalmen|V1045|60140|1|50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||44963||44963|60143||1|0|G|0|||0 484846|A10AE0601|Tresiba|stl|100|ae/ml|3|ml|5|áfpen|FlexTouch|A10AE06|01.12.2016||R|0|1|0|G|0|NAS|0|0|0|100|DKK|8379|13031|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulin degludec||8379||8379|13031||1|0|G|0|||0 485006|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.01.2012||R|0|0|0|G|0|ANS|0|0|1|100|XEU|1344|3348|lyfalmen|||1|5|0||Anstalt zur gewerblichen Produktion|Anstalt zur gewerblichen Produktion|Prednisólón||1344||1344|3348||2|0|G|0|||0 485303|D01AE1604|Amorolfin Alvogen|lakk|5|%|5|ml|1|glas||D01AE16|01.05.2021||L|0|0|0|0|0|POF|0|0|1|100|IKR|||lyfalmen|||2|5|0||Alvogen|Alvogen|Amorolfín|||||5077||2|0|E|0|||0 485304|C02KX0501|Adempas|filmhtfl|2|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|0|BRE|0|1|0|100|DKK|375088|473016|lyfsjukr|||1|84|0|37,3300|Vistor hf|Bayer AG|Riociguatum||375088||375088|473016||1|0|L|0|||0 485348|J07BX0305|COVID-19 Vaccine Moderna (Spikevax)|stl|||5|ml|10|hgl|hvert hgl.10x0,5ml sk.|J07BX03|01.02.2021||R|0|0|0|0|0|MOD|0|0|0|100|IKR|||lyfalmen|||1|50|0||MODERNA BIOTECH SPAIN, S.L|MODERNA BIOTECH SPAIN, S.L|Covid-19 vaccines|||||||1|0||0|||0 485398|C02DD0102|Nipruss|irs|60|mg|5|lykjur|1|pakki||C02DD01|01.03.2021||R|0|0|0|0|0|ORE|0|0|0|100|NOK|74353|97315|lyfalmen|||2|5|0|6,0000|Oresund Pharma ApS|Oresund Pharma ApS|Nitroprusside||74353||74353|97315||2|H|0|0|||0 485462|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|30|mg|30|stk|1|þpakki|20+10 mg|N02AA55|01.11.2019||R|1|0|0|0|0|GOV|0|0|0|100|DKK|6010|8650|lyfalmen|V1006|8650|2|30|0|8,0000|Alvogen|Alvogen ehf|Oxycodonum í blöndum||5196||5196|8650||2|0|E|1|30|dagar|0 485549|R03AK0705|Bufomix Easyhaler|innönddu|329|mcg/sk|60|skammtar|3|innö.t|320+9 mcg/sk|R03AK07|01.11.2014||R|0|0|0|G|0|COR|0|0|0|100|DKK|13885|20609|lyfalmen|||2|180|0|90,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||13885||13885|20609||1|0|G|0|||0 485553|L04AX0402|Lenalidomid Alvogen|hylki|10|mg|21|stk|1|þpakki|hart|L04AX04|01.04.2019||R|1|1|1|0|0|ALO|0|1|0|100|XEU|621395|766233|lyfsjukr|||2|21|0|21,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Lenalídómíd||610846||610846|766233||2|0|L|0|||0 485592|QL04AD0101|Sporimune vet.|mixtúra|50|mg/ml|25|ml|1|glas||QL04AD01|01.06.2020||R|0|0|0|0|0|VEB|0|0|0|100|SEK|6405|12322|vetalmen|||0|25|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Ciclosporin||6405||6405|12322||2|0||0|||0 485593|J01FA0904|Clarithromycin Krka|filmhtfl|500|mg|21|stk|1|þpakki||J01FA09|01.09.2018||R|1|0|0|0|0|KNM|0|0|1|100|IKR|4800|4939|lyfalmen|V0116|4939|2|21|0|21,0000|LYFIS ehf|Krka d.d. Novo mesto|Klaritrómýcín||2500||2500|4939||2|0||0|||0 485764|J05AJ0301|Tivicay|filmhtfl|50|mg|30|stk|1|glas||J05AJ03|01.04.2014||R|1|0|1|0|0|VIC|0|1|0|100|DKK|69735|91474|lyfsjukr|||1|30|0|30,0000|Vistor hf|ViiV Healthcare BV|Dolutegravír||69735||69735|91474||1|0|L|0|||0 485799|A10BK0401|Steglatro|filmhtfl|5|mg|28|stk|1|þpakki||A10BK04|01.01.2019||R|1|0|0|G|0|MSD|0|0|0|100|DKK|5656|9283|lyfalmen|||1|28|0|14,0000|Vistor hf|M.S.D.|Ertugliflozin||5656||5656|9283||1|0|G|0|||0 485911|L04AX0402|Lenalidomid Alvogen|hylki|5|mg|21|stk|1|þpakki|hart|L04AX04|01.04.2019||R|1|1|1|0|0|ALO|0|1|0|100|XEU|676991|834204|lyfsjukr|||2|21|0|10,5000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Lenalídómíd||665498||665498|834204||2|0|L|0|||0 486750|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.09.2017||L|0|0|0|0|0|KPA|0|0|1|100|IKR|||lyflausa|||0|15|0||Alvogen|Karo Pharma AB|Hýdrókortisón|||||||2|0||0|||0 486779|M01AE0218|Naproxen Mylan|töflur|250|mg|20|stk|1|þpakki||M01AE02|01.04.1995||L|1|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Icepharma hf|Mylan AB|Naproxen|||||||2|0||0|||0 486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|0|0|0|G|0|HES|0|0|1|100|DKK|336|1960|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Dexametasón||336||336|1960||1|0|G|0|||0 486886|S01CA0101|Maxitrol|augndr|||5|ml|1|glas||S01CA01|01.07.1990||R|0|0|0|G|0|HES|0|0|1|100|DKK|527|2223|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Dexametasón||527||527|2223||1|0|G|0|||0 487105|L01ED0201|Zykadia|hylki|150|mg|150|stk|1|þpakki|3 x 50|L01ED02|01.05.2017||R|1|0|1|0|0|NEL|0|1|0|100|DKK|796365|996966|lyfsjukr|||1|150|0||Vistor hf|Novartis Europharm Ltd|Ceritinib||796365||796365|996966||1|0|L|0|||0 487361|H02AB0910|Hydrokortison Orion|töflur|10|mg|100|stk|1|þpakki||H02AB09|01.11.2015||R|0|0|0|G|0|ARN|0|0|1|100|DKK|1770|3934|lyfalmen|||2|100|0|33,3300|Vistor hf|Orion Corporation|Hýdrókortisón||1770||1770|3934||1|0|G|0|||0 487692|L04AB0101|Enbrel|sts|10|mg|4|hgl|1|pakki|+ leysir, lausn|L04AB01|01.12.2012||R|0|1|1|0|0|PEU|0|1|0|100|DKK|24416|34155|lyfsjukr|||1|4|0|5,7200|Icepharma hf|Pfizer Europe MA EEIG|Etanercept||24416||24416|34155||1|0|L|0|||0 487827|M01AB0517|Diclomex|sþ-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.04.2013||R|1|0|0|G|0|RTH|0|0|1|100|IKR|2489|4924|lyfalmen|||2|100|0|50,0000|Alvogen|ratiopharm GmbH|Díklófenak||2489||2489|4924||2|0|G|0|||0 487961|QC01CE9001|Vetmedin vet.|tuggutfl|5|mg|100|stk|1|þpakki|fyrir hunda|QC01CE90|01.04.2017||R|0|0|0|0|0|BIV|0|0|0|100|DKK|9214|17651|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||9214||9214|17651||1|0||0|||0 488024|J07BX0306|COVID-19 Vaccine Pfizer (Comirnaty)|stþ|||1|stk|195|hgl|hvert hgl.6x0,3ml sk.e.þynning|J07BX03|01.01.2021||R|0|0|0|0|0|BNT|0|0|0|100|IKR|||lyfalmen|||1|195|0||Icepharma hf|BioNTech Manufacturing GmbH|Covid-19 vaccines|||||||1|0||0|||0 488468|L01EJ0101|Jakavi|töflur|5|mg|56|stk|1|þpakki||L01EJ01|01.02.2014||R|1|0|1|0|0|NEL|0|1|0|100|DKK|219724|279786|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||219724||219724|279786||1|0|L|0|||0 488730|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|1|1|1|G|0|ATE|0|0|0|100|DKK|2692|5203|lyfalmen|||1|50|0|14,2857|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Acitretín||2692||2692|5203||1|0|G|0|||0 488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|1|1|1|G|0|ATE|0|0|0|100|DKK|7468|11777|lyfalmen|||1|50|0|35,7143|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Acitretín||7468||7468|11777||1|0|G|0|||0 488813|N07BA0106|Nicotinell|forðapl|21|mg/sólh|7|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|7|0|10,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 489128|A10BD2301|Segluromet|filmhtfl|1007,5|mg|196|stk|1|þpakki|7,5mg/1000mg|A10BD23|01.04.2019||R|1|0|0|G|0|DSM|0|0|0|100|DKK|20376|29045|lyfalmen|||1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme|Ertugliflozin og metformin||20376||20376|29045||1|0|G|0|||0 489149|G03GA0503|Bemfola|stl|150|ae|0,25|ml|1|penni||G03GA05|01.01.2015||R|0|0|1|G|0|FBA|0|0|0|100|SEK|6130|9935|lyfalmen|||1|0,25|0|2,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||6130||6130|9935||3|0|G|0|||0 489259|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|0|RAG|0|1|0|100|DKK|76533|100073|lyfsjukr|||1|1,6|0|71,1100|Vistor hf|Amgen|Darbepóetín alfa||||76533|100073||1|0|L|0|||0 489264|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.09.2017||L|0|0|0|0|0|KPA|0|0|1|100|IKR|||lyflausa|||0|30|0||Alvogen|Karo Pharma AB|Hýdrókortisón|||||||2|0||0|||0 489274|R03AK0707|Symbicort (Lyfjaver)|innúðal|164,5|mcg/sk|120|skammtar|1|sk-ílá|160+4,5 mcg/sk|R03AK07|01.02.2021||R|0|0|0|G|0|LVR|0|0|0|100|SEK|5723|7597|lyfalmen|||3|120|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||4431||4431|7597||3|0|G|0|||0 489349|N03AX0901|Lamictal|dreifit.|5|mg|60|stk|1|glas||N03AX09|01.10.2019||R|0|0|0|G|0|GPH|0|0|0|100|DKK|1553|3635|lyfalmen|||1|60|0|1,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||1553||1553|3635||1|0|G|0|||0 489662|A10AE5401|Suliqua|stl|||3|ml|5|áfpen|100 ein/ml + 33 mcg/ml|A10AE54|01.05.2018||R|0|1|0|0|0|SGB|0|0|0|100|XEU|19771|28711|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi-aventis groupe|Insulin glargine og lixisenatide||19771||19771|28711||1|0|E|0|||0 490174|M01AH0504|Etoricoxib Krka|filmhtfl|60|mg|30|stk|1|þpakki||M01AH05|01.05.2021||R|1|0|0|G|0|KNM|0|0|1|100|IKR|2308|3012|lyfalmen|V0825|3012|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1100||1100|3012||2|0|G|0|||0 490525|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.2020||R|0|0|0|G|0|RDT|0|0|0|100|DKK|2329|4704|lyfalmen|||1|25|0|0,1667|Vistor hf|Recordati Ireland Limited|Metóprólól||2329||2329|4704||1|0|G|0|||0 490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|10306|10695|lyfalmen|V0112|2733|1|100|0|50,0000|Icepharma hf|Upjohn EESV|Atorvastatín||6682||6682|10695||1|0|E|0|||0 490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|12581|14297|lyfalmen|V0113|2735|1|100|0|100,0000|Icepharma hf|Upjohn EESV|Atorvastatín||9299||9299|14297||1|0|E|0|||0 490823|R03AL0601|Spiolto Respimat|innöndl|5|mcg|3|rörlyk|1|pakki|Stök áfyllingarpakkn|R03AL06|01.08.2019||R|0|0|0|G|0|BOE|0|0|0|100|DKK|19626|25509|lyfalmen|||1|3|0||Vistor hf|Boehringer Ingelheim International GmbH|Olodaterol og tiotropiumbromide||17445||17445|25509||1|0|G|0|||0 490827|J01CF0503|Flucloxacillin WH|sts/irs|1000|mg|10|hgl|1|pakki||J01CF05|01.08.2020||R|0|0|0|0|0|WEH|0|0|1|100|XEU|14644|21654|lyfalmen|||2|10|0|5,0000|Williams & Halls efh|Williams & Halls ehf|Flúkloxacillín||14644||14644|21654||2|0|0|0|||0 490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|14773|17654|lyfalmen|V0114|2736|1|100|0|200,0000|Icepharma hf|Upjohn EESV|Atorvastatín||11738||11738|17654||1|0|E|0|||0 491213|N03AX2201|Fycompa|filmhtfl|6|mg|28|stk|1|þpakki||N03AX22|01.02.2020||R|1|0|0|G|0|SIE|0|0|0|100|SEK|20494|29194|lyfalmen|||1|28|0|21,0000|Eisai AB|Eisai GmbH|Perampanel||20494||20494|29194||1|0|G|0|||0 491230|J05AP5501|Epclusa|filmhtfl|500|mg|28|stk|1|glas|400 mg + 100 mg|J05AP55|01.10.2016||R|0|0|1|0|0|GSE|0|1|0|100|DKK|1361388|1699697|lyfsjukr|||1|28|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|Sofosbuvír og Velpatasvír||1361388||1361388|1699697||2|0|L|0|||0 491237|L02BX0301|Zytiga|filmhtfl|500|mg|56|stk|1|þpakki||L02BX03|01.12.2017||R|0|0|0|0|0|JCI|0|1|0|100|SEK|355182|448258|lyfsjukr|||1|56|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Abírateron||355182||355182|448258||1|0|L|0|||0 491257|A10BK0401|Steglatro|filmhtfl|5|mg|98|stk|1|þpakki||A10BK04|01.01.2019||R|1|0|0|G|0|MSD|0|0|0|100|DKK|19770|28709|lyfalmen|||1|98|0|49,0000|Vistor hf|M.S.D.|Ertugliflozin||19770||19770|28709||1|0|G|0|||0 491321|L04AB0101|Enbrel|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.08.2013||R|0|1|1|0|0|PEU|0|1|0|100|DKK|117855|153090|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Europe MA EEIG|Etanercept||117855||117855|153090||1|0|L|0|||0 491593|M05BX0402|XGEVA|stl|120|mg|1,7|ml|1|hgl|lausn|M05BX04|01.01.2018||R|0|1|0|0|0|AEB|0|0|0|100|DKK|43359|58114|lyfalmen|||1|1,7|0|363,6364|Vistor hf|Amgen Europe B.V.|Denosúmab||43359||43359|58114||1|H|0|0|||0 491660|N05CD0806|Buccolam|munnh.l|7,5|mg|1,5|ml|4|spr|munngjaf.spr|N05CD08|01.08.2020||R|0|0|0|0|0|LOS|0|0|1|100|DKK|12702|18981|lyfalmen|||2|6|0|3,0000|Laboratorios Lesvi, S.L.|Laboratorios Lesvi, S.L.|Mídazólam||12702||12702|18981||3|0|E|2|450|mg|0 491695|N06AX2107|Duloxetine Mylan|sþ-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.10.2015|31.07.2021|R|0|0|0|0|0|ASD|0|0|0|100|SEK|2216|3525|lyfalmen|||2|28|0|28,0000|Icepharma hf|Mylan S.A.S.|Duloxetín||1473||1473|3525||2|0|E|0|||0 492377|L01EA0401|Bosulif|filmhtfl|500|mg|28|stk|1|þpakki||L01EA04|01.09.2014||R|1|0|1|0|0|PEU|0|1|0|100|DKK|524225|658500|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|bosutinib||524225||524225|658500||1|0|L|0|||0 492405|N04BA0202|Madopar Depot|forðahlk|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.01.1991||R|1|0|0|G|0|ROA|0|0|0|100|DKK|2633|5122|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche A.S.|Levódópa og dópadekarboxýl­asa­hemill||2633||2633|5122||2|0|G|0|||0 492507|S01BA0201|Softacort|augndr|3,35|mg/ml|0,4|ml|30|sk-ílá|lausn í staksk.íláti|S01BA02|01.05.2018||R|0|0|0|G|0|TEA|0|0|1|100|SEK|1530|3604|lyfalmen|||1|12|0||Vistor hf|Laboratories THEA|Hydrocortisone||1530||1530|3604||1|0|G|0|||0 492815|C10BA0501|Atozet|filmhtfl|20|mg|90|stk|1|þpakki|10 mg + 10 mg|C10BA05|01.03.2015||R|0|0|0|0|0|NVO|0|0|0|100|DKK|16607|24356|lyfalmen|||1|90|0||Vistor hf|N.V. Organon|Atorvastin og ezetimibe||16607||16607|24356||1|0||0|||0 492917|QD07XB0201|Dermanolon|húðúði|19,47|mg/ml|75|ml|1|úðaílá|1,77+17,7 mg/ml|QD07XB02|01.11.2017||R|0|0|0|0|0|VEB|0|0|0|100|IKR|2758|5403|vetalmen|||0|75|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Triamcinolon||||2758|5403||2|0||0|||0 493113|R02AA0306|Strepsils Jordbær Sukkerfri|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.2011||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0||0|||0 493143|QN02AE0102|Bupredine vet|stl|0,3|mg/ml|10|ml|1|hgl||QN02AE01|01.06.2018||R|0|0|0|0|0|VEB|1|0|0|100|IKR|3725|7238|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Buprenorphinhýdróklóríð||||3725|7238||2|0||1|30|dagar|0 493173|N06BA0902|Atomoxetin Actavis|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|ATE|0|0|0|100|XEU|6572|3284|lyfalmen|V0813|2940|2|28|0|6,3000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atomoxetín||1298||1298|3284||1|0|E|0|||0 493218|B03AC0001|Monofer|irl|100|mg/ml|5|ml|1|hgl||B03AC|01.07.2013||R|0|1|0|G|0|PAC|0|0|1|100|DKK|22761|32062|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||22761||22761|32062||1|0|G|0|||0 493496|N05AX1303|TREVICTA|stl|175|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|G|0|JCI|0|0|0|100|SEK|108244|141136|lyfalmen|||1|1|0|70,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||108244||108244|141136||1|0|G|0|||0 493534|L01XC2401|Darzalex|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC24|01.06.2017||R|0|1|0|0|0|JCI|0|1|0|100|SEK|67245|88325|lyfsjukr|||1|5|0||Vistor hf|Janssen-Cilag International N.V.|Daratumumab||67245||67245|88325||1|H|L|0|||0 493782|L04AD0204|Dailiport|forðahlk|3|mg|50|stk|1|stsk.þ||L04AD02|01.09.2020||R|0|0|1|G|0|SHS|0|0|0|100|DKK|28545|39377|lyfalmen|||2|50|0|30,0000|Artasan ehf|Sandoz A/S|Tacrolimus||28545||28545|39377||1|0|G|0|||0 493888|C09CA0107|Losartan Medical Valley|filmhtfl|12,5|mg|98|stk|1|þpakki||C09CA01|01.10.2017||R|1|0|0|G|0|VAL|0|0|0|100|IKR|1455|3501|lyfalmen|V0213|3225|2|98|0|24,5000|Acare ehf|Medical Valley Invest AB|Lósartan||1455||1455|3501||2|0|G|0|||0 493896|C10AA0509|Atorvastatin Xiromed|filmhtfl|20|mg|98|stk|1|þpakki||C10AA05|01.04.2018||R|1|0|0|G|0|MVX|0|0|0|100|IKR|1960|2779|lyfalmen|V0113|2681|2|98|0|98,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||931||931|2779||2|0|G|0|||0 494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|þpakki||N02CX01|01.04.1974||R|1|0|0|G|0|HES|0|0|0|100|DKK|3279|6011|lyfalmen|||1|100|0|33,3333|Vistor hf|Novartis Healthcare A/S|Pízótífen||3279||3279|6011||1|0|G|0|||0 494237|L01XC0201|MabThera|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|0|1|0|0|0|RRG|0|1|0|100|DKK|74781|97857|lyfsjukr|||1|20|0||Icepharma hf|Roche Registration GmbH|Rítúxímab||74781||74781|97857||2|H|L|0|||0 494286|L01XC0201|MabThera|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|0|1|0|0|0|RRG|0|1|0|100|DKK|187063|239165|lyfsjukr|||1|50|0||Icepharma hf|Roche Registration GmbH|Rítúxímab||187063||187063|239165||2|H|L|0|||0 494435|N01BB2001|Emla|krem|50|mg/g|5|g|5|túpa|25mg/g+25mg/g|N01BB20|01.09.2021||R|0|0|0|0|0|MAR|0|0|1|100|DKK|2486|4920|lyfalmen|V1024|4920|1|25|0||Icepharma hf|Aspen Pharma|Blöndur||2486||2486|4920||2|0||0|||0 494533|G04BE0807|Tadalafil Mylan|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.01.2018||R|1|0|0|0|0|MBP|0|0|0|100|DKK|7282|7257|lyfalmen|V0145|7257|2|8|0|16,0000|BGP Products ApS|Mylan S.A.S|Tadalafíl||4184||4184|7257||2|0|E|0|||0 494534|N01BB2001|Emla|krem|50|mg/g|30|g|1|túpa|25mg/g+25mg/g|N01BB20|01.03.2021||R|0|0|0|0|0|MAR|0|0|1|100|DKK|3610|6467|lyfalmen|||1|30|0||Icepharma hf|Aspen Pharma|Blöndur||3610||3610|6467||2|0||0|||0 494559|D10AF0101|Dalacin|húðfl|10|mg/ml|60|ml|1|glas|fleyti|D10AF01|01.10.1995||R|0|0|0|0|0|PLS|0|0|0|100|DKK|1970|4209|lyfalmen|||1|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||1970||1970|4209||1|0||0|||0 494578|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|14|stk|1|þpakki||A02BC05|01.10.2015||L|1|0|0|0|0|ATE|0|0|0|100|IKR|||lyflausa|||2|14|0|9,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Esómeprazól|||||||1|0||0|||0 494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2150|4457|lyfalmen|V0128|2547|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||2150||2150|4457||1|0|G|0|||0 494724|G03FA0102|Kliogest|töflur|||84|stk|1|skífup||G03FA01|01.10.1986||R|0|0|0|G|0|NAS|0|0|0|100|DKK|3125|5799|lyfalmen|V0410|4307|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||3125||3125|5799||1|0|G|0|||0 494885|A16AA0402|Procysbi|hylki|75|mg|250|stk|1|glas||A16AA04|01.04.2016||R|0|1|1|0|0|CFS|0|1|0|100|XEU|793984|994005|lyfsjukr|||1|250|0|9,3700|Chiesi Pharma AB|Chiesi Farmaceutici S.p.A|Mercaptamín||793984||793984|994005||3|0|L|0|||0 495203|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.01.2019||R|0|1|0|0|0|FEC|0|1|0|100|XEU|412937|520089|lyfsjukr|||1|20|0|4,6500|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||412937||412937|520089||2|H|L|0|||0 495256|A02BC0404|Rabeprazol Medical Valley|sþ-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.09.2018||R|0|0|0|G|0|VAL|0|0|1|100|IKR|3000|3838|lyfalmen|V0010|3838|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Rabeprazól||1700||1700|3838||2|0|G|0|||0 495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|þpakki||A04AA01|01.01.1991||R|1|0|0|G|0|NAA|0|0|1|100|DKK|20914|7913|lyfalmen|V0384|4878|1|15|0|7,5000|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||4661||4661|7913||1|0|G|0|||0 495637|J02AC0304|Voriconazole Accord|filmhtfl|200|mg|30|stk|1|þpakki||J02AC03|01.04.2018||R|1|1|0|G|0|ACC|0|0|1|100|XEU|71623|93862|lyfalmen|||2|30|0|15,0000|Artasan ehf|Accord Healthcare Limited|Voricónazól||71623||71623|93862||1|0|G|0|||0 495757|N06AX2601|Brintellix|filmhtfl|10|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|LUN|0|0|0|100|DKK|5203|8659|lyfalmen|||1|28|0|28,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||5203||5203|8659||1|0||0|||0 496076|N06BA0408|Methylphenidate Teva|hylki|60|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.11.2019||R|1|1|0|0|0|TVI|0|0|0|100|XEU|9316|9864|lyfalmen|V0997|9864|2|30|0|60,0000|Teva Pharma Iceland ehf|Teva B.V|Metýlfenídat||6078||6078|9864||1|0|E|1|30|dagar|0 496174|QJ01MA9001|Baytril vet.|töflur|150|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|BAN|0|0|0|100|DKK|4356|8435|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||4356||4356|8435||2|0||0|||0 496614|B03BB0108|Folsyra Evolan|töflur|5|mg|105|stk|1|þpakki||B03BB01|01.11.2019||R|1|0|0|G|0|EVO|0|0|1|100|IKR|2100|4388|lyfalmen|||2|105|0|1312,5000|LYFIS ehf|Evolan Pharma AB|Fólínsýra||2100||2100|4388||2|0|G|0|||0 496912|N02AA0507|OxyContin Depot|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.11.2020||R|1|0|0|G|0|MUP|0|0|0|100|DKK|888|2720|lyfalmen|V0596|2371|1|28|0|1,8600|Icepharma hf|Mundipharma A/S|Oxýcódon||888||888|2720||2|0|G|1|30|dagar|0 496925|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|þpakki||R06AA04|01.12.2016||L|1|0|0|0|0|GCA|0|0|1|100|DKK|||lyfalmen|||0|100|0|50,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Klemastín|||||5396||1|0||0|||0 496935|N02AG0201|Ketogan|eþ-stíll|||10|stk|1|pakki|10 + 50 mg|N02AG02|01.07.1994||R|0|0|0|G|0|PLS|0|0|0|100|DKK|446|2112|lyfalmen|||1|10|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||446||446|2112||1|0|G|1|30|dagar|0 496950|N02AG0201|Ketogan|töflur|||20|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|0|G|0|PLS|0|0|0|100|DKK|806|2607|lyfalmen|||1|20|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||806||806|2607||1|0|G|1|30|dagar|0 497012|A07AA1201|Dificlir|filmhtfl|200|mg|20|stk|1|þpakki||A07AA12|01.08.2012||R|1|0|0|0|0|TPM|0|1|1|100|XEU|215039|273960|lyfsjukr|||1|20|0|10,0000|Vistor hf|Tillotts Pharma GmbH|Fidaxomicin||215039||215039|273960||1|0|L|0|||0 497083|H02AB0912|Alkindi|kyrnhylk|1|mg|50|stk|1|glas|Kyrni í hylkjum sem á að opna|H02AB09|01.08.2019||R|1|0|0|G|0|DIU|0|0|1|100|SEK|14779|21840|lyfalmen|||1|50|0|1,6667|Diurnal Ltd.|Diurnal Europe B.V.|Hýdrókortisón||14779||14779|21840||2|0|G|0|||0 497099|N02AG0201|Ketogan|töflur|||100|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|0|G|0|PLS|0|0|0|100|DKK|3072|5726|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||3072||3072|5726||1|0|G|1|30|dagar|0 497730|H03BB0212|Thiamazole Uni-Pharma|töflur|5|mg|100|stk|1|þpakki||H03BB02|01.12.2018||R|0|0|0|G|0|UNI|0|0|0|100|XEU|4038|7056|lyfalmen|||2|100|0|50,0000|Artasan ehf|Uni-Pharma Kleon Tsetis|thiamazole||4038||4038|7056||1|0|G|0|||0 497905|C07AB0213|Metoprololsuccinat Hexal|forðatfl|25|mg|100|stk|1|glas|23,75 mg metoprololsuccinat|C07AB02|01.01.2020||R|1|0|0|G|0|SSA|0|0|0|100|DKK|848|2665|lyfalmen|V0050|2510|2|100|0|16,6667|Artasan ehf|Hexal A/S|Metóprólól||848||848|2665||1|0|G|0|||0 497995|S01EC0304|Dorzolamide Alvogen|augndr|20|mg/ml|5|ml|1|ílát||S01EC03|01.01.2019||R|0|0|0|G|0|POF|0|0|0|100|XEU|1862|4061|lyfalmen|||2|5|0|16,6667|Alvogen|Alvogen|Dorzólamíð||1862||1862|4061||2|0|G|0|||0 498051|A10BX0204|Repaglinide Krka|töflur|2|mg|120|stk|1|þpakki||A10BX02|01.11.2014||R|1|0|0|G|0|KNM|0|0|0|100|IKR|2300|4664|lyfalmen|V0472|4664|2|120|0|60,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2300||2300|4664||2|0|G|0|||0 498481|N05AX1210|Aripiprazol Medical Valley|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.10.2016||R|1|1|0|G|0|VAL|0|0|0|100|XEU|6294|3422|lyfalmen|V0683|3422|2|56|0|37,3300|Acare ehf|Medical Valley Invest AB|Aripiprazól||1398||1398|3422||2|0|G|0|||0 498552|QN01AX9401|AQUI-S vet.|baðþ|540|g/líter|1000|ml|1|glas||QN01AX94|01.06.2016||R|0|0|0|0|0|SAS|0|0|0|100|NOK|66095|106545|veteldis|||0|1000|0||Vistor hf|Scan Aqua AS|Isoeugenol||66095||66095|106545||1|0||0|||0 498656|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|18|stk|1|þpakki||N02CC01|01.12.2019||R|1|0|0|G|0|BFP|0|0|0|100|XEU|6860|5173|lyfalmen|V0234|5173|2|18|0|36,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||2670||2670|5173||1|0|G|0|||0 498877|N06BA0905|Atomoxetin STADA|hylki|10|mg|30|stk|1|þpakki|hart hylki|N06BA09|01.08.2020||R|1|1|0|0|0|LYF|0|0|0|100|IKR|4000|3150|lyfalmen|V0812|3150|2|30|0|3,7500|LYFIS ehf|LYFIS ehf|Atomoxetín||1200||1200|3150||2|0|E|0|||0 498978|G03AC0904|Desirett|filmhtfl|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.03.2020||R|0|0|0|0|0|EXH|0|0|0|100|XEU|1468|2955|lyfalm11|V0590|2955|2|84|0|84,0000|Acare ehf|Exeltis Healthcare S.L.|Desógestrel||1310||1310|2955||2|0||0|||1 499189|N03AX2201|Fycompa|filmhtfl|4|mg|28|stk|1|þpakki||N03AX22|01.02.2020||R|1|0|0|G|0|SIE|0|0|0|100|SEK|20494|29194|lyfalmen|||1|28|0|14,0000|Eisai AB|Eisai GmbH|Perampanel||20494||20494|29194||1|0|G|0|||0 499273|B01AF0101|Xarelto|filmhtfl|20|mg|28|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|G|0|FIN|0|0|0|100|DKK|8702|13475|lyfalmen|V1036|13464|1|28|0|28,0000|Icepharma hf|Bayer AG|Rivaoxaban||||8702|13475||2|0|G|0|||0 499436|R03AK1101|Flutiform|innúðal|130|mcg/sk|120|skammtar|1|pakki|125+5 mcg/sk|R03AK11|01.01.2014||R|0|0|0|G|0|MUP|0|0|0|100|DKK|5970|9715|lyfalmen|||1|120|0|30,0000|Icepharma hf|Mundipharma A/S|Formóteról og flútikasón||5970||5970|9715||2|0|G|0|||0 499865|J01FA0905|Clarithromycin Alvogen|filmhtfl|500|mg|14|stk|1|þpakki||J01FA09|01.10.2020||R|1|0|0|0|0|POF|0|0|1|100|IKR|2475|3425|lyfalmen|V0116|3293|2|14|0|14,0000|Alvogen|Alvogen|Klaritrómýcín||1400||1400|3425||2|0|E|0|||0 499902|N02BE0127|Dolorin Junior|mixtúra|24|mg/ml|200|ml|1|glas||N02BE01|01.07.2021||L|0|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|200|0|0,1600|Williams & Halls efh|Williams & Halls ehf|Paracetamól|||||||2|0||0|||0 499920|N06AX2601|Brintellix|filmhtfl|20|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|LUN|0|0|0|100|DKK|9789|14971|lyfalmen|||1|28|0|56,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||9789||9789|14971||1|0||0|||0 500188|S02CA0303|Ciflox|eyrnadr|||10|ml|1|dropaí|2 mg + 10 mg/ml|S02CA03|01.05.2021||R|0|0|0|G|0|HES|0|0|1|100|DKK|2092|4377|lyfalmen|||1|10|0||Vistor hf|Novartis Healthcare A/S|Hýdrókortisón og sýkingalyf||2092||2092|4377||1|0|G|0|||0 500402|C07AB0214|Bloxazoc|forðatfl|25|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|G|0|KNM|0|0|0|100|IKR|900|2640|lyfalmen|V0050|2510|2|100|0|16,6667|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||830||830|2640||2|0|G|0|||0 500476|L01EX1001|Rydapt|hylki|25|mg|112|stk|1|þpakki|4 x 28|L01EX10|01.04.2018||R|0|0|1|0|0|NEL|0|1|0|100|DKK|1960046|2444260|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Midostaurin||1960046||1960046|2444260||1|0|L|0|||0 500481|J05AR1701|Descovy|filmhtfl|210|mg|30|stk|1|glas|200+10 mg|J05AR17|01.10.2016||R|0|0|1|0|0|GSE|0|1|0|100|DKK|61537|81106|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|emtricitabine og tenofovir alafenamide||61537||61537|81106||2|0|L|0|||0 501204|R03DX0801|Cinqaero|irþ|10|mg/ml|2,5|ml|1|hgl||R03DX08|01.12.2018||R|0|0|0|0|0|TVB|0|1|0|100|NOK|17008|24908|lyfsjukr|||1|2,5|0|3,5211|Actavis Pharmaceuticals Iceland ehf.|Teva B.V.|Reslizumab||17008||17008|24908||1|H|L|0|||0 501278|G04BD1201|Betmiga|forðatfl|25|mg|30|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|G|0|APE|0|0|0|100|XEU|5626|9242|lyfalmen|||1|30|0|15,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||5626||5626|9242||1|0|G|0|||0 501364|N06BA0403|Ritalin Uno|hylki|60|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.11.2015||R|1|1|0|0|0|HES|0|0|0|100|DKK|13879|14554|lyfalmen|V0997|9864|1|30|0|60,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||9486||9486|14554||1|0|E|1|30|dagar|0 501382|C01CA1702|Midodrin Evolan|töflur|5|mg|100|stk|1|þpakki||C01CA17|01.07.2021||R|1|0|0|G|0|EVO|0|0|0|100|IKR|13500|20079|lyfalmen|V0969|20079|2|100|0|16,6666|LYFIS ehf|Evolan Pharma AB|midodrine||13500||13500|20079||2|0|G|0|||0 501660|B01AF0101|Xarelto|filmhtfl|2,5|mg|168|stk|1|þpakki||B01AF01|01.04.2015|31.08.2021|R|1|1|0|G|0|FIN|0|0|0|100|DKK|26204|36416|lyfalmen|||1|168|0|21,0000|Icepharma hf|Bayer AG|Rivaoxaban||26204||26204|36416||2|0|G|0|||0 501735|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1|0||0|||0 501880|QA12AX0003|Calmafusion|irl|||500|ml|12|glös|380mg/60mg/50 mg/ml|QA12AX|01.03.2021||R|0|0|0|0|0|INC|1|0|0|100|IKR|10644|20364|vetalmen|||0|6000|0||Dýraheilsa ehf|Interchemie Werken De Adelaar Eesti AS|Kalsíum í blöndum með D-vítamíni/eða öðrum efnum||10644||10644|20364||2|0||0|||0 501950|R03DC0306|Montelukast ratiopharm|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.11.2019||R|1|0|0|G|0|TSA|0|0|0|100|XEU|9884|15102|lyfalmen|V0490|15102|2|98|0|98,0000|Alvogen|Teva Sweden AB|Montelúkast||9884||9884|15102||2|0|G|0|||0 502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|1|0|0|G|0|ROA|0|0|0|100|DKK|2309|4676|lyfalmen|V0434|4676|1|100|0|16,6667|Icepharma hf|Roche A.S.|Levódópa og dópadekarboxýl­asa­hemill||2309||2309|4676||2|0|G|0|||0 502157|L01XC2801|Imfinzi|irþ|50|mg/ml|2,4|ml|1|hgl|120 mg/2,4 ml|L01XC28|01.06.2019||R|0|0|0|0|0|AZE|0|1|0|100|SEK|106366|138801|lyfsjukr|||1|2,4|0||Vistor hf|AstraZeneca AB|Durvalumab||||106366|138801||1|H|L|0|||0 502299|M02AA1506|Diclofenac Teva|hlaup|23,2|mg/g|50|g|1|túpa||M02AA15|01.07.2021||L|0|0|0|0|0|TVI|0|0|1|100|IKR|||lyflausa|||0|50|0||Teva Pharma Iceland ehf|Teva B.V|Díklófenak|||||||1|0||0|||0 502341|QP52AF0203|Nematel Vet.|pasta|439|mg/g|30,33|g|1|spr||QP52AF02|01.12.2020||R|0|0|0|0|0|VEB|0|0|0|100|SEK|1314|2265|vetorma|||0|30,33|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Pyrantelum||||1314|2265||2|0||0|||0 502349|G04BE0313|Sildenafil Medical Valley|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.03.2018||R|1|0|0|0|0|VAL|0|0|0|100|XEU|3529|3853|lyfalmen|V0143|3426|2|12|0|12,0000|Acare ehf|Medical Valley Invest AB|Síldenafíl||1711||1711|3853||2|0|E|0|||0 502486|S01LA0501|Eylea|stl|40|mg/ml|1|áf.spr|1|pakki||S01LA05|01.08.2020||R|0|1|0|0|0|FIN|0|1|0|100|DKK|115550|150223|lyfsjukr|||1|1|0||Icepharma hf|Bayer AG|Aflibercept||115550||115550|150223||2|H|L|0|||0 502647|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|30|stk|1|þpakki|með br. losunarhraða|G04CA02|01.12.2017||R|1|0|0|G|0|MED|0|0|0|100|IKR|2098|4386|lyfalmen|V0926|4386|2|30|0|30,0000|Medical ehf|Medical ehf|Tamsúlósín||2098||2098|4386||2|0|G|0|||0 502761|QP51AA0101|Metrobactin vet|töflur|250|mg|100|stk|1|þpakki||QP51AA01|01.04.2018||R|0|0|0|0|0|VEB|0|0|0|100|IKR|3335|5748|vetorma|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Metronidazolum||3335||3335|5748||2|0||0|||0 502790|A10BD2401|Steglujan|filmhtfl|105|mg|28|stk|1|þpakki|5/100 mg|A10BD24|01.03.2019||R|1|0|0|G|0|MBV|0|0|0|100|DKK|10181|15295|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|sitagliptin og ertugliflozin||10024||10024|15295||1|0|G|0|||0 502843|L04AC1601|Tremfya|stl|100|mg|1|stk|1|áfpen|m. áfastri nál og nálarhlíf|L04AC16|01.03.2019||R|0|0|1|0|0|JCI|0|1|0|100|SEK|327733|414119|lyfsjukr|||1|1|0|55,8659|Vistor hf|Janssen-Cilag International N.V.|Guselkumab||327733||327733|414119||1|0|L|0|||0 502851|N06AB0314|Fluoxetine Vitabalans|filmhtfl|20|mg|100|stk|1|þpakki||N06AB03|01.08.2021||R|1|0|0|G|0|VIB|0|0|0|100|IKR|2050|3150|lyfalmen|V0039|3033|2|100|0|100,0000|LYFIS ehf|Vitabalans Oy|Flúoxetín||1200||1200|3150||2|0|G|0|||0 502904|A10BK0101|Forxiga|filmhtfl|10|mg|28|stk|1|þpakki||A10BK01|01.11.2015||R|1|0|0|G|0|AZE|0|0|0|100|SEK|5645|9268|lyfalmen|||1|28|0|28,0000|Vistor hf|AstraZeneca AB|Dapagliflozin||5645||5645|9268||1|0|G|0|||0 503078|N02BE0115|Paracet|eþ-stíll|125|mg|10|stk|1|pakki||N02BE01|01.04.2019||L|0|0|0|0|0|KPA|0|0|1|100|IKR|||lyflausa|||0|10|0|0,4167|Alvogen|Karo Pharma AB|Paracetamól|||||||2|0|0|0|||0 503406|R03BB0501|Eklira Genuair|innönddu|322|mcg|60|skammtar|1|innö.t||R03BB05|01.12.2015||R|0|0|0|G|0|ZEN|0|0|0|100|SEK|4836|8154|lyfalmen|||1|60|0|30,0000|Vistor hf|AstraZeneca AB|Aclídínumbrómíð||4836||4836|8154||1|0|G|0|||0 504020|B05AA0114|Albuman|irl|40|g/líter|250|ml|1|hgl|lausn|B05AA01|01.04.2013||R|0|0|0|0|0|SPP|0|0|0|100|XEU|6381|10281|lyfalmen|||1|250|0||Williams & Halls efh|Sanquin Plasma Product|albumin||6381||6381|10281||2|H|0|0|||0 504026|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|28|stk|1|glas|hart|A02BC01|01.10.2019||L|1|0|0|0|0|VAL|0|0|0|100|IKR|||lyflausa|||2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól|||||||2|0||0|||0 504119|A10BB1202|Glimeryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.11.2011||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1455|2874|lyfalmen|V0494|2737|2|90|0|180,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Glímepíríð||1000||1000|2874||1|0|G|0|||0 504120|R03AL0302|Anoro Ellipta|innönddu|77|mcg/sk|30|skammtar|1|innö.t|55+22 mcg|R03AL03|01.11.2014||R|0|0|0|G|0|RGP|0|0|0|100|DKK|6217|10055|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline (Ireland) Limited|Vilanterol og umeclidinium bromide||6217||6217|10055||1|0|G|0|||0 504169|G04BE0302|Revatio|mixtduft|10|mg/ml|112|ml|1|glas||G04BE03|01.04.2016||R|0|0|1|G|0|UPJ|0|0|0|100|DKK|36114|48951|lyfalmen|||1|112|0|22,4000|Icepharma hf|Upjohn EESV|Síldenafíl||36114||36114|48951||1|0|G|0|||0 504231|N02AB0310|Fentanyl Alvogen|forðapl|25|mcg/klst|5|stk|1|skpoki||N02AB03|01.11.2020||R|0|0|0|G|0|RTH|0|0|0|100|XEU|1971|4142|lyfalmen|V0219|4141|2|5|0|7,5000|Alvogen|ratiopharm GmbH|Fentanýl||1921||1921|4142||2|0|G|1|30|dagar|0 504502|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.09.2017||R|0|0|0|G|0|CPM|0|0|1|100|DKK|544|2247|lyfalmen|||1|30|0||Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Hýdrókortisón bútýrat||544||544|2247||1|0|G|0|||0 504763|M05BA0803|Zoledronic acid Actavis|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.09.2020||R|0|1|0|0|0|GRP|0|0|0|100|XEU|10867|5573|lyfalmen|||2|5|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zoledronsýra||2961||2961|5573||1|H|0|0|||0 504923|QN04BC0201|Prascend|töflur|1|mg|60|stk|1|þpakki|handa hestum|QN04BC02|01.05.2014||R|0|0|0|0|0|BIV|0|0|0|100|DKK|17477|33328|vetalmen|||0|60|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pergolide||17477||17477|33328||1|0||0|||0 505003|S01ED5122|Fixopost|augndr|||0,2|ml|30|sk-ílá|50 mcg/ml + 5 mg/ml|S01ED51|01.01.2020||R|0|0|0|G|0|LTH|0|0|0|100|SEK|2477|4907|lyfalmen|||2|6|0|30,0000|Vistor hf|Laboratoires THEA|Tímólól í blöndum||2477||2477|4907||1|0|G|0|||0 505095|N06AX1613|Venlafaxin Medical Valley|forðatfl|150|mg|100|stk|1|glas||N06AX16|01.10.2017||R|0|0|0|G|0|VAL|0|0|0|100|XEU|3094|2872|lyfalmen|V0335|2598|2|100|0|150,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||998||998|2872||2|0|G|0|||0 505571|J01MA0207|Ciprofloxacin Navamedic|irl|2|mg/ml|200|ml|10|pokar||J01MA02|01.05.2021||R|0|0|0|0|0|NAV|0|0|1|100|XEU|8605|13342|lyfalmen|||2|2000|0|5,0000|Icepharma hf|Navamedic ASA|Cíprófloxacín||8605||8605|13342||2|0|0|0|||0 505647|N07BA0147|Nicorette QuickMist|munnhúði|1|mg/sk|150|skammtar|2|úðapum|2 x 150 úðaskammtar|N07BA01|01.11.2012||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|300|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 505803|N06BA0703|Aspendos|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.05.2019||R|1|0|1|0|0|MOL|0|0|0|100|IKR|5200|8655|lyfalmen|V0657|8655|2|30|0|10,0000|LYFIS ehf|Medochemie Limited|Modafinil||5200||5200|8655||2|0|E|2|||0 505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|0|0|PLS|0|0|0|100|DKK|3030|5668|lyfalmen|||1|10|0||Icepharma hf|Pfizer ApS|Doxórúbicín||3030||3030|5668||1|H|0|0|||0 505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|0|0|PLS|0|0|0|100|DKK|7575|11924|lyfalmen|||1|25|0||Icepharma hf|Pfizer ApS|Doxórúbicín||7575||7575|11924||1|H|0|0|||0 506756|M01AH0504|Etoricoxib Krka|filmhtfl|90|mg|100|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|5601|7554|lyfalmen|V0831|7554|2|100|0|150,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||4400||4400|7554||2|0|G|0|||0 506788|R03AK1401|Atectura Breezhaler|innönddu|252,5|mcg/sk|90|stk|3|stsk.þ|125 mcg/127,5mcg|R03AK14|01.01.2021||R|0|0|0|G|0|NEP|0|0|0|100|DKK|13481|20053|lyfalmen|||1|270|0||Vistor hf|Novartis Europharm Limited|Indacaterol og mometasone||13481||13481|20053||1|0|G|0|||0 506938|N02AA0507|OxyContin Depot|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.11.2020||R|1|0|0|G|0|MUP|0|0|0|100|DKK|14195|21036|lyfalmen|V0587|13785|1|98|0|52,2700|Icepharma hf|Mundipharma A/S|Oxýcódon||14195||14195|21036||2|0|G|1|30|dagar|0 507822|N06BA0903|Atomoxetin Medical Valley|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.11.2019||R|1|1|0|0|0|VAL|0|0|0|100|XEU|10140|3284|lyfalmen|V0812|2940|2|28|0|3,5000|Acare ehf|Medical Valley Invest AB|Atomoxetín||1298||1298|3284||2|0|E|0|||0 507834|N07CA0102|Betahistin ratiopharm|töflur|16|mg|100|stk|1|þpakki||N07CA01|01.12.2013||R|1|0|0|G|0|RHA|0|0|0|100|IKR|4233|7324|lyfalmen|||2|100|0|66,6700|Alvogen|ratiopharm Oy|Betahistín||4233||4233|7324||2|0|G|0|||0 507915|C03DA0103|Spiron|töflur|50|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|G|0|COR|0|0|0|100|DKK|1857|4054|lyfalmen|V0092|4054|2|100|0|66,6600|Vistor hf|Orion Corporation|Spírónólaktón||1857||1857|4054||1|0|G|0|||0 507916|S01AA1301|Fucithalmic|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.08.2015||R|0|0|0|G|0|AML|0|0|1|100|SEK|861|2683|lyfalmen|||1|5|0||Amdipharm Limited|Amdipharm Limited|Fúsidínsýra||861||861|2683||2|0|G|0|||0 508350|N03AX1603|Pregabalin Krka|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|3276|3838|lyfalmen|V0687|2612|2|56|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1700||1700|3838||2|0|E|0|||0 508589|J02AC0102|Candizol|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.02.2015||R|1|0|0|0|0|ATE|0|0|1|100|XEU|705|2238|lyfalmen|||2|2|0|1,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúkónazól||538||538|2238||1|0|E|0|||0 508634|J07BM0301|Gardasil 9|stl|||0,5|ml|1|áf.spr|dreifa + 2 nálar|J07BM03|01.04.2018||R|0|0|0|0|0|MVA|0|0|0|100|DKK|19505|28345|lyfalmen|||1|0,5|0||Vistor hf|MSD VACCINS|Papillomavírus (mannagerð 6, 11, 16, 18, 31, 33, 45, 52, 58)||19505||19505|28345||1|0||0|||0 508671|QJ01MA9001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|0|0|0|0|0|BAN|0|0|0|100|DKK|4863|9397|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||4863|9397||2|0||0|||0 508689|QJ01MA9001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|BAN|0|0|0|100|DKK|4381|8482|vetalmen|||0|50|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||4381||4381|8482||2|0||0|||0 508705|QJ01MA9001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|BAN|0|0|0|100|DKK|12980|24796|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||12980||12980|24796||2|0||0|||0 508921|L01CD0401|Jevtana|irþ|60|mg|1|hgl|1|pakki|+ leysir|L01CD04|01.08.2011||R|0|0|0|0|0|SGB|0|1|0|100|XEU|616309|773027|lyfsjukr|||1|1|0||Vistor hf|Sanofi-aventis groupe|Cabazitaxel||616309||616309|773027||1|H|L|0|||0 509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|0|0|0|G|0|LBK|0|0|0|100|DKK|8518|13222|lyfalmen|||1|10|0|133,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||8518||8518|13222||1|0|G|0|||0 509050|L04AA0604|Mykofenolatmofetil Actavis|filmhtfl|500|mg|50|stk|1|þpakki||L04AA06|01.06.2020||R|0|1|1|G|0|ATE|0|0|0|100|XEU|6541|7524|lyfalmen|V0187|7524|2|50|0|12,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mýcófenólsýra||4378||4378|7524||1|0|G|0|||0 509127|QG02CB0301|Finilac|mixtúra|50|mcg/ml|15|ml|1|glas||QG02CB03|01.03.2016||R|0|0|0|0|0|BVL|0|0|0|100|IKR|5425|10463|vetalmen|||0|15|0||Dýraheilsa ehf|Le Vet B.V.|Kabergólín||5425||5425|10463||2|0||0|||0 509259|J07BB0209|VaxigripTetra|stl|15|mcg|0,5|ml|1|áfspr|dreifa í áf. sprautu|J07BB02|01.06.2020||R|0|0|0|0|0|SPU|0|0|0|100|XEU|1381|3399|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur|Inflúensa, hreinsaðir mótefnavakar||1381||1381|3399||2|0||0|||0 509296|QA11JA0001|Vitamin AD3E pro injectione|stl|||100|ml|1|hgl|176,47 / 50 / 100 mg/ml|QA11JA|01.01.2021||R|0|0|0|0|0|Bel|0|0|0|100|XEU|1619|3182|vetalmen|||0|100|0||Icepharma hf|Bela-Pharma GmbH & CO KG|Vítamínblöndur||1619||1619|3182||2|0||0|||0 509504|QJ51CR0201|Clavubactin vet.|töflur|312,5|mg|100|stk|1|þpakki|250 mg+ 62,5 mg|QJ51CR02|01.03.2015||R|0|0|0|0|0|BVL|0|0|0|100|IKR|5785|11146|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Amoxillinum og ensim hemill||5785||5785|11146||2|0||0|||0 509577|G03HB0102|Diane mite|töflur|||63|stk|1|þpakki||G03HB01|01.06.2013||R|0|1|0|0|0|BAB|0|0|0|100|DKK|2094|3921|lyfalm11|V0134|3317|1|63|0|84,0000|Icepharma hf|Bayer AB|Cýpróterón og östrógen||2094||2094|3921||2|0||0|||0 509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|þpakki|150+300 mg|J05AR01|01.05.2004||R|1|0|1|0|0|VIC|0|1|0|100|DKK|43033|57702|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare BV|Zídóvúdín og lamívúdín||43033||43033|57702||1|0|L|0|||0 509806|L01XC2401|Darzalex|stl|1800|mg|15|ml|1|hgl|120mg/ml|L01XC24|01.10.2020||R|0|1|0|0|0|JCI|0|1|0|100|SEK|805503|1008331|lyfsjukr|||1|15|0||Vistor hf|Janssen-Cilag International N.V.|Daratumumab||805503||805503|1008331||1|H|L|0|||0 509895|QD11AH9102|Cytopoint|stl|20|mg|1|ml|2|hgl||QD11AH91|01.08.2021||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|15934|30400|vetalmen|||1|2|0||Icepharma hf|Zoetis Belgium S.A.|lokivetmab||15934||15934|30400||2|0||0|||0 510462|J01DH0205|Meropenem WH|sts/irs|1|g/hgl|10|hgl|1|pakki|lausn|J01DH02|01.06.2019||R|0|0|0|0|0|WEH|0|0|1|100|XEU|23708|23708|lyfalmen|||2|10|0|3,3333|Williams & Halls efh|Williams & Halls ehf|Meropenem||16136||16136|23708||2|0|0|0|||0 510553|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.04.2014||R|1|0|0|G|0|OHS|0|0|0|100|DKK|458|2128|lyfalmen|V0601|2102|2|100|0|100,0000|Vistor hf|Orifarm Healthcare A/S|Fúrósemíð||458||458|2128||1|0|G|0|||0 510810|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|0|RAG|0|1|0|100|DKK|140820|181652|lyfsjukr|||1|1,2|0|133,3300|Vistor hf|Amgen|Darbepóetín alfa||||140820|181652||1|0|L|0|||0 510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3959|3607|lyfalmen|V0445|2884|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fínasteríð||1532||1532|3607||1|0|G|0|||0 510983|N03AX1610|Pregabalin Medical Valley|hylki|150|mg|100|stk|1|þpakki||N03AX16|01.06.2019||R|1|0|0|0|0|VAL|0|0|0|100|IKR|4149|4664|lyfalmen|V0687|4664|2|100|0|50,0000|Acare ehf|Medical Valley Invest AB|Pregabalín||2300||2300|4664||2|0|E|0|||0 511263|N02AJ0602|Parkodin forte|filmhtfl|530|mg|30|stk|1|þpakki|30+500 mg|N02AJ06|01.12.2017||R|1|0|0|0|0|ATE|0|0|1|100|XEU|773|2562|lyfalmen|||2|30|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||773||773|2562||1|0|E|3|||0 511303|G03FB0501|Trisekvens|töflur|||84|stk|1|skífup||G03FB05|01.12.1980||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2562|5024|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2562||2562|5024||1|0|G|0|||0 511418|A10BD2301|Segluromet|filmhtfl|1002,5|mg|196|stk|1|þpakki|2,5mg/1000mg|A10BD23|01.04.2019||R|1|0|0|G|0|DSM|0|0|0|100|DKK|20376|29045|lyfalmen|||1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme|Ertugliflozin og metformin||20376||20376|29045||1|0|G|0|||0 511506|L01DB0106|Doxorubicin medac|irþ|2|mg/ml|25|ml|1|hgl|lausn|L01DB01|01.08.2017||R|0|0|0|0|0|WIL|0|0|0|100|XEU|2512|4955|lyfalmen|||2|25|0||Williams & Halls efh|medac Gesellschaft|Doxórúbicín||||2512|4955||2|H|0|0|||0 511560|G03GA1001|REKOVELLE|stl|36|mcg|1,08|ml|1|áfpen|+ 6 inndælingarnálar|G03GA10|01.08.2018||R|0|0|1|G|0|FEP|0|0|0|100|DKK|42250|56711|lyfalmen|||1|1,08|0|3,0000|Vistor hf|Ferring Pharmaceuticals A/S|Follitrópín delta||42250||42250|56711||1|0|G|0|||0 511688|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1|0||0|||0 511900|B02BC3002|TISSEEL|vefjalím|||2|ml|1|áf.spr|4 nálar og 2 millistykki|B02BC30|01.06.2020||R|0|0|0|0|0|BAM|0|0|0|100|SEK|16590|24332|lyfalmen|||1|2|0||Icepharma hf|Baxter Medical AB|Blöndur||16590||16590|24332||2|H|0|0|||0 511932|G02BA0303|Jaydess|leginnle|13,5|mg|1|stk|1|þpakki||G02BA03|01.01.2014||R|0|1|0|0|0|BAB|0|0|0|100|DKK|15450|20377|lyfalm11|||1|1|0||Icepharma hf|Bayer AB|Plast lyfjalykkja (IUD) með prógestógen||15450||15450|20377||2|0|E|0|||1 511988|B05BA1024|SmofKabiven extra Nitrogen|irl|||1012|ml|4|pokar|fleyti|B05BA10|01.05.2021||R|0|0|0|0|0|FKA|0|0|0|100|DKK|34862|47367|lyfalmen|||1|4048|0||Vistor hf|Fresenius Kabi AB|Blöndur||34862||34862|47367||1|0|0|0|||0 512465|J05AR0304|Emtricitabine/Tenofovir disoproxil Mylan|filmhtfl|445|mg|30|stk|1|þpakki|200+245 mg|J05AR03|01.06.2020||R|1|1|1|0|0|ASD|0|1|0|100|DKK|50632|67313|lyfsjukr|||2|30|0|30,0000|Icepharma hf|Mylan S.A.S.|Tenófóvír dísóproxíl og emtrícítabín||50632||50632|67313||2|0|L|0|||0 512477|A02BC0113|Omeprazol Sandoz|sþ-hylki|20|mg|100|stk|1|glas||A02BC01|01.01.2020||R|1|0|0|G|0|SHS|0|0|1|100|DKK|2663|2306|lyfalmen|V0006|2186|2|100|0|100,0000|Artasan ehf|Sandoz A/S|Ómeprazól||587||587|2306||1|0|G|0|||0 512532|N07BA0154|Nicorette Quickmist Cool Berry|munnhúði|1|mg/sk|150|skammtar|2|úðapum|2 x 150 úðaskammar|N07BA01|01.09.2020||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|300|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 512608|B05XA3101|Peditrace|irþ|||10|ml|10|hgl||B05XA31|01.07.1993||R|0|0|0|0|0|FKA|0|0|0|100|DKK|6378|10277|lyfalmen|||1|100|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með öðrum efnum||6378||6378|10277||1|0|0|0|||0 512646|G04BD1202|Betmiga (Lyfjaver)|forðatfl|50|mg|90|stk|1|þpakki||G04BD12|01.01.2021||R|1|0|0|G|0|LVR|0|0|0|100|XEU|15243|22478|lyfalmen|V0651|22478|3|90|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Mírabegrón||15243||15243|22478||3|0|G|0|||0 512821|H02AB0912|Alkindi|kyrnhylk|0,5|mg|50|stk|1|glas|Kyrni í hylkjum sem á að opna|H02AB09|01.08.2019||R|1|0|0|G|0|DIU|0|0|1|100|SEK|7390|11595|lyfalmen|||1|50|0|0,8333|Diurnal Ltd.|Diurnal Europe B.V.|Hýdrókortisón||7336||7336|11595||2|0|G|0|||0 512918|M01AH0504|Etoricoxib Krka|filmhtfl|120|mg|30|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|1971|3563|lyfalmen|||2|30|0|60,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1500||1500|3563||2|0|G|0|||0 513195|C10AA0106|Simvastatin Bluefish|filmhtfl|20|mg|100|stk|1|þpakki||C10AA01|01.02.2014||R|1|0|0|G|0|BLS|0|0|0|100|XEU|1015|2371|lyfalmen|V0109|2353|2|100|0|66,6700|Artasan ehf|Bluefish Pharmaceuticals AB|Simvastatín||634||634|2371||1|0|G|0|||0 513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|0|0|0|0|0|MAR|0|0|1|100|IKR|||lyflausa|||0|35|0||Icepharma hf|Aspen Pharma|Lídókaín|||||||2|0||0|||0 513391|QJ51CR0201|Clavubactin vet.|töflur|62,5|mg|100|stk|1|þpakki|50 mg + 12,5 mg|QJ51CR02|01.03.2015||R|0|0|0|0|0|BVL|0|0|0|100|IKR|2789|3901|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Amoxillinum og ensim hemill||1985||1985|3901||2|0|0|0|||0 513494|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|2561|5029|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||2561||2561|5029||2|0||0|||0 513758|QJ01CR0201|Combisyn|stl|175|mg/ml|100|ml|1|hgl|140+35 mg/ml|QJ01CR02|01.11.2011||R|0|0|0|0|0|BRO|0|0|0|100|XEU|2013|3644|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Ltd|Amoxicillín og beta-laktamasa hemill||1854||1854|3644||2|0|0|0|||0 513993|N02BG0901|Penthrox|innö.guf|99,9|%|3|ml|1|glas||N02BG09|01.10.2019||R|0|0|0|0|0|MCL|0|0|0|100|DKK|4813|8123|lyfalmen|||1|3|0||Icepharma hf|Medical Developments NED B.V.|Methoxyflurane||4813||4813|8123|30.9.2021|1|H|0|0|||0 514029|C03DA0407|Eplerenon Krka|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.12.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|9764|6315|lyfalmen|V0111|6315|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Eplerenón||3500||3500|6315||2|0||0|||0 514090|C09AA0211|Enalapril Krka|töflur|5|mg|250|stk|1|glas||C09AA02|01.06.2015||R|1|0|0|G|0|KRK|0|0|0|100|IKR|2000|4251|lyfalmen|||2|250|0|125,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2000||2000|4251||2|0|G|0|||0 514105|N05AH0415|Quetiapin Krka|forðatfl|150|mg|100|stk|1|þpakki||N05AH04|01.04.2018||R|0|1|0|G|0|KRK|0|0|0|100|IKR|6000|7554|lyfalmen|V0910|7540|2|100|0|37,5000|LYFIS ehf|Krka Sverige AB|Quetíapín||4400||4400|7554||2|0|G|0|||0 514280|J07BB0210|Influvactetra|stl|||0,5|ml|10|áf.spr|með nál|J07BB02|01.10.2019||R|0|0|0|0|0|MDK|0|0|0|100|DKK|15426|22730|lyfalmen|||1|5|0||Icepharma hf|Mylan Denmark ApS|Inflúensa, hreinsaðir mótefnavakar||15426||15426|22730||2|0||0|||0 514840|N06BA0901|Strattera|hylki|100|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2013||R|1|1|0|0|0|DAN|0|0|0|100|XEU|17357|25388|lyfalmen|V0818|11879|1|28|0|35,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||||17357|25388||2|0|E|0|||0 514870|N06AX2105|Duloxetin Krka|sþ-hylki|30|mg|30|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|0|KNM|0|0|0|100|IKR|2131|2530|lyfalmen|V0692|2494|2|30|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||750||750|2530||2|0|G|0|||0 514949|M04AA0106|Allopurinol Alvogen|töflur|100|mg|100|stk|1|þpakki||M04AA01|01.03.2021||R|1|0|0|G|0|POF|0|0|0|100|IKR|842|2657|lyfalmen|||2|100|0|25,0000|Alvogen|Alvogen|Allópúrinol||842||842|2657||2|0|G|0|||0 515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|þpakki||N06AX18|01.06.2000||R|1|0|0|0|0|PLS|0|0|0|100|DKK|4009|5229|lyfalmen|||1|60|0|30,0000|Icepharma hf|Pfizer ApS|Reboxetin||2711||2711|5229||1|0|G|0|||0 515094|QR06AB0401|Histodine|stl|10|mg/ml|100|ml|1|hgl|lausn|QR06AB04|01.03.2018||R|0|0|0|0|0|VEB|1|0|0|100|IKR|2756|5399|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Chlorphenamine maleate||||2756|5399||2|0||0|||0 515399|G03GA0503|Bemfola|stl|300|ae|0,5|ml|1|penni||G03GA05|01.01.2015||R|0|0|1|G|0|FBA|0|0|0|100|SEK|12337|18479|lyfalmen|||1|0,5|0|4,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||12337||12337|18479||3|0|G|0|||0 515699|C08CA0106|Amlodipin Medical Valley|töflur|5|mg|112|stk|1|þpakki||C08CA01|01.04.2020||R|1|0|0|G|0|VAL|0|0|0|100|XEU|1527|2497|lyfalmen|V0056|2497|2|112|0|112,0000|Acare ehf|Medical Valley Invest AB|Amlódipín||726||726|2497||2|0|G|0|||0 516033|M01AB0523|Dimax Rapid|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.07.2021||R|1|0|0|G|0|POF|0|0|1|100|XEU|633|2204|lyfalmen|V0188|1911|2|30|0|15,0000|Alvogen|Alvogen|Díklófenak||513||513|2204||2|0|G|0|||0 516182|L01BC5901|Lonsurf|filmhtfl|28,19|mg|20|stk|1|þpakki|20 mg + 8,19 mg|L01BC59|01.09.2016||R|0|0|1|0|0|LLS|0|1|0|100|DKK|119516|155156|lyfsjukr|||1|20|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||119516|155156||2|0|L|0|||0 516532|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.07.2021||R|0|0|0|0|0|PBV|0|0|0|100|XEU|3267|5995|lyfalmen|V1052|5995|1|50|0||Williams & Halls efh|Piramal Critical Care B.V.|Fentanýl||3267||3267|5995||1|0|0|1|30|dagar|0 516694|C09CA0107|Losartan Medical Valley|filmhtfl|50|mg|98|stk|1|þpakki||C09CA01|01.08.2019||R|1|0|0|G|0|VAL|0|0|0|100|IKR|1800|2907|lyfalmen|V0069|2884|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Lósartan||1024||1024|2907||2|0|G|0|||0 516803|L01EA0103|Imatinib ratiopharm|filmhtfl|100|mg|120|stk|1|þpakki||L01EA01|01.01.2019||R|1|0|1|0|0|RTH|0|1|0|100|XEU|99352|66391|lyfsjukr|||2|120|0||Alvogen|ratiopharm GmbH|Imatinib||49903||49903|66391||2|0|L|0|||0 516972|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|30|stk|1|þpakki||A04AA01|01.12.2015||R|1|0|0|G|0|BLS|0|0|1|100|XEU|6789|10842|lyfalmen|V0384|9756|2|30|0|15,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Ondansetrón||6789||6789|10842||1|0|G|0|||0 517693|N05AH0413|Quetiapin ratiopharm|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|1|0|G|0|TAB|0|0|0|100|IKR|9000|5077|lyfalmen|V0273|5008|2|100|0|50,0000|Alvogen|Teva Pharma B.V.|Quetíapín||2600||2600|5077||2|0|G|0|||0 517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2896|5484|lyfalmen|V0462|3661|1|90|0|11,2500|Vistor hf|Novo-Nordisk A/S|Repaglíníð||2896||2896|5484||1|0|G|0|||0 517728|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|1|G|0|EIG|0|0|0|100|SEK|30221|41497|lyfalmen|||1|100|0|28,5700|Vistor hf|Eisai GmbH|Rúfínamíð||30221||30221|41497||1|0|G|0|||0 517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|G|0|NAS|0|0|0|100|DKK|3080|5737|lyfalmen|V0471|3723|1|90|0|22,5000|Vistor hf|Novo-Nordisk A/S|Repaglíníð||3080||3080|5737||1|0|G|0|||0 517803|H02AB0208|Dexavit|stl/irl|4|mg/ml|1|ml|3|lykjur||H02AB02|01.03.2019||R|0|0|0|0|0|VIT|0|0|1|100|DKK|3527|6352|lyfalmen|||2|3|0|8,0000|Vital Pharma Nordic ApS|Vital Pharma Nordic ApS|Dexametasón||3527||3527|6352||1|0|0|0|||0 517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|G|0|NAS|0|0|0|100|DKK|3315|6061|lyfalmen|V0472|3498|1|90|0|45,0000|Vistor hf|Novo-Nordisk A/S|Repaglíníð||3315||3315|6061||1|0|G|0|||0 517824|C01CA0302|Noradrenalin Abcur|irþ|1|mg/ml|10|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|0|ABC|0|0|0|100|SEK|28913|39843|lyfalmen|||2|100|0|16,6667|Icepharma hf|Abcur AB|Noradrenalín||28913||28913|39843||2|H|0|0|||0 517914|QI09AL0801|Suvaxyn Circo+MH RTU|stl|||100|ml|1|hgl|fleyti|QI09AL08|01.01.2017||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|9791|16876|vetorma|||0|100|0||Icepharma hf|Zoetis Belgium S.A.|Mycoplasma hyopneumoniae, Recombinat Porcine Circovirus||9791||9791|16876||2|0||0|||0 518224|N04BD0202|Rasagilin Krka|töflur|1|mg|112|stk|1|þpakki||N04BD02|01.01.2016||R|0|0|0|G|0|KNM|0|0|0|100|IKR|23524|29328|lyfalmen|V0711|29328|2|112|0|112,0000|LYFIS ehf|Krka d.d. Novo mesto|Rasagilín||20600||20600|29328||2|0|G|0|||0 518241|M01AB0509|Modifenac|forðahlk|75|mg|20|stk|1|þpakki||M01AB05|01.11.2000||R|1|0|0|G|0|ATE|0|0|1|100|DKK|1063|2961|lyfalmen|||1|20|0|15,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díklófenak||1063||1063|2961||1|0|G|0|||0 518258|M01AB0509|Modifenac|forðahlk|75|mg|100|stk|1|þpakki|með breyttan losunarhraða|M01AB05|01.11.2000||R|1|0|0|G|0|ATE|0|0|1|100|DKK|4391|7542|lyfalmen|||1|100|0|75,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díklófenak||4391||4391|7542||1|0|G|0|||0 518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2001||R|0|0|0|0|0|NVO|0|0|0|100|DKK|1983|3784|lyfalm11|V0590|2955|1|84|0|84,0000|Vistor hf|N.V. Organon|Desógestrel||1983||1983|3784||1|0||0|||1 518341|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 518534|A10AE0601|Tresiba|stl|100|ae/ml|3|ml|5|rörlyk||A10AE06|01.08.2021||R|0|1|0|G|0|NAS|0|0|0|100|DKK|7971|12469|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulin degludec||7971||7971|12469||1|0|G|0|||0 518897|A10BH0501|Trajenta|filmhtfl|5|mg|90|stk|1|þpakki||A10BH05|01.12.2012||R|1|0|0|G|0|BII|0|0|0|100|DKK|15558|22912|lyfalmen|||1|90|0|90,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||15558||15558|22912||1|0|G|0|||0 518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|0|0|0|0|0|MEA|0|0|1|100|DKK|955|2812|lyfalmen|||1|125|0|3,1250|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||955||955|2812||2|0|E|0|||0 519070|M01AE0116|Ibuprofen Bril|filmhtfl|600|mg|100|stk|1|þpakki||M01AE01|01.11.2016||R|1|0|0|G|0|PIL|0|0|1|100|IKR|792|2310|lyfalmen|V0564|2284|2|100|0|50,0000|Williams & Halls efh|Brillpharma (Ireland) Limited|Íbúprófen||590||590|2310||2|0|G|0|||0 519096|N06AB1008|Escitalopram STADA|filmhtfl|10|mg|100|stk|1|þpakki||N06AB10|01.08.2021||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2200|4526|lyfalmen|V0325|4526|2|100|0|100,0000|LYFIS ehf|STADA Arzneimittel AG|Escítalópram||2200||2200|4526||2|0|0|0|||0 519112|QJ01EW1002|Equibactin vet.|pasta|400|mg|45|g|1|áfspr|333,3 + 66,7 mg|QJ01EW10|01.03.2016||R|0|0|0|0|0|BVL|0|0|0|100|IKR|2463|4841|vetalmen|||0|45|0||Dýraheilsa ehf|Le Vet B.V.|Sulfadiazinum og trimethoprimum||||2463|4841||2|0||0|||0 519162|H02AB0208|Dexavit|stl/irl|4|mg/ml|5|ml|5|lykjur||H02AB02|01.04.2021||R|0|0|0|0|0|VIT|0|0|1|100|DKK|46921|62619|lyfalmen|||2|25|0|66,6670|Vital Pharma Nordic ApS|Vital Pharma Nordic ApS|Dexametasón||46921||46921|62619||1|0|0|0|||0 519172|L01EB0201|Erlotinib WH|filmhtfl|100|mg|30|stk|1|þpakki||L01EB02|01.06.2020||R|0|1|1|0|0|WEH|0|1|0|100|XEU|258350|274493|lyfsjukr|||2|30|0||Williams & Halls efh|Williams & Halls ehf|Erlotinib||215468||215468|274493||2|0|L|0|||0 519463|J01EE0108|Eusaprim|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.07.2011||R|0|0|0|0|0|AEP|0|0|1|100|DKK|1041|2931|lyfalmen|||1|100|0|2,5000|Icepharma hf|Aspen Pharma Trading Limited|Súlfametoxazól og trímetóprím||1041||1041|2931||2|0|E|0|||0 519655|A12BA0103|Kaliumklorid Orifarm (Lyfjaver)|forðatfl|750|mg|100|stk|1|glas||A12BA01|01.06.2021||L|1|0|0|G|0|LVR|0|0|0|100|DKK|||lyfalmen|V1047|2676|3|100|0|25,0000|Lyfjaver ehf|Lyfjaver ehf|Kalíumklóríð|||||2676||3|0|G|0|||0 519722|N07BC0102|Buvidal|stl|64|mg|0,18|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|0|0|0|CMS|0|1|0|100|DKK|57266|75704|lyfsjukr|||1|0,18|0|30,4762|Vistor hf|Camurus AB|Búprenorfín||57266||57266|75704||1|H|L|1|30|dagar|0 519755|L01EX1001|Rydapt|hylki|25|mg|56|stk|1|þpakki|2x28|L01EX10|01.03.2020||R|0|0|1|0|0|NEL|0|1|0|100|DKK|947577|1185032|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Midostaurin||947577||947577|1185032||1|0|L|0|||0 520029|N03AX1404|Levetiracetam Actavis|filmhtfl|250|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|G|0|GRP|0|0|0|100|XEU|2989|5612|lyfalmen|V0515|5198|2|100|0|16,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||2989||2989|5612||1|0|G|0|||0 520082|C09CA0107|Losartan Medical Valley|filmhtfl|12,5|mg|112|stk|1|þpakki||C09CA01|01.07.2020||R|1|0|0|G|0|VAL|0|0|0|100|IKR|1629|3686|lyfalmen|V0213|3686|2|112|0|28,0000|Acare ehf|Medical Valley Invest AB|Lósartan||1590||1590|3686||2|0|G|0|||0 520186|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|G|0|JAS|0|0|0|100|SEK|23019|32388|lyfalmen|||1|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||23019||23019|32388||1|0|G|0|||0 520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|17048|24963|lyfalmen|V0143|3426|1|12|0|12,0000|Icepharma hf|Upjohn EESV|Síldenafíl||17048||17048|24963||1|0|E|0|||0 520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|5547|9133|lyfalmen|V0144|1315|1|4|0|8,0000|Icepharma hf|Upjohn EESV|Síldenafíl||5547||5547|9133||1|0|E|0|||0 520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|15349|22624|lyfalmen|V0144|3944|1|12|0|24,0000|Icepharma hf|Upjohn EESV|Síldenafíl||15349||15349|22624||1|0|E|0|||0 520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1394|2689|lyfalmen|V0056|2229|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Amlódipín||865||865|2689||1|0|G|0|||0 520546|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|þpakki|8+2 mg|N07BC51|01.07.2016||R|0|0|1|0|0|IND|0|1|0|100|DKK|9338|14351|lyfsjukr|||1|28|0|28,0000|Vistor hf|Indivior Europe Limited|Búprenorfín í blöndum||9338||9338|14351||1|0|L|1|30|dagar|0 520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2254|2689|lyfalmen|V0057|2229|2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Amlódipín||865||865|2689||1|0|G|0|||0 520633|N06AB0607|Sertralin Krka|filmhtfl|100|mg|250|stk|1|ílát||N06AB06|01.11.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|9918|8380|lyfalmen|||2|250|0|500,0000|LYFIS ehf|Krka Sverige AB|Sertralín||5000||5000|8380||2|0|G|0|||0 520659|G04BD0806|Solifenacin Mylan|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.07.2019||R|1|0|0|G|0|MYL|0|0|0|100|DKK|11601|9075|lyfalmen|V0440|9075|2|90|0|90,0000|Icepharma hf|Mylan AB|Sólífenacín||5505||5505|9075||2|0|G|0|||0 520759|M03BC5101|Norgesic|töflur|||30|stk|1|þpakki||M03BC51|01.03.1981||R|1|0|0|G|0|MEA|0|0|1|100|DKK|636|2373|lyfalmen|||1|30|0|7,5000|Icepharma hf|Meda AB|Orfenadrín í blöndum||636||636|2373||2|0|G|0|||0 520936|L01AX0304|Temozolomide Accord|hylki|100|mg|5|stk|1|skpoki|hart|L01AX03|01.06.2021||R|0|0|1|0|0|CLU|0|1|0|100|XEU|8300|12922|lyfsjukr|||2|5|0||Artasan ehf|Accord Healthcare S.L.U.|Temozolomid||8300||8300|12922||1|0|L|0|||0 521273|B01AA0303|Warfarin Teva|töflur|3|mg|100|stk|1|þpakki||B01AA03|01.01.2019||R|1|0|0|G|0|TVI|0|0|0|100|XEU|1586|3681|lyfalmen|||2|100|0|40,0000|Teva Pharma Iceland ehf|Teva B.V|Warfarín||1586||1586|3681||1|0|G|0|||0 521428|N07BA0154|Nicorette Quickmist Cool Berry|munnhúði|1|mg/sk|150|skammtar|1|úðapum|1 x 150 úðaskammtar|N07BA01|01.09.2020||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|150|0|5,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 522158|L01XC0302|Kanjinti|st/irþ|420|mg|1|hgl|1|pakki||L01XC03|01.07.2020||R|0|0|0|0|0|AEB|0|1|0|100|DKK|200795|256244|lyfsjukr|||2|1|0||Vistor hf|Amgen Europe B.V.|Trastuzumab||200795||200795|256244||1|H|L|0|||0 522175|N02BE0124|Paracaff|filmhtfl|565|mg|20|stk|1|þpakki|500+65 mg|N02BE01|01.04.2019||L|1|0|0|0|0|ACE|0|0|1|100|IKR|||lyflausa|||0|20|0|3,7666|Acare ehf|Acare ehf|Paracetamól|||||||2|0|0|0|||0 522290|C01BD0702|Dronedarone STADA|filmhtfl|400|mg|100|stk|1|þpakki||C01BD07|01.08.2020||R|1|1|1|0|0|ASR|0|0|0|100|IKR|12900|17877|lyfalmen|V1027|17511|2|100|0|50,0000|LYFIS ehf|STADA Arzneimittel AG|Dronedarón||11900||11900|17877||2|0|E|0|||0 522427|L03AB1301|Plegridy|stl|125|mcg|2|áf-penni|1|pakki||L03AB13|01.07.2015||R|0|0|1|G|0|BNB|0|0|0|100|XEU|85732|111707|lyfalmen|||1|2|0|28,0900|Icepharma hf|Biogen Netherlands B.V.|Peginterferón beta-1a||85732||85732|111707||2|0|G|0|||0 522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|0|0|0|0|0|NEL|0|1|0|100|DKK|145775|187815|lyfsjukr|||1|1|0|0,5000|Vistor hf|Novartis Europharm Ltd|Basiliximab||145775||145775|187815||1|H|L|0|||0 522985|D01AE1603|Amorolfin Apofri|lakk|5|%|3|ml|1|glas||D01AE16|01.05.2018||L|0|0|0|0|0|APO|0|0|1|100|IKR|||lyflausa|||2|3|0||LYFIS ehf|Apofri AB|Amorolfín|||||||2|0||0|||0 523151|N05AH0410|Quetiapin Actavis|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.08.2013||R|1|0|0|G|0|ATE|0|0|0|100|XEU|4785|3305|lyfalmen|V0285|3287|2|100|0|25,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Quetíapín||1313||1313|3305||1|0|G|0|||0 523273|H02AB0901|Solu-Cortef|sts|100|mg|1|hgl|1|pakki|Act-O-Vial|H02AB09|01.02.2021||R|0|0|0|G|0|PLS|0|0|1|100|DKK|577|2292|lyfalmen|||1|1|0|3,3333|Icepharma hf|Pfizer Aps|Hýdrókortisón||577||577|2292||1|0|G|0|||0 523274|S01XA2008|Artelac|augndr|||10|ml|1|plglas||S01XA20|01.05.1998||L|0|0|0|G|0|HEG|0|0|0|100|IKR|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar samsetningar|||||1916||1|0|G|0|||0 523284|L01EF0101|Ibrance|filmhtfl|75|mg|21|stk|1|þpakki||L01EF01|01.03.2021||R|1|0|1|0|0|PEU|0|1|0|100|DKK|311653|394120|lyfsjukr|||1|21|0||Icepharma hf|Pfizer Europe MA EEIG|Palbociclib||311653||311653|394120||1|0|L|0|||0 523346|L01XC0304|Ontruzant|st/irþ|150|mg|150|mg|1|hgl||L01XC03|01.05.2020||R|0|0|0|0|0|SUN|0|1|0|100|DKK|80921|105622|lyfsjukr|||1|150|0||Vistor hf|Samsung Bioepis NL B.V.|Trastuzumab||80921||80921|105622||1|H|L|0|||0 523350|B02BD0801|NovoSeven|sts|2|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|0|0|0|0|NAS|0|1|0|100|DKK|163225|209517|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Storkuþáttur VIIa||163225||163225|209517||1|H|L|0|||0 523355|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.09.2017||R|1|0|0|0|0|GPA|0|0|0|100|XEU|1622|2599|lyfalmen|V0144|1315|2|4|0|8,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||800||800|2599||1|0|E|0|||0 523758|L01EA0301|Tasigna|hylki|150|mg|112|stk|1|þpakki||L01EA03|01.03.2013||R|0|1|1|0|0|NEL|0|1|0|100|DKK|343965|434307|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotinib||343965||343965|434307||1|0|L|0|||0 523773|QD06AA0201|Animed vet.|húðúði|2,45|% w/w|211|ml|1|úðaílá||QD06AA02|01.06.2016||R|0|0|0|0|0|ANI|0|0|0|100|IKR|1098|2158|vetalmen|||0|211|0||Dýraheilsa ehf|aniMedica GmbH|Chlortetracycline||1098||1098|2158||2|0||0|||0 523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|þpakki||R06AD02|01.10.1995||R|1|0|0|G|0|SNP|0|0|1|100|XEU|941|2793|lyfalmen|V0903|2534|1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||941||941|2793||1|0|G|0|||0 523937|C10AX0903|Ezetimib Krka|töflur|10|mg|100|stk|1|þpakki||C10AX09|01.05.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|10278|7004|lyfalmen|V0954|6205|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Ezetimíb||4000||4000|7004||2|0|E|0|||0 523967|N02AA0506|Oxikodon Depot Actavis|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1504|3568|lyfalmen|V0584|3568|2|28|0|7,4700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||1504||1504|3568||1|0|G|1|30|dagar|0 524223|C01DA1401|Imdur|forðatfl|30|mg|98|stk|1|þpakki||C01DA14|01.07.1993||R|1|0|0|G|0|TOG|0|0|0|100|SEK|2012|4267|lyfalmen|V1001|4267|1|98|0|73,5000|Navamedic AB|TopRidge Pharma (Ireland) Limited|Ísósorbíð mónónítrat||2012||2012|4267||1|0|G|0|||0 524276|A02BC0401|Pariet|sh-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.06.2011||R|0|0|0|0|0|EIS|0|0|1|100|IKR|7518|6501|lyfalmen|V0010|3838|1|98|0|98,0000|Vistor hf|Eisai Ltd|Rabeprazól||3635||3635|6501||1|0|E|0|||0 524367|N06AB0313|Fluoxetin WH|hylki|20|mg|98|stk|1|þpakki|Hart|N06AB03|01.07.2017||R|0|0|0|G|0|WEH|0|0|0|100|IKR|1122|3042|lyfalmen|V0039|2972|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Flúoxetín||1122||1122|3042||2|0|G|0|||0 524630|N03AX1610|Pregabalin Medical Valley|hylki|300|mg|70|stk|1|þpakki||N03AX16|01.04.2020||R|1|0|0|0|0|VAL|0|0|0|100|IKR|2900|4237|lyfalmen|V0689|4237|2|70|0|70,0000|Acare ehf|Medical Valley Invest AB|Pregabalín||1990||1990|4237||2|0|E|0|||0 524981|D11AX2101|Mirvaso|hlaup|3|mg/g|30|g|1|túpa||D11AX21|01.03.2016||R|0|0|0|0|0|GAL|0|0|0|100|XEU|6793|10848|lyfalmen|||1|30|0||Icepharma hf|Galderma International|Brimonidine||6793||6793|10848||2|0|E|0|||0 525014|M03BC5101|Norgesic|töflur|||100|stk|1|þpakki||M03BC51|01.06.1981||R|1|0|0|G|0|MEA|0|0|1|100|DKK|1273|3250|lyfalmen|||1|100|0|25,0000|Icepharma hf|Meda AB|Orfenadrín í blöndum||1273||1273|3250||2|0|G|0|||0 525122|R03AK0605|Salmex|innönddu|300|mcg/sk|60|skammtar|1|innö.t|50/250 mcg/sk|R03AK06|01.05.2019||R|0|0|0|G|0|GPN|0|0|0|100|DKK|3918|6468|lyfalmen|V0437|5862|2|60|0|30,0000|Icepharma hf|Glenmark Pharmaceuticals Nordic AB|Salmeteról og fluticason||3611||3611|6468||2|0|G|0|||0 525418|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||500|ml|20|pokar|lausn|B05BB01|01.07.2018||R|0|0|0|0|0|BAM|0|0|1|100|SEK|4549|7759|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||4549||4549|7759||2|0|0|0|||0 525689|N02CD0301|AJOVY|stl|225|mg|1,5|ml|1|áfpen||N02CD03|01.07.2020||R|0|0|1|0|0|TGH|0|0|0|100|XEU|76207|93025|lyfalmen|||1|1,5|0|30,0000|Actavis Pharmaceuticals Iceland ehf.|TEVA GmbH|Fremanezumab||70961||70961|93025||1|0|E|0|||0 525720|B01AF0101|Xarelto|filmhtfl|20|mg|100|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|G|0|FIN|0|0|0|100|DKK|30657|42049|lyfalmen|V0977|42049|1|100|0|100,0000|Icepharma hf|Bayer AG|Rivaoxaban||||30657|42049||2|0|G|0|||0 525857|B05XA0103|Kaliumklorid B.Braun|irþ|1|mmol/ml|50|ml|20|hgl||B05XA01|01.09.2010||R|0|0|0|0|0|RAU|0|0|0|100|XEU|5547|9133|lyfalmen|||2|1000|0||Actavis Group hf|B.Braun Melsungen AG|Kalíumklóríð||5547||5547|9133||2|H|0|0|||0 525865|B05XA0303|Natriumklorid B.Braun|irþ|1|mmol/ml|50|ml|20|hgl||B05XA03|01.09.2010||R|0|0|0|0|0|RAU|0|0|0|100|XEU|5072|8479|lyfalmen|||2|1000|0||Actavis Group hf|B.Braun Melsungen AG|Natríumklóríð||5072||5072|8479||2|H|0|0|||0 525913|C07AB0706|Bisoprolol Medical Valley|filmhtfl|10|mg|105|stk|1|glas||C07AB07|01.02.2021||R|1|0|0|G|0|VAL|0|0|0|100|XEU|2073|4351|lyfalmen|V1040|4351|2|105|0|105,0000|Acare ehf|Medical Valley Invest AB|bisoprolol||2073||2073|4351||2|0|G|0|||0 525945|J01MA0205|Ciprofloxacin Villerton|irl|2|mg/ml|100|ml|10|pokar||J01MA02|01.02.2016||R|0|0|0|0|0|VIN|0|0|1|100|DKK|2455|4877|lyfalmen|||2|1000|0|2,5000|Icepharma hf|Villerton Invest SA|Cíprófloxacín||||2455|4877||2|0|0|0|||0 525998|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|1000|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||4863||2|0||0|||0 526004|V07AB0009|Sterilt Vann B. Braun|leysir|||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|1000|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||4925||2|0||0|||0 526376|N03AG0103|Orfiril Retard|forðatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|1|0|G|0|DEA|0|0|0|100|XEU|7392|11672|lyfalmen|||1|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||7392||7392|11672||1|0|G|0|||0 526396|N03AX1408|Levetiracetam STADA|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.08.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|9168|12509|lyfalmen|V0516|12509|2|100|0|66,6700|LYFIS ehf|STADA Arzneimittel AG|Levetíracetam||8000||8000|12509||2|0|G|0|||0 526496|H02AB0207|Dexamethasone Krka|töflur|4|mg|100|stk|1|þpakki|stakskammtaþynna|H02AB02|01.04.2018||R|0|0|0|G|0|KNM|0|0|1|100|IKR|15000|13060|lyfalmen|V0423|13060|2|100|0|266,6666|LYFIS ehf|Krka d.d. Novo mesto|Dexametasón||8400||8400|13060||2|0|G|0|||0 526521|C03DA0404|Kalspar|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2015||R|1|0|0|0|0|WEH|0|0|0|100|XEU|14551|6533|lyfalmen|V0111|6315|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Eplerenón||3658||3658|6533||2|0|E|0|||0 526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|1|0|G|0|DEA|0|0|0|100|XEU|4119|7167|lyfalmen|||1|100|0|40,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||4119||4119|7167||1|0|G|0|||0 527132|N02CC0402|Maxalt Smelt|frþ.tfl|10|mg|18|stk|1|þpakki||N02CC04|01.06.2019||R|0|0|0|G|0|NVO|0|0|0|100|DKK|6343|10228|lyfalmen|V0621|8917|1|18|0|18,0000|Vistor hf|N.V. Organon|Rizatriptan||6343||6343|10228||1|0|G|0|||0 527355|N01AB0803|Sevoflurane Piramal|innö.guf|100|%|250|ml|1|fl||N01AB08|01.01.2021||R|0|0|0|0|0|PBV|0|0|0|100|XEU|19073|26199|lyfalmen|||1|250|0||Williams & Halls efh|Piramal Critical Care B.V.|Sevóflúran||17946||17946|26199||2|H|0|0|||0 527453|N03AX1404|Levetiracetam Actavis|filmhtfl|1000|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|G|0|GRP|0|0|0|100|XEU|10512|13057|lyfalmen|V0516|12509|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||8398||8398|13057||1|0|G|0|||0 527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|0|0|0|G|0|IMM|0|0|0|100|DKK|1518|3587|lyfalmen|||1|5|0||Vistor hf|Immedica Pharma AB|Emedastín||1518||1518|3587||1|0|G|0|||0 527632|A10AB0506|Fiasp [FlexTouch]|stl|100|ein/ml|3|ml|5|áfpen||A10AB05|01.07.2018||R|0|0|0|G|0|NAS|0|0|0|100|DKK|5145|8579|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5145||5145|8579||1|0|G|0|||0 527685|M01AH0503|Coxerit|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|WEH|0|0|1|100|IKR|2273|3012|lyfalmen|V0825|2811|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||1100||1100|3012||2|0|G|0|||0 527714|N05AX1303|TREVICTA|stl|525|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|G|0|JCI|0|0|0|100|SEK|252891|321037|lyfalmen|||1|1|0|210,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||252891||252891|321037||1|0|G|0|||0 527914|QS02CA0103|Saniotic vet.|eyrnadr|||20|ml|1|glas|fyrir hundi og ketti|QS02CA01|01.08.2015||R|0|0|0|0|0|RPG|0|0|0|100|XEU|1733|3406|vetalmen|||0|20|0||Icepharma hf|Richter Pharma AG|Prednisolonum og sýkingalyf||1733||1733|3406||2|0||0|||0 528055|C03DA0103|Spiron|töflur|25|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|G|0|COR|0|0|0|100|DKK|954|2424|lyfalmen|V0046|2424|2|100|0|33,3333|Vistor hf|Orion Corporation|Spírónólaktón||673||673|2424||1|0|G|0|||0 528076|D11AX1002|Finasterid STADA|filmhtfl|1|mg|30|stk|1|þpakki||D11AX10|01.07.2018||R|1|0|0|0|0|ASR|0|0|0|100|IKR|3884|6844|lyfalmen|||2|30|0|30,0000|LYFIS ehf|STADA Arzneimittel AG|Fínasteríð||3884||3884|6844||2|0||0|||0 528214|N04BC0505|Oprymea|forðatfl|0,52|mg|100|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|G|0|KNM|0|0|0|100|IKR|8816|13632|lyfalmen|||2|100|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||8816||8816|13632||2|0|G|0|||0 528241|A04AD0101|Scopoderm|forðapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|DKK|||lyfalmen|||0|2|0|2,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Skópólamín|||||3121||1|0||0|||0 528267|A02BC0501|Nexium|sþ-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2013||R|1|0|0|0|0|GRH|0|0|1|100|DKK|9293|6241|lyfalmen|V0011|4880|1|100|0|66,6700|Vistor hf|Grünenthal GmbH|Esómeprazól||3446||3446|6241||1|0|G|0|||0 528303|N02AA0507|OxyContin Depot|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.11.2020||R|1|0|0|G|0|MUP|0|0|0|100|DKK|2525|4973|lyfalmen|V0584|3568|1|28|0|7,4700|Icepharma hf|Mundipharma A/S|Oxýcódon||2525||2525|4973||2|0|G|1|30|dagar|0 528311|M01AE0116|Ibuprofen Bril|filmhtfl|400|mg|100|stk|1|þpakki||M01AE01|01.11.2016||R|1|0|0|G|0|PIL|0|0|1|100|IKR|668|2417|lyfalmen|V0562|2417|2|100|0|33,3300|Williams & Halls efh|Brillpharma (Ireland) Limited|Íbúprófen||668||668|2417||2|0|G|0|||0 528418|D07AC1302|Ovixan|krem|1|mg/g|100|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|G|0|GAB|0|0|1|100|SEK|1967|4205|lyfalmen|||2|100|0||Vistor hf|Galenica AB|Mómetasón||1967||1967|4205||1|0|G|0|||0 528472|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|120|skammtar|1|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|G|0|LVR|0|0|0|100|SEK|5797|9477|lyfalmen|V0971|9477|3|120|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||5797||5797|9477||3|0|G|0|||0 528584|A07EC0202|Pentasa|forðatfl|1|g|60|stk|1|þpakki|6 x 10 stk|A07EC02|01.06.2012||R|1|0|0|G|0|FEL|0|0|0|100|DKK|6279|10140|lyfalmen|||1|60|0|40,0000|Vistor hf|Ferring Lægemidler A/S|Mesalazín (5-amínósalicýlsýra)||6279||6279|10140||1|0|G|0|||0 528874|N02CC0405|Rizatriptan ratiopharm|munndr.t|10|mg|18|stk|1|þpakki||N02CC04|01.02.2018||R|0|0|0|G|0|RTH|0|0|0|100|XEU|6162|8917|lyfalmen|V0621|8917|2|18|0|18,0000|Alvogen|ratiopharm GmbH|Rizatriptan||5390||5390|8917||2|0|G|0|||0 528948|N05AE0403|Ziprasidon Actavis|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.11.2020||R|1|0|0|G|0|ATE|0|0|0|100|XEU|20888|23519|lyfalmen|||2|56|0|56,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ziprasidon||15999||15999|23519||1|0|G|0|||0 529142|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|7,5|mg|100|stk|1|þpakki|5+2,5 mg|N02AA55|01.11.2019||R|1|0|0|0|0|GOV|0|0|0|100|DKK|5275|8502|lyfalmen|V1003|8502|2|100|0|6,6667|Alvogen|Alvogen ehf|Oxycodonum í blöndum||5089||5089|8502||2|0|E|1|30|dagar|0 529352|N05AX1304|Paliperidon Krka|forðatfl|3|mg|28|stk|1|þpakki||N05AX13|01.08.2018||R|0|0|0|0|0|KNM|0|0|0|100|IKR|9787|14969|lyfalmen|V0963|14969|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Paliperídón||9787||9787|14969||2|0|E|0|||0 529735|N03AB0501|Pro-Epanutin|irþ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|0|0|0|0|0|PLS|0|0|0|100|DKK|61774|81405|lyfalmen|||1|100|0|11,1000|Icepharma hf|Pfizer ApS|Fosfenýtóín||61774||61774|81405||1|H|0|0|||0 529955|J05AE0803|Atazanavir Krka|hylki|300|mg|30|stk|1|glas||J05AE08|01.06.2020||R|0|0|1|0|0|KAN|0|1|0|100|IKR|39565|53315|lyfsjukr|||2|30|0|30,0000|Krka Sverige AB|Krka d.d. Novo mesto|Atazanavír||39565||39565|53315||2|0|L|0|||0 530162|A06AD6502|Movicol|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.07.2014||L|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|8|0||Artasan ehf|Norgine A/S|Makrógól 3350|||||||1|0||0|||0 530188|A06AD6502|Movicol|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.09.2011||L|0|0|0|0|0|NOI|0|0|0|100|XEU|||lyfalmen|||0|50|0|25,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||7104||1|0|E|0|||0 530255|M01AH0504|Etoricoxib Krka|filmhtfl|30|mg|30|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|2488|4251|lyfalmen|V0824|4251|2|30|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||2000||2000|4251||2|0|G|0|||0 530701|QN05CM9204|Nerfasin vet.|stl|20|mg/ml|25|ml|1|hgl|nautg. hestar,hundar og kettir|QN05CM92|01.07.2013||R|0|0|0|0|0|BVL|1|0|0|100|XEU|1548|3042|vetalmen|||0|25|0||Dýraheilsa ehf|Le Vet B.V.|Xylazinum||1548||1548|3042||2|0||0|||0 530741|G03FA0105|Activelle|töflur|||84|stk|1|pakki|þp 1+0,5 mg|G03FA01|01.03.2000||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2715|5235|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2715||2715|5235||1|0|G|0|||0 530828|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|6046|9820|lyfalmen|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||6046||6046|9820||1|0|0|0|||0 531360|N06BA0404|Methylphenidate Sandoz|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.11.2019||R|1|1|0|0|0|SHS|0|0|0|100|DKK|6679|6242|lyfalmen|V0622|6242|2|30|0|54,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||3447||3447|6242||1|0|E|1|30|dagar|0 531382|A10BK0401|Steglatro|filmhtfl|15|mg|98|stk|1|þpakki||A10BK04|01.01.2019||R|1|0|0|G|0|MSD|0|0|0|100|DKK|19792|28740|lyfalmen|||1|98|0|147,0000|Vistor hf|M.S.D.|Ertugliflozin||19792||19792|28740||1|0|G|0|||0 531501|N05CH0105|Slenyto|forðatfl|1|mg|60|stk|1|þpakki||N05CH01|01.12.2019||R|1|0|0|0|0|RNU|0|0|1|100|XEU|6649|10650|lyfalmen|||2|60|0|30,0000|Williams & Halls efh|RAD Neurim Pharmaceuticals EEC SARL|Melatonin||6649||6649|10650||2|0|0|0|||0 531894|J01DD0103|Cefotaxim Navamedic|sts|1|g|10|ml|10|hgl|lausn|J01DD01|01.05.2021||R|0|0|0|0|0|NAV|0|0|1|100|XEU|6468|10400|lyfalmen|||2|100|0|2,5000|Icepharma hf|Navamedic ASA|Cefotaximum||6468||6468|10400||2|0|0|0|||0 532257|C10AA0704|Rosuvastatin Xiromed|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.12.2020||R|0|0|0|0|0|VAL|0|0|0|100|XEU|2585|4863|lyfalmen|V0117|4773|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||2445||2445|4863||2|0|E|0|||0 532351|C09BA0204|Enalapril HCTZ Medical Valley|töflur|32,5|mg|100|stk|1|glas|20+12,5 mg|C09BA02|01.02.2021||R|1|0|0|G|0|VAL|0|0|0|100|XEU|2199|2583|lyfalmen|V0098|2583|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Enalapríl og þvagræsilyf||788||788|2583||2|0|G|0|||0 532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|0|0|0|0|0|CNI|0|0|0|100|SEK|817|2622|lyfalmen|||1|30|0|3,0000|Vistor hf|McNeil Sweden AB|Mebendazól||817||817|2622||1|0||0|||0 532526|L04AA4201|Mayzent|filmhtfl|0,25|mg|12|stk|1|þpakki|Skammtastillingarpakkning|L04AA42|01.11.2020||R|1|1|1|0|0|NEP|0|1|0|100|DKK|24340|34059|lyfsjukr|||1|12|0||Vistor hf|Novartis Europharm Limited|Siponimod||24340||24340|34059||1|0|L|0|||0 532707|N04BD0203|Rasagilin WH|töflur|1|mg|100|stk|1|þpakki||N04BD02|01.05.2016||R|0|0|0|G|0|WEH|0|0|0|100|XEU|44006|28756|lyfalmen|V0711|26186|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Rasagilín||19804||19804|28756||2|0|G|0|||0 532726|N06AB1008|Escitalopram STADA|filmhtfl|20|mg|100|stk|1|þpakki||N06AB10|01.08.2021||R|1|0|0|G|0|ASR|0|0|0|100|IKR|3500|6315|lyfalmen|V0327|6315|2|100|0|200,0000|LYFIS ehf|STADA Arzneimittel AG|Escítalópram||3500||3500|6315||2|0|0|0|||0 532821|L01XG0101|Bortezomib W&H|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XG01|01.02.2016||R|0|1|0|0|0|WEH|0|1|0|100|XEU|111828|145594|lyfsjukr|||2|1|0||Williams & Halls efh|Williams & Halls ehf|Bortezomib||111828||111828|145594||2|H|L|0|||0 532869|QP51AJ0103|Baycoxine vet|mixtúra|50|mg/ml|1000|ml|1|glas||QP51AJ01|01.08.2018||R|0|0|0|0|0|BAN|0|0|0|100|DKK|25291|43592|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|Toltrazuril||25291||25291|43592||2|0||0|||0 532983|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|BAM|0|0|0|100|SEK|1903|4117|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||1903||1903|4117||2|0|0|0|||0 532984|N02AJ0601|Parkodin|filmhtfl|510|mg|100|stk|1|þpakki|10+500 mg|N02AJ06|01.06.2018||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1285|3267|lyfalmen|||2|100|0|16,6667|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||1285||1285|3267||1|0|E|3|||0 533001|A10BA0205|Metformin EQL|filmhtfl|500|mg|105|stk|1|glas||A10BA02|01.07.2020||R|1|0|0|G|0|EQL|0|0|0|100|IKR|500|2186|lyfalmen|V0500|2165|2|105|0|26,2500|LYFIS ehf|EQL Pharma AB|Metformín||500||500|2186||2|0|G|0|||0 533147|B02BD0208|Afstyla|sts|3000|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|1|0|0|CSB|0|1|0|100|SEK|242828|308521|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||242828||242828|308521||2|0|L|0|||0 533363|L04AA3601|Ocrevus|irþ|300|mg|10|ml|1|hgl|lausn|L04AA36|01.04.2018||R|0|0|0|0|0|RRG|0|1|0|100|DKK|769563|963632|lyfsjukr|||1|10|0|91,1854|Icepharma hf|Roche Registration GmbH|Ocrelizumab||||769563|963632||2|H|L|0|||0 533563|R03AK0605|Salmex|innönddu|150|mcg/sk|60|skammtar|1|innö.t|50/100 mcg/sk|R03AK06|01.01.2021||R|0|0|0|G|0|GPN|0|0|0|100|DKK|3417|5590|lyfalmen|V0436|5590|2|60|0|30,0000|Icepharma hf|Glenmark Pharmaceuticals Nordic AB|Salmeteról og fluticason||2973||2973|5590||2|0|G|0|||0 533979|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|án rotvarnar/án laktósa|H02AB04|01.01.2021||R|0|0|0|G|0|PLS|0|0|1|100|DKK|467|2141|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer Aps|Metýlprednisólón||467||467|2141||1|0|G|0|||0 534166|N05AB0302|Trilafon Dekanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.04.2014||R|0|0|0|G|0|COR|0|0|0|100|DKK|21510|30479|lyfalmen|||1|10|0|154,5714|Vistor hf|Orion Corporation|Perfenazín||21510||21510|30479||1|0|G|0|||0 534471|L04AA1001|Rapamune|filmhtfl|1|mg|100|stk|1|þpakki||L04AA10|01.06.2012||R|0|0|1|G|0|PEU|0|0|0|100|DKK|55815|73868|lyfalmen|||1|100|0|33,3300|Icepharma hf|Pfizer Europe MA EEIG|Sirolimus||55815||55815|73868||1|0|G|0|||0 534497|QJ01CA0402|Vetrimoxin L.A.|stl|150|mg/ml|100|ml|1|hgl||QJ01CA04|01.11.2014||R|0|0|0|0|0|CES|0|0|0|100|XEU|2851|5579|vetalmen|||0|100|0||Icepharma hf|Ceva Sante Animale|Amoxicillinum||2851||2851|5579||2|0||0|||0 534512|C10AA0703|Rosuvastatin Krka|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|KRK|0|0|0|100|IKR|5481|4870|lyfalmen|V0117|4870|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||2450||2450|4870||2|0|E|0|||0 534712|N07BC0202|Metadon Abcur|töflur|5|mg|100|stk|1|þpakki||N07BC02|01.04.2020||R|1|0|0|G|0|ABC|0|0|0|100|SEK|2353|4737|lyfalmen|||1|100|0|20,0000|Icepharma hf|Abcur AB|Metadón||2353||2353|4737||2|0|G|1|30|dagar|0 534885|L01AA0601|Holoxan|sts/irs|1000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|0|0|BAM|0|0|0|100|SEK|5102|8520|lyfalmen|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||5102||5102|8520||2|H|0|0|||0 534942|R01AD5801|Dymista|nefúði|187|mcg/sk|120|skammtar|1|glas|137+50mcg|R01AD58|01.10.2019||R|0|0|0|G|0|MEA|0|0|1|100|DKK|2998|5624|lyfalmen|||1|120|0|30,0000|Icepharma hf|Meda AB|Fluticasone í samsetningum||2998||2998|5624||2|0|G|0|||0 535265|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.11.2013||R|1|0|0|G|0|ORA|0|0|0|100|DKK|2136|4438|lyfalmen|V0092|4054|2|100|0|66,6667|Artasan ehf|Orifarm Healthcare A/S|Spírónólaktón||2136||2136|4438||1|0|G|0|||0 535453|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|19 mg/4 mg|QP54AB51|01.04.2018|31.08.2021|R|0|0|0|0|0|BIV|0|0|0|100|XEU|2323|4004|vetorma|||0|3|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Milbemycin oxime í blöndum||2323||2323|4004||1|0||0|||0 535685|M01AH0503|Coxerit|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|WEH|0|0|1|100|IKR|2378|3907|lyfalmen|V0826|3647|2|28|0|42,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||1750||1750|3907||2|0|G|0|||0 535773|P03AA5401|Tenutex|áburður|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|Bioglan AB|Dísúlfíram í blöndum|||||||2|0||0|||0 536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|G|0|HES|0|0|0|100|DKK|356|1988|lyfalmen|||1|10|0|25,0000|Vistor hf|Novartis Healthcare A/S|Pílókarpín||356||356|1988||1|0|G|0|||0 536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|G|0|HES|0|0|0|100|DKK|370|2007|lyfalmen|||1|10|0|25,0000|Vistor hf|Novartis Healthcare A/S|Pílókarpín||370||370|2007||1|0|G|0|||0 536179|N05CD0804|Midazolam Accord|stl/irl|5|mg/ml|10|ml|10|lykjur||N05CD08|01.07.2019||R|0|0|0|0|0|AEE|0|0|0|100|XEU|5927|9656|lyfalmen|||2|100|0|33,3333|Artasan ehf|Accord Healthcare B.V.|Mídazólam||5927||5927|9656||1|H|0|2|450|mg|0 536385|C10AA0509|Atorvastatin Xiromed|filmhtfl|10|mg|98|stk|1|þpakki||C10AA05|01.04.2018||R|1|0|0|G|0|MVX|0|0|0|100|IKR|1960|2779|lyfalmen|V0112|2679|2|98|0|49,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||931||931|2779||2|0|G|0|||0 536460|N05AX1302|Xeplion|stl|150|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|JCI|0|0|0|100|SEK|85594|111533|lyfalmen|||1|1|0|60,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||85594||85594|111533||1|0|E|0|||0 536682|J02AC0106|Fungyn|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.01.2018||R|1|0|0|0|0|POF|0|0|1|100|IKR|14133|10995|lyfalmen|V0419|10058|2|28|0|28,0000|Alvogen|Alvogen|Flúkónazól||6900||6900|10995||2|0|E|0|||0 536745|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|0|0|BAM|0|0|0|100|SEK|2551|5009|lyfalmen|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||2551||2551|5009||2|H|0|0|||0 536958|N02CC0406|Rizatriptan Alvogen|munndr.t|10|mg|2|stk|1|þpakki||N02CC04|01.08.2020||L|0|0|0|0|0|POF|0|0|0|100|XEU|||lyflausa|||2|2|0|2,0000|Alvogen|Alvogen|Rizatriptan|||||||2|0|0|0|||0 537111|J05AR1701|Descovy|filmhtfl|225|mg|30|stk|1|glas|200+25 mg|J05AR17|01.10.2016||R|0|0|1|0|0|GSE|0|1|0|100|DKK|61537|81106|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|emtricitabine og tenofovir alafenamide||61537||61537|81106||2|0|L|0|||0 537465|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|FKA|0|0|1|100|DKK|5243|8714|lyfalmen|||1|7500|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||5243||5243|8714||1|0|0|0|||0 537580|R03DC0306|Montelukast ratiopharm|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.07.2019||R|1|0|0|G|0|TSA|0|0|0|100|XEU|10730|16267|lyfalmen|V0492|16267|2|98|0|39,2000|Alvogen|Teva Sweden AB|Montelúkast||10730||10730|16267||2|0|G|0|||0 537600|C07AG0207|Carvedilol STADA|töflur|3,125|mg|30|stk|1|þpakki||C07AG02|01.03.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|1500|3563|lyfalmen|||2|30|0|2,5000|LYFIS ehf|STADA Arzneimittel AG|Carvedílól||1500||1500|3563||2|0|G|0|||0 537772|N02AE0105|Buprenorphine Alvogen|forðapl|20|mcg/klst|4|stk|1|skpoki||N02AE01|01.03.2021||R|0|0|0|G|0|POF|0|0|0|100|IKR|3504|6321|lyfalmen|V0945|6321|2|4|0|11,2000|Alvogen|Alvogen|Búprenorfín||3504||3504|6321||2|0|G|1|30|dagar|0 537842|N05AH0206|Clozapin Medical|töflur|25|mg|500|stk|1|glas||N05AH02|01.12.2017||R|1|0|0|G|0|MED|0|0|0|100|IKR|14000|13473|lyfalmen|||2|500|0|41,6666|Medical ehf|Medical ehf|Klózapín||8700||8700|13473||2|0|G|0|||0 537866|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|25|stk|1|glas||C01DA02|01.05.2014||L|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|25|0|2,5000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||2412||1|0|G|0|||0 537873|N05CM0901|Sefitude|húðuðtfl|445|mg|60|stk|1|þpakki||N05CM09|01.06.2018||L|1|0|0|0|0|FLO|0|0|0|100|IKR|||lyflausa|||1|60|0||Florealis ehf|Florealis ehf|Valerianae radix|||||||2|0||0|||0 538181|A02AD0106|Rennie|sog/tugg|||24|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|24|0|2,4000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2|0||0|||0 538199|A02AD0106|Rennie|sog/tugg|||48|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|48|0|4,8000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2|0||0|||0 538207|A02AD0106|Rennie|sog/tugg|||96|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|96|0|9,6000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2|0||0|||0 538272|N04BC0409|Adartrel (Lyfjaver)|filmhtfl|0,25|mg|12|stk|1|þpakki||N04BC04|01.11.2020||R|1|0|0|G|0|LVR|0|0|0|100|XEU|1079|2983|lyfalmen|||3|12|0|0,5000|Lyfjaver ehf|Lyfjaver ehf|Rópíníról||1079||1079|2983||3|0|G|0|||0 538555|L04AX0306|Metojectpen|stl|12,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|2832|5396|lyfalmen|||1|1|0|5,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2832||2832|5396||2|0|G|0|||0 538713|R03BB0702|Incruse Ellipta|innönddu|55|mcg|30|skammtar|1|innö.t|afmældir skammtar|R03BB07|01.10.2015||R|0|0|0|G|0|RGP|0|0|0|100|DKK|4417|7577|lyfalmen|||1|30|0|30,0000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Umeclidiniumbrómið||4417||4417|7577||1|0|G|0|||0 539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|þpakki||N03AG04|01.10.1992||R|1|0|1|G|0|SNP|0|0|0|100|XEU|8139|12700|lyfalmen|||1|100|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||8139||8139|12700||1|0|G|0|||0 539310|A10AB0507|Fiasp [Penfill]|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2018||R|0|0|0|G|0|NAS|0|0|0|100|DKK|4877|8211|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||4877||4877|8211||1|0|G|0|||0 539385|L01XC1701|OPDIVO|irþ|10|mg/ml|4|ml|1|hgl||L01XC17|01.06.2016||R|0|1|0|0|0|BMS|0|1|0|100|DKK|64807|85241|lyfsjukr|||1|4|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Nivolumab||64807||64807|85241||1|H|L|0|||0 539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|ATE|0|0|1|100|DKK|747|2526|lyfalmen|||2|25|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||747||747|2526||1|0||2|130|töflur|0 539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|ATE|0|0|0|100|DKK|1133|3057|lyfalmen|||2|100|0|20,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||1133||1133|3057||1|0||2|130|töflur|0 539783|D01AC2001|Daktacort|krem|||15|g|1|túpa||D01AC20|01.04.1986||L|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|McNeil Sweden AB|Blöndur|||||||1|0||0|||0 539793|L01EF0201|Kisqali|filmhtfl|200|mg|63|stk|1|þpakki||L01EF02|01.11.2018||R|0|0|1|0|0|NEL|0|1|0|100|DKK|490753|616871|lyfsjukr|||1|63|0||Vistor hf|Novartis Europharm Ltd|Ribociclib||490753||490753|616871||1|0|L|0|||0 539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|0|0|0|G|0|PLS|0|0|0|100|DKK|1707|3847|lyfalmen|||1|40|0|8,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1707||1707|3847||1|0|G|0|||0 539990|C10AX0905|Ezetimibe ratiopharm|töflur|10|mg|98|stk|1|þpakki||C10AX09|01.12.2018||R|1|0|0|0|0|RTH|0|0|0|100|DKK|9317|6602|lyfalmen|V0954|6081|2|98|0|98,0000|Alvogen|ratiopharm GmbH|Ezetimíb||3708||3708|6602||2|0||0|||0 540009|B05BA1021|SmofKabiven|irl|550|kcal|493|ml|6|pokar|fleyti|B05BA10|01.03.2014||R|0|0|0|0|0|FKA|0|0|0|100|DKK|18306|26694|lyfalmen|||1|2958|0||Vistor hf|Fresenius Kabi AB|Blöndur||18306||18306|26694||1|0|0|0|||0 540133|H05BX0102|Cinacalcet WH|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|WEH|0|0|0|100|XEU|41521|11939|lyfalmen|V0721|11614|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||7586||7586|11939||2|0||0|||0 540141|N03AX1213|Gabapentin Teva|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.10.2019|31.07.2021|R|1|0|0|G|0|TVA|0|0|0|100|DKK|12641|18897|lyfalmen|||2|100|0|44,4400|Alvogen|Teva B.V.|Gabapentín||12641||12641|18897||2|0|G|0|||0 540220|S01FA5601|MYDRANE|stl|||20|lykjur|1|pakki|0,2+3,1+10 mg/ml|S01FA56|01.10.2017||R|0|0|0|0|0|TEA|0|0|0|100|SEK|21788|30831|lyfalmen|V1042|30831|1|20|0||Vistor hf|Laboratories THEA|Tropikamid í blöndum||21788||21788|30831||1|H|0|0|||0 540503|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|60|pokar|lausn|B05BB01|01.03.2020||R|0|0|0|0|0|BAM|0|0|1|100|DKK|7360|11628|lyfalmen|||1|6000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||7360||7360|11628||2|0|0|0|||0 540857|L01XC3201|Tecentriq|irþ|840|mg|14|ml|1|hgl|lausn|L01XC32|01.02.2020||R|0|1|0|0|0|RRG|0|1|0|100|DKK|481256|605059|lyfsjukr|||1|14|0||Icepharma hf|Roche Registration GmbH|Atezolizumab||481256||481256|605059||2|H|L|0|||0 540859|N06BA0903|Atomoxetin Medical Valley|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.12.2019||R|1|1|0|0|0|VAL|0|0|0|100|XEU|10140|3284|lyfalmen|V0813|2940|2|28|0|6,3000|Acare ehf|Medical Valley Invest AB|Atomoxetín||1298||1298|3284||2|0|E|0|||0 540958|L04AX0401|Revlimid|hylki|2,5|mg|21|stk|1|þpakki|hart|L04AX04|01.09.2015||R|1|1|1|0|0|BSQ|0|1|0|100|DKK|638856|801069|lyfsjukr|||1|21|0|5,2500|Bristol-Myers Squibb Pharma EEIG|Bristol-Myers Squibb Pharma EEIG|Lenalídómíd||638856||638856|801069||2|0|L|0|||0 541169|R02AA0302|Strepsils med honning og citron|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.1982||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0||0|||0 541493|N03AX1602|Lyrica (Lyfjaver)|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.12.2019||R|1|0|0|0|0|LVR|0|0|0|100|DKK|2267|4618|lyfalmen|V0685|2160|3|56|0|4,6667|Lyfjaver ehf|Lyfjaver ehf|Pregabalín||2267||2267|4618||3|0|E|0|||0 541846|C02KX0501|Adempas|filmhtfl|0,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|0|BRE|0|1|0|100|DKK|187545|239765|lyfsjukr|||1|42|0|4,6700|Vistor hf|Bayer AG|Riociguatum||187545||187545|239765||1|0|L|0|||0 542216|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|LEM|0|0|1|100|XEU|5145|8579|lyfalmen|||2|800|0|3,3300|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||5145||5145|8579||2|0|0|0|||0 542291|L01BC0603|Ecansya|filmhtfl|150|mg|60|stk|1|þpakki||L01BC06|01.06.2020||R|0|0|1|0|0|KAN|0|0|0|100|IKR|4301|7418|lyfalmen|||2|60|0||Krka Sverige AB|Krka d.d. Novo mesto|Capecitabín||4301||4301|7418||2|0|0|0|||0 542434|N05AX1208|Aripiprazol W&H|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|1|0|0|G|0|WEH|0|0|0|100|XEU|5261|3422|lyfalmen|V0682|3422|2|56|0|18,6670|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||1398||1398|3422||2|0|G|0|||0 542474|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|skammtar|1|túpa|mælipumpa|G03CA03|01.07.2019||R|0|0|0|G|0|BES|0|0|0|100|DKK|1318|3312|lyfalmen|||2|64|0||Vistor hf|Besins Healthcare Ireland Limited|Estradíól||1318||1318|3312||1|0|G|0|||0 542694|G04CA5202|Dutaprostam|hylki|0,9|mg|90|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.02.2021||R|0|0|0|G|0|ZET|0|0|0|100|DKK|9343|9054|lyfalmen|V1010|9053|2|90|0|90,0000|Alvogen|Zentiva, k.s.|Dútasteríð og tamsúlósínhýdroklóríð||5490||5490|9054||2|0|G|0|||0 542744|B05BB0214|Plasmalyte Glucos|irl|50|mg/ml|1000|ml|10|pokar||B05BB02|01.09.2015||R|0|0|0|0|0|BAM|0|0|0|100|SEK|3946|6929|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar í blöndum með kol­vetnum||3946||3946|6929||2|0|0|0|||0 542893|H05BX0106|Cinacalcet ratiopharm|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.07.2018||R|1|0|0|0|0|RTH|0|0|0|100|XEU|17482|8468|lyfalmen|V0720|8242|2|28|0|14,0000|Alvogen|ratiopharm GmbH|Cinacalcet||5064||5064|8468||2|0||0|||0 543274|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|G|0|JAS|0|0|0|100|SEK|17344|25370|lyfalmen|||1|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||17344||17344|25370||1|0|G|0|||0 543374|S01ED5118|Dorzolamide/Timolol Alvogen|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamid 20mg/ml|S01ED51|01.11.2011|31.07.2021|R|0|0|0|G|0|POF|0|0|0|100|XEU|1535|3611|lyfalmen|||2|5|0|25,0000|Alvogen|Alvogen|Tímólól í blöndum||1535||1535|3611||2|0|G|0|||0 543592|N01AB0701|Suprane|innönd.l|||240|ml|6|glas||N01AB07|01.09.2014||R|0|0|0|0|0|BAM|0|0|0|100|SEK|89466|116430|lyfalmen|||1|1440|0||Icepharma hf|Baxter Medical AB|Desflúran||89466||89466|116430||2|H|0|0|||0 543663|N07BA0151|Nicorette Cooldrops|munnstfl|2|mg|20|stk|1|pakki||N07BA01|01.07.2016||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|20|0|1,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 543744|R01AA0503|Nezeril|nefúði|0,5|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|7,5|0|9,3750|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1|0||0|||0 544374|L01EM0101|Zydelig|filmhtfl|150|mg|60|stk|1|glas||L01EM01|01.07.2016||R|1|0|1|0|0|GSE|0|1|0|100|DKK|540258|678441|lyfsjukr|||1|60|0|30,0000|Gilead Sience Sweden AB|Gilead Sciences Ireland|Idelalisib||540258||540258|678441||2|0|L|0|||0 544385|J06BA0208|Privigen|irl|100|mg/ml|400|ml|1|hgl||J06BA02|01.02.2014||R|0|0|0|0|0|CSB|0|1|0|100|SEK|359981|454227|lyfsjukr|||1|400|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||359981||359981|454227||2|H|L|0|||0 544429|L04AD0202|Prograf|hylki|0,5|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|1|G|0|ASP|0|0|0|100|XEU|11515|17347|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||11515||11515|17347||1|0|G|0|||0 545090|N04BC0505|Oprymea|forðatfl|2,1|mg|100|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|G|0|KNM|0|0|0|100|IKR|27126|37583|lyfalmen|||2|100|0|120,0000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||27126||27126|37583||2|0|G|0|||0 545104|L01XC0201|MabThera|stl|1400|mg|11,7|ml|1|hgl|lausn|L01XC02|01.10.2014||R|0|1|0|0|0|RRG|0|1|0|100|DKK|263752|334545|lyfsjukr|||1|11,7|0||Icepharma hf|Roche Registration GmbH|Rítúxímab||263752||263752|334545||2|H|L|0|||0 545176|G03HB0103|Cypretyl|töflur|||63|stk|1|þpakki||G03HB01|01.10.2012||R|0|1|0|0|0|RTH|0|0|0|100|XEU|1604|3317|lyfalm11|V0134|3317|2|63|0|84,0000|Alvogen|ratiopharm GmbH|Cýpróterón og östrógen||1604||1604|3317||2|0||0|||0 545554|M01AE0116|Ibuprofen Bril|filmhtfl|200|mg|20|stk|1|þpakki||M01AE01|01.11.2016||L|1|0|0|0|0|PIL|0|0|1|100|IKR|||lyflausa|||2|20|0|3,3333|Williams & Halls efh|Brillpharma (Ireland) Limited|Íbúprófen|||||||2|0||0|||0 545639|G04BD0807|Solifenacin Krka|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|3533|4664|lyfalmen|V0438|4657|2|30|0|30,0000|Krka Sverige AB|Krka d.d. Novo mesto|Sólífenacín||2300||2300|4664||2|0|G|0|||0 545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|0|0|0|0|0|GPH|0|0|1|100|DKK|877|2705|lyfalmen|||1|15|0||Vistor hf|GlaxoSmithKline Pharma A/S|Múpírócín||877||877|2705||1|0||0|||0 545705|N02AB0310|Fentanyl Alvogen|forðapl|100|mcg/klst|5|stk|1|skpoki||N02AB03|01.11.2020||R|0|0|0|G|0|RTH|0|0|0|100|XEU|5451|8211|lyfalmen|V0223|8209|2|5|0|30,0000|Alvogen|ratiopharm GmbH|Fentanýl||4877||4877|8211||2|0|G|1|30|dagar|0 545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|G|0|LBK|0|0|0|100|DKK|832|2643|lyfalmen|||1|100|0|6,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||832||832|2643||1|0|G|0|||0 545827|R06AD0203|Prometazin Actavis|filmhtfl|25|mg|100|stk|1|þpakki||R06AD02|01.07.2017||R|1|0|0|G|0|ATE|0|0|1|100|XEU|1176|2534|lyfalmen|V0903|2534|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Prómetazín||753||753|2534||1|0|G|0|||0 545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|G|0|LBK|0|0|0|100|DKK|1913|4131|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||1913||1913|4131||1|0|G|0|||0 545996|V01AA0507|Alutard SQ, birkifrjo|stl|||5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|67787|89011|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|trjáfrjó||67787||67787|89011||1|0|G|0|||0 546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|50624|67303|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|trjáfrjó||50624||50624|67303||1|0|G|0|||0 546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|||5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|59112|78038|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|grasfrjó||59112||59112|78038||1|0|G|0|||0 546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|48961|65199|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|grasfrjó||48961||48961|65199||1|0|G|0|||0 546660|N07BC0202|Metadon Abcur|töflur|5|mg|20|stk|1|þpakki||N07BC02|01.04.2020||R|1|0|0|G|0|ABC|0|0|0|100|SEK|541|2243|lyfalmen|||1|20|0|4,0000|Icepharma hf|Abcur AB|Metadón||541||541|2243||2|0|G|1|30|dagar|0 546844|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|100|stk|1|glas||A02BC04|01.10.2012||R|0|0|0|G|0|ATE|0|0|1|100|XEU|4115|4124|lyfalmen|V0010|3916|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rabeprazól||1908||1908|4124||1|0|G|0|||0 547054|A07EC0203|Pentasa Sachet|forðakyr|4|g|30|pokar|1|pakki||A07EC02|01.04.2017||R|0|0|0|G|0|FER|0|0|0|100|DKK|15161|22366|lyfalmen|||1|30|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||15161||15161|22366||1|0|G|0|||0 547094|B05BB0122|Natriumklorid B. Braun|irl|9|mg/ml|100|ml|20|glös|lausn|B05BB01|01.01.2018||R|0|0|0|0|0|RAU|0|0|1|100|XEU|3013|5645|lyfalmen|||2|2000|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||3013||3013|5645||2|0|0|0|||0 547200|C09DA0312|Valsartan/Hydroklortiazid Jubilant|filmhtfl|172,5|mg|98|stk|1|þpakki|160/12,5 mg|C09DA03|01.11.2018||R|1|0|0|G|0|JUB|0|0|0|100|IKR|4100|5765|lyfalmen|V0581|5765|2|98|0|98,0000|Acare ehf|Jubilant Pharmaceuticals nv|Valsartan og þvagræsilyf||3100||3100|5765||2|0|G|0|||0 547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|þpakki||A02BX02|01.01.1986||L|1|0|0|0|0|ORC|0|0|1|100|IKR|||lyfalmen|||0|60|0|15,0000|Vistor hf|Orion Corporation|Súkralfat|||||5334||1|0||0|||0 547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|0|0|0|0|0|RGP|0|0|0|100|DKK|9189|14146|lyfalmen|||1|100|0|0,3800|Vistor hf|GlaxoSmithKline (Ireland) Limited|Eptifibatíð||9189||9189|14146||1|H|0|0|||0 547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|0|0|0|0|0|RGP|0|0|0|100|DKK|2955|5565|lyfalmen|||1|10|0|0,1000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Eptifibatíð||2955||2955|5565||1|H|0|0|||0 547925|B05BB0214|Plasmalyte Glucos|irl|50|mg/ml|500|ml|20|pokar||B05BB02|01.09.2015||R|0|0|0|0|0|BAM|0|0|0|100|SEK|6457|10385|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar í blöndum með kol­vetnum||||6457|10385||2|0|0|0|||0 548121|L03AB0801|Betaferon|sts|250|mcg/ml|15|spr|1|pakki|+leysir|L03AB08|01.07.2013||R|0|0|1|G|0|FIN|0|0|0|100|DKK|101508|132759|lyfalmen|||1|15|0|30,0000|Icepharma hf|Bayer AG|Interferón beta-1b||101508||101508|132759||2|0|G|0|||0 548136|C07AB0704|Bisbetol|filmhtfl|5|mg|100|stk|1|þpakki||C07AB07|01.01.2017||R|0|0|0|G|0|WEH|0|0|0|100|XEU|2122|4419|lyfalmen|V1038|3092|2|100|0|50,0000|Williams & Halls efh|Williams & Halls ehf|bisoprolol||2122||2122|4419||2|0|G|0|||0 548162|M04AA0304|Aburic|filmhtfl|80|mg|28|stk|1|þpakki||M04AA03|01.03.2020||R|1|0|0|0|0|WEH|0|0|0|100|XEU|8770|9752|lyfalmen|V1011|9068|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|febuxostat||5997||5997|9752||2|0|E|0|||0 548506|D07AC1301|Elocon|húðlausn|0,1|%|30|ml|1|túpa||D07AC13|01.02.2014|30.09.2021|R|0|0|0|G|0|NVO|0|0|1|100|DKK|525|2221|lyfalmen|||1|30|0||Vistor hf|N.V. Organon|Mómetasón||525||525|2221||1|0|G|0|||0 548563|S01XA2011|Oculac|augndr|50|mg/ml|10|ml|1|glas|með rotvörn|S01XA20|01.11.2013||L|0|0|0|G|0|CLA|0|0|0|100|XEU|||lyfalmen|||0|10|0||Vistor hf|Alcon Nordic A/S|Gervitár og aðrar óvirkar samsetningar|||||2161||1|0|G|0|||0 548894|B02BC3002|TISSEEL|vefjalím|||2|ml|10|áf.spr|+ Duo sett|B02BC30|01.01.2013||R|0|0|0|0|0|BAM|0|0|0|100|SEK|146192|188333|lyfalmen|||1|20|0||Icepharma hf|Baxter Medical AB|Blöndur||146192||146192|188333||2|H|0|0|||0 549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|0|0|0|G|0|JAS|0|0|0|100|SEK|6767|10812|lyfalmen|||1|5|0|151,5152|Vistor hf|Janssen-Cilag AB|Halóperídól||6767||6767|10812||1|0|G|0|||0 549442|C10AA0704|Rosuvastatin Xiromed|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.04.2018||R|0|0|0|0|0|VAL|0|0|0|100|IKR|4950|5283|lyfalmen|V0117|4870|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||2750||2750|5283||2|0|E|0|||0 549545|QM01AE0301|Romefen vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.2020||R|0|0|0|0|0|CES|1|0|0|100|DKK|4224|8184|vetalmen|||0|100|0||Icepharma hf|Ceva Sante Animale|Ketóprófen||4224||4224|8184||2|0||0|||0 549674|B01AF0101|Xarelto|filmhtfl|15|mg|98|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|G|0|FIN|0|0|0|100|DKK|30238|41519|lyfalmen|V0976|41208|1|98|0|73,5000|Icepharma hf|Bayer AG|Rivaoxaban||||30238|41519||2|0|G|0|||0 550111|S01AA0102|Oftan Chlora|augnsm|10|mg/g|3,5|g|1|túpa||S01AA01|01.02.2018||R|0|0|0|G|0|SAO|0|0|1|100|XEU|896|2731|lyfalmen|||2|3,5|0||Icepharma hf|Santen Oy|Klóramfeníkól||896||896|2731||2|0|G|0|||0 550147|QN01BB0201|Lidor vet.|stl|20|mg/ml|50|ml|1|hgl|lausn|QN01BB02|01.05.2019||R|0|0|0|0|0|RPG|1|0|0|100|XEU|1269|2494|vetalmen|||0|50|0||Icepharma hf|Richter Pharma AG|Lidocaine||1269||1269|2494||2|0||0|||0 550256|J02AC0102|Candizol|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1479|2110|lyfalmen|V0551|2110|2|7|0|1,7500|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúkónazól||445||445|2110||1|0|E|0|||0 550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|60|0|0,4800|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||||1|0||0|||0 550731|N02BE0103|Panodil Junior|eþ-stíll|125|mg|10|stk|1|þpakki||N02BE01|01.05.2019||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|10|0|0,4167|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||||1|0||0|||0 550803|A10BX0204|Repaglinide Krka|töflur|1|mg|120|stk|1|þpakki||A10BX02|01.11.2013||R|1|0|0|G|0|KNM|0|0|0|100|IKR|2518|4964|lyfalmen|V0471|4964|2|120|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2518||2518|4964||2|0|G|0|||0 551043|B01AC0701|Persantin|húðuðtfl|100|mg|100|stk|1|þpakki||B01AC07|01.05.2014||R|1|0|0|G|0|GGM|0|0|0|100|NOK|2874|5454|lyfalmen|||1|100|0|25,0000|Glenwood GmbH P. Erzeugnisse|Glenwood GmbH P. Erzeugnisse|Dípýrídamól||2874||2874|5454||2|0|G|0|||0 551328|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.06.2013||L|0|0|0|0|0|TEA|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Laboratories THEA|Ketotifen|||||||1|0||0|||0 551388|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.08.2012||R|0|0|0|0|0|BAM|0|0|0|100|SEK|7487|11803|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Mannitól||7487||7487|11803||2|H|0|0|||0 551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|0|0|0|G|0|MEA|0|0|1|100|DKK|1555|3638|lyfalmen|||1|1|0|2,6667|Icepharma hf|Meda AB|Tríamcínólón||1555||1555|3638|30.9.2021|2|0|G|0|||0 551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|þpakki||M01AX01|01.04.1995||R|1|0|0|G|0|MEA|0|0|1|100|DKK|4799|8103|lyfalmen|||1|100|0|50,0000|Icepharma hf|Meda AB|Nabúmeton||4799||4799|8103||2|0|G|0|||0 551683|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|þpakki||N07BA03|01.06.2021||R|0|0|0|0|0|PEU|0|0|1|100|DKK|19532|28382|lyfalmen|V1050|28382|1|112|0|56,0000|Icepharma hf|Pfizer Europe MA EEIG|Vareniclin||||19532|28382||1|0||0|||0 551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|EIS|0|0|1|100|IKR|1812|2276|lyfalmen|||1|28|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|2276||1|0|E|0|||0 551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|EIS|0|0|1|100|IKR|2691|3966|lyfalmen|V0467|2772|1|56|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3966||1|0|E|0|||0 551904|L01XC0204|Rixathon|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.05.2020||R|0|1|0|0|0|HSS|0|1|0|100|DKK|52524|69706|lyfsjukr|||2|20|0||Artasan ehf|Sandoz GmbH|Rítúxímab||52524||52524|69706||1|H|L|0|||0 551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|EIS|0|0|1|100|IKR|2821|2276|lyfalmen|V0003|2178|1|28|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|2276||1|0|E|0|||0 551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|EIS|0|0|1|100|IKR|5587|3966|lyfalmen|V0010|2193|1|56|0|56,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3966||1|0|E|0|||0 552328|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|BAM|0|0|1|100|SEK|1605|3707|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1605||1605|3707||2|0|0|0|||0 552377|M01AE0102|Ibufen|filmhtfl|400|mg|50|stk|1|glas||M01AE01|01.11.2012||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Íbúprófen|||||||1|0||0|||0 552648|C07AB0215|Metoprolol Alvogen|forðatfl|23,75|mg|100|stk|1|þpakki||C07AB02|01.01.2021||R|1|0|0|G|0|GOV|0|0|0|100|XEU|1052|2510|lyfalmen|V0050|2510|2|100|0|15,8333|Alvogen|Alvogen ehf|Metóprólól||735||735|2510||2|0|G|0|||0 552764|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|100|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|QAS|0|0|0|100|GBP|16222|26150|veteldis|||0|100|0||PHARMAQ Ltd.|PHARMAQ AS|Tricaine Methane Sulfónat||16222||16222|26150||1|0||0|||0 552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|þpakki||N03AF02|01.10.2000||R|1|0|0|G|0|HES|0|0|0|100|DKK|3060|5710|lyfalmen|||1|100|0|15,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||3060||3060|5710||1|0|G|0|||0 552913|QJ01GB0301|Genta-Equine|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01GB03|01.01.2019||R|0|0|0|0|0|FRA|1|0|0|100|IKR|3657|7109|vetalmen|||0|100|0||Dýraheilsa ehf|Franklin Pharmaceuticals Ltd.|Gentamicin||3657||3657|7109||2|0||0|||0 553076|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|50|ml|10|glas|lausn|V08CA02|01.10.2017||R|0|0|0|0|0|GEH|0|0|0|100|NOK|168050|215518|lyfalmen|||1|500|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||168050||168050|215518||2|H|0|0|||0 553206|N02CC0601|Relpax|filmhtfl|40|mg|18|stk|1|þpakki||N02CC06|01.08.2009||R|1|0|0|G|0|UPJ|0|0|0|100|DKK|6112|9910|lyfalmen|V0237|9910|1|18|0|18,0000|Icepharma hf|Upjohn EESV|Eletriptan||||6112|9910||1|0|G|0|||0 553339|N02CC0601|Relpax|filmhtfl|40|mg|6|stk|1|þpakki||N02CC06|01.10.2001||R|1|0|0|G|0|UPJ|0|0|0|100|DKK|2308|4675|lyfalmen|V0237|3303|1|6|0|6,0000|Icepharma hf|Upjohn EESV|Eletriptan||2308||2308|4675||1|0|G|0|||0 553382|R06AD0102|Alimemazin Evolan|hylki|20|mg|100|stk|1|glas|hart|R06AD01|01.09.2018||R|1|0|0|G|0|EVO|0|0|1|100|IKR|5684|9321|lyfalmen|||2|100|0|66,6667|LYFIS ehf|Evolan Pharma AB|Alímemazín||5684||5684|9321||2|0|G|0|||0 553387|J01CR0205|Spectracillin|filmhtfl|1000|mg|14|stk|1|þpakki|875+125 mg|J01CR02|01.12.2018||R|0|0|0|0|0|WEH|0|0|1|100|IKR|1430|2599|lyfalmen|V0169|2599|2|14|0|8,1667|Williams & Halls efh|Williams & Halls ehf|Amoxicillín og beta-laktamasa hemill||800||800|2599||2|0||0|||0 553555|J07BX0307|COVID-19 Vaccine AstraZeneca (Vaxzevria)|stl|||5|ml|10|hgl|hvert hgl.10x0,5ml sk.|J07BX03|01.03.2021||R|0|0|0|0|0|AZE|0|0|0|100|IKR|||lyfalmen|||1|50|0||Vistor hf|AstraZeneca AB|Covid-19 vaccines|||||||1|0||0|||0 553580|QN01BB0202|BelOcain vet.|stl|20|mg/ml|100|ml|12|hgl|lausn|QN01BB02|01.06.2019||R|0|0|0|0|0|Bel|1|0|0|100|IKR|15300|24075|vetalmen|||0|1200|0||Icepharma hf|Bela-Pharma GmbH & CO KG|Lidocaine||12600||12600|24075||2|0||0|||0 553720|L01EJ0101|Jakavi|töflur|15|mg|56|stk|1|þpakki||L01EJ01|01.02.2014||R|1|0|1|0|0|NEL|0|1|0|100|DKK|435071|547618|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||435071||435071|547618||1|0|L|0|||0 554131|L01XC0303|Trazimera|st/irþ|150|mg|150|mg|1|hgl||L01XC03|01.04.2020||R|0|0|0|0|0|PEU|0|1|0|100|DKK|83842|109317|lyfsjukr|||1|150|0||Icepharma hf|Pfizer Europe MA EEIG|Trastuzumab||83842||83842|109317||1|H|L|0|||0 554154|QA12CE9902|Selevitan, vet.|stl|||100|ml|5|hgl||QA12CE99|01.05.1983||R|0|0|0|0|0|BID|1|0|0|100|DKK|9442|18084|vetalmen|||0|500|0||Vistor hf|Boehringer Ingelheim Danmark|Selen blöndur||9442||9442|18084||1|0||0|||0 554441|N02AA0508|Oxycodone Alvogen|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.12.2020||R|1|0|0|G|0|GOV|0|0|0|100|XEU|19307|28072|lyfalmen|V0588|28072|2|98|0|104,5300|Alvogen|Alvogen ehf|Oxýcódon||19307||19307|28072||2|0|G|1|30|dagar|0 554582|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|100|stk|1|glas||B01AC04|01.11.2013||R|1|0|0|G|0|ATE|0|0|0|100|XEU|6308|5759|lyfalmen|V0029|5759|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klópídógrel||3096||3096|5759||1|0|G|0|||0 554720|L04AX0601|Imnovid|hylki|3|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|1|0|0|BSE|0|1|0|100|DKK|1231184|1537759|lyfsjukr|||1|21|0|21,0000|Celgene Europe ltd|Bristol-Myers Squibb Pharma EEIG|Pomalidómide||1231184||1231184|1537759||2|0|L|0|||0 555196|L04AC1001|Cosentyx|stl|150|mg|2|áf-penni|1|pakki||L04AC10|01.07.2015||R|0|0|1|0|0|NEL|0|1|0|100|DKK|163916|210377|lyfsjukr|||1|2|0|30,0000|Vistor hf|Novartis Europharm Ltd|Secukinumab||163916||163916|210377||1|0|L|0|||0 555235|N05AB0303|Peratsin|húðuðtfl|4|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|G|0|COR|0|0|0|100|DKK|1586|3681|lyfalmen|||2|100|0|13,3300|Vistor hf|Orion Corporation|Perfenazín||1586||1586|3681||1|0|G|0|||0 555268|N05AB0303|Peratsin|húðuðtfl|8|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|G|0|COR|0|0|0|100|DKK|2207|4536|lyfalmen|||2|100|0|26,6700|Vistor hf|Orion Corporation|Perfenazín||2207||2207|4536||1|0|G|0|||0 555292|N05AB0303|Peratsin|húðuðtfl|2|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|G|0|COR|0|0|0|100|DKK|1128|3050|lyfalmen|||2|100|0|6,6700|Vistor hf|Orion Corporation|Perfenazín||1128||1128|3050||1|0|G|0|||0 556146|J01FF0104|Clindamycin EQL Pharma|hylki|300|mg|21|stk|1|þpakki||J01FF01|01.05.2019||R|1|0|0|0|0|EQL|0|0|1|100|IKR|2011|3563|lyfalmen|V0461|3563|2|21|0|5,2500|LYFIS ehf|EQL Pharma AB|Klindamýcín||1500||1500|3563||2|0|E|0|||0 556242|QD07XB0202|Recicort|eyrnadr|||20|ml|1|dropaí|1,77+17,7 mg/ml|QD07XB02|01.12.2017||R|0|0|0|0|0|BVL|0|0|0|100|IKR|1328|2610|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet B.V.|Triamcinolon||||1328|2610||2|0||0|||0 556578|N02BE5106|Panodil Extra|filmhtfl|565|mg|20|stk|1|þpakki|500+65 mg|N02BE51|01.12.2019||L|1|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)|||||||1|0|0|0|||0 556694|C10AX1401|Praluent|stl|150|mg/ml|2|áf-penni|1|pakki|lausn í áf.lyfjapenna|C10AX14|01.02.2016||R|0|0|0|0|0|SGB|0|0|0|100|XEU|69701|91431|lyfalmen|||1|2|0|55,5556|Vistor hf|Sanofi-aventis groupe|Alirocumab||69701||69701|91431||1|0|E|0|||0 556903|C10AX0904|Ezetimib Medical Valley|töflur|10|mg|100|stk|1|þpakki||C10AX09|01.07.2018||R|0|0|0|0|0|VAL|0|0|0|100|DKK|11259|6569|lyfalmen|V0954|6205|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Ezetimíb||3684||3684|6569||2|0|E|0|||0 556921|H01AC0104|Saizen|sts|5,83|mg/ml|1,03|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|1|0|0|MEC|0|1|0|100|SEK|18799|27373|lyfsjukr|||1|1,03|0|9,0000|Icepharma hf|Merck AB|Sómatrópín||18799||18799|27373||2|0|L|0|||0 556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|1|0|0|G|0|HES|0|0|0|100|DKK|4637|7880|lyfalmen|V0972|6921|1|100|0|30,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||4637||4637|7880||1|0|G|0|||0 556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|1|0|0|G|0|HES|0|0|0|100|DKK|9699|14848|lyfalmen|V0973|12066|1|100|0|60,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||9699||9699|14848||1|0|G|0|||0 557073|N06BA0903|Atomoxetin Medical Valley|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|VAL|0|0|0|100|XEU|10140|3284|lyfalmen|V0814|2940|2|28|0|8,7500|Acare ehf|Medical Valley Invest AB|Atomoxetín||1298||1298|3284||2|0|E|0|||0 557239|R03AK0606|Salmeterol/Fluticasone Neutec|innönddu|300|mcg/sk|60|skammtar|1|innö.t|50/250 mcg/sk|R03AK06|01.05.2021||R|0|0|0|G|0|NET|0|0|0|100|DKK|3918|5862|lyfalmen|V0437|5862|2|60|0|30,0000|Lyfjaver ehf|Neutec Inhaler Ireland Limited|Salmeteról og fluticason||3171||3171|5862||3|0|G|0|||0 557907|N02BE0109|Panodil Hot|mixtduft|500|mg|10|skammtar|1|pakki||N02BE01|01.10.2014||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|10|0|1,6700|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||||1|0||0|||0 557980|M01AH0105|Cloxabix|hylki|100|mg|20|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|G|0|WEH|0|0|1|100|XEU|1360|3370|lyfalmen|||2|20|0|10,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||1360||1360|3370||2|0|G|0|||0 558386|N01BB2001|Emla|plástur|||20|stk|1|pakki|25mg+25mg/plástur|N01BB20|01.07.2020||L|0|0|0|0|0|MAR|0|0|0|100|DKK|||lyfalmen|||1|20|0||Icepharma hf|Aspen Pharma|Blöndur|||||8845||2|0||0|||0 558417|L01EA0401|Bosulif|filmhtfl|400|mg|28|stk|1|þpakki||L01EA04|01.03.2019||R|1|0|1|0|0|PEU|0|1|0|100|DKK|493410|620175|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|Bosutinib||493410||493410|620175||1|0|L|0|||0 558770|L04AA2701|Gilenya|hylki|0,5|mg|28|stk|1|þpakki||L04AA27|01.09.2011||R|0|1|1|0|0|NEL|0|1|0|100|DKK|220021|280156|lyfsjukr|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||220021|280156||1|0|L|0|||0 558892|N07BA0151|Nicorette Cooldrops|munnstfl|2|mg|160|stk|1|pakki|8 x 20 stykki|N07BA01|01.07.2016||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|160|0|10,6700|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0 559165|M02AA1505|Voltaren Forte|hlaup|23,2|mg/g|100|g|1|túpa||M02AA15|01.06.2020||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|100|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Díklófenak|||||||1|0||0|||0 559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||||2|0||0|||0 559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||||2|0||0|||0 559618|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|0|0|0|G|0|PLS|0|0|0|100|DKK|4441|7611|lyfalmen|||1|1|0|90,0000|Icepharma hf|Pfizer ApS|Estradíól||4441||4441|7611||1|0|G|0|||0 560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|0|0|0|G|0|HEG|0|0|0|100|XEU|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar samsetningar|||||1920||1|0|G|0|||0 560085|L01CD0105|Abraxane|irs|5|mg/ml|100|mg|1|hgl||L01CD01|01.05.2016||R|0|0|0|0|0|BMS|0|1|0|100|DKK|38349|51777|lyfsjukr|||1|100|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Paklítaxel||38349||38349|51777||2|H|L|0|||0 560293|L01XK0101|Lynparza|filmhtfl|100|mg|56|stk|1|þpakki||L01XK01|01.03.2020||R|0|0|1|0|0|AZA|0|1|0|100|SEK|364961|460421|lyfsjukr|||1|56|0||Vistor hf|AstraZeneca AB|Olaparib||364961||364961|460421||1|0|L|0|||0 560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|2|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Acíklóvír|||||||1|0||0|||0 560490|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|0|0|0|0|0|COR|0|0|0|100|DKK|104985|137083|lyfalmen|||1|5|0|1,1400|Vistor hf|Orion Corporation|Levosimendan||104985||104985|137083||1|H|0|0|||0 560682|L01EA0102|Imatinib Accord|filmhtfl|400|mg|30|stk|1|þpakki||L01EA01|01.09.2017||R|0|0|1|0|0|ACC|0|1|0|100|XEU|163028|116644|lyfsjukr|||2|30|0||Artasan ehf|Accord Healthcare Limited|Imatinib||89635||89635|116644||1|0|L|0|||0 560982|M04AA0305|Febuxostat Krka|filmhtfl|80|mg|28|stk|1|þpakki||M04AA03|01.07.2021||R|1|0|0|0|0|KAN|0|0|0|100|IKR|6000|9068|lyfalmen|V1011|9068|2|28|0|28,0000|Krka Sverige AB|Krka d.d. Novo mesto|febuxostat||5500||5500|9068||2|0|E|0|||0 561022|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1|0||0|||0 561239|L01EL0101|IMBRUVICA|filmhtfl|420|mg|28|stk|1|þpakki||L01EL01|01.04.2020||R|1|0|1|0|0|JCI|0|1|0|100|SEK|711218|891067|lyfsjukr|||1|28|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||711218||711218|891067||1|0|L|0|||0 561745|R03AL0601|Spiolto Respimat|innöndl|5|mcg|1|rörlyk|1|pakki|innöndunartæki og 1 áfylling|R03AL06|01.08.2019||R|0|0|0|G|0|BOE|0|0|0|100|DKK|6122|9924|lyfalmen|||1|1|0||Vistor hf|Boehringer Ingelheim International GmbH|Olodaterol og tiotropiumbromide||6122||6122|9924||1|0|G|0|||0 561780|C02KX0501|Adempas|filmhtfl|1,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|0|BRE|0|1|0|100|DKK|187545|239765|lyfsjukr|||1|42|0|14,0000|Vistor hf|Bayer AG|Riociguatum||187545||187545|239765||1|0|L|0|||0 562014|C09BA0201|Darazið|töflur|32,5|mg|100|stk|1|þpakki|20+12,5 mg|C09BA02|01.06.2011||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1579|3015|lyfalmen|V0098|2583|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Enalapríl og þvagræsilyf||1102||1102|3015||1|0|G|0|||0 562176|B02BD0401|BeneFIX|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD04|01.02.2013||R|0|0|1|0|0|PEU|0|1|0|100|DKK|47359|63173|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Faktor IX||47359||47359|63173||1|0|L|0|||0 562254|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|90|sk-hyl|án rotvarnarefnis|S01EE01|01.03.2013||R|0|0|0|G|0|TEA|0|0|0|100|SEK|4105|7148|lyfalmen|||1|18|0|90,0000|Vistor hf|Laboratories THEA|Latanóprost||4105||4105|7148||1|0|G|0|||0 562419|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.01.2019||R|0|1|0|0|0|FEC|0|1|0|100|XEU|905607|1132833|lyfsjukr|||1|20|0|11,6300|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||905607||905607|1132833||2|H|L|0|||0 562668|L04AA2601|Benlysta|irs|400|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|0|0|RGP|0|1|0|100|DKK|71672|93924|lyfsjukr|||1|1|0|16,0000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Belimumab||71672||71672|93924||1|H|L|0|||0 563192|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|10|ml|10|áfspr|lausn,áf.spr.|V08CA02|01.10.2017||R|0|0|0|0|0|GEH|0|0|0|100|NOK|33610|45784|lyfalmen|||1|100|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||33610||33610|45784||2|H|0|0|||0 563502|N02AA0101|Contalgin|forðatfl|5|mg|100|stk|1|þpakki||N02AA01|01.10.1993||R|1|0|0|G|0|MDI|0|0|0|100|DKK|1314|3307|lyfalmen|||1|100|0|5,0000|Icepharma hf|Mundipharma A/S|Morfín||1314||1314|3307||2|0|G|1|30|dagar|0 563527|H05BX0102|Cinacalcet WH|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|WEH|0|0|0|100|XEU|22687|8458|lyfalmen|V0720|8242|2|28|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||5057||5057|8458||2|0||0|||0 563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|0|0|0|G|0|SAO|0|0|0|100|XEU|3553|6388|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||||3553|6388||2|0|G|0|||0 563730|QJ01CE9003|Penethaone vet.|sts|5|m.ae/hgl|1|hgl|1|pakki|+leysir|QJ01CE90|01.03.2016||R|0|0|0|0|0|DIV|0|0|0|100|IKR|1398|2748|vetalmen|||0|1|0||Dýraheilsa ehf|Divasa-Farmavic S.A.|Penetamathýdrójoðíð||||1398|2748||2|0||0|||0 563756|H01CB0501|Signifor|stl|0,3|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|ROD|0|0|0|100|DKK|437397|550511|lyfalmen|||1|60|0|15,0000|Recordati AB|Recordati Rare Diseases|PAsireótið disapartate||437397||437397|550511||1|0|E|0|||0 563899|QP54AA0105|Noromectin|áhella|0,5|% w/v|1000|ml|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|NIL|0|0|0|100|IKR|10463|18034|vetorma|||0|1000|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Limited|Ivermectinum||10463||10463|18034||2|0||0|||0 563905|J02AC0106|Fungyn|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.01.2017||L|1|0|0|0|0|GOV|0|0|1|100|IKR|||lyflausa|||2|1|0|0,7500|Alvogen|Alvogen ehf|Flúkónazól|||||||2|0||0|||0 564048|J07BA0103|TicoVac|stl|2,4|mcg/sk|0,5|ml|1|áfspr|bóluefni|J07BA01|01.06.2019||R|0|0|0|0|0|PLS|0|0|0|100|DKK|3523|6347|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Aps|Heilabólguveira óvirk, borin með blóðmaur||3523||3523|6347||1|0||0|||0 564124|N06DA0405|Galantamin STADA|forðahlk|8|mg|30|stk|1|þpakki|Hart forðahylki|N06DA04|01.04.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|3200|5902|lyfalmen|||2|30|0|15,0000|LYFIS ehf|STADA Arzneimittel AG|Galantamín||3200||3200|5902||2|0|G|0|||0 564270|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|1|0|0|TMA|0|1|0|100|DKK|19157|27866|lyfsjukr|||1|1|0||Lyfjaver ehf|Takeda Manufacturing Austria AG|Storkuþáttur VIII||19157||19157|27866||3|0|L|0|||0 564441|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|glas||R06AX27|01.11.2012||R|1|0|0|G|0|NVO|0|0|1|100|DKK|845|2661|lyfalmen|||1|120|0|12,0000|Vistor hf|N.V. Organon|Deslóratadín||845||845|2661||1|0|G|0|||0 564448|C08CA0105|Amlodipin Bluefish|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.05.2020||R|1|0|0|G|0|BLS|0|0|0|100|XEU|1400|2605|lyfalmen|V0056|2229|2|100|0|100,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Amlódipín||804||804|2605||1|0|G|0|||0 564827|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|9 mg/2 mg|QP54AB51|01.04.2018|31.08.2021|R|0|0|0|0|0|BIV|0|0|0|100|XEU|2216|3819|vetorma|||0|3|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Milbemycin oxime í blöndum||2216||2216|3819||1|0||0|||0 565251|A10BJ0602|Rybelsus|töflur|14|mg|30|stk|1|þpakki||A10BJ06|01.12.2020||R|0|0|0|0|0|NAS|0|0|0|100|DKK|21171|30051|lyfalmen|||1|30|0||Vistor hf|Novo-Nordisk A/S|Semaglutide||21171||21171|30051||1|0|E|0|||0 565303|C01CA0303|Noradrenalina Normon|irþ|1|mg/ml|10|ml|100|lykjur|lausn|C01CA03|01.04.2019||R|0|0|0|0|0|LNA|0|0|0|100|XEU|264572|335565|lyfalmen|||2|1000|0|166,6667|Williams & Halls efh|Laboratorios Normon, S.A.|Noradrenalín||264572||264572|335565||2|H|0|0|||0 565400|N05AH0411|Quetiapine Teva|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2014||R|1|0|0|G|0|TSA|0|0|0|100|IKR|8782|6109|lyfalmen|V0286|5627|2|100|0|50,0000|Alvogen|Teva Sweden AB|Quetíapín||3350||3350|6109||2|0|G|0|||0 565685|QA04AD9001|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.04.2015||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|8233|15790|vetalmen|||0|20|0||Icepharma hf|Zoetis Belgium S.A.|maropitant||||8233|15790||2|0||0|||0 565921|C07AB0213|Metoprololsuccinat Hexal|forðatfl|100|mg|100|stk|1|glas|95 mg metoprololsuccinat|C07AB02|01.12.2019||R|1|0|0|G|0|SSA|0|0|0|100|DKK|2170|4168|lyfalmen|V0049|2910|2|100|0|66,6667|Artasan ehf|Hexal A/S|Metóprólól||1940||1940|4168||1|0|G|0|||0 565982|H01BA0401|Glypressin|stl|0,1|mg/ml|8,5|ml|5|lykjur|lausn|H01BA04|01.08.2012||R|0|0|0|0|0|FEL|0|0|0|100|DKK|22751|32049|lyfalmen|||1|42,5|0|0,3600|Vistor hf|Ferring Lægemidler A/S|Terlípressín||22751||22751|32049||1|H|0|0|||0 566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|0|0|0|G|0|NEL|0|0|0|100|DKK|1456|3502|lyfalmen|||1|5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Brinzólamíð||1456||1456|3502||1|0|G|0|||0 566924|R03AK0705|Bufomix Easyhaler|innönddu|164,5|mcg/sk|120|skammtar|3|innö.t|160+4,5 mcg/sk|R03AK07|01.11.2014||R|0|0|0|G|0|COR|0|0|0|100|DKK|14084|20883|lyfalmen|||2|360|0|90,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||14084||14084|20883||1|0|G|0|||0 567028|L01EH0101|Tyverb|filmhtfl|250|mg|84|stk|1|glas||L01EH01|01.02.2012||R|1|0|1|0|0|NEL|0|1|0|100|DKK|175106|224294|lyfsjukr|||1|84|0||Vistor hf|Novartis Europharm Ltd|Lapatinib||175106||175106|224294||1|0|L|0|||0 567332|C10AA0508|Lipistad|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|G|0|ASR|0|0|0|100|IKR|3587|2806|lyfalmen|V0114|2736|2|100|0|200,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||950||950|2806||2|0|G|0|||0 567371|M05BA0306|Pamidronatdinatrium Pfizer|irþ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.02.2019||R|0|1|0|0|0|PLS|0|0|0|100|DKK|5887|9601|lyfalmen|||2|10|0|1,5000|Icepharma hf|Pfizer ApS|Pamídrónsýra||5887||5887|9601||1|H|0|0|||0 567400|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.06.2015||L|0|0|0|G|0|AEP|0|0|0|100|DKK|||lyfalmen|||0|15|0|75,0000|Icepharma hf|Aspen Pharma Trading Limited|Estríól|||||3261||2|0|G|0|||0 567460|C01CA2407|Jext|stl|150|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|1|0|G|0|ALK|0|0|1|100|DKK|5520|9096|lyfalmen|||1|1|0|0,3000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5520|9096||1|0|G|0|||0 567461|D07AC1702|Flutivate|smyrsli|0,005|%|100|g|1|túpa||D07AC17|01.12.2017||R|0|0|0|G|0|GPH|0|0|1|100|DKK|1971|4211|lyfalmen|||1|100|0||Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||1971||1971|4211||1|0|G|0|||0 567503|N05AX0801|Risperdal|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|1|0|0|G|0|JAS|0|0|0|100|SEK|2574|5041|lyfalmen|V0291|2393|1|60|0|12,0000|Vistor hf|Janssen-Cilag AB|Risperídón||2574||2574|5041||1|0|G|0|||0 567510|C07AG0101|Trandate|filmhtfl|200|mg|100|stk|1|glas||C07AG01|01.06.2013||R|1|0|0|G|0|AEP|0|0|0|100|DKK|3377|6146|lyfalmen|||1|100|0|33,3333|Icepharma hf|Aspen Pharma Trading Limited|Labetalól||3377||3377|6146||2|0|G|0|||0 567545|R01AC0201|Livostin|nefúði|0,5|mg/úðask|15|ml|1|glas||R01AC02|01.06.1998||L|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0|12,5000|Vistor hf|McNeil Sweden AB|Levókabastín|||||||1|0||0|||0 567802|L04AX0501|Esbriet|filmhtfl|267|mg|252|stk|1|þpakki||L04AX05|01.11.2017||R|1|1|1|0|0|RRG|0|0|0|100|DKK|337317|426039|lyfalmen|||1|252|0|28,0300|Icepharma hf|Roche Registration GmbH|Pírfenidon||||337317|426039||2|0|E|0|||0 567805|M01AE0116|Ibuprofen Bril|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.11.2016||L|1|0|0|0|0|PIL|0|0|1|100|IKR|||lyflausa|||2|30|0|10,0000|Williams & Halls efh|Brillpharma (Ireland) Limited|Íbúprófen|||||||2|0||0|||0 567980|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 568054|N02CD0101|Aimovig|stl|70|mg|1|ml|1|áfpen||N02CD01|01.12.2018||R|0|0|1|0|0|NEL|0|0|0|100|DKK|65884|86604|lyfalmen|||1|1|0|28,0000|Vistor hf|Novartis Europharm Ltd|Erenumab||65884||65884|86604||1|0|E|0|||0 568324|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.04.2019||R|0|0|0|0|0|LHS|0|0|0|100|XEU|6152|10604|vetbolu|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Escherichia bóluefni + Clostridium bóluefni||6152||6152|10604||2|0|0|0|||0 568413|QN01AX0305|Ketabel vet.|stl|100|mg/ml|10|ml|1|hgl|lausn|QN01AX03|01.04.2021||R|0|0|0|0|0|Bel|1|0|0|100|XEU|1584|3113|vetalmen|||0|10|0||Icepharma hf|Bela-Pharma GmbH & CO KG|Ketaminum||1584||1584|3113||2|0|0|1|30|dagar|0 568478|M01AH0502|Coxient|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|ZET|0|0|1|100|IKR|2446|4044|lyfalmen|V0826|3647|2|28|0|42,0000|Alvogen|Zentiva, k.s.|Etoríkoxíb||1850||1850|4044||2|0|G|0|||0 568708|N06AX1613|Venlafaxin Medical Valley|forðatfl|75|mg|100|stk|1|glas||N06AX16|01.10.2017||R|0|0|0|G|0|VAL|0|0|0|100|XEU|2795|2872|lyfalmen|V0334|2598|2|100|0|75,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||998||998|2872||2|0|G|0|||0 568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|0|0|0|0|0|GPH|0|0|1|100|DKK|979|2845|lyfalmen|||1|3|0||Vistor hf|GlaxoSmithKline Pharma A/S|Mupirocin||979||979|2845||1|0||0|||0 568745|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC05|01.02.2020||L|1|0|0|0|0|ATE|0|0|0|100|IKR|||lyflausa|||2|28|0|18,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Esómeprazól|||||||1|0|0|0|||0 568840|C08CA0201|Feldil|forðatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2450|2709|lyfalmen|V0058|2709|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Felódipín||880||880|2709||1|0|G|0|||0 568865|C08CA0201|Feldil|forðatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3716|3330|lyfalmen|V0059|3130|2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Felódipín||1331||1331|3330||1|0|G|0|||0 569171|H02AB0609|Prednisolon EQL Pharma|töflur|5|mg|25|stk|1|þpakki||H02AB06|01.02.2019||R|1|0|0|G|0|EQL|0|0|1|100|IKR|759|2543|lyfalmen|||2|25|0|12,5000|LYFIS ehf|EQL Pharma AB|Prednisólón||759||759|2543||2|0|G|0|||0 569174|M01AH0503|Coxerit|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|WEH|0|0|1|100|IKR|776|2186|lyfalmen|V0827|2186|2|7|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||500||500|2186||2|0|G|0|||0 569257|J05AR1301|Triumeq|filmhtfl|950|mg|30|stk|1|glas|50+600+300 mg|J05AR13|01.12.2014||R|0|0|1|0|0|VIC|0|1|0|100|DKK|124231|161020|lyfsjukr|||1|30|0||Vistor hf|ViiV Healthcare BV|Abacavír, dolutegravír og lamivudín||124231||124231|161020||1|0|L|0|||0 569378|L01AA0601|Holoxan|sts/irs|2000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|0|0|BAM|0|0|0|100|SEK|10236|15587|lyfalmen|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||10236||10236|15587||2|H|0|0|||0 569422|A02BC0114|Omeprazol Medical Valley|sþ-hylki|40|mg|100|stk|1|glas|hart|A02BC01|01.07.2016||R|1|0|0|G|0|VAL|0|0|1|100|IKR|4800|2874|lyfalmen|V0001|2874|2|100|0|200,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||1000||1000|2874||2|0|G|0|||0 569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|1|0|0|HES|0|0|0|100|DKK|12842|19174|lyfalmen|||1|5|0|18,1800|Vistor hf|Novartis Healthcare A/S|Baklófen||12842||12842|19174||1|0|0|0|||0 569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|1|0|0|HES|0|0|0|100|DKK|14767|21823|lyfalmen|||1|20|0|18,1800|Vistor hf|Novartis Healthcare A/S|Baklófen||14767||14767|21823||1|0|0|0|||0 569514|N06AX2105|Duloxetin Krka|sþ-hylki|30|mg|100|stk|1|þpakki||N06AX21|01.02.2017||R|0|0|0|G|0|KNM|0|0|0|100|IKR|4602|5971|lyfalmen|V0811|5162|2|100|0|50,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||3250||3250|5971||2|0|G|0|||0 570106|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|15|mg|100|stk|1|þpakki|10+5 mg|N02AA55|01.11.2019||R|1|0|0|0|0|GOV|0|0|0|100|DKK|10026|13682|lyfalmen|V1005|13682|2|100|0|13,3333|Alvogen|Alvogen ehf|Oxycodonum í blöndum||8852||8852|13682||2|0|E|1|30|dagar|0 570122|M09AX1001|Evrysdi|mixtduft|0,75|mg/ml|80|ml|1|glas|lausn|M09AX10|01.10.2021||R|0|0|1|0|0|RRG|0|1|0|100|DKK|1217429|1520652|lyfsjukr|||1|80|0||Icepharma hf|Roche Registration GmbH|Risdiplam||1217429||1217429|1520652||2|0|L|0|||0 570227|QN02BG9102|Librela|stl|15|mg|1|ml|2|hgl||QN02BG91|01.08.2021||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|11915|22776|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Bedinvetmab||11915||11915|22776||2|0||2|||0 570272|C10AA0104|Simvastatin Alvogen|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.07.2017||R|1|0|0|G|0|GOV|0|0|0|100|XEU|3638|2602|lyfalmen|V0110|2602|2|100|0|133,3333|Alvogen|Alvogen ehf|Simvastatín||802||802|2602||2|0|G|0|||0 570421|L04AX0306|Metojectpen|stl|10|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|2422|4832|lyfalmen|||1|1|0|4,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2422||2422|4832||2|0|G|0|||0 570649|N04BA0207|Sinemet depot mite|forðatfl|125|mg|100|stk|1|þpakki|25+100 mg|N04BA02|01.02.2018||R|1|0|0|G|0|NVO|0|0|0|100|DKK|2286|4644|lyfalmen|||1|100|0|16,6667|Vistor hf|N.V. Organon|Levódópa og dópadekarboxýl­asa­hemill||2286||2286|4644||1|0|G|0|||0 570775|M01AH0108|Celecoxib Medical|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.05.2018||R|1|0|0|G|0|DIC|0|0|1|100|IKR|3584|6431|lyfalmen|V0196|6059|2|100|0|100,0000|LYFIS ehf|Medical ehf|Celekoxíb||3584||3584|6431||2|0|G|0|||0 571030|QM01AA9001|Danilon equidos|kyrni|1,5|g|10|g|18|pokar||QM01AA90|01.07.2014||R|0|0|0|0|0|EST|0|0|0|100|DKK|3225|6289|vetalmen|||0|180|0||Vistor hf|Laboratorios Dr. ESTEVE S.A.|Suxibuzone||3225||3225|6289||1|0||0|||0 571063|R06AX2707|Dasselta|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.09.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|650|2048|lyfalmen|V0908|2048|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Deslóratadín||400||400|2048||2|0|G|0|||0 571158|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|15|stk|1|þpakki||A04AA01|01.12.2015||R|1|0|0|G|0|BLS|0|0|1|100|XEU|3363|6127|lyfalmen|V0384|4878|2|15|0|7,5000|Artasan ehf|Bluefish Pharmaceuticals AB|Ondansetrón||3363||3363|6127||1|0|G|0|||0 571181|R07AA0201|Curosurf|innönddr|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.2015||R|0|0|0|0|0|CHI|0|0|0|100|XEU|69030|90583|lyfalmen|||1|1,5|0|0,7500|Chiesi Farmaceutici SpA|Chiesi Farmaceutici SpA|Náttúrulegir fosfólípíðar||69030||69030|90583||1|H|0|0|||0 571358|L01XC1501|Gazyvaro|irþ|1000|mg|1|hgl|1|pakki||L01XC15|01.02.2015||R|0|0|0|0|0|RRG|0|1|0|100|DKK|519062|652079|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration GmbH|Obinutuzumab||519062||519062|652079||2|H|L|0|||0 571647|QN02BG9102|Librela|stl|20|mg|1|ml|2|hgl||QN02BG91|01.08.2021||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|13710|26181|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Bedinvetmab||13710||13710|26181||2|0||2|||0 571667|N03AX1602|Lyrica (Lyfjaver)|hylki|150|mg|100|stk|1|þpakki||N03AX16|01.12.2019||R|1|0|0|0|0|LVR|0|0|0|100|DKK|15757|23186|lyfalmen|V0687|4664|3|100|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Pregabalín||15757||15757|23186||3|0|E|0|||0 571872|J01CR0206|Amoxicillin/Clavulanic Acid Normon|sts/irs|1200|mg|100|hgl|1|pakki|1000+200 mg|J01CR02|01.09.2019||R|0|0|0|0|0|LNA|0|0|1|100|XEU|54336|71998|lyfalmen|||2|100|0|33,3333|Williams & Halls efh|Laboratorios Normon, S.A.|Amoxicillín og beta-laktamasa hemill||54336||54336|71998||2|0|0|0|||0 571902|N05AH0416|Quetiapin Medical Valley|forðatfl|150|mg|100|stk|1|þpakki||N05AH04|01.09.2019||R|1|1|0|G|0|VAL|0|0|0|100|IKR|5400|7540|lyfalmen|V0910|7540|2|100|0|37,5000|Acare ehf|Medical Valley Invest AB|Quetíapín||4390||4390|7540||2|0|0|0|||0 572062|L01AX0304|Temozolomide Accord|hylki|250|mg|5|stk|1|skpoki|hart|L01AX03|01.04.2018||R|0|0|1|0|0|CLU|0|1|0|100|XEU|36521|49465|lyfsjukr|||2|5|0||Artasan ehf|Accord Healthcare S.L.U.|Temozolomid||36521||36521|49465||1|0|L|0|||0 572119|J01DD0206|Ceftazidima Normon|sts|1|g/hgl|50|hgl|1|pakki|50 lykjur Sjúkrahússpakkning|J01DD02|01.08.2020||R|0|0|0|0|0|LNA|0|0|1|100|XEU|85228|111070|lyfalmen|||2|50|0|12,5000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftazidím||85228||85228|111070||2|0|0|0|||0 572422|L04AD0201|Advagraf|forðahlk|5|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|1|G|0|APE|0|0|0|100|XEU|70287|92173|lyfalmen|V1046|92170|1|50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||70287||70287|92173||1|0|G|0|||0 572697|R06AE0706|Zensitin|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.01.2018||L|1|0|0|G|0|WEH|0|0|1|100|IKR|||lyfalmen|V0575|1677|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Cetirizín|||||2695||2|0|G|0|||0 572777|N05AX1210|Aripiprazol Medical Valley|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2020||R|1|1|0|G|0|VAL|0|0|0|100|XEU|6654|3422|lyfalmen|V0684|3422|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Aripiprazól||1398||1398|3422||2|0|G|0|||0 573177|S01ED5110|Duotrav|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|G|0|NEL|0|0|0|100|DKK|3032|5671|lyfalmen|V0994|2448|1|2,5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Tímólól í blöndum||3032||3032|5671||1|0|G|0|||0 573382|J05AP5101|Harvoni|filmhtfl|490|mg|28|stk|1|glas|400 mg + 90 mg|J05AP51|01.09.2015||R|1|0|1|0|0|GSE|0|1|0|100|DKK|2042098|2546309|lyfsjukr|||1|28|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|Sofosbuvir og ledipasvir||||2042098|2546309||2|0|L|0|||0 573477|L01XC0301|Herceptin|st/irþ|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|0|0|0|0|0|RRG|0|1|0|100|DKK|84435|110067|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration GmbH|Trastuzumab||84435||84435|110067||2|H|L|0|||0 573579|N05AX1210|Aripiprazol Medical Valley|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2020||R|1|1|0|G|0|VAL|0|0|0|100|XEU|6132|3422|lyfalmen|V0683|3422|2|56|0|37,3300|Acare ehf|Medical Valley Invest AB|Aripiprazól||1398||1398|3422||2|0|G|0|||0 573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|10|hgl|1|pakki||J01DH02|01.10.1995||R|0|0|0|0|0|PLS|0|0|1|100|DKK|14114|15018|lyfalmen|||1|10|0|1,6667|Icepharma hf|Pfizer ApS|Meropenem||9823||9823|15018||1|0|0|0|||0 573642|J01DH0201|Meronem|sts/irs|1|g/hgl|10|hgl|1|pakki||J01DH02|01.10.1995||R|0|0|0|0|0|PLS|0|0|1|100|DKK|22979|23709|lyfalmen|||1|10|0|3,3333|Icepharma hf|Pfizer ApS|Meropenem||16137||16137|23709||1|0|0|0|||0 573863|V03AB3403|FOMEPIZOLE SERB|irþ|5|mg/ml|20|ml|5|lykjur||V03AB34|01.06.2020||R|0|0|0|0|0|SER|0|0|0|100|XEU|91789|119368|lyfalmen|||1|100|0||SERB SA|SERB SA|Fómepízól||91789||91789|119368||3|H|0|0|||0 574086|QI09AL0101|Eryseng Parvo|stl|||50|ml|1|hgl|dreifa|QI09AL01|01.09.2016||R|0|0|0|0|0|LHS|0|0|0|100|IKR|9978|17198|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Porcine parvovirus + erysipelothrix||9978||9978|17198||2|0||0|||0 574395|N05CD0804|Midazolam Accord|stl/irl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.06.2020||R|0|0|0|0|0|AEE|0|0|0|100|XEU|1396|3419|lyfalmen|||2|10|0|3,3333|Artasan ehf|Accord Healthcare B.V.|Mídazólam||1396||1396|3419||1|H|0|2|450|mg|0 574423|L01XC1301|Perjeta|irþ|420|mg|14|ml|1|hgl||L01XC13|01.06.2013||R|0|0|0|0|0|RRG|0|1|0|100|DKK|404363|509426|lyfsjukr|||1|14|0||Icepharma hf|Roche Registration GmbH|Pertuzumab||404363||404363|509426||2|H|L|0|||0 574510|A04AA0101|Zofran|mixtúra|0,8|mg/ml|50|ml|1|glas||A04AA01|01.07.2016||R|0|0|0|G|0|NAA|0|0|1|100|DKK|8710|13486|lyfalmen|||1|50|0|2,5000|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||8710||8710|13486||1|0|G|0|||0 574597|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.11.2016||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1|0||0|||0 575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.10.1995||R|1|0|0|G|0|UPJ|0|0|0|100|DKK|7329|7196|lyfalmen|V0322|2912|1|98|0|98,0000|Icepharma hf|Upjohn EESV|Sertralín||4140||4140|7196||1|0|G|0|||0 575356|N06BA0903|Atomoxetin Medical Valley|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.11.2019||R|1|1|0|0|0|VAL|0|0|0|100|XEU|13805|3421|lyfalmen|V0817|3068|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||1397||1397|3421||2|0|E|0|||0 575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.03.2001||R|1|0|0|G|0|UPJ|0|0|0|100|DKK|12497|7196|lyfalmen|V0323|4166|1|98|0|196,0000|Icepharma hf|Upjohn EESV|Sertralín||4140||4140|7196||1|0|G|0|||0 575458|A10AE5401|Suliqua|stl|||3|ml|5|áfpen|100 ein/ml + 50 mcg/ml|A10AE54|01.05.2018||R|0|1|0|0|0|SGB|0|0|0|100|XEU|23735|33294|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi-aventis groupe|Insulin glargine og lixisenatide||23735||23735|33294||1|0|E|0|||0 575484|L01AA0903|Bendamustine medac|st/irþ|2,5|mg/ml|100|mg|1|hgl|lausn|L01AA09|01.03.2018||R|0|0|0|0|0|WIL|0|1|0|100|XEU|37945|51266|lyfsjukr|||2|100|0||Williams & Halls efh|medac Gesellschaft|Bendamústín||37945||37945|51266||2|H|L|0|||0 575504|B02BD0801|NovoSeven|sts|8|mg|1|hgl|1|pakki|+áfyllt sprauta með leysi|B02BD08|01.10.2015||R|0|0|0|0|0|NAS|0|1|0|100|DKK|735667|921475|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Storkuþáttur VIIa||735667||735667|921475||1|H|L|0|||0 575571|J01CA0413|Amoxin|filmhtfl|500|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|RTH|0|0|1|100|SEK|1308|2324|lyfalmen|V0159|2324|2|20|0|6,6667|Alvogen|ratiopharm GmbH|Amoxicillín||600||600|2324||2|0|E|0|||0 575589|J01CA0413|Amoxin|filmhtfl|500|mg|30|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|RTH|0|0|1|100|SEK|1603|2777|lyfalmen|V0160|2777|2|30|0|10,0000|Alvogen|ratiopharm GmbH|Amoxicillín||929||929|2777||2|0|E|0|||0 575621|J01CA0413|Amoxin|filmhtfl|750|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|RTH|0|0|1|100|SEK|1458|3017|lyfalmen|V0158|3017|2|20|0|10,0000|Alvogen|ratiopharm GmbH|Amoxicillín||1104||1104|3017||2|0|E|0|||0 575715|G03GA1001|REKOVELLE|stl|72|mcg|2,16|ml|1|áfpen|+ 9 inndælingarnálar|G03GA10|01.08.2018||R|0|0|1|G|0|FEP|0|0|0|100|DKK|84501|110150|lyfalmen|||1|2,16|0|6,0000|Vistor hf|Ferring Pharmaceuticals A/S|Follitrópín delta||84501||84501|110150||1|0|G|0|||0 576123|L04AX0601|Imnovid|hylki|1|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|1|0|0|BSE|0|1|0|100|DKK|1193692|1491130|lyfsjukr|||1|21|0|7,0000|Celgene Europe ltd|Bristol-Myers Squibb Pharma EEIG|Pomalidómide||1193692||1193692|1491130||2|0|L|0|||0 576253|B01AC2202|Prasugrel Krka|filmhtfl|10|mg|30|stk|1|þpakki||B01AC22|01.04.2019||R|0|1|0|G|0|KAN|0|0|0|100|IKR|6577|10551|lyfalmen|V0806|10551|2|30|0|30,0000|Krka Sverige AB|Krka d.d. Novo mesto|Prasugrel||6577||6577|10551||2|0|G|0|||0 576518|QN05CM1803|Sedadex|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.03.2017||R|0|0|0|0|0|VEB|1|0|0|100|IKR|5680|10947|vetalmen|||2|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Dexmedetomidinum||5680||5680|10947||2|0||0|||0 576714|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.12.2012||R|0|0|0|G|0|AEP|0|0|0|100|IKR|6315|10190|lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma Trading Limited|Merkaptópúrín||6315||6315|10190||2|0|G|0|||0 576797|V03AE0205|Sevelamercarbonat Stada|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.10.2017||R|1|0|0|0|0|ASR|0|0|0|100|IKR|13500|14780|lyfalmen|V0680|14780|2|180|0|22,5000|LYFIS ehf|STADA Arzneimittel AG|Sevelamer||9650||9650|14780||2|0||0|||0 576846|L01AX0304|Temozolomide Accord|hylki|250|mg|5|stk|1|skpoki|hart|L01AX03|01.06.2021||R|0|0|1|0|0|CLU|0|1|0|100|XEU|36521|49465|lyfsjukr|||2|5|0||Artasan ehf|Accord Healthcare S.L.U.|Temozolomid||36521||36521|49465||1|0|L|0|||0 577021|N02AJ0601|Parkodin|filmhtfl|510|mg|30|stk|1|þpakki|10+500 mg|N02AJ06|01.06.2018||R|1|0|0|0|0|ATE|0|0|1|100|XEU|452|2120|lyfalmen|||2|30|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||452||452|2120||1|0|E|3|||0 577135|C09DX0401|Entresto|filmhtfl|100|mg|56|stk|1|þpakki|49 + 51 mg|C09DX04|01.04.2016||R|0|0|0|0|0|NEL|0|0|0|100|DKK|20220|28848|lyfalmen|V0727|26665|1|56|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||20220||20220|28848||1|0|E|0|||0 577505|L04AC0701|RoActemra|stl|162|mg|4|áf-penni|1|pakki||L04AC07|01.03.2019||R|0|1|1|0|0|RRG|0|1|0|100|DKK|139411|179899|lyfsjukr|||1|4|0|32,4000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||139411||139411|179899||2|0|L|0|||0 577616|N06BA0905|Atomoxetin STADA|hylki|60|mg|30|stk|1|þpakki|hart hylki|N06BA09|01.08.2020||R|1|1|0|0|0|LYF|0|0|0|100|IKR|4500|3287|lyfalmen|V0816|3287|2|30|0|22,5000|LYFIS ehf|LYFIS ehf|Atomoxetín||1300||1300|3287||2|0|E|0|||0 577711|C01CA0601|Fenylefrin Abcur|stl|0,05|mg/ml|10|ml|10|lykjur||C01CA06|01.09.2013||R|0|0|0|0|0|ABC|0|0|0|100|SEK|11024|16671|lyfalmen|||2|100|0|1,2500|Icepharma hf|Abcur AB|Phenylephrin||11024||11024|16671||2|H|0|0|||0 578261|J07AH0703|NeisVac-C|stl|||0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.07.2015||R|0|0|0|0|0|PLS|0|0|0|100|DKK|4396|7549|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer ApS|Hreinsuð meningókokka C, poly­sakkaríð mótefnavakar||4396||4396|7549||1|0||0|||0 578368|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|100|ml|10|glas|lausn|V08CA02|01.10.2017||R|0|0|0|0|0|GEH|0|0|0|100|NOK|336100|424526|lyfalmen|||1|1000|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||336100||336100|424526||2|H|0|0|||0 578537|J05AR2501|DOVATO|filmhtfl|350|mg|30|stk|1|glas|50 mg/300 mg|J05AR25|01.09.2020||R|1|0|1|0|0|VIC|0|1|0|100|DKK|100965|132083|lyfsjukr|||1|30|0|30,0000|Vistor hf|ViiV Healthcare BV|Dolutegravir og lamivudin||100965||100965|132083||1|0|L|0|||0 578654|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|þpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|CHP|0|0|0|100|XEU|6655|11471|vetorma|||0|20|0||Icepharma hf|Chanelle Pharmaceuticals|Prazikvantelum í blöndum||6655||6655|11471||2|0||0|||0 578991|R03AK1401|Atectura Breezhaler|innönddu|385|mcg/sk|90|stk|3|stsk.þ|125 mcg/260mcg|R03AK14|01.01.2021||R|0|0|0|G|0|NEP|0|0|0|100|DKK|14890|21993|lyfalmen|||1|270|0||Vistor hf|Novartis Europharm Limited|Indacaterol og mometasone||14890||14890|21993||1|0|G|0|||0 579043|H02AB0205|Dexametason Abcur|töflur|4|mg|100|stk|1|þpakki||H02AB02|01.06.2016||R|1|0|0|G|0|ABC|0|0|1|100|IKR|14658|14436|lyfalmen|V0423|13060|2|100|0|266,6600|Icepharma hf|Abcur AB|Dexametasón||9400||9400|14436||2|0|G|0|||0 579184|L01CD0205|Docetaxel Accord|irþ|160|mg|8|ml|1|hgl|lausn|L01CD02|01.06.2020||R|0|0|0|0|0|CLU|0|0|0|100|XEU|33702|45900|lyfalmen|||2|8|0||Artasan ehf|Accord Healthcare S.L.U.|Docetaxel||33702||33702|45900||1|H|0|0|||0 579240|L01XC1701|OPDIVO|irþ|10|mg/ml|10|ml|1|hgl||L01XC17|01.06.2016||R|0|1|0|0|0|BMS|0|1|0|100|DKK|161939|207918|lyfsjukr|||1|10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Nivolumab||161939||161939|207918||1|H|L|0|||0 579322|L01BC0503|Gemcitabine W&H|irs|1000|mg|1000|mg|1|hgl|innrennslistofn|L01BC05|01.02.2019||R|0|0|0|0|0|WEH|0|0|0|100|XEU|8946|13811|lyfalmen|||2|1000|0||Williams & Halls efh|Williams & Halls ehf|Gemcitabín||8946||8946|13811||2|H|0|0|||0 579491|R03AL0601|Spiolto Respimat|innöndl|5|mcg|3|rörlyk|1|pakki|Innöndunartæki og 3 áfyllingar|R03AL06|01.08.2019||R|0|0|0|G|0|BOE|0|0|0|100|DKK|19746|26270|lyfalmen|||1|3|0||Vistor hf|Boehringer Ingelheim International GmbH|Olodaterol og tiotropiumbromide||17998||17998|26270||1|0|G|0|||0 579796|N02AJ0602|Parkodin forte|filmhtfl|530|mg|100|stk|1|þpakki|30+500 mg|N02AJ06|01.02.2018||R|1|0|0|0|0|ATE|0|0|1|100|IKR|1810|3989|lyfalmen|||2|100|0|33,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||1810||1810|3989||1|0|E|1|||0 579910|L04AA3701|OLUMIANT|filmhtfl|4|mg|28|stk|1|þpakki||L04AA37|01.04.2020||R|0|1|1|0|0|NED|0|1|0|100|XEU|119073|154605|lyfsjukr|||1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Baricitinib||119073||119073|154605||2|0|L|0|||0 579911|B01AF0301|Lixiana|filmhtfl|60|mg|30|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|G|0|OPE|0|0|0|100|DKK|9786|14967|lyfalmen|||1|30|0|30,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||9786||9786|14967||1|0|G|0|||0 579932|C03DA0406|Eplerenon Alvogen|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.06.2014||R|1|0|0|0|0|POF|0|0|0|100|IKR|3302|2544|lyfalmen|V0107|2530|2|30|0|15,0000|Alvogen|Alvogen|Eplerenón||760||760|2544||2|0|E|0|||0 579972|C03DA0403|Eplerenon Bluefish|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.05.2015||R|1|0|0|0|0|BLS|0|0|0|100|XEU|14011|9853|lyfalmen|V0111|6315|2|100|0|100,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Eplerenón||6070||6070|9853||1|0|E|0|||0 580104|N07BB0501|Selincro|filmhtfl|18|mg|14|stk|1|þpakki||N07BB05|01.06.2013||R|1|0|0|0|0|LBK|0|0|0|100|DKK|8147|12711|lyfalmen|||1|14|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||8147||8147|12711||1|0||0|||0 580144|L01CD0203|Docetaxel Kabi|irþ|20|mg/ml|8|ml|1|hgl|lausn|L01CD02|01.01.2016||R|0|0|0|0|0|FKD|0|0|0|100|DKK|10105|15406|lyfalmen|||1|8|0||Vistor hf|Fresenius Kabi Deutschland GmbH|Docetaxel||10105||10105|15406||1|H|0|0|||0 580699|H01BA0208|NOCDURNA|frþ.tfl|25|mcg|30|stk|1|þpakki||H01BA02|01.04.2017||R|0|0|0|G|0|FEL|0|0|0|100|DKK|3833|6774|lyfalmen|||1|30|0|1,8750|Vistor hf|Ferring Lægemidler A/S|Desmópressín||3833||3833|6774||1|0|G|0|||0 580713|R03AL1201|Enerzair Breezhaler|innönddu|||30|stk|1|stsk.þ|114 mcg/46 mcg/136mcg|R03AL12|01.01.2021||R|0|0|0|G|0|NEP|0|0|0|100|DKK|8344|12983|lyfalmen|||1|30|0||Vistor hf|Novartis Europharm Limited|Indacaterol, glycopyrronium bromide, mometasone||8344||8344|12983||1|0|G|0|||0 580960|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|BAM|0|0|1|100|SEK|1519|3589|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1519||1519|3589||2|0|0|0|||0 581379|C08CA0106|Amlodipin Medical Valley|töflur|10|mg|112|stk|1|þpakki||C08CA01|01.04.2020||R|1|0|0|G|0|VAL|0|0|0|100|XEU|2691|2497|lyfalmen|V0057|2497|2|112|0|224,0000|Acare ehf|Medical Valley Invest AB|Amlódipín||726||726|2497||2|0|G|0|||0 581417|S01ED5116|Taptiqom|augndr|||0,3|ml|30|Sk-ílá|15mcg/ml + 5mg/ml|S01ED51|01.07.2015||R|0|0|0|G|0|SAO|0|0|0|100|XEU|3090|5751|lyfalmen|||1|9|0|30,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3090||3090|5751||2|0|G|0|||0 581474|N02BA5105|Treo Hindbær|freyðit|550|mg|20|stk|1|tfílát|500+50 mg|N02BA51|01.06.2020||L|0|0|0|0|0|MDK|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Icepharma hf|Mylan Denmark ApS|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||2|0||0|||0 581661|N02CC0406|Rizatriptan Alvogen|munndr.t|5|mg|6|stk|1|þpakki||N02CC04|01.01.2015||R|0|0|0|G|0|POF|0|0|0|100|XEU|3387|6160|lyfalmen|||2|6|0|3,0000|Alvogen|Alvogen|Rizatriptan||3387||3387|6160||2|0|G|0|||0 581792|L02BB0305|Bicalutamide Alvogen|filmhtfl|150|mg|90|stk|1|þpakki||L02BB03|01.11.2016||R|0|0|0|G|0|GOV|0|0|0|100|IKR|33214|45283|lyfalmen|||2|90|0|270,0000|Alvogen|Alvogen ehf|Bíkalútamíð||33214||33214|45283||2|0|G|0|||0 581890|QN02AF0103|Torphasol vet.|stl|10|mg/ml|20|ml|1|hgl||QN02AF01|01.02.2011||R|0|0|0|0|0|ANI|1|0|0|100|XEU|13664|26094|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||13664||13664|26094||2|0||2|||0 581969|S01EE0401|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.07.2011||R|0|0|0|G|0|NEL|0|0|0|100|DKK|2296|4658|lyfalmen|V0669|3953|1|2,5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Travóprost||2296||2296|4658||1|0|G|0|||0 582004|L01EX0801|Lenvima|hylki|4|mg|30|stk|1|þpakki||L01EX08|01.12.2018||R|0|0|1|0|0|SIE|0|1|0|100|SEK|233942|297470|lyfsjukr|||1|30|0||Eisai AB|Eisai GmbH|Lenvatinib||233942||233942|297470||1|0|L|0|||0 582034|QM01AC0608|Novaquin|mixtúra|15|mg/ml|125|ml|1|glas|dreifa|QM01AC06|01.03.2018||R|0|0|0|0|0|VEB|0|0|0|100|IKR|4185|8110|vetalmen|||0|125|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Meloxícam||||4185|8110||2|0||0|||0 582096|N03AF0203|Oxcarbazepin Jubilant|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.11.2018||R|1|0|0|G|0|JUB|0|0|0|100|DKK|4052|6921|lyfalmen|V0972|6921|2|100|0|30,0000|Acare ehf|Jubilant Pharmaceuticals nv|Oxkarbazepín||3940||3940|6921||2|0|G|0|||0 582122|G03GA0503|Bemfola|stl|450|ae|0,75|ml|1|penni||G03GA05|01.01.2015||R|0|0|1|G|0|FBA|0|0|0|100|SEK|16791|24609|lyfalmen|||1|0,75|0|6,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||16791||16791|24609||3|0|G|0|||0 582221|V08AB0201|Omnipaque|stl|140|mg J/ml|200|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|GEH|0|0|0|100|NOK|22270|31441|lyfalmen|||1|2000|0||Icepharma hf|GE Healthcare AS|Iohexol||22270||22270|31441||2|H|0|0|||0 582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|GEH|0|0|0|100|NOK|18138|26463|lyfalmen|||1|1000|0||Icepharma hf|GE Healthcare AS|Iohexol||18138||18138|26463||2|H|0|0|||0 582611|A10BJ0601|Ozempic|stl|1|mg|3|ml|1|áfpen|+4 einnota nálar|A10BJ06|01.01.2019||R|0|0|0|0|0|NON|0|0|0|100|DKK|18699|27235|lyfalmen|||1|3|0|27,2727|Vistor hf|Novo-Nordisk|Semaglutide||18699||18699|27235||1|0|E|0|||0 582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|GEH|0|0|0|100|NOK|54413|72095|lyfalmen|||1|3000|0||Icepharma hf|GE Healthcare AS|Iohexol||54413||54413|72095||2|H|0|0|||0 582671|H02AB0912|Alkindi|kyrnhylk|5|mg|50|stk|1|glas|Kyrni í hylkjum sem á að opna|H02AB09|01.08.2019||R|1|0|0|G|0|DIU|0|0|1|100|SEK|73897|96739|lyfalmen|||1|50|0|8,3333|Diurnal Ltd.|Diurnal Europe B.V.|Hýdrókortisón||73897||73897|96739||2|0|G|0|||0 582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|GEH|0|0|0|100|NOK|22645|31915|lyfalmen|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||22645||22645|31915||2|H|0|0|||0 582981|G02BB0102|Ornibel|sk-innl|||3|stk|1|pakki|0,120 mg/0,015 mg/24 klst|G02BB01|01.06.2019||R|0|0|0|0|0|EXH|0|0|0|100|DKK|3587|5293|lyfalm11|V0983|5293|2|3|0|84,0000|Acare ehf|Exeltis Healthcare S.L.|Skeiðarinnleg með progestógeni og östrógeni||3208||3208|5293||2|0||0|||1 582990|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|1|0|0|MEC|0|1|0|100|SEK|31915|43640|lyfsjukr|||1|1,5|0|18,0000|Icepharma hf|Merck AB|Sómatrópín||31915||31915|43640||2|0|L|0|||0 583105|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.08.2013||R|0|0|0|G|0|UPJ|0|0|0|100|DKK|1941|4170|lyfalmen|||1|2,5|0|25,0000|Icepharma hf|Upjohn EESV|Latanóprost||1941||1941|4170||1|0|G|0|||0 583126|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|GEH|0|0|0|100|NOK|46263|61787|lyfalmen|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||46263||46263|61787||2|H|0|0|||0 583443|C07AA0705|Sotalol Mylan|töflur|80|mg|100|stk|1|þpakki||C07AA07|01.01.1994||R|1|0|0|G|0|MYL|0|0|0|100|SEK|1160|3095|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Sótalól||1160||1160|3095||2|0|G|0|||0 583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|GEH|0|0|0|100|NOK|78127|102089|lyfalmen|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||78127||78127|102089||2|H|0|0|||0 583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|GEH|0|0|0|100|NOK|24752|34580|lyfalmen|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||24752||24752|34580||2|H|0|0|||0 583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|GEH|0|0|0|100|NOK|39603|53363|lyfalmen|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||39603||39603|53363||2|H|0|0|||0 583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|GEH|0|0|0|100|NOK|74255|97191|lyfalmen|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||74255||74255|97191||2|H|0|0|||0 583888|G04BD0807|Solifenacin Krka|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|4061|7087|lyfalmen|V0985|7087|2|30|0|60,0000|Krka Sverige AB|Krka d.d. Novo mesto|Sólífenacín||4061||4061|7087||2|0|G|0|||0 583916|B05BB0122|Natriumklorid B. Braun|irl|9|mg/ml|250|ml|10|pokar|lausn|B05BB01|01.02.2018||R|0|0|0|0|0|RAU|0|0|1|100|XEU|1967|4205|lyfalmen|||2|2500|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||1967||1967|4205||2|0|0|0|||0 584306|J01EE0110|Cotrim|töflur|480|mg|30|stk|1|þpakki|80+400 mg|J01EE01|01.01.2021||R|1|0|0|0|0|TVB|0|0|1|100|XEU|1111|3027|lyfalmen|||2|30|0|7,5000|Actavis Pharmaceuticals Iceland ehf.|Teva B.V.|Súlfametoxazól og trímetóprím||||1111|3027||1|0|E|0|||0 584577|A04AD1202|Aprepitant Medical Valley|hylki|||3|stk|1|þpakki|samsett pakkning|A04AD12|01.07.2019||R|1|0|0|G|0|VAL|0|0|1|100|XEU|7866|9498|lyfalmen|V0986|9498|2|3|0|1,7273|Acare ehf|Medical Valley Invest AB|Aprepitant||5812||5812|9498||2|0|G|0|||0 584738|N03AX1212|Gabapenstad|hylki|300|mg|120|stk|1|þpakki|hart|N03AX12|01.07.2019||R|1|0|0|G|0|ASR|0|0|0|100|IKR|1800|2943|lyfalmen|V0250|2943|2|120|0|20,0000|LYFIS ehf|STADA Arzneimittel AG|Gabapentín||1050||1050|2943||2|0|G|0|||0 584834|N06AX2701|Spravato|nefúði|28|mg|28|mg|1|úðaílá|lausn|N06AX27|01.10.2020||R|0|1|0|0|0|JCI|0|1|0|100|SEK|32132|43914|lyfsjukr|||1|28|0||Vistor hf|Janssen-Cilag International N.V.|Esketamine||32132||32132|43914||1|H|L|1|30|dagar|0 584851|C09AA0201|Daren|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.09.2020||R|1|0|0|G|0|TVI|0|0|0|100|XEU|589|2309|lyfalmen|V0448|2309|2|100|0|50,0000|Teva Pharma Iceland ehf|Teva B.V|Enalapríl||589||589|2309||1|0|G|0|||0 585283|S01ED5122|Fixopost|augndr|||0,2|ml|90|sk-ílá|50 mcg/ml + 5 mg/ml|S01ED51|01.01.2020||R|0|0|0|G|0|LTH|0|0|0|100|SEK|7304|11551|lyfalmen|||2|18|0|90,0000|Vistor hf|Laboratoires THEA|Tímólól í blöndum||7304||7304|11551||1|0|G|0|||0 585287|C09DX0401|Entresto|filmhtfl|100|mg|168|stk|1|þpakki|49 + 51 mg|C09DX04|01.07.2020||R|0|0|0|0|0|NEL|0|0|0|100|DKK|60660|79996|lyfalmen|V0727|79996|1|168|0|84,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||60660||60660|79996||1|0|E|0|||0 585359|L01XC1801|KEYTRUDA|irþ|25|mg/ml|4|ml|1|hgl||L01XC18|01.07.2017||R|0|1|0|0|0|MBV|0|1|0|100|DKK|505470|635174|lyfsjukr|||1|4|0||Vistor hf|Merck Sharp & Dohme B.V.|Pembrolizumab||505470||505470|635174||1|H|L|0|||0 585458|M02AA1502|Voltaren|hlaup|11,6|mg/g|75|g|1|túpa||M02AA15|01.11.2018||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|75|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Díklófenak|||||||1|0||0|||0 585516|A10BK0301|Jardiance|filmhtfl|25|mg|90|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|G|0|BOE|0|0|0|100|DKK|17764|25948|lyfalmen|||1|90|0|128,5700|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||17764||17764|25948||1|0|G|0|||0 585661|B01AB0101|Heparin Leo|stl|100|ae/ml|10|ml|10|hgl||B01AB01|01.03.2014||R|0|0|0|0|0|LEP|0|0|1|100|DKK|5855|9557|lyfalmen|||1|100|0|1,0000|Vistor hf|LEO Pharma A/S|Heparín||5855||5855|9557||1|0||0|||0 585692|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.07.2016||R|1|0|0|G|0|VAL|0|0|1|100|IKR|2500|2186|lyfalmen|V0006|2186|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||500||500|2186||2|0|G|0|||0 585754|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|10|áf.spr||B01AX05|01.09.2017||R|0|0|0|G|0|MYR|0|0|0|100|DKK|23191|32606|lyfalmen|||1|4|0|20,0000|Icepharma hf|Mylan IRE Healthcare Limited|Fondaparinux||23191||23191|32606||2|0|G|0|||0 585869|J07BC0201|Havrix|stl|1440|ein/ml|1|ml|1|dæla|einnota dæla|J07BC02|01.07.1994||R|0|0|0|0|0|GPH|0|0|0|100|DKK|3967|6958|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3967||3967|6958||1|0||0|||0 585905|G04BD0807|Solifenacin Krka|filmhtfl|5|mg|100|stk|1|þpakki||G04BD08|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|11089|10720|lyfalmen|V0440|10083|2|100|0|100,0000|Krka Sverige AB|Krka d.d. Novo mesto|Sólífenacín||6700||6700|10720||2|0|G|0|||0 585914|L01XC0204|Rixathon|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.05.2020||R|0|1|0|0|0|HSS|0|1|0|100|DKK|131479|170034|lyfsjukr|||2|50|0||Artasan ehf|Sandoz GmbH|Rítúxímab||131479||131479|170034||1|H|L|0|||0 586005|N03AX1212|Gabapenstad|hylki|400|mg|100|stk|1|þpakki|hart|N03AX12|01.07.2019||R|1|0|0|G|0|ASR|0|0|0|100|IKR|1833|3150|lyfalmen|V0251|3150|2|100|0|22,2200|LYFIS ehf|STADA Arzneimittel AG|Gabapentín||1200||1200|3150||2|0|G|0|||0 586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|0|0|0|G|0|HES|0|0|0|100|DKK|26627|36951|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||26627||26627|36951||1|0|G|0|||0 586223|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|LEM|0|0|1|100|XEU|12376|18532|lyfalmen|||2|800|0|10,0000|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||12376||12376|18532||2|0|0|0|||0 586241|J01GB0101|Tobi Podhaler|innönddu|28|mg|224|stk|1|þpakki|hart hylki+innönd.tæki|J01GB01|01.04.2012||R|0|0|0|0|0|MYE|0|1|1|100|DKK|310256|392383|lyfsjukr|||1|224|0|56,0000|Icepharma hf|Mylan Ireland Limited|Tobramýcín||310256||310256|392383||2|0|L|0|||0 586312|C10AX1301|Repatha|stl|140|mg|2|áf-penni|1|pakki||C10AX13|01.10.2016||R|0|0|0|0|0|AEB|0|0|0|100|DKK|66474|87350|lyfalmen|||1|2|0|28,0000|Vistor hf|Amgen Europe B.V.|Evolocumab||66474||66474|87350||1|0|E|0|||0 586579|N06AX1613|Venlafaxin Medical Valley|forðatfl|150|mg|110|stk|1|glas||N06AX16|01.08.2019||R|0|0|0|G|0|VAL|0|0|0|100|XEU|3094|2858|lyfalmen|V0335|2858|2|110|0|165,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||988||988|2858||2|0|G|0|||0 586627|N06AX1613|Venlafaxin Medical Valley|forðatfl|300|mg|30|stk|1|þpakki||N06AX16|01.11.2019||R|0|0|0|0|0|VAL|0|0|0|100|IKR|2358|4743|lyfalmen|||2|30|0|90,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||2358||2358|4743||2|0|0|0|||0 586797|N06BA0902|Atomoxetin Actavis|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|ATE|0|0|0|100|XEU|6572|3284|lyfalmen|V0815|2940|2|28|0|14,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atomoxetín||1298||1298|3284||1|0|E|0|||0 586959|L01BC0207|Flúoróúracil Accord|stl/irl|50|mg/ml|100|ml|1|hgl||L01BC02|01.12.2019||R|0|0|0|0|0|AEE|0|0|0|100|XEU|4384|7532|lyfalmen|||2|100|0||Artasan ehf|Accord Healthcare B.V.|Flúóróúracíl||4384||4384|7532||1|H|0|0|||0 586967|B01AF0201|Eliquis|filmhtfl|5|mg|168|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|G|0|BSM|0|0|0|100|DKK|28015|38707|lyfalmen|V0652|38704|1|168|0|84,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||28015|38707||1|0|G|0|||0 587112|M01AH0106|Celecoxib Actavis|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|G|0|ATE|0|0|1|100|XEU|4243|6059|lyfalmen|V0196|6059|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Celekoxíb||3314||3314|6059||1|0|G|0|||0 587176|N07BA0150|Nicotinell Spearmint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1|0||0|||0 587522|L04AB0601|Simponi|stl|100|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.11.2014||R|0|1|1|0|0|JAN|0|1|0|100|DKK|153481|197399|lyfsjukr|||1|1|0|60,2400|Vistor hf|Janssen Biologics B.V.|Golimumab||153481||153481|197399||1|0|L|0|||0 587641|C09DA0602|Candpress Comp|töflur|28,5|mg|100|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2012||R|1|0|0|0|0|ATE|0|0|0|100|XEU|6144|9955|lyfalmen|||2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Candesartan og þvagræsilyf||6144||6144|9955||1|0|E|0|||0 587658|M05BA0606|Ibandronic acid WH|stl|3|mg|3|ml|1|áfspr||M05BA06|01.05.2018||R|0|1|0|0|0|WEH|0|0|0|100|IKR|11132|16820|lyfalmen|||2|3|0|0,5000|Williams & Halls efh|Williams & Halls ehf|Íbandrónsýra||11132||11132|16820||2|0|E|0|||0 587958|C09CA0604|Kairasec|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.2017||R|1|0|0|G|0|VAL|0|0|0|100|XEU|4093|6384|lyfalmen|V0081|6384|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Candesartan||3550||3550|6384||2|0|G|0|||0 588134|L04AC1201|Kyntheum|stl|210|mg|1,5|ml|2|áf.spr||L04AC12|01.10.2018||R|0|0|1|0|0|OEL|0|1|0|100|DKK|161873|207836|lyfsjukr|||1|3|0|28,0000|Vistor hf|LEO Pharma A/S|Brodalumab||161873||161873|207836||1|0|L|0|||0 588195|N05AX1208|Aripiprazol W&H|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|1|0|0|G|0|WEH|0|0|0|100|XEU|6235|3422|lyfalmen|V0683|3422|2|56|0|37,3300|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||1398||1398|3422||2|0|G|0|||0 588227|H01AX0101|Somavert|sts|20|mg|30|hgl|1|pakki|+30 áf.spr.m.leysi|H01AX01|01.10.2017||R|0|0|1|0|0|PEU|0|1|0|100|DKK|661559|829305|lyfsjukr|||1|30|0|60,0000|Icepharma hf|Pfizer Europe MA EEIG|Pegvisómant||661559||661559|829305||1|0|L|0|||0 588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.10.1995||R|1|0|0|0|0|PLS|0|0|1|100|DKK|1845|4037|lyfalmen|V0461|3393|1|20|0|5,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1845||1845|4037||1|0|E|0|||0 588911|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|G|0|ATE|0|0|0|100|XEU|17003|12499|lyfalmen|V0282|12246|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Olanzapín||7993||7993|12499||1|0|G|0|||0 589153|L01EC0201|Tafinlar|hylki|50|mg|120|stk|1|glas||L01EC02|01.11.2013||R|1|0|1|0|0|NEL|0|1|0|100|DKK|518869|651839|lyfsjukr|||1|120|0||Vistor hf|Novartis Europharm Ltd|Dabrafenib||518869||518869|651839||1|0|L|0|||0 589302|N02AX0213|Tramadol Krka|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|3500|5214|lyfalmen|V0228|5214|2|100|0|50,0000|Krka Sverige AB|Krka d.d. Novo mesto|Tramadól||2700||2700|5214||2|0|G|1|30|dagar|0 589312|N03AX2201|Fycompa|mixtúra|0,5|mg/ml|340|ml|1|glas||N03AX22|01.10.2019||R|0|0|0|G|0|SIE|0|0|0|100|SEK|25151|35085|lyfalmen|||1|340|0|21,2500|Eisai AB|Eisai GmbH|Perampanel||25151||25151|35085||1|0|G|0|||0 589379|C10AA0509|Atorvastatin Xiromed|filmhtfl|10|mg|105|stk|1|glas||C10AA05|01.08.2021||R|1|0|0|G|0|MVX|0|0|0|100|IKR|2100|2870|lyfalmen|V0112|2870|2|105|0|52,5000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||997||997|2870||2|0|G|0|||0 589888|N01AF0302|Pentocur|sts|0,5|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|0|ABC|0|0|0|100|SEK|10413|15830|lyfalmen|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||10413||10413|15830||2|H|0|0|||0 589893|N06BA0404|Methylphenidate Sandoz|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.11.2019||R|1|1|0|0|0|SHS|0|0|0|100|DKK|4217|5671|lyfalmen|V0691|5671|2|30|0|18,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||3032||3032|5671||1|0|E|1|30|dagar|0 590252|G04BE0312|Granpidam|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.01.2018||R|1|0|1|G|0|CLU|0|0|0|100|XEU|39536|53279|lyfalmen|V0984|27989|2|90|0|36,0000|Artasan ehf|Accord Healthcare S.L.U.|Síldenafíl||39536||39536|53279||1|0|G|0|||0 590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|0|0|0|0|0|BAE|0|0|1|100|IKR|||lyflausa|||0|20|0||Icepharma hf|Bayer AB|Klótrímazól|||||||2|0||0|||0 590562|C01DA1403|Ismo|forðatfl|60|mg|98|stk|1|glas||C01DA14|01.10.1999||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2907|4482|lyfalmen|V0041|3757|2|98|0|147,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ísósorbíð mónónítrat||2168||2168|4482||1|0|G|0|||0 590825|L01XG0301|Ninlaro|hylki|2,3|mg|1|stk|3|þpakki|hvert hylki sérpakkað í þynnu|L01XG03|01.01.2019||R|0|0|1|0|0|TPA|0|1|0|100|DKK|804355|1006904|lyfsjukr|||1|3|0||Vistor hf|Takeda Pharma A/S|Ixazomib||804355||804355|1006904||1|0|L|0|||0 590845|N06AB0406|Citalopram STADA|filmhtfl|10|mg|100|stk|1|þpakki||N06AB04|01.01.2020||R|1|0|0|G|0|ASR|0|0|0|100|IKR|1600|3700|lyfalmen|V0317|3700|2|100|0|50,0000|LYFIS ehf|STADA Arzneimittel AG|Cítalópram||1600||1600|3700||2|0|G|0|||0 590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|0|0|0|0|0|BOI|0|0|0|100|DKK|140633|181419|lyfalmen|||1|1|0|0,7500|Vistor hf|Boehringer Ingelheim|Tenekteplasi||140633||140633|181419||1|H|0|0|||0 591260|N06DA0302|Exelon (Lyfjaver)|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|1|0|G|0|LVR|0|0|0|100|DKK|9012|13902|lyfalmen|V0347|13902|3|30|0|14,5300|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||9012||9012|13902||3|0|G|0|||0 591405|L04AA2901|Xeljanz|filmhtfl|5|mg|56|stk|1|þpakki||L04AA29|01.12.2017||R|0|1|1|0|0|PEU|0|1|0|100|DKK|115853|150600|lyfsjukr|||1|56|0|28,0000|Icepharma hf|Pfizer Europe MA EEIG|Tofacitinib||115853||115853|150600||1|0|L|0|||0 591418|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.01.2018||R|0|0|0|0|0|MAR|0|0|1|100|DKK|1965|4203|lyfalmen|V0561|3567|1|100|0||Icepharma hf|Aspen Pharma|Lídókaín||1965||1965|4203||2|0||0|||0 591540|J01CR0202|Augmentin|töflur|625|mg|21|stk|1|þpakki|500+125 mg|J01CR02|01.09.2015||R|0|0|0|0|0|GPH|0|0|1|100|DKK|1104|3017|lyfalmen|V0168|3017|1|21|0|7,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og beta-laktamasa hemill ||1104||1104|3017||1|0|E|0|||0 591812|L01XC0204|Rixathon|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.05.2020||R|0|1|0|0|0|HSS|0|1|0|100|DKK|131479|170034|lyfsjukr|||2|50|0||Artasan ehf|Sandoz GmbH|Rítúxímab||131479||131479|170034||1|H|L|0|||0 592068|J01DD0402|Ceftriaxona Normon|sts|1000|mg|1|stk|1|hgl|+ 1 lykja með leysi.|J01DD04|01.06.2018||R|0|0|0|0|0|LNA|0|0|1|100|XEU|2261|4610|lyfalmen|||2|1|0|0,5000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftríaxón||2261||2261|4610|31.7.2021|2|0|0|0|||0 592418|M01AH0504|Etoricoxib Krka|filmhtfl|60|mg|30|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|2308|3012|lyfalmen|||2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1100||1100|3012|31.8.2021|2|0|G|0|||0 592498|QC09CA0701|Semintra|mixtúra|4|mg/ml|30|ml|1|glas|fyrir ketti|QC09CA07|01.04.2016||R|0|0|0|0|0|BIV|0|0|0|100|DKK|3814|7406|vetalmen|||1|30|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Telmisartanum||3814||3814|7406||1|0||0|||0 592961|H05BX0107|Cinacalcet STADA|filmhtfl|90|mg|28|stk|1|þpakki||H05BX01|01.12.2020||R|1|0|0|0|0|ASR|0|0|0|100|IKR|41798|43747|lyfalmen|V0722|43747|2|28|0|42,0000|LYFIS ehf|STADA Arzneimittel AG|Cinacalcet||32000||32000|43747||2|0||0|||0 592977|L01EX0401|Caprelsa|filmhtfl|300|mg|30|stk|1|þpakki||L01EX04|01.07.2012||R|1|1|1|0|0|GEB|0|1|0|100|XEU|686927|858329|lyfsjukr|||1|30|0||Vistor hf|Genzyme Europe B.V.|Vandetanib||684895||684895|858329||1|0|L|0|||0 593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|G|0|ROA|0|0|0|100|DKK|905|2744|lyfalmen|||1|150|0|9,3750|Icepharma hf|Roche A.S.|Klónazepam||905||905|2744||2|0|G|2|450|töflur|0 593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|G|0|ROA|0|0|0|100|DKK|1159|3093|lyfalmen|||1|100|0|25,0000|Icepharma hf|Roche A.S.|Klónazepam||1159||1159|3093||2|0|G|2|100|töflur|0 593438|N06AX2106|Duloxetin W&H|sþ-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.08.2015||R|1|0|0|G|0|WEH|0|0|0|100|XEU|7332|4540|lyfalmen|V0694|4357|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||2210||2210|4540||2|0|G|0|||0 593527|M01AH0504|Etoricoxib Krka|filmhtfl|90|mg|30|stk|1|þpakki||M01AH05|01.05.2021||R|1|0|0|G|0|KNM|0|0|1|100|IKR|2548|3907|lyfalmen|V0826|3907|2|30|0|45,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1750||1750|3907||2|0|G|0|||0 593555|N03AX1610|Pregabalin Medical Valley|hylki|75|mg|70|stk|1|þpakki||N03AX16|01.06.2019||R|1|0|0|0|0|VAL|0|0|0|100|IKR|1556|3474|lyfalmen|V0686|2546|2|70|0|17,5000|Acare ehf|Medical Valley Invest AB|Pregabalín||1436||1436|3474||2|0|E|0|||0 594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|0|0|0|G|0|MEA|0|0|1|100|DKK|17817|26021|lyfalmen|||1|12|0|32,0000|Icepharma hf|Meda AB|Tríamcínólón||17817||17817|26021||2|0|G|0|||0 594343|N02AE0104|Buprenorphine ratiopharm|forðapl|20|mcg/klst|4|stk|1|skpoki||N02AE01|01.06.2018|31.07.2021|R|0|0|0|G|0|RTH|0|0|0|100|IKR|3504|6321|lyfalmen|||2|4|0|11,2000|Alvogen|ratiopharm GmbH|Búprenorfín||2500||3504|6321||2|0|G|1|30|dagar|0 594709|C01CA1702|Midodrin Evolan|töflur|5|mg|50|stk|1|þpakki||C01CA17|01.05.2018||R|1|0|0|G|0|EVO|0|0|0|100|IKR|10293|15665|lyfalmen|V0969|10040|2|50|0|8,3333|LYFIS ehf|Evolan Pharma AB|midodrine||10293||10293|15665||2|0|G|0|||0 595176|C10AA0509|Atorvastatin Xiromed|filmhtfl|80|mg|105|stk|1|glas||C10AA05|01.08.2021||R|1|0|0|0|0|MVX|0|0|0|100|IKR|5142|8575|lyfalmen|V0115|8365|2|105|0|420,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||5142||5142|8575||2|0|E|0|||0 595198|G04BD1201|Betmiga|forðatfl|25|mg|90|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|G|0|APE|0|0|0|100|XEU|15588|22953|lyfalmen|V1031|22950|1|90|0|45,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||15588||15588|22953||1|0|G|0|||0 595364|N06BA0409|Methylphenidate STADA|hylki|20|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.10.2020||R|1|1|0|0|0|ASR|0|0|0|100|IKR|3000|4870|lyfalmen|V0959|4752|2|30|0|20,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||2450||2450|4870||2|0|E|1|30|dagar|0 595455|A10BA0205|Metformin EQL|filmhtfl|500|mg|330|stk|1|glas||A10BA02|01.07.2020||R|1|0|0|G|0|EQL|0|0|0|100|IKR|2000|4251|lyfalmen|||2|330|0|82,5000|LYFIS ehf|EQL Pharma AB|Metformín||2000||2000|4251||2|0|G|0|||0 595966|B02BD0207|ReFacto AF|sts|250|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|1|0|0|PEU|0|1|0|100|DKK|19468|28294|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur VIII||19468||19468|28294||1|0|L|0|||0 596085|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|0|RAG|0|1|0|100|DKK|48004|63989|lyfsjukr|||1|2|0|44,4400|Vistor hf|Amgen|Darbepóetín alfa||||48004|63989||1|0|L|0|||0 596223|N07BA0153|Zonnic Pepparmint|munnhúði|1|mg/úðask|40|skammtar|1|glas||N07BA01|01.11.2018||L|0|0|0|0|0|NIC|0|0|1|100|IKR|||lyflausa|||0|40|0|1,3333|LYFIS ehf|Niconovum AB|Nikótín|||||||2|0||0|||0 596523|QP52AC5501|Drontaste|töflur|344|mg|2|stk|1|þpakki|150+144+50 mg|QP52AC55|01.10.2017||R|0|0|0|0|0|VEO|0|0|0|100|DKK|1258|2168|vetorma|||0|2|0||Icepharma hf|Vetoquinol S.A.|Febantel, Pyrantelembonat,Prazikvantel||1258||1258|2168||2|0||0|||0 597167|J01DD0206|Ceftazidima Normon|sts|2|g/hgl|50|hgl|1|pakki|50 lykjur Sjúkrahússpakkning|J01DD02|01.08.2020||R|0|0|0|0|0|LNA|0|0|1|100|XEU|92511|104106|lyfalmen|||2|50|0|25,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftazidím||79722||79722|104106||2|0|0|0|||0 597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|þpakki||J01FF01|01.06.1979||R|1|0|0|0|0|PLS|0|0|1|100|DKK|1679|3809|lyfalmen|||1|24|0|3,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1679||1679|3809||1|0|E|0|||0 597433|L01XC1101|Yervoy|stþ|5|mg/ml|10|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|0|0|BMS|0|1|0|100|DKK|539724|677777|lyfsjukr|||1|10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||539724||539724|677777||1|H|L|0|||0 597488|M03BX0107|Baclofen Sintetica í mænuvökva|irl|2|mg/ml|5|ml|1|lykja||M03BX01|01.06.2021||R|1|0|1|0|0|SIN|0|0|0|100|XEU|14144|17660|lyfalmen|||2|5|0|18,1800|Williams & Halls efh|Sintetica GmbH|Baklófen||11742||11742|17660||2|0|0|0|||0 597565|L03AB1301|Plegridy|stl|125|mcg|2|áf.spr|1|pakki||L03AB13|01.07.2015||R|0|0|1|G|0|BNB|0|0|0|100|XEU|98592|127973|lyfalmen|||1|2|0|28,0900|Icepharma hf|Biogen Netherlands B.V.|Peginterferón beta-1a||98592||98592|127973||2|0|G|0|||0 597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|0|0|0|0|0|TAE|0|0|1|100|IKR|||lyflausa|||0|30|0||Alvogen|Trimb Healthcare AB|Ekónazól|||||||2|0||0|||0 598021|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.06.2014||R|1|0|0|G|0|ADI|0|0|0|100|SEK|2307|4673|lyfalmen|||1|100|0|33,3333|Abcur AB|Amdipharm Limited|Acetazólamíð||2307||2307|4673||2|0|G|0|||0 598499|M01AE0112|ibuxin rapid|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.09.2012||L|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Alvogen|ratiopharm GmbH|Íbúprófen|||||||2|0||0|||0 598859|M05BA0306|Pamidronatdinatrium Pfizer|irþ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.02.2019||R|0|1|0|0|0|PLS|0|0|0|100|DKK|5209|8668|lyfalmen|||2|10|0|1,0000|Icepharma hf|Pfizer ApS|Pamídrónsýra||5209||5209|8668||1|H|0|0|||0 598908|N07BA0106|Nicotinell|forðapl|7|mg/sólh|21|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|21|0|10,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0 598925|M01AE0114|Nurofen Apelsin|mixtúra|40|mg/ml|100|ml|1|glas||M01AE01|01.04.2013||L|0|0|0|0|0|EKI|0|0|1|100|DKK|||lyfalmen|||0|100|0|3,3333|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Íbúprófen|||||2226||1|0||0|||0 599010|L01EK0101|INLYTA|filmhtfl|5|mg|56|stk|1|þpakki||L01EK01|01.05.2013||R|1|0|1|0|0|PEU|0|1|0|100|DKK|503647|632907|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Europe MA EEIG|Axitinib||503647||503647|632907||1|0|L|0|||0 599176|L01XA0303|Oxaliplatin Actavis|irþ|5|mg/ml|20|ml|1|hgl|lausn|L01XA03|01.03.2018||R|0|0|0|0|0|ATE|0|0|0|100|XEU|7546|11884|lyfalmen|||2|20|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxalíplatín||7546||7546|11884||1|H|0|0|||0 599248|QC01CE9001|Vetmedin vet.|tuggutfl|1,25|mg|100|stk|1|þpakki|fyrir hunda|QC01CE90|01.04.2017||R|0|0|0|0|0|BIV|0|0|0|100|DKK|3606|7012|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||3606||3606|7012||1|0||0|||0 599320|QV03AB9002|Narcostop|stl|5|mg/ml|10|ml|1|hgl|fyrir hunda og ketti|QV03AB90|01.07.2013||R|0|0|0|0|0|BVL|1|0|0|100|XEU|4290|8309|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Atipamesól||4290||4290|8309||2|0||0|||0 599460|S01XA2024|Oculac án rotvarnar|augndr|50|mg/ml|0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.11.2013||L|0|0|0|G|0|CLA|0|0|0|100|XEU|||lyfalmen|||0|8|0||Vistor hf|Alcon Nordic A/S|Gervitár og aðrar óvirkar samsetningar|||||2522||1|0|G|0|||0 599462|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|G|0|JAS|0|0|0|100|SEK|28003|38692|lyfalmen|||1|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||||28003|38692||1|0|G|0|||0 599632|B01AA0303|Warfarin Teva|töflur|1|mg|100|stk|1|þpakki||B01AA03|01.01.2019||R|1|0|0|G|0|TVI|0|0|0|100|XEU|1255|3225|lyfalmen|||2|100|0|13,3333|Teva Pharma Iceland ehf|Teva B.V|Warfarín||1255||1255|3225||1|0|G|0|||0 599883|N06AX1610|Venlafaxine Bluefish|forðahlk|75|mg|100|stk|1|þpakki|hart|N06AX16|01.05.2015||R|1|0|0|G|0|BLS|0|0|0|100|XEU|3471|3671|lyfalmen|V0334|2598|2|100|0|75,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1579||1579|3671||1|0|G|0|||0 954851|V09AB0301|DaTSCAN|stl|74|MBq/ml|5|ml|1|hgl||V09AB03|01.10.2013||R|0|0|0|0|0|EAG|0|0|0|100|NOK|111682|145412|lyfalmen|||1|5|0||Icepharma hf|GE Healthcare B.V.|Lofendýlat||111682||111682|145412||2|H|0|0|||0 957657|A12BA0201|Polycítra - forskriftarlyf|mixtúra|||500|ml|1|fl|Potassium citrats 102 mg/g|A12BA02|01.04.2014||R|0|0|0|0|0|PAR|0|0|0|100|IKR|15120|22309|lyfalmen|||0|500|0|12,7500|PharmArctica ehf|PharmArctica - forskriftarlyf|potassium citrate||15120||15120|22309||2|0||0|||0 957665|A12BA0102|Kalíum Klórið - forskriftarlyf|mixtúra|33|mg/g|300|ml|1|fl|35,34 mg/ml|A12BA01|01.04.2014||R|0|0|0|0|0|PAR|0|0|0|100|IKR|3296|6035|lyfalmen|||0|300|0|3,5400|PharmArctica ehf|PharmArctica - forskriftarlyf|Kalíumklóríð||3296||3296|6035||2|0||0|||0 968365|D07CB0101|TNG-smyrsl - forskriftarlyf|smyrsli|||15|ml|1|dos||D07CB01|01.04.2014||R|0|0|0|0|0|PAR|0|0|1|100|IKR|1918|4138|lyfalmen|||0|15|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Triamcinolonum og sýklalyf||1918||1918|4138||2|0||0|||0 968373|V03AB1505|Naloxonhydrochlorid - forskriftarlyf|mixtúra|1|mg/ml|500|ml|1|fl||V03AB15|01.04.2014||R|0|0|0|0|0|PAR|0|0|1|100|IKR|18870|27471|lyfalmen|||0|500|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Naloxón||18870||18870|27471||2|0||0|||0 968406|D05AA0001|Tjara 26 / ASVEP - forskriftarlyf|smyrsli|||100|ml|1|dos||D05AA|01.04.2014||R|0|0|0|0|0|PAR|0|0|0|100|IKR|2929|5529|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tjörur||2929||2929|5529||2|0||0|||0 968414|D05AA0002|Koltjörusmyrsl - forskriftarlyf|smyrsli|||100|ml|1|dos||D05AA|01.04.2014||R|0|0|0|0|0|PAR|0|0|0|100|IKR|3650|6522|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tjörur||3650||3650|6522||2|0||0|||0 970013|A01AD1102|Magical Mouthwash - forskriftarlyf|mixtúra|||100|ml|1|fl||A01AD11|01.04.2015||R|0|0|0|0|0|PAR|0|0|1|100|IKR|4187|7261|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Ýmis lyf||4187||4187|7261||2|0||0|||0 970039|C09AA0106|Captopril mixtúra - forskriftarlyf|lausn|1|mg/ml|100|ml|1|fl||C09AA01|01.02.2017||R|0|0|0|0|0|PAR|0|0|0|100|IKR|15995|23513|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Kaptópríl||15995||15995|23513||2|0||0|||0 970063|N07BB0401|Naltrexone Hydrochloride-forskriftarlyf|lausn|1|mg/ml|100|ml|1|fl||N07BB04|01.03.2017||R|0|0|0|0|0|PAR|0|0|0|100|IKR|2095|4381|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Naltrexone||2095||2095|4381||2|0|E|0|||0 974784|A01AC0001|Clobetasol propionate - forskriftarlyf|munnskol|0,5|mg/ml|300|ml|1|fl||A01AC|01.02.2018||R|0|0|0|0|0|PAR|0|0|1|100|IKR|3375|6143|lyfalmen|||0|300|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Corticosteroids for local oral treatment||||3375|6143||2|0||0|||0 974792|C09AA0106|Captopril mixtúra - forskriftarlyf|lausn|2,5|mg/ml|100|ml|1|fl||C09AA01|01.07.2018||R|0|0|0|0|0|PAR|0|0|0|100|IKR|23568|33082|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Kaptópríl||23568||23568|33082||2|0||0|||0 974809|A01AC0002|Fluticasone propionate - forskriftarlyf|munnskol|0,1|mg/ml|300|ml|1|fl||A01AC|01.12.2018||R|0|0|0|0|0|PAR|0|0|1|100|IKR|3962|6951|lyfalmen|||0|300|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Corticosteroids for local oral treatment||||3962|6951||2|0||0|||0 974825|D07XA0103|HTH krem - forskriftarlyf|krem|||30|g|1|túpa|4%/0,025%/1%|D07XA01|01.06.2019||R|0|0|0|0|0|PAR|0|0|1|100|IKR|3475|6281|lyfalmen|||0|30|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Hydrocortisone||3475||3475|6281||2|0|0|0|||0 974841|D10AD0104|Tretinoin - forskriftarlyf|krem|0,05|%|30|g|1|túpa||D10AD01|01.01.2020||R|0|0|0|0|0|PAR|0|0|0|100|IKR|2979|5598|lyfalmen|||0|30|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tretínóín||2979||2979|5598||2|0|0|0|||0 980005|C07AA0513|Propranolol hydrochloride-forskriftarlyf|mixtúra|2|mg/ml|100|ml|1|fl||C07AA05|01.12.2014||R|0|0|0|0|0|PAR|0|0|0|100|IKR|5245|8717|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Própranólól||5245||5245|8717||2|0||0|||0 980071|D07AD0102|Clobetazol in Dermazink - forskriftarlyf|lausn|50|mg|120|ml|1|fl||D07AD01|01.02.2017||R|0|0|0|0|0|PAR|0|0|1|100|IKR|16998|24894|lyfalmen|||0|120|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Klóbetasól||16998||16998|24894||2|0||0|||0 985145|A07EA0102|Prednisolon - forskriftarlyf|eþ-stíll|10|mg|10|stk|1|pakki||A07EA01|01.01.2021||R|0|0|0|0|0|PAR|0|0|0|100|IKR|9369|14393|lyfalmen|||0|10|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Prednisolone||9369||9369|14393||2|0|0|0|||0 985153|A07EA0102|Prednisolon - forskriftarlyf|eþ-stíll|20|mg|10|stk|1|pakki||A07EA01|01.01.2021||R|0|0|0|0|0|PAR|0|0|0|100|IKR|10090|15386|lyfalmen|||0|10|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Prednisolone||10090||10090|15386||2|0|0|0|||0 985161|D10AD0104|Tretinoin - forskriftarlyf|krem|0,1|%|30|g|1|túpa||D10AD01|01.07.2021||R|0|0|0|0|0|PAR|0|0|0|100|IKR|3292|6029|lyfalmen|||0|30|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tretínóín||3292||3292|6029||2|0|0|0|||0